Citrus Sinensis ID: 022206
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 301 | 2.2.26 [Sep-21-2011] | |||||||
| Q41328 | 354 | Pto-interacting protein 1 | N/A | no | 0.960 | 0.816 | 0.813 | 1e-140 | |
| O80719 | 365 | Probable receptor-like pr | no | no | 0.950 | 0.783 | 0.727 | 1e-120 | |
| O49339 | 366 | PTI1-like tyrosine-protei | no | no | 0.797 | 0.655 | 0.756 | 1e-106 | |
| Q8H1G6 | 361 | PTI1-like tyrosine-protei | no | no | 0.797 | 0.664 | 0.747 | 1e-105 | |
| B9DFG5 | 408 | PTI1-like tyrosine-protei | no | no | 0.794 | 0.585 | 0.738 | 1e-104 | |
| P93749 | 365 | Probable protein kinase A | no | no | 0.933 | 0.769 | 0.600 | 1e-96 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.757 | 0.306 | 0.495 | 1e-60 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.750 | 0.319 | 0.508 | 5e-60 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.946 | 0.625 | 0.441 | 2e-59 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.754 | 0.315 | 0.495 | 6e-59 |
| >sp|Q41328|PTI1_SOLLC Pto-interacting protein 1 OS=Solanum lycopersicum GN=PTI1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 498 bits (1281), Expect = e-140, Method: Compositional matrix adjust.
Identities = 235/289 (81%), Positives = 264/289 (91%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCF CC++DD+ +A+ NGPF+ +N AGN GG E+ +E +TV +QPIAVP I+VDE
Sbjct: 1 MSCFSCCDDDDMHRATDNGPFMAHNSAGNNGGQRATESAQRETQTVNIQPIAVPSIAVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
LK+ TDNFG+ +LIGEGSYGRVY GVL+SGRAAAIKKLDSSKQPD+EFLAQVSMVSRLK+
Sbjct: 61 LKDITDNFGSKALIGEGSYGRVYHGVLKSGRAAAIKKLDSSKQPDREFLAQVSMVSRLKD 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
ENVVEL+GY VDG RVLAYE+A GSLHDILHG+KGVKGA+PGPVLSWAQRVKIAVGAA
Sbjct: 121 ENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWAQRVKIAVGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GLEYLHEKA+P IIHR+IKSSN+LLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTFG
Sbjct: 181 KGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 240
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
YHAPEYAMTGQ+SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 241 YHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
|
A serine-threonine kinase involved in the hypersensitive response (HR)-mediated signaling cascade. Solanum lycopersicum (taxid: 4081) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O80719|Y2706_ARATH Probable receptor-like protein kinase At2g47060 OS=Arabidopsis thaliana GN=At2g47060 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 432 bits (1111), Expect = e-120, Method: Compositional matrix adjust.
Identities = 216/297 (72%), Positives = 244/297 (82%), Gaps = 11/297 (3%)
Query: 1 MSCFGCC-EEDDIRKASKNG-------PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIA 52
MSCFGCC E+DD+ K + G F P N A + E K V +QPI
Sbjct: 1 MSCFGCCGEDDDMHKTADYGGRHNQAKHFPPGNDARH---HQASETAQKGPPVVKLQPIE 57
Query: 53 VPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQV 112
VP+I ELKE TD+FG+NSLIGEGSYGRVY+GVL + +AIKKLDS+KQPD EFLAQV
Sbjct: 58 VPIIPFSELKEATDDFGSNSLIGEGSYGRVYYGVLNNDLPSAIKKLDSNKQPDNEFLAQV 117
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
SMVSRLK++N V+L+GY VDG R+L+YE A+ GSLHDILHG+KGVKGA+PGPVLSW QR
Sbjct: 118 SMVSRLKHDNFVQLLGYCVDGNSRILSYEFANNGSLHDILHGRKGVKGAQPGPVLSWYQR 177
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
VKIAVGAARGLEYLHEKA P IIHR+IKSSNVLLF+DD+AKI+DFDLSNQAPD AARLHS
Sbjct: 178 VKIAVGAARGLEYLHEKANPHIIHRDIKSSNVLLFEDDVAKIADFDLSNQAPDMAARLHS 237
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
TRVLGTFGYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDH LPRGQQSLVTW
Sbjct: 238 TRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHRLPRGQQSLVTW 294
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49339|PTI12_ARATH PTI1-like tyrosine-protein kinase 2 OS=Arabidopsis thaliana GN=PTI12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 383 bits (983), Expect = e-106, Method: Compositional matrix adjust.
Identities = 183/242 (75%), Positives = 211/242 (87%), Gaps = 2/242 (0%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQ--E 107
PI VP +SVDE+KEKTDNFG+ SLIGEGSYGRVY+ L G+A A+KKLD + + + E
Sbjct: 53 PIEVPPLSVDEVKEKTDNFGSKSLIGEGSYGRVYYATLNDGKAVALKKLDVAPEAETNTE 112
Query: 108 FLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVL 167
FL QVSMVSRLK+EN+++LVGY VD LRVLAYE A+ GSLHDILHG+KGV+GA+PGP L
Sbjct: 113 FLNQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTL 172
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
W RVKIAV AARGLEYLHEK +P +IHR+I+SSNVLLF+D AK++DF+LSNQAPD A
Sbjct: 173 DWLTRVKIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKVADFNLSNQAPDNA 232
Query: 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
ARLHSTRVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLV
Sbjct: 233 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 292
Query: 288 TW 289
TW
Sbjct: 293 TW 294
|
Probable tyrosine-protein kinase involved in oxidative burst-mediated signaling leading to specific genes expression. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q8H1G6|PTI11_ARATH PTI1-like tyrosine-protein kinase 1 OS=Arabidopsis thaliana GN=PTI11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 381 bits (979), Expect = e-105, Method: Compositional matrix adjust.
Identities = 181/242 (74%), Positives = 213/242 (88%), Gaps = 2/242 (0%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS--KQPDQE 107
PI VP +S+DE+KEKT+NFG+ +LIGEGSYGRVY+ L G A A+KKLD + + D E
Sbjct: 50 PIEVPPLSLDEVKEKTENFGSKALIGEGSYGRVYYATLNDGVAVALKKLDVAPEAETDTE 109
Query: 108 FLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVL 167
FL+QVSMVSRLK+EN+++L+G+ VDG LRVLAYE A+ GSLHDILHG+KGV+GA+PGP L
Sbjct: 110 FLSQVSMVSRLKHENLIQLLGFCVDGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTL 169
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
W RVKIAV AARGLEYLHEK++P +IHR+I+SSNVLLF+D AKI+DF+LSNQAPD A
Sbjct: 170 DWITRVKIAVEAARGLEYLHEKSQPPVIHRDIRSSNVLLFEDYKAKIADFNLSNQAPDNA 229
Query: 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
ARLHSTRVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLV
Sbjct: 230 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 289
Query: 288 TW 289
TW
Sbjct: 290 TW 291
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|B9DFG5|PTI13_ARATH PTI1-like tyrosine-protein kinase 3 OS=Arabidopsis thaliana GN=PTI13 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 379 bits (972), Expect = e-104, Method: Compositional matrix adjust.
Identities = 178/241 (73%), Positives = 210/241 (87%), Gaps = 2/241 (0%)
Query: 51 IAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQ--EF 108
I VP +S+DELKEKTDNFG+ SLIGEGSYGR Y+ L+ G+A A+KKLD++ +P+ EF
Sbjct: 96 IDVPALSLDELKEKTDNFGSKSLIGEGSYGRAYYATLKDGKAVAVKKLDNAAEPESNVEF 155
Query: 109 LAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS 168
L QVS VS+LK++N VEL GY V+G R+LAYE A+ GSLHDILHG+KGV+GA+PGP L
Sbjct: 156 LTQVSRVSKLKHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLD 215
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
W QRV+IAV AARGLEYLHEK +P +IHR+I+SSNVLLF+D AKI+DF+LSNQ+PD AA
Sbjct: 216 WIQRVRIAVDAARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAA 275
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVT 288
RLHSTRVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVT
Sbjct: 276 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 335
Query: 289 W 289
W
Sbjct: 336 W 336
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P93749|Y2197_ARATH Probable protein kinase At2g41970 OS=Arabidopsis thaliana GN=At2g41970 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 353 bits (905), Expect = 1e-96, Method: Compositional matrix adjust.
Identities = 182/303 (60%), Positives = 229/303 (75%), Gaps = 22/303 (7%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNP--GGFYVKE----------APAKEMKTVTV 48
M C G +E+ + N P N AGNP GG E APAK V
Sbjct: 1 MFCCGGADEEPAGPPA-NQYAAPPNKAGNPNFGGGNRGEPRNPNAPRSGAPAK------V 53
Query: 49 QPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLD--SSKQPDQ 106
PI +P +++DEL NFG +LIGEGSYGRV+ G + G A AIKKLD SS++PD
Sbjct: 54 LPIEIPSVALDELNRMAGNFGNKALIGEGSYGRVFCGKFK-GEAVAIKKLDASSSEEPDS 112
Query: 107 EFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV 166
+F +Q+S+VSRLK+++ VEL+GY ++ R+L Y+ A+KGSLHD+LHG+KGV+GA+PGPV
Sbjct: 113 DFTSQLSVVSRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGVQGAEPGPV 172
Query: 167 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226
L+W QRVKIA GAA+GLE+LHEK +P I+HR+++SSNVLLFDD +AK++DF+L+N + D
Sbjct: 173 LNWNQRVKIAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFNLTNASSDT 232
Query: 227 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286
AARLHSTRVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+P+GQQSL
Sbjct: 233 AARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSL 292
Query: 287 VTW 289
VTW
Sbjct: 293 VTW 295
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 233 bits (594), Expect = 1e-60, Method: Compositional matrix adjust.
Identities = 119/240 (49%), Positives = 161/240 (67%), Gaps = 12/240 (5%)
Query: 51 IAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-DQEFL 109
++V ++ EL++ TD F ++GEG +GRVY G + G A+K L Q D+EF+
Sbjct: 332 LSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFI 391
Query: 110 AQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 169
A+V M+SRL + N+V+L+G ++G R L YE GS+ LH L W
Sbjct: 392 AEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHEG----------TLDW 441
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229
R+KIA+GAARGL YLHE + PR+IHR+ K+SNVLL DD K+SDF L+ +A + +
Sbjct: 442 DARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQH 501
Query: 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
+ STRV+GTFGY APEYAMTG + KSDVYS+GVVLLELLTGR+PVD + P G+++LVTW
Sbjct: 502 I-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTW 560
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 231 bits (589), Expect = 5e-60, Method: Compositional matrix adjust.
Identities = 120/236 (50%), Positives = 162/236 (68%), Gaps = 10/236 (4%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLD-SSKQPDQEFLAQVS 113
+ S +EL + T+ F +L+GEG +G VY G+L GR A+K+L Q D+EF A+V
Sbjct: 364 LFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVE 423
Query: 114 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 173
+SR+ + ++V +VG+ + G R+L Y++ S L+ LHG+K V L WA RV
Sbjct: 424 TLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGEKSV--------LDWATRV 475
Query: 174 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 233
KIA GAARGL YLHE PRIIHR+IKSSN+LL D+ A++SDF L+ A D + +T
Sbjct: 476 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHI-TT 534
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
RV+GTFGY APEYA +G+++ KSDV+SFGVVLLEL+TGRKPVD + P G +SLV W
Sbjct: 535 RVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEW 590
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 229 bits (584), Expect = 2e-59, Method: Compositional matrix adjust.
Identities = 137/310 (44%), Positives = 181/310 (58%), Gaps = 25/310 (8%)
Query: 1 MSCFGCCEEDDIRKAS-----------KNGPFVPNNPAGNP-GGFYVKEAPAKEMKTVTV 48
M CF C + D K + ++ P V NN +G P GG + K +
Sbjct: 1 MGCFSCFDSSDDEKLNPVDESNHGQKKQSQPTVSNNISGLPSGGEKLSSKTNGGSKRELL 60
Query: 49 QP------IAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSS 101
P IA + EL T NF ++ +GEG +GRVY G L S G+ A+K+LD +
Sbjct: 61 LPRDGLGQIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRN 120
Query: 102 K-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG 160
Q ++EFL +V M+S L + N+V L+GY DG R+L YE GSL D LH K
Sbjct: 121 GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE 180
Query: 161 AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A L W R+KIA GAA+GLE+LH+KA P +I+R+ KSSN+LL + K+SDF L+
Sbjct: 181 A-----LDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLA 235
Query: 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280
P STRV+GT+GY APEYAMTGQ++ KSDVYSFGVV LEL+TGRK +D +P
Sbjct: 236 KLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMP 295
Query: 281 RGQQSLVTWV 290
G+Q+LV W
Sbjct: 296 HGEQNLVAWA 305
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 228 bits (580), Expect = 6e-59, Method: Compositional matrix adjust.
Identities = 117/236 (49%), Positives = 166/236 (70%), Gaps = 9/236 (3%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDS-SKQPDQEFLAQVSM 114
S +EL E T F +++GEG +G VY G L+ G+ A+K+L + S Q D+EF A+V +
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEI 418
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
+SR+ + ++V LVGY + R+L YE+ S +L LHGK G+ PVL W++RV+
Sbjct: 419 ISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGK-GL------PVLEWSKRVR 471
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
IA+G+A+GL YLHE P+IIHR+IKS+N+LL D+ A+++DF L+ + D STR
Sbjct: 472 IAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLA-RLNDTTQTHVSTR 530
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWV 290
V+GTFGY APEYA +G+++ +SDV+SFGVVLLEL+TGRKPVD T P G++SLV W
Sbjct: 531 VMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWA 586
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 301 | ||||||
| 170676254 | 354 | Pto kinase interactor 1 [Capsicum annuum | 0.960 | 0.816 | 0.820 | 1e-139 | |
| 350537875 | 354 | pto-interacting protein 1 [Solanum lycop | 0.960 | 0.816 | 0.813 | 1e-138 | |
| 225432163 | 360 | PREDICTED: pto-interacting protein 1 [Vi | 0.960 | 0.802 | 0.824 | 1e-137 | |
| 357442089 | 476 | Pto kinase interactor [Medicago truncatu | 0.960 | 0.607 | 0.789 | 1e-134 | |
| 357442087 | 361 | Pto kinase interactor [Medicago truncatu | 0.960 | 0.800 | 0.789 | 1e-134 | |
| 1586940 | 370 | Ser/Thr kinase | 0.943 | 0.767 | 0.802 | 1e-134 | |
| 255548287 | 362 | Serine/threonine-protein kinase PBS1, pu | 0.960 | 0.798 | 0.793 | 1e-133 | |
| 225437716 | 362 | PREDICTED: pto-interacting protein 1 [Vi | 0.960 | 0.798 | 0.793 | 1e-133 | |
| 224130874 | 362 | predicted protein [Populus trichocarpa] | 0.960 | 0.798 | 0.786 | 1e-132 | |
| 359811321 | 361 | pto-interacting protein 1-like [Glycine | 0.960 | 0.800 | 0.782 | 1e-132 |
| >gi|170676254|gb|ACB30366.1| Pto kinase interactor 1 [Capsicum annuum] | Back alignment and taxonomy information |
|---|
Score = 501 bits (1289), Expect = e-139, Method: Compositional matrix adjust.
Identities = 237/289 (82%), Positives = 264/289 (91%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCF CCE+DD+ +AS NGPF+ +N AGN GG + E+ KE +TV +QPIAVP I+VDE
Sbjct: 1 MSCFSCCEDDDMNRASDNGPFMAHNSAGNNGGLHATESAQKEPQTVNIQPIAVPSIAVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
LK+ TDNFG+ +LIGEGSYGRVY GVL+SGRAAAIKKLDSSKQPD+EFLAQVSMVSRLK+
Sbjct: 61 LKDITDNFGSKALIGEGSYGRVYHGVLKSGRAAAIKKLDSSKQPDREFLAQVSMVSRLKD 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
ENVVEL+GY VDG RVLAYE+A GSLHDILHG+KGVKGA+PGPVLSW QRVKIAVGAA
Sbjct: 121 ENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWVQRVKIAVGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GLEYLHEKA+P IIHR+IKSSN+LLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTFG
Sbjct: 181 KGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 240
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
YHAPEYAMTGQ+SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 241 YHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
|
Source: Capsicum annuum Species: Capsicum annuum Genus: Capsicum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350537875|ref|NP_001233803.1| pto-interacting protein 1 [Solanum lycopersicum] gi|75319610|sp|Q41328.2|PTI1_SOLLC RecName: Full=Pto-interacting protein 1; Short=Pti1; AltName: Full=Pto kinase interactor 1 gi|3668069|gb|AAC61805.1| Pto kinase interactor 1 [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 498 bits (1281), Expect = e-138, Method: Compositional matrix adjust.
Identities = 235/289 (81%), Positives = 264/289 (91%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCF CC++DD+ +A+ NGPF+ +N AGN GG E+ +E +TV +QPIAVP I+VDE
Sbjct: 1 MSCFSCCDDDDMHRATDNGPFMAHNSAGNNGGQRATESAQRETQTVNIQPIAVPSIAVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
LK+ TDNFG+ +LIGEGSYGRVY GVL+SGRAAAIKKLDSSKQPD+EFLAQVSMVSRLK+
Sbjct: 61 LKDITDNFGSKALIGEGSYGRVYHGVLKSGRAAAIKKLDSSKQPDREFLAQVSMVSRLKD 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
ENVVEL+GY VDG RVLAYE+A GSLHDILHG+KGVKGA+PGPVLSWAQRVKIAVGAA
Sbjct: 121 ENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWAQRVKIAVGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GLEYLHEKA+P IIHR+IKSSN+LLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTFG
Sbjct: 181 KGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 240
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
YHAPEYAMTGQ+SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 241 YHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225432163|ref|XP_002267003.1| PREDICTED: pto-interacting protein 1 [Vitis vinifera] gi|297736804|emb|CBI26005.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 494 bits (1271), Expect = e-137, Method: Compositional matrix adjust.
Identities = 240/291 (82%), Positives = 264/291 (90%), Gaps = 2/291 (0%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPA-GNPGGFYVKEAP-AKEMKTVTVQPIAVPVISV 58
MSCF CCEEDDI KAS GP+V NN A G+ G +++ EA + + +TV V PIAV ISV
Sbjct: 1 MSCFSCCEEDDIHKASDTGPYVANNSAVGHNGNYHMTEASRSNDTQTVDVLPIAVSAISV 60
Query: 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL 118
DELKE TDNFG +LIGEGSYGRVY G+L++G+AAAIKKLDSSKQPDQEFLAQVSMVSRL
Sbjct: 61 DELKEITDNFGQQALIGEGSYGRVYHGLLKTGQAAAIKKLDSSKQPDQEFLAQVSMVSRL 120
Query: 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
KNENVVELVGY VDG LRV+AYE+AS GSLHDILHG+KGVKGA+PGPVLSW+QRVKIAVG
Sbjct: 121 KNENVVELVGYSVDGGLRVVAYEYASNGSLHDILHGRKGVKGAQPGPVLSWSQRVKIAVG 180
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
AA+GLEYLHEKA P IIHR+IKSSNVLLFDDD+AKI+DFDLSNQAPD+AARLHSTRVLGT
Sbjct: 181 AAKGLEYLHEKARPHIIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDSAARLHSTRVLGT 240
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
FGYHAPEYAMTGQ+SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 241 FGYHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 291
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357442089|ref|XP_003591322.1| Pto kinase interactor [Medicago truncatula] gi|355480370|gb|AES61573.1| Pto kinase interactor [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 484 bits (1246), Expect = e-134, Method: Compositional matrix adjust.
Identities = 229/290 (78%), Positives = 261/290 (90%), Gaps = 1/290 (0%)
Query: 1 MSCFGCCEEDDIRKASKNG-PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCCEED+ KA+++G P+V NPAGN G ++ + + +TV VQPI VP I D
Sbjct: 116 MSCFGCCEEDEFHKAAESGGPYVVKNPAGNDGNYHASDTAKQGAQTVKVQPIEVPEIQAD 175
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
ELKE TDNFG +SLIGEGSYGRVY+GVL+SG+AAAIKKLD+SKQPD+EFLAQVSMVSRLK
Sbjct: 176 ELKEVTDNFGQDSLIGEGSYGRVYYGVLKSGQAAAIKKLDASKQPDEEFLAQVSMVSRLK 235
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++N V+L+GY VDG R+LAYE AS GSLHDILHG+KGVKGA+PGPVL+WAQRVKIAVGA
Sbjct: 236 HDNFVQLLGYCVDGNSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRVKIAVGA 295
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGLEYLHEKA+P IIHR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 296 ARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 355
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
GYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 356 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 405
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357442087|ref|XP_003591321.1| Pto kinase interactor [Medicago truncatula] gi|355480369|gb|AES61572.1| Pto kinase interactor [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 483 bits (1244), Expect = e-134, Method: Compositional matrix adjust.
Identities = 229/290 (78%), Positives = 261/290 (90%), Gaps = 1/290 (0%)
Query: 1 MSCFGCCEEDDIRKASKNG-PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCCEED+ KA+++G P+V NPAGN G ++ + + +TV VQPI VP I D
Sbjct: 1 MSCFGCCEEDEFHKAAESGGPYVVKNPAGNDGNYHASDTAKQGAQTVKVQPIEVPEIQAD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
ELKE TDNFG +SLIGEGSYGRVY+GVL+SG+AAAIKKLD+SKQPD+EFLAQVSMVSRLK
Sbjct: 61 ELKEVTDNFGQDSLIGEGSYGRVYYGVLKSGQAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++N V+L+GY VDG R+LAYE AS GSLHDILHG+KGVKGA+PGPVL+WAQRVKIAVGA
Sbjct: 121 HDNFVQLLGYCVDGNSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGLEYLHEKA+P IIHR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
GYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|1586940|prf||2205248A Ser/Thr kinase | Back alignment and taxonomy information |
|---|
Score = 483 bits (1243), Expect = e-134, Method: Compositional matrix adjust.
Identities = 228/284 (80%), Positives = 258/284 (90%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCF CC++DD+ +A+ NGPF+ +N AGN GG E+ +E +TV +QPIAVP I+VDE
Sbjct: 1 MSCFSCCDDDDMHRATDNGPFMAHNSAGNNGGQRATESAQRETQTVNIQPIAVPSIAVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
LK+ TDNFG+ +LIGEGSYGRVY GVL+SGRAAAIKKLDSSKQPD+EFLAQVSMVSRLK+
Sbjct: 61 LKDITDNFGSKALIGEGSYGRVYHGVLKSGRAAAIKKLDSSKQPDREFLAQVSMVSRLKD 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
ENVVEL+GY VDG RVLAYE+A GSLHDILHG+KGVKGA+PGPVLSWAQRVKIAVGAA
Sbjct: 121 ENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWAQRVKIAVGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GLEYLHEKA+P IIHR+IKSSN+LLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTFG
Sbjct: 181 KGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTFG 240
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284
YHAPEYAMTGQ+SSKSDVYSFGVVLLELLTGRKPVDHTLPRG +
Sbjct: 241 YHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGNR 284
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255548287|ref|XP_002515200.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223545680|gb|EEF47184.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 480 bits (1236), Expect = e-133, Method: Compositional matrix adjust.
Identities = 230/290 (79%), Positives = 259/290 (89%), Gaps = 1/290 (0%)
Query: 1 MSCFGCCEEDDIRKASKNG-PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCCEEDD+ KA+ +G P+ + AGN GG++ E + + V +QPI VP ISVD
Sbjct: 1 MSCFGCCEEDDMHKAADSGGPYPVKSSAGNVGGYHASETAPRGAQAVKIQPIEVPSISVD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
ELKE TDNFG NSLIGEGSYGRVY+G+L+SG+AAAIKKLD+SKQPD EFLAQVSMVSRLK
Sbjct: 61 ELKEVTDNFGINSLIGEGSYGRVYYGILKSGQAAAIKKLDASKQPDDEFLAQVSMVSRLK 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+EN V+L+GY VDG RVLAYE AS GSLHDILHG+KGVKGA+PGPVLSW QRVKIAVGA
Sbjct: 121 HENFVQLLGYCVDGNSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLSWQQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A+GLEYLHEKA+P IIHR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 AKGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
GYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225437716|ref|XP_002280340.1| PREDICTED: pto-interacting protein 1 [Vitis vinifera] gi|297744052|emb|CBI37022.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 480 bits (1235), Expect = e-133, Method: Compositional matrix adjust.
Identities = 230/290 (79%), Positives = 259/290 (89%), Gaps = 1/290 (0%)
Query: 1 MSCFGCCEEDDIRKASKNG-PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCCE+DDI A ++G PF NPAGN GG+ + K + V VQPIAVP I D
Sbjct: 1 MSCFGCCEDDDIHTAPESGNPFAAKNPAGNDGGYRHTDPAPKGTQAVKVQPIAVPPIPFD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
ELKE TDNFGT++LIGEGSYGRVY+G+L++G+AAAIKKLD+SKQPD+EFLAQVSMVSRLK
Sbjct: 61 ELKEITDNFGTSALIGEGSYGRVYYGLLKNGQAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++N VEL+GY VDG R+LAYE AS GSLHDILHG+KGVKGA+PGP+LSWAQRVKIAVGA
Sbjct: 121 HDNFVELIGYCVDGGSRILAYEFASNGSLHDILHGRKGVKGAQPGPILSWAQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGL+YLHEKA P IIHR+IKSSNVLLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 ARGLDYLHEKASPHIIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
GYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224130874|ref|XP_002320946.1| predicted protein [Populus trichocarpa] gi|222861719|gb|EEE99261.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 476 bits (1225), Expect = e-132, Method: Compositional matrix adjust.
Identities = 228/290 (78%), Positives = 259/290 (89%), Gaps = 1/290 (0%)
Query: 1 MSCFGCCEEDDIRKASKNG-PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCCEEDD++KA+ NG P+ + AG+ G ++ E + + V +QPI VP ISVD
Sbjct: 1 MSCFGCCEEDDVQKAADNGGPYAVKSSAGHVGNYHASETAPRGPQAVKIQPIEVPAISVD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
ELKE T NFGT+SLIGEGSYGRVY+GVL+S +AAAIKKLD+SKQPD EFLAQVSMVSRLK
Sbjct: 61 ELKEVTVNFGTDSLIGEGSYGRVYYGVLKSEQAAAIKKLDASKQPDDEFLAQVSMVSRLK 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+EN V+L+GY VDG RVLAYE AS GSLHDILHG+KGVKGA+PGPVL+W QRVKIAVGA
Sbjct: 121 HENFVQLLGYCVDGGSRVLAYEFASNGSLHDILHGRKGVKGAQPGPVLTWPQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A+GLEYLHEKA+PRIIHR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 AKGLEYLHEKADPRIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
GYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359811321|ref|NP_001241285.1| pto-interacting protein 1-like [Glycine max] gi|223452480|gb|ACM89567.1| serine/threonine protein kinase [Glycine max] gi|255639418|gb|ACU20004.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 475 bits (1223), Expect = e-132, Method: Compositional matrix adjust.
Identities = 227/290 (78%), Positives = 257/290 (88%), Gaps = 1/290 (0%)
Query: 1 MSCFGCCEEDDIRKASKNG-PFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCF CCEEDD+ KA+++G P+V NPAGN G + E + + V QPI VP IS D
Sbjct: 1 MSCFSCCEEDDLHKAAESGGPYVVKNPAGNDGNYLASETAKQGTQPVKPQPIEVPNISAD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
ELKE TDNFG ++LIGEGSYGRVY+GVL+S AAAIKKLD+SKQPD+EFLAQVSMVSRLK
Sbjct: 61 ELKEVTDNFGQDALIGEGSYGRVYYGVLKSELAAAIKKLDASKQPDEEFLAQVSMVSRLK 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+EN V+L+GY +DG R+LAYE AS GSLHDILHG+KGVKGA+PGPVL+WAQRVKIAVGA
Sbjct: 121 HENFVQLLGYCIDGSSRILAYEFASNGSLHDILHGRKGVKGAQPGPVLTWAQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGLEYLHEKA+P IIHR+IKSSNVL+FDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKADPHIIHRDIKSSNVLIFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
GYHAPEYAMTGQ+++KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 241 GYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 301 | ||||||
| TAIR|locus:2088990 | 364 | AT3G17410 [Arabidopsis thalian | 0.960 | 0.793 | 0.720 | 1.6e-109 | |
| TAIR|locus:2023767 | 363 | AT1G48210 [Arabidopsis thalian | 0.960 | 0.796 | 0.716 | 2.1e-109 | |
| TAIR|locus:2098083 | 361 | AT3G62220 [Arabidopsis thalian | 0.960 | 0.800 | 0.703 | 6e-103 | |
| TAIR|locus:2023752 | 364 | AT1G48220 [Arabidopsis thalian | 0.960 | 0.793 | 0.613 | 8.1e-92 | |
| TAIR|locus:2009115 | 361 | AT1G06700 [Arabidopsis thalian | 0.840 | 0.700 | 0.693 | 1.6e-88 | |
| TAIR|locus:2054502 | 366 | AT2G30740 [Arabidopsis thalian | 0.797 | 0.655 | 0.719 | 2e-88 | |
| TAIR|locus:2081277 | 408 | AT3G59350 [Arabidopsis thalian | 0.946 | 0.698 | 0.608 | 2e-88 | |
| TAIR|locus:2054492 | 338 | AT2G30730 [Arabidopsis thalian | 0.840 | 0.748 | 0.662 | 5.4e-86 | |
| TAIR|locus:2064557 | 365 | AT2G41970 [Arabidopsis thalian | 0.950 | 0.783 | 0.570 | 3.6e-82 | |
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.780 | 0.324 | 0.522 | 9.3e-59 |
| TAIR|locus:2088990 AT3G17410 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1082 (385.9 bits), Expect = 1.6e-109, P = 1.6e-109
Identities = 209/290 (72%), Positives = 238/290 (82%)
Query: 1 MSCFGCCEE-DDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
M CFGCC +D R+ S+ GP +N G GG + + P K + + +QPI+V I D
Sbjct: 1 MGCFGCCGGGEDFRRVSETGPKPVHNTGGYNGGHHQRADPPKNLPVIQMQPISVAAIPAD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
EL++ TDN+G+ SLIGEGSYGRV++G+L+SG+AAAIKKLDSSKQPDQEFLAQVSMVSRL+
Sbjct: 61 ELRDITDNYGSKSLIGEGSYGRVFYGILKSGKAAAIKKLDSSKQPDQEFLAQVSMVSRLR 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRVKIAVGA 179
ENVV L+GY VDGPLRVLAYE+A GSLHDILH LSW QRVKIAVGA
Sbjct: 121 QENVVALLGYCVDGPLRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWHQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGLEYLHEKA P +IHR+IKSSNVLLFDDD+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKANPHVIHRDIKSSNVLLFDDDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
GYHAPEYAMTG +S+KSDVYSFGVVLLELLTGRKPVDHTLPRGQQS+VTW
Sbjct: 241 GYHAPEYAMTGTLSTKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSVVTW 290
|
|
| TAIR|locus:2023767 AT1G48210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1081 (385.6 bits), Expect = 2.1e-109, P = 2.1e-109
Identities = 207/289 (71%), Positives = 236/289 (81%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCFG C +D R A+ GP +NPAG GG Y + P + +QPI+VP I VDE
Sbjct: 1 MSCFGWCGSEDFRNATDTGPRPAHNPAGYNGGHYQRADPPMNQPVIPMQPISVPAIPVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
L++ TDN+G+ +LIGEGSYGRV++GVL+SG AAAIKKLDSSKQPDQEFL+Q+SMVSRL++
Sbjct: 61 LRDITDNYGSKTLIGEGSYGRVFYGVLKSGGAAAIKKLDSSKQPDQEFLSQISMVSRLRH 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRVKIAVGAA 180
+NV L+GY VDGPLRVLAYE A KGSLHD LH ++W QRVKIAVGAA
Sbjct: 121 DNVTALMGYCVDGPLRVLAYEFAPKGSLHDTLHGKKGAKGALRGPVMTWQQRVKIAVGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
RGLEYLHEK P++IHR+IKSSNVLLFDDD+AKI DFDLS+QAPD AARLHSTRVLGTFG
Sbjct: 181 RGLEYLHEKVSPQVIHRDIKSSNVLLFDDDVAKIGDFDLSDQAPDMAARLHSTRVLGTFG 240
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
YHAPEYAMTG +SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 241 YHAPEYAMTGTLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
|
|
| TAIR|locus:2098083 AT3G62220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1020 (364.1 bits), Expect = 6.0e-103, P = 6.0e-103
Identities = 204/290 (70%), Positives = 229/290 (78%)
Query: 1 MSCFGCCEEDDIRKASKNGPF-VPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVD 59
MSCFGCC EDD+ A+ G + GN G E K ++V VQPI V I D
Sbjct: 1 MSCFGCCREDDLPGANDYGGHNMTKQSGGNDGRRNGSETAQKGAQSVKVQPIEVAAILAD 60
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
EL E T++FGTNSLIGEGSY RVY GVL++G+ AAIKKLDS+KQP++EFLAQVSMVSRLK
Sbjct: 61 ELIEATNDFGTNSLIGEGSYARVYHGVLKNGQRAAIKKLDSNKQPNEEFLAQVSMVSRLK 120
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRVKIAVGA 179
+ N VEL+GY VDG R+L +E A GSLHDILH LSW QRVKIAVGA
Sbjct: 121 HVNFVELLGYSVDGNSRILVFEFAQNGSLHDILHGRKGVKGAKPGPLLSWHQRVKIAVGA 180
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARGLEYLHEKA P +IHR+IKSSNVL+FD+D+AKI+DFDLSNQAPD AARLHSTRVLGTF
Sbjct: 181 ARGLEYLHEKANPHVIHRDIKSSNVLIFDNDVAKIADFDLSNQAPDMAARLHSTRVLGTF 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
GYHAPEYAMTGQ+S+KSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW
Sbjct: 241 GYHAPEYAMTGQLSAKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 290
|
|
| TAIR|locus:2023752 AT1G48220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 915 (327.2 bits), Expect = 8.1e-92, P = 8.1e-92
Identities = 178/290 (61%), Positives = 220/290 (75%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE 60
MSCFG C +D+R + GP +N G G + + P V +QPIAVP I VDE
Sbjct: 1 MSCFGWCGSEDVRNPADTGPSQAHNSIGYNGRHHQRADPPMNQPVVNMQPIAVPAIPVDE 60
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
L++ T+NF + L+G+GSYGRV++GVL+SG+ AAIKKL +KQPDQEFL+QVSMVSRL +
Sbjct: 61 LEDITENFSSEVLVGKGSYGRVFYGVLKSGKEAAIKKLYPTKQPDQEFLSQVSMVSRLHH 120
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRVKIAVGAA 180
ENVV L+ Y VDGPLRVLAYE A+ G+LHD+LH ++W +RVKIA+GAA
Sbjct: 121 ENVVALMAYCVDGPLRVLAYEFATYGTLHDVLHGQTGVIGALQGPVMTWQRRVKIALGAA 180
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV-LGTF 239
RGLEYLH+K P++IHR+IK+SN+LLFDDDIAKI DFDL +QAP+ A RLHS R+ LG
Sbjct: 181 RGLEYLHKKVNPQVIHRDIKASNILLFDDDIAKIGDFDLYDQAPNMAGRLHSCRMALGAS 240
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
H PE+AMTG +++KSDVYSFGVVLLELLTGRKPVD TLPRGQQ+LVTW
Sbjct: 241 RSHCPEHAMTGILTTKSDVYSFGVVLLELLTGRKPVDRTLPRGQQNLVTW 290
|
|
| TAIR|locus:2009115 AT1G06700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 884 (316.2 bits), Expect = 1.6e-88, P = 1.6e-88
Identities = 179/258 (69%), Positives = 210/258 (81%)
Query: 36 KEAP-AK-EMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAA 93
K AP AK E+K + PI VP +S+DE+KEKT+NFG+ +LIGEGSYGRVY+ L G A
Sbjct: 35 KPAPVAKHEVKKEAL-PIEVPPLSLDEVKEKTENFGSKALIGEGSYGRVYYATLNDGVAV 93
Query: 94 AIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDI 151
A+KKLD + + D EFL+QVSMVSRLK+EN+++L+G+ VDG LRVLAYE A+ GSLHDI
Sbjct: 94 ALKKLDVAPEAETDTEFLSQVSMVSRLKHENLIQLLGFCVDGNLRVLAYEFATMGSLHDI 153
Query: 152 LHXXXXXXXXXXXXXLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211
LH L W RVKIAV AARGLEYLHEK++P +IHR+I+SSNVLLF+D
Sbjct: 154 LHGRKGVQGAQPGPTLDWITRVKIAVEAARGLEYLHEKSQPPVIHRDIRSSNVLLFEDYK 213
Query: 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 271
AKI+DF+LSNQAPD AARLHSTRVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTG
Sbjct: 214 AKIADFNLSNQAPDNAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG 273
Query: 272 RKPVDHTLPRGQQSLVTW 289
RKPVDHT+PRGQQSLVTW
Sbjct: 274 RKPVDHTMPRGQQSLVTW 291
|
|
| TAIR|locus:2054502 AT2G30740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 883 (315.9 bits), Expect = 2.0e-88, P = 2.0e-88
Identities = 174/242 (71%), Positives = 199/242 (82%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQ--E 107
PI VP +SVDE+KEKTDNFG+ SLIGEGSYGRVY+ L G+A A+KKLD + + + E
Sbjct: 53 PIEVPPLSVDEVKEKTDNFGSKSLIGEGSYGRVYYATLNDGKAVALKKLDVAPEAETNTE 112
Query: 108 FLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXL 167
FL QVSMVSRLK+EN+++LVGY VD LRVLAYE A+ GSLHDILH L
Sbjct: 113 FLNQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTL 172
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
W RVKIAV AARGLEYLHEK +P +IHR+I+SSNVLLF+D AK++DF+LSNQAPD A
Sbjct: 173 DWLTRVKIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKVADFNLSNQAPDNA 232
Query: 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
ARLHSTRVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLV
Sbjct: 233 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 292
Query: 288 TW 289
TW
Sbjct: 293 TW 294
|
|
| TAIR|locus:2081277 AT3G59350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 883 (315.9 bits), Expect = 2.0e-88, P = 2.0e-88
Identities = 177/291 (60%), Positives = 213/291 (73%)
Query: 3 CFGCCEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQP--IAVPVISVDE 60
C C E+ + P + N G + ++ A +P I VP +S+DE
Sbjct: 48 CCACHVEEPYHSSENEHLRSPKHH--NDFGHHTRKPQAAVKPDALKEPPSIDVPALSLDE 105
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRL 118
LKEKTDNFG+ SLIGEGSYGR Y+ L+ G+A A+KKLD++ +P+ EFL QVS VS+L
Sbjct: 106 LKEKTDNFGSKSLIGEGSYGRAYYATLKDGKAVAVKKLDNAAEPESNVEFLTQVSRVSKL 165
Query: 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQRVKIAVG 178
K++N VEL GY V+G R+LAYE A+ GSLHDILH L W QRV+IAV
Sbjct: 166 KHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQRVRIAVD 225
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
AARGLEYLHEK +P +IHR+I+SSNVLLF+D AKI+DF+LSNQ+PD AARLHSTRVLGT
Sbjct: 226 AARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAARLHSTRVLGT 285
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
FGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTW
Sbjct: 286 FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 336
|
|
| TAIR|locus:2054492 AT2G30730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 860 (307.8 bits), Expect = 5.4e-86, P = 5.4e-86
Identities = 169/255 (66%), Positives = 202/255 (79%)
Query: 37 EAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIK 96
+ P K + PI VP +SVDE+ E+TDNFG NSLIGEGSYGRVY+ L G+A A+K
Sbjct: 16 QKPQDLAKPKEILPIIVPSLSVDEVNEQTDNFGPNSLIGEGSYGRVYYATLNDGKAVALK 75
Query: 97 KLDSSKQPDQ--EFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHX 154
KLD + + + EFL+QVSMVSRLK+EN+++LVGY VD LRVLAYE A+ GSLHDILH
Sbjct: 76 KLDLAPEDETNTEFLSQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHG 135
Query: 155 XXXXXXXXXXXXLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214
L W RVKIAV AARGLEYLHEK +P++IHR+I+SSN+LLFDD AKI
Sbjct: 136 RKGVQDALPGPTLDWITRVKIAVEAARGLEYLHEKVQPQVIHRDIRSSNILLFDDYQAKI 195
Query: 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+DF+LSNQ+PD AARL STRVLG+FGY++PEYAMTG+++ KSDVY FGVVLLELLTGRKP
Sbjct: 196 ADFNLSNQSPDNAARLQSTRVLGSFGYYSPEYAMTGELTHKSDVYGFGVVLLELLTGRKP 255
Query: 275 VDHTLPRGQQSLVTW 289
VDHT+PRGQQSLVTW
Sbjct: 256 VDHTMPRGQQSLVTW 270
|
|
| TAIR|locus:2064557 AT2G41970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 824 (295.1 bits), Expect = 3.6e-82, P = 3.6e-82
Identities = 170/298 (57%), Positives = 215/298 (72%)
Query: 1 MSCFGCCEEDDIRKASKNGPFVPNNPAGNP--GGFYVKE-----APAKEMKTVTVQPIAV 53
M C G +E+ + N P N AGNP GG E AP + V PI +
Sbjct: 1 MFCCGGADEEPAGPPA-NQYAAPPNKAGNPNFGGGNRGEPRNPNAP-RSGAPAKVLPIEI 58
Query: 54 PVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLD--SSKQPDQEFLAQ 111
P +++DEL NFG +LIGEGSYGRV+ G + G A AIKKLD SS++PD +F +Q
Sbjct: 59 PSVALDELNRMAGNFGNKALIGEGSYGRVFCGKFK-GEAVAIKKLDASSSEEPDSDFTSQ 117
Query: 112 VSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXXLSWAQ 171
+S+VSRLK+++ VEL+GY ++ R+L Y+ A+KGSLHD+LH L+W Q
Sbjct: 118 LSVVSRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGVQGAEPGPVLNWNQ 177
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
RVKIA GAA+GLE+LHEK +P I+HR+++SSNVLLFDD +AK++DF+L+N + D AARLH
Sbjct: 178 RVKIAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFNLTNASSDTAARLH 237
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289
STRVLGTFGYHAPEYAMTGQ++ KSDVYSFGVVLLELLTGRKPVDHT+P+GQQSLVTW
Sbjct: 238 STRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQQSLVTW 295
|
|
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 603 (217.3 bits), Expect = 9.3e-59, P = 9.3e-59
Identities = 127/243 (52%), Positives = 164/243 (67%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS-KQPDQEF 108
P + +S +ELKE T NF + S++GEG +G+VY G+L G A AIKKL S Q D+EF
Sbjct: 362 PASTRFLSYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKKLTSGGPQGDKEF 421
Query: 109 LAQVSMVSRLKNENVVELVGYYV--DGPLRVLAYEHASKGSLHDILHXXXXXXXXXXXXX 166
++ M+SRL + N+V+LVGYY D +L YE GSL LH
Sbjct: 422 QVEIDMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHGPLGLNCP----- 476
Query: 167 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226
L W R+KIA+ AARGL YLHE ++P +IHR+ K+SN+LL ++ AK++DF L+ QAP+
Sbjct: 477 LDWDTRMKIALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGLAKQAPEG 536
Query: 227 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286
STRV+GTFGY APEYAMTG + KSDVYS+GVVLLELLTGRKPVD + P GQ++L
Sbjct: 537 RGNHLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL 596
Query: 287 VTW 289
VTW
Sbjct: 597 VTW 599
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q41328 | PTI1_SOLLC | 2, ., 7, ., 1, 1, ., 1 | 0.8131 | 0.9601 | 0.8163 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 301 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-46 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-45 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-42 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-36 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-35 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-12 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-07 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-06 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.002 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.002 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.003 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.004 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.004 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.004 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 2e-48
Identities = 67/200 (33%), Positives = 101/200 (50%), Gaps = 18/200 (9%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYY 130
+GEG +G VY + +G+ AIK + +E L ++ ++ +L + N+V+L G +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
D L E+ GSL D+L +G LS + ++I + GLEYLH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG--------KLSEDEILRILLQILEGLEYLHSN- 111
Query: 191 EPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE-YAM 248
IIHR++K N+LL D+ K++DF LS + L + GT Y APE
Sbjct: 112 --GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLG 167
Query: 249 TGQMSSKSDVYSFGVVLLEL 268
G S KSD++S GV+L EL
Sbjct: 168 KGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 2e-46
Identities = 69/213 (32%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 71 NSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENV 123
+GEG++G VY G L+ A+K L Q EFL + ++ +L + NV
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
V+L+G + + E+ G L L K P LS + + A+ ARG+
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLR--------KNRPKLSLSDLLSFALQIARGM 115
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLHSTRVLGTFGYH 242
EYL K IHR++ + N L+ ++ + KISDF LS + D R ++ +
Sbjct: 116 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWM 170
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE G+ +SKSDV+SFGV+L E+ T G +P
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 1e-45
Identities = 66/213 (30%), Positives = 107/213 (50%), Gaps = 21/213 (9%)
Query: 71 NSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENV 123
+GEG++G VY G L+ A+K L Q EFL + ++ +L + N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
V+L+G + ++ E+ G L D L + LS + + A+ ARG+
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-------KELSLSDLLSFALQIARGM 116
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLHSTRVLGTFGYH 242
EYL K IHR++ + N L+ ++ + KISDF LS + D ++ ++ +
Sbjct: 117 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWM 171
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE G+ +SKSDV+SFGV+L E+ T G +P
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-43
Identities = 68/209 (32%), Positives = 105/209 (50%), Gaps = 12/209 (5%)
Query: 74 IGEGSYGRVYFGVLRSG----RAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVELV 127
+GEG++G VY G L+ A+K L ++ +FL + ++ +L + NVV L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G + L E+ G L D L + V + LS + A+ A+G+EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLHSTRVLGTFGYHAPEY 246
K + +HR++ + N L+ +D + KISDF LS + D R + L + APE
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPES 178
Query: 247 AMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
G +SKSDV+SFGV+L E+ T G P
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 4e-43
Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 21/210 (10%)
Query: 74 IGEGSYGRVYFGVLR-----SGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G VY G L+ + A+K L +S++ +EFL + S++ +L + N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+G G + E+ G L D L K G L+ +++A+ A+G+EYL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLR--------KHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHSTRVLGTFGYHAPE 245
K +HR++ + N L+ ++ + KISDF LS D R L APE
Sbjct: 119 ESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APE 174
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
G+ +SKSDV+SFGV+L E+ T G +P
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-42
Identities = 72/219 (32%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELVGY 129
+G GS+G VY + G+ A+K L + DQ ++ ++ RL + N+V L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ D L E+ G L D L LS + KIA+ RGLEYLH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGG---------PLSEDEAKKIALQILRGLEYLHSN 117
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
IIHR++K N+LL ++ + KI+DF L+ + +++ L + +GT Y APE +
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLG 172
Query: 250 GQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
G K DV+S GV+L ELLTG+ P Q L+
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI 211
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-40
Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ--VSMVSRLKNENVVELVGY 129
+GEGS+G+VY ++G+ AIK + K + ++ +LK+ N+V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ D L E+ G L D+L + LS + LEYLH K
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGR---------LSEDEARFYLRQILSALEYLHSK 116
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
I+HR++K N+LL +D K++DF L+ Q +T V GT Y APE +
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFV-GTPEYMAPEVLLG 170
Query: 250 GQMSSKSDVYSFGVVLLELLTGRKP 274
D++S GV+L ELLTG+ P
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 1e-36
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 74 IGEGSYGRVYFG-VLRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVG-YY 130
IG+G +G VY R+G+ AIK + + +E + + ++ + K+ N+V+ G Y
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
L + E S GSL D+L L+ +Q + +GLEYLH
Sbjct: 68 KKDELW-IVMEFCSGGSLKDLLKSTNQT--------LTESQIAYVCKELLKGLEYLHSN- 117
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
IIHR+IK++N+LL D K+ DF LS Q D AR ++GT + APE
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR---NTMVGTPYWMAPEVINGK 172
Query: 251 QMSSKSDVYSFGVVLLELLTGRKP 274
K+D++S G+ +EL G+ P
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-36
Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 20/209 (9%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLD---SSKQPDQEFLAQVSMVSRLKNENVVELVG 128
L+G GS+G VY + + +G A+K ++ S++ + ++ ++S L++ N+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 129 YYVDGPLRVL--AYEHASKGSLHDILHGKKGVKGAKPGPVL-SWAQRVKIAVGAARGLEY 185
D L E+ S GSL +L + P PV+ + +++ GL Y
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKL----PEPVIRKYTRQI------LEGLAY 116
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH I+HR+IK +N+L+ D + K++DF + + D + V GT + APE
Sbjct: 117 LHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ +D++S G ++E+ TG+ P
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 8e-35
Identities = 74/221 (33%), Positives = 122/221 (55%), Gaps = 22/221 (9%)
Query: 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
+ IG+G +G V G R G+ A+K L Q FLA+ S+++ L++ N+V+L+G +
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
G + E+ +KGSL D L ++ V++ AQ++ A+ G+EYL EK
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLR-------SRGRAVITLAQQLGFALDVCEGMEYLEEK-- 121
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ 251
+HR++ + NVL+ +D +AK+SDF L A +A+ S ++ + APE +
Sbjct: 122 -NFVHRDLAARNVLVSEDLVAKVSDFGL---AKEASQGQDSGKL--PVKWTAPEALREKK 175
Query: 252 MSSKSDVYSFGVVLLELLT-GRKPVDHTLPR-GQQSLVTWV 290
S+KSDV+SFG++L E+ + GR P PR + +V V
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVP----YPRIPLKDVVPHV 212
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-30
Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 42/220 (19%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVG 128
IG+GS+G+VY G+ +K++D S ++E L +V ++ +L + N+++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGP---VLSWAQRVKIAVGAARGLEY 185
+ + + E+A G L + KK K KP P +L W V++ + L+Y
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDWF--VQLCLA----LKY 118
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-----VLGTFG 240
LH + +I+HR+IK N+ L + + K+ DF +S L ST V+GT
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKV-------LSSTVDLAKTVVGTPY 168
Query: 241 YHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y +PE Y + KSD++S G VL EL T + P
Sbjct: 169 YLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-29
Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQ---EFLAQVSMVSRLKNENVVELVG 128
LIG G++G VY G+ L +G AIK++ K ++ + ++ ++ LK+ N+V+ +G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ E+A GSL I+ K GP + +GL YLHE
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIK--------KFGP-FPESLVAVYVYQVLQGLAYLHE 117
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
+ +IHR+IK++N+L D + K++DF ++ + D + S V+GT + APE
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIE 172
Query: 249 TGQMSSKSDVYSFGVVLLELLTGRKP 274
S+ SD++S G ++ELLTG P
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 68/218 (31%), Positives = 99/218 (45%), Gaps = 24/218 (11%)
Query: 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE----FLAQVSMVSRLK-NENVVEL 126
+GEGS+G VY R + A+K L + + FL ++ +++ L N+V+L
Sbjct: 6 RKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
++ D L E+ GSL D+L L ++ LEYL
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI------LSALEYL 117
Query: 187 HEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHSTR----VLGTFGY 241
H K IIHR+IK N+LL D + K+ DF L+ PD + +GT GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 242 HAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVD 276
APE + SS SD++S G+ L ELLTG P +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 18/213 (8%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKK--LDSSKQPDQEFLAQVSMVSRLKNEN 122
+ ++G+GS G VY + +G+ A+KK +D ++ ++ L ++ + ++
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 123 VVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
VV+ G +Y +G + + E+ GSL D+L + P PVL+ IA +
Sbjct: 61 VVKCYGAFYKEGEIS-IVLEYMDGGSLADLLKKVGKI----PEPVLA-----YIARQILK 110
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL+YLH K IIHR+IK SN+L+ KI+DF +S + + +T V GT Y
Sbjct: 111 GLDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CNTFV-GTVTY 166
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+PE S +D++S G+ LLE G+ P
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 67/214 (31%), Positives = 102/214 (47%), Gaps = 31/214 (14%)
Query: 74 IGEGSYGRVYFGVLR--SGR--AAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G G++G V GV SG+ A+K L + +EFL + S++++L + +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G G +L E A G L L ++ + + + A +V A G+ YL
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSD---LKELAHQV------AMGMAYLE 112
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG------Y 241
K +HR++ + NVLL + AKISDF +S A S T +
Sbjct: 113 SK---HFVHRDLAARNVLLVNRHQAKISDFGMSR-----ALGAGSDYYRATTAGRWPLKW 164
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+APE G+ SSKSDV+S+GV L E + G KP
Sbjct: 165 YAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 62/209 (29%), Positives = 112/209 (53%), Gaps = 17/209 (8%)
Query: 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVEL 126
F +GEGSYG VY + + +G+ AIK + ++ QE + ++S++ + + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQCDSPYIVKY 63
Query: 127 VG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
G Y+ + L ++ E+ GS+ DI+ L+ + I +GLEY
Sbjct: 64 YGSYFKNTDLWIVM-EYCGAGSVSDIMKIT--------NKTLTEEEIAAILYQTLKGLEY 114
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH + IHR+IK+ N+LL ++ AK++DF +S Q D A+ ++ V+GT + APE
Sbjct: 115 LHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPE 169
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
++K+D++S G+ +E+ G+ P
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 71/207 (34%), Positives = 112/207 (54%), Gaps = 19/207 (9%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVG-Y 129
+G G+ G V + R +G+ A+K +L+ ++ ++ L ++ ++ + + +V G +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
Y +G + + E+ GSL IL K V+G P +L KIAV +GL YLHEK
Sbjct: 69 YNNGDI-SICMEYMDGGSLDKIL---KEVQGRIPERILG-----KIAVAVLKGLTYLHEK 119
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
+IIHR++K SN+L+ K+ DF +S Q ++ A+ T V GT Y APE
Sbjct: 120 H--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK---TFV-GTSSYMAPERIQG 173
Query: 250 GQMSSKSDVYSFGVVLLELLTGRKPVD 276
S KSD++S G+ L+EL TGR P
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 73/215 (33%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 73 LIGEGSYGRVYFGVLRSGR---------AAAIKKLDSSKQPD--QEFLAQVSMVSRLKNE 121
+G+GS FGV+R G A+K L S K D +FL + +++ L +E
Sbjct: 2 KLGDGS-----FGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHE 56
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N++ L G + PL + E A GSL D L K G L AV A
Sbjct: 57 NLIRLYGVVLTHPLM-MVTELAPLGSLLDRLR--KDALGHFLISTLC-----DYAVQIAN 108
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT-FG 240
G+ YL K R IHR++ + N+LL DD KI DF L P L F
Sbjct: 109 GMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA 165
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ APE T S SDV+ FGV L E+ T G +P
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-25
Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 16/207 (7%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGY 129
IG+GS+G V+ V ++ R A+K++D SK + +E + + ++++L + ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
++D + E+A G LH +L ++G +P L Q + + GL +LH K
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRG----RP---LPEDQVWRFFIQILLGLAHLHSK 120
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
+I+HR+IKS N+ L D KI D ++ D + ++GT Y +PE
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPELCED 175
Query: 250 GQMSSKSDVYSFGVVLLELLTGRKPVD 276
+ KSDV++ GVVL E TG+ P D
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-25
Identities = 63/222 (28%), Positives = 110/222 (49%), Gaps = 31/222 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRA------AAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVE 125
+GEG++G+V+ G A+K L + D ++F + +++ ++EN+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPV---LSWAQRVKIAVGAA 180
G +G ++ +E+ G L+ L HG P L+ +Q ++IAV A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST---RVLG 237
G+ YL A +HR++ + N L+ D + KI DF +S +++T RV G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRD-------VYTTDYYRVGG 182
Query: 238 T----FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ PE M + +++SDV+SFGVVL E+ T G++P
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-25
Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 13/201 (6%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYY 130
IG+G++G VY GVL+ A+K S+ PD ++FL + ++ + + N+V+L+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
V + E GSL L KK L+ + +++++ AA G+EYL K
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNR--------LTVKKLLQMSLDAAAGMEYLESK- 112
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
IHR++ + N L+ ++++ KISDF +S + + + APE G
Sbjct: 113 --NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 251 QMSSKSDVYSFGVVLLELLTG 271
+ +S+SDV+S+G++L E +
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 1e-24
Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 67 NFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNE 121
+F +G+GSYG VY V R + A+K++D +E + ++ +++ + +
Sbjct: 1 DFKVLKKLGKGSYGSVY-KVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHP 59
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV-LSWAQRVKIAVGAA 180
N++ ++DG + E+A G L + K K K P W +I +
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAI--SKRKKKRKLIPEQEIW----RIFIQLL 113
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
RGL+ LHE+ +I+HR++KS+N+LL +D+ KI D +S A+ +GT
Sbjct: 114 RGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK----TQIGTPH 166
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE S KSD++S G +L E+ T P
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 2e-24
Identities = 63/204 (30%), Positives = 115/204 (56%), Gaps = 23/204 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
IGEG +G V G +G+ A+K K D + Q FL + +++++L ++N+V L+G +
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVIL 69
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
L ++ E SKG+L + L + ++S Q ++ ++ A G+EYL K
Sbjct: 70 HNGLYIVM-ELMSKGNLVNFLRTRGRA-------LVSVIQLLQFSLDVAEGMEYLESK-- 119
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ 251
+++HR++ + N+L+ +D +AK+SDF L+ + ++++ + APE +
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---VDNSKL--PVKWTAPEALKHKK 173
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
SSKSDV+S+GV+L E+ + GR P
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 3e-24
Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 36/221 (16%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLD----SSKQPDQEFLAQVSMVSRLKNE------ 121
LIG+G+YGRVY + + +G A+K+++ + + D Q MV L++E
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDS---RQKDMVKALRSEIETLKD 64
Query: 122 ----NVVELVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKI 175
N+V+ +G+ + E+ GS+ L +G+ + V + ++V
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR-----FEEQLVRFFTEQV-- 117
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
GL YLH K I+HR++K+ N+L+ D I KISDF +S ++ D + +
Sbjct: 118 ----LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170
Query: 236 LGTFGYHAPEYAMTGQM--SSKSDVYSFGVVLLELLTGRKP 274
G+ + APE + S+K D++S G V+LE+ GR+P
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 4e-24
Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 19/223 (8%)
Query: 54 PVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQV 112
++S + +E N IGEG+ G VY R +G+ AIKK+ KQ + + ++
Sbjct: 10 DIVSEGDPRELYKNL---EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEI 66
Query: 113 SMVSRLKNENVVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171
++ K+ N+V+ Y V L V E+ GSL DI+ ++ Q
Sbjct: 67 LIMKDCKHPNIVDYYDSYLVGDELWV-VMEYMDGGSLTDIITQNF--------VRMNEPQ 117
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
+ +GLEYLH + +IHR+IKS N+LL D K++DF + Q ++ +
Sbjct: 118 IAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN 174
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
S V+GT + APE K D++S G++ +E+ G P
Sbjct: 175 S--VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 4e-24
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 74 IGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVEL 126
+GEG +G+V +G A+K L+ S + +F ++ ++ L +EN+V+
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 127 VG--YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G G L E+ GSL D L + ++ + + + +G++
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR--------DQINLKRLLLFSSQICKGMD 123
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP--DAAARLHSTRVLGTFGYH 242
YL + R IHR++ + N+L+ +D+ KISDF L+ P + F Y
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT 270
APE T + SS SDV+SFGV L EL T
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 5e-24
Identities = 67/222 (30%), Positives = 111/222 (50%), Gaps = 29/222 (13%)
Query: 74 IGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVE 125
+GEG++G+VY G L S + AIK L + +P QEF + ++S L++ N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 126 LVGYYV-DGPLRVLAYEHASKGSLH----------DILHGKKGVKGAKPGPVLSWAQRVK 174
L+G + P +L +E+ + G LH D+ L + +
Sbjct: 73 LLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS---LDCSDFLH 128
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA-RLHST 233
IA+ A G+EYL + +HR++ + N L+ + KISDF LS A R+ S
Sbjct: 129 IAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+L + PE + G+ +++SD++SFGVVL E+ + G +P
Sbjct: 186 SLL-PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 8e-24
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 24/208 (11%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQ-EFLAQ-VSMVSRLKNENVVELVGY 129
IG+GS+G VY + R+ + AIK +D + D+ E + Q + +S+ ++ + + G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGLEYL 186
++ G + E+ GS D+L KPG + IA GLEYL
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLL---------KPGKL----DETYIAFILREVLLGLEYL 114
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246
HE+ IHR+IK++N+LL ++ K++DF +S Q ++ ++ +GT + APE
Sbjct: 115 HEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF--VGTPFWMAPEV 169
Query: 247 AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
K+D++S G+ +EL G P
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 8e-24
Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ G A+K L + FL + ++ +L+++ +V+L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ SKGSL D L K G G L V +A A G+ Y+
Sbjct: 74 PIYIVT-EYMSKGSLLDFL--KDG-----EGRALKLPNLVDMAAQVAAGMAYIERM---N 122
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEYAMTGQ 251
IHR+++S+N+L+ D + KI+DF L+ D ++ R F + APE A+ G+
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGR 179
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
+ KSDV+SFG++L EL+T GR P
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-23
Identities = 63/204 (30%), Positives = 108/204 (52%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G+G +G V+ G AIK L + FL + ++ +L++E +V+L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ SKGSL D L G+ G L Q V +A A G+ Y+
Sbjct: 74 PIYIVT-EYMSKGSLLDFLKGEMGK-------YLRLPQLVDMAAQIASGMAYVERM---N 122
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEYAMTGQ 251
+HR+++++N+L+ ++ + K++DF L+ D ++ R F + APE A+ G+
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGR 179
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
+ KSDV+SFG++L EL T GR P
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 5e-23
Identities = 63/212 (29%), Positives = 108/212 (50%), Gaps = 32/212 (15%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV-- 131
+G G +G V+ G+ + A+K L ++FLA+ ++ +L++ +++L Y V
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL--YAVCT 71
Query: 132 -DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ P+ ++ E GSL + L G G L Q + +A A G+ YL +
Sbjct: 72 LEEPIYIVT-ELMKYGSLLEYLQGGAGRA-------LKLPQLIDMAAQVASGMAYLEAQ- 122
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-----HSTRVLGTF--GYHA 243
IHR++ + NVL+ +++I K++DF L AR+ + R F + A
Sbjct: 123 --NYIHRDLAARNVLVGENNICKVADFGL--------ARVIKEDIYEAREGAKFPIKWTA 172
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
PE A+ + S KSDV+SFG++L E++T GR P
Sbjct: 173 PEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 8e-23
Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 23/210 (10%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIK--KLDSSKQPDQEFLAQ----VSMVSRLKNENVVE 125
L+G GS+G VY G+ L G A+K L Q QE + Q ++++S+L++ N+V+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+G + + E GSL +L G+ P PV+ R + GLEY
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQILL-----GLEY 117
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH++ +HR+IK +N+L+ + + K++DF ++ Q + S + G+ + APE
Sbjct: 118 LHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKSFK--GSPYWMAPE 171
Query: 246 YAM-TGQMSSKSDVYSFGVVLLELLTGRKP 274
G +D++S G +LE+ TG+ P
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 2e-22
Identities = 65/204 (31%), Positives = 107/204 (52%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G+G +G V+ G AIK L + FL + ++ +L+++ +V L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E KGSL D L K+G G L Q V +A A G+ Y+
Sbjct: 74 PIYIVT-EFMGKGSLLDFL--KEG-----DGKYLKLPQLVDMAAQIADGMAYIERM---N 122
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEYAMTGQ 251
IHR+++++N+L+ D+ + KI+DF L+ D ++ R F + APE A+ G+
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGR 179
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
+ KSDV+SFG++L EL+T GR P
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-22
Identities = 71/238 (29%), Positives = 116/238 (48%), Gaps = 23/238 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNEN 122
+ S +GEG+ G V L+ +G A+K + + PD ++ L ++ + K+
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 123 VVELVGYYVDGPLRVL--AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV--KIAVG 178
+V+ G ++D + A E+ GSL D ++ K +G + G ++V KIA
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIG------EKVLGKIAES 113
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
+GL YLH + +IIHR+IK SN+LL K+ DF +S + ++ A T GT
Sbjct: 114 VLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---GTFT-GT 166
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV--DHTLPRGQQSLVTWVLTSS 294
Y APE S SDV+S G+ LLE+ R P + P G L+++++
Sbjct: 167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-22
Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDS-SKQPDQEFLAQVSMVSRLKNENVVELVGYYVD 132
+G G +G V+ G+ ++ AIK L S Q+F +V + RL++++++ L
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
G + E KGSL L + G VL A + +A A G+ YL E+
Sbjct: 74 GEPVYIITELMEKGSLLAFL-------RSPEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM 252
IHR++ + N+L+ +D + K++DF L+ + ++ + + APE A G
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 253 SSKSDVYSFGVVLLELLT 270
S+KSDV+SFG++L E+ T
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 3e-22
Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ G A+K L + FL + ++ +L+++ +V+L +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 134 -PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
P+ ++ E+ SKGSL D L +G K L Q V +A A G+ YL +
Sbjct: 74 EPIYIVT-EYMSKGSLLDFLKSGEGKK-------LRLPQLVDMAAQIAEGMAYLESR--- 122
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL-----HSTRVLGTF--GYHAPE 245
IHR++ + N+L+ ++ + KI+DF L ARL ++ R F + APE
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGL--------ARLIEDDEYTAREGAKFPIKWTAPE 174
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A G+ + KSDV+SFG++L E++T GR P
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-22
Identities = 66/224 (29%), Positives = 109/224 (48%), Gaps = 24/224 (10%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFG-VLRSGRAAAIKKLDSSKQPDQEFL-AQV 112
V+ + + DNF IGEGS G V +GR A+KK+D KQ +E L +V
Sbjct: 11 VVDPGDPRSYLDNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEV 67
Query: 113 SMVSRLKNENVVELVG-YYVDGPLRVLAYEHASKGSLHDIL-HGKKGVKGAKPGPVLSWA 170
++ ++ N+VE+ Y V L V+ E G+L DI+ H + ++
Sbjct: 68 VIMRDYQHPNIVEMYSSYLVGDELWVV-MEFLEGGALTDIVTHTR-----------MNEE 115
Query: 171 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230
Q + + + L +LH + +IHR+IKS ++LL D K+SDF Q R
Sbjct: 116 QIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR 172
Query: 231 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
S ++GT + APE ++ D++S G++++E++ G P
Sbjct: 173 KS--LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 3e-22
Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 23/227 (10%)
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
L + T F +IGEG+YG+VY ++G+ AIK +D + ++E + +++ +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 120 N-ENVVELVGYYVDGPLRV------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
N N+ G ++ L E GS+ D++ G + +++
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--- 117
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
I RGL YLHE ++IHR+IK N+LL + K+ DF +S Q R ++
Sbjct: 118 --ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172
Query: 233 TRVLGTFGYHAPE-----YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+GT + APE ++SDV+S G+ +EL G+ P
Sbjct: 173 --FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-21
Identities = 71/214 (33%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSK-QPDQEFLAQ-VSMVSRLKNENVVELVGYY 130
IG G+ VY + L + AIK++D K Q + L + V +S+ + NVV+ +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
V G L + S GSL DI +K + P L A + +GLEYLH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDI------MKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR--VLGTFGYHAPEYAM 248
+ IHR+IK+ N+LL +D KI+DF +S D R R +GT + APE M
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VM 178
Query: 249 TGQM--SSKSDVYSFGVVLLELLTGRKPVDHTLP 280
K+D++SFG+ +EL TG P P
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPY-SKYP 211
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-21
Identities = 75/212 (35%), Positives = 105/212 (49%), Gaps = 33/212 (15%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
IG GS+G VYF +R+ AIKK+ S KQ + Q+ + +V + +L++ N +E G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGLEY 185
Y+ L E+ GS DIL K KP Q V+IA GA +GL Y
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDILEVHK-----KP------LQEVEIAAICHGALQGLAY 130
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH IHR+IK+ N+LL + K++DF A+ + +GT + APE
Sbjct: 131 LHSHER---IHRDIKAGNILLTEPGTVKLADFG------SASLVSPANSFVGTPYWMAPE 181
Query: 246 --YAM-TGQMSSKSDVYSFGVVLLELLTGRKP 274
AM GQ K DV+S G+ +E L RKP
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-21
Identities = 69/206 (33%), Positives = 115/206 (55%), Gaps = 25/206 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
IG+G +G V G R G A+K K D++ Q FLA+ S++++L++ N+V+L+G V
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 132 D--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ G L ++ E+ +KGSL D L ++ VL +K ++ +EYL
Sbjct: 70 EEKGGLYIVT-EYMAKGSLVDYLR-------SRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
+HR++ + NVL+ +D++AK+SDF L+ + A+ T L + APE
Sbjct: 122 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE----ASSTQDTGKL-PVKWTAPEALRE 173
Query: 250 GQMSSKSDVYSFGVVLLELLT-GRKP 274
+ S+KSDV+SFG++L E+ + GR P
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 6e-21
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD- 132
+G G +G V+ G R AIK + + +F+ + ++ +L + N+V+L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
P+ ++ E+ + G L + L +KG G +L V +EYL
Sbjct: 72 RPIFIV-TEYMANGCLLNYLRERKGKLGT--EWLLDMCSDV------CEAMEYLESNG-- 120
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT---FGYHAPEYAMT 249
IHR++ + N L+ +D++ K+SDF L+ D T GT + PE
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD----QYTSSQGTKFPVKWAPPEVFDY 175
Query: 250 GQMSSKSDVYSFGVVLLELLTGRK 273
+ SSKSDV+SFGV++ E+ + K
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-21
Identities = 73/234 (31%), Positives = 113/234 (48%), Gaps = 24/234 (10%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVY-FGVLRSGRAAAIKKLDSSKQPDQEFLAQVS 113
++ ++ L + TD + IG+G+YG+VY + G AA+K LD D+E A+ +
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYN 70
Query: 114 MVSRLKNE-NVVELVG------YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV 166
++ L N NVV+ G V G L L E + GS+ +++ G G
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLW-LVLELCNGGSVTELVKGL-----LICGQR 124
Query: 167 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226
L A I GA GL++LH RIIHR++K +N+LL + K+ DF +S Q
Sbjct: 125 LDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL--T 179
Query: 227 AARLHSTRVLGTFGYHAPEYAMTGQM-----SSKSDVYSFGVVLLELLTGRKPV 275
+ RL +GT + APE Q ++ DV+S G+ +EL G P+
Sbjct: 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 1e-20
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELVGY 129
IG G++G+VY V L +G A+K++ D+ + +E ++ ++ LK+ N+V+ G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
V + E+ S G+L ++L G +L + GL YLH
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEH---------GRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFD----LSNQAPDAAARLHSTRVLGTFGYHAPE 245
I+HR+IK +N+ L + + K+ DF L N + S GT Y APE
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA--GTPAYMAPE 173
Query: 246 YAMTGQMSSK---SDVYSFGVVLLELLTGRKP 274
G+ +D++S G V+LE+ TG++P
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 1e-20
Identities = 66/206 (32%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYV 131
IG G+YG VY + +G AIK + D E + Q +SM+ ++ N+V G Y+
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
+ E+ GSL DI GP LS Q + +GL YLHE
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQ-------VTRGP-LSELQIAYVCRETLKGLAYLHET-- 120
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA---M 248
IHR+IK +N+LL +D K++DF +S Q A+ S +GT + APE A
Sbjct: 121 -GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPEVAAVER 177
Query: 249 TGQMSSKSDVYSFGVVLLELLTGRKP 274
G K D+++ G+ +EL + P
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-20
Identities = 63/223 (28%), Positives = 112/223 (50%), Gaps = 22/223 (9%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVS 113
++SV + K+K F IG+G+ G VY + + +G+ AIK+++ +QP +E +
Sbjct: 11 IVSVGDPKKKYTRFEK---IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 114 MVSR-LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+V R K+ N+V + Y+ G + E+ + GSL D++ + Q
Sbjct: 68 LVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQI 117
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLH 231
+ + LE+LH ++IHR+IKS N+LL D K++DF Q P+ + R
Sbjct: 118 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-- 172
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ ++GT + APE K D++S G++ +E++ G P
Sbjct: 173 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-20
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ G AIK L + FLA+ +++ +L++ +V L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ GSL D L +G+K L+ + + +A A G+ ++ K
Sbjct: 74 PIYIIT-EYMENGSLVDFLKTPEGIK-------LTINKLIDMAAQIAEGMAFIERK---N 122
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEYAMTGQ 251
IHR+++++N+L+ + KI+DF L+ D ++ R F + APE G
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGT 179
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
+ KSDV+SFG++L E++T GR P
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 6e-20
Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 74 IGEGSYGRVYFGVL------RSGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G+V+ + A+K L ++S+ Q+F + +++ L+++++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDIL--HGK-----KGVKGAKPGPVLSWAQRVKIAVGA 179
G +G ++ +E+ G L+ L HG G + PG L+ Q + IA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQ-LTLGQMLAIASQI 131
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A G+ YL A +HR++ + N L+ + KI DF +S R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ PE + + +++SD++SFGVVL E+ T G++P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 6e-20
Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 20/211 (9%)
Query: 74 IGEGSYGRVYFGVLR-SGRAA----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+G G++G VY GV G AIK L ++S + ++E L + +++ + + +VV L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+G + L + G L D + K G++ +L+W ++ A+G+ YL
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQY--LLNWCVQI------AKGMSYL 125
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246
EK R++HR++ + NVL+ KI+DF L+ H+ + A E
Sbjct: 126 EEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 247 AMTGQMSSKSDVYSFGVVLLELLT-GRKPVD 276
+ + KSDV+S+GV + EL+T G KP +
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-20
Identities = 61/202 (30%), Positives = 103/202 (50%), Gaps = 18/202 (8%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
L+G+G++G V+ G L+ A+K K D ++ +FL++ ++ + + N+V+L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ E G L KK L Q VK A+ AA G+ YL K
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKK--------DELKTKQLVKFALDAAAGMAYLESK- 112
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT--FGYHAPEYAM 248
IHR++ + N L+ ++++ KISDF +S Q D ++S+ L + APE
Sbjct: 113 --NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG---IYSSSGLKQIPIKWTAPEALN 167
Query: 249 TGQMSSKSDVYSFGVVLLELLT 270
G+ SS+SDV+S+G++L E +
Sbjct: 168 YGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 8e-20
Identities = 63/223 (28%), Positives = 112/223 (50%), Gaps = 22/223 (9%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVS 113
++SV + K+K F IG+G+ G VY + + +G+ AI++++ +QP +E +
Sbjct: 12 IVSVGDPKKKYTRF---EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 114 MVSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+V R KN N+V + Y+ G + E+ + GSL D++ + Q
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQI 118
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLH 231
+ + LE+LH ++IHR+IKS N+LL D K++DF Q P+ + R
Sbjct: 119 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-- 173
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ ++GT + APE K D++S G++ +E++ G P
Sbjct: 174 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-19
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 13/209 (6%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE 121
E+TD + L G G YG VY GV + A+K L +EFL + +++ +K+
Sbjct: 4 ERTDITMKHKL-GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHP 62
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N+V+L+G P + E + G+L D L ++ + VL + +A +
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVL-----LYMATQISS 115
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
+EYL +K IHR++ + N L+ ++ + K++DF LS H+ +
Sbjct: 116 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKW 171
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
APE + S KSDV++FGV+L E+ T
Sbjct: 172 TAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-19
Identities = 62/223 (27%), Positives = 115/223 (51%), Gaps = 22/223 (9%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLA-QV 112
++S+ + K+K + IG+G+ G V+ + + +G+ AIK+++ KQP +E + ++
Sbjct: 11 IVSIGDPKKKYTRY---EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
++ LKN N+V + ++ G + E+ + GSL D++ + AQ
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV----------TETCMDEAQI 117
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLH 231
+ + LE+LH ++IHR+IKS NVLL D K++DF Q P+ + R
Sbjct: 118 AAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR-- 172
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ ++GT + APE K D++S G++ +E++ G P
Sbjct: 173 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-19
Identities = 61/212 (28%), Positives = 109/212 (51%), Gaps = 28/212 (13%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKN---ENVVEL 126
LIG G+YG VY G + +GR A+K LD+ + +V+++S+L+ N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGL 183
G Y+ GP + E+A GS+ ++ K GP+ A++ I+V L
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLM---------KAGPI---AEKY-ISVIIREVLVAL 114
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
+Y+H+ +IHR+IK++N+L+ + K+ DF ++ A + +GT + A
Sbjct: 115 KYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVA--ALLNQNSSKRSTFVGTPYWMA 169
Query: 244 PEYAMTGQM-SSKSDVYSFGVVLLELLTGRKP 274
PE G+ +K+D++S G+ + E+ TG P
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-19
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 74 IGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVELVGYY 130
IG+GS+G VY G+ R+ AIK +D + D+ + +++++S+ + + G Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ G + E+ GS D+L KPGP L I +GL+YLH +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL---------KPGP-LEETYIATILREILKGLDYLHSE- 120
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
R IHR+IK++NVLL + K++DF ++ Q D ++ +GT + APE
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQS 176
Query: 251 QMSSKSDVYSFGVVLLELLTGRKP 274
K+D++S G+ +EL G P
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-19
Identities = 62/216 (28%), Positives = 112/216 (51%), Gaps = 23/216 (10%)
Query: 73 LIGEGSYGRV----YFGVLRSGR--AAAIKKL--DSSKQPDQEFLAQVSMVSRL-KNENV 123
+GEG++G+V G+ A+K L D++++ + ++++ M+ + K++N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 124 VELVGYYV-DGPLRVLAYEHASKGSLHDILHGK-------KGVKGAKPGPVLSWAQRVKI 175
+ L+G +GPL V+ E+A+ G+L D L + P L+ V
Sbjct: 79 INLLGVCTQEGPLYVVV-EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
A ARG+E+L K + IHR++ + NVL+ +D + KI+DF L+ +T
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 236 LGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLT 270
+ APE A+ ++ + +SDV+SFGV+L E+ T
Sbjct: 195 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-19
Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 22/223 (9%)
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKL----DSSKQPDQEFLAQVSM 114
E + + D G ++G+G+YG VY L + AIK++ QP E ++++
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE---EIAL 58
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
S LK+ N+V+ +G + + E GSL +L K G ++ + +++
Sbjct: 59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI- 117
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAAARLHST 233
GL+YLH+ +I+HR+IK NVL+ + KISDF S + A +
Sbjct: 118 -----LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--AGINPCTE 167
Query: 234 RVLGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLTGRKP 274
GT Y APE G + +D++S G ++E+ TG+ P
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-19
Identities = 63/223 (28%), Positives = 112/223 (50%), Gaps = 22/223 (9%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVS 113
++SV + K+K F IG+G+ G VY + + +G+ AIK+++ +QP +E +
Sbjct: 11 IVSVGDPKKKYTRF---EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 114 MVSRL-KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+V R KN N+V + Y+ G + E+ + GSL D++ + Q
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQI 117
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLH 231
+ + L++LH ++IHR+IKS N+LL D K++DF Q P+ + R
Sbjct: 118 AAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-- 172
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ ++GT + APE K D++S G++ +E++ G P
Sbjct: 173 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-19
Identities = 60/224 (26%), Positives = 108/224 (48%), Gaps = 34/224 (15%)
Query: 73 LIGEGSYGRVYFG----VLRSGRA---AAIKKLD--SSKQPDQEFLAQVSMVSRLKNENV 123
+G G++G VY G +L G A+K L ++ Q +EFL + ++S + N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAK-PGPVLSWAQRVKIAVGAARG 182
V+L+G + + + E G D+L + + + P+L+ + + I + A+G
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGG---DLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDD-----IAKISDFDL------SNQAPDAAARLH 231
YL + IHR++ + N L+ + + KI DF L S+ L
Sbjct: 119 CVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
R + APE + G+ +++SDV+SFGV++ E+LT G++P
Sbjct: 176 PVR------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-19
Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 17/203 (8%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFL-AQVSMVSRLKNENVVELVGYYV 131
IGEGS G V ++S G+ A+KK+D KQ +E L +V ++ ++ENVVE+ Y+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
G + E G+L DI+ + ++ Q + + + L LH +
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR----------MNEEQIAAVCLAVLKALSVLHAQG- 136
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ 251
+IHR+IKS ++LL D K+SDF Q R S ++GT + APE
Sbjct: 137 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLP 192
Query: 252 MSSKSDVYSFGVVLLELLTGRKP 274
+ D++S G++++E++ G P
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-19
Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 30/217 (13%)
Query: 71 NSLIGEGSYGRVYFGVLR-SGR---AAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVV 124
+IG G +G V G L+ G+ AIK L + Q +FL + S++ + + N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 125 ELVGYYVDG-PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
L G P+ ++ E+ GSL L G + Q V + G A G+
Sbjct: 69 RLEGVVTKSRPVMIIT-EYMENGSLDKFLRENDGK--------FTVGQLVGMLRGIASGM 119
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-----VLGT 238
+YL +E +HR++ + N+L+ + + K+SDF LS + D+ A ++T+ + T
Sbjct: 120 KYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT-YTTKGGKIPIRWT 175
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + +S SDV+SFG+V+ E+++ G +P
Sbjct: 176 ----APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 5e-19
Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 74 IGEGSYGRVYFGVLRS------GRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+G+GS+G VY G+ + AIK + ++S + EFL + S++ +VV
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKK-GVKGAKPGPVLSWAQRVKIAVGAARGLE 184
L+G G ++ E +KG L L ++ + + + +++A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----DLSNQ---APDAAARLHSTRVLG 237
YL K + +HR++ + N ++ +D KI DF D+ L R
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-PVR--- 186
Query: 238 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ APE G ++KSDV+SFGVVL E+ T
Sbjct: 187 ---WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-19
Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 18/204 (8%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVELVGYY 130
IG+GS+G V+ G+ R+ + AIK +D + D+ + +++++S+ + V + G Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ + E+ GS D+L +PGP L Q I +GL+YLH +
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL---------EPGP-LDETQIATILREILKGLDYLHSEK 121
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
+ IHR+IK++NVLL + K++DF ++ Q D ++ +GT + APE
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQS 176
Query: 251 QMSSKSDVYSFGVVLLELLTGRKP 274
SK+D++S G+ +EL G P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-19
Identities = 53/209 (25%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQE-FLAQVSMVSRLKNENVVELV-GYY 130
+G+G++G+VY + +G AA K + + + E F+ ++ ++S K+ N+V L Y+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ L +L E G+L I+ ++ + L+ Q + L +LH
Sbjct: 73 YENKLWIL-IEFCDGGALDSIM-----LELERG---LTEPQIRYVCRQMLEALNFLHSH- 122
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
++IHR++K+ N+LL D K++DF +S + + + +GT + APE
Sbjct: 123 --KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACE 178
Query: 251 QMSS-----KSDVYSFGVVLLELLTGRKP 274
K+D++S G+ L+EL P
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-19
Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 25/217 (11%)
Query: 74 IGEGSYGRVYFGVLR------SGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+G G++G VY G+ R A+K L S+Q + +FL + ++S+ ++N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV----LSWAQRVKIAVGAAR 181
L+G + R + E + G L K ++ +P P L+ + A A+
Sbjct: 74 LIGVSFERLPRFILLELMAGGDL------KSFLRENRPRPERPSSLTMKDLLFCARDVAK 127
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
G +YL E IHR+I + N LL +AKI+DF ++ A+ R +
Sbjct: 128 GCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ PE + G +SK+DV+SFGV+L E+ + G P
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-18
Identities = 65/222 (29%), Positives = 110/222 (49%), Gaps = 20/222 (9%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFL-AQV 112
V+S + +E D+F IGEGS G V + +G+ A+KK+D KQ +E L +V
Sbjct: 14 VVSPGDPREYLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEV 70
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
++ +ENVV++ Y+ G + E G+L DI+ + ++ Q
Sbjct: 71 VIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----------MNEEQI 120
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
+ + R L YLH + +IHR+IKS ++LL D K+SDF Q + S
Sbjct: 121 ATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
++GT + APE ++ D++S G++++E++ G P
Sbjct: 178 --LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-18
Identities = 58/213 (27%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 74 IGEGSYGRVYFGVL------RSGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G+V+ + A+K L D+S ++F + +++ L++E++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPV--LSWAQRVKIAVGAARG 182
G V+G ++ +E+ G L+ L HG V A+ L+ +Q + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
+ YL A +HR++ + N L+ ++ + KI DF +S + +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
PE M + +++SDV+S GVVL E+ T G++P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-18
Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 19/217 (8%)
Query: 74 IGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVEL 126
+GE ++G++Y G L + AIK L P Q EF + S+++ L + N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDIL-----HGKKGVKGAKPGPV---LSWAQRVKIAVG 178
+G + +E+ ++G LH+ L H G + G V L + IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
A G+EYL + +H+++ + N+L+ + KISD LS + A + L
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ PE M G+ SS SD++SFGVVL E+ + G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-18
Identities = 68/209 (32%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQ---EFLAQVSMVSRLKNENVVEL--- 126
IGEG+YG VY SG A+KK+ + D L +++++ L++ N+VEL
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 127 -VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
VG ++D V+ Y SL D + P P S +Q + + RGL+Y
Sbjct: 75 VVGKHLDSIFLVMEYCEQDLASLLDNM----------PTP-FSESQVKCLMLQLLRGLQY 123
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LHE IIHR++K SN+LL D KI+DF L+ A T + T Y APE
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYRAPE 178
Query: 246 --YAMTGQMSSKSDVYSFGVVLLELLTGR 272
T ++ D+++ G +L ELL +
Sbjct: 179 LLLGCTTYTTA-IDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-18
Identities = 65/227 (28%), Positives = 110/227 (48%), Gaps = 36/227 (15%)
Query: 74 IGEGSYGRVY----------------FGVLRSGR----AAAIKKLDSSKQPDQEFLAQVS 113
+GEG +G V+ F V R GR A I + D++K +FL +V
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNV-RKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 114 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL----------HGKKGVKGAKP 163
++SRLK+ N++ L+G VD + E+ G L+ L +G V A
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 164 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQ 222
P +S++ + +A+ A G++YL + +HR++ + N L+ ++ KI+DF +S N
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 269
R+ VL + A E + G+ ++ SDV++FGV L E+L
Sbjct: 189 YAGDYYRIQGRAVL-PIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-18
Identities = 61/215 (28%), Positives = 118/215 (54%), Gaps = 17/215 (7%)
Query: 67 NFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLA---QVSMVSRLKNEN 122
+ IGEGS+G++Y +S IK++D +K P +E A +V +++++K+ N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+V + + + E+ G L ++ ++GV ++ +LSW V+I++G
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSE-DQILSWF--VQISLG---- 113
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L+++H++ +I+HR+IKS N+ L + +AK+ DF ++ Q D+ ++ +GT Y
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYY 168
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
+PE ++K+D++S G VL EL T + P +
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 71/212 (33%), Positives = 106/212 (50%), Gaps = 33/212 (15%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
IG GS+G VYF + A+KK+ S KQ + Q+ + +V + +LK+ N +E G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGLEY 185
Y+ L E+ GS D+L K KP Q V+IA GA +GL Y
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHK-----KP------LQEVEIAAITHGALQGLAY 136
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH +IHR+IK+ N+LL + K++DF ++++ A + +GT + APE
Sbjct: 137 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPE 187
Query: 246 YAMT---GQMSSKSDVYSFGVVLLELLTGRKP 274
+ GQ K DV+S G+ +E L RKP
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIE-LAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 2e-18
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 38/215 (17%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEF----LAQVSMVSRLKNENVVELVG 128
IGEG+YG+VY ++G A+KK+ + F + ++ ++ +L++ N+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 129 YYVDGPLRVLAYEHASKGSL--------HDI--LHGKKGVKGAKPGPVLSWAQRVKIAVG 178
KGS+ HD+ L VK + +Q
Sbjct: 66 IVTSKG----------KGSIYMVFEYMDHDLTGLLDSPEVK-------FTESQIKCYMKQ 108
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
GL+YLH I+HR+IK SN+L+ +D + K++DF L+ + ++ RV+ T
Sbjct: 109 LLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-T 164
Query: 239 FGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
Y PE + + + D++S G +L EL G+
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 62/221 (28%), Positives = 116/221 (52%), Gaps = 33/221 (14%)
Query: 74 IGEGSYGRVY----FGVLRSGR----AAAIKKL--DSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG +G+V +G+ +S A+K L +++ + + ++++ ++ + K++N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 123 VVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGP------------VLSW 169
++ L+G +GPL V+ E+A+KG+L + L ++ PGP LS+
Sbjct: 80 IINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARR-----PPGPDYTFDITKVPEEQLSF 133
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229
V A ARG+EYL + R IHR++ + NVL+ +D++ KI+DF L+ D
Sbjct: 134 KDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY 190
Query: 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
++ + APE + +SDV+SFG+++ E+ T
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-18
Identities = 72/213 (33%), Positives = 107/213 (50%), Gaps = 32/213 (15%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
IG GS+G VYF +R+ AIKK+ S KQ + Q+ + +V + R+K+ N +E G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGLEY 185
Y+ L E+ GS D+L K KP Q V+IA GA +GL Y
Sbjct: 93 CYLREHTAWLVMEYCL-GSASDLLEVHK-----KP------LQEVEIAAITHGALQGLAY 140
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH +IHR+IK+ N+LL + K++DF ++ A A + +GT + APE
Sbjct: 141 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPE 191
Query: 246 YAMT---GQMSSKSDVYSFGVVLLELLTGRKPV 275
+ GQ K DV+S G+ +EL + P+
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-18
Identities = 75/246 (30%), Positives = 124/246 (50%), Gaps = 28/246 (11%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVL--RSGRAAAIKKLDSSKQPDQE 107
P++ I D + +D + IG+G+YG+V F VL ++G AA+K LD D+E
Sbjct: 2 PLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKV-FKVLNKKNGSKAAVKILDPIHDIDEE 60
Query: 108 FLAQVSMVSRLKNE-NVVELVGYY-----VDGPLRVLAYEHASKGSLHDILHG--KKGVK 159
A+ +++ L + NVV+ G Y +G L E + GS+ D++ G K+G +
Sbjct: 61 IEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER 120
Query: 160 GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219
+P ++++ I A GL++LH + IHR++K +N+LL + K+ DF +
Sbjct: 121 MEEP--IIAY-----ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGV 170
Query: 220 SNQAPDAAARLHSTRVLGTFGYHAPEY-AMTGQMSS----KSDVYSFGVVLLELLTGRKP 274
S Q + RL +GT + APE A Q+ S + DV+S G+ +EL G P
Sbjct: 171 SAQL--TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
Query: 275 VDHTLP 280
+ P
Sbjct: 229 LADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-18
Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
IG G +G V+ G R AIK + +++F+ + ++ +L + +V+L G +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
L +E G L D L ++G S + + + G+ YL
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQRG--------KFSQETLLGMCLDVCEGMAYLESSN--- 120
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT---FGYHAPEYAMTG 250
+IHR++ + N L+ ++ + K+SDF ++ D T GT + +PE
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD----QYTSSTGTKFPVKWSSPEVFSFS 176
Query: 251 QMSSKSDVYSFGVVLLELLT-GRKPVDH 277
+ SSKSDV+SFGV++ E+ + G+ P ++
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-18
Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 18/204 (8%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVELVGYY 130
IG+GS+G V+ G+ R+ + AIK +D + D+ + +++++S+ + V + G Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ G + E+ GS D+L + GP + Q + +GL+YLH +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL---------RAGPFDEF-QIATMLKEILKGLDYLHSEK 121
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
+ IHR+IK++NVLL + K++DF ++ Q D ++ +GT + APE
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQS 176
Query: 251 QMSSKSDVYSFGVVLLELLTGRKP 274
SK+D++S G+ +EL G P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-18
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 73 LIGEGSYGRVYF----GVLRSGRAA--AIKKLDSSKQPD--QEFLAQVSMVSRLKNENVV 124
+G G +G V+ G+ G +K L +K + EF ++ M +L ++NVV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILH-GKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
L+G + + E+ G L L K + KP P LS Q+V + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP-LSTKQKVALCTQIALGM 130
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
++L + R +HR++ + N L+ K+S LS + L + A
Sbjct: 131 DHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKLRNALIPLRWLA 186
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLT 270
PE S+KSDV+SFGV++ E+ T
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-18
Identities = 72/213 (33%), Positives = 106/213 (49%), Gaps = 35/213 (16%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
IG GS+G VYF +R+ AIKK+ S KQ + Q+ + +V + +L++ N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GAARGLEY 185
Y+ L E+ GS D+L K KP Q V+IA GA +GL Y
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLEVHK-----KP------LQEVEIAAVTHGALQGLAY 130
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF-DLSNQAPDAAARLHSTRVLGTFGYHAP 244
LH +IHR++K+ N+LL + + K+ DF S AP + +GT + AP
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAP 180
Query: 245 EYAMT---GQMSSKSDVYSFGVVLLELLTGRKP 274
E + GQ K DV+S G+ +E L RKP
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 5e-18
Identities = 66/216 (30%), Positives = 115/216 (53%), Gaps = 23/216 (10%)
Query: 74 IGEGSYGRVYF----GVLRSGRA----AAIKKL--DSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG +G+V G+ + A+K L D++ + + ++++ M+ + K++N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 123 VVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKK--GVKGA-----KPGPVLSWAQRVK 174
++ L+G DGPL VL E+ASKG+L + L ++ G+ + P L++ V
Sbjct: 80 IINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
A ARG+EYL A + IHR++ + NVL+ +D++ KI+DF L+ + +T
Sbjct: 139 CAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ APE + +SDV+SFGV+L E+ T
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-18
Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV-D 132
+G G +G V+ G + A+K L Q FL + +++ L+++ +V L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
P+ ++ E+ +KGSL D L +G K P + + + A G+ Y+ K
Sbjct: 74 EPIYIIT-EYMAKGSLLDFLKSDEGGKVLLP-------KLIDFSAQIAEGMAYIERK--- 122
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEYAMTG 250
IHR+++++NVL+ + + KI+DF L+ D ++ R F + APE G
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFG 179
Query: 251 QMSSKSDVYSFGVVLLELLT-GRKP 274
+ KSDV+SFG++L E++T G+ P
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 6e-18
Identities = 63/209 (30%), Positives = 107/209 (51%), Gaps = 21/209 (10%)
Query: 74 IGEGSYGRVYFGVLRSGRA---AAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVG 128
+G G++G V GV + + AIK K ++ K E + + ++ +L N +V ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ +L E AS G L+ L GKK ++ + V++ + G++YL
Sbjct: 63 V-CEAEALMLVMEMASGGPLNKFLSGKK--------DEITVSNVVELMHQVSMGMKYLEG 113
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEY 246
K +HR++ + NVLL + AKISDF LS +A A + R G + ++APE
Sbjct: 114 K---NFVHRDLAARNVLLVNQHYAKISDFGLS-KALGADDSYYKARSAGKWPLKWYAPEC 169
Query: 247 AMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ SS+SDV+S+G+ + E + G+KP
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 9e-18
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 74 IGEGSYGRVYF-GVLRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
IGEG++G V+ +G A+KK+ + + L ++ + ++ VV+L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ G VL E+ L ++L +P L AQ +G+ Y+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLR-----DEERP---LPEAQVKSYMRMLLKGVAYMHAN 118
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
I+HR++K +N+L+ D + KI+DF L+ + RL+S +V T Y APE
Sbjct: 119 ---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYG 174
Query: 250 GQMSSKS-DVYSFGVVLLELLTGR 272
+ D+++ G + ELL G
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 9e-18
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 33/211 (15%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVG 128
+GEG+YG VY ++G A+KK LD+ ++ P L ++S++ LK+ N+V+L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP-STALREISLLKELKHPNIVKLLD 65
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
L +E+ L L + G P + S ++ RGL Y H
Sbjct: 66 VIHTERKLYLVFEYCDM-DLKKYLDKRPG--PLSPNLIKSIMYQL------LRGLAYCHS 116
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS------TRVLGTFGYH 242
RI+HR++K N+L+ D + K++DF L AR T + T Y
Sbjct: 117 H---RILHRDLKPQNILINRDGVLKLADFGL--------ARAFGIPLRTYTHEVVTLWYR 165
Query: 243 APEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
APE + + S + D++S G + E++TG+
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-17
Identities = 65/216 (30%), Positives = 115/216 (53%), Gaps = 23/216 (10%)
Query: 74 IGEGSYGRVYF----GVLR------SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG +G+V G+ + + A + K D++++ + ++++ M+ + K++N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 123 VVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKK--GVK-----GAKPGPVLSWAQRVK 174
++ L+G DGPL V+ E+ASKG+L + L ++ G++ P LS+ V
Sbjct: 86 IINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
A ARG+EYL A + IHR++ + NVL+ +D++ KI+DF L+ +T
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ APE + +SDV+SFGV+L E+ T
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-17
Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 74 IGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVG 128
IG+GS+G V V R G+ K++D ++E +++V+++ LK+ N+V
Sbjct: 8 IGKGSFGTVR-KVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 129 YYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+D + L Y E+ G L ++ K + + W +I L
Sbjct: 67 RIIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFI-W----RILTQLLLALYE 120
Query: 186 LH--EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
H ++HR++K +N+ L ++ K+ DF L+ ++ + +GT Y +
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMS 178
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
PE KSD++S G ++ EL P
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-17
Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 14/197 (7%)
Query: 74 IGEGSYGRVYFGVLRSGRA-AAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYY 130
IG G++G V+ G LR+ A+K + PD +FL + ++ + + N+V L+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ E G L + GP L + +++ AA G+EYL K
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTE--------GPRLKVKELIQMVENAAAGMEYLESK- 113
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
IHR++ + N L+ + ++ KISDF +S + D + APE G
Sbjct: 114 --HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 251 QMSSKSDVYSFGVVLLE 267
+ SS+SDV+SFG++L E
Sbjct: 172 RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 65/254 (25%), Positives = 112/254 (44%), Gaps = 43/254 (16%)
Query: 40 AKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFG-VLRSGRAAAIKKL 98
+K K++T+ I + LKE ++I G G Y G +++G +K++
Sbjct: 677 SKVSKSITINDI------LSSLKE-------ENVISRGKKGASYKGKSIKNGMQFVVKEI 723
Query: 99 DSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGV 158
+ +A + +L++ N+V+L+G L +E+ +L ++L
Sbjct: 724 NDVNSIPSSEIADMG---KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---- 776
Query: 159 KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218
LSW +R KIA+G A+ L +LH + P ++ N+ +++ D
Sbjct: 777 --------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR 825
Query: 219 LSNQAP---DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 275
LS D + S Y APE T ++ KSD+Y FG++L+ELLTG+ P
Sbjct: 826 LSLPGLLCTDTKCFISS-------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA 878
Query: 276 DHTLPRGQQSLVTW 289
D S+V W
Sbjct: 879 DAEF-GVHGSIVEW 891
|
Length = 968 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-17
Identities = 61/214 (28%), Positives = 108/214 (50%), Gaps = 27/214 (12%)
Query: 73 LIGEGSYGRVYFGVLR-SGR---AAAIKKLDS--SKQPDQEFLAQVSMVSRLKNENVVEL 126
+IG G +G V+ G+L+ GR A AIK L +++ Q+FL++ S++ + + N++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G ++ E+ G+L L G S Q V + G A G++YL
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGE--------FSSYQLVGMLRGIAAGMKYL 123
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG-----Y 241
++ +HR++ + N+L+ + K+SDF LS D ++T + G +
Sbjct: 124 ---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT----SGGKIPIRW 176
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + +S SDV+SFG+V+ E+++ G +P
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-17
Identities = 61/219 (27%), Positives = 111/219 (50%), Gaps = 29/219 (13%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKL---------DSSKQPDQEFLA-QVSMVSRLKN 120
+LIG GS+G VY G+ SG A+K++ K+ + LA +++++ L++
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGP-VLSWAQRVKIAVGA 179
EN+V+ +G +D + E+ GS+ +L+ GA V ++ +++
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQI------ 115
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP----DAAARLHSTRV 235
+GL YLH + IIHR+IK +N+L+ + KISDF +S + +
Sbjct: 116 LKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
G+ + APE + K+D++S G +++E+LTG+ P
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-17
Identities = 51/147 (34%), Positives = 77/147 (52%), Gaps = 16/147 (10%)
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+Y DG + + EH GSL +L KK G P +L KI++ RGL YL E
Sbjct: 68 FYSDGEISICM-EHMDGGSLDQVL--KKA--GRIPENILG-----KISIAVLRGLTYLRE 117
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
K + I+HR++K SN+L+ K+ DF +S Q D+ A +GT Y +PE
Sbjct: 118 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQ 171
Query: 249 TGQMSSKSDVYSFGVVLLELLTGRKPV 275
+ +SD++S G+ L+E+ GR P+
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-17
Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKL-------DSSKQPDQEFLAQVSMVSRLKNENVVE 125
++G+G+YG VY G+ G+ A+K++ ++++ ++ +V ++ LK+ N+V+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+G +D + E GS+ IL+ G P PV K G+ Y
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRF----GPLPEPVFC-----KYTKQILDGVAY 117
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL----GTFGY 241
LH ++HR+IK +NV+L + I K+ DF + + + +L GT +
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE KSD++S G + E+ TG+ P
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 6e-17
Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYV 131
IG G+YG VY + +G AAIK + D + Q + M+ K+ N+V G Y+
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
+ E GSL DI H GP LS +Q ++ +GL YLH K +
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYH--------VTGP-LSESQIAYVSRETLQGLYYLHSKGK 127
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-- 249
+HR+IK +N+LL D+ K++DF +S Q A+ S +GT + APE A
Sbjct: 128 ---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVAAVER 182
Query: 250 -GQMSSKSDVYSFGVVLLELLTGRKPV 275
G + D+++ G+ +EL + P+
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-17
Identities = 61/214 (28%), Positives = 111/214 (51%), Gaps = 25/214 (11%)
Query: 73 LIGEGSYGRVYFGVLRSG---RAAAIKKLD--SSKQPDQEFLAQVSMVSRL-KNENVVEL 126
+IGEG++G+V +++ AAIK L +S+ ++F ++ ++ +L + N++ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPG--------PVLSWAQRVKIAVG 178
+G + +A E+A G+L D L K V P L+ Q ++ A
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLR-KSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
A G++YL EK + IHR++ + NVL+ ++ +KI+DF LS ++ + +G
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGR 179
Query: 239 FG--YHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ A E ++KSDV+SFGV+L E+++
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 7e-17
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V +G R AIK + + EF+ + ++ +L +E +V+L G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
+ E+ S G L + L ++ K +P +L + V G+ YL K +
Sbjct: 72 RPIYIVTEYMSNGCLLNYL--REHGKRFQPSQLLEMCKDV------CEGMAYLESK---Q 120
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEYAMTGQ 251
IHR++ + N L+ D K+SDF LS D +++ V F + PE + +
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLYSK 177
Query: 252 MSSKSDVYSFGVVLLELLT-GRKPVD 276
SSKSDV++FGV++ E+ + G+ P +
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-17
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 35/218 (16%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSS--KQPDQEFLAQVSMVSRLKNENVVELVGY 129
IG G++G V + + SG A+K++ S+ ++ + L + +V +++ + +V +
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MRSSDCPYIVKF 68
Query: 130 YVDGPLRVLAYE----------HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
Y L E S + ++ K P +L KIAV
Sbjct: 69 Y-----GALFREGDCWICMELMDISLDKFYKYVYEVL--KSVIPEEILG-----KIAVAT 116
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
+ L YL K E +IIHR++K SN+LL + K+ DF +S Q D+ A+ TR G
Sbjct: 117 VKALNYL--KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGCR 171
Query: 240 GYHAPEYAMTGQMSS---KSDVYSFGVVLLELLTGRKP 274
Y APE +SDV+S G+ L E+ TG+ P
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 9e-17
Identities = 62/242 (25%), Positives = 105/242 (43%), Gaps = 40/242 (16%)
Query: 74 IGEGSYGRVYFGV--LRSGRAAAIKKLD----SSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G+GS+G+V V +G+ A+K L ++ + L + +++SR+ + +V+L
Sbjct: 1 LGKGSFGKVL-LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 128 GYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR----- 181
Y ++ L E+A G L L + + + AR
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHLS-----------------KEGRFSEERARFYAAE 101
Query: 182 ---GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
LEYLH II+R++K N+LL D K++DF L+ + +R ++ GT
Sbjct: 102 IVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV-DHTLPRGQQSLVTWVLTSSHFL 297
Y APE + D +S GV+L E+LTG+ P + ++ L FL
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFL 216
Query: 298 SS 299
S
Sbjct: 217 SP 218
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 9e-17
Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFL-AQVSMVSRLKNENVVELVGYYV 131
IGEGS G V + SGR A+K +D KQ +E L +V ++ +++NVVE+ Y+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
G + E G+L DI+ + L+ Q + + L YLH +
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR----------LNEEQIATVCESVLQALCYLHSQG- 137
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ 251
+IHR+IKS ++LL D K+SDF Q + S ++GT + APE
Sbjct: 138 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTP 193
Query: 252 MSSKSDVYSFGVVLLELLTGRKP 274
++ D++S G++++E++ G P
Sbjct: 194 YGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 18/216 (8%)
Query: 74 IGEGSYGRVYFG------VLRSGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G+V+ + A+K L D + ++F + +++ L++E++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPV-----LSWAQRVKIAVGA 179
G DG ++ +E+ G L+ L HG + P L +Q + IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A G+ YL A +HR++ + N L+ + + KI DF +S +
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ PE M + +++SDV+SFGV+L E+ T G++P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-16
Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 73 LIGEGSYGRVYFGVLR-SGRA---AAIKKLDS--SKQPDQEFLAQVSMVSRLKNENVVEL 126
+IG G +G V G L+ G+ AIK L S +++ ++FL++ S++ + + N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G ++ E G+L L G + Q V + G A G++YL
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQ--------FTVIQLVGMLRGIAAGMKYL 122
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG---TFGYHA 243
+E +HR++ + N+L+ + + K+SDF LS D + T LG + A
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
PE + +S SDV+S+G+V+ E+++ G +P
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-16
Identities = 35/93 (37%), Positives = 47/93 (50%), Gaps = 6/93 (6%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
LEYLH K IIHR+IK N+LL + I+DF+++ + +T GT GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTTSTSGTPGY 165
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE S D +S GV E L G++P
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-16
Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 18/216 (8%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKK---LDSSKQPDQEFLAQVSMVSRLKN 120
+ ++ T S +G G+ G V KK + + ++ L ++ ++ ++
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS 62
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+V G +++ + E GSL I KKG G P +L KIAV
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIY--KKG--GPIPVEILG-----KIAVAVV 113
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
GL YL+ RI+HR+IK SN+L+ K+ DF +S + ++ A T V GT
Sbjct: 114 EGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA---DTFV-GTST 167
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
Y +PE G+ + KSDV+S G+ ++EL G+ P
Sbjct: 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 1e-16
Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 23/211 (10%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQP------DQEFLAQVSMVSRLKNENVV 124
+GEG+Y VY +GR AIKK+ ++ + L ++ ++ LK+ N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
L+ + L +E L ++ K V P + S+ RGLE
Sbjct: 66 GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIV--LTPADIKSYMLM------TLRGLE 116
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
YLH I+HR++K +N+L+ D + K++DF L+ ++ + +V+ T Y AP
Sbjct: 117 YLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM-THQVV-TRWYRAP 171
Query: 245 EYAMTGQM-SSKSDVYSFGVVLLELLTGRKP 274
E + D++S G + ELL R P
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 17/216 (7%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD----SSKQPDQEFLAQVSMVSRLK 119
NF IG+G + VY + L GR A+KK+ + Q+ L ++ ++ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSL-HDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ NV++ + +++ + E A G L I H KK K P + W V++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTI-WKYFVQLC-- 116
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
LE++H K RI+HR+IK +NV + + K+ D L HS ++GT
Sbjct: 117 --SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y +PE + KSD++S G +L E+ + P
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 2e-16
Identities = 64/229 (27%), Positives = 109/229 (47%), Gaps = 27/229 (11%)
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK 119
L++ F L+G G+YG+VY G +++G+ AAIK +D + ++E +++M+ +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60
Query: 120 N-ENVVELVGYYV-------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171
+ N+ G ++ D L L E GS+ D++ KG L
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLW-LVMEFCGAGSVTDLIKNTKG-------NTLKEEW 112
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
I RGL +LH+ ++IHR+IK NVLL ++ K+ DF +S Q R +
Sbjct: 113 IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 169
Query: 232 STRVLGTFGYHAPEYAMTGQMSS-----KSDVYSFGVVLLELLTGRKPV 275
+ +GT + APE + KSD++S G+ +E+ G P+
Sbjct: 170 T--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-16
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYV 131
+G G+YG VY L +G AA+K + D + Q + MV K+ N+V G Y+
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
+ E+ GSL DI H GP LS Q + +GL YLH K +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYH--------VTGP-LSELQIAYVCRETLQGLAYLHSKGK 127
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM--- 248
+HR+IK +N+LL D+ K++DF ++ + A+ S +GT + APE A
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAAVEK 182
Query: 249 TGQMSSKSDVYSFGVVLLELLTGRKPV 275
G + D+++ G+ +EL + P+
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-16
Identities = 57/204 (27%), Positives = 105/204 (51%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ A+K + + FLA+ +++ L+++ +V+L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 73
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E +KGSL D L +G K +P P L + + A G+ ++ ++
Sbjct: 74 PIYIIT-EFMAKGSLLDFLKSDEGSK--QPLPKL-----IDFSAQIAEGMAFIEQR---N 122
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPEYAMTGQ 251
IHR+++++N+L+ + KI+DF L+ D ++ R F + APE G
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGS 179
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
+ KSDV+SFG++L+E++T GR P
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-16
Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 74 IGEGSYGRVYFGVLR-----SGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG +G+V +G A+K L + +Q + +++++ L +EN+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 127 VGYYVDGPLRV--LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G + + L E+ GSL D L P L+ AQ + A G+
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL----------PKHKLNLAQLLLFAQQICEGMA 121
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA--RLHSTRVLGTFGYH 242
YLH + IHR++ + NVLL +D + KI DF L+ P+ R+ F Y
Sbjct: 122 YLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY- 177
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT 270
A E + S SDV+SFGV L ELLT
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-16
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 71 NSLIGEGSYGRVYFGVLRSGR----AAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVV 124
IGEG +G VY GV S A A+K K +S ++FL + ++ + + ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+L+G + P+ ++ E A G L L K L A + + + L
Sbjct: 71 KLIGVITENPVWIV-MELAPLGELRSYLQVNKYS--------LDLASLILYSYQLSTALA 121
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
YL K R +HR+I + NVL+ D K+ DF LS + + + +++ + AP
Sbjct: 122 YLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLS-RYLEDESYYKASKGKLPIKWMAP 177
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
E + +S SDV+ FGV + E+L G KP
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-16
Identities = 62/231 (26%), Positives = 109/231 (47%), Gaps = 34/231 (14%)
Query: 67 NFGTNSLIGEGSYGRVY--FGVLRSGRAA----AIKKLDSSKQPDQ--EFLAQVSMVSRL 118
N +GEG +G+V GRA A+K L + + + L++ +++ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 119 KNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR----- 172
+ +V++L G DGPL +L E+A GSL L + V P + S R
Sbjct: 61 NHPHVIKLYGACSQDGPL-LLIVEYAKYGSLRSFLRESRKVG---PSYLGSDGNRNSSYL 116
Query: 173 -------------VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219
+ A +RG++YL AE +++HR++ + NVL+ + KISDF L
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGL 173
Query: 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
S + + + ++ + A E +++SDV+SFGV+L E++T
Sbjct: 174 SRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-16
Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 39/221 (17%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKL-----DSSKQPD--QEFLAQVSMVSRLKNENVV 124
+G G++ Y +++G A+K++ SS+Q + + ++ +++RL + +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 125 ELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
++G D + E + GS+ +L K G A + RGL
Sbjct: 67 RMLGATCEDSHFNLFV-EWMAGGSVSHLLS--------KYGA-FKEAVIINYTEQLLRGL 116
Query: 184 EYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHST--------- 233
YLHE +IIHR++K +N+L+ +I+DF AAARL +
Sbjct: 117 SYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFG-------AAARLAAKGTGAGEFQG 166
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
++LGT + APE Q DV+S G V++E+ T + P
Sbjct: 167 QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-16
Identities = 46/186 (24%), Positives = 91/186 (48%), Gaps = 14/186 (7%)
Query: 95 IKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHG 154
+ +L ++ D L ++ ++S L++ N++ +++D ++ E+A+ G+L+D +
Sbjct: 35 LTRLSEKERRDA--LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVR 92
Query: 155 KKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214
+KG + + + Y+H+ I+HR+IK+ N+ L + K+
Sbjct: 93 QKGQ-------LFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKL 142
Query: 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
DF +S + V+GT Y +PE + + KSD+++ G VL ELLT ++
Sbjct: 143 GDFGISKILGSE--YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRT 200
Query: 275 VDHTLP 280
D T P
Sbjct: 201 FDATNP 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-16
Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 20/216 (9%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKN 120
K D+F S +G G+ G V + +KL + + + ++ ++ +
Sbjct: 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS 62
Query: 121 ENVVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+V G +Y DG + + EH GSL +L K + P +L K+++
Sbjct: 63 PYIVGFYGAFYSDGEISI-CMEHMDGGSLDQVLKEAKRI----PEEILG-----KVSIAV 112
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
RGL YL EK + I+HR++K SN+L+ K+ DF +S Q D+ A +GT
Sbjct: 113 LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTR 166
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 275
Y +PE S +SD++S G+ L+EL GR P+
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-16
Identities = 57/223 (25%), Positives = 106/223 (47%), Gaps = 25/223 (11%)
Query: 74 IGEGSYGRVY----FGVL--RSGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
IG+G++GRV+ G+L A+K L ++S +F + ++++ + N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILH-------------GKKGVKGAKPGPVLSWAQR 172
L+G G L +E+ + G L++ L K LS ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
+ IA A G+ YL +E + +HR++ + N L+ ++ + KI+DF LS A S
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ PE + +++SDV+++GVVL E+ + G +P
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-16
Identities = 66/219 (30%), Positives = 108/219 (49%), Gaps = 27/219 (12%)
Query: 74 IGEGSYGRVYF----GVLR---------SGRA--AAIKKL--DSSKQPDQEFLAQVSMVS 116
+GEG +G V+ G+ G+ A+K L D +K +FL ++ ++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 117 RLKNENVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKK---GVKGAKPGPVLSWAQR 172
RLKN N++ L+G V D PL + E+ G L+ L ++ A P +S A
Sbjct: 73 RLKNPNIIRLLGVCVSDDPL-CMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLH 231
+ +AV A G++YL A +HR++ + N L+ + KI+DF +S N R+
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
VL + A E + G+ ++ SDV++FGV L E+ T
Sbjct: 189 GRAVL-PIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-15
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV-D 132
+G G +G V+ G R+ AIK ++ +++F+ + ++ +L + +V+L G
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71
Query: 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
PL ++ E G L + L ++G +LS Q V G+EYL +
Sbjct: 72 KPLYIVT-EFMENGCLLNYLRQRQGKLS--KDMLLSMCQDV------CEGMEYLERNS-- 120
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG------YHAPEY 246
IHR++ + N L+ + K+SDF ++ D + G + PE
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-------DEYTSSSGAKFPVKWSPPEV 172
Query: 247 AMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ SSKSDV+SFGV++ E+ T G+ P
Sbjct: 173 FNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 59/216 (27%), Positives = 110/216 (50%), Gaps = 23/216 (10%)
Query: 74 IGEGSYGRVYFGVL--------RSGRAAAIKKL--DSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG +G+V + A+K L D++++ + ++++ M+ + K++N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 123 VVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVK 174
++ L+G DGPL V+ E+ASKG+L + L ++ P +++ V
Sbjct: 83 IINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
ARG+EYL A + IHR++ + NVL+ ++++ KI+DF L+ + +T
Sbjct: 142 CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ APE + +SDV+SFGV++ E+ T
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-15
Identities = 61/214 (28%), Positives = 110/214 (51%), Gaps = 25/214 (11%)
Query: 73 LIGEGSYGRVYFGVLRSG---RAAAIKKLD--SSKQPDQEFLAQVSMVSRLKNE-NVVEL 126
+IGEG++G+V ++ AAIK++ +SK ++F ++ ++ +L + N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPG--------PVLSWAQRVKIAVG 178
+G LA E+A G+L D L K V P LS Q + A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
ARG++YL +K + IHR++ + N+L+ ++ +AKI+DF LS ++ + +G
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGR 172
Query: 239 FG--YHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ A E ++ SDV+S+GV+L E+++
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-15
Identities = 62/234 (26%), Positives = 113/234 (48%), Gaps = 27/234 (11%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSM 114
I + L++ F ++G G+YG+VY G +++G+ AAIK +D ++ ++E +++M
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINM 65
Query: 115 VSRLKNE-NVVELVGYYV-------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV 166
+ + + N+ G ++ D L L E GS+ D++ KG +
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLW-LVMEFCGAGSVTDLVKNTKGNALKE---- 120
Query: 167 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226
W + + RGL +LH ++IHR+IK NVLL ++ K+ DF +S Q
Sbjct: 121 -DWIAYICREI--LRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 174
Query: 227 AARLHSTRVLGTFGYHAPEYAMTGQ-----MSSKSDVYSFGVVLLELLTGRKPV 275
R ++ +GT + APE + +SD++S G+ +E+ G P+
Sbjct: 175 VGRRNT--FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK 119
K D+F S +G G+ G V F V SG A K + +P + + ++ ++
Sbjct: 3 KDDDFEKISELGAGN-GGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 120 NENVVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ +V G +Y DG + + EH GSL +L KK G P +L K+++
Sbjct: 62 SPYIVGFYGAFYSDGEISI-CMEHMDGGSLDQVL--KKA--GRIPEQILG-----KVSIA 111
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
+GL YL EK +I+HR++K SN+L+ K+ DF +S Q D+ A +GT
Sbjct: 112 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGT 165
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 275
Y +PE S +SD++S G+ L+E+ GR P+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 45/119 (37%), Positives = 64/119 (53%), Gaps = 16/119 (13%)
Query: 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
P +L KIAV + LEYLH K +IHR++K SNVL+ + K+ DF +S
Sbjct: 101 PEDILG-----KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGY 153
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSS-----KSDVYSFGVVLLELLTGRKPVD 276
D+ A+ T G Y APE + +++ KSDV+S G+ ++EL TGR P D
Sbjct: 154 LVDSVAK---TIDAGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-15
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 74 IGEGSYGRV---YFGVLRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G G++G V + + +S + A+K L ++ E L + +++ +L N +V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G + +L E A G L+ L K V + +V + G++YL
Sbjct: 63 GI-CEAESWMLVMELAELGPLNKFLQKNKHVTEKN---ITELVHQVSM------GMKYLE 112
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--GYHAPE 245
E +HR++ + NVLL AKISDF LS +A A + + G + ++APE
Sbjct: 113 ET---NFVHRDLAARNVLLVTQHYAKISDFGLS-KALGADENYYKAKTHGKWPVKWYAPE 168
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ SSKSDV+SFGV++ E + G+KP
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-15
Identities = 56/206 (27%), Positives = 106/206 (51%), Gaps = 26/206 (12%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
IGEGS+G+ + G+ IK+++ SK +E +V+++S +K+ N+V+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ + + ++ G L+ ++ ++GV + +L W ++ +A L+++H++
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPED-QILDWFVQICLA------LKHVHDR 120
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL-----GTFGYHAP 244
+I+HR+IKS N+ L D K+ DF + A L+ST L GT Y +P
Sbjct: 121 ---KILHRDIKSQNIFLTKDGTIKLGDFGI-------ARVLNSTVELARTCIGTPYYLSP 170
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLT 270
E ++KSD+++ G VL E+ T
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-15
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 66 DNFGTNSLIGEGSYGRVY-FGVLRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNE 121
+ + ++GEG+YG V +G AIKK + + + L +V ++ +L++E
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 122 NVVELVGYY-VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV--LSWAQRVKIAVG 178
N+V L + G L L +E+ + +L ++L G G P V W Q ++
Sbjct: 61 NIVNLKEAFRRKGRL-YLVFEYVER-TLLELLEASPG--GLPPDAVRSYIW-QLLQ---- 111
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
+ Y H IIHR+IK N+L+ + + K+ DF + A T + T
Sbjct: 112 ---AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALR-ARPASPLTDYVAT 164
Query: 239 FGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE + K DV++ G ++ ELL G
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-15
Identities = 70/223 (31%), Positives = 108/223 (48%), Gaps = 31/223 (13%)
Query: 74 IGEGSYGRVYFGVL------RSGRAAAIKKL-DSSKQP-DQEFLAQVSMVSRLKNENVVE 125
+GE +G+VY G L +A AIK L D ++ P +EF + M SRL++ N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 126 LVGYYV-DGPLRVLAYEHASKGSLHDIL-----HGKKG-------VKGAKPGPVLSWAQR 172
L+G + PL ++ + + S LH+ L H G VK L A
Sbjct: 73 LLGVVTKEQPLSMI-FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST-----LEPADF 126
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
V I A G+E+L + ++H+++ + NVL+FD KISD L + A
Sbjct: 127 VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
L + +PE M G+ S SD++S+GVVL E+ + G +P
Sbjct: 184 GNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-15
Identities = 58/213 (27%), Positives = 110/213 (51%), Gaps = 23/213 (10%)
Query: 73 LIGEGSYGRVYFGVLRSG---RAAAIKKLD--SSKQPDQEFLAQVSMVSRL-KNENVVEL 126
+IGEG++G+V ++ AAIK++ +SK ++F ++ ++ +L + N++ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGA 179
+G LA E+A G+L D L + ++ LS Q + A
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
ARG++YL +K + IHR++ + N+L+ ++ +AKI+DF LS ++ + +G
Sbjct: 134 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 185
Query: 240 G--YHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ A E ++ SDV+S+GV+L E+++
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 7e-15
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 74 IGEGSYGRVYFG-VLRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVG-Y 129
+G G+ G VY L + R A+K LD + + ++ ++++ ++ + + ++ G +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+V+ + + E GSL V P VL +IAV +GL YL
Sbjct: 69 FVENRISICT-EFMDGGSLD--------VYRKIPEHVLG-----RIAVAVVKGLTYLWSL 114
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
+I+HR++K SN+L+ K+ DF +S Q ++ A+ + +GT Y APE
Sbjct: 115 ---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY----VGTNAYMAPERISG 167
Query: 250 GQMSSKSDVYSFGVVLLELLTGRKP 274
Q SDV+S G+ +EL GR P
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 74 IGEGSYGRVYFGVLRS------GRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVE 125
+G+GS+G VY G+ + AIK ++ + + EFL + S++ +VV
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVL-SWAQRVKIAVGAARGLE 184
L+G G ++ E ++G L L + P S + +++A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
YL+ + +HR++ + N ++ +D KI DF ++ + + L + +P
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLT 270
E G ++ SDV+SFGVVL E+ T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
IGEG+YG VY +G AIKK+ + + + L ++ ++ L + N+++L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ L +E D+ +K + G L + +GL + H
Sbjct: 67 FRHKGDLYLVFEFM----DTDLYKL---IKDRQRG--LPESLIKSYLYQLLQGLAFCHSH 117
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLH--STRVLGTFGYHAPEY 246
I+HR++K N+L+ + + K++DF L+ H TR Y APE
Sbjct: 118 ---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPEL 169
Query: 247 AMT-GQMSSKSDVYSFGVVLLELLTGR 272
+ S+ D++S G + ELL+ R
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-14
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 73 LIGEGSYGRVYFGVLR-SGR---AAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVEL 126
+IG G +G V G L+ G+ AIK L + Q +FL++ S++ + + N++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G ++ E+ GSL L G + Q V + G A G++YL
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ--------FTVIQLVGMLRGIASGMKYL 122
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLGTFGYHA 243
++ +HR++ + N+L+ + + K+SDF LS P+AA ++ + A
Sbjct: 123 ---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTA 177
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
PE + +S SDV+S+G+V+ E+++ G +P
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 47/224 (20%)
Query: 74 IGEGSYGRVYFGVL---RSGRAAAIKKLDSSKQPDQEF----LAQVSMVSRLKNENVVEL 126
IG G+YGRVY + G+ AIKK K+ +++++ LK+ENVV L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 127 VGYYV-DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSW---AQRVKIAVGAAR 181
V ++ V L +++A HD+ ++ + A+RV I +
Sbjct: 68 VEVFLEHADKSVYLLFDYAE----HDLWQ------------IIKFHRQAKRVSIPPSMVK 111
Query: 182 --------GLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKISDFDLSN--QAPDAA 227
G+ YLH ++HR++K +N+L+ + + KI D L+ AP
Sbjct: 112 SLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP-LK 167
Query: 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLT 270
V+ T Y APE + + +K+ D+++ G + ELLT
Sbjct: 168 PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-14
Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 35/222 (15%)
Query: 66 DNFGTNSLIGEGSYGRVY----FGVLRSGRA--AAIKKLDSSKQPD--QEFLAQVSMVSR 117
+N +G G++G+V +G+ +S A+K L + + ++++ ++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 118 LKN-ENVVELVGY-YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
L N EN+V L+G + GP+ V+ E+ G L + L K+ L+ +
Sbjct: 95 LGNHENIVNLLGACTIGGPILVI-TEYCCYGDLLNFLRRKRES-------FLTLEDLLSF 146
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL-------SNQAPDAAA 228
+ A+G+ +L K IHR++ + NVLL I KI DF L SN A
Sbjct: 147 SYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNA 203
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
RL + APE + +SDV+S+G++L E+ +
Sbjct: 204 RL-------PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 3e-14
Identities = 57/241 (23%), Positives = 88/241 (36%), Gaps = 66/241 (27%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSS------KQPD--QE-----FLAQVSMVSRL 118
+IGEGS+ V + + + AIK LD K E L + +L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 119 -----KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW--AQ 171
EN+ Y+V E+A G L + G+ + A+
Sbjct: 68 YYTFQDEENL-----YFV--------LEYAPNGELLQYIR----KYGSLDEKCTRFYAAE 110
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ--------- 222
+ LEYLH K IIHR++K N+LL D KI+DF +
Sbjct: 111 ILLA-------LEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160
Query: 223 ---------APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 273
+ R +GT Y +PE SD+++ G ++ ++LTG+
Sbjct: 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
Query: 274 P 274
P
Sbjct: 221 P 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-14
Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 20/210 (9%)
Query: 73 LIGEGSYGRVYFGV-LRSGRA----AAIKKLD--SSKQPDQEFLAQVSMVSRLKNENVVE 125
L+G G +G V+ G+ + G + AIK + S +Q QE + + L + +V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L+G G L + + GSL D + + P +L+W ++ A+G+ Y
Sbjct: 74 LLGI-CPGASLQLVTQLSPLGSLLDHVRQHRDSLD--PQRLLNWCVQI------AKGMYY 124
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
L E R++HRN+ + N+LL D I +I+DF +++ + + + A E
Sbjct: 125 LEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ G+ + +SDV+S+GV + E+++ G +P
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-14
Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 12/206 (5%)
Query: 74 IGEGSYGRVYFGVLR---SGRA---AAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVE 125
+G+GS+G VY G R G A A+K ++ S + EFL + S++ +VV
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPG-PVLSWAQRVKIAVGAARGLE 184
L+G G ++ E + G L L + PG P + + +++A A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
YL+ K + +HR++ + N ++ D KI DF ++ + + L + AP
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLT 270
E G ++ SD++SFGVVL E+ +
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-14
Identities = 59/224 (26%), Positives = 104/224 (46%), Gaps = 39/224 (17%)
Query: 73 LIGEGSYGRVYFGVLRSG-----RAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVE 125
L+ EG++GR+++G+L +K + Q L + ++ L ++N++
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 126 LVGYYV-DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
++ + DG + Y + + G+L L + + P LS Q V +A+ A G+
Sbjct: 73 ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNP-QALSTQQLVHMAIQIACGMS 131
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH-- 242
YLH++ +IH++I + N ++ ++ KI+D LS R L YH
Sbjct: 132 YLHKR---GVIHKDIAARNCVIDEELQVKITDNALS-------------RDLFPMDYHCL 175
Query: 243 -----------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A E + + SS SDV+SFGV+L EL+T G+ P
Sbjct: 176 GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-14
Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD---SSKQPDQEFLA---QVSMVSRLK 119
N+ L+G+G++GRVY + +GR A+K++ S + +E A ++ ++ L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+E +V+ G D + E+ GS+ D L G + R K
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--------KAYGALTETVTR-KYTRQI 113
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR----- 234
G+EYLH I+HR+IK +N+L K+ DF A+ RL +
Sbjct: 114 LEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDF-------GASKRLQTICSSGTG 163
Query: 235 ---VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
V GT + +PE K+DV+S G ++E+LT + P
Sbjct: 164 MKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 7e-14
Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 72 SLIGEGSYGRVY-FGVLRSGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKN-ENVVELV 127
IG G+ G+VY ++G A+K++ +K+ ++ L + +V + + +V+
Sbjct: 21 GEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
GY++ + E S + D L K ++G P +L K+ V + L YL
Sbjct: 81 GYFITDSDVFICMELMS--TCLDKL--LKRIQGPIPEDILG-----KMTVAIVKALHYLK 131
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY- 246
EK +IHR++K SN+LL K+ DF +S + D+ A+ TR G Y APE
Sbjct: 132 EKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPERI 186
Query: 247 ---AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ ++DV+S G+ L+EL TG+ P
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-13
Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 74 IGEGSYGRVYFGVLRS--GRAAAIKK----LDSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G+G+YG VY VL G A+K+ LD SK + + ++ ++ + + +V+
Sbjct: 9 LGKGNYGSVY-KVLHRPTGVTMAMKEIRLELDESKF--NQIIMELDILHKAVSPYIVDFY 65
Query: 128 G-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G ++++G + + E+ GSL D L+ P VL +I +GL++L
Sbjct: 66 GAFFIEGAV-YMCMEYMDAGSL-DKLYAGGVATEGIPEDVLR-----RITYAVVKGLKFL 118
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246
K E IIHR++K +NVL+ + K+ DF +S + A+ + +G Y APE
Sbjct: 119 --KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPER 172
Query: 247 AMTGQMSS------KSDVYSFGVVLLELLTGRKP 274
+G + +SDV+S G+ +LE+ GR P
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 30/221 (13%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEF----LAQVSMVSRLKN 120
D + + I EG+YG VY ++G A+KKL K+ + F L +++++ +L++
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE-KEGFPITSLREINILLKLQH 63
Query: 121 ENVVEL----VGYYVDGPLRVLAY-EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
N+V + VG +D V+ Y EH K + P ++ +
Sbjct: 64 PNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMET-----------MKQP-FLQSEVKCL 111
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
+ G+ +LH+ I+HR++K+SN+LL + I KI DF L+ + T++
Sbjct: 112 MLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQL 166
Query: 236 LGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPV 275
+ T Y APE + + S+ D++S G + ELLT +KP+
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 24/210 (11%)
Query: 72 SLIGEGSYGRV---YFGVLR--SGRAAAIKKLD-SSKQPDQEFLAQVSMVSRLKNENVVE 125
+G+G++G V + L+ +G A+KKL S+ + ++F ++ ++ L+++N+V+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 126 L--VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
V Y L E+ GSL D L + + +L +A ++ +G+
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRK--LLLYASQI------CKGM 121
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG---TFG 240
EYL K R +HR++ + N+L+ ++ KI DF L+ P + R G F
Sbjct: 122 EYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP-QDKEYYKVREPGESPIFW 177
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
Y APE + S SDV+SFGVVL EL T
Sbjct: 178 Y-APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 26/219 (11%)
Query: 74 IGEGSYGRVY--------------FGVLRSGRA---AAIKKL--DSSKQPDQEFLAQVSM 114
+GEG +G V+ F + SG A+K L D++K +FL ++ +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQR 172
+SRLK+ N++ L+ + + E+ G L+ L H + +S++
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLH 231
+ +A A G++YL + +HR++ + N L+ + KI+DF +S N R+
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
VL + + E + G+ ++ SDV++FGV L E+LT
Sbjct: 190 GRAVL-PIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-13
Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 46/220 (20%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVG 128
+G+G +G V ++ +G+ A KKLD ++ +Q L + ++ ++ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-- 58
Query: 129 YYVDGPLRVLAYEHASKGSLHDIL--------------HGKKGVKGAKPGPVLSWAQRVK 174
AY +K L ++ G+ P A+ +
Sbjct: 59 ----------AYAFETKDDLCLVMTLMNGGDLKYHIYNVGE---------PGFPEARAIF 99
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
A GLE+LH++ RI++R++K NVLL D +ISD L A +
Sbjct: 100 YAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGL---AVELKGGKKIKG 153
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT GY APE D ++ G L E++ GR P
Sbjct: 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 57/204 (27%), Positives = 107/204 (52%), Gaps = 24/204 (11%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNENVVELVG-YY 130
+G+G++G+VY + +G AA K +++ + + ++++ ++ +++ + +V+L+G +Y
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 131 VDGPLRVLAYEHASKGSLHDI-LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
DG L ++ E G++ I L +G+ +P Q I L+YLH
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRGLT--EP-------QIQVICRQMLEALQYLHSM 129
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
+IIHR++K+ NVLL D K++DF +S + R S +GT + APE M
Sbjct: 130 ---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMC 184
Query: 250 GQMSS-----KSDVYSFGVVLLEL 268
M K+D++S G+ L+E+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-13
Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 26/208 (12%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKL-----DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
I +G++G VY R +G AIK L + Q + M+ + ++ V +L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV-LSWAQRVKIAVGAARGLEYL 186
+ L E+ + G ++ G + WA+ + G+E L
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIK--------TLGGLPEDWAK--QYIAEVVLGVEDL 113
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246
H++ IIHR+IK N+L+ K++DF LS L + + +GT Y APE
Sbjct: 114 HQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDYLAPET 164
Query: 247 AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ SD +S G V+ E L G P
Sbjct: 165 ILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 8e-13
Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 39/221 (17%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKK----LDSSKQPDQEFLAQVSMVSRLKN---ENV 123
+ IGEG+YG VY L +GR A+KK L P L +++++ +L++ N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP-LSTLREIALLKQLESFEHPNI 63
Query: 124 VEL----VGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
V L G D L++ L +EH + L L K KPG L +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLS-----KCPKPG--LPPETIKDLMRQ 115
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-----T 233
RG+++LH RI+HR++K N+L+ D KI+DF L AR++S T
Sbjct: 116 LLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGL--------ARIYSFEMALT 164
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
V+ T Y APE + ++ D++S G + EL R+P
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 27/207 (13%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLD---SSKQPDQEFLAQVSMVSRLKNENVVELVGY 129
+G+GSYG V R+ G+ IKKL+ +S++ + + ++S+LK+ N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 130 YV--DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
+ DG L ++ G L+ L +KG +L Q V+ V A L+YLH
Sbjct: 68 WEGEDGLLYIVM-GFCEGGDLYHKLKEQKG-------KLLPENQVVEWFVQIAMALQYLH 119
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFD----LSNQAPDAAARLHSTRVLGTFGYHA 243
EK I+HR++K+ NV L +I K+ D L NQ D A+ L +GT Y +
Sbjct: 120 EK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DMASTL-----IGTPYYMS 170
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLT 270
PE + KSDV++ G + E+ T
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 50/222 (22%)
Query: 73 LIGEGSYGRVYFGVL----RSGRAAAIKKLD--SSKQPDQEFLAQVSMVSRLKNENVVEL 126
+IG+G +G VY G L A+K L+ + + ++FL + ++ + NV+ L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 127 VGYYVD---GPLRVLAYEHASKGSLHDILHG--KKGVKGAKPGPVLSWAQRVKIAVG--- 178
+G + PL VL Y + HG + ++ P VK +G
Sbjct: 62 LGICLPSEGSPLVVLPY----------MKHGDLRNFIRSETHNPT------VKDLIGFGL 105
Query: 179 -AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD---------AAA 228
A+G+EYL A + +HR++ + N +L + K++DF L+ D A
Sbjct: 106 QVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGA 162
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+L + A E T + ++KSDV+SFGV+L EL+T
Sbjct: 163 KL-------PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKK-LDSSKQPDQEFLA--QVSMVSRL 118
EK +N G L+GEGSYG V + +G+ AIKK L+S + +A ++ M+ +L
Sbjct: 1 EKYENLG---LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL 57
Query: 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV-KIAV 177
++EN+V L+ + L +E L D+ G+ RV K
Sbjct: 58 RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLD----------ESRVRKYLF 107
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
RG+E+ H IIHR+IK N+L+ + K+ DF + AA T +
Sbjct: 108 QILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVYTDYVA 162
Query: 238 TFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTG 271
T Y APE + ++ D+++ G ++ E+LTG
Sbjct: 163 TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 1e-12
Identities = 68/216 (31%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVG 128
I +G+YGRV+ +S G AIK + + K + L + ++S+ ++ VV+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 129 YYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA--VGAARGLEY 185
Y G + L E+ G L +L G+ A R+ IA V A LEY
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENV----GSLDE---DVA-RIYIAEIVLA---LEY 108
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS------NQAPDAAARLHSTRVLGTF 239
LH IIHR++K N+L+ + K++DF LS Q R++GT
Sbjct: 109 LHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP 165
Query: 240 GYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
Y APE + GQ SK+ D +S G +L E L G P
Sbjct: 166 DYIAPE-VILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-12
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 73 LIGEGSYGRVYFGVL----RSGRAAAIKKLDSSKQPDQE--FLAQVSMVSRLKNENVVEL 126
++G G +G + G L + AI L + Q FLA+ + + + N+V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G G ++ E+ S G+L L +G L Q + + G A G++YL
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--------LVAGQLMGMLPGLASGMKYL 123
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST-RVLGTFGYHAPE 245
+E +H+ + + VL+ D + KIS F + D + +++T + APE
Sbjct: 124 ---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE--DKSEAIYTTMSGKSPVLWAAPE 178
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
SS SDV+SFG+V+ E+++ G +P
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEF----LAQVSMVSRLKNENVVELVG 128
+GEG++G VY +++GR A+KK+ + D F L ++ ++ +LK+ NVV L+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLID 74
Query: 129 YYVDGPLRVLAYEHASKGSLHDIL----HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
V+ P + +GS++ + H G+ P L+ +Q + G+
Sbjct: 75 MAVERPDK----SKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIKCYMLQLLEGIN 129
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL---------SNQAPDAAARLHSTRV 235
YLHE I+HR+IK++N+L+ + I KI+DF L + + T +
Sbjct: 130 YLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 236 LGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
+ T Y PE + + ++ D++ G V E+ T R
Sbjct: 187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 58/212 (27%), Positives = 108/212 (50%), Gaps = 20/212 (9%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAA----AIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVE 125
++G G++G VY G+ + G AIK L+ + P + EF+ + +++ + + ++V
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L+G + P L + G L D +H K G++ +L+W ++ A+G+ Y
Sbjct: 74 LLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQL--LLNWCVQI------AKGMMY 124
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
L E+ R++HR++ + NVL+ + KI+DF L+ ++ + A E
Sbjct: 125 LEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKPVD 276
+ + +SDV+S+GV + EL+T G KP D
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 25/200 (12%)
Query: 89 SGRAAAIKKLDSSKQPDQE----FLAQVSMVSRLKNENVVELVGYYVDGPLRVLA-YEHA 143
+G AIK L + ++ F + ++ +RL + N+V L+ P + A +E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSN 203
+L ++L A G L + ++ + L H + I+HR++K N
Sbjct: 62 PGRTLREVL--------AADGA-LPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQN 109
Query: 204 VLLFDDDI---AKISDFDLSNQAPDA--AARLHSTR---VLGTFGYHAPEYAMTGQMSSK 255
+++ + AK+ DF + P A TR VLGT Y APE ++
Sbjct: 110 IMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPN 169
Query: 256 SDVYSFGVVLLELLTGRKPV 275
SD+Y++G++ LE LTG++ V
Sbjct: 170 SDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 38/216 (17%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLD-------SSKQPDQEFLAQVSMVSRLKNENVVE 125
IG G++G V+ R G+ A+KK+ S K+ ++ M+ K++NV+
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKR----VFRELKMLCFFKHDNVLS 63
Query: 126 LVGYYVDGPLRVLAYEHA------SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV-G 178
+ + P + +E + LH I+ P P LS + VK+ +
Sbjct: 64 ALD--ILQPPHIDPFEEIYVVTELMQSDLHKII--------VSPQP-LS-SDHVKVFLYQ 111
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN-QAPDAAARLHSTRVLG 237
RGL+YLH I+HR+IK N+L+ + + KI DF L+ + PD H T+ +
Sbjct: 112 ILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVV 166
Query: 238 TFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGR 272
T Y APE M + +S D++S G + ELL R
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-12
Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 36/225 (16%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD---SSKQPDQEFLA---QVSMVSRLK 119
N+ L+G+G++GRVY +GR A+K++ S + +E A ++ ++ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 120 NENVVELVGYYVDGPLRVLA--YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+E +V+ G D R L+ EH GS+ D L K L+ K
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL---------KSYGALTENVTRKYTR 113
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS----- 232
G+ YLH I+HR+IK +N+L K+ DF A+ RL +
Sbjct: 114 QILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFG-------ASKRLQTICLSG 163
Query: 233 ---TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
V GT + +PE K+D++S G ++E+LT + P
Sbjct: 164 TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-12
Identities = 58/233 (24%), Positives = 99/233 (42%), Gaps = 46/233 (19%)
Query: 71 NSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQP-----DQEFLAQVSM---------- 114
+ +GEG+YG+V +G+ AIKK+ + D++ + +
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGK-KGVKGAKPGPVLSWAQRV 173
++ +K+EN++ LV YV+G L + DI+ K V K L+ +Q
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINL---------VMDIMASDLKKVVDRKI--RLTESQVK 122
Query: 174 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF-------------DLS 220
I + GL LH+ +HR++ +N+ + I KI+DF LS
Sbjct: 123 CILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 221 NQAPDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
+++V+ T Y APE M + D++S G + ELLTG+
Sbjct: 180 KDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 6e-12
Identities = 57/212 (26%), Positives = 104/212 (49%), Gaps = 29/212 (13%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELV-G 128
++GEGS+GR + S + A+K +L S ++ + +++++K+ N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ DG L ++ E+ G L + ++G K +L W ++ + V +++HE
Sbjct: 67 FEADGHLYIVM-EYCDGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGV------QHIHE 118
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV------LGTFGYH 242
K R++HR+IKS N+ L + K+ DF +ARL ++ +GT Y
Sbjct: 119 K---RVLHRDIKSKNIFLTQNGKVKLGDF--------GSARLLTSPGAYACTYVGTPYYV 167
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
PE ++KSD++S G +L EL T + P
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-12
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 40/215 (18%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVEL---- 126
+GEG+Y VY G R +G A+K LD+ + + ++S++ LK+EN+V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 127 --------VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
V Y+D L+ H +G+L P V S+ ++
Sbjct: 68 HTENKLMLVFEYMDKDLKKYMDTHGVRGAL-------------DPNTVKSFTYQL----- 109
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
+G+ + HE R++HR++K N+L+ K++DF L+ +A S V+ T
Sbjct: 110 -LKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLA-RAFGIPVNTFSNEVV-T 163
Query: 239 FGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y AP+ + + S S D++S G ++ E++TGR
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 20/221 (9%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGV-LRSGR----AAAIKKLDSSKQP--DQEFLAQVSMVS 116
K F ++G G++G VY G+ + G AIK+L + P ++E L + +++
Sbjct: 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 64
Query: 117 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
+ N +V L+G + ++++ + G L D + K G++ +L+W
Sbjct: 65 SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNWC------ 115
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
V A+G+ YL E+ R++HR++ + NVL+ KI+DF L+ H+
Sbjct: 116 VQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVD 276
+ A E + + +SDV+S+GV + EL+T G KP D
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 68/253 (26%), Positives = 109/253 (43%), Gaps = 54/253 (21%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKK-LDSSKQPDQEFLA--QVSMVSRLKNENVVELVGY 129
IGEGSYG V+ R +G+ AIKK ++S P + +A ++ M+ +LK+ N+V L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ L +E+ L+++ +GV KI + + + H+
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEH---------LIKKIIWQTLQAVNFCHKH 119
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS------TRVLGTFGYHA 243
IHR++K N+L+ K+ DF AR+ + T + T Y A
Sbjct: 120 ---NCIHRDVKPENILITKQGQIKLCDFGF--------ARILTGPGDDYTDYVATRWYRA 168
Query: 244 PEYAMTG--QMSSKSDVYSFGVVLLELLT------GRKPVDH------TL----PRGQQS 285
PE + G Q DV++ G V ELLT G+ VD TL PR QQ
Sbjct: 169 PEL-LVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQ- 226
Query: 286 LVTWVLTSSHFLS 298
+ +++ F
Sbjct: 227 ----IFSTNQFFK 235
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 15/213 (7%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD----SSKQPDQEFLAQVSMVSRLKNE 121
NF IG G + VY L G A+KK+ + + + ++ ++ +L +
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
NV++ +++ + E A G L ++ K K P + W K V
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV-W----KYFVQLCS 117
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
LE++H + R++HR+IK +NV + + K+ D L HS ++GT Y
Sbjct: 118 ALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+PE + KSD++S G +L E+ + P
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 1e-11
Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 44/222 (19%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVE 125
IG G+YG V V R+GR AIKK+ S D A+ + ++ L++EN++
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRHENIIG 63
Query: 126 LVGYYVDGPLRVLAYEHASKGS------------LHDILHGKKGVKGAKPGPVLSWAQRV 173
L L +L + LH ++ + L+ +
Sbjct: 64 L--------LDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQ---------PLT-DDHI 105
Query: 174 K-IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLH 231
+ RGL+YLH +IHR++K SN+L+ + KI DF L+ PD +
Sbjct: 106 QYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
T + T Y APE ++ +K+ D++S G + ELLT +
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-11
Identities = 49/209 (23%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ--PDQEFLAQ--VSMVSRLKNENVVELVG 128
++G G++G V+ ++ + I K +Q D+ AQ ++ L + N++E
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+++ ++ E+A G+L + + K+ +L + ++ +A L ++H
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQ-KRCNSLLDEDTILHFFVQILLA------LHHVHT 119
Query: 189 KAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 247
K I+HR++K+ N+LL + KI DF +S + + V+GT Y +PE
Sbjct: 120 K---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELC 173
Query: 248 MTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
+ KSD+++ G VL EL + ++ +
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 57/210 (27%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVG 128
IGEG+YG VY G ++G+ A+KK L+S ++ P + ++S++ L++ N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA-IREISLLKELQHPNIVCLQD 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ L +E S L L + V S+ ++ +G+ + H
Sbjct: 67 VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQI------LQGILFCHS 119
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
+ R++HR++K N+L+ + + K++DF L+ +A R+++ V+ T Y APE +
Sbjct: 120 R---RVLHRDLKPQNLLIDNKGVIKLADFGLA-RAFGIPVRVYTHEVV-TLWYRAPEVLL 174
Query: 249 TGQM-SSKSDVYSFGVVLLELLTGRKPVDH 277
S+ D++S G + E+ T +KP+ H
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMAT-KKPLFH 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 53/212 (25%), Positives = 106/212 (50%), Gaps = 20/212 (9%)
Query: 73 LIGEGSYGRVYFGV-------LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVE 125
++G G++G VY G+ ++ A + + ++S + ++E L + +++ + + V
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L+G + ++ L + G L D + K G++ +L+W ++ A+G+ Y
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQD--LLNWCVQI------AKGMSY 124
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
L E R++HR++ + NVL+ + KI+DF L+ H+ + A E
Sbjct: 125 LEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKPVD 276
+ + + +SDV+S+GV + EL+T G KP D
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 62/235 (26%), Positives = 105/235 (44%), Gaps = 42/235 (17%)
Query: 74 IGEGSYGRVYF-----------------GVLRSGRAAAIKKL--DSSKQPDQEFLAQVSM 114
+GEG +G V+ + A+K L D+S ++FL +V +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQR 172
+SRL + N+ L+G P + E+ G L+ L H + A LS++
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
+ +A A G+ YL +HR++ + N L+ + KI+DF +S + + +
Sbjct: 133 LYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSR---NLYSSDYY 186
Query: 233 TRVLGTFGYHAP--------EYAMTGQMSSKSDVYSFGVVLLELLT--GRKPVDH 277
RV G AP E + G+ ++KSDV++FGV L E+LT +P +H
Sbjct: 187 -RVQG----RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIK------KLDSSKQPD-QEFLAQVSMVSRLKNENVVE 125
++GEG +G V G L + +K KLD + +EFL++ + + + NV++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 126 LVGYYVDG--------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
L+G + P+ +L + G LH L + + P+ +K V
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPF--MKHGDLHSFLLYSRLGGLPEKLPL---QTLLKFMV 120
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ--APDAAARLHSTRV 235
A G+EYL + IHR++ + N +L +D ++DF LS + + D + ++
Sbjct: 121 DIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ A E +SKSDV++FGV + E+ T G+ P
Sbjct: 178 --PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 15/213 (7%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNE 121
NF IG G + VY L + A+KK+ + D Q+ + ++ ++ +L +
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
NV++ + +++ + E A G L ++ K K P + W K V
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-W----KYFVQLCS 117
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
+E++H + R++HR+IK +NV + + K+ D L HS ++GT Y
Sbjct: 118 AVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+PE + KSD++S G +L E+ + P
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 23/208 (11%)
Query: 74 IGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVEL 126
+GEG +G+V +G A+K L + + ++ ++ L +EN+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 127 VGYYVDGPLR--VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G + L E GSL + L K K Q++K AV +G++
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK--------QQLKYAVQICKGMD 123
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN--QAPDAAARLHSTRVLGTFGYH 242
YL + + +HR++ + NVL+ + KI DF L+ + + F Y
Sbjct: 124 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY- 179
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT 270
APE + + SDV+SFGV L ELLT
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 53/203 (26%), Positives = 106/203 (52%), Gaps = 22/203 (10%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNENVVELV-GYY 130
+G+G++G+VY + +G AA K +D+ + + ++++ ++ +++ + N+V+L+ +Y
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ L +L E + G++ ++ ++ +P L+ Q + L YLHE
Sbjct: 73 YENNLWILI-EFCAGGAVDAVM-----LELERP---LTEPQIRVVCKQTLEALNYLHEN- 122
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
+IIHR++K+ N+L D K++DF +S + R S +GT + APE M
Sbjct: 123 --KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCE 178
Query: 251 QMSS-----KSDVYSFGVVLLEL 268
K+DV+S G+ L+E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 17/211 (8%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQ---EFLAQVSMVSRLKNE 121
+ F ++GEG+YG V + + AIKK S++ ++ L ++ M+ LK E
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N+VEL + L +E+ K L + ++ G P V S+ ++ +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVRSYIYQL------IK 111
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
+ + H+ I+HR+IK N+L+ +D+ K+ DF + + + + T + T Y
Sbjct: 112 AIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNANYTEYVATRWY 167
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
+PE + D++S G +L EL G+
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 33/91 (36%), Positives = 48/91 (52%)
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+H +IHR+IKS+N+LL + + K+ DF S + GT Y APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
S K+D++S GV+L ELLT ++P D
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-11
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD---SSKQPDQEFLA---QVSMVSRLK 119
N+ L+G+G++GRVY + +GR A K++ S + +E A ++ ++ L+
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 120 NENVVELVGYYVDGPLRVLA--YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+E +V+ G D + L E+ GS+ D L K L+ + K
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---------KAYGALTESVTRKYTR 113
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-VL 236
G+ YLH I+HR+IK +N+L K+ DF S + R V
Sbjct: 114 QILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT 170
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT + +PE K+DV+S G ++E+LT + P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 33/89 (37%), Positives = 51/89 (57%)
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
L E +++HR++KS+N+ L I K+ DF S Q D+ + ++ GT Y APE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ S K+D++S GV+L ELLT +P
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 6e-11
Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 5/95 (5%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A L++LH II+R++K N+LL ++ K++DF LS ++ D + +S GT
Sbjct: 108 ALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTV 162
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE + +D +SFGV++ E+LTG P
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 8e-11
Identities = 51/193 (26%), Positives = 85/193 (44%), Gaps = 19/193 (9%)
Query: 77 GSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136
GS GRV F + G+ + L ++ L + ++ + + +V+ + V G +
Sbjct: 77 GSEGRV-FVATKPGQPDPVV-LKIGQKGTT--LIEAMLLQNVNHPSVIRMKDTLVSGAIT 132
Query: 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIH 196
+ H L+ L + L Q + I GL YLH + RIIH
Sbjct: 133 CMVLPH-YSSDLYTYLTKRSRP--------LPIDQALIIEKQILEGLRYLHAQ---RIIH 180
Query: 197 RNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKS 256
R++K+ N+ + D D I D + Q P A + GT +APE + +SK+
Sbjct: 181 RDVKTENIFINDVDQVCIGDLGAA-QFPVVAPAFLG--LAGTVETNAPEVLARDKYNSKA 237
Query: 257 DVYSFGVVLLELL 269
D++S G+VL E+L
Sbjct: 238 DIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 36/215 (16%)
Query: 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFL------AQVSMVSRLKNENVV 124
S +G G+YG+V +GR AIKKL +P Q + ++ ++ + +ENV+
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLS---RPFQSAIHAKRTYRELRLLKHMDHENVI 77
Query: 125 ELVGYYV-DGPLR----VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
L+ + L V H L++I+ +K LS +
Sbjct: 78 GLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK----------LSDDHIQFLVYQI 127
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
RGL+Y+H IIHR++K SN+ + +D KI DF L+ D T + T
Sbjct: 128 LRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM-----TGYVATR 179
Query: 240 GYHAPEYAMTGQMS-SKS-DVYSFGVVLLELLTGR 272
Y APE M M +++ D++S G ++ ELLTG+
Sbjct: 180 WYRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-10
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 74 IGEGSYGRVYFGVLRSGRAAA---IKKLDSSKQPDQE--FLAQVSMVSRLKNENVVELVG 128
IG G +G+V G G + A +K+L +S PD++ FL +V L + NV++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
++ +L E G L + L +G+ + QR +A A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV--LQR--MACEVASGLLWLHQ 118
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLHSTRVLGTFGYHAPEYA 247
IH ++ N L D KI D+ L+ Q P+ + + APE
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELV 174
Query: 248 -------MTGQMSSKSDVYSFGVVLLELLT 270
+ + KS+++S GV + EL T
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L YLH+ E RI+HR++ +N++L +DD I+DF L+ Q + T V+GT Y
Sbjct: 126 LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYS 180
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
PE K+DV++FG +L ++ T + P
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 65/233 (27%), Positives = 99/233 (42%), Gaps = 29/233 (12%)
Query: 67 NFGTNSLIGEGSYGRVYF----GVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN 122
NF ++G G+YG+V+ G +G+ A+K L + + A+ + R
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTER----Q 56
Query: 123 VVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ-----RVKIA 176
V+E V P V L Y + LH IL V G + L + V++
Sbjct: 57 VLEAVR---RCPFLVTLHYAFQTDTKLHLIL---DYVNGGELFTHLYQREHFTESEVRVY 110
Query: 177 VGA-ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHSTR 234
+ L++LH+ II+R+IK N+LL + ++DF LS + + R +S
Sbjct: 111 IAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-- 165
Query: 235 VLGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 285
GT Y APE G D +S GV+ ELLTG P + QS
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELV 127
++G+G +G V +R +G+ A KKL+ + + + L + ++ ++ + VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 128 GYY--VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
Y D VL + H G+ G + + V A GLE
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRA---------VFYAAEICCGLED 117
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH++ RI++R++K N+LL D +ISD L+ P+ + RV GT GY APE
Sbjct: 118 LHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGYMAPE 171
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ + D ++ G +L E++ G+ P
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 64/228 (28%), Positives = 109/228 (47%), Gaps = 35/228 (15%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKN 120
D F IGEG+YG+VY + +G A+KK LD+ K+ P + ++ ++ +L +
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA-IREIKILRQLNH 65
Query: 121 ENVVELVGYYVDGPLRV----------LAYEHASKGSLHDILHG--KKGVKGAKPGPVLS 168
N+V L D + L +E+ HD L G + G+ + S
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD----HD-LMGLLESGLVHFSEDHIKS 120
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
+ +++ GL Y H+K +HR+IK SN+LL + K++DF L+ +
Sbjct: 121 FMKQL------LEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPV 275
R ++ +V+ T Y PE + + + DV+S G +L EL T +KP+
Sbjct: 172 RPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 50/224 (22%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVG 128
S IGEG+YG V +G AIKK+ + Q L ++ ++ R K+EN++ ++
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILD 70
Query: 129 YYVDGPLRVLAYEHASKGSLHDI----------LHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+R ++E S +D+ L+ K +K LS
Sbjct: 71 I-----IRPPSFE-----SFNDVYIVQELMETDLY--KLIKTQH----LSNDHIQYFLYQ 114
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS------ 232
RGL+Y+H ++HR++K SN+LL + KI DF L AR+
Sbjct: 115 ILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL--------ARIADPEHDHT 163
Query: 233 ---TRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
T + T Y APE + + +K+ D++S G +L E+L+ R
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-10
Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 38/225 (16%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFL------AQVSMV 115
E + + S +G G+YG V ++G A+KKL +P Q + ++ ++
Sbjct: 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL---SRPFQSIIHAKRTYRELRLL 70
Query: 116 SRLKNENVVELVGYYVDGPLR-------VLAYEHASKGSLHDILHGKKGVKGAKPGPVLS 168
+K+ENV+ L+ + P R V H L++I+ +K L+
Sbjct: 71 KHMKHENVIGLLDVFT--PARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LT 118
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
+ RGL+Y+H IIHR++K SN+ + +D KI DF L+ D
Sbjct: 119 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 175
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
+TR Y APE + +++ D++S G ++ ELLTGR
Sbjct: 176 GYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 7e-10
Identities = 40/176 (22%), Positives = 81/176 (46%), Gaps = 28/176 (15%)
Query: 111 QVSMVSRLKNENVVELVGYYVDG----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV 166
++ + R+ + N++++ G+ +D P L E+ ++G L ++L +K
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD--------- 118
Query: 167 LSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225
LS+ ++ +A+ +GL L++ +P ++N+ S + L+ ++ KI L
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSS 175
Query: 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSS----KSDVYSFGVVLLELLTGRKPVDH 277
V Y + + M + S K D+YS GVVL E+ TG+ P ++
Sbjct: 176 PP----FKNV-NFMVYFSYK--MLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224
|
Length = 283 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-10
Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL++LH K I++R++K N+LL D KI+DF + + A+ + GT Y
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDY 162
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + + ++ D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 63/231 (27%), Positives = 93/231 (40%), Gaps = 61/231 (26%)
Query: 74 IGEGSYGRVY---------FGVLRSGRA---------------AAIKKLDSSKQPDQEFL 109
IG G+YG VY F L+S R A +K+L++ P+ L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 110 AQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 169
V SR E V LV +VD LR + K P P L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRT----YLDKV----------------PPPGLPA 107
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229
+ RGL++LH I+HR++K N+L+ K++DF L AR
Sbjct: 108 ETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL--------AR 156
Query: 230 LHS-----TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 275
++S T V+ T Y APE + ++ D++S G + E+ RKP+
Sbjct: 157 IYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-09
Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GLE+LH++ RII+R++K NVLL +D +ISD L+ + D ++ + GT G+
Sbjct: 109 GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGF 163
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + D ++ GV L E++ R P
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 46/217 (21%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLA--QVSMVSRLKNENVVELVGYY 130
+GEGSY VY G+ R +G+ A+K + + F A + S++ LK+ N+V
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV------ 66
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVK--------------GAKPGPVLSWAQRVKIA 176
LHDI+H K+ + PG + + R+
Sbjct: 67 ----------------LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-FM 109
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
RGL Y+H + I+HR++K N+L+ K++DF L+ +A ++ +S+ V+
Sbjct: 110 FQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLA-RAKSIPSQTYSSEVV 165
Query: 237 GTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
T Y P+ + SS D++ G + +E+L G+
Sbjct: 166 -TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 17/98 (17%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN---QAPD----AAARLHS 232
ARG+E+L A + IHR++ + N+LL ++++ KI DF L+ + PD ARL
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 237
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ APE +++SDV+SFGV+L E+ +
Sbjct: 238 -----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 10/99 (10%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN---QAPDAAARLHSTRVL 236
ARG+E+L A + IHR++ + N+LL ++++ KI DF L+ + PD R S R+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARL- 238
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ APE +++SDV+SFGV+L E+ + G P
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 62/252 (24%), Positives = 96/252 (38%), Gaps = 58/252 (23%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKL--DSSKQP--DQEFLAQVSMVSRLKNENVV--- 124
LIG+G G VY R A+KK+ D S+ P + FL + + + L + +V
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 125 ------ELVGY---YVDG-PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
+ V Y Y++G L+ L K SL L K V
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS----------- 117
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL--------FDDDIAKI----SDFDLSNQ 222
I +EY+H K ++HR++K N+LL D A + L
Sbjct: 118 IFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 223 APDAAARLHST----RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-------- 270
+ S +++GT Y APE + S +D+Y+ GV+L ++LT
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234
Query: 271 -GRK-PVDHTLP 280
GRK +
Sbjct: 235 KGRKISYRDVIL 246
|
Length = 932 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-------PDQEFLAQV--SMVSRLKNENVV 124
+G+GS+G VY +++ +A A ++L K+ P++ A ++S+L + +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+ +++ + E+ L L K G LS Q + + G+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELK-----HTGKTLSENQVCEWFIQLLLGVH 120
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN---QAPDAAARLHSTRVLGTFGY 241
Y+H++ RI+HR++K+ N+ L +++ KI DF +S + D A T GT Y
Sbjct: 121 YMHQR---RILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLA-----TTFTGTPYY 171
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLEL 268
+PE SKSD++S G +L E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKL----DSSKQPDQEFLAQVSMVSRLKNE 121
NF IGEG+YG VY +G A+KK+ ++ P + ++S++ L +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNHP 59
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N+V+L+ L +E LH L KK + + + +
Sbjct: 60 NIVKLLDVIHTENKLYLVFEF-----LHQDL--KKFMDASPLSG-IPLPLIKSYLFQLLQ 111
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL + H R++HR++K N+L+ + K++DF L+ +A R ++ V+ T Y
Sbjct: 112 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVV-TLWY 166
Query: 242 HAPEYAMTGQM-SSKSDVYSFGVVLLELLTGR 272
APE + + S+ D++S G + E++T R
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 23/216 (10%)
Query: 74 IGEGSYGRVYFGVLRSGRA---AAIKKLD---SSKQPDQEFLAQVSMVSRLKNENVVELV 127
+GEG +G V G L + A+K + ++ ++FL++ + + NV+ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 128 GYYVDG------PLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQR-VKIAVGA 179
G + P V+ G LH +L+ + G P Q VK
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG-----DCPQYLPTQMLVKFMTDI 121
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A G+EYL K IHR++ + N +L ++ ++DF LS + +
Sbjct: 122 ASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ A E ++KSDV+SFGV + E+ T G+ P
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 34/213 (15%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYY 130
IG G+ G VY + R +GR A+K + + + ++ ++ ++ + + NVV+ +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141
Query: 131 -VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+G ++VL E GSL +G + +A G+ YLH +
Sbjct: 142 DHNGEIQVL-LEFMDGGSL----------EGTH---IADEQFLADVARQILSGIAYLHRR 187
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLGTFGYHAPEY 246
I+HR+IK SN+L+ KI+DF +S Q D +GT Y +PE
Sbjct: 188 ---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC-----NSSVGTIAYMSPER 239
Query: 247 AMTGQMSSK-----SDVYSFGVVLLELLTGRKP 274
T D++S GV +LE GR P
Sbjct: 240 INTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLA--QVSMVSRLKN 120
K D++ +GEGSY VY G + +G+ A+K + ++ F A + S++ LK+
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKH 62
Query: 121 ENVVEL--VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
N+V L + + + V Y H D K G P V + ++
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMD-----KHPGGLHPENVKLFLFQL----- 112
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
RGL Y+H++ I+HR++K N+L+ D K++DF L+ +A + +S V+ T
Sbjct: 113 -LRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLA-RAKSVPSHTYSNEVV-T 166
Query: 239 FGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTG 271
Y P+ + + + S+ D++ G + +E++ G
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 33/209 (15%)
Query: 74 IGEGSYGRVYFG-VLRSGRAAAIKKL----DSSKQPDQEFLAQVSMVSRLK-NENVVELV 127
IGEG++ V ++G+ AIK + S +Q + L ++ + RL + N++ L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64
Query: 128 GYYVDGPLRVLAYE-HASKGSLHDILHGKKGVKGAKPGP---VLSWA-QRVKIAVGAARG 182
D LA +L++++ G+K +P P V S+ Q +K
Sbjct: 65 EVLFDRKTGRLALVFELMDMNLYELIKGRK-----RPLPEKRVKSYMYQLLK-------S 112
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L+++H I HR+IK N+L+ DDI K++DF ++ T + T Y
Sbjct: 113 LDHMHRNG---IFHRDIKPENILI-KDDILKLADF---GSCRGIYSKPPYTEYISTRWYR 165
Query: 243 APEYAMT-GQMSSKSDVYSFGVVLLELLT 270
APE +T G K D+++ G V E+L+
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 58/232 (25%), Positives = 94/232 (40%), Gaps = 62/232 (26%)
Query: 74 IGEGSYGRVY----------FGVLRSGRA---------------AAIKKLDSSKQPDQEF 108
IGEG+YG+V+ F L+ R A ++ L++ + P+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 109 LAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS 168
L V VSR E + LV +VD L + P P +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK--------------------VPEPGVP 108
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
+ RGL++LH R++HR++K N+L+ K++DF L A
Sbjct: 109 TETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------A 157
Query: 229 RLHS-----TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 275
R++S T V+ T Y APE + ++ D++S G + E+ RKP+
Sbjct: 158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 39/221 (17%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
+G G+YG V + R+G AIKKL Q + + ++ ++ +K+ENV+ L+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 130 YV-DGPLR-------VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV-GAA 180
+ D L V+ + G L + H K R++ V
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTDLGKL--MKHEKLS------------EDRIQFLVYQML 128
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GL+Y+H IIHR++K N+ + +D KI DF L+ Q TR
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 241 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR---KPVDH 277
Y APE + +++ D++S G ++ E+LTG+ K DH
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 65/222 (29%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV-- 124
NF ++G G+YG+V+ SG DS K + L + ++V + K
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGH-------DSGKLYAMKVLKKATIVQKAKTTEHTRT 53
Query: 125 --ELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR-----VKIA 176
+++ + P V L Y + LH IL + G + LS +R V+I
Sbjct: 54 ERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL---DYINGGELFTHLSQRERFKEQEVQIY 110
Query: 177 VGA-ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHSTR 234
G LE+LH+ II+R+IK N+LL + ++DF LS + D R +S
Sbjct: 111 SGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-- 165
Query: 235 VLGTFGYHAPEYAMTGQMSSKS--DVYSFGVVLLELLTGRKP 274
GT Y AP+ G D +S GV++ ELLTG P
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 7/102 (6%)
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
A GL++LHE+ II+R++K NVLL + KI+DF + + ++
Sbjct: 102 AAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTF 156
Query: 236 LGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVD 276
GT Y APE ++ Q + D ++ GV+L E+L G+ P +
Sbjct: 157 CGTPDYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 5e-09
Identities = 40/117 (34%), Positives = 62/117 (52%), Gaps = 19/117 (16%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN-QAPDAAARLHSTRVLGTF 239
RGL+Y+H ++HR++K SN+L+ ++ KI DF L+ Q P T + T
Sbjct: 119 RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP------QMTGYVSTR 169
Query: 240 GYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPV----DHTLPRGQQSLVTWVL 291
Y APE +T Q + D++S G + E+L G KP+ DH Q S++T +L
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGKDHV---NQFSIITDLL 222
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-09
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL++LH K II+R++K NV+L D KI+DF + + R ++ GT Y
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDY 162
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + + D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-09
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 39/218 (17%)
Query: 73 LIGEGSYGRVYFGVLR--SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVEL 126
+IG G +G VY G + +G+ A+K LD KQ + L + M+S + + +
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 127 V--GYYVDGPLRV-LAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
V Y P ++ + + G LH L HG V S A+ A
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----------VFSEAEMRFYAAEIIL 108
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----DLSNQAPDAAARLHSTRVLG 237
GLE++H + +++R++K +N+LL + +ISD D S + P A+ +G
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VG 157
Query: 238 TFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 274
T GY APE G S +D +S G +L +LL G P
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 5e-09
Identities = 38/101 (37%), Positives = 55/101 (54%), Gaps = 13/101 (12%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-----NQAPDAAARLHSTRV 235
GL+Y+H ++HR++K N+L+ D KI DF L+ N +A T
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG---FMTEY 169
Query: 236 LGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPV 275
+ T Y APE ++ Q +K+ DV+S G +L ELL GRKPV
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 46/217 (21%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+GEG+Y V+ G + + A+K +L+ + + +VS++ LK+ N+V
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV------ 66
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGA-------------KPGPVLSWAQRVKIAV 177
+LHDI+H ++ + G ++S VKI +
Sbjct: 67 ----------------TLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMS-MHNVKIFM 109
Query: 178 -GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
RGL Y H++ +I+HR++K N+L+ + K++DF L+ +A + +S V+
Sbjct: 110 FQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLA-RAKSVPTKTYSNEVV 165
Query: 237 GTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
T Y P+ + + + S+ D++ G +L E+ TGR
Sbjct: 166 -TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 7e-09
Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 25/209 (11%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVG 128
IGEG+YG VY +G A+KK L++ + P + ++S++ L + N+V L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA-IREISLLKELNHPNIVRLLD 65
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV--KIAVGAARGLEYL 186
L +E D+ KK + + P+ + +G+ Y
Sbjct: 66 VVHSENKLYLVFEFLD----LDL---KKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246
H R++HR++K N+L+ + K++DF L+ +A R ++ V+ T Y APE
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLA-RAFGVPVRTYTHEVV-TLWYRAPEI 170
Query: 247 AMTG-QMSSKSDVYSFGVVLLELLTGRKP 274
+ Q S+ D++S G + E++ R+P
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 7e-09
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 38/216 (17%)
Query: 74 IGEGSYGRV-YFGVLRSGRAAAIKKLDSS--KQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+G+G +G V V +G+ A KKLD K+ E +A L + ++E V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMA-------LLEKEILEKV--- 50
Query: 131 VDGPLRV-LAYEHASKGSL---HDILHGKK--------GVKGAKPGPVLSWAQRVKIAVG 178
+ P V LAY SK L +++G G +G + V+ ++ ++
Sbjct: 51 -NSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQI----- 104
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
G+ +LH I++R++K NVLL D ++SD L+ + D T+ GT
Sbjct: 105 -TCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGT 157
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GY APE S D ++ G + E++ GR P
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 22/214 (10%)
Query: 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNEN 122
F ++G+G +G V +R +G+ A K+L+ + + + L + ++ ++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 123 VVELVGYY--VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
VV L Y D VL + H G G + + L +A +
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEER---ALFYAAEILC----- 113
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
GLE LH + ++R++K N+LL D +ISD L+ + P+ RV GT G
Sbjct: 114 -GLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPE--GESIRGRV-GTVG 166
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE + + D + G ++ E++ G+ P
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 73 LIGEGSYGRVYFGVLR--SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVEL 126
+IG G +G VY G + +G+ A+K LD KQ + L + M+S + + +
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 127 V--GYYVDGPLRV-LAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
V Y P ++ + + G LH L HG V S + A
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-----------VFSEKEMRFYATEIIL 108
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----DLSNQAPDAAARLHSTRVLG 237
GLE++H + +++R++K +N+LL + +ISD D S + P A+ +G
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VG 157
Query: 238 TFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKP 274
T GY APE G S +D +S G +L +LL G P
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-08
Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 38/215 (17%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAI-----------KKLDSSKQPDQEFLAQVSMVSRLKNEN 122
+G+G++ +Y GVLR I K L S + F S++S+L +++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+V+L G V ++ E+ G L LH +K L W ++ +A A
Sbjct: 63 LVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKN------NVSLHW--KLDVAKQLASA 113
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDI-------AKISDFDLSNQAPDAAARLHSTRV 235
L YL +K +++H N+ N+L+ + K+SD + R+
Sbjct: 114 LHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPW 170
Query: 236 LGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLEL 268
+ APE GQ ++ +D +SFG LLE+
Sbjct: 171 I------APECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-08
Identities = 37/94 (39%), Positives = 57/94 (60%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL++LH+K II+R++K NVLL D KI+DF + + + + ++ GT Y
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + GQ ++S D +SFGV+L E+L G+ P
Sbjct: 163 IAPE-ILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 60/218 (27%), Positives = 91/218 (41%), Gaps = 26/218 (11%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS-----KQPDQEFLAQVSMVSR 117
K +F +G GS+GRV + +G AIK L KQ Q + S++
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQV-QHVAQEKSILME 74
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS-WAQRVKIA 176
L + +V ++ + D E G L H +K G P V + + +A
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGEL--FTHLRKA--GRFPNDVAKFYHAELVLA 130
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
EYLH K II+R++K N+LL + K++DF + + PD L
Sbjct: 131 ------FEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL-----C 176
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT Y APE + D ++ GV+L E + G P
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 35/99 (35%), Positives = 48/99 (48%), Gaps = 9/99 (9%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL--SNQAPDAAARLHSTRVLG 237
A GL +LH K II+R++K NV+L + KI+DF + N R G
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR----TFCG 163
Query: 238 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
T Y APE D ++FGV+L E+L G+ P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 44/229 (19%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLA-----QVSMVSRLKNENVVEL 126
+G G+YG V + R+G AIKKL Q E A +++++ +++ENV+ L
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENVIGL 79
Query: 127 VGYYVDGPL--------RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ + V+ Y L I+ G LS + +
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYMQTD---LQKIM-----------GHPLSEDKVQYLVYQ 125
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
GL+Y+H IIHR++K N+ + +D KI DF L+ A DA T + T
Sbjct: 126 MLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHA-DA----EMTGYVVT 177
Query: 239 FGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286
Y APE + +++ D++S G ++ E+LTG+ TL +G+ L
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK-----TLFKGKDYL 221
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 35/227 (15%)
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGR--AAAIKKLDSSK-----QPDQEFLAQV 112
+ K K ++F +G GS+GRV ++ AIK+ + SK Q D F ++
Sbjct: 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SER 82
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW--A 170
+++ + + V L G + D L E G L K P V + A
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRF----PNDVGCFYAA 138
Query: 171 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230
Q V I EYL I++R++K N+LL D K++DF A++
Sbjct: 139 QIVLI-------FEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGF--------AKV 180
Query: 231 HSTR---VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
TR + GT Y APE + +D ++ G+ + E+L G P
Sbjct: 181 VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GLE LH + RI++R++K N+LL D +ISD L+ + P+ RV GT GY
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--GETIRGRV-GTVGY 167
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + + D + G ++ E++ G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-08
Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 74 IGEGSYGRVYF-GVLRSGRAAAIKKLDSS-----KQPDQEFLAQVSMVSRLKNENVVELV 127
+G G +GRV V R A+K + Q + F + ++ + +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEK-EILEECNHPFIVKLY 59
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
+ D + E+ G L IL + G + R IA EYLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDR--------GLFDEYTARFYIA-CVVLAFEYLH 110
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 247
+ II+R++K N+LL + K+ DF + + + + GT Y APE
Sbjct: 111 NRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWT--FCGTPEYVAPEII 164
Query: 248 MTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ D +S G++L ELLTGR P
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
RGL+Y+H IIHR++K SNV + +D +I DF L+ QA D +TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 241 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE + +++ D++S G ++ ELL G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-08
Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 20/221 (9%)
Query: 68 FGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDS---SKQPDQEFLAQVSMVSRLKN 120
F ++G+G +G V L+ S + A+K L + S +EFL + + + +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 121 ENVVELVGYYVDG------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
NV++L+G + P+ ++ G LH L + G +P L V+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR--IGEEPF-TLPLQTLVR 117
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
+ A G+EYL K IHR++ + N +L ++ ++DF LS +
Sbjct: 118 FMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ A E ++ SDV++FGV + E++T G+ P
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 5e-08
Identities = 68/241 (28%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE----- 121
NF ++G G+YG+V+ +G D+ K + L + ++V + K
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGH-------DTGKLYAMKVLQKAALVQKAKTVEHTRT 53
Query: 122 --NVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLS-WAQR----- 172
NV+E V P V L Y ++ LH IL G G + + QR
Sbjct: 54 ERNVLEHVR---QSPFLVTLHYAFQTEAKLHLILDYVSG------GEMFTHLYQRDNFSE 104
Query: 173 --VKIAVGAA-RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAA 228
V+ G LE+LH+ I++R+IK N+LL + ++DF LS + +
Sbjct: 105 DEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE 161
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
R +S GT Y APE K+ D +S G+++ ELLTG P R QS V
Sbjct: 162 RTYS--FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV 219
Query: 288 T 288
+
Sbjct: 220 S 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
RGL+Y+H ++HR++K SN+LL + KI DF L+ + + T + T
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVTRW 173
Query: 241 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPV 275
Y APE + + + DV+S G + ELL GRKP+
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 35/103 (33%), Positives = 56/103 (54%), Gaps = 18/103 (17%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN---QAPD----AAARLHS 232
A+G+E+L A + IHR++ + N+LL ++++ KI DF L+ + PD ARL
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 243
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ APE + +SDV+SFGV+L E+ + G P
Sbjct: 244 -----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-08
Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 46/217 (21%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+GEG+Y V+ G + + A+K +L+ + + +VS++ LK+ N+V
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV------ 67
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGV--------KGAKP-----GPVLSWAQRVKIAV 177
+LHDI+H K + K K G ++S VKI +
Sbjct: 68 ----------------TLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMS-MHNVKIFL 110
Query: 178 -GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
RGL Y H + +++HR++K N+L+ + K++DF L+ +A + +S V+
Sbjct: 111 YQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSVPTKTYSNEVV 166
Query: 237 GTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
T Y P+ + + + S++ D++ G + E+ +GR
Sbjct: 167 -TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-08
Identities = 52/216 (24%), Positives = 97/216 (44%), Gaps = 44/216 (20%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+GEG+Y VY G + + A+K +L+ + + +VS++ LK+ N+V
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV------ 67
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGV--------KGAKP-----GPVLSWAQRVKIAV 177
+LHDI+H +K + K K G ++
Sbjct: 68 ----------------TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLF 111
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
RGL Y H + +++HR++K N+L+ + K++DF L+ +A + +S V+
Sbjct: 112 QLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYSNEVV- 166
Query: 238 TFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
T Y P+ + + S++ D++ G + E+ TGR
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-08
Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 3/106 (2%)
Query: 165 PVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224
P LS+ V + A G+E+L K +HR++ + NVL+ + + KI DF L+
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIM 290
Query: 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
+ + + APE ++ SDV+SFG++L E+ T
Sbjct: 291 RDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 55/221 (24%), Positives = 101/221 (45%), Gaps = 54/221 (24%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLA--QVSMVSRLKNENVVELVGYY 130
+GEGSY VY G + +G+ A+K++ + F A + S++ LK+ N+V
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV------ 66
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR-----------------V 173
+LHDI+H KK + V + V
Sbjct: 67 ----------------TLHDIIHTKKTLT-----LVFEYLDTDLKQYMDDCGGGLSMHNV 105
Query: 174 KIAV-GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
++ + RGL Y H++ R++HR++K N+L+ + K++DF L+ +A ++ +S
Sbjct: 106 RLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLA-RAKSVPSKTYS 161
Query: 233 TRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
V+ T Y P+ + + + S+ D++ G + E+ TGR
Sbjct: 162 NEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 9e-08
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 6/93 (6%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GLE L + RI++R++K N+LL D +ISD L+ Q P+ RV GT GY
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV--RGRV-GTVGY 167
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + + D + G ++ E++ G+ P
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 9e-08
Identities = 53/210 (25%), Positives = 104/210 (49%), Gaps = 17/210 (8%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
+G GS G V+ V + A+KK+ + Q + L ++ ++ RL ++N+V++ Y V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKV--YEV 70
Query: 132 DGPL-RVLAYEHASKGSLHDILHGKKGV-----KGAKPGPVLSWAQRVKIAVGAARGLEY 185
GP L + S L+ + ++ + + GP+ R+ RGL+Y
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL-FMYQLLRGLKY 129
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIA-KISDFDLSN-QAPDAAARLHSTRVLGTFGYHA 243
+H ++HR++K +NV + +D+ KI DF L+ P + + + + L T Y +
Sbjct: 130 IHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186
Query: 244 PEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
P ++ +K+ D+++ G + E+LTG+
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 60/241 (24%), Positives = 98/241 (40%), Gaps = 56/241 (23%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLD-SSKQPDQEF---LAQVSMVSRLKNENVVELV 127
L+G+G GRV+ L+ +G+ A+K LD + L + +++ L + + L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS------WAQRVKIAVGAAR 181
+ L ++ G L +L +PG LS +A V +A
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQ-------RQPGKCLSEEVARFYAAEVLLA----- 115
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-----------------P 224
LEYLH I++R++K N+LL + +SDFDLS Q+
Sbjct: 116 -LEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 225 DAAARLHSTRV----------LGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRK 273
+ T +GT Y APE ++G S D ++ G++L E+L G
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGTT 230
Query: 274 P 274
P
Sbjct: 231 P 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 56/223 (25%), Positives = 106/223 (47%), Gaps = 40/223 (17%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKK--LDSSKQPDQEF----LAQVSMVSRLKNENVVEL 126
IG+G++G V+ + + + A+KK +++ K+ F L ++ ++ LK+ENVV L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNL 76
Query: 127 VGYYVDGPLRVLAYEHASKGSL--------HDI--LHGKKGVKGAKPGPVLSWAQRVKIA 176
+ + KGS HD+ L K VK + ++ K+
Sbjct: 77 IEICRTKATP----YNRYKGSFYLVFEFCEHDLAGLLSNKNVK-------FTLSEIKKVM 125
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHST 233
GL Y+H +I+HR++K++N+L+ D I K++DF L+ + + ++ ++
Sbjct: 126 KMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182
Query: 234 RVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPV 275
RV+ T Y PE + D++ G ++ E+ T R P+
Sbjct: 183 RVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 18/129 (13%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN---QAPDAAARLHSTRVLG 237
RGL+Y+H +IHR++K SN+L+ +D +I DF ++ +P T +
Sbjct: 118 RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY-FMTEYVA 173
Query: 238 TFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP----RGQQSLVTWVL- 291
T Y APE ++ + ++ D++S G + E+L GR+ + P Q L+ VL
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL---FPGKNYVHQLKLILSVLG 229
Query: 292 -TSSHFLSS 299
S L+
Sbjct: 230 SPSEEVLNR 238
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 1e-07
Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 47/218 (21%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEF-----LAQVSMVSRLK-NENVVEL 126
+G+G++G VY + G AIKK+ K+ + L +V + +L + N+V+L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM---KKKFYSWEECMNLREVKSLRKLNEHPNIVKL 63
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+ + +E+ +G+L+ ++ +KG + + S ++ +GL ++
Sbjct: 64 KEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS-ESVIRSIIYQI------LQGLAHI 115
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHS----TRVLGTFGY 241
H+ HR++K N+L+ ++ KI+DF L AR + S T + T Y
Sbjct: 116 HKHG---FFHRDLKPENLLVSGPEVVKIADFGL--------AREIRSRPPYTDYVSTRWY 164
Query: 242 HAPE-------YAMTGQMSSKSDVYSFGVVLLELLTGR 272
APE Y SS D+++ G ++ EL T R
Sbjct: 165 RAPEILLRSTSY------SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 20/217 (9%)
Query: 74 IGEGSYGRVYFGVLRSGRAAA---IKKLDSSKQPDQE--FLAQVSMVSRLKNENVVELVG 128
IG G +G+V G + SG A +K+L S ++ FL + L++ N+++ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ +L E G L L + + P P QR +A A GL +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTT--LQR--MACEIALGLLHLHK 118
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA- 247
IH ++ N LL D KI D+ LS+ + ++ + APE
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175
Query: 248 ------MTGQMSSKSDVYSFGVVLLELLT-GRKPVDH 277
+ + +S+V+S GV + EL G +P H
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIK--KLDSSKQPDQEFLAQVSMVSRL----- 118
+F ++G+GS+G+V + + AIK K D Q D + +MV +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDD---VECTMVEKRVLALQ 57
Query: 119 -KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
K + +L + E+ + G L + H ++ K +P V A+ I+V
Sbjct: 58 DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAE---ISV 112
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL- 236
G L +LH + II+R++K NV+L + KI+DF + + +TR
Sbjct: 113 G----LFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV---TTRTFC 162
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
GT Y APE D +++GV+L E+L G+ P D
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 23/209 (11%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKK--LDSSKQPDQEF-LAQVSMVSRLKNENVVELVGY 129
IGEG+YG V+ R + A+K+ LD + L ++ ++ LK++N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 130 YVDGPLRVLAYEHASKG--SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
L +E+ + D +G P V S+ ++ +GL + H
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGD-----IDPEIVKSFMFQL------LKGLAFCH 116
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 247
++HR++K N+L+ + K++DF L+ +A R +S V+ T Y P+
Sbjct: 117 SH---NVLHRDLKPQNLLINKNGELKLADFGLA-RAFGIPVRCYSAEVV-TLWYRPPDVL 171
Query: 248 MTGQMSSKS-DVYSFGVVLLELLTGRKPV 275
++ S S D++S G + EL +P+
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 67 NFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD---SSKQPDQEFLA---QVSMVSRLK 119
N+ L+G G++G VY +GR A+K++ S++ +E A ++ ++ L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 120 NENVVELVGYYVDGPLRVLA--YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
++ +V+ G D + L+ E+ GS+ D L GA V R +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQIL-- 116
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-VL 236
+G+ YLH I+HR+IK +N+L K+ DF S + + V
Sbjct: 117 ---QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT + +PE K+DV+S ++E+LT + P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE 121
K+ D FG N E + V G +K+ D+++ V M+ +
Sbjct: 148 KKDLDIFGINP-ADESTRSYVILSFENKGDYMDMKQADTTQY--------VPMLEIKEAS 198
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
++ D P +Y+ ++ + ++L G +G +LS+ +V AR
Sbjct: 199 KYSDIQRSNYDRPA---SYKGSNDSEVKNLL-SDDGSEGLTTLDLLSFTYQV------AR 248
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
G+E+L K +HR++ + NVLL I KI DF L+ + + +
Sbjct: 249 GMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKW 305
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
APE ++ SDV+S+G++L E+ +
Sbjct: 306 MAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 41/201 (20%), Positives = 76/201 (37%), Gaps = 20/201 (9%)
Query: 77 GSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
GS G V+ + +K + K P +E + ++ + + ++ L+ Y
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGRE----IDILKTISHRAIINLIHAYRWK 158
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
+ D+ V + P L Q + I L YLH +
Sbjct: 159 STVCMVMPKYK----CDLF---TYVDRSGP---LPLEQAITIQRRLLEALAYLHGRG--- 205
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS 253
IIHR++K+ N+ L + + A + DF + + GT ++PE
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC 265
Query: 254 SKSDVYSFGVVLLELLTGRKP 274
+K+D++S G+VL E+
Sbjct: 266 AKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 35/103 (33%), Positives = 53/103 (51%), Gaps = 18/103 (17%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL-------SNQAPDAAARLHS 232
A+G+++L K IHR++ + NVLL D +AKI DF L SN ARL
Sbjct: 222 AQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL-- 276
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ APE + +SDV+S+G++L E+ + G+ P
Sbjct: 277 -----PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 5/92 (5%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
LEYLH + +++R+IK N++L D KI+DF L + A + + GT Y
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 162
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE D + GVV+ E++ GR P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 4/93 (4%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L+YLH +E +++R++K N++L D KI+DF L + A + + GT Y
Sbjct: 107 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 162
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE D + GVV+ E++ GR P
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 5e-07
Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 27/220 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAA---AIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+G G+YG VY + G+ A+K+++ + +++++ LK+ NV+ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVF 67
Query: 131 VDGPLRV--LAYEHASKGSLHDILHGKKGVKGAKPG--PVLSWAQRVK-IAVGAARGLEY 185
+ R L +++A HD+ H K + +K PV VK + G+ Y
Sbjct: 68 LSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDD-------DIAKISDFDLSNQAPDAAARLHSTRVLGT 238
LH ++HR++K +N+L+ + IA + L N A L V+ T
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP--VVVT 178
Query: 239 FGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDH 277
F Y APE + + +K+ D+++ G + ELLT +P+ H
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 41/120 (34%), Positives = 54/120 (45%), Gaps = 13/120 (10%)
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD----FDLSNQAPDAAARL 230
I GA RGL YLH+ IHRNIK+S++L+ D + +S + L A
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 231 H----STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286
ST VL + G + KSD+YS G+ EL TGR P + R Q L
Sbjct: 163 DFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIYSVGITACELATGRVPF-QDMLRTQMLL 220
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 7e-07
Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 5/95 (5%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L +LHE+ II+R++K NVLL D K++D+ + + ++ GT Y
Sbjct: 108 ALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNY 162
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
APE + D ++ GV++ E++ GR P D
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 7e-07
Identities = 34/107 (31%), Positives = 51/107 (47%), Gaps = 11/107 (10%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLHSTRVLGTF 239
R L+Y+H + HR++K N+L D KI DF L+ A D + T + T
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 240 GYHAPEY--AMTGQMSSKSDVYSFGVVLLELLTGR-----KPVDHTL 279
Y APE + + + D++S G + E+LTG+ K V H L
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 217
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 7e-07
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 5/93 (5%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L+YLH +I++R++K N++L D KI+DF L + AA + + GT Y
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEY 161
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE D + GVV+ E++ GR P
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 8e-07
Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 21/217 (9%)
Query: 74 IGEGSYGRVYFGVLRSGRAA---AIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+G G+YG VY + G+ A+K+++ + +++++ LK+ NV+ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVF 67
Query: 131 VDGPLRV--LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ R L +++A H I+ + K K L + + G+ YLH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWH-IIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 189 KAEPRIIHRNIKSSNVLLFDD-------DIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
++HR++K +N+L+ + IA + L N A L V+ TF Y
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP--VVVTFWY 181
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDH 277
APE + + +K+ D+++ G + ELLT +P+ H
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 50/215 (23%), Positives = 87/215 (40%), Gaps = 24/215 (11%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRA-AAIKKLD-----SSKQPDQEFLAQVSMVSRLK 119
D+ +G G++GRV+ R A+K + KQ +Q + ++ +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVS 59
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+ ++ L D + E+ G L L L +A + A
Sbjct: 60 HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSN---STGLFYASEIVCA--- 113
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
LEYLH K I++R++K N+LL + K++DF + + D L GT
Sbjct: 114 ---LEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL-----CGTP 162
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE + + D ++ G+++ E+L G P
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 55/229 (24%), Positives = 94/229 (41%), Gaps = 23/229 (10%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS----KQPDQEFLA 110
V + +L+ K +++ +IG G++G V +S + KL S K+ D F
Sbjct: 32 VRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 111 QVSMVSRLKNEN-VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 169
+ + N VV+L + D + E+ G L +++ + W
Sbjct: 92 EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--------KW 143
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229
A+ V A L+ +H +IHR++K N+LL K++DF + D
Sbjct: 144 AKFYTAEVVLA--LDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGM 197
Query: 230 LHSTRVLGTFGYHAPEYAMT----GQMSSKSDVYSFGVVLLELLTGRKP 274
+ +GT Y +PE + G + D +S GV L E+L G P
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 5/95 (5%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L YLHE+ II+R++K NVLL + K++D+ + + ++ GT Y
Sbjct: 108 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNY 162
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
APE D ++ GV++ E++ GR P D
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 49/222 (22%), Positives = 91/222 (40%), Gaps = 35/222 (15%)
Query: 72 SLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFL---AQVSMVSRLKNENVVE 125
+LIG+ + + + + A+KK++ ++ ++ +L++ N++
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
V ++ + + GS D+L H +G+ P L+ A +K L
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGL------PELAIAFILK---DVLNAL 114
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS--------NQAPDAAARLHSTRV 235
+Y+H K IHR++K+S++LL D +S S Q S +
Sbjct: 115 DYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171
Query: 236 LGTFGYHAPEY---AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
L + +PE + G + KSD+YS G+ EL G P
Sbjct: 172 L---PWLSPEVLQQNLQG-YNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 2e-06
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 38/222 (17%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLD-----SSKQPDQEFLAQVSMVSRLK 119
D+F +G GS+GRV + SG+ A+K L KQ + L + ++ ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH-VLNEKRILQSIR 59
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILH--GKKGVKGAKPGPVLSWAQRVKIAV 177
+ +V L G + D L E+ G L L G+ A+ +A +V +A
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVAR-----FYAAQVVLA- 113
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
LEYLH I++R++K N+LL D KI+DF + + L G
Sbjct: 114 -----LEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL-----CG 160
Query: 238 TFGYHAPEYAMTGQMSSK-----SDVYSFGVVLLELLTGRKP 274
T Y APE + SK D ++ G+++ E+L G P
Sbjct: 161 TPEYLAPEI-----ILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 31/98 (31%), Positives = 46/98 (46%), Gaps = 8/98 (8%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L YLH +++R++K N++L D KI+DF L + A + + GT Y
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 162
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV---DH 277
APE D + GVV+ E++ GR P DH
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 58/233 (24%), Positives = 92/233 (39%), Gaps = 42/233 (18%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAA-AIKKLDSS-----KQPDQEFLAQVSMVSRLK 119
++F T LI G+YG VY + R A+KK++ Q Q F + +++ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAE 59
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPV----LSWAQRVKI 175
N VV + + + E+ G +L K PV + +A+ V
Sbjct: 60 NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLL------KNIGALPVDMARMYFAETV-- 111
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS--------------N 221
LEYLH I+HR++K N+L+ K++DF LS +
Sbjct: 112 -----LALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGH 163
Query: 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
D +V GT Y APE + D ++ G++L E L G P
Sbjct: 164 IEKD-TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL+YLHE +I++R++K N+LL + KI+DF L + R ST GT +
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT-ST-FCGTPEF 167
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + D + GV++ E+L G P
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 5/92 (5%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
LE+LH++ II+R++K N+LL K++DF L ++ H+ GT Y
Sbjct: 113 LEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT--FCGTIEYM 167
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE M D +S G ++ ++LTG P
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 52/225 (23%), Positives = 95/225 (42%), Gaps = 36/225 (16%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE-----FLAQVS---MVS 116
D + IGEG+YG+VY +G+ A+KK D+E L ++S M+S
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM--DEEGIPPTALREISLLQMLS 58
Query: 117 R-------LKNENVVELVGYYVDGPLRVLAYEH-ASKGSLHDILHGKKGVKGAKPGPVLS 168
L E+V E G P L +E+ S +G+ + + S
Sbjct: 59 ESIYIVRLLDVEHVEEKNG----KPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKS 114
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDFDLSNQAPDAA 227
+ ++ G+ + H+ ++HR++K N+L+ + KI+D L +A
Sbjct: 115 FMYQLLK------GVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLG-RAFSIP 164
Query: 228 ARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTG 271
+ ++ ++ T Y APE + S+ D++S G + E+
Sbjct: 165 VKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 36/215 (16%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVG 128
IG+GS+G+V ++ G+ A+K L K+ + +A+ +++ LKN LVG
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVL--LKNVKHPFLVG 60
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK---------IAVGA 179
L Y + L+ +L G G + QR + A
Sbjct: 61 ---------LHYSFQTADKLYFVLDYVNG------GELFFHLQRERSFPEPRARFYAAEI 105
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A L YLH II+R++K N+LL ++DF L + ++ GT
Sbjct: 106 ASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTP 160
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE D + G VL E+L G P
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 7/96 (7%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLG 237
+ L+Y+H +IHR++K SN+LL D K++DF L+ ++ + T +
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 238 TFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
T Y APE + +K D++S G +L E+L G+
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
A A GL +LH K II+R++K NV+L + KI+DF + + + + +
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--NMWDGVTTKTF 161
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
GT Y APE D ++FGV+L E+L G+ P +
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 7e-06
Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 51/221 (23%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEF----LAQVSMVSRLKNENVVELVG 128
IGEG+YG VY R + A+KK+ +Q D+ + ++S++ +++ N+V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVRL-- 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGV------------KGAKPGPVLSWAQR-VKI 175
D++H +K + K P + R +K
Sbjct: 67 --------------------QDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKT 106
Query: 176 AV-GAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--DDIAKISDFDLSNQAPDAAARLHS 232
+ RG+ Y H R++HR++K N LL D + K++DF L+ +A R +
Sbjct: 107 YLYQILRGIAYCHSH---RVLHRDLKPQN-LLIDRRTNALKLADFGLA-RAFGIPVRTFT 161
Query: 233 TRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGR 272
V+ T Y APE + + S+ D++S G + E++ +
Sbjct: 162 HEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 5/94 (5%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L +LHE+ II+R++K NVLL + K++D+ + + ST GT Y
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI-RPGDTTST-FCGTPNYI 163
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
APE D ++ GV++ E++ GR P D
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 8e-06
Identities = 33/103 (32%), Positives = 49/103 (47%), Gaps = 18/103 (17%)
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL-------SNQAPDAAARLHS 232
A+G+ +L K IHR++ + N+LL I KI DF L SN ARL
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL-- 278
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ APE + +SDV+S+G++L E+ + G P
Sbjct: 279 -----PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 8e-06
Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
G+++LH IIHR++K SN+++ D KI DF L A A T + T Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL---ARTACTNFMMTPYVVTRYY 188
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTG 271
APE + D++S G ++ EL+ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 29/98 (29%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF--- 239
L +LH+K II+R++K NVLL + K++DF + + + + + TF
Sbjct: 109 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG------IFNGKTTSTFCGT 159
Query: 240 -GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
Y APE D ++ GV+L E+L G P +
Sbjct: 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 4/92 (4%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
R ++YLHE RIIHR+IK+ N+ + + DF + D A + GT
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA-GTIA 248
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
+APE D++S G+VL E+ T
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
G+++LH IIHR++K SN+++ D KI DF L A A T + T Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYY 183
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
APE + D++S G ++ E++ G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 23/226 (10%)
Query: 58 VDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS----KQPDQEFLAQVS 113
+ +L+ K +++ +IG G++G V +S R KL S K+ D F +
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 114 MVSRLKNEN-VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+ N VV+L + D + E+ G L +++ P WA+
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-----VPE---KWARF 146
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
V A L+ +H IHR++K N+LL K++DF + + +
Sbjct: 147 YTAEVVLA--LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRC 200
Query: 233 TRVLGTFGYHAPEYAMT----GQMSSKSDVYSFGVVLLELLTGRKP 274
+GT Y +PE + G + D +S GV L E+L G P
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 56/231 (24%), Positives = 100/231 (43%), Gaps = 27/231 (11%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR---SGRAAAIK---KLDSSKQPDQEF 108
+ +L+ K ++F +IG G++G V ++R S + A+K K + K+ D F
Sbjct: 32 AEKITKLRMKAEDFDVIKVIGRGAFGEVQ--LVRHKSSKQVYAMKLLSKFEMIKRSDSAF 89
Query: 109 L-AQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVL 167
+ +++ +E +V+L + D + E+ G L +++ +
Sbjct: 90 FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-------- 141
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
WA+ V A L+ +H IHR++K N+LL K++DF + DA
Sbjct: 142 KWARFYTAEVVLA--LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM-DAN 195
Query: 228 ARLHSTRVLGTFGYHAPEYAMT----GQMSSKSDVYSFGVVLLELLTGRKP 274
+ +GT Y +PE + G + D +S GV L E+L G P
Sbjct: 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 6/93 (6%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
LE+LH+ I++R++K N+LL + DF LS + + GT Y
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163
Query: 243 APEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + + +K D +S GV++ E+ G P
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 34/214 (15%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSS--KQPDQ--EFLAQVSMVSRLKNENVVELVG 128
+G+G YG+V+ + +G A+K++ S + ++ L + +++ K+E +V+L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS------WAQRVKIAVGAARG 182
+ D LA E+ G +L+ VLS + + AV A
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLG---------VLSEDHARFYMAEMFEAVDA--- 116
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
LHE IHR++K N L+ K++DF LS +S V+G+ Y
Sbjct: 117 ---LHELG---YIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANS--VVGSPDYM 165
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
APE D +S G +L E L G P
Sbjct: 166 APEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-05
Identities = 42/171 (24%), Positives = 69/171 (40%), Gaps = 24/171 (14%)
Query: 109 LAQVSMVSRLKNE-------NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGA 161
L + S SR + N+V L Y V L +HA G L + +
Sbjct: 26 LRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP-- 83
Query: 162 KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221
V WA + +A L+ LH + I+ R++ +N+LL D +++ F +
Sbjct: 84 -EECVKRWAAEMVVA------LDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWS 133
Query: 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
+ D+ + Y APE + + D +S G +L ELLTG+
Sbjct: 134 EVEDSCDGEAVENM-----YCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 6e-05
Identities = 54/220 (24%), Positives = 88/220 (40%), Gaps = 23/220 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQV----SMVSRLKN 120
+F SL+G G +G V + +G A+K + S QE ++ ++S +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+ +L + D L E+ G L +L+ + AQ A
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDE------DMAQ-----FYLA 109
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+ +H + +HR+IK NVL+ K++DF S A ++S +GT
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPD 168
Query: 241 YHAPEYAMTGQMSSKS------DVYSFGVVLLELLTGRKP 274
Y APE T K D +S GV+ E++ GR P
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 7e-05
Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
G+++LH IIHR++K SN+++ D KI DF L A A T + T Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYY 191
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
APE + D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 74 IGEGSYGRVYFGVLRS----GRA----AAIKKLDSS-KQPDQEFLAQVSMVSRLKNENVV 124
+G+G++ +++ G+ R G +K LD S + + F SM+S+L ++++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G V G ++ E+ GSL L K + SW ++++A A L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINI------SW--KLEVAKQLAWALH 114
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD--FDLSNQAPDAAARLHSTRVLGTFGYH 242
+L +K + H N+ + NVLL ++ K + F + + L +L +
Sbjct: 115 FLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWV 171
Query: 243 APEYAMTGQ-MSSKSDVYSFGVVLLELLTG-RKPV 275
PE Q +S +D +SFG L E+ +G KP+
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 1e-04
Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 12/102 (11%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
G+++LH IIHR++K SN+++ D KI DF L A A T + T Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRYY 184
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLE------LLTGRKPVDH 277
APE + D++S G ++ E L GR +D
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 31/119 (26%), Positives = 46/119 (38%), Gaps = 30/119 (25%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL------------ 230
L+ +H+ IHR+IK N+L+ D K++DF L + A R
Sbjct: 114 LDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 231 ---------------HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ +GT Y APE + D +S GV+L E+L G P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 40/147 (27%), Positives = 57/147 (38%), Gaps = 47/147 (31%)
Query: 195 IHRNIKSSNVLLFDDDIAKISDF--------------------------DLSNQAPDA-- 226
IHR+IK N+L+ D K++DF D SN+ D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 227 -------------AARLH----STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 269
AAR H + ++GT Y APE + + D +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 270 TGRKPVDHTLP-RGQQSLVTWVLTSSH 295
G+ P P Q ++ W TS H
Sbjct: 243 VGQPPFLAQTPLETQMKVINW-QTSLH 268
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 25/92 (27%), Positives = 46/92 (50%), Gaps = 5/92 (5%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L +LH +I+R++K N+LL + K++DF + + + +T GT Y
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG--ILNGVTTTTFCGTPDYI 163
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + D ++ GV++ E++ G+ P
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 55/216 (25%), Positives = 88/216 (40%), Gaps = 36/216 (16%)
Query: 73 LIGEGSYGRVYFGVL-RSGRAAAIKKLDS----SKQPDQEFLAQVSMVSRLKNENVVELV 127
+IG+GS+G+V G+ A+K L +++ + +A+ +++ LKN LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVL--LKNVKHPFLV 59
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK---------IAVG 178
G L Y + L+ +L G G + QR + A
Sbjct: 60 G---------LHYSFQTTEKLYFVLDFVNG------GELFFHLQRERSFPEPRARFYAAE 104
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
A L YLH I++R++K N+LL ++DF L + + +T GT
Sbjct: 105 IASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGT 159
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE + D + G VL E+L G P
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 8e-04
Identities = 34/149 (22%), Positives = 52/149 (34%), Gaps = 45/149 (30%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF------------------------- 217
+E +H+ IHR+IK N+L+ D K++DF
Sbjct: 114 IESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 218 --------DLSNQAPDAAARLH---STRVL-----GTFGYHAPEYAMTGQMSSKSDVYSF 261
++ R R L GT Y APE + + D +S
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230
Query: 262 GVVLLELLTGRKPVDHTLPRG-QQSLVTW 289
GV+L E+L G+ P P Q ++ W
Sbjct: 231 GVILYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 6/94 (6%)
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+H + +HR+IK NVLL + +++DF + + S+ +GT Y +PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPE 173
Query: 246 Y--AM---TGQMSSKSDVYSFGVVLLELLTGRKP 274
AM G+ + D +S GV + E+L G P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 9e-04
Identities = 47/221 (21%), Positives = 92/221 (41%), Gaps = 29/221 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAAA---IKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVELVG 128
IG G +G+V + + A +K+L ++ + EFL Q L++ N+++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
V+ +L +E+ G L L ++ + +L ++A A G+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMACEIAAGVTHMHK 117
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDL--SNQAPD---------AAARLHSTRVLG 237
+H ++ N L D K+ D+ + S D R + ++G
Sbjct: 118 H---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 238 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL-TGRKPVDH 277
F +T + + S+V++ GV L EL +P H
Sbjct: 175 EF----HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 39/216 (18%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV--ELVGYYV 131
IG+GS+G+V ++K D+ + + + + +VSR + + + V V
Sbjct: 1 IGKGSFGKV----------MQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV 50
Query: 132 DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV-KIAVGAAR-------- 181
+ P V L + S L+ +L G G + QR + + AR
Sbjct: 51 NCPFIVPLKFSFQSPEKLYLVLAFING------GELFHHLQREGRFDLSRARFYTAELLC 104
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLS--NQAPDAAARLHSTRVLGT 238
LE LH+ +I+R++K N+LL + IA + DF L N D + GT
Sbjct: 105 ALENLHKF---NVIYRDLKPENILLDYQGHIA-LCDFGLCKLNMKDDDK----TNTFCGT 156
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE + + D ++ GV+L E+LTG P
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 30/115 (26%), Positives = 53/115 (46%), Gaps = 18/115 (15%)
Query: 162 KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221
K P+L + + + A +EY+H+K ++IHR+IK N+ L D + DF
Sbjct: 261 KDRPLLKQTRAIMKQLLCA--VEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFG--- 312
Query: 222 QAPDAAARLHSTRV------LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
A R +GT ++PE +D++S G++LL++L+
Sbjct: 313 ----TAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 59/258 (22%), Positives = 100/258 (38%), Gaps = 58/258 (22%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV 124
D+F + +IG G++G V + +G A+K L + ++E +A + R + + +V
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHI----RAERDILV 56
Query: 125 ELVGYYV--------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
E G +V D L E G + +L K + ++ +A
Sbjct: 57 EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA---ETVLA 113
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----------------DLS 220
+ A L + IHR+IK N+LL K+SDF +L+
Sbjct: 114 IDAIHQLGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLT 164
Query: 221 NQAPD--AAARLHSTR---------------VLGTFGYHAPEYAMTGQMSSKSDVYSFGV 263
+ P + ++S R +GT Y APE M + D +S GV
Sbjct: 165 HNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224
Query: 264 VLLELLTGRKPVDHTLPR 281
++ E+L G P P+
Sbjct: 225 IMYEMLIGYPPFCSETPQ 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 31/108 (28%), Positives = 52/108 (48%), Gaps = 4/108 (3%)
Query: 160 GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219
GA+ P L AQ +A ++Y+H + IIHR+IK+ NVL+ + + DF
Sbjct: 251 GARLRP-LGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGA 306
Query: 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLE 267
+ A + + + GT +APE + D++S G+V+ E
Sbjct: 307 ACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 6/87 (6%)
Query: 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY--AM-- 248
+HR+IK NVLL + +++DF S A + S +GT Y +PE AM
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180
Query: 249 -TGQMSSKSDVYSFGVVLLELLTGRKP 274
G+ + D +S GV + E+L G P
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.004
Identities = 32/116 (27%), Positives = 43/116 (37%), Gaps = 36/116 (31%)
Query: 195 IHRNIKSSNVLLFDDDIAKISDF----------------DLSNQAPDAAARLHST----- 233
IHR+IK N+LL K+SDF LS+ P S
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 234 ----------RVL-----GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
R L GT Y APE + + + D +S GV++ E+L G P
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 40/164 (24%), Positives = 69/164 (42%), Gaps = 41/164 (25%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQ----------------VSMVS 116
I G++G+VY G + + + A+K + + ++ + Q V +
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 117 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
L++ N V LV Y+ G G + +LH + G + VK
Sbjct: 72 SLQSANNVYLVMEYLIG------------GDVKSLLH----IYGYFDEEM-----AVKYI 110
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
A L+YLH IIHR++K N+L+ ++ K++DF LS
Sbjct: 111 SEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 301 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.92 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.85 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.64 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.63 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.58 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.58 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.54 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.48 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.47 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.45 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.33 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.32 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.3 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.28 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.19 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.15 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.14 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 99.1 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.07 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.05 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.03 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.96 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.83 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.81 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.81 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.78 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.76 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.75 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.66 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.65 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.63 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.6 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.6 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.53 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.51 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.41 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.38 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.36 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 98.36 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.28 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.27 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.26 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.19 | |
| PLN02236 | 344 | choline kinase | 98.04 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.95 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.91 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.89 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 97.84 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.82 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.76 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.73 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.73 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.67 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.63 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.6 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.48 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.45 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.44 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.43 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 97.33 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 97.17 | |
| PTZ00384 | 383 | choline kinase; Provisional | 97.17 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 97.0 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.97 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.81 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.79 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=358.75 Aligned_cols=204 Identities=30% Similarity=0.482 Sum_probs=184.9
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
..++|.+.+.||+|+||+||+|+++ ++..||||.+.+... ..+.+..|+.+|+.++|||||.+++++.+.+.+|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4578999999999999999999987 789999999876542 335578999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC------CceE
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD------DIAK 213 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~------~~vk 213 (301)
||||+||+|.++++.+.. +++..+..++.||+.||++||+++ ||||||||+|||++.. -.+|
T Consensus 88 MEyC~gGDLs~yi~~~~~---------l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGR---------LPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred EEeCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEE
Confidence 999999999999998763 899999999999999999999999 9999999999999864 4689
Q ss_pred EeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCcC
Q 022206 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~ 282 (301)
|+|||+|+.+...... .+.+|+|.|||||++....|+.|+|+||+|+|+|+|++|++||+..++.+
T Consensus 156 IADFGfAR~L~~~~~a---~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 156 IADFGFARFLQPGSMA---ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred ecccchhhhCCchhHH---HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 9999999998865544 67899999999999999999999999999999999999999999665543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-52 Score=345.38 Aligned_cols=204 Identities=26% Similarity=0.381 Sum_probs=184.5
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
..++|+++++||+|+||+||+++.+ +++.+|+|++++... ......+|..+|..++||+||+++..|++.+.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3578999999999999999999977 799999999976433 34568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
|+||+.||.|...|++... +++..+..++.+|+.||.|||++| ||||||||+|||+|.+|+++|+|||
T Consensus 103 Vld~~~GGeLf~hL~~eg~---------F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGR---------FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred EEeccCCccHHHHHHhcCC---------cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccc
Confidence 9999999999999987654 899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
+++....... .+.+++||+.|||||++.+..|+..+|+||||+++|+|++|.+||.+.+..
T Consensus 171 L~k~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~ 231 (357)
T KOG0598|consen 171 LCKEDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK 231 (357)
T ss_pred cchhcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH
Confidence 9986544332 235689999999999999999999999999999999999999999876643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-51 Score=359.82 Aligned_cols=199 Identities=28% Similarity=0.467 Sum_probs=185.2
Q ss_pred CCCCCCceecccCceEEEEEEE-CCCCEEEEEEcCC----CCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDS----SKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
.+|...+.||+|+|++||.+++ .+|+.||+|++.+ .....+.+.+|+++.+.|+|||||+++++|++.++.|+|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6799999999999999999998 5899999999976 4555678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
|+|..++|..++++.+. +++.++..++.||+.||.|||+++ |+|||||..|+|++++.+|||+|||||
T Consensus 98 ELC~~~sL~el~Krrk~---------ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKP---------LTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLA 165 (592)
T ss_pred EecCCccHHHHHHhcCC---------CCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEeccccee
Confidence 99999999999986553 999999999999999999999999 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
........+. .+.||||.|.|||++....++..+||||+||+||.||+|++||+..
T Consensus 166 t~le~~~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk 221 (592)
T KOG0575|consen 166 TQLEYDGERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK 221 (592)
T ss_pred eeecCccccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence 9987654432 6789999999999999999999999999999999999999999865
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=339.72 Aligned_cols=201 Identities=26% Similarity=0.435 Sum_probs=176.3
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--------hHHHHHHHHHHhccCCCceeeeeeEEEcCC
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--------DQEFLAQVSMVSRLKNENVVELVGYYVDGP 134 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 134 (301)
..+.|.+.+.||+|+||.|-+|..+ +|+.||||.+++.... .....+|+++|++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 5577899999999999999999976 8999999999753322 234679999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC---Cc
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---DI 211 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~ 211 (301)
..|+||||++||+|.+.+-.++. +.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~---------l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~l 317 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY---------LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCL 317 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc---------cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceE
Confidence 99999999999999999987764 777778899999999999999999 9999999999999866 68
Q ss_pred eEEeccccCCCCCccccccccccccccccccCccccccCCC---CccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM---SSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
+||+|||+|+....... ..++||||.|.|||++.+..+ ..++|+|||||+||.+++|.+||.+-.
T Consensus 318 lKItDFGlAK~~g~~sf---m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~ 385 (475)
T KOG0615|consen 318 LKITDFGLAKVSGEGSF---MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY 385 (475)
T ss_pred EEecccchhhcccccee---hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence 99999999998864432 267899999999999987643 347899999999999999999997543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=330.66 Aligned_cols=208 Identities=25% Similarity=0.384 Sum_probs=180.2
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeee-EEEcCCe-eEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVG-YYVDGPL-RVL 138 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~~-~~l 138 (301)
..+|++.+.||+|.||+||++.+. +|..+|.|.+...... .++...|+.+|++|+|||||++++ -+.++.. ++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 457999999999999999999976 8999999998754433 467889999999999999999998 4444444 899
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC--eEecCCCCCceEEcCCCceEEec
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR--IIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
|||+|.+|+|.++++.-+... ..+++..+|.++.|++.||..+|+. +++ |+||||||.||+++.+|.|||+|
T Consensus 98 vmE~c~~GDLsqmIk~~K~qk-----r~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGD 171 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQK-----RLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGD 171 (375)
T ss_pred HHHhhcccCHHHHHHHHHhcc-----ccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeecc
Confidence 999999999999997544332 2389999999999999999999993 233 99999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
||+++........ ....+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||.+++-
T Consensus 172 fGL~r~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~ 233 (375)
T KOG0591|consen 172 FGLGRFLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL 233 (375)
T ss_pred chhHhHhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH
Confidence 9999887664433 2567899999999999999999999999999999999999999998743
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=322.20 Aligned_cols=200 Identities=27% Similarity=0.375 Sum_probs=184.6
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
..++|++++.||.|+||+|.+++.+ +|..+|+|++++...- .+...+|..+|+.+.||+++++++.+.+.+.+|+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 4578999999999999999999988 7999999999865432 2557789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||||++||.|..++++... +++..+..++.||+.||+|||+.+ |++|||||+|||+|.+|.+||+|||
T Consensus 122 vmeyv~GGElFS~Lrk~~r---------F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGR---------FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred EEeccCCccHHHHHHhcCC---------CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEecc
Confidence 9999999999999988654 899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
.|+..... +-+.||||.|+|||.+....|+.++|+|||||++|||+.|.+||.+.++
T Consensus 190 FAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 190 FAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred ceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 99887654 2567999999999999999999999999999999999999999998877
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-49 Score=328.86 Aligned_cols=198 Identities=30% Similarity=0.435 Sum_probs=179.3
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCC--CCCchHHHHHHHHHHhccCCCceeeeeeEEEcCC-eeEEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDS--SKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP-LRVLAY 140 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 140 (301)
..+.+.++.||+|+.|+||+++++ +++.+|+|++.. +....+++.+|+++++..+||+||.+|+.|..+. ...|+|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 346778889999999999999998 799999999943 3444578999999999999999999999999988 499999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||++|+|++++...+. +++.....++.++++||.|||+ ++ ||||||||+|||++..|.|||||||.
T Consensus 158 EYMDgGSLd~~~k~~g~---------i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGR---------IPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred hhcCCCCHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccc
Confidence 99999999999986542 8999999999999999999996 66 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
+..+-... ..+++||..|||||.+.+..|+.++||||||++++|+++|+.||...
T Consensus 226 S~~lvnS~----a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 226 SGILVNSI----ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred cHHhhhhh----cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 98776552 26778999999999999999999999999999999999999999764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-49 Score=340.26 Aligned_cols=207 Identities=27% Similarity=0.399 Sum_probs=183.5
Q ss_pred HHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHhcc-CCCceeeeeeEEEcCCe
Q 022206 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (301)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 135 (301)
.....+|..++.||+|+|++|++|+.+ +++.||||++.+...- .+.+.+|-.+|.+| .||.|++++..|+|+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 445679999999999999999999977 7999999999764322 23466788889999 89999999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
+|+|+||+++|+|.++|++... +++..+..++.||+.||+|||++| ||||||||+|||+|.++++||+
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs---------fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikIT 216 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS---------FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKIT 216 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc---------chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEe
Confidence 9999999999999999988754 899999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccc---------ccc--ccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAAR---------LHS--TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 216 Dfg~a~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|||.|+.+...... ... ..++||..|.+||++.....+..+|+|+||||||+|+.|.+||.+.++
T Consensus 217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne 292 (604)
T KOG0592|consen 217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE 292 (604)
T ss_pred eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence 99999887543322 112 458899999999999999999999999999999999999999987664
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-47 Score=330.64 Aligned_cols=229 Identities=55% Similarity=0.920 Sum_probs=204.2
Q ss_pred cccccCHHHHHHhhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeeeeeEE
Q 022206 52 AVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYY 130 (301)
Q Consensus 52 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~ 130 (301)
....++..++...+++|.-.+.||+|+||.||+|...++..||||++...... ..+|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56678999999999999999999999999999999998899999998876655 66799999999999999999999999
Q ss_pred EcCC-eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC
Q 022206 131 VDGP-LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (301)
Q Consensus 131 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 209 (301)
.+.+ ..+||+||+++|+|.+.|...... .++|..+++|+.++|+||+|||....++|||||||+.|||+|++
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~ 213 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED 213 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence 9998 499999999999999999876532 38999999999999999999999888889999999999999999
Q ss_pred CceEEeccccCCCCCc-cccccccccc-cccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCcCccccc
Q 022206 210 DIAKISDFDLSNQAPD-AAARLHSTRV-LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (301)
Q Consensus 210 ~~vkl~Dfg~a~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~ 287 (301)
++.||+|||+|+..+. .... ... .||..|+|||+......+.++|||||||+|.||+||+.|.+...+.....++
T Consensus 214 ~~aKlsDFGLa~~~~~~~~~~---~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~ 290 (361)
T KOG1187|consen 214 FNAKLSDFGLAKLGPEGDTSV---STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLV 290 (361)
T ss_pred CCEEccCccCcccCCccccce---eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHH
Confidence 9999999999966654 2211 222 7999999999999889999999999999999999999998876666666778
Q ss_pred ccc
Q 022206 288 TWV 290 (301)
Q Consensus 288 ~~~ 290 (301)
+|.
T Consensus 291 ~w~ 293 (361)
T KOG1187|consen 291 EWA 293 (361)
T ss_pred HHH
Confidence 876
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=331.74 Aligned_cols=207 Identities=25% Similarity=0.352 Sum_probs=181.0
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch----HHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
..++|++++.||+|+||.||+|+-+ +|..+|+|+++++.... ..++.|-.+|....++.||+++..|++.+++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 3468999999999999999999976 79999999998765443 457778888988899999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||||++||++..+|..... |++..+..++.+++.|++.+|+.| +|||||||+|+|||..|++||+|||
T Consensus 219 iMEylPGGD~mTLL~~~~~---------L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFG 286 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDT---------LTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFG 286 (550)
T ss_pred EEEecCCccHHHHHHhcCc---------CchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeecccc
Confidence 9999999999999987653 999999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcc----------------------ccc-----cc------------------cccccccccccCccccccCCCC
Q 022206 219 LSNQAPDA----------------------AAR-----LH------------------STRVLGTFGYHAPEYAMTGQMS 253 (301)
Q Consensus 219 ~a~~~~~~----------------------~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~~ 253 (301)
|+.-+... ... .. ....+|||.|+|||++.+..|+
T Consensus 287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~ 366 (550)
T KOG0605|consen 287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG 366 (550)
T ss_pred ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence 98432110 000 00 0125799999999999999999
Q ss_pred ccccchhhHHHHHHHHhCCCCCCCCCCcC
Q 022206 254 SKSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (301)
Q Consensus 254 ~~~DvwslG~il~~l~~g~~pf~~~~~~~ 282 (301)
..+|+||||||+||||.|.+||.+.+|..
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~ 395 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETPQE 395 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999999999999888754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-48 Score=313.40 Aligned_cols=210 Identities=25% Similarity=0.360 Sum_probs=182.2
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
+.|+.+.++|+|+||+||+++++ +|+.||||++.-+... .+-.++|+++|++|+|+|+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 56888999999999999999988 7999999998654443 2457899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
||+. ++.+-|...... ++...+..+++|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+
T Consensus 82 ~~dh-TvL~eLe~~p~G--------~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR 149 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNG--------VPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFAR 149 (396)
T ss_pred ecch-HHHHHHHhccCC--------CCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhH
Confidence 9998 444445444322 888999999999999999999999 9999999999999999999999999998
Q ss_pred CCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCcCccccccc
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTW 289 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 289 (301)
.+...... .+..+.|.+|.|||++.+ ..|+..+||||+||++.||++|.+-|.+.++.+|-..|..
T Consensus 150 ~L~~pgd~--YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~k 216 (396)
T KOG0593|consen 150 TLSAPGDN--YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRK 216 (396)
T ss_pred hhcCCcch--hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHH
Confidence 87642221 255678999999999988 6899999999999999999999999999998877666544
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=337.25 Aligned_cols=206 Identities=24% Similarity=0.371 Sum_probs=181.7
Q ss_pred HHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHhcc-CCCceeeeeeEEEcCCe
Q 022206 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (301)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 135 (301)
....++|.++++||+|+||+|+++..+ +++.+|||++++...- -+..+.|..++... +||.+++++..|++.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 455689999999999999999999988 7899999999875432 24567788887776 59999999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
+|+||||+.||++..+.+... +++..+..++.+++.||+|||++| ||+||||.+|||+|.+|++||+
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~----------F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiA 510 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDV----------FSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIA 510 (694)
T ss_pred EEEEEEecCCCcEEEEEeccc----------ccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEec
Confidence 999999999999555444333 999999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCcC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~ 282 (301)
|||+++....... .+++++|||.|||||++.+..|+.++|+|||||+|||||.|+.||.+++..+
T Consensus 511 DFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee 575 (694)
T KOG0694|consen 511 DFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE 575 (694)
T ss_pred ccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 9999987653332 3478999999999999999999999999999999999999999999776543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=324.08 Aligned_cols=203 Identities=37% Similarity=0.584 Sum_probs=175.2
Q ss_pred CCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCC-eeEEEEec
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP-LRVLAYEH 142 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~ 142 (301)
...+.+.||+|+||+||++.++....||+|++...... ...+.+|+.+|.+++|||||+++|++.+.. .+.+||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 34445569999999999999995445999999764433 357999999999999999999999999887 79999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC-ceEEeccccCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSN 221 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg~a~ 221 (301)
+++|+|.+++..... ..+++..++.++.||++||.|||+++ +||||||||+|||++.++ ++||+|||+++
T Consensus 122 ~~~GsL~~~l~~~~~-------~~l~~~~~l~~aldiArGm~YLH~~~--~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRK-------RKLPLKVRLRIALDIARGMEYLHSEG--PIIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred CCCCcHHHHHhhccc-------CCCCHHHHHHHHHHHHHHHHHHhcCC--CeeecccChhhEEEcCCCCEEEECCCccce
Confidence 999999999987411 12999999999999999999999997 389999999999999998 99999999997
Q ss_pred CCCccccccccccccccccccCccccc--cCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAM--TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
....... ..+...||+.|||||++. ...|+.++||||||+++|||+||+.||.+..+
T Consensus 193 ~~~~~~~--~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 193 EKVISKT--SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred eeccccc--cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 7654321 113367999999999999 66999999999999999999999999998776
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-47 Score=325.71 Aligned_cols=217 Identities=25% Similarity=0.371 Sum_probs=187.0
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcC--CeeE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRV 137 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 137 (301)
..+.|+.+++||+|.||.||+|++. +|+.||+|++..+... ..-..+|+.+|++|.||||+++.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 3457999999999999999999976 8999999998765533 24578999999999999999999998866 6899
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+|+|||+. +|.-++....- .+++.++..++.||+.||.|||.+| |+|||||..|||||++|.+||+||
T Consensus 195 lVFeYMdh-DL~GLl~~p~v--------kft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDF 262 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGV--------KFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADF 262 (560)
T ss_pred EEEecccc-hhhhhhcCCCc--------ccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccc
Confidence 99999998 99988876432 3999999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCcCccccccccccc
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVLTS 293 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 293 (301)
|||+......... .+..+-|+.|.|||++.+ ..|+.++|+||.||||.||++|++.|.+.+...|-..|-.++++
T Consensus 263 GLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGS 338 (560)
T KOG0600|consen 263 GLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGS 338 (560)
T ss_pred cceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCC
Confidence 9998665544332 245567999999999887 47999999999999999999999999999887776666555443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=325.09 Aligned_cols=203 Identities=30% Similarity=0.450 Sum_probs=179.5
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----C--CchHHHHHHHHHHhccC-CCceeeeeeEEEcCC
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----K--QPDQEFLAQVSMVSRLK-NENVVELVGYYVDGP 134 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 134 (301)
...++|.+.+.||+|+||+|++|.+. ++..||+|++++. . .....+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 45679999999999999999999976 7899999987654 1 12355678999999999 999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC-CceE
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAK 213 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~vk 213 (301)
.+++||||+.||+|.+++..... +.+..+..++.|++.|++|||++| |+||||||+|||++.+ +++|
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~---------l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~K 161 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGR---------LKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLK 161 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCC---------CChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEE
Confidence 99999999999999999987432 888999999999999999999999 9999999999999999 9999
Q ss_pred EeccccCCCCCccccccccccccccccccCccccccCC-CC-ccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MS-SKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|+|||++...... .....+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.+.+
T Consensus 162 l~DFG~s~~~~~~--~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 162 LSDFGLSAISPGE--DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred EeccccccccCCC--CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 9999999877411 11236779999999999999877 85 78999999999999999999998754
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=325.94 Aligned_cols=206 Identities=31% Similarity=0.482 Sum_probs=182.2
Q ss_pred CCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
..+.+++.||+|.||.||+|.++....||+|.++......+.+.+|+++|++|+|++||++++++..++.++||||||+.
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 34556788999999999999999878999999988777788999999999999999999999999998899999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
|+|.++|+.... ..+...+.+.++.||++||+||++++ +|||||..+||||+++..+||+|||+|+...+
T Consensus 286 GsLl~yLr~~~~-------~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 286 GSLLDYLRTREG-------GLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred CcHHHHhhhcCC-------CccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCC
Confidence 999999987332 23888999999999999999999999 99999999999999999999999999995554
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCcC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRG 282 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~ 282 (301)
...... ....-+..|+|||.+....++.+||||||||+||||+| |+.||...+..+
T Consensus 356 ~~Y~~~-~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e 412 (468)
T KOG0197|consen 356 DEYTAS-EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE 412 (468)
T ss_pred Cceeec-CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH
Confidence 433221 22234778999999999999999999999999999999 999998877643
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=327.42 Aligned_cols=198 Identities=31% Similarity=0.457 Sum_probs=181.1
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch---HHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+..+.. +.+.+|+++++.|+||||+.++++|++...+++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57899999999999999999987 78999999998766655 457889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+.| +|..++..... ++++.+..++.+++.||.|||+.+ |+|||+||+|||++.+|++|++|||+|+
T Consensus 82 ~a~g-~L~~il~~d~~---------lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar 148 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK---------LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLAR 148 (808)
T ss_pred hhhh-hHHHHHHhccC---------CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhh
Confidence 9988 99999987654 999999999999999999999998 9999999999999999999999999998
Q ss_pred CCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
.......- .+...|||.|||||+..+..|+..+|+|||||++|||++|++||-..
T Consensus 149 ~m~~~t~v--ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~ 203 (808)
T KOG0597|consen 149 AMSTNTSV--LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR 203 (808)
T ss_pred hcccCcee--eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH
Confidence 87654332 24567999999999999999999999999999999999999999754
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=315.08 Aligned_cols=215 Identities=26% Similarity=0.393 Sum_probs=189.3
Q ss_pred hhCCCCCCceecccCceEEEEEEE-CCCCEEEEEEcCCCCCch----HHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVL-RSGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
...+|++.+.||+|.||+|-+|.. ..|+.||||.+.++...+ -.+.+|+++|..|+||||+.++++|.+.+.+.|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 345899999999999999999995 589999999998765543 347899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||||..+|.|++++..+.. +++.++..+++||..|+.|||.++ ++|||||.+|||+|.++++||+|||
T Consensus 131 vMEYaS~GeLYDYiSer~~---------LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGS---------LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred EEEecCCccHHHHHHHhcc---------ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccc
Confidence 9999999999999987764 999999999999999999999998 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCCCcCccccccccccccCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVLTSSHF 296 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 296 (301)
++-....... -.++||+|.|.+||++.+..| ++.+|-||||++||.|+.|..||++.+- ..+|.++....+|
T Consensus 199 LSNly~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvrQIs~GaYr 271 (668)
T KOG0611|consen 199 LSNLYADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVRQISRGAYR 271 (668)
T ss_pred hhhhhccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHHHhhccccc
Confidence 9866544332 267899999999999999988 5789999999999999999999987543 4555555555554
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=294.81 Aligned_cols=208 Identities=27% Similarity=0.392 Sum_probs=184.6
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
.+|...+.||+|.||.||+|++. +|+.||||++...... .....+|++.|+.++|+||+.++++|...+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46888999999999999999976 8999999999866544 4568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|++. +|...++.... .++..++..++.++++||+|||++. |+||||||.|+|++.+|.+||+|||+|+
T Consensus 82 fm~t-dLe~vIkd~~i--------~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr 149 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNI--------ILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLAR 149 (318)
T ss_pred eccc-cHHHHhccccc--------ccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchh
Confidence 9987 99999987653 3899999999999999999999999 9999999999999999999999999999
Q ss_pred CCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCcCccccc
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~ 287 (301)
......... ...+-|-.|.|||++.+ +.|+..+|+||.|||+.||+-|.+-|.+.++.+|-..|
T Consensus 150 ~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~I 214 (318)
T KOG0659|consen 150 FFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKI 214 (318)
T ss_pred ccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHH
Confidence 887654432 22367889999998887 57899999999999999999999999998887665544
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=293.89 Aligned_cols=203 Identities=29% Similarity=0.424 Sum_probs=183.8
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
...++|++.+.||+|.||.||+|+.+ ++-.||+|++.++.. ..+++.+|+++...|+||||++++++|.++...|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 34678999999999999999999966 789999999976532 3467899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+++||...|+|...|....... +++...+.+..|++.||.|+|..+ |+||||||+|+|++.++.+||+||
T Consensus 99 LilEya~~gel~k~L~~~~~~~-------f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKR-------FDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred EEEEecCCchHHHHHHhccccc-------ccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCC
Confidence 9999999999999998655432 888889999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|.+...+... + .+.+||..|.+||+..+..++..+|+|++|++.||++.|.+||.+.+
T Consensus 169 GwsV~~p~~k-R---~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 169 GWSVHAPSNK-R---KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred CceeecCCCC-c---eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 9998776332 2 67899999999999999999999999999999999999999998766
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=323.33 Aligned_cols=203 Identities=27% Similarity=0.352 Sum_probs=182.6
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
.+-|++++.||+|+.|.|.+|++. +|+.+|||++.+... ....+.+|+-+|+.+.||||+++|++|.+...+|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 456899999999999999999976 899999999976522 235688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
+||++||.|.+++-.++. +++.++..++.||+.|+.|||..+ |+||||||+|+|++..+++||+|||.
T Consensus 91 lEyv~gGELFdylv~kG~---------l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGM 158 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGP---------LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGM 158 (786)
T ss_pred EEecCCchhHHHHHhhCC---------CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccce
Confidence 999999999999987664 899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCCCcC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~~~~ 282 (301)
|......... .+.||+|.|.|||++.+..| +.++||||.|||||.||||++||++++.+.
T Consensus 159 AsLe~~gklL---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~ 219 (786)
T KOG0588|consen 159 ASLEVPGKLL---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV 219 (786)
T ss_pred eecccCCccc---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH
Confidence 9776554433 56699999999999999988 578999999999999999999999776543
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=302.22 Aligned_cols=208 Identities=27% Similarity=0.382 Sum_probs=181.2
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch----HHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
..++|++++.||+|.-|+||+++.+ ++..+|+|++.+..... .+...|-++|..+.||.+..+|..++.+...++
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 3457888999999999999999988 57999999998754432 346678899999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
+||||+||+|..+++++.... +++..+..++.+++.||+|||.+| ||+|||||+||||.++|+|.|+||+
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~-------fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFD 224 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKR-------FSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFD 224 (459)
T ss_pred EEecCCCccHHHHHhhCCCCc-------cchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeecc
Confidence 999999999999999887543 999999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCc---------------------------------ccc---------------------ccccccccccccccCc
Q 022206 219 LSNQAPD---------------------------------AAA---------------------RLHSTRVLGTFGYHAP 244 (301)
Q Consensus 219 ~a~~~~~---------------------------------~~~---------------------~~~~~~~~gt~~y~aP 244 (301)
|+..... ... ...+..++||-.|+||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 8644211 000 0123356799999999
Q ss_pred cccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 245 E~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
|++.+..++.++|+|+|||++|||+.|..||.+.+.+
T Consensus 305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~ 341 (459)
T KOG0610|consen 305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK 341 (459)
T ss_pred eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch
Confidence 9999999999999999999999999999999887654
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=315.54 Aligned_cols=203 Identities=25% Similarity=0.354 Sum_probs=175.9
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
++|++++.||+|+||+||+|.+. +++.||+|++.+.. .....+.+|+.++..++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999977 68999999986532 12245778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++|+|.+++..... +++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla 148 (363)
T cd05628 81 EFLPGGDMMTLLMKKDT---------LTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLC 148 (363)
T ss_pred cCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCc
Confidence 99999999999976432 889999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccc---------------------------------cccccccccccccCccccccCCCCccccchhhHHHHHH
Q 022206 221 NQAPDAAAR---------------------------------LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLE 267 (301)
Q Consensus 221 ~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~ 267 (301)
......... ......+||+.|+|||++.+..++.++|||||||++|+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 228 (363)
T cd05628 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228 (363)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHH
Confidence 754321100 00123479999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCC
Q 022206 268 LLTGRKPVDHTLP 280 (301)
Q Consensus 268 l~~g~~pf~~~~~ 280 (301)
|++|+.||.+.++
T Consensus 229 ll~G~~Pf~~~~~ 241 (363)
T cd05628 229 MLIGYPPFCSETP 241 (363)
T ss_pred HHhCCCCCCCCCH
Confidence 9999999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=296.77 Aligned_cols=210 Identities=26% Similarity=0.372 Sum_probs=182.8
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch---HHHHHHHHHHhccCCCceeeeeeEEE--cCCeeE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYYV--DGPLRV 137 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~ 137 (301)
..+.|+.++.|++|+||.||+|+++ +++.||+|+++.+.... -..++|+.+|.+++|||||.+-++.. +-+.+|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3467999999999999999999987 79999999997655332 24689999999999999999998876 445799
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+|||||+. +|..++...+. .+...++..++.|+++|++|||.+. |+|||||++|+|+++.|.+||+||
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q--------~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDF 221 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQ--------PFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADF 221 (419)
T ss_pred eeHHHHHh-hHHHHHHhccC--------CCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEeccc
Confidence 99999988 99999987662 3899999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCcCccccc
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~ 287 (301)
|+|+..+..... .+..+-|..|.|||++.+ ..|+...|+||+|||+.||+++++-|.+.+..+|-..|
T Consensus 222 GLAR~ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~I 290 (419)
T KOG0663|consen 222 GLAREYGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKI 290 (419)
T ss_pred chhhhhcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHH
Confidence 999988776433 255678999999999887 47899999999999999999999999998776655444
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=313.65 Aligned_cols=210 Identities=24% Similarity=0.396 Sum_probs=185.4
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHH--HHHHHHHHhccC-CCceeeeeeEEEcCC-eeE
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQE--FLAQVSMVSRLK-NENVVELVGYYVDGP-LRV 137 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~--~~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~~ 137 (301)
...++|.+++.||.|.||.||+|+.+ ++..||||.+++.-...++ -.+|++.|++|+ ||||+++.+++.+.+ .++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 35678999999999999999999976 7999999999866555554 368999999998 999999999999888 999
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+|||||+. +|+++++.+.. .+++..+..|+.||++||+|+|.+| ++|||+||+|||+.....|||+||
T Consensus 87 fVfE~Md~-NLYqLmK~R~r--------~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDF 154 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRNR--------LFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADF 154 (538)
T ss_pred eeHHhhhh-hHHHHHhhcCC--------cCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccc
Confidence 99999987 99999987743 3999999999999999999999999 999999999999998999999999
Q ss_pred ccCCCCCccccccccccccccccccCccccc-cCCCCccccchhhHHHHHHHHhCCCCCCCCCCcCccccc
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~ 287 (301)
|+|+........ +..+.|..|.|||++. ...|+.+.|+||+|||++|+++-++.|.+.+..+|-..|
T Consensus 155 GLARev~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KI 222 (538)
T KOG0661|consen 155 GLAREVRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKI 222 (538)
T ss_pred ccccccccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHH
Confidence 999988665433 6678899999999875 467899999999999999999999999998876654443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=302.48 Aligned_cols=208 Identities=26% Similarity=0.380 Sum_probs=182.1
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch--HHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
...++|++...||.|..++||+|++. .++.||||+++.+.-.. +.+.+|++.|+.++||||++++..|..+..+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 34578999999999999999999977 78999999998765443 6789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|.||.+|++.+++....... +.+..+..|++++++||.|||.+| .||||||+.||||+.+|.|||+|||.
T Consensus 103 mpfMa~GS~ldIik~~~~~G-------l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDG-------LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred ehhhcCCcHHHHHHHHcccc-------ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCcee
Confidence 99999999999997654321 889999999999999999999999 99999999999999999999999998
Q ss_pred CCCCCcccccc--ccccccccccccCcccccc--CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 220 SNQAPDAAARL--HSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+..+.....+. ....+.||+.|||||++.. ..|+.|+||||||++..||.+|..||....|
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP 237 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP 237 (516)
T ss_pred eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh
Confidence 76654332221 1156789999999999643 5899999999999999999999999987654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=314.21 Aligned_cols=200 Identities=29% Similarity=0.500 Sum_probs=182.8
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchH-HHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQ-EFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
..|.....||+|+.|.||.|+.. +++.||||.+.......+ -+.+|+.+|+..+|+|||++++.|...+.+|+||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 46888999999999999999966 789999999988777654 4789999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
+||+|.+++.... +++.++..|+.+++.||+|||.+| |+|||||.+|||++.+|.+||+|||++...
T Consensus 353 ~ggsLTDvVt~~~----------~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi 419 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR----------MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQI 419 (550)
T ss_pred CCCchhhhhhccc----------ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecc
Confidence 9999999998755 899999999999999999999999 999999999999999999999999999887
Q ss_pred CccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
...... ..+.+|||.|||||+.....|+++.||||||++++||+-|++||-..+|
T Consensus 420 ~~~~~K--R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P 474 (550)
T KOG0578|consen 420 SEEQSK--RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP 474 (550)
T ss_pred ccccCc--cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh
Confidence 654432 2677899999999999999999999999999999999999999976554
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=301.24 Aligned_cols=203 Identities=30% Similarity=0.485 Sum_probs=172.8
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeeeeeEEEcCC--eeEEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGP--LRVLAY 140 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~ 140 (301)
..+|...+.||+|+||.||++... +|...|||........ .+.+.+|+.+|++++|||||++++...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 457888999999999999999977 5999999998765322 355899999999999999999999744433 689999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC-CCceEEecccc
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDL 219 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~ 219 (301)
||+++|+|.+++..... .+++..+..++.|+++||.|||++| ||||||||+|||++. ++.+||+|||+
T Consensus 96 Ey~~~GsL~~~~~~~g~--------~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--------KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGL 164 (313)
T ss_pred eccCCCcHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcc
Confidence 99999999999987653 2899999999999999999999999 999999999999999 79999999999
Q ss_pred CCCCCccc-cccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 220 SNQAPDAA-ARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 220 a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
+....... .........||+.|||||++... ....++|||||||++.||+||++||.+.
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 88766411 11112356799999999999853 3345999999999999999999999873
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=308.40 Aligned_cols=200 Identities=27% Similarity=0.393 Sum_probs=177.3
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
..++|++.+.||+|+||.||+|+++ +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 3578999999999999999999987 68999999986432 223567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
+|||+.+++|.+++..... +++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 96 v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg 163 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGR---------FPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFG 163 (329)
T ss_pred EEcCCCCChHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999976432 788889999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
++....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.++
T Consensus 164 ~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 220 (329)
T PTZ00263 164 FAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220 (329)
T ss_pred CceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH
Confidence 987654322 335789999999999999999999999999999999999999976554
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=302.53 Aligned_cols=204 Identities=34% Similarity=0.478 Sum_probs=170.9
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---------------hHHHHHHHHHHhccCCCceeee
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---------------DQEFLAQVSMVSRLKNENVVEL 126 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---------------~~~~~~e~~~l~~l~h~~iv~~ 126 (301)
...+.|++++.||+|.||.|-+|++. +++.||||++.+.... .+...+|+.+|++|+|+|||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999977 7999999999653221 2578899999999999999999
Q ss_pred eeEEEc--CCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCce
Q 022206 127 VGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204 (301)
Q Consensus 127 ~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Ni 204 (301)
+++..+ .+.+|||+|||..|.+.+.-... +.+.+.+++.++.+++.||+|||.+| ||||||||.|+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~---------~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNL 241 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDK---------PELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNL 241 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCc---------ccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhhe
Confidence 999875 56899999999988876543221 12899999999999999999999999 99999999999
Q ss_pred EEcCCCceEEeccccCCCCCc-----cccccccccccccccccCccccccC---C-CCccccchhhHHHHHHHHhCCCCC
Q 022206 205 LLFDDDIAKISDFDLSNQAPD-----AAARLHSTRVLGTFGYHAPEYAMTG---Q-MSSKSDVYSFGVVLLELLTGRKPV 275 (301)
Q Consensus 205 ll~~~~~vkl~Dfg~a~~~~~-----~~~~~~~~~~~gt~~y~aPE~~~~~---~-~~~~~DvwslG~il~~l~~g~~pf 275 (301)
|++++|+|||+|||.+..... ..... ...+|||.|+|||++.+. . .+.+.||||+||+||.|+.|+.||
T Consensus 242 Ll~~~g~VKIsDFGVs~~~~~~~~~~~d~~L--~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF 319 (576)
T KOG0585|consen 242 LLSSDGTVKISDFGVSNEFPQGSDEGSDDQL--SRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF 319 (576)
T ss_pred EEcCCCcEEeeccceeeecccCCccccHHHH--hhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence 999999999999999876622 22111 346899999999988763 2 356789999999999999999999
Q ss_pred CCCCC
Q 022206 276 DHTLP 280 (301)
Q Consensus 276 ~~~~~ 280 (301)
-++..
T Consensus 320 ~~~~~ 324 (576)
T KOG0585|consen 320 FDDFE 324 (576)
T ss_pred ccchH
Confidence 87544
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=303.43 Aligned_cols=198 Identities=24% Similarity=0.359 Sum_probs=175.6
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
++|++.+.||+|+||.||+|.++ +++.||+|++.... .....+.+|+.+++.++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47899999999999999999987 78999999986432 22355788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++++|.+++..... +++..+..++.|++.||+|||++| ++||||||+|||+++++.+||+|||++
T Consensus 81 e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~ 148 (291)
T cd05612 81 EYVPGGELFSYLRNSGR---------FSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFA 148 (291)
T ss_pred eCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcc
Confidence 99999999999976432 788999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
....... ....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 149 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~ 203 (291)
T cd05612 149 KKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203 (291)
T ss_pred hhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 7654321 335689999999999998999999999999999999999999977544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=313.71 Aligned_cols=202 Identities=24% Similarity=0.307 Sum_probs=173.4
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
+|++++.||+|+||.||+|++. +++.||+|++.+... ....+.+|+.+++.++|+||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 6889999999999999999976 789999999865321 23457889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 82 ~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~ 149 (382)
T cd05625 82 YIPGGDMMSLLIRMG---------IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (382)
T ss_pred CCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCc
Confidence 999999999987543 2788889999999999999999999 9999999999999999999999999975
Q ss_pred CCCccc---------------------------------------------cccccccccccccccCccccccCCCCccc
Q 022206 222 QAPDAA---------------------------------------------ARLHSTRVLGTFGYHAPEYAMTGQMSSKS 256 (301)
Q Consensus 222 ~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 256 (301)
...... ........+||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 229 (382)
T cd05625 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 229 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCee
Confidence 321000 00001234689999999999999999999
Q ss_pred cchhhHHHHHHHHhCCCCCCCCCC
Q 022206 257 DVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 257 DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|||||||++|+|++|++||...++
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~ 253 (382)
T cd05625 230 DWWSVGVILYEMLVGQPPFLAQTP 253 (382)
T ss_pred eEEechHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=312.15 Aligned_cols=202 Identities=24% Similarity=0.304 Sum_probs=173.7
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
.|++++.||+|+||+||+|++. +++.||+|++..... ....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 6889999999999999999976 789999999865322 23457889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+++|+|.+++..... +++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++.
T Consensus 82 ~~~gg~L~~~l~~~~~---------~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~ 149 (381)
T cd05626 82 YIPGGDMMSLLIRMEV---------FPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCT 149 (381)
T ss_pred cCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence 9999999999976432 788899999999999999999999 9999999999999999999999999975
Q ss_pred CCCcccc---------------------------------------------ccccccccccccccCccccccCCCCccc
Q 022206 222 QAPDAAA---------------------------------------------RLHSTRVLGTFGYHAPEYAMTGQMSSKS 256 (301)
Q Consensus 222 ~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 256 (301)
....... ........||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 229 (381)
T cd05626 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC 229 (381)
T ss_pred ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcc
Confidence 4311000 0001234699999999999988999999
Q ss_pred cchhhHHHHHHHHhCCCCCCCCCC
Q 022206 257 DVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 257 DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|||||||++|+|++|..||...++
T Consensus 230 DiwSlG~il~elltG~~Pf~~~~~ 253 (381)
T cd05626 230 DWWSVGVILFEMLVGQPPFLAPTP 253 (381)
T ss_pred ceeehhhHHHHHHhCCCCCcCCCH
Confidence 999999999999999999977654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=293.93 Aligned_cols=206 Identities=24% Similarity=0.360 Sum_probs=177.6
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCc-eeeeeeEEEcCC-----
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNEN-VVELVGYYVDGP----- 134 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~----- 134 (301)
...|..+++||+|+||+||+|+.+ +|+.||+|++..+.. ......+|+.+++.|+|+| |+++++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 456777888999999999999977 799999999976544 3456789999999999999 999999998877
Q ss_pred -eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceE
Q 022206 135 -LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (301)
Q Consensus 135 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (301)
.+++|+||++. +|..++....... ..++...+..++.||+.||+|||+++ |+||||||+||||+++|.+|
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~-----~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lK 160 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKP-----QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLK 160 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEe
Confidence 89999999987 9999998755321 12666889999999999999999999 99999999999999999999
Q ss_pred EeccccCCCCCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
|+|||+|+...-.... .+..++|..|.|||++.+. .|+...||||+|||++||+++++-|.+.+..
T Consensus 161 laDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~ 227 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI 227 (323)
T ss_pred eeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH
Confidence 9999999865533222 2455789999999999876 7899999999999999999999999987763
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=313.54 Aligned_cols=203 Identities=24% Similarity=0.303 Sum_probs=174.4
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
.+|++++.||+|+||.||+|++. +++.||+|++.+.. .....+.+|+.+++.++|+||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999977 78999999986432 22355778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++|+|.+++..... +++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~~g~L~~~i~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a 148 (376)
T cd05598 81 DYIPGGDMMSLLIRLGI---------FEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLC 148 (376)
T ss_pred eCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCC
Confidence 99999999999976432 788889999999999999999999 999999999999999999999999997
Q ss_pred CCCCccc-----------------------------------------cccccccccccccccCccccccCCCCccccch
Q 022206 221 NQAPDAA-----------------------------------------ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVY 259 (301)
Q Consensus 221 ~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 259 (301)
....... .........||+.|+|||++.+..++.++|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 228 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 228 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeee
Confidence 5321000 00001234699999999999999999999999
Q ss_pred hhHHHHHHHHhCCCCCCCCCC
Q 022206 260 SFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 260 slG~il~~l~~g~~pf~~~~~ 280 (301)
||||++|+|++|+.||.+.++
T Consensus 229 SlGvilyell~G~~Pf~~~~~ 249 (376)
T cd05598 229 SVGVILYEMLVGQPPFLADTP 249 (376)
T ss_pred eccceeeehhhCCCCCCCCCH
Confidence 999999999999999987665
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=310.47 Aligned_cols=207 Identities=31% Similarity=0.491 Sum_probs=178.1
Q ss_pred HHHHHhhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCch---HHHHHHHHHHhccCCCceeeeeeEEEcCCe
Q 022206 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (301)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 135 (301)
.++....+...+.+.||+|.||+||+|++. ..||||+++...... +.|.+|+.++++.+|.||+-+.|++.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 444455567788999999999999999986 579999998655443 568999999999999999999999988776
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
.||..||+|-+|+.+++-.+. .+.....+.|+.|++.|+.|||.++ |||||||..|||+.+++.|||+
T Consensus 463 -AIiTqwCeGsSLY~hlHv~et--------kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIg 530 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQET--------KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIG 530 (678)
T ss_pred -eeeehhccCchhhhhccchhh--------hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEe
Confidence 999999999999999987653 2889999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCcccccc---CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
||||+................|...|||||+++. ..|++.+||||||+++|||++|..||. ..+
T Consensus 531 DFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~ 597 (678)
T KOG0193|consen 531 DFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQN 597 (678)
T ss_pred cccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCC
Confidence 9999977655433322344567889999999875 468999999999999999999999998 444
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=312.25 Aligned_cols=203 Identities=26% Similarity=0.333 Sum_probs=173.8
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
++|++++.||+|+||.||+++.. +++.||+|++.+... ....+.+|+++++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47899999999999999999976 789999999864321 2345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++|+|.+++..... +++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla 148 (377)
T cd05629 81 EFLPGGDLMTMLIKYDT---------FSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLS 148 (377)
T ss_pred eCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccc
Confidence 99999999999975432 788899999999999999999999 999999999999999999999999998
Q ss_pred CCCCcccc------------c---------------------------------cccccccccccccCccccccCCCCcc
Q 022206 221 NQAPDAAA------------R---------------------------------LHSTRVLGTFGYHAPEYAMTGQMSSK 255 (301)
Q Consensus 221 ~~~~~~~~------------~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 255 (301)
+....... . ......+||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 228 (377)
T cd05629 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc
Confidence 63221000 0 00012468999999999999999999
Q ss_pred ccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 256 SDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 256 ~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+|||||||++|+|++|.+||.+.++
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~ 253 (377)
T cd05629 229 CDWWSLGAIMFECLIGWPPFCSENS 253 (377)
T ss_pred eeeEecchhhhhhhcCCCCCCCCCH
Confidence 9999999999999999999976554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=309.07 Aligned_cols=220 Identities=23% Similarity=0.363 Sum_probs=191.7
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCe-eEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPL-RVLA 139 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv 139 (301)
.++|..++.+|+|+||.+++++++ ++..+++|.+...... ++...+|+.++++++|||||.+.+.|.+++. .+|+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 468999999999999999999988 6889999998765443 3467889999999999999999999998888 9999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|+||+||+|.+.+..+++. -+++..+..++.|++.|+.|||+.. |+|||||+.|||+++++.|||+|||+
T Consensus 83 m~Y~eGg~l~~~i~~~k~~-------~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGl 152 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGV-------LFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGL 152 (426)
T ss_pred EeecCCCCHHHHHHHHhhc-------cccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhh
Confidence 9999999999999887732 2899999999999999999999888 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCcCccccccccccccCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVLTSSHFLSS 299 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 299 (301)
|+........ ..+..|||.|++||++.+..|+.++|||||||++|||++-+++|.+.+. ..++..+.....++.+
T Consensus 153 aK~l~~~~~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m---~~Li~ki~~~~~~Plp 227 (426)
T KOG0589|consen 153 AKILNPEDSL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM---SELILKINRGLYSPLP 227 (426)
T ss_pred hhhcCCchhh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch---HHHHHHHhhccCCCCC
Confidence 9998766522 2667899999999999999999999999999999999999999987665 4444444444444433
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=310.81 Aligned_cols=203 Identities=26% Similarity=0.372 Sum_probs=175.3
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
++|++.+.||+|+||.||+|++. +++.||||++.... .....+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999987 78999999986432 22345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+.+|+|.+++..... +++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 81 E~~~~g~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 148 (364)
T cd05599 81 EYLPGGDMMTLLMKKDT---------FTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLC 148 (364)
T ss_pred CCCCCcHHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccc
Confidence 99999999999975432 889999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccc------------------------------------cccccccccccccCccccccCCCCccccchhhHHH
Q 022206 221 NQAPDAAAR------------------------------------LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVV 264 (301)
Q Consensus 221 ~~~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~i 264 (301)
......... ......+||+.|+|||++.+..++.++|||||||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 228 (364)
T cd05599 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228 (364)
T ss_pred eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhH
Confidence 654321100 00012468999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCC
Q 022206 265 LLELLTGRKPVDHTLP 280 (301)
Q Consensus 265 l~~l~~g~~pf~~~~~ 280 (301)
+|+|++|..||.+.++
T Consensus 229 l~el~~G~~Pf~~~~~ 244 (364)
T cd05599 229 MYEMLVGYPPFCSDNP 244 (364)
T ss_pred HHHhhcCCCCCCCCCH
Confidence 9999999999987654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=297.39 Aligned_cols=201 Identities=25% Similarity=0.390 Sum_probs=173.9
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
.|+..+.||+|+||.||+|.+. +++.||+|.+..... ....+.+|+.+++.++|+||+++++++.+++..+++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 4788899999999999999976 799999999864322 22357789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++.
T Consensus 81 ~~~~g~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~ 150 (285)
T cd05631 81 IMNGGDLKFHIYNMGN-------PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAV 150 (285)
T ss_pred ecCCCcHHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcE
Confidence 9999999988754321 12788999999999999999999999 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 151 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 151 QIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred EcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 6543221 1344689999999999999999999999999999999999999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=323.23 Aligned_cols=228 Identities=26% Similarity=0.452 Sum_probs=194.0
Q ss_pred hhCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCe
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 135 (301)
...+....+.||+|+||+||+|+.. +...||||.++..... +.+|++|++++..|+|||||+++|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3456777889999999999999853 3567999999765443 5789999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCC-C----CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAK-P----GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~-~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 210 (301)
+++|+|||..|||.+||.......... . .+.++..+.+.|+.||+.||.||-++. +|||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 999999999999999997655433222 2 234899999999999999999999998 99999999999999999
Q ss_pred ceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCcCccccccc
Q 022206 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLVTW 289 (301)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~ 289 (301)
.|||+|||+++.....+.........-.++|||||.+...+++.+|||||+||+|||+++ |+.||.+.++. +.|+.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~---EVIe~ 717 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ---EVIEC 717 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH---HHHHH
Confidence 999999999999887776655545567899999999999999999999999999999998 99999988773 44455
Q ss_pred cccccCCC
Q 022206 290 VLTSSHFL 297 (301)
Q Consensus 290 ~~~~~~~~ 297 (301)
+..++...
T Consensus 718 i~~g~lL~ 725 (774)
T KOG1026|consen 718 IRAGQLLS 725 (774)
T ss_pred HHcCCccc
Confidence 55554433
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=310.60 Aligned_cols=204 Identities=22% Similarity=0.331 Sum_probs=175.3
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
...++|++.+.||+|+||.||+++++ +++.+|+|++.+.. .....+.+|+.+++.++||||+++++.+.++...+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999987 68899999986421 12345778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+||||+++|+|.+++.... +++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 120 lv~Ey~~gg~L~~~l~~~~----------~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DF 186 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNYD----------VPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADF 186 (370)
T ss_pred EEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEec
Confidence 9999999999999997543 788899999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCC----CCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ----MSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|++........ .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.
T Consensus 187 G~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~ 252 (370)
T cd05621 187 GTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 252 (370)
T ss_pred ccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH
Confidence 99876533221 1123457999999999987543 77899999999999999999999976653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=306.58 Aligned_cols=200 Identities=24% Similarity=0.387 Sum_probs=175.8
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-C-CCEEEEEEcCCC----CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-S-GRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
..++|++.+.||+|+||.||+|.++ + +..||+|++... ......+.+|+.+++.++||||+++++++.+++..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 4568999999999999999999865 3 468999988643 222356788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+||||+.+|+|.+++..... +++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DF 175 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKR---------FPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDF 175 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecC
Confidence 99999999999999976542 888999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.++
T Consensus 176 G~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 233 (340)
T PTZ00426 176 GFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233 (340)
T ss_pred CCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH
Confidence 998765322 1345789999999999988899999999999999999999999987654
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=305.13 Aligned_cols=198 Identities=26% Similarity=0.402 Sum_probs=176.4
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
++|++.+.||+|+||.||+|++. +++.||+|++.+.. .....+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999987 68999999986532 22346788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++++|.+++..... +++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 81 e~~~g~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a 148 (333)
T cd05600 81 EYVPGGDFRTLLNNLGV---------LSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLS 148 (333)
T ss_pred eCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCC
Confidence 99999999999975432 788999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...++
T Consensus 149 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 203 (333)
T cd05600 149 KGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203 (333)
T ss_pred ccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH
Confidence 76543 12445789999999999999999999999999999999999999987554
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=301.76 Aligned_cols=194 Identities=24% Similarity=0.328 Sum_probs=169.0
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCC
Q 022206 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 146 (301)
+.||+|+||.||+|+++ +++.||+|++.... .....+.+|+.++++++||||+++++++.+++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999976 78999999987532 12245778999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCcc
Q 022206 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (301)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (301)
+|.+++..... +++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~~~---------~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~ 148 (323)
T cd05571 81 ELFFHLSRERV---------FSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred cHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC
Confidence 99999875432 889999999999999999999999 999999999999999999999999998753222
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 227 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 149 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 149 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred CC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 11 1234579999999999999999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=308.28 Aligned_cols=207 Identities=21% Similarity=0.324 Sum_probs=176.9
Q ss_pred HHHHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCC
Q 022206 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP 134 (301)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 134 (301)
.+....++|++.+.||+|+||.||+|+++ +++.+|+|++.+.. .....+.+|+.+++.++||||+++++.+.++.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445689999999999999999999987 78999999986422 12244678899999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
..++||||+++|+|.+++.... +++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL 183 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKL 183 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEE
Confidence 9999999999999999997543 788889999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccccccccccccccccccCccccccCC----CCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ----MSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+|||++........ .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.
T Consensus 184 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 252 (371)
T cd05622 184 ADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (371)
T ss_pred EeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH
Confidence 99999876543221 1123457999999999987543 78899999999999999999999987554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=306.66 Aligned_cols=203 Identities=27% Similarity=0.372 Sum_probs=175.4
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
++|++.+.||+|+||.||+|+++ +++.||+|++... ......+.+|+.++..++|++|+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999987 6899999998642 222346778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++|+|.+++..... +++..+..++.|++.||+|||+.| |+||||||+|||++.++.++|+|||++
T Consensus 81 E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~ 148 (360)
T cd05627 81 EFLPGGDMMTLLMKKDT---------LSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLC 148 (360)
T ss_pred eCCCCccHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCC
Confidence 99999999999975432 889999999999999999999999 999999999999999999999999998
Q ss_pred CCCCcccc---------------------------------ccccccccccccccCccccccCCCCccccchhhHHHHHH
Q 022206 221 NQAPDAAA---------------------------------RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLE 267 (301)
Q Consensus 221 ~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~ 267 (301)
........ .......+||+.|+|||++.+..++.++|||||||++|+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilye 228 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeee
Confidence 65432110 000123469999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCC
Q 022206 268 LLTGRKPVDHTLP 280 (301)
Q Consensus 268 l~~g~~pf~~~~~ 280 (301)
|++|+.||.+.++
T Consensus 229 l~tG~~Pf~~~~~ 241 (360)
T cd05627 229 MLIGYPPFCSETP 241 (360)
T ss_pred cccCCCCCCCCCH
Confidence 9999999987655
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=294.60 Aligned_cols=210 Identities=26% Similarity=0.365 Sum_probs=174.4
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcC--C---eeEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG--P---LRVLA 139 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~---~~~lv 139 (301)
-.|+-.+++|+|+||.||+|... +++.||||+.-.+... -.+|+++|+.+.|||||++.-+|... . ...+|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 35778899999999999999977 6899999988655443 34689999999999999998887632 2 45689
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC-CceEEeccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDFD 218 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~Dfg 218 (301)
|||++. +|.++++..... +..++...+.-+..||++||+|||+.| |+||||||.|+|+|.+ |.+||||||
T Consensus 101 leymP~-tL~~~~r~~~~~-----~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRA-----NQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHhchH-HHHHHHHHHhhc-----CCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCC
Confidence 999987 999999842111 112777888889999999999999999 9999999999999976 999999999
Q ss_pred cCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCcCcccccccc
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWV 290 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 290 (301)
.|+.+...... .....|-.|.|||++.+ ..|+.+.||||.||++.||+-|++-|.+.+..+|-..|-.+
T Consensus 172 SAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~ 241 (364)
T KOG0658|consen 172 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKV 241 (364)
T ss_pred cceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHH
Confidence 99988765543 44567889999999887 57999999999999999999999999998877766655443
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=298.29 Aligned_cols=195 Identities=24% Similarity=0.341 Sum_probs=169.1
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCC
Q 022206 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 146 (301)
+.||+|+||.||+++++ ++..||+|++.... .....+.+|+.+++.++||||+++++.+.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999976 78999999986432 22345678999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCcc
Q 022206 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (301)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (301)
+|..++..... +++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++......
T Consensus 81 ~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 81 ELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred cHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC
Confidence 99998865432 889999999999999999999999 999999999999999999999999998653222
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 227 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 149 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 200 (323)
T cd05595 149 GAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (323)
T ss_pred CCc--cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH
Confidence 111 1345689999999999988999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=296.12 Aligned_cols=192 Identities=24% Similarity=0.318 Sum_probs=167.9
Q ss_pred ecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCCCH
Q 022206 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (301)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL 148 (301)
||+|+||.||+|++. +++.||+|++... ......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999987 6889999998642 22235577899999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCcccc
Q 022206 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (301)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (301)
.+++..... +++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 148 (312)
T cd05585 81 FHHLQREGR---------FDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD 148 (312)
T ss_pred HHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC
Confidence 999975432 888999999999999999999999 99999999999999999999999999875432221
Q ss_pred ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 149 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 197 (312)
T cd05585 149 --KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197 (312)
T ss_pred --ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence 1234578999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=299.80 Aligned_cols=201 Identities=29% Similarity=0.475 Sum_probs=182.2
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch--HHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
..|...+.||+|+||.||+|.+. +++.||+|++..+.... +++.+|+.++..++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45777899999999999999976 89999999998765543 6788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
|.||++.+++..... +.+..+..++.+++.||.|||.++ .+|||||+.|||+..+|.|||+|||.+..
T Consensus 93 ~~gGsv~~lL~~~~~---------~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~q 160 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNI---------LDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQ 160 (467)
T ss_pred hcCcchhhhhccCCC---------CccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeee
Confidence 999999999987552 477777789999999999999999 99999999999999999999999999988
Q ss_pred CCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
......+. .+++|||.|||||++....|+.++||||||++.+||++|.+||.+..|
T Consensus 161 l~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 161 LTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred eechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 76654432 678999999999999999999999999999999999999999998877
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=297.37 Aligned_cols=195 Identities=25% Similarity=0.336 Sum_probs=169.6
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCC
Q 022206 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 146 (301)
+.||+|+||.||+++++ +++.||+|++.... .....+.+|+.+++.++||||+++++.+.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999977 78999999986532 22346778999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCcc
Q 022206 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (301)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (301)
+|.+++..... +++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 81 ELFFHLSRERV---------FSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD 148 (328)
T ss_pred CHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc
Confidence 99998865432 889999999999999999999999 999999999999999999999999998754322
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 227 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 149 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~ 200 (328)
T cd05593 149 AAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (328)
T ss_pred ccc--cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH
Confidence 111 1345689999999999988999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=307.66 Aligned_cols=210 Identities=26% Similarity=0.329 Sum_probs=185.0
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccC-C-----CceeeeeeEEEcCCeeEEE
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-N-----ENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~~~~~~lv 139 (301)
+|+++++||+|+||.|.+|.+. +++.||||+++..+....+...|+.+|..|+ | -|+|+++++|...+++|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 5788999999999999999976 7999999999988777788888999999997 4 3899999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC--CceEEecc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD--DIAKISDF 217 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~--~~vkl~Df 217 (301)
+|.+.. +|+++++.++-. .++...+..++.||+.+|.+||+.+ |||+||||+|||+.+. ..|||+||
T Consensus 267 fELL~~-NLYellK~n~f~-------Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKFR-------GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred ehhhhh-hHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEec
Confidence 999976 999999876643 2899999999999999999999999 9999999999999864 47999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCcCcccccccccc
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVLT 292 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 292 (301)
|.|........ ..+-+..|.|||++.+..|+.+.||||||||++||++|.+.|.+.+..+|-..|-.+++
T Consensus 336 GSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG 405 (586)
T KOG0667|consen 336 GSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLG 405 (586)
T ss_pred ccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhC
Confidence 99987655432 33456789999999999999999999999999999999999999988777766654443
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=304.41 Aligned_cols=203 Identities=22% Similarity=0.329 Sum_probs=174.4
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
..++|++.+.||+|+||.||+++++ +++.||+|++.+.. .....+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568999999999999999999987 78999999986422 122446789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||||+++|+|.+++.... +++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 121 v~Ey~~gg~L~~~l~~~~----------l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG 187 (370)
T cd05596 121 VMEYMPGGDLVNLMSNYD----------IPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (370)
T ss_pred EEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEecc
Confidence 999999999999987543 788889999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccC----CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG----QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.
T Consensus 188 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 252 (370)
T cd05596 188 TCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (370)
T ss_pred ceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH
Confidence 9876543211 112345799999999988653 378899999999999999999999987554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=299.02 Aligned_cols=204 Identities=23% Similarity=0.380 Sum_probs=182.8
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
..+-|.+.+.||+|.|+.|-+|++. +|..||||++.+.+.. ...+..|+..|+..+|||||++|++......+|+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 4567999999999999999999977 9999999999876654 35788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC-CCceEEeccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFD 218 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg 218 (301)
+|.-++|+|++|+-++... +.+..+.+++.||+.|+.|+|+.. +|||||||+|+.+.+ -|.|||.|||
T Consensus 96 LELGD~GDl~DyImKHe~G--------l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFG 164 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEG--------LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFG 164 (864)
T ss_pred EEecCCchHHHHHHhhhcc--------ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeecc
Confidence 9999999999999776542 899999999999999999999998 999999999987764 6899999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCC-ccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS-SKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
++-........ ++.||++.|.|||++.+..|+ +++||||||||||.|++|++||+..++.
T Consensus 165 FSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS 225 (864)
T KOG4717|consen 165 FSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS 225 (864)
T ss_pred ccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch
Confidence 98777665443 677999999999999999996 5789999999999999999999876553
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=302.98 Aligned_cols=203 Identities=27% Similarity=0.375 Sum_probs=177.8
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
++|++.+.||+|+||.||+|++. +++.||+|++.... .....+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999987 79999999986432 23356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++++|.+++.... .+++..+..++.|++.||+|||+.| ++||||||+|||++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~ 148 (350)
T cd05573 81 EYMPGGDLMNLLIRKD---------VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLC 148 (350)
T ss_pred cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCC
Confidence 9999999999997653 2889999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccc---------------------------cccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCC
Q 022206 221 NQAPDAA---------------------------ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 273 (301)
Q Consensus 221 ~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~ 273 (301)
....... .........||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCC
Confidence 7654432 0011234568999999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 022206 274 PVDHTLP 280 (301)
Q Consensus 274 pf~~~~~ 280 (301)
||...+.
T Consensus 229 Pf~~~~~ 235 (350)
T cd05573 229 PFYSDTL 235 (350)
T ss_pred CCCCCCH
Confidence 9987654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=296.20 Aligned_cols=198 Identities=25% Similarity=0.404 Sum_probs=169.4
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHH---hccCCCceeeeeeEEEcCCeeEEE
Q 022206 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMV---SRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
|++.+.||+|+||.||+|.+. +++.||+|++.+.. .....+.+|..++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999977 78999999986432 2224455665554 567899999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+++++|...+.... +++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+
T Consensus 81 ~E~~~~~~L~~~~~~~~----------l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05589 81 MEYAAGGDLMMHIHTDV----------FSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGL 147 (324)
T ss_pred EcCCCCCcHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccC
Confidence 99999999999886532 889999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+........ ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 148 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~ 206 (324)
T cd05589 148 CKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE 206 (324)
T ss_pred CccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH
Confidence 865432221 12345789999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=295.28 Aligned_cols=200 Identities=25% Similarity=0.325 Sum_probs=171.2
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCC-CceeeeeeEEEcCCeeEEEE
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 140 (301)
+|++++.||+|+||.||+|+++ +++.||+|++.+.. .....+..|..++..+.| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999977 68899999986532 223457788888988876 46888999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++|+|.+++..... +++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 E~~~~g~L~~~~~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~ 148 (324)
T cd05587 81 EYVNGGDLMYHIQQVGK---------FKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMC 148 (324)
T ss_pred cCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcc
Confidence 99999999999875432 788999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 149 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (324)
T cd05587 149 KENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 206 (324)
T ss_pred eecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 65322111 11345689999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=288.08 Aligned_cols=215 Identities=27% Similarity=0.373 Sum_probs=182.2
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCC---CCCchHHHHHHHHHHhccCCCceeeeeeEEEc-----CC
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDS---SKQPDQEFLAQVSMVSRLKNENVVELVGYYVD-----GP 134 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 134 (301)
....|..++.||+|+||.|..+.++ +|+.||||++.. .....++..+|+++|+.++|+||+.+++++.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456777899999999999999987 899999999862 23345778899999999999999999999865 34
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
.+|+|+|+|+. +|.++++.++. ++...+..+++||+.||+|+|+.+ |+||||||.|+|++.+..+||
T Consensus 100 DvYiV~elMet-DL~~iik~~~~---------L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI 166 (359)
T KOG0660|consen 100 DVYLVFELMET-DLHQIIKSQQD---------LTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKI 166 (359)
T ss_pred eeEEehhHHhh-HHHHHHHcCcc---------ccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEe
Confidence 58999999965 99999987653 899999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccccccccccccccccccCccccc-cCCCCccccchhhHHHHHHHHhCCCCCCCCCCcCccccccccc
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVL 291 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 291 (301)
+|||+|+...........+..+.|..|.|||++. ...|+.+.||||+|||+.||++|++-|.+.+...|-.++-.+.
T Consensus 167 ~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l 244 (359)
T KOG0660|consen 167 CDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL 244 (359)
T ss_pred ccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence 9999998875432222225567799999999765 4689999999999999999999999999987766665554443
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=291.11 Aligned_cols=202 Identities=23% Similarity=0.377 Sum_probs=173.0
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
.++|++.+.||+|+||.||+|+++ ++..||+|++..... ....+.+|+.+++.++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 467999999999999999999987 789999999865432 23467789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+++ +|.+++..... .+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++.
T Consensus 84 ~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~ 151 (288)
T cd07871 84 YLDS-DLKQYLDNCGN--------LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLAR 151 (288)
T ss_pred CCCc-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCccee
Confidence 9986 99998865432 2788899999999999999999999 9999999999999999999999999986
Q ss_pred CCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
........ .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.
T Consensus 152 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~ 209 (288)
T cd07871 152 AKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV 209 (288)
T ss_pred eccCCCcc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 54332211 133467999999998865 5689999999999999999999999976553
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=295.12 Aligned_cols=200 Identities=25% Similarity=0.324 Sum_probs=171.0
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEEEE
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
+|++.+.||+|+||.||+|++. +++.||+|++.+... .......|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999987 688999999875322 123456677777766 5799999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++|+|.+++..... +++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 E~~~~g~L~~~~~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~ 148 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR---------FKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred cCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCc
Confidence 99999999999875432 788999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 149 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~ 206 (323)
T cd05616 149 KENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206 (323)
T ss_pred eecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH
Confidence 65432211 12345789999999999999999999999999999999999999987553
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=292.07 Aligned_cols=201 Identities=23% Similarity=0.384 Sum_probs=171.3
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
.++|++.+.||+|+||.||+|+++ +++.||+|++...... ...+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999987 7899999998754322 3457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+. ++|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.
T Consensus 84 ~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 151 (303)
T cd07869 84 YVH-TDLCQYMDKHPG--------GLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR 151 (303)
T ss_pred CCC-cCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcce
Confidence 996 488887765432 2788899999999999999999999 9999999999999999999999999986
Q ss_pred CCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
........ .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 152 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 152 AKSVPSHT--YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred eccCCCcc--CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 54322211 133467999999998865 457889999999999999999999997643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=297.09 Aligned_cols=202 Identities=22% Similarity=0.304 Sum_probs=172.8
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
++|++.+.||+|+||.||+++++ +++.||+|++.+.. .....+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999987 68899999986421 12244778889999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+.+|+|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 Ey~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a 149 (331)
T cd05624 81 DYYVGGDLLTLLSKFED--------RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSC 149 (331)
T ss_pred eCCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccce
Confidence 99999999999975321 2788999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCcccccc-----CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
......... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+
T Consensus 150 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 150 LKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred eeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 765432211 1233568999999998865 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=296.33 Aligned_cols=195 Identities=25% Similarity=0.342 Sum_probs=168.3
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCC
Q 022206 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 146 (301)
+.||+|+||.||++.+. +++.||+|++.... .....+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999976 78999999986532 12345678899999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
+|.+++..... +++..+..++.||+.||.|||+ .+ |+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 81 ELFFHLSRERV---------FSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 148 (325)
T ss_pred cHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence 99998865432 8899999999999999999997 78 99999999999999999999999999865432
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 149 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~ 201 (325)
T cd05594 149 DGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 201 (325)
T ss_pred CCcc--cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH
Confidence 2111 1345689999999999988999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=296.10 Aligned_cols=203 Identities=26% Similarity=0.389 Sum_probs=182.4
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccC-CCceeeeeeEEEcCCee
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLR 136 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 136 (301)
.....|++.+.||+|.||.||+++.+ +|+.+|+|.+.+... ....+.+|+.+|+++. ||||+.++++|.+....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34568999999999999999999988 699999999976544 2357899999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC----Cce
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD----DIA 212 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~----~~v 212 (301)
++|||+|.||.|.+.+.... +++..+..++.|++.+++|||+.| |+||||||+|+|+... +.+
T Consensus 112 ~lvmEL~~GGeLfd~i~~~~----------~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~i 178 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKKH----------YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRI 178 (382)
T ss_pred EEEEEecCCchHHHHHHHcc----------CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcE
Confidence 99999999999999998761 899999999999999999999999 9999999999999743 479
Q ss_pred EEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
|++|||++....... .....+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.+..
T Consensus 179 k~~DFGla~~~~~~~---~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~ 244 (382)
T KOG0032|consen 179 KLIDFGLAKFIKPGE---RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF 244 (382)
T ss_pred EEeeCCCceEccCCc---eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh
Confidence 999999998877622 226678999999999999999999999999999999999999999887643
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=295.72 Aligned_cols=202 Identities=22% Similarity=0.312 Sum_probs=172.2
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
++|++.+.||+|+||.||++++. +++.||+|++.+.. .....+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999977 68999999986421 22345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++|+|.+++..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 81 e~~~g~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~ 149 (331)
T cd05597 81 DYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSC 149 (331)
T ss_pred ecCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCce
Confidence 99999999999965321 2888999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCcccccc-----CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
......... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+
T Consensus 150 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 150 LRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred eecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 655432211 1123468999999999863 456889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=295.99 Aligned_cols=212 Identities=24% Similarity=0.406 Sum_probs=171.9
Q ss_pred hCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhcc-CCCceeeeeeEEEcC-C
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDG-P 134 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~ 134 (301)
.++|++.+.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.++..+ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 468999999999999999999742 3568999998754322 35688999999999 899999999988754 4
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCC-----------------------------------------------------C
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKG-----------------------------------------------------A 161 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~-----------------------------------------------------~ 161 (301)
.++++|||+++|+|.+++........ .
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 68899999999999999975321100 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCccccccccccccccccc
Q 022206 162 KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241 (301)
Q Consensus 162 ~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y 241 (301)
.....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++................+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 00124778889999999999999999999 999999999999999999999999999765433222222334467889
Q ss_pred cCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCC
Q 022206 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTL 279 (301)
Q Consensus 242 ~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~ 279 (301)
+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999998899999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=288.69 Aligned_cols=202 Identities=24% Similarity=0.367 Sum_probs=173.4
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
++|++.+.||+|+||.||+|+++ +++.+|+|++..... ....+.+|+.+++.++|+||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999987 688999999865432 23567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+++++|..+..... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 148 (287)
T cd07848 81 YVEKNMLELLEEMPN---------GVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFAR 148 (287)
T ss_pred cCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcc
Confidence 999977766544322 2888999999999999999999999 9999999999999999999999999997
Q ss_pred CCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
........ ......|++.|+|||++.+..++.++|||||||++|+|++|++||.+.+.
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~ 206 (287)
T cd07848 149 NLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE 206 (287)
T ss_pred cccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCH
Confidence 75432211 11345689999999999988899999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=301.09 Aligned_cols=187 Identities=33% Similarity=0.545 Sum_probs=168.9
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCCCHHH
Q 022206 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD 150 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~ 150 (301)
++-||+|+.|.||+|+.+ ++.||||+++.- -..+++-|++|+|+||+.+.++|.....++||||||..|.|++
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~el------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVREL------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhh------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 567999999999999988 689999987532 2346888999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCcccccc
Q 022206 151 ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230 (301)
Q Consensus 151 ~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 230 (301)
+|+.... +.......|..+|+.|+.|||.+- |||||||.-||||..+..|||+|||.++........
T Consensus 202 VLka~~~---------itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk- 268 (904)
T KOG4721|consen 202 VLKAGRP---------ITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK- 268 (904)
T ss_pred HHhccCc---------cCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhhh-
Confidence 9987653 788889999999999999999997 999999999999999999999999999877655333
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 231 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
..++||..|||||++++...+.++|||||||+|||||||..||.+.+
T Consensus 269 --MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 269 --MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred --hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc
Confidence 67899999999999999999999999999999999999999997644
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=293.47 Aligned_cols=196 Identities=25% Similarity=0.354 Sum_probs=168.1
Q ss_pred CceecccCceEEEEEEEC----CCCEEEEEEcCCCC-----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 71 NSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
++.||+|+||.||+++.. +++.||+|++.... .....+.+|+.+++.++||||+++++++.+++..+++||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999853 57899999986421 223456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+.+++|.+++..... +.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 148 (323)
T cd05584 81 YLSGGELFMHLEREGI---------FMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK 148 (323)
T ss_pred CCCCchHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCe
Confidence 9999999999875432 778888899999999999999999 9999999999999999999999999986
Q ss_pred CCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 149 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~ 205 (323)
T cd05584 149 ESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR 205 (323)
T ss_pred ecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH
Confidence 4322211 12345689999999999988899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=299.20 Aligned_cols=203 Identities=23% Similarity=0.311 Sum_probs=174.9
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
++|++.+.||+|+||.||+|+++ +++.||+|++..... ....+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999977 789999999875432 3345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++++|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a 149 (330)
T cd05601 81 EYQPGGDLLSLLNRYED--------QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSA 149 (330)
T ss_pred CCCCCCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCC
Confidence 99999999999976532 2889999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCccccc------cCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAM------TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
......... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||...+.
T Consensus 150 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 214 (330)
T cd05601 150 ARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214 (330)
T ss_pred eECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH
Confidence 765433221 113346899999999886 45678899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=291.80 Aligned_cols=195 Identities=26% Similarity=0.371 Sum_probs=165.4
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhc-cCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSR-LKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
+.||+|+||.||+|++. +++.||+|++.... ........|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999977 68899999986532 122344556666654 4899999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
|+|.+++..... +++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~~~~~~~---------~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 81 GDLMFHIQSSGR---------FDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMN 148 (316)
T ss_pred CcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence 999999875432 888999999999999999999999 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~ 201 (316)
T cd05592 149 GEG--KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE 201 (316)
T ss_pred CCC--ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH
Confidence 221 12445789999999999988999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=294.42 Aligned_cols=200 Identities=24% Similarity=0.329 Sum_probs=170.3
Q ss_pred CCCCCceecccCceEEEEEEEC----CCCEEEEEEcCCCC-----CchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCee
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 136 (301)
+|++.+.||+|+||.||+++.. +++.||+|++.+.. .....+.+|+.+++.+ +|+||+++++++.+++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5889999999999999999853 57899999986421 2234577899999999 489999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
++||||+++|+|.+++..... +++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~D 148 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDN---------FSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTD 148 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEee
Confidence 999999999999999875432 888999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
||++......... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 149 fG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 211 (332)
T cd05614 149 FGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEG 211 (332)
T ss_pred CcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCC
Confidence 9998764332211 11345689999999998765 47889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=293.29 Aligned_cols=195 Identities=21% Similarity=0.332 Sum_probs=167.2
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
+.||+|+||.||+|+++ +++.||+|++.+.. .....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999987 68899999987532 2224466788888765 799999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
++|...+..... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~ 148 (321)
T cd05591 81 GDLMFQIQRSRK---------FDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGIL 148 (321)
T ss_pred CcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence 999998875432 788899999999999999999999 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...++
T Consensus 149 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~ 201 (321)
T cd05591 149 NGVT--TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE 201 (321)
T ss_pred CCcc--ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH
Confidence 2211 2345689999999999988999999999999999999999999986654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=292.11 Aligned_cols=200 Identities=29% Similarity=0.440 Sum_probs=176.0
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
.++|++.+.||+|+||.||++++. ++..+|+|.+...... ...+.+|+++++.++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 578999999999999999999987 7889999998754332 3568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+++++|.+++..... +++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||++.
T Consensus 84 ~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 152 (331)
T cd06649 84 HMDGGSLDQVLKEAKR---------IPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (331)
T ss_pred cCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccc
Confidence 9999999999976432 788999999999999999999852 29999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
...... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 153 ~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 153 QLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred cccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 654322 134568999999999998899999999999999999999999996543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=292.16 Aligned_cols=195 Identities=25% Similarity=0.362 Sum_probs=167.4
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
+.||+|+||.||+|+++ +++.||+|++.+.. .....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999987 68999999986432 2234566778888766 699999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
|+|.+++..... +++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~i~~~~~---------l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~ 148 (320)
T cd05590 81 GDLMFHIQKSRR---------FDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF 148 (320)
T ss_pred chHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence 999998875432 889999999999999999999999 99999999999999999999999999865432
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 201 (320)
T cd05590 149 NGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE 201 (320)
T ss_pred CCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence 211 12345789999999999988999999999999999999999999976554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=292.81 Aligned_cols=192 Identities=23% Similarity=0.352 Sum_probs=166.7
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
+.||+|+||.||+|+++ +++.||+|++++... ....+.+|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999987 789999999875322 224577888898888 699999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
|+|.+++..... +++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~~~~~~~---------l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 148 (329)
T cd05588 81 GDLMFHMQRQRK---------LPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR 148 (329)
T ss_pred CCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence 999998865432 899999999999999999999999 99999999999999999999999999865322
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
... ......||+.|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 149 PGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 111 12345789999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=294.62 Aligned_cols=196 Identities=26% Similarity=0.386 Sum_probs=165.9
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
..+|+.++.||+|+||.||+|++. +++.||+|++...... ...+.+|+++++.++|+||+++++++.+++.+++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 457888999999999999999977 7899999998654322 3568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+++++|.+... ..+..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++.
T Consensus 153 ~~~~~~L~~~~~-------------~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 153 FMDGGSLEGTHI-------------ADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSR 216 (353)
T ss_pred cCCCCccccccc-------------CCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccce
Confidence 999999865321 566778889999999999999999 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCcccccc-----CCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
........ .....||+.|+|||++.. ...+.++|||||||++|+|++|+.||...
T Consensus 217 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 217 ILAQTMDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred eccccccc--ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 65432211 134568999999998743 23356899999999999999999999743
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=293.68 Aligned_cols=203 Identities=21% Similarity=0.304 Sum_probs=172.3
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
++|++.+.||+|+||.||+++++ +++.+|+|++.+.. .....+.+|+.++..++|++|+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999987 68889999986421 12234778889999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++|+|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ey~~~g~L~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a 149 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC 149 (332)
T ss_pred eccCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchh
Confidence 99999999999975322 2788899999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
........ .......||+.|+|||++. ...++.++|||||||++|+|++|+.||...+.
T Consensus 150 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~ 213 (332)
T cd05623 150 LKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (332)
T ss_pred eecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH
Confidence 65432211 1123357999999999886 34678899999999999999999999976543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=291.68 Aligned_cols=200 Identities=24% Similarity=0.326 Sum_probs=171.0
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccC-CCceeeeeeEEEcCCeeEEEE
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 140 (301)
+|+..+.||+|+||.||+|+++ +++.||+|++.+.. .....+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788899999999999999977 78999999986532 12245677888888775 577888999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++|+|.+++..... +++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++
T Consensus 81 Ey~~~g~L~~~i~~~~~---------l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~ 148 (323)
T cd05615 81 EYVNGGDLMYHIQQVGK---------FKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred cCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccc
Confidence 99999999999875432 889999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..+
T Consensus 149 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (323)
T cd05615 149 KEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206 (323)
T ss_pred cccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 75432211 12345689999999999988899999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=291.97 Aligned_cols=195 Identities=23% Similarity=0.329 Sum_probs=164.5
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHH-HHHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQV-SMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
+.||+|+||.||+|++. +++.||+|++.+... ....+..|. .+++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999987 678899999864321 122334443 356788999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
++|.+++..... +.+..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 81 GELFYHLQRERC---------FLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 148 (325)
T ss_pred CcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence 999999975432 778888899999999999999999 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 201 (325)
T cd05602 149 HNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 201 (325)
T ss_pred CCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH
Confidence 211 12445799999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=282.04 Aligned_cols=209 Identities=23% Similarity=0.310 Sum_probs=183.1
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch----HHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
..++|..+++||+|.||+|.+++-+ +++.+|+|+++++..-. ..-..|-.+|...+||.+..+--.|+..+++++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 4678999999999999999999977 89999999998754332 234567889999999999999888999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||||..||.|.-.|.+... +++.....+-.+|+.||.|||+++ ||+||||.+|+|+|++|++||+|||
T Consensus 246 VMeyanGGeLf~HLsrer~---------FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFG 313 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERV---------FSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFG 313 (516)
T ss_pred EEEEccCceEeeehhhhhc---------ccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecc
Confidence 9999999999998877543 899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCcCcccc
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSL 286 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~ 286 (301)
+++...... ....++||||.|+|||++....|+.++|+|.+||++|||++|++||...+......+
T Consensus 314 LCKE~I~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL 379 (516)
T KOG0690|consen 314 LCKEEIKYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL 379 (516)
T ss_pred cchhccccc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH
Confidence 997654322 234678999999999999999999999999999999999999999987665444333
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=290.51 Aligned_cols=195 Identities=26% Similarity=0.366 Sum_probs=166.4
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhc-cCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSR-LKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
+.||+|+||.||+|+++ +++.||+|++.... ........|..++.. ++|+||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999987 78999999986532 223445667777765 4899999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
++|.+++..... +++..+..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 g~L~~~i~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 81 GDLMFHIQDKGR---------FDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVF 148 (316)
T ss_pred CcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeeccc
Confidence 999999875432 788999999999999999999999 99999999999999999999999999864322
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~ 201 (316)
T cd05620 149 GDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE 201 (316)
T ss_pred CCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 111 12445789999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.53 Aligned_cols=194 Identities=24% Similarity=0.359 Sum_probs=165.1
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHH-HHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVS-MVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
+.||+|+||+||+|+++ +++.||+|++..... ....+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999987 799999999864321 2233444544 56789999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
|+|.+++..... +++..+..++.||+.||+|||++| |+||||||+|||+++++.+||+|||++.....
T Consensus 81 g~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (323)
T cd05575 81 GELFFHLQRERS---------FPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE 148 (323)
T ss_pred CCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc
Confidence 999999875432 788999999999999999999999 99999999999999999999999999865432
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 149 HSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred CCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 221 1234568999999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=279.27 Aligned_cols=202 Identities=25% Similarity=0.396 Sum_probs=177.3
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
...+.|++.+.||+|.|+.|+++.+. +|+.+|+|.++... ...+++.+|+.+-+.|+||||+++.+.+.+....|+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 34678999999999999999999977 79999999886433 344778999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC---CCceEEe
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKIS 215 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~vkl~ 215 (301)
|+|++.|++|..-+-.+. .+++..+..++.||+++|.|+|.++ |||||+||+|+++.. ..-|||+
T Consensus 88 vFe~m~G~dl~~eIV~R~---------~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~ 155 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVARE---------FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLA 155 (355)
T ss_pred EEecccchHHHHHHHHHH---------HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeec
Confidence 999999999987664432 2888999999999999999999999 999999999999964 3469999
Q ss_pred ccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|||+|......... ..+.|||.|||||+++..+|+..+|||+.||+||.|+.|++||.+.+
T Consensus 156 ~FGvAi~l~~g~~~---~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~ 216 (355)
T KOG0033|consen 156 DFGLAIEVNDGEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 216 (355)
T ss_pred ccceEEEeCCcccc---ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc
Confidence 99999888743322 56689999999999999999999999999999999999999997733
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=303.32 Aligned_cols=201 Identities=27% Similarity=0.446 Sum_probs=175.4
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC--CCchHHHHHHHHHHhccCCCceeeeeeEEEcC------Cee
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS--KQPDQEFLAQVSMVSRLKNENVVELVGYYVDG------PLR 136 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~ 136 (301)
..|...+.||+|+||.||+++++ +|+.||||.++.. ....+.+.+|+++|++|+|+|||+++++-.+. ...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 45778889999999999999977 8999999999763 44567789999999999999999999975433 356
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC--C--ce
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD--D--IA 212 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~--~--~v 212 (301)
.++||||.||||+..++...+.. .+++...+.++.++..||.|||++| |+||||||.||++..+ | ..
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~------GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~Iy 163 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAY------GLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIY 163 (732)
T ss_pred eEEEeecCCCcHHHHhcCccccc------CCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEE
Confidence 89999999999999998765543 2899999999999999999999999 9999999999999643 3 57
Q ss_pred EEeccccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
||+|||.|+.+...... ....||+.|++||+... ..|+..+|.|||||++|++.||..||...
T Consensus 164 KLtDfG~Arel~d~s~~---~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 164 KLTDFGAARELDDNSLF---TSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred eeecccccccCCCCCee---eeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 99999999998877643 67789999999999885 78899999999999999999999999653
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=290.98 Aligned_cols=192 Identities=23% Similarity=0.354 Sum_probs=165.6
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
+.||+|+||.||+|+++ +++.+|+|++.+... ....+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999977 688999999875322 224467788887766 799999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
++|..++..... +++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~~~~~~~---------l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~ 148 (329)
T cd05618 81 GDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 148 (329)
T ss_pred CCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccC
Confidence 999988865432 889999999999999999999999 99999999999999999999999999865322
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 149 PGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 211 12345789999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=288.28 Aligned_cols=213 Identities=26% Similarity=0.403 Sum_probs=174.2
Q ss_pred hCCCCCCceecccCceEEEEEEECC-----------------CCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRS-----------------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVE 125 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~ 125 (301)
.++|++.+.||+|+||.||+|.+.+ +..||+|.+...... ...+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4679999999999999999998532 336999998754322 356889999999999999999
Q ss_pred eeeEEEcCCeeEEEEecCCCCCHHHHhcCCCCCCC----------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeE
Q 022206 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG----------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRII 195 (301)
Q Consensus 126 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iv 195 (301)
+++++.+.+..+++|||+.+++|.+++........ ......+++..++.++.|++.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 99999999999999999999999999865432111 111134778889999999999999999999 99
Q ss_pred ecCCCCCceEEcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh--CCC
Q 022206 196 HRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT--GRK 273 (301)
Q Consensus 196 H~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~--g~~ 273 (301)
||||||+|||+++++.+||+|||++................++..|+|||++....++.++||||||+++|+|++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999876543322222233456788999999988889999999999999999986 678
Q ss_pred CCCCCCC
Q 022206 274 PVDHTLP 280 (301)
Q Consensus 274 pf~~~~~ 280 (301)
||.+.+.
T Consensus 241 p~~~~~~ 247 (304)
T cd05096 241 PYGELTD 247 (304)
T ss_pred CCCcCCH
Confidence 8876543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=291.10 Aligned_cols=193 Identities=24% Similarity=0.353 Sum_probs=166.9
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
+.||+|+||.||+|+.. +++.+|+|++.+... ....+.+|..++.++ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999977 688999999975432 224467888888887 699999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
++|.+++..... +++..+..++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~~~~~~~---------l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 148 (327)
T cd05617 81 GDLMFHMQRQRK---------LPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG 148 (327)
T ss_pred CcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccC
Confidence 999998865432 889999999999999999999999 99999999999999999999999999865322
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 149 PGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred CCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence 111 123457899999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=290.64 Aligned_cols=194 Identities=24% Similarity=0.347 Sum_probs=164.6
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHH-HHHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQV-SMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
+.||+|+||.||+|++. +++.||+|++.+... ....+..|. .+++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999987 689999999864321 223344454 457889999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
++|...+..... +++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 81 GELFFHLQRERC---------FLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred CCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCC
Confidence 999988865432 788889999999999999999999 99999999999999999999999999875322
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 149 PEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred CCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 221 1234578999999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=284.70 Aligned_cols=201 Identities=25% Similarity=0.400 Sum_probs=173.6
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
+|++.+.||+|+||.||++.+. +++.||+|++...... ...+.+|+.+++.++|+||+++++.+.+++..+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4888999999999999999976 7899999998653221 2346789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+.+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.
T Consensus 81 ~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~ 150 (285)
T cd05605 81 LMNGGDLKFHIYNMGN-------PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAV 150 (285)
T ss_pred ccCCCcHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCce
Confidence 9999999988864321 12889999999999999999999999 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
........ ....|++.|+|||++.+..++.++||||+|+++|+|++|+.||.+...
T Consensus 151 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~ 206 (285)
T cd05605 151 EIPEGETI---RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206 (285)
T ss_pred ecCCCCcc---ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence 65432211 234689999999999888899999999999999999999999986544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=289.04 Aligned_cols=195 Identities=25% Similarity=0.380 Sum_probs=166.0
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhc-cCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSR-LKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
+.||+|+||.||+|++. +++.||+|++.... ........|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999987 68899999986532 223445667777765 5899999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
|+|.+++..... +++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05619 81 GDLMFHIQSCHK---------FDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENML 148 (316)
T ss_pred CcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCC
Confidence 999999975432 788899999999999999999999 99999999999999999999999999865322
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~ 201 (316)
T cd05619 149 GDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE 201 (316)
T ss_pred CCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH
Confidence 111 11345689999999999988999999999999999999999999976553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=304.20 Aligned_cols=202 Identities=20% Similarity=0.320 Sum_probs=166.9
Q ss_pred HHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCC------CceeeeeeEEEcC-
Q 022206 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN------ENVVELVGYYVDG- 133 (301)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~- 133 (301)
....++|++.+.||+|+||+||+|.+. +++.||||++............|+++++.++| .+++++++++..+
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 334578999999999999999999976 68899999997544444556677777777654 4588888888754
Q ss_pred CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCCceEEcCCC--
Q 022206 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDD-- 210 (301)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~-- 210 (301)
...++|||++ +++|.+++.... .+++..+..++.||+.||.|||+ .| |+||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~~---------~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKHG---------PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTV 271 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcc
Confidence 5788999988 668888886543 28889999999999999999997 58 99999999999998765
Q ss_pred --------------ceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCC
Q 022206 211 --------------IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276 (301)
Q Consensus 211 --------------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~ 276 (301)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|++||.
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 4999999987543221 145678999999999999999999999999999999999999998
Q ss_pred CCCCc
Q 022206 277 HTLPR 281 (301)
Q Consensus 277 ~~~~~ 281 (301)
+.+..
T Consensus 347 ~~~~~ 351 (467)
T PTZ00284 347 THDNL 351 (467)
T ss_pred CCChH
Confidence 76543
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=302.24 Aligned_cols=215 Identities=32% Similarity=0.468 Sum_probs=181.4
Q ss_pred HHHHhhCCCCCCceecccCceEEEEEEEC--CC--CE-EEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEE
Q 022206 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR--SG--RA-AAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYY 130 (301)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~--~~-vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 130 (301)
.+....++-.+.++||+|+||.||+|+.+ ++ .. ||+|....+. ....++.+|+++|+.++|||||++||+.
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34445567777899999999999999965 22 23 8999887422 2236789999999999999999999999
Q ss_pred EcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC
Q 022206 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (301)
Q Consensus 131 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 210 (301)
..+..+++|||+|.||+|.++|.+.+. .++..+.+.++.+.+.||+|||+++ ++||||..+|+|++.++
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~--------~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~ 299 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKK--------SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKG 299 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCC
Confidence 999999999999999999999988764 2899999999999999999999999 99999999999999999
Q ss_pred ceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCcCccccc
Q 022206 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLV 287 (301)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~ 287 (301)
.+||+|||+++......... ....-+..|+|||.+....++.++|||||||++||+++ |..||.+....+....|
T Consensus 300 ~vKISDFGLs~~~~~~~~~~--~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI 375 (474)
T KOG0194|consen 300 VVKISDFGLSRAGSQYVMKK--FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI 375 (474)
T ss_pred eEEeCccccccCCcceeecc--ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH
Confidence 99999999987665222111 11134789999999999999999999999999999999 89999988776555544
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=304.04 Aligned_cols=206 Identities=20% Similarity=0.264 Sum_probs=175.0
Q ss_pred CCCCCCceecccCceEEEEEEEC-C-CCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-S-GRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
..|.+.+.||+|+||.||+|... + +..||+|.+...... ...+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34999999999999999999866 4 678899977544333 24567899999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++|+|.+++...... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 147 ~~gg~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~ 218 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKE-----HLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQ 218 (478)
T ss_pred CCCCCHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence 9999999988542211 123788999999999999999999999 99999999999999999999999999976
Q ss_pred CCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
.............+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~ 275 (478)
T PTZ00267 219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275 (478)
T ss_pred cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 644322222345579999999999999999999999999999999999999997654
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=291.90 Aligned_cols=195 Identities=24% Similarity=0.359 Sum_probs=165.6
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHH-HHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVS-MVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
+.||+|+||.||+|+++ +++.+|+|++.+.. .....+..|.. +++.++||||+++++++...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999977 78999999986432 22234445544 46779999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
|+|..++..... +++..+..++.||+.||+|||+.| |+||||||+|||+++++.+||+|||++.....
T Consensus 81 ~~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~ 148 (325)
T cd05604 81 GELFFHLQRERS---------FPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA 148 (325)
T ss_pred CCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCC
Confidence 999988865432 889999999999999999999999 99999999999999999999999999865432
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~ 201 (325)
T cd05604 149 QSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV 201 (325)
T ss_pred CCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH
Confidence 211 12345789999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=289.76 Aligned_cols=199 Identities=28% Similarity=0.440 Sum_probs=174.8
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
.++|++.+.||+|+||.||++.+. ++..+|+|.+...... ...+.+|+++++.++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999987 6889999988754332 3568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
|+.+++|.+++..... +++..+..++.|++.||.|||+. + ++|+||||+|||+++++.+||+|||++
T Consensus 84 ~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~ 151 (333)
T cd06650 84 HMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 151 (333)
T ss_pred cCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcc
Confidence 9999999999975432 78888999999999999999974 6 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
....... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 152 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 152 GQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred hhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 6553321 133468999999999998889999999999999999999999997544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=290.97 Aligned_cols=200 Identities=25% Similarity=0.402 Sum_probs=168.1
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHhccCCCceeeeeeEEEcC-----CeeE
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDG-----PLRV 137 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 137 (301)
+|++.+.||+|+||.||+|++. ++..||+|++.... .....+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5889999999999999999977 78999999986432 2234578899999999999999999987643 2479
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+||||+. ++|.+++..... +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 81 lv~e~~~-~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Df 147 (338)
T cd07859 81 VVFELME-SDLHQVIKANDD---------LTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDF 147 (338)
T ss_pred EEEecCC-CCHHHHHHhccc---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccC
Confidence 9999996 589998875432 889999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCcccc-ccccccccccccccCcccccc--CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 218 DLSNQAPDAAA-RLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 218 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 148 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred ccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99876432221 111134568999999998865 678999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=293.66 Aligned_cols=207 Identities=26% Similarity=0.350 Sum_probs=185.3
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
.....|.+.+.||+|.|++|.+|++. ++..||||.++++... ...+.+|+++|+.|+|||||+++.+......+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 45678999999999999999999987 8999999999876544 3458899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||||+.+|.+++++.+... ..+..+..++.|++.|++|||+++ |+|||||++|||++.+.++||+|||
T Consensus 133 V~eya~~ge~~~yl~~~gr---------~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfg 200 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR---------MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFG 200 (596)
T ss_pred EEEeccCchhHHHHHhccc---------chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccc
Confidence 9999999999999987764 566889999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCCCcCcc
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~ 284 (301)
++......... .+++|++.|.|||++.+..| ++.+|+||+|+++|.|+.|.+||++.+-....
T Consensus 201 fS~~~~~~~~l---qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr 264 (596)
T KOG0586|consen 201 FSTFFDYGLML---QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR 264 (596)
T ss_pred cceeecccccc---cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc
Confidence 99887654433 67899999999999998877 67899999999999999999999986654433
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=294.19 Aligned_cols=194 Identities=21% Similarity=0.304 Sum_probs=168.9
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
..+|++++.||+|+||.||+|.+. +++.||+|... ...+.+|++++++++||||+++++++......++++|++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 467999999999999999999976 78999999753 234678999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
. ++|..++..... +++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 166 ~-~~L~~~l~~~~~---------l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 166 K-TDLYCYLAAKRN---------IAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred C-CCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 6 589888865432 788999999999999999999999 999999999999999999999999998654
Q ss_pred CccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||-.
T Consensus 233 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 233 VDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 322111 12345799999999999998999999999999999999999988754
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=281.76 Aligned_cols=196 Identities=24% Similarity=0.369 Sum_probs=167.2
Q ss_pred ecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCCCH
Q 022206 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (301)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL 148 (301)
||+|+||+||++.++ +++.+|+|.+...... ...+..|+.+++.++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999977 7899999998653322 14467899999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCcccc
Q 022206 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (301)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (301)
.+++...... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 152 (280)
T cd05608 81 RYHIYNVDEE-----NPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS 152 (280)
T ss_pred HHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence 9887532211 123889999999999999999999999 99999999999999999999999999876543222
Q ss_pred ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 153 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 153 K--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred c--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 234568999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=303.01 Aligned_cols=210 Identities=24% Similarity=0.330 Sum_probs=176.1
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCC----
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP---- 134 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 134 (301)
...++|++.+.||+|+||.||+|++. +++.||+|++...... ...+.+|+..+..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34579999999999999999999976 7999999998754333 245778999999999999999988765332
Q ss_pred ----eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC
Q 022206 135 ----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (301)
Q Consensus 135 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 210 (301)
.+++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-----~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKT-----NRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNG 180 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCC
Confidence 368999999999999998653321 123889999999999999999999999 99999999999999999
Q ss_pred ceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~ 250 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM 250 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 9999999998765433222222456799999999999999999999999999999999999999976543
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=289.95 Aligned_cols=196 Identities=24% Similarity=0.352 Sum_probs=169.2
Q ss_pred CceecccCceEEEEEEEC----CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 71 NSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
++.||+|+||.||+++.. +++.+|+|++..... ....+.+|++++++++||||+++++++.+++..++||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 357999999999999852 588999999865322 2345678999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 81 ~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 148 (318)
T cd05582 81 RGGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 148 (318)
T ss_pred CCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCccc
Confidence 9999999986543 2889999999999999999999999 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
...... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 149 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~ 203 (318)
T cd05582 149 IDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR 203 (318)
T ss_pred CCCCCc--eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH
Confidence 433211 1345789999999999988899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=282.15 Aligned_cols=201 Identities=24% Similarity=0.394 Sum_probs=166.9
Q ss_pred CCCCCCceecccCceEEEEEEEC--CCCEEEEEEcCCCCC---chHHHHHHHHHHhcc---CCCceeeeeeEEE-----c
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRL---KNENVVELVGYYV-----D 132 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~ 132 (301)
++|++.+.||+|+||.||+|++. ++..||+|.+..... ......+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47999999999999999999974 468899998864332 223456677776655 6999999999875 3
Q ss_pred CCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCce
Q 022206 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (301)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (301)
....+++|||+.+ +|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~ 149 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDKVPE-------PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQI 149 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCE
Confidence 4568999999974 89999865432 12788999999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.
T Consensus 150 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~ 214 (290)
T cd07862 150 KLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214 (290)
T ss_pred EEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH
Confidence 999999987654321 12445689999999999888899999999999999999999999987554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=286.95 Aligned_cols=194 Identities=24% Similarity=0.358 Sum_probs=167.1
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
+.||+|+||+||+|+++ ++..||+|++.+.. .....+.+|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999987 68899999987532 2234567788888877 699999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
++|.+++..... +++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 81 ~~L~~~~~~~~~---------l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 148 (318)
T cd05570 81 GDLMFHIQRSGR---------FDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL 148 (318)
T ss_pred CCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCc
Confidence 999998876532 889999999999999999999999 99999999999999999999999999865322
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
... ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+
T Consensus 149 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 149 GGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred CCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 211 1134568999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=316.09 Aligned_cols=210 Identities=25% Similarity=0.333 Sum_probs=183.9
Q ss_pred HHHHHHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEc
Q 022206 58 VDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVD 132 (301)
Q Consensus 58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 132 (301)
..++..+.++|+++++||+|+||.|.+++++ +++.||.|++++.. ....-|..|-.+|..-+.+=|++++-.|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3456667789999999999999999999987 79999999998732 223457778888988888999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCce
Q 022206 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (301)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (301)
+.++|+||||++||+|-.++.+... +++.-+..++.+|+.||.-||+.| +|||||||+|||+|..|++
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~~---------~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHi 214 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFDR---------LPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHI 214 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcCC---------ChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcE
Confidence 9999999999999999999987652 899999999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCccccccccccccccccccCcccccc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
||+|||.+..+... +...+...+|||.|+|||++.. ..|+...|+||+||++|||+.|..||..++-
T Consensus 215 kLADFGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl 286 (1317)
T KOG0612|consen 215 KLADFGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL 286 (1317)
T ss_pred eeccchhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH
Confidence 99999998776543 3334567789999999999853 4688999999999999999999999987554
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=281.81 Aligned_cols=217 Identities=32% Similarity=0.485 Sum_probs=189.0
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
.-|.++.+||+|+||.||+|.++ +|+.+|||.+..+. ..+++..|+.+|.++..+++|++|+.|.....+++|||||.
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 34677889999999999999988 79999999987643 45778999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
.|++.++++.+.. .+.+.++..++...++||+|||... -+|||||..|||++.+|+.||+|||.|-.+.
T Consensus 112 AGSiSDI~R~R~K--------~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 112 AGSISDIMRARRK--------PLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLT 180 (502)
T ss_pred CCcHHHHHHHhcC--------CccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhh
Confidence 9999999976543 3999999999999999999999997 8999999999999999999999999998776
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC---------cCccccccccccccC
Q 022206 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP---------RGQQSLVTWVLTSSH 295 (301)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~---------~~~~~~~~~~~~~~~ 295 (301)
..... .++..|||.|||||++..-.|+.++||||||++..||..|++||.+..| .+-+.+.+...+++.
T Consensus 181 DTMAK--RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~ 258 (502)
T KOG0574|consen 181 DTMAK--RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSE 258 (502)
T ss_pred hhHHh--hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhH
Confidence 54332 2677899999999999999999999999999999999999999987654 233444455555555
Q ss_pred C
Q 022206 296 F 296 (301)
Q Consensus 296 ~ 296 (301)
|
T Consensus 259 F 259 (502)
T KOG0574|consen 259 F 259 (502)
T ss_pred H
Confidence 5
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=291.90 Aligned_cols=213 Identities=25% Similarity=0.428 Sum_probs=173.8
Q ss_pred hCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhcc-CCCceeeeeeEEEcCCe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 135 (301)
.++|++.+.||+|+||.||+|++. ++..||+|.+...... ...+.+|+.+++.+ +|+||+++++++.+.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 458999999999999999999853 2357999999754333 34578899999999 89999999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCC---------------------------------------------------------
Q 022206 136 RVLAYEHASKGSLHDILHGKKGV--------------------------------------------------------- 158 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------- 158 (301)
.++||||+++|+|.+++......
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999999999998643210
Q ss_pred ----CCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCcccccccccc
Q 022206 159 ----KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234 (301)
Q Consensus 159 ----~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 234 (301)
........+++..++.++.|++.||.|||+++ ++||||||+|||+++++.+||+|||++..............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 00011124788889999999999999999999 99999999999999999999999999876543322111122
Q ss_pred ccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 235 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
..+++.|+|||++.+..++.++|||||||++|+|++ |+.||.....
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~ 320 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc
Confidence 335678999999988899999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=289.20 Aligned_cols=198 Identities=24% Similarity=0.308 Sum_probs=169.1
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCC-----
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGP----- 134 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 134 (301)
..++|++.+.||+|+||.||++.+. ++..||+|++..... ....+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999976 689999999865322 2356778999999999999999999986443
Q ss_pred -eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceE
Q 022206 135 -LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (301)
Q Consensus 135 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (301)
..+++|||+++ +|.+.+... ++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~k 163 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 163 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhcc-----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEE
Confidence 47999999976 676666421 778888999999999999999999 99999999999999999999
Q ss_pred EeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 164 l~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 164 ILDFGLARTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred EecCCCccccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 999999875433221 134568999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=313.32 Aligned_cols=213 Identities=27% Similarity=0.449 Sum_probs=182.4
Q ss_pred hCCCCCCceecccCceEEEEEEEC--CCC----EEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR--SGR----AAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 136 (301)
..+.++.+.||+|+||.||.|... .+. .||+|.+.+... ...+|.+|..+|+.++|||||+++|++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 345667889999999999999965 343 489999876533 346799999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
+|++|||+||+|..+|++....... ...++..+++.++.|+++|+.||+++. +|||||..+|+|++....|||+|
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~--~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQ--PSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCC--CCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcc
Confidence 9999999999999999876433222 234899999999999999999999998 99999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCcC
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRG 282 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~ 282 (301)
||+|+.+...+.............|||||.+....++.++|||||||++||++| |..||.+.++.+
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~ 912 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE 912 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH
Confidence 999996665554433334455789999999999999999999999999999999 999999877643
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=269.70 Aligned_cols=204 Identities=27% Similarity=0.426 Sum_probs=179.2
Q ss_pred HHHHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-----c----hHHHHHHHHHHhcc-CCCceeeeee
Q 022206 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-----P----DQEFLAQVSMVSRL-KNENVVELVG 128 (301)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~----~~~~~~e~~~l~~l-~h~~iv~~~~ 128 (301)
.......+|.-.+.||.|..++|.++.++ +|..+|+|++..... . .+...+|+.+|+++ .||+|+++.+
T Consensus 11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 33456678899999999999999999877 799999998853211 1 13456789999998 6999999999
Q ss_pred EEEcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC
Q 022206 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (301)
Q Consensus 129 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 208 (301)
+|+.+...++|+|.|+.|.|.++|..... +++.....|+.|+++++.|||..+ ||||||||+|||+++
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts~Vt---------lSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILldd 158 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTSKVT---------LSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDD 158 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhhhee---------ecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeecc
Confidence 99999999999999999999999987653 899999999999999999999999 999999999999999
Q ss_pred CCceEEeccccCCCCCccccccccccccccccccCccccc------cCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 209 DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM------TGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 209 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
+.++||+|||++..++..... ...||||+|+|||.+. ...|+..+|+|++|||+|.|+.|.+||-+.
T Consensus 159 n~~i~isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR 231 (411)
T KOG0599|consen 159 NMNIKISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR 231 (411)
T ss_pred ccceEEeccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH
Confidence 999999999999999877654 6789999999999875 246888999999999999999999999653
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=289.75 Aligned_cols=212 Identities=23% Similarity=0.384 Sum_probs=173.5
Q ss_pred hCCCCCCceecccCceEEEEEEE------CCCCEEEEEEcCCCCC--chHHHHHHHHHHhcc-CCCceeeeeeEEEcCCe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 135 (301)
.++|++.+.||+|+||.||+|++ .++..||+|+++.... ..+.+.+|+.+++.+ +||||+++++++.+++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45799999999999999999974 1466899999865432 235678899999999 89999999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCC------------------------------------------------------
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGA------------------------------------------------------ 161 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~------------------------------------------------------ 161 (301)
.++||||+++|+|.+++.........
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999999999999653311000
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCccccc
Q 022206 162 ------------KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229 (301)
Q Consensus 162 ------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 229 (301)
.....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 01124788889999999999999999999 999999999999999999999999998765433221
Q ss_pred cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCC
Q 022206 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTL 279 (301)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~ 279 (301)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 11122345678999999999999999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=276.89 Aligned_cols=193 Identities=24% Similarity=0.365 Sum_probs=166.1
Q ss_pred ecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCCCH
Q 022206 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (301)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL 148 (301)
||+|+||.||+++.+ +++.+|+|.+..... .......|+++++.++||||+++++.+.++...+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999977 799999999864221 223456799999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCcccc
Q 022206 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (301)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (301)
.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 150 (277)
T cd05607 81 KYHIYNVGE-------RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT 150 (277)
T ss_pred HHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce
Confidence 988864432 12788889999999999999999999 99999999999999999999999999876543321
Q ss_pred ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
. ....|++.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 151 ~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 151 I---TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred e---eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 1 33468999999999988889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=278.36 Aligned_cols=200 Identities=26% Similarity=0.400 Sum_probs=172.7
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
.|++.+.||+|+||.||++.+. +++.+|+|.+...... ...+.+|+.++++++|++|+++++.+.+.+..+++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 4778899999999999999987 7899999998653322 2346789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+.+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.
T Consensus 81 ~~~g~~L~~~l~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~ 150 (285)
T cd05630 81 LMNGGDLKFHIYHMGE-------AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAV 150 (285)
T ss_pred ecCCCcHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeecccee
Confidence 9999999998864332 12788999999999999999999999 9999999999999999999999999986
Q ss_pred CCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
........ ....|++.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 151 ~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 151 HVPEGQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred ecCCCccc---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 65432211 23468999999999998899999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=296.33 Aligned_cols=201 Identities=21% Similarity=0.338 Sum_probs=165.1
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcC--------Ce
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG--------PL 135 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~ 135 (301)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ....+|+.+++.++|+||+++++++... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 467999999999999999999986 68999999886443 2345799999999999999998876432 24
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC-ceEE
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKI 214 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~vkl 214 (301)
+++||||+++ +|.+++...... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARN-----NHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceee
Confidence 6789999986 787776532111 123889999999999999999999999 99999999999999664 7999
Q ss_pred eccccCCCCCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+|||+++........ ....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.
T Consensus 213 ~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 276 (440)
T PTZ00036 213 CDFGSAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS 276 (440)
T ss_pred eccccchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 999999766433221 345689999999988764 689999999999999999999999987654
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=278.60 Aligned_cols=201 Identities=24% Similarity=0.384 Sum_probs=173.0
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
.|+..+.||+|+||+||++.+. +++.+|+|.+...... ...+.+|+++++.++|+||+.+++.+.+++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677889999999999999976 7899999998654322 2346789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+.+++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.
T Consensus 81 ~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~ 150 (285)
T cd05632 81 IMNGGDLKFHIYNMGN-------PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAV 150 (285)
T ss_pred eccCccHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcce
Confidence 9999999988864331 12899999999999999999999999 9999999999999999999999999986
Q ss_pred CCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
........ ....|++.|+|||++.+..++.++|+||||+++|+|++|..||.+..+
T Consensus 151 ~~~~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~ 206 (285)
T cd05632 151 KIPEGESI---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206 (285)
T ss_pred ecCCCCcc---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 54332211 234689999999999888999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=288.23 Aligned_cols=206 Identities=26% Similarity=0.395 Sum_probs=183.2
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
.+...+.++||+|-||.|.++....+..||+|.++..... +.+|.+|+++|.+|+||||++++++|..++.+++++||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 4567889999999999999999887899999999765433 46899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++|+|.+++.++.... +.....++|+.||+.||+||.+.+ +|||||.++|+|++.++++||+|||.++.
T Consensus 617 mEnGDLnqFl~aheapt-------~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPT-------AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred HhcCcHHHHHHhccCcc-------cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccc
Confidence 99999999998875322 345566789999999999999999 99999999999999999999999999998
Q ss_pred CCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh--CCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT--GRKPVDHTLP 280 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~--g~~pf~~~~~ 280 (301)
+...+........+.+++|||+|.+...+++.++|+|+||+++||+++ ...||...++
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 877766555566778899999999999999999999999999999765 8999987655
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=273.50 Aligned_cols=203 Identities=26% Similarity=0.445 Sum_probs=176.1
Q ss_pred CCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
++|++.+.||+|+||.||++.++++..+|+|.+.........+.+|+.++++++||||+++++++.+.+..+++|||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 46888999999999999999988778999999876666667889999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
|+|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 84 ~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 84 GCLLNYLRQRQG--------KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD 152 (256)
T ss_pred CcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence 999999875432 2788999999999999999999999 99999999999999999999999999876543
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
.... ......++..|+|||++.+..++.++|+||||+++|+|++ |+.||...+.
T Consensus 153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~ 207 (256)
T cd05114 153 DEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN 207 (256)
T ss_pred Ccee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 2221 1122235668999999988889999999999999999999 9999976554
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=278.04 Aligned_cols=191 Identities=22% Similarity=0.386 Sum_probs=165.4
Q ss_pred ceecccCceEEEEEEECCCCEEEEEEcCCCCCch----HHHHHHHHHHhccCCCceeeeeeEEEc----CCeeEEEEecC
Q 022206 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVGYYVD----GPLRVLAYEHA 143 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~ 143 (301)
..||+|+++.||+|.+. ++.||+|++....... +.+.+|+.+|++++||||+++++++.+ ....+++|||+
T Consensus 26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 57999999999999984 8899999997654433 456799999999999999999999876 35689999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
++|+|.+++..... +++...+.++.|++.||.|||+. + ++||||||+|||+++++.+||+|||++..
T Consensus 105 ~~g~L~~~l~~~~~---------~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~ 172 (283)
T PHA02988 105 TRGYLREVLDKEKD---------LSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKI 172 (283)
T ss_pred CCCcHHHHHhhCCC---------CChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhh
Confidence 99999999976432 78889999999999999999985 7 88999999999999999999999999875
Q ss_pred CCccccccccccccccccccCcccccc--CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
..... ....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 173 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~ 227 (283)
T PHA02988 173 LSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT 227 (283)
T ss_pred hcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH
Confidence 53321 23457899999999876 6789999999999999999999999987654
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=282.33 Aligned_cols=202 Identities=21% Similarity=0.378 Sum_probs=171.9
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
.++|.+.+.||+|+||.||+|+++ +++.||+|.+..... ....+.+|+.++++++|+||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 467999999999999999999987 688999999865432 23457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+++ +|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 85 YLDK-DLKQYMDDCGN--------IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR 152 (309)
T ss_pred CCCC-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccce
Confidence 9986 88888765432 2788899999999999999999999 9999999999999999999999999986
Q ss_pred CCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
........ .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+.
T Consensus 153 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 210 (309)
T cd07872 153 AKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV 210 (309)
T ss_pred ecCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 54332211 123457899999998865 4678999999999999999999999977654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=290.35 Aligned_cols=202 Identities=27% Similarity=0.385 Sum_probs=170.6
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCC-----eeE
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGP-----LRV 137 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 137 (301)
+|++.+.||+|+||.||++.+. +++.||+|++..... ....+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5889999999999999999976 799999999864322 2356788999999999999999999998776 789
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+|+||+.+ +|.+.+.... .+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Df 147 (372)
T cd07853 81 VVTELMQS-DLHKIIVSPQ---------PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDF 147 (372)
T ss_pred EEeecccc-CHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccc
Confidence 99999975 8888876543 2889999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCcC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~ 282 (301)
|++......... ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.++..
T Consensus 148 g~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 212 (372)
T cd07853 148 GLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212 (372)
T ss_pred cceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH
Confidence 998765432211 11234578999999998774 57899999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=287.46 Aligned_cols=198 Identities=23% Similarity=0.297 Sum_probs=169.7
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcC------
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG------ 133 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 133 (301)
..++|++.+.||+|+||.||++.+. +++.||||++..... ....+.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999976 689999999875322 235678899999999999999999987543
Q ss_pred CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceE
Q 022206 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (301)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (301)
...++||||+++ +|.+.+... ++...+..++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~k 166 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 166 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHhc-----------CCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEE
Confidence 357999999976 777777431 778889999999999999999999 99999999999999999999
Q ss_pred EeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|+|||++........ .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 167 L~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 167 ILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred EEeCCCccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 999999976543221 134568999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=306.00 Aligned_cols=211 Identities=23% Similarity=0.311 Sum_probs=175.3
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
++|++.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+++++.++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999987 6899999998754322 356889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCC--CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 141 EHASKGSLHDILHGKKGVKGA--KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||++|++|.+++......... .....++...++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998642211110 01123567788899999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccc----------------ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 219 LSNQAPDAAA----------------RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 219 ~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
++........ ........||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~ 235 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence 9976521110 001123468999999999999999999999999999999999999997643
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=287.15 Aligned_cols=199 Identities=23% Similarity=0.286 Sum_probs=170.1
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcC-----
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG----- 133 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 133 (301)
...++|++.+.||+|+||.||++.+. +++.+|+|++...... ...+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35679999999999999999999976 6899999998754322 34677899999999999999999988643
Q ss_pred -CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCce
Q 022206 134 -PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (301)
Q Consensus 134 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (301)
...+++|||+++ +|.+.+... ++...+..++.|++.||.|||+.| |+||||||+|||++.++.+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~~-----------l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~ 158 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 158 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCE
Confidence 347999999976 677766431 778889999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 159 kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 159 KILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred EEeeCcccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999976543221 134568999999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=273.79 Aligned_cols=205 Identities=26% Similarity=0.448 Sum_probs=177.4
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
.++|++.++||+|+||.||+|...++..|++|.+.......+.+.+|+.++++++|+||+++++.+.+.+..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 46799999999999999999998878889999987665556788999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
+++|.+++..... ..+++...+.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 85 ~~~L~~~l~~~~~-------~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 85 KGSLLDFLKSDEG-------GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIE 154 (261)
T ss_pred CCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecC
Confidence 9999999975432 12788889999999999999999999 9999999999999999999999999997664
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
..... ......++..|+|||++....++.++||||||+++|+|++ |..||....+
T Consensus 155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 210 (261)
T cd05072 155 DNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210 (261)
T ss_pred CCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH
Confidence 32211 1122345678999999988889999999999999999998 9999976544
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=291.37 Aligned_cols=194 Identities=23% Similarity=0.280 Sum_probs=167.0
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
...|.+.+.||+|+||.||+|.+. +++.||+|.... ..+.+|++++++++|+||+++++++..++..+++||++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 457999999999999999999987 688999996432 33678999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
. ++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 243 ~-~~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 243 R-SDLYTYLGARLR--------PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFA 310 (461)
T ss_pred C-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceec
Confidence 6 588888865432 2899999999999999999999999 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 275 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf 275 (301)
.............||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 311 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 4332211123456899999999999999999999999999999999987654
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=283.93 Aligned_cols=204 Identities=25% Similarity=0.395 Sum_probs=181.3
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
..+.|+.-++||+|+||.|+-++.+ +|+-+|.|.+.+.. ......++|-++|.+++.+.||.+--.|.+.+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3467889999999999999999977 79999999886432 223457789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
|+..|+||+|.-.|..... +.+++..++.++.+|+.||++||+.+ ||+|||||+|||+|+.|+|+|+|+|
T Consensus 263 VLtlMNGGDLkfHiyn~g~-------~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLG 332 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN-------PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLG 332 (591)
T ss_pred EEEeecCCceeEEeeccCC-------CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccc
Confidence 9999999999998876653 34999999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
||..++..... ...+||.+|||||++.+..|+...|+|||||+||+|+.|+.||.....
T Consensus 333 LAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 333 LAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred eEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 99888765543 445899999999999999999999999999999999999999976544
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=287.44 Aligned_cols=199 Identities=19% Similarity=0.280 Sum_probs=171.8
Q ss_pred hCCCCCCceecccCceEEEEEEEC---CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
..+|++++.||+|+||.||++... .+..|++|.+... ....+|+.+++.++|+||+++++++......+++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 457999999999999999999854 4678999987643 235679999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
++. ++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.
T Consensus 167 ~~~-~~l~~~l~~~~---------~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 167 KYK-CDLFTYVDRSG---------PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred hcC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 996 48888885432 2899999999999999999999999 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
...............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 66543332222345799999999999999999999999999999999999999976543
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=280.58 Aligned_cols=204 Identities=27% Similarity=0.442 Sum_probs=170.8
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCC----EEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
..+|++.+.||+|+||.||+|.+. ++. .||+|++..... ....+.+|+.+++.++|+||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 467999999999999999999865 333 489999864332 245688899999999999999999998765 567
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+++||+++|+|.+++..... .++...++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~Df 153 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDF 153 (316)
T ss_pred eeeecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccc
Confidence 89999999999999976532 2788889999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
|++................++..|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 154 G~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~ 217 (316)
T cd05108 154 GLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 217 (316)
T ss_pred cccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99987654332221222334678999999999999999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=286.36 Aligned_cols=193 Identities=24% Similarity=0.299 Sum_probs=161.5
Q ss_pred ecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhcc---CCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL---KNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
||+|+||+||+|++. +++.||+|++.+... .......|..++..+ .||||+++++.+.+....++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999987 689999999864321 112344555666554 699999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
|+|.+++..... +++..+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 g~L~~~l~~~~~---------~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 81 GELFWHLQKEGR---------FSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLT 148 (330)
T ss_pred ChHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCC
Confidence 999998875432 889999999999999999999999 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
.... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.
T Consensus 149 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~ 202 (330)
T cd05586 149 DNKT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT 202 (330)
T ss_pred CCCC--ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH
Confidence 2211 2345799999999988764 578999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=266.91 Aligned_cols=200 Identities=21% Similarity=0.312 Sum_probs=171.1
Q ss_pred HhhCCCCC-CceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHH-hccCCCceeeeeeEEEc----CCe
Q 022206 63 EKTDNFGT-NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMV-SRLKNENVVELVGYYVD----GPL 135 (301)
Q Consensus 63 ~~~~~y~~-~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----~~~ 135 (301)
..+++|.+ -++||-|--|+|..+.++ +++.+|+|++..+ ...++|+++. ..-.|||||.++++|.+ ...
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 35677876 567999999999999987 8999999998644 4466777764 34479999999999763 467
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC---CCce
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIA 212 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~v 212 (301)
+.+|||.++||.|...++.+... .+++.++..|+.||..|+.|||+.+ |.||||||+|+|... +..+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~-------afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~l 203 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQ-------AFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPL 203 (400)
T ss_pred eEeeeecccchHHHHHHHHcccc-------cchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcce
Confidence 88999999999999999877643 3999999999999999999999999 999999999999974 5579
Q ss_pred EEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
||+|||+|+........ .+.+.||.|.|||++....|+...|+||+||++|.|++|.+||....
T Consensus 204 KLtDfGFAK~t~~~~~L---~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h 267 (400)
T KOG0604|consen 204 KLTDFGFAKETQEPGDL---MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_pred EecccccccccCCCccc---cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC
Confidence 99999999887653322 45678999999999999999999999999999999999999997643
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=274.55 Aligned_cols=212 Identities=29% Similarity=0.468 Sum_probs=175.7
Q ss_pred CCCCCCceecccCceEEEEEEECC-C-----CEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRS-G-----RAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
.+|++.+.||+|+||.||+|.... + ..+++|.+...... ...+.+|+.+++.++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 478999999999999999998652 2 57999998654332 356889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGA-------KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~-------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 210 (301)
++|||+++++|.+++......... .....+++..++.++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 999999999999999754321111 01134788899999999999999999999 99999999999999999
Q ss_pred ceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
.++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+..+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999876543322222234456889999999988889999999999999999998 9999987654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=273.14 Aligned_cols=203 Identities=27% Similarity=0.423 Sum_probs=171.8
Q ss_pred CCCCCCceecccCceEEEEEEEC----CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
.+|++.+.||+|+||.||+|.++ .+..||+|.+...... ...+.+|+.+++.++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56899999999999999999854 3568999998764332 34688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.++++|||.
T Consensus 85 ~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~ 153 (266)
T cd05064 85 TEYMSNGALDSFLRKHEG--------QLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRR 153 (266)
T ss_pred EEeCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcc
Confidence 999999999999975432 2789999999999999999999999 99999999999999999999999998
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
+......... ......++..|+|||.+.+..++.++|||||||++|++++ |..||.+...
T Consensus 154 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~ 214 (266)
T cd05064 154 LQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214 (266)
T ss_pred cccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 7654322111 1112335678999999999999999999999999999775 9999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=281.11 Aligned_cols=192 Identities=25% Similarity=0.366 Sum_probs=164.2
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
...+|++++.||+|+||.||+|+.. ++..||+|+.... ....|+.++++++|+||+++++++.+....++|+|+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 3457999999999999999999987 6789999975432 235689999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+.+ +|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 139 ~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 206 (357)
T PHA03209 139 YSS-DLYTYLTKRSR--------PLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF 206 (357)
T ss_pred cCC-cHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccc
Confidence 965 88888865332 2889999999999999999999999 99999999999999999999999999875
Q ss_pred CCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPV 275 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf 275 (301)
...... .....||+.|+|||++.+..++.++|||||||++|+|+++..|+
T Consensus 207 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 207 PVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccCcc---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 432211 13456899999999999999999999999999999999854444
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=270.98 Aligned_cols=203 Identities=26% Similarity=0.430 Sum_probs=175.0
Q ss_pred CCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
.+|++.+.||+|+||.||++.++++..+|+|.+.........+.+|+.+++.++|+||+++++++.+.+..+++|||+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 46889999999999999999988778899999876655667788999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
++|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 84 ~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 84 GCLLNYLRERKG--------KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence 999999875432 2789999999999999999999999 99999999999999999999999999876543
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...++
T Consensus 153 ~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 207 (256)
T cd05059 153 DQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN 207 (256)
T ss_pred cccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH
Confidence 2211 1111223467999999988899999999999999999999 8999976544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=300.02 Aligned_cols=206 Identities=22% Similarity=0.337 Sum_probs=169.3
Q ss_pred hCCCCCCceecccCceEEEEEEECCC-CEEEEEEcCCC-CCchHHHHHHHHHHhccC-CCceeeeeeE-EEc----C--C
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSG-RAAAIKKLDSS-KQPDQEFLAQVSMVSRLK-NENVVELVGY-YVD----G--P 134 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~-~~~----~--~ 134 (301)
.-++++.+.|.+|||+.||+|.+..+ ..||+|++-.. ......+.+|+.+|+.|+ |+|||.+++. ... . -
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34678899999999999999998754 99999987543 334567899999999997 9999999993 221 1 2
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
..+|+||||.||.|-++++.+... .|++.++++|+.|+++|+++||... ++|||||||-+||||..+|..||
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~-------~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQT-------RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhc-------cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEe
Confidence 467899999999999999865432 2999999999999999999999984 67999999999999999999999
Q ss_pred eccccCCCCCccccccc-------cccccccccccCcccc---ccCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLH-------STRVLGTFGYHAPEYA---MTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
||||.|........... .-...-|+.|.|||++ .+..++.|+|||+|||+||-|+....||++-
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 99999865432221100 0112358999999987 4678899999999999999999999999764
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=270.90 Aligned_cols=205 Identities=27% Similarity=0.457 Sum_probs=176.8
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
.++|++.+.||+|++|.||+|.+.+++.||+|.+.........+.+|+.++++++|+||+++++++...+..+++|||+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 46799999999999999999998777889999998766566778999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
+++|.+++..... ..+++..+..++.|++.||.+||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 85 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 85 YGSLLEYLQGGAG-------RALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred CCcHHHHHhccCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 9999999976431 23889999999999999999999999 9999999999999999999999999987664
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
..... .......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+..+
T Consensus 155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 210 (261)
T cd05068 155 EDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210 (261)
T ss_pred CCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 32111 0111223457999999988889999999999999999999 9999976554
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=274.71 Aligned_cols=200 Identities=26% Similarity=0.398 Sum_probs=166.2
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhcc---CCCceeeeeeEEEc-----CC
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRL---KNENVVELVGYYVD-----GP 134 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~ 134 (301)
+|++.+.||+|+||.||+|+++ +++.||+|.+...... .....+|+.+++.+ +|+||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5889999999999999999987 7899999998653222 23456677766655 79999999998764 34
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
..+++||++.+ +|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl 149 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP-------PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKL 149 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 57999999985 89888865432 12789999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+|||++........ .....+|+.|+|||++.+..++.++|||||||++|+|++|++||.....
T Consensus 150 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~ 212 (288)
T cd07863 150 ADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 212 (288)
T ss_pred CccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH
Confidence 99999876543221 1334678999999999888899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=270.89 Aligned_cols=203 Identities=27% Similarity=0.426 Sum_probs=175.4
Q ss_pred CCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
++|.+.+.||+|+||.||++.+.++..+|+|.+.........+.+|+.++++++||||+++++++.+.+..+++|||+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 56889999999999999999988777899999876655567789999999999999999999999988899999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 84 ~~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 84 GCLLNYLREHGK--------RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 999999975432 2788999999999999999999999 99999999999999999999999999876543
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
.... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 153 ~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 207 (256)
T cd05113 153 DEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN 207 (256)
T ss_pred Ccee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 2211 1112235678999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=274.53 Aligned_cols=213 Identities=26% Similarity=0.455 Sum_probs=177.2
Q ss_pred hCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 136 (301)
.++|.+.+.||+|+||.||+|.+. ++..||+|.+...... ...+.+|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 457889999999999999999864 2478999998765443 35788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKG-----AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (301)
+++|||+++++|.+++........ ......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 999999999999999975432110 112234788899999999999999999999 999999999999999999
Q ss_pred eEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~ 230 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999875533222111233346788999999999999999999999999999998 9999976544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=269.58 Aligned_cols=203 Identities=27% Similarity=0.403 Sum_probs=174.2
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc------hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
++|.+.+.||+|++|.||+|... +++.+++|.+...... ...+.+|++++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57999999999999999999976 6899999988643221 2457889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
++||+++++|.+++..... +++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 82 v~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg 149 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGA---------LTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG 149 (263)
T ss_pred EEEECCCCcHHHHHHHhCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 9999999999999875432 788889999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccc-cccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 219 LSNQAPDAAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 219 ~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
++........... .....++..|+|||++.+..++.++||||||+++|+|++|+.||.+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 212 (263)
T cd06625 150 ASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212 (263)
T ss_pred cceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch
Confidence 9876543221111 0234578899999999988899999999999999999999999976543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=282.61 Aligned_cols=197 Identities=28% Similarity=0.405 Sum_probs=168.7
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcC------
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG------ 133 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 133 (301)
..++|++.+.||+|+||.||+|.+. +++.||+|++..... ....+.+|+.+++.++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999976 788999999875432 234577899999999999999999987543
Q ss_pred CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceE
Q 022206 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (301)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (301)
...+++++++ +++|.+++.... +++..+..++.|++.||.|||+++ |+||||||+|||+++++.+|
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~k 158 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQK----------LSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELR 158 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEE
Confidence 3468999988 679998886433 889999999999999999999999 99999999999999999999
Q ss_pred EeccccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|+|||++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..
T Consensus 159 l~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 220 (343)
T cd07878 159 ILDFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220 (343)
T ss_pred EcCCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 99999987654321 34568999999999876 568899999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=272.26 Aligned_cols=193 Identities=25% Similarity=0.397 Sum_probs=169.9
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
++|++.+.||+|+||.||+|.+. +++.+|+|.+...... ...+.+|++++++++||||+++++.+...+..+++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 46889999999999999999976 7899999998654322 35688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++++|..+.. +++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~~l~~~~~-------------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~ 144 (279)
T cd06619 81 MDGGSLDVYRK-------------IPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQ 144 (279)
T ss_pred CCCCChHHhhc-------------CCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCccee
Confidence 99999976531 678888999999999999999999 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
..... .....++..|+|||++.+..++.++|+||||+++|+|++|+.||...
T Consensus 145 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 145 LVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred ccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 54321 13457899999999999889999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=285.19 Aligned_cols=212 Identities=24% Similarity=0.390 Sum_probs=173.6
Q ss_pred hhCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccC-CCceeeeeeEEEcCC
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK-NENVVELVGYYVDGP 134 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 134 (301)
..++|++.+.||+|+||.||+|.+. .+..||+|++...... .+.+.+|+++++++. ||||+++++++.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3578999999999999999999863 1346999999654332 356889999999996 999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCC------------------------------------------------------
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKG------------------------------------------------------ 160 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~------------------------------------------------------ 160 (301)
..++|||||++|+|.+++........
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999999865321000
Q ss_pred ---------------------------------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEc
Q 022206 161 ---------------------------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207 (301)
Q Consensus 161 ---------------------------------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 207 (301)
......+++..++.++.|++.||+|||+.+ ++||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 000124778888999999999999999999 99999999999999
Q ss_pred CCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCC
Q 022206 208 DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHT 278 (301)
Q Consensus 208 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~ 278 (301)
+++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 999999999999876543222212233456788999999988889999999999999999997 99999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=275.62 Aligned_cols=198 Identities=28% Similarity=0.434 Sum_probs=173.1
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
++|++.+.||+|+||.||++.+. ++..+++|.+...... ...+.+|++++++++||||+++++.+.+++..+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999977 6888999988654332 24578899999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
+++++|.+++..... +++..+..++.|++.||.|||+ .+ ++|+||||+|||+++++.++|+|||++.
T Consensus 81 ~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (308)
T cd06615 81 MDGGSLDQVLKKAGR---------IPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG 148 (308)
T ss_pred cCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcc
Confidence 999999999976432 7889999999999999999997 57 9999999999999999999999999986
Q ss_pred CCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
...... .....+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+
T Consensus 149 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 149 QLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred cccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 553321 134568899999999988889999999999999999999999996544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=276.69 Aligned_cols=204 Identities=23% Similarity=0.376 Sum_probs=163.5
Q ss_pred CceecccCceEEEEEEEC---CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEc--CCeeEEEEecCCC
Q 022206 71 NSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRVLAYEHASK 145 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 145 (301)
.++||+|+||+||+|+++ +++.+|+|.+..... .....+|+.++++++||||+++++++.. +...+++|||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 458999999999999965 468899999865432 3457889999999999999999998854 4568899999865
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEE----cCCCceEEeccccCC
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKISDFDLSN 221 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~vkl~Dfg~a~ 221 (301)
+|.+++..............+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++.
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 89888764332221111234889999999999999999999999 9999999999999 456789999999997
Q ss_pred CCCccccc-cccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 222 QAPDAAAR-LHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 222 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 65432211 11234568999999999876 458899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=283.92 Aligned_cols=200 Identities=27% Similarity=0.420 Sum_probs=174.3
Q ss_pred CCCC--CceecccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 67 NFGT--NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 67 ~y~~--~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
-|++ .++||+|.||+||-|+++ +|+.||||++++.. +....+++|+.+|..+.||.||.+...|++.++.++||
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 4554 678999999999999977 89999999997643 33467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC---ceEEecc
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDF 217 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~Df 217 (301)
|.+.|.-|.-+|...+++ +++.....++.||+.||.|||.++ |+|+||||+|||+.+.. .+|||||
T Consensus 643 EKl~GDMLEMILSsEkgR--------L~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDF 711 (888)
T KOG4236|consen 643 EKLHGDMLEMILSSEKGR--------LPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDF 711 (888)
T ss_pred hhhcchHHHHHHHhhccc--------chHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccc
Confidence 999874444444444332 888888999999999999999999 99999999999997543 7999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|+|+.++....+ ...+|||.|+|||+++++.|+..-|+||.|||+|--++|..||..+++
T Consensus 712 GfARiIgEksFR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd 771 (888)
T KOG4236|consen 712 GFARIIGEKSFR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED 771 (888)
T ss_pred cceeecchhhhh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc
Confidence 999998765544 567899999999999999999999999999999999999999977654
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=272.90 Aligned_cols=197 Identities=27% Similarity=0.407 Sum_probs=175.1
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
++|++.+.||+|+||.||++.+. +++.+|+|++.... .....+.+|+++++++.||||+++++++.++...+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47899999999999999999977 68999999986432 22356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++++|.+++..... +++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~~~~~~~---------l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~ 148 (290)
T cd05580 81 EYVPGGELFSHLRKSGR---------FPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFA 148 (290)
T ss_pred ecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCc
Confidence 99999999999976532 889999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus 149 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 149 KRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred cccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 776443 134468999999999988888999999999999999999999997655
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=269.89 Aligned_cols=204 Identities=29% Similarity=0.497 Sum_probs=173.8
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
.++|++.+.||+|+||.||+|++.+...|++|.+.........+.+|++++++++|+||+++++.+. +...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 3569999999999999999999876678999999876655677899999999999999999999874 456799999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
+++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 84 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 84 KGSLLDFLKGEMG-------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 153 (262)
T ss_pred CCcHHHHHhhccc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecc
Confidence 9999999975322 12788999999999999999999999 9999999999999999999999999987654
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
..... ......++..|+|||+..+..++.++||||||+++|+|++ |..||.+..+
T Consensus 154 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~ 209 (262)
T cd05071 154 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209 (262)
T ss_pred ccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh
Confidence 33221 1122345678999999988889999999999999999999 8999976654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=273.68 Aligned_cols=202 Identities=27% Similarity=0.461 Sum_probs=176.5
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
...+|++.+.||+|++|.||+|.+. +++.+++|.+...... ...+.+|+.+++.++|+||+++++.+..+...++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 3468999999999999999999976 7899999998754433 4567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+++++|.+++.... +++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 98 ~~~~~~L~~~~~~~~----------~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 98 YLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred ccCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccch
Confidence 999999999986532 788899999999999999999999 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
........ .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+
T Consensus 165 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~ 221 (296)
T cd06654 165 QITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (296)
T ss_pred hccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Confidence 65332211 1334688999999999888889999999999999999999999976654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=282.80 Aligned_cols=203 Identities=23% Similarity=0.353 Sum_probs=174.3
Q ss_pred HhhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCC---CchHHHHHHHHHHhccC-CCceeeeeeEEEcCCeeEE
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 138 (301)
.+...|++++.||+|+.++||++...+.+.+|+|++.... .....+.+|+..|.+|+ |.+|+++++|-..++.+|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 4456799999999999999999998878888888775433 33467999999999995 7999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
|||+-+. +|..+|++.... .+...+..+..|++.++.++|.+| |||.||||.|+|+- .|.+||+|||
T Consensus 438 vmE~Gd~-DL~kiL~k~~~~--------~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFG 504 (677)
T KOG0596|consen 438 VMECGDI-DLNKILKKKKSI--------DPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFG 504 (677)
T ss_pred Eeecccc-cHHHHHHhccCC--------CchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeec
Confidence 9998765 999999877643 343478889999999999999999 99999999999995 5789999999
Q ss_pred cCCCCCccccccccccccccccccCccccccC-----------CCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-----------QMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
+|..+............+||+.||+||.+... ..+.++||||||||||+|+.|++||.+.
T Consensus 505 IA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~ 575 (677)
T KOG0596|consen 505 IANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI 575 (677)
T ss_pred hhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence 99988877666666778999999999987432 2457899999999999999999999763
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=267.97 Aligned_cols=204 Identities=27% Similarity=0.441 Sum_probs=175.9
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
.++|++.++||+|+||.||+|..++++.+|+|.+.........+.+|+.++++++|+||+++++++. .+..+++|||+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 4679999999999999999999888899999999877766778999999999999999999999864 556899999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
+++|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 84 ~~~L~~~~~~~~~-------~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 84 NGSLVDFLKTPEG-------IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 9999999865432 13788999999999999999999999 9999999999999999999999999986654
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
..... ......++..|+|||++....++.++||||||+++|+|++ |++||.+.+.
T Consensus 154 ~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 209 (260)
T cd05067 154 DNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209 (260)
T ss_pred CCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh
Confidence 22211 1122345678999999988889999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=268.89 Aligned_cols=204 Identities=27% Similarity=0.421 Sum_probs=175.7
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
.+|.+.+.||+|++|.||+|.++ ++..+++|.+..+......+.+|++++++++|+||+++++++..++..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 46888899999999999999976 68899999987665556778999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
+++|.+++..... ..+++..++.++.|++.+|+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 ~~~L~~~~~~~~~-------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 86 YGNLLDYLRECNR-------QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 155 (263)
T ss_pred CCcHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccc
Confidence 9999999865432 12788899999999999999999999 9999999999999999999999999987664
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
..... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.
T Consensus 156 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~ 211 (263)
T cd05052 156 GDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 211 (263)
T ss_pred cceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 43221 1112234668999999988899999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=266.32 Aligned_cols=201 Identities=31% Similarity=0.460 Sum_probs=175.2
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
+|.+.+.||+|++|.||+|.++ +++.|++|.+.... .....+.+|+++++.++|+||+++++++.+.+..+++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 5788899999999999999987 78999999986432 3346688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++++|.+++..... ..++...++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~ 150 (256)
T cd08529 81 AENGDLHKLLKMQRG-------RPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKL 150 (256)
T ss_pred CCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEccccccee
Confidence 999999999976421 13888999999999999999999999 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
....... .....+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+
T Consensus 151 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 151 LSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred ccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 5443221 133467899999999998889999999999999999999999997655
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=267.30 Aligned_cols=205 Identities=29% Similarity=0.483 Sum_probs=178.6
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
.++|++.+.||+|+||.||+|.++++..+++|.+........++.+|+.+++.++|+||+++++++.+....+++|||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 46899999999999999999998877889999998776667789999999999999999999999998899999999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 85 ~~~L~~~i~~~~~-------~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 85 KGSLLDFLKSGEG-------KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred CCCHHHHHhcccc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceecc
Confidence 9999999976432 12889999999999999999999999 9999999999999999999999999987664
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+.
T Consensus 155 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 210 (261)
T cd05034 155 DDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210 (261)
T ss_pred chhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 32211 1112234678999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=268.38 Aligned_cols=202 Identities=29% Similarity=0.423 Sum_probs=172.8
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
.++|++.+.||+|+||.||+|++. +++.||+|++..... ....+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 468999999999999999999976 788999999865433 234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++..
T Consensus 88 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~ 155 (267)
T cd06646 88 CGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAK 155 (267)
T ss_pred CCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCcccee
Confidence 99999999986543 2788999999999999999999999 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
....... .....+++.|+|||.+. ...++.++|+||||+++|+|++|+.||....+
T Consensus 156 ~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~ 214 (267)
T cd06646 156 ITATIAK--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred ecccccc--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence 5322211 13346888999999874 34577899999999999999999999965543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=271.08 Aligned_cols=212 Identities=28% Similarity=0.427 Sum_probs=174.0
Q ss_pred CCCCCCceecccCceEEEEEEEC-----CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
++|++.+.||+|+||.||+|... ++..+++|.+...... ...+.+|+.++++++|+||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 57889999999999999999852 4678999998753332 2467889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCC--------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC
Q 022206 139 AYEHASKGSLHDILHGKKGVK--------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~--------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 210 (301)
+|||+.+++|.+++....... .......+++..++.++.|++.||+|||+++ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985432100 0001123788889999999999999999999 99999999999999999
Q ss_pred ceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.+..+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999976543322222233446778999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=270.20 Aligned_cols=213 Identities=25% Similarity=0.413 Sum_probs=174.2
Q ss_pred hCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 136 (301)
.++|++.+.||+|+||.||+|.++ ++..||+|++..... ...++.+|+.+++.++|+||+++++++.++...
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 467999999999999999999854 246799999864332 234578899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGA-KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
+++|||+++++|.+++......... .....+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEEC
Confidence 9999999999999999653321111 11123677889999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~ 227 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999876543332211223345788999999988889999999999999999999 7899976544
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=271.60 Aligned_cols=197 Identities=32% Similarity=0.541 Sum_probs=171.8
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHH---HHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~---~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
|++++.||+|+||+||+++.. +++.+|+|.+......... ..+|+.++++++|+||+++++++.+....+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678899999999999999988 5779999999876544433 345899999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
.+++|.+++.... .+++..++.++.|++.||.+||+.+ ++|+||||+||++++++.++|+|||.+...
T Consensus 81 ~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---------PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHHHHS---------SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred ccccccccccccc---------ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999998322 2899999999999999999999999 999999999999999999999999998653
Q ss_pred CccccccccccccccccccCccccc-cCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
..... ......++..|+|||++. +..++.++|+||||+++|+|++|..||...
T Consensus 149 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 149 SENNE--NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp TSTTS--EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccc--ccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 11111 124456899999999988 788899999999999999999999999876
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=267.43 Aligned_cols=204 Identities=29% Similarity=0.487 Sum_probs=174.4
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
.++|++.+.||+|+||.||+|...++..+++|.+.......+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 3579999999999999999999888888999999876666678999999999999999999999875 456889999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
+++|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....
T Consensus 84 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 84 KGSLLDFLKDGEG-------RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIE 153 (260)
T ss_pred CCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeecc
Confidence 9999999975432 12788999999999999999999999 9999999999999999999999999987654
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++ |.+||.+.+.
T Consensus 154 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 209 (260)
T cd05070 154 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 209 (260)
T ss_pred Ccccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 32211 1112235668999999988889999999999999999999 9999976544
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=273.76 Aligned_cols=203 Identities=23% Similarity=0.374 Sum_probs=172.3
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
+.++|++.+.||+|+||.||+|.++ +++.||+|.+..... ....+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 3578999999999999999999987 689999999864332 2346778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+.+ +|.+++..... .+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++
T Consensus 84 e~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~ 151 (301)
T cd07873 84 EYLDK-DLKQYLDDCGN--------SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLA 151 (301)
T ss_pred ecccc-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcch
Confidence 99975 89998865432 2788899999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
......... .....+++.|+|||++.+ ..++.++||||||+++|+|++|++||...+.
T Consensus 152 ~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~ 210 (301)
T cd07873 152 RAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV 210 (301)
T ss_pred hccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 654332211 123356889999998765 4578899999999999999999999976553
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=302.46 Aligned_cols=209 Identities=22% Similarity=0.387 Sum_probs=170.9
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEc--CCee
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVD--GPLR 136 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 136 (301)
...++|++++.||+|+||.||+|++. ++..+|+|++..... ....+..|+.+++.|+||||++++++|.+ ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 45678999999999999999999987 678899999875432 23568889999999999999999998864 4578
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC----CCeEecCCCCCceEEcC----
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE----PRIIHRNIKSSNVLLFD---- 208 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~----~~ivH~Dlkp~Nill~~---- 208 (301)
|+||||+++++|.++|...... ...+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~-----~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKM-----FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 9999999999999999653211 1138999999999999999999998431 23999999999999964
Q ss_pred -------------CCceEEeccccCCCCCccccccccccccccccccCcccccc--CCCCccccchhhHHHHHHHHhCCC
Q 022206 209 -------------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRK 273 (301)
Q Consensus 209 -------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~ 273 (301)
.+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||+||+|++|..
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 23589999999876543221 134568999999998864 457899999999999999999999
Q ss_pred CCCCCC
Q 022206 274 PVDHTL 279 (301)
Q Consensus 274 pf~~~~ 279 (301)
||....
T Consensus 242 PF~~~~ 247 (1021)
T PTZ00266 242 PFHKAN 247 (1021)
T ss_pred CCCcCC
Confidence 997543
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=270.02 Aligned_cols=203 Identities=30% Similarity=0.481 Sum_probs=173.1
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhcc-CCCceeeeeeEEEcC------Cee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDG------PLR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~------~~~ 136 (301)
.+.|++.+.||+|+||.||+|... +++.+|+|.+.........+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 467889999999999999999976 689999999977666667788999999998 699999999998753 468
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
+++|||+.+++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred EEEEEcCCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEcc
Confidence 999999999999999876432 12788999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
||++........ ......|++.|+|||++. +..++.++|||||||++|+|++|..||....
T Consensus 155 fg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 155 FGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred CCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 999876543221 123456899999999886 3457889999999999999999999997544
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=266.52 Aligned_cols=201 Identities=24% Similarity=0.376 Sum_probs=174.1
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
+|++.+.||+|+||.||++.+. ++..+++|.+.... ...+.+.+|+.+++.++|+||+++++.+.+++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5888999999999999999987 78999999885432 23356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++...
T Consensus 81 ~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 150 (255)
T cd08219 81 DGGDLMQKIKLQRG-------KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150 (255)
T ss_pred CCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceee
Confidence 99999998865332 12788999999999999999999999 999999999999999999999999998655
Q ss_pred CccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
..... ......+++.|+|||++.+..++.++|+||||+++|+|++|..||...+
T Consensus 151 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 151 TSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred ccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 43221 1133568889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=265.65 Aligned_cols=198 Identities=28% Similarity=0.448 Sum_probs=166.4
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCCCH
Q 022206 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL 148 (301)
+.||+|+||.||+|.+. +++.+|+|.+..... ....+.+|+++++.++|+||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999976 789999998764332 235688999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCcccc
Q 022206 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (301)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (301)
.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 149 (252)
T cd05084 81 LTFLRTEGP--------RLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY 149 (252)
T ss_pred HHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccc
Confidence 999864321 2788999999999999999999999 99999999999999999999999999876443211
Q ss_pred ccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
.........+..|+|||.+.+..++.++||||||+++|+|++ |..||....+
T Consensus 150 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~ 202 (252)
T cd05084 150 ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN 202 (252)
T ss_pred cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH
Confidence 111111123467999999988889999999999999999998 9999976554
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=270.74 Aligned_cols=204 Identities=26% Similarity=0.426 Sum_probs=168.9
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCC----EEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
.++|++.+.||+|+||.||+|.+. +++ .+++|.+..... ...++..|+..++++.|+||+++++++. +...+
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 357899999999999999999975 444 477787753322 2245677888899999999999999875 45678
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+++||+++|+|.+++..... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Df 153 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRD--------SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADF 153 (279)
T ss_pred EEEEeCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCC
Confidence 89999999999999975432 2788999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
|++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..+
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~ 217 (279)
T cd05111 154 GVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217 (279)
T ss_pred ccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99976543332222234456788999999988889999999999999999998 9999987654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=271.97 Aligned_cols=203 Identities=27% Similarity=0.463 Sum_probs=177.1
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
...++|++.+.||+|+||.||++... +++.||+|.+...... .+.+.+|+.+++.++|+||+++++++..++..++||
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 34578999999999999999999976 7999999998654333 356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++++|.+++.... +++..+..++.|++.+|.|||+.+ ++||||||+|||++.++.++|+|||++
T Consensus 96 e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~ 162 (297)
T cd06656 96 EYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC 162 (297)
T ss_pred cccCCCCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccc
Confidence 9999999999986533 788899999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...++
T Consensus 163 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~ 220 (297)
T cd06656 163 AQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (297)
T ss_pred eEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 665332211 1334678899999999888899999999999999999999999976544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=269.45 Aligned_cols=202 Identities=31% Similarity=0.441 Sum_probs=173.2
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
.++|++.+.||+|+||.||+|++. +++.||+|++...... ...+.+|+.+++.++||||+++++.+.+.+..+++|||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357889999999999999999976 6899999998654332 34577899999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++++|.+++..... +++..++.++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++..
T Consensus 88 ~~~~~L~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd06645 88 CGGGSLQDIYHVTGP---------LSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQ 155 (267)
T ss_pred cCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeE
Confidence 999999999865432 889999999999999999999999 99999999999999999999999999865
Q ss_pred CCccccccccccccccccccCccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
...... ......|++.|+|||++. ...++.++|+|||||++|+|++|..||....+
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~ 214 (267)
T cd06645 156 ITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred ccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc
Confidence 532211 113446899999999874 45678899999999999999999999965443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=268.00 Aligned_cols=203 Identities=31% Similarity=0.501 Sum_probs=177.0
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
..+|++.+.||.|+||.||+|.+.++..+++|++..... ....+.+|+.+++.++|+||+++++++.+....+++|||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 357999999999999999999988889999999876554 3567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
++++|.+++...... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++...
T Consensus 85 ~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 85 EKGSLLAFLRSPEGQ-------VLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred ccCCHHHHHhcCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhc
Confidence 999999999764321 2788999999999999999999999 999999999999999999999999998766
Q ss_pred CccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTL 279 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~ 279 (301)
...... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||....
T Consensus 155 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~ 209 (261)
T cd05148 155 KEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209 (261)
T ss_pred CCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence 432211 123345678999999988889999999999999999998 899997654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=267.58 Aligned_cols=203 Identities=22% Similarity=0.373 Sum_probs=173.6
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
++|++.+.||+|+||.||+|+.. +++.||+|.+..... ....+.+|+++++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999976 789999998754222 2245788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++++|.+++...... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~ 153 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQ-----KRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EecCCCcHHHHHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccc
Confidence 999999999988643211 112788899999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 154 RFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred eeccchhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 765433221 12346888999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=270.35 Aligned_cols=213 Identities=24% Similarity=0.425 Sum_probs=175.4
Q ss_pred hCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
..+|.+.+.||+|+||.||++.+. ++..+|+|.+..... ....+.+|++++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 457899999999999999999852 345689998865432 2356889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhcCCCCCCC----CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceE
Q 022206 138 LAYEHASKGSLHDILHGKKGVKG----AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~----~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (301)
++|||+++++|.+++........ ......+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 99999999999999975432100 011123899999999999999999999999 99999999999999999999
Q ss_pred EeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
|+|||++................+++.|+|||++.+..++.++|+||||+++|+|++ |..||....+
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~ 228 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999876543322111223345778999999998889999999999999999998 9999976554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=265.84 Aligned_cols=204 Identities=28% Similarity=0.464 Sum_probs=173.6
Q ss_pred CCCCCCceecccCceEEEEEEEC-C---CCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-S---GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
++|++.+.||+|+||.||+|.++ . ...|++|.+...... ...+.+|+.+++.++|+||+++++.+.+++..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 57999999999999999999975 2 457999998654332 35688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+
T Consensus 84 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~ 152 (266)
T cd05033 84 TEYMENGSLDKFLRENDG--------KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGL 152 (266)
T ss_pred EEcCCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccch
Confidence 999999999999976432 2889999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
+................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~ 214 (266)
T cd05033 153 SRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN 214 (266)
T ss_pred hhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH
Confidence 987752222211222335678999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=277.12 Aligned_cols=212 Identities=25% Similarity=0.415 Sum_probs=171.9
Q ss_pred hCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhcc-CCCceeeeeeEEEc-CC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVD-GP 134 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~ 134 (301)
.++|++.+.||+|+||.||+|... +++.||+|++...... ...+.+|+.++.++ +|+||+++++++.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357999999999999999999743 3578999998754322 24577899999999 79999999998764 46
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCC----------------------------------------------------C
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGA----------------------------------------------------K 162 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~----------------------------------------------------~ 162 (301)
.++++|||+++++|.+++......... .
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 788999999999999998643321000 0
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCcccccccccccccccccc
Q 022206 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242 (301)
Q Consensus 163 ~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 242 (301)
....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++................++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 0124788999999999999999999999 9999999999999999999999999998764433222223345677899
Q ss_pred CccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCC
Q 022206 243 APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTL 279 (301)
Q Consensus 243 aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~ 279 (301)
|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~ 280 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999999999998 999997644
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=263.97 Aligned_cols=198 Identities=25% Similarity=0.421 Sum_probs=168.5
Q ss_pred CceecccCceEEEEEE-ECCCCEEEEEEcCCCCCc-hHHHHHHHHHHhccC-CCceeeeeeEEEcCCeeEEEEecCCCCC
Q 022206 71 NSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHASKGS 147 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~gs 147 (301)
.+.||+|+|+.|--+. ..++.+||||++.+.... +..+.+|++++.+.+ |+||++++++|.++.++|+|||-|.||.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 4579999999999888 458999999999876443 567899999999985 9999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC---ceEEeccccCCCCC
Q 022206 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAP 224 (301)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~Dfg~a~~~~ 224 (301)
|...+.+++. +++.++.++..+|+.||.+||.+| |.||||||+|||-.+.. -|||+||.+..-..
T Consensus 163 lLshI~~~~~---------F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 163 LLSHIQKRKH---------FNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred HHHHHHHhhh---------ccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccc
Confidence 9999988764 899999999999999999999999 99999999999997644 48999999975543
Q ss_pred ccccc-----cccccccccccccCccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 225 DAAAR-----LHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 225 ~~~~~-----~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
..... ..-.+.+|+..|||||+.. ...|+.+.|.||||||+|.|++|++||.+.-.
T Consensus 231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 22111 1113457899999999763 34689999999999999999999999987543
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=271.14 Aligned_cols=213 Identities=30% Similarity=0.462 Sum_probs=176.2
Q ss_pred HHHHHHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhcc-CCCceeeeeeEEE----
Q 022206 58 VDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYV---- 131 (301)
Q Consensus 58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~---- 131 (301)
.+.+....++|++.+.||+|+||.||+|.+. +++.+++|++.........+.+|+.+++.+ +|+||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 3445566789999999999999999999976 688999999876544456788899999999 6999999999874
Q ss_pred -cCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC
Q 022206 132 -DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (301)
Q Consensus 132 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 210 (301)
++...+++|||+++++|.+++...... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~ 161 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKR-----GERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEG 161 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhcc-----CccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCC
Confidence 456789999999999999987632111 123788899999999999999999999 99999999999999999
Q ss_pred ceEEeccccCCCCCccccccccccccccccccCcccccc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
.++|+|||++......... .....|++.|+|||++.. ..++.++|||||||++|+|++|+.||....+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred CEEEccCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 9999999998765432211 133468999999998753 4578899999999999999999999976554
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=268.68 Aligned_cols=213 Identities=26% Similarity=0.415 Sum_probs=176.2
Q ss_pred hCCCCCCceecccCceEEEEEEECC------CCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRS------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 136 (301)
.++|++.+.||+|+||.||+|.++. +..|++|.+...... ...+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4689999999999999999998652 368999998654332 24678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGA-KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
+++|||+++++|.+++......... .....+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 9999999999999999754321110 11223778899999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.++
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 227 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH
Confidence 9999876544332222233456789999999988889999999999999999998 9999976554
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=255.10 Aligned_cols=211 Identities=27% Similarity=0.372 Sum_probs=175.6
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC-CchHHHHHHHHHHhccCCCceeeeeeEEEcCC-----ee
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP-----LR 136 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 136 (301)
..++|++.+.||+|+|+.||+++.- +++.+|+|++.-.. ...+..++|+...++++|||+++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 4578999999999999999999954 78999999987554 45577899999999999999999998865433 48
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
|++++|...|+|.+.++..+... ..+++.+.+.|+.++++||++||+.. +++.||||||.|||+.+.+.++|.|
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg-----~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKG-----NFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcC-----CccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEe
Confidence 99999999999999998665432 23899999999999999999999986 4699999999999999999999999
Q ss_pred cccCCCCCccccccc-------cccccccccccCcccccc---CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 217 FDLSNQAPDAAARLH-------STRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 217 fg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
||.+....-...... ......|..|.|||++.- ...+.++|||||||+||.|+.|..||+....
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~ 246 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ 246 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence 999877543221100 112346899999998853 4568899999999999999999999976544
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=275.04 Aligned_cols=205 Identities=25% Similarity=0.326 Sum_probs=176.9
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch----HHHHHHHHHHhcc-CCCceeeeeeEEEcCCee
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 136 (301)
.+..+|..+.+||+|+||+|.++..+ +.+.+|||+++++..-+ +--+.|-.+|... +-|.+++++..|++-+++
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 35678999999999999999999987 67889999998754322 2234566666555 457899999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
|+||||+.||+|-..++.-.. +.+..++.++.+|+-||-+||++| |++||||.+|||++.+|++||+|
T Consensus 426 yFVMEyvnGGDLMyhiQQ~Gk---------FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~D 493 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGK---------FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIAD 493 (683)
T ss_pred eeEEEEecCchhhhHHHHhcc---------cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeee
Confidence 999999999999998876543 778889999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
||+++...... ..+.+++|||.|+|||++..+.|+..+|+||+||+||||+.|++||++.+..
T Consensus 494 FGmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~ 556 (683)
T KOG0696|consen 494 FGMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 556 (683)
T ss_pred cccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 99997654332 2346789999999999999999999999999999999999999999887653
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=269.08 Aligned_cols=202 Identities=25% Similarity=0.400 Sum_probs=172.1
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
.+.|++++.||+|+||.||+|++. ++..+++|.+...... ...+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 367999999999999999999987 6899999998754322 35678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++++|..++..... .+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 91 CPGGAVDAIMLELDR--------GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred CCCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCcccee
Confidence 999999988764322 2788999999999999999999999 99999999999999999999999998865
Q ss_pred CCccccccccccccccccccCccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
....... .....+++.|+|||++. ...++.++|+|||||++|+|++|..||...+
T Consensus 160 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 160 NVKTLQR--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred ccccccc--cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 4322111 13345788999999874 3456789999999999999999999997654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=264.86 Aligned_cols=202 Identities=26% Similarity=0.401 Sum_probs=170.4
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC------chHHHHHHHHHHhccCCCceeeeeeEEEcC--Cee
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ------PDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLR 136 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 136 (301)
.+|++.+.||+|+||.||++.+. ++..|++|.+..... ....+.+|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999976 689999998753221 124577899999999999999999988763 568
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
+++|||+++++|.+++..... +++.....++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~D 149 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA---------LTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGD 149 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECc
Confidence 899999999999999875432 678888999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 217 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
||++......... .......++..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 213 (265)
T cd06652 150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE 213 (265)
T ss_pred CccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc
Confidence 9998765322111 01123458889999999988889999999999999999999999997643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=270.94 Aligned_cols=202 Identities=28% Similarity=0.469 Sum_probs=176.6
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
...+|++.+.||.|++|.||++.+. +++.|++|.+..... ....+.+|+.+++.++|+||+++++.+.++...++|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 3457999999999999999999976 789999998865433 34567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+++++|.+++.... +++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 97 ~~~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~ 163 (296)
T cd06655 97 YLAGGSLTDVVTETC----------MDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCA 163 (296)
T ss_pred ecCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccch
Confidence 999999999986543 789999999999999999999999 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
........ .....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...++
T Consensus 164 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~ 220 (296)
T cd06655 164 QITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (296)
T ss_pred hccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 65433211 1334688899999999888899999999999999999999999977554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=286.27 Aligned_cols=194 Identities=33% Similarity=0.486 Sum_probs=171.1
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
.|.-++.||.|+||.||.|++. +.+.||||++..+.+. ..+++.|+.+|++++|||++.+-++|..+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4677888999999999999976 7899999999765433 3678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
||-| +-.+++.-.+. ++.+..+..|+.+.+.||+|||+++ .||||||..|||+++.|.|||+|||.|.
T Consensus 107 YClG-SAsDlleVhkK--------plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAs 174 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSAS 174 (948)
T ss_pred HHhc-cHHHHHHHHhc--------cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchh
Confidence 9976 78888765442 2888999999999999999999999 9999999999999999999999999986
Q ss_pred CCCccccccccccccccccccCccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
..... ..++|||.|||||++. .+.|+.++||||||++..||.-.++|+-..
T Consensus 175 i~~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM 228 (948)
T KOG0577|consen 175 IMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 228 (948)
T ss_pred hcCch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc
Confidence 65432 6679999999999875 468999999999999999999999997653
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=265.44 Aligned_cols=207 Identities=25% Similarity=0.369 Sum_probs=169.5
Q ss_pred CCCCceecccCceEEEEEEEC-C---CCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCe-----
Q 022206 68 FGTNSLIGEGSYGRVYFGVLR-S---GRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPL----- 135 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 135 (301)
|.+.+.||+|+||.||+|... + +..||+|.+...... ...+.+|+..++.++|+||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 678899999999999999865 2 478999998754332 2467889999999999999999998765544
Q ss_pred -eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 136 -RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 136 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
.++++||+++++|..++........ ...+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl 154 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGL---PEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCV 154 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCC---cccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEE
Confidence 7899999999999999854322111 123888999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..+
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~ 221 (273)
T cd05035 155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN 221 (273)
T ss_pred CCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999876544332211222335678999999988889999999999999999999 9999976554
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=268.53 Aligned_cols=212 Identities=26% Similarity=0.405 Sum_probs=173.5
Q ss_pred CCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
+|++.+.||+|+||.||+|... ....+++|.+...... ...+.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 5888999999999999999853 2356888888654432 3468889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCC---------------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCc
Q 022206 139 AYEHASKGSLHDILHGKKGVK---------------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSN 203 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~---------------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~N 203 (301)
++||+.+++|.+++....... .......+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999986532110 0112234888999999999999999999999 9999999999
Q ss_pred eEEcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCc
Q 022206 204 VLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (301)
Q Consensus 204 ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~ 281 (301)
||+++++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999999876543322111223345778999999988889999999999999999998 99999766543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=269.11 Aligned_cols=204 Identities=26% Similarity=0.439 Sum_probs=169.8
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCC----EEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
..+|++.+.||+|+||.||+|.+. ++. .||+|++...... ...+.+|+.+++.++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 467999999999999999999865 444 4899988654332 35678899999999999999999988754 577
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+++||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+||
T Consensus 85 l~~~~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~df 153 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKD--------RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDF 153 (279)
T ss_pred EEEEcCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCC
Confidence 89999999999999975432 2888999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
|++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 154 G~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 217 (279)
T cd05109 154 GLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217 (279)
T ss_pred CceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99876643322211122235678999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=269.09 Aligned_cols=213 Identities=24% Similarity=0.415 Sum_probs=175.8
Q ss_pred hCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
..+|.+.+.||+|+||.||+|.+. ++..+++|.+...... .+.+.+|+.++++++|+||+++++++.+.+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 356888999999999999999853 3456889988654433 356889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhcCCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC
Q 022206 138 LAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 210 (301)
+||||+++++|.+++....... .......+++..++.++.||+.||+|||+++ ++||||||+||++++++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence 9999999999999997543210 0011223788999999999999999999999 99999999999999999
Q ss_pred ceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||....+
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 231 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 231 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999876544332222233456788999999998899999999999999999999 9999976544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=286.03 Aligned_cols=197 Identities=25% Similarity=0.406 Sum_probs=169.9
Q ss_pred CCCceecccCceEEEEEEEC-CCCEEEEEEc---C--CCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCe--eEEEE
Q 022206 69 GTNSLIGEGSYGRVYFGVLR-SGRAAAIKKL---D--SSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL--RVLAY 140 (301)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~---~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~lv~ 140 (301)
+...+||+|+|-+||+|.+. +|..||--.+ + +.....+.+..|+.+|+.|+|+||+++++.|.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 35668999999999999987 6888884333 2 233334789999999999999999999999987665 78899
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC-CCceEEecccc
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDL 219 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~ 219 (301)
|.+..|+|..|+++.+. .....+..|++||++||.|||++. |||||||||-+||||+. -|.|||+|+||
T Consensus 123 EL~TSGtLr~Y~kk~~~---------vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGL 192 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR---------VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGL 192 (632)
T ss_pred ecccCCcHHHHHHHhcc---------CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhH
Confidence 99999999999988765 778899999999999999999985 67999999999999985 68999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|........ ....|||.|||||+.. ..|+..+||||||+++.||+|+..||.....
T Consensus 193 Atl~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n 248 (632)
T KOG0584|consen 193 ATLLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN 248 (632)
T ss_pred HHHhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC
Confidence 987765432 3468999999999776 8899999999999999999999999987544
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=264.42 Aligned_cols=204 Identities=25% Similarity=0.448 Sum_probs=175.0
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
.++|++.+.||+|+||.||++....+..+++|.+.......+.+.+|+++++.++|+||+++++.+.+ ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 47899999999999999999997777889999987665556778899999999999999999999887 77899999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
+++|.+++...... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 84 ~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 84 KGSLLDFLKSDEGS-------KQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred CCcHHHHHHhCCcc-------ccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 99999999764321 2778889999999999999999999 9999999999999999999999999987654
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
..... ......++..|+|||++....++.++|+||||+++|++++ |+.||.+.+.
T Consensus 154 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 209 (260)
T cd05073 154 DNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209 (260)
T ss_pred CCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence 32211 1122235677999999988889999999999999999998 9999986554
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=271.63 Aligned_cols=213 Identities=29% Similarity=0.434 Sum_probs=173.8
Q ss_pred hCCCCCCceecccCceEEEEEEEC--------CCCEEEEEEcCCCCC--chHHHHHHHHHHhcc-CCCceeeeeeEEEcC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 133 (301)
.++|.+.+.||+|+||.||++++. +...+|+|.+..... ....+.+|+.+++.+ +|+||+++++++.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 367999999999999999999853 134699999875432 234678899999999 799999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhcCCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEE
Q 022206 134 PLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (301)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill 206 (301)
+..+++|||+.+++|.+++....... ...+...+++..++.++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 99999999999999999997643211 0012234888999999999999999999999 9999999999999
Q ss_pred cCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 207 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
++++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 9999999999999876543222111122234578999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=267.35 Aligned_cols=201 Identities=23% Similarity=0.377 Sum_probs=169.9
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
+|++.+.||+|++|.||+|+++ ++..||+|++..... ....+.+|+.+++.++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5888999999999999999986 789999999865322 235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+. ++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~-~~l~~~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 150 (285)
T cd07861 81 LS-MDLKKYLDSLPK------GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARA 150 (285)
T ss_pred CC-CCHHHHHhcCCC------CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceee
Confidence 98 589888865331 123889999999999999999999999 99999999999999999999999999865
Q ss_pred CCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
....... .....+++.|+|||.+.+. .++.++||||||+++|+|++|++||.+..
T Consensus 151 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~ 206 (285)
T cd07861 151 FGIPVRV--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206 (285)
T ss_pred cCCCccc--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 4322111 1233568899999987654 56889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=289.85 Aligned_cols=202 Identities=24% Similarity=0.405 Sum_probs=176.6
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCC-CCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDS-SKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
+.|+++..||.|+||+||+|..+ ++-..|.|++.. +....++++.|+.+|..+.||+||++++.|..++.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 46788889999999999999988 466677888864 3344578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
.||-++.++..-.. .+++.++..+++|++.||.|||+++ |||||||..|||++-+|.++|+|||.+...
T Consensus 112 ~GGAVDaimlEL~r--------~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGR--------VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred CCchHhHHHHHhcc--------ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc
Confidence 99999998865543 3999999999999999999999999 999999999999999999999999998665
Q ss_pred CccccccccccccccccccCcccc-----ccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYA-----MTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
..... ....+.|||.|||||+. ...+|+.++||||||++|.+|..+.+|..+.++
T Consensus 181 ~~t~q--kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp 240 (1187)
T KOG0579|consen 181 KSTRQ--KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP 240 (1187)
T ss_pred hhHHh--hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch
Confidence 43322 23678999999999976 456899999999999999999999999877665
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=263.95 Aligned_cols=203 Identities=30% Similarity=0.495 Sum_probs=172.7
Q ss_pred CCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
++|++.+.||+|++|.||+|.+..+..+++|.+.........+.+|+.++++++|+|++++++++. .+..+++|||+.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 568899999999999999999887678999998766555677889999999999999999998875 4568899999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 85 ~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 85 GSLLDFLKEGDG-------KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 999999975432 12788899999999999999999999 99999999999999999999999999876543
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+..+
T Consensus 155 ~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 209 (260)
T cd05069 155 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN 209 (260)
T ss_pred Cccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 2211 1122345678999999988889999999999999999999 9999977544
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=268.19 Aligned_cols=212 Identities=28% Similarity=0.487 Sum_probs=176.5
Q ss_pred CHHHHHHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhcc-CCCceeeeeeEEEc--
Q 022206 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVD-- 132 (301)
Q Consensus 57 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-- 132 (301)
+..++....+.|++.+.||+|+||.||+|++. +++.+|+|++.........+..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 33444455678999999999999999999986 689999999876655556788899999888 69999999999853
Q ss_pred ----CCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC
Q 022206 133 ----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (301)
Q Consensus 133 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 208 (301)
....+++|||+.+|+|.+++...... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~ 156 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGN-------ALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTE 156 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECC
Confidence 46789999999999999999754321 2778888999999999999999999 999999999999999
Q ss_pred CCceEEeccccCCCCCccccccccccccccccccCccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 209 DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 209 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
++.++|+|||++........ ......|++.|+|||.+. ...++.++|+||||+++|+|++|..||.+..+
T Consensus 157 ~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~ 231 (282)
T cd06636 157 NAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231 (282)
T ss_pred CCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH
Confidence 99999999999876533221 113456899999999875 34678899999999999999999999976543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=267.85 Aligned_cols=213 Identities=25% Similarity=0.411 Sum_probs=173.7
Q ss_pred hCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 136 (301)
.++|++.+.||+|+||.||+|.++ .+..||+|.+...... ...+.+|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 468999999999999999999754 2458999988654432 24577899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCC-CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKG-AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
+++|||+.+|+|.+++........ ....+.+....+..++.|++.||.|||+++ ++||||||+||++++++.++|+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEEC
Confidence 999999999999999975332111 111233567788999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
|||+++...............++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+...
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~ 227 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999876543322222223345778999999988889999999999999999998 8999976543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=264.06 Aligned_cols=201 Identities=26% Similarity=0.443 Sum_probs=172.7
Q ss_pred CCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCc-------hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
+|.+.+.||+|+||.||+|...+++.+|+|.+...... ...+.+|+++++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 58889999999999999999888999999988643321 14578899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
+||+++++|.+++..... +++..+..++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||+
T Consensus 81 ~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 148 (265)
T cd06631 81 MEFVPGGSISSILNRFGP---------LPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGC 148 (265)
T ss_pred EecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchh
Confidence 999999999999975432 788889999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccc----ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 220 SNQAPDAAA----RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 220 a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
+........ ........++..|+|||++.+..++.++|+||||+++|+|++|..||...+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred hHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 875432111 111123458899999999988889999999999999999999999997644
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=268.73 Aligned_cols=212 Identities=29% Similarity=0.404 Sum_probs=173.7
Q ss_pred CCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
.+|++.+.||+|+||.||+|.+. .+..||+|++...... ...+.+|+.++..++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45788899999999999999864 2578999998754432 255788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhcCCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC
Q 022206 138 LAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 210 (301)
+++||+.+++|.+++....... .......+++..++.++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985322110 0011234788889999999999999999999 99999999999999999
Q ss_pred ceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 232 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999876644332222233446789999999988889999999999999999998 9999977554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=266.62 Aligned_cols=201 Identities=27% Similarity=0.384 Sum_probs=172.5
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
++|++.+.||+|++|.||+|.++ +++.||+|++..... ..+.+.+|+.+++.++|+|++++++++.+....+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47899999999999999999987 689999998864322 23457889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+++++|..++.... .+++..+..++.|++.+|+|||+.+ ++|+||||+||++++++.++|+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (286)
T cd07847 81 YCDHTVLNELEKNPR---------GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFAR 148 (286)
T ss_pred ccCccHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccce
Confidence 999988888775432 2889999999999999999999999 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+..+
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~ 206 (286)
T cd07847 149 ILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD 206 (286)
T ss_pred ecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 76443211 123457889999998876 4578899999999999999999999976554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=271.11 Aligned_cols=203 Identities=22% Similarity=0.372 Sum_probs=162.3
Q ss_pred ceecccCceEEEEEEEC---CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEE--cCCeeEEEEecCCCC
Q 022206 72 SLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV--DGPLRVLAYEHASKG 146 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~g 146 (301)
.+||+|+||.||+|+.+ ++..||+|.+..... ...+.+|+.+++.++||||+++++++. .+...++++||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 57999999999999965 457899999865432 345788999999999999999999885 35678999999875
Q ss_pred CHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEE----cCCCceEEeccccCCC
Q 022206 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKISDFDLSNQ 222 (301)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~vkl~Dfg~a~~ 222 (301)
+|.+++..............+++..++.++.|++.||.|||+.+ ++||||||+|||+ +.++.+||+|||++..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 88888754322111112234888999999999999999999999 9999999999999 4567999999999976
Q ss_pred CCccccc-cccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 223 APDAAAR-LHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 223 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
....... .......+|+.|+|||++.+ ..++.++|||||||++|+|+||++||....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 5433211 11234568999999998876 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=266.29 Aligned_cols=199 Identities=28% Similarity=0.451 Sum_probs=175.7
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
++|++.+.||.|++|.||+|++. +++.+++|.+..... ....+.+|+++++.++|+||+++++++.++...++++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46889999999999999999977 689999999875432 235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++++|.+++.... +++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~~~~L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 147 (274)
T cd06609 81 CGGGSCLDLLKPGK----------LDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQ 147 (274)
T ss_pred eCCCcHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccccccee
Confidence 99999999997642 889999999999999999999999 99999999999999999999999999877
Q ss_pred CCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
...... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+
T Consensus 148 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 148 LTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred eccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 654321 1234467889999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=266.22 Aligned_cols=211 Identities=28% Similarity=0.460 Sum_probs=173.5
Q ss_pred hCCCCCCceecccCceEEEEEEECC------CCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRS------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 136 (301)
.++|.+.+.||+|++|.||+|.+.. +..|++|.+...... ...+.+|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 3678999999999999999999753 567899988644332 34688899999999999999999999988899
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC---ceE
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAK 213 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~vk 213 (301)
+++|||+++++|.+++........ ....+++..++.++.||+.||+|||+.+ ++||||||+||+++.++ .+|
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPE--RPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceE
Confidence 999999999999999976542211 1124889999999999999999999999 99999999999998754 599
Q ss_pred EeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
|+|||++.................++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~ 227 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999887643222111122334568999999988889999999999999999997 9999987554
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=269.88 Aligned_cols=210 Identities=28% Similarity=0.434 Sum_probs=170.7
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCC--EEEEEEcCCCCC--chHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR--AAAIKKLDSSKQ--PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 138 (301)
.++|++.+.||+|+||.||+|.++ ++. .+++|.+..... ....+.+|+.++.++ +|+||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 468999999999999999999976 454 457777653222 234678899999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc
Q 022206 139 AYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (301)
+|||+++++|.+++........ ......+++..++.++.|++.||+|||+.| ++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 9999999999999975432111 011234889999999999999999999999 999999999999999999
Q ss_pred eEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
+||+|||++........ .....++..|+|||++.+..++.++||||||+++|+|+| |..||.+.+.
T Consensus 163 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 229 (303)
T cd05088 163 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 229 (303)
T ss_pred EEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh
Confidence 99999999864322111 122234667999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=270.67 Aligned_cols=205 Identities=28% Similarity=0.416 Sum_probs=175.4
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
++|++.+.||+|++|.||+|... +++.+|+|.+...... ...+.+|+++++.++|+||+++++.+.++...+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47889999999999999999987 5899999998765433 245788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+.+++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~ 150 (316)
T cd05574 81 DYCPGGELFRLLQRQPG-------KCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLS 150 (316)
T ss_pred EecCCCCHHHHHHhCCC-------CccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchh
Confidence 99999999999875432 23889999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccc---------------------------cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCC
Q 022206 221 NQAPDAAAR---------------------------LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 273 (301)
Q Consensus 221 ~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~ 273 (301)
......... .......|+..|+|||++.+..++.++||||||+++|+|++|..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~ 230 (316)
T cd05574 151 KQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230 (316)
T ss_pred hcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCC
Confidence 654322110 01123467889999999988889999999999999999999999
Q ss_pred CCCCCCC
Q 022206 274 PVDHTLP 280 (301)
Q Consensus 274 pf~~~~~ 280 (301)
||...+.
T Consensus 231 pf~~~~~ 237 (316)
T cd05574 231 PFKGSNR 237 (316)
T ss_pred CCCCCch
Confidence 9976543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=262.93 Aligned_cols=203 Identities=30% Similarity=0.449 Sum_probs=176.0
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
.++|++.+.||+|+||.||+|.+. +++.+++|++..... ....+.+|++++++++|+||+++++++.++...+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367999999999999999999976 688999999875433 346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+.+++|.+++..... .+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 82 ~~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 150 (262)
T cd06613 82 CGGGSLQDIYQVTRG--------PLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQ 150 (262)
T ss_pred CCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchh
Confidence 999999999876421 2889999999999999999999999 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCccccccC---CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTG---QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
....... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.++
T Consensus 151 ~~~~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~ 209 (262)
T cd06613 151 LTATIAK--RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP 209 (262)
T ss_pred hhhhhhc--cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 5432211 1334678899999998776 788999999999999999999999976553
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=268.48 Aligned_cols=203 Identities=26% Similarity=0.407 Sum_probs=173.6
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
.++|++.+.||.|+||.||++.+. ++..+|+|.+...... ...+.+|++++++++|+||+++++.+.++...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 357999999999999999999976 6899999998654322 34688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++++|.+++..... .+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 84 ~~~~~L~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~ 152 (280)
T cd06611 84 CDGGALDSIMLELER--------GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAK 152 (280)
T ss_pred cCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchh
Confidence 999999999875432 2889999999999999999999999 99999999999999999999999998766
Q ss_pred CCccccccccccccccccccCccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
....... .....+++.|+|||++. ...++.++|+||||+++|+|++|+.||...++
T Consensus 153 ~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~ 213 (280)
T cd06611 153 NKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213 (280)
T ss_pred hcccccc--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH
Confidence 5432211 13346889999999875 34567799999999999999999999976543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=268.06 Aligned_cols=202 Identities=26% Similarity=0.427 Sum_probs=171.3
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
++|++++.||+|+||.||++.+. ++..+|+|.+...... ...+.+|+.++++++|+||+++++.+...+..+++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46889999999999999999987 7899999988654322 35688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
+++++|.+++..... ...+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++.
T Consensus 81 ~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 151 (286)
T cd06622 81 MDAGSLDKLYAGGVA------TEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSG 151 (286)
T ss_pred cCCCCHHHHHHhccc------cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcc
Confidence 999999999875321 1138899999999999999999997 47 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCccccccC------CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTG------QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
....... ....+++.|+|||++.+. .++.++|+|||||++|+|++|+.||.....
T Consensus 152 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 212 (286)
T cd06622 152 NLVASLA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY 212 (286)
T ss_pred cccCCcc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch
Confidence 6533221 234578899999988544 347899999999999999999999975443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=262.50 Aligned_cols=202 Identities=31% Similarity=0.506 Sum_probs=177.7
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
.++|++.+.||+|+||.||+|... ++..+++|.+..... ...+.+|+++++.++|+||+++++.+.+....++++||+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 368999999999999999999987 589999999875533 567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
.+++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 81 ~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~ 149 (256)
T cd06612 81 GAGSVSDIMKITNK--------TLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQL 149 (256)
T ss_pred CCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhc
Confidence 99999999865332 2889999999999999999999999 999999999999999999999999998776
Q ss_pred CccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
...... .....++..|+|||++.+..++.++||||||+++|+|++|+.||....+
T Consensus 150 ~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~ 204 (256)
T cd06612 150 TDTMAK--RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP 204 (256)
T ss_pred ccCccc--cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch
Confidence 543211 1334578899999999888999999999999999999999999976544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=288.84 Aligned_cols=206 Identities=19% Similarity=0.297 Sum_probs=161.6
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC--CCCEEEEE------------------EcCCCCCchHHHHHHHHHHhccCCCc
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIK------------------KLDSSKQPDQEFLAQVSMVSRLKNEN 122 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK------------------~~~~~~~~~~~~~~e~~~l~~l~h~~ 122 (301)
...++|++++.||+|+||+||++..+ .+...++| .+.........+.+|+.++++++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999999999998764 22222222 11112222345788999999999999
Q ss_pred eeeeeeEEEcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCC
Q 022206 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSS 202 (301)
Q Consensus 123 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~ 202 (301)
|+++++++.+.+..+++++++.+ +|.+++....... ........+..++.||+.||.|||+++ |+||||||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~----~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~ 296 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDW----KDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLE 296 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccc----cccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 99999999999999999999965 7877775432110 011345677889999999999999999 999999999
Q ss_pred ceEEcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCC-CCCC
Q 022206 203 NVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK-PVDH 277 (301)
Q Consensus 203 Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~-pf~~ 277 (301)
|||++.++.+||+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|++|.. ||..
T Consensus 297 NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~ 371 (501)
T PHA03210 297 NIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD 371 (501)
T ss_pred HEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence 999999999999999999766433221 1234579999999999999999999999999999999999875 4543
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=264.44 Aligned_cols=202 Identities=25% Similarity=0.385 Sum_probs=161.8
Q ss_pred ceecccCceEEEEEEEC---CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCC
Q 022206 72 SLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 146 (301)
+.||+|+||.||+|... ....+++|.+...... ...+.+|+..++.++|+||+++++.+.+....+++|||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 36999999999999754 3457888877543322 245788999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCcc
Q 022206 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (301)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (301)
+|.+++....... .....+..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++......
T Consensus 81 ~L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 153 (269)
T cd05042 81 DLKNYLRSNRGMV----AQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPE 153 (269)
T ss_pred cHHHHHHhccccc----cccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccc
Confidence 9999997654211 112467778899999999999999999 999999999999999999999999998654332
Q ss_pred ccccccccccccccccCcccccc-------CCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 227 AARLHSTRVLGTFGYHAPEYAMT-------GQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
..........+++.|+|||++.. ..++.++|||||||++|+|++ |..||....+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (269)
T cd05042 154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD 215 (269)
T ss_pred hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 21111233345778999998743 356789999999999999999 8899976543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=262.80 Aligned_cols=201 Identities=27% Similarity=0.474 Sum_probs=172.1
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----------hHHHHHHHHHHhccCCCceeeeeeEEEcCCe
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----------DQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 135 (301)
+|.+...||+|++|.||+|.+. +++.+++|.+...... ...+.+|+.++++++|+||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788899999999999999976 6889999988643221 1357789999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
.++++||+++++|.+++..... +++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~ 148 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGA---------FEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKIS 148 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccC---------ccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEec
Confidence 9999999999999999976432 788889999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccc----cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAAR----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 216 Dfg~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|||++......... .......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.+..
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 216 (267)
T cd06628 149 DFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216 (267)
T ss_pred ccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc
Confidence 99998776532111 01123457889999999988888999999999999999999999997643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=262.34 Aligned_cols=204 Identities=25% Similarity=0.402 Sum_probs=174.9
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
++|++.+.||+|+||.||+|... +++.+++|.++... .....+.+|++++++++|+|++++++.+.+.+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999987 89999999886322 22456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++++|.+++...... ...++...++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 82 e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~ 153 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQ-----KRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred ecCCCCCHHHHHHHhccc-----CCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEecccee
Confidence 999999999998643211 123788999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 154 ~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 154 RFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred eeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 655432211 123457889999999988889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=265.33 Aligned_cols=199 Identities=29% Similarity=0.381 Sum_probs=176.0
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
+|++.+.||.|+||.||+|.+. ++..+++|++.... ...+.+.+|++++++++||||+++++.+.++...++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999987 79999999987533 223578889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+.+++|.+++.... .+++..+..++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++.
T Consensus 81 ~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~ 148 (258)
T cd05578 81 LLLGGDLRYHLSQKV---------KFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIAT 148 (258)
T ss_pred CCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeeccccc
Confidence 999999999997652 2888999999999999999999999 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
....... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 149 ~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 149 KVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred ccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 7654321 1334678899999999888899999999999999999999999987664
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=262.33 Aligned_cols=202 Identities=26% Similarity=0.392 Sum_probs=170.8
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC------chHHHHHHHHHHhccCCCceeeeeeEEEc--CCee
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ------PDQEFLAQVSMVSRLKNENVVELVGYYVD--GPLR 136 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 136 (301)
.+|+..+.||+|+||.||+|.+. ++..|++|.+..... ....+.+|+.+++.++|+||+++++++.+ +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47999999999999999999976 689999998864321 12457789999999999999999998875 3678
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
++++||+++++|.+++..... +++...+.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~d 149 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGA---------LTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGD 149 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEcc
Confidence 899999999999999975432 788889999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCcccc-ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 217 FDLSNQAPDAAA-RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 217 fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
||++........ ........++..|+|||++.+..++.++|+|||||++|+|++|+.||.+..
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~ 213 (266)
T cd06651 150 FGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE 213 (266)
T ss_pred CCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc
Confidence 999876532111 111123457889999999998889999999999999999999999997654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=267.12 Aligned_cols=201 Identities=23% Similarity=0.395 Sum_probs=170.7
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
.++|++.+.||+|++|.||+|..+ +++.||+|.+..... ....+.+|+++++.++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 478999999999999999999987 789999999865432 23456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+.+ +|.+++..... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~~~-~L~~~~~~~~~--------~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 151 (291)
T cd07844 84 YLDT-DLKQYMDDCGG--------GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLAR 151 (291)
T ss_pred cCCC-CHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccc
Confidence 9985 99998875432 2788999999999999999999999 9999999999999999999999999986
Q ss_pred CCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
........ .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+..
T Consensus 152 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 152 AKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred ccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 54322111 122346888999998865 457889999999999999999999997554
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=265.60 Aligned_cols=200 Identities=25% Similarity=0.427 Sum_probs=170.2
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
|++.+.||+|+||.||++.+. ++..+++|.+..... ....+.+|+++++.++|+||+++++++..+...++++||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 678889999999999999987 678899998865432 235678899999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
++|..++..... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 87 ~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 155 (282)
T cd06643 87 GAVDAVMLELER--------PLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 155 (282)
T ss_pred CcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccc
Confidence 999998764321 2889999999999999999999999 99999999999999999999999999876543
Q ss_pred cccccccccccccccccCccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
.... .....+++.|+|||++. +..++.++|+|||||++|+|++|++||...++
T Consensus 156 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 213 (282)
T cd06643 156 TIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP 213 (282)
T ss_pred cccc--cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH
Confidence 2211 13446899999999874 34577899999999999999999999976543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=265.55 Aligned_cols=198 Identities=30% Similarity=0.435 Sum_probs=166.9
Q ss_pred CCCCceecccCceEEEEEEE-----CCCCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEc--CCeeEE
Q 022206 68 FGTNSLIGEGSYGRVYFGVL-----RSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRVL 138 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 138 (301)
|++.+.||+|+||+||++.. .++..||+|.+..... ....+.+|+++++.++||||+++++++.. ....++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48899999999999988753 2578899999875433 34567889999999999999999998765 346889
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
+|||+++++|.+++.... +++..++.++.|++.||.|||+.+ ++||||||+||++++++.++|+|||
T Consensus 86 v~e~~~~~~l~~~~~~~~----------l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg 152 (283)
T cd05080 86 IMEYVPLGSLRDYLPKHK----------LNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFG 152 (283)
T ss_pred EecCCCCCCHHHHHHHcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecc
Confidence 999999999999997543 899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccc-cccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 219 LSNQAPDAAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 219 ~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
++........... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 9876654322111 12223566799999998888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=266.79 Aligned_cols=201 Identities=36% Similarity=0.564 Sum_probs=166.6
Q ss_pred CCceecccCceEEEEEEEC-----CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 70 TNSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
+.+.||.|+||.||+|.+. .+..|+||.+...... .+.+.+|++.+++++||||+++++++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999966 3678999999654333 46789999999999999999999999988889999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ ++|++|+++||+++.++.+||+|||++..
T Consensus 83 ~~~g~L~~~L~~~~~-------~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNK-------EPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRP 152 (259)
T ss_dssp -TTEBHHHHHHHTCT-------TTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEE
T ss_pred ccccccccccccccc-------cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 999999999987621 12899999999999999999999999 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
..................|+|||.+....++.++||||||+++|||++ |+.||.+.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~ 211 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN 211 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 632222112233446788999999998889999999999999999999 7899977644
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=283.81 Aligned_cols=204 Identities=24% Similarity=0.361 Sum_probs=182.5
Q ss_pred hhCCCCCCceecccCceEEEEEEECC-CCEEEEEEcCCC----CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
...+++++..||-|+||+|=++..++ ...+|+|.+++. ....+.+..|-.+|..++.+.||++|-.|.++.+.|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 34578888899999999999999774 334888888653 3334668889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
+||-|-||.|+..|..+.. +....+..++..+++|++|||++| ||+|||||+|+|++.+|-+||.|||
T Consensus 498 LmEaClGGElWTiLrdRg~---------Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGS---------FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred hHHhhcCchhhhhhhhcCC---------cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehh
Confidence 9999999999999987664 888889999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCcC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~ 282 (301)
+|+.+...... -+++|||.|.|||++.+..++.++|.||||+++|||++|.+||.+.+|-.
T Consensus 566 FAKki~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk 626 (732)
T KOG0614|consen 566 FAKKIGSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK 626 (732)
T ss_pred hHHHhccCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH
Confidence 99998776543 57899999999999999999999999999999999999999999887743
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=271.14 Aligned_cols=199 Identities=19% Similarity=0.285 Sum_probs=165.1
Q ss_pred CCceeccc--CceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 70 TNSLIGEG--SYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 70 ~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
++++||+| +|++||++..+ +++.||+|.+...... ...+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 78999999976 7999999998754322 245778999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
++++|.+++...... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+...
T Consensus 82 ~~~~l~~~~~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 82 AYGSAKDLICTHFMD-------GMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred CCCcHHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 999999999653321 2788999999999999999999999 999999999999999999999999865443
Q ss_pred Ccccccc-----ccccccccccccCcccccc--CCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 224 PDAAARL-----HSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 224 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
....... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 152 INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 2111100 0122346778999999876 46889999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=268.11 Aligned_cols=203 Identities=25% Similarity=0.372 Sum_probs=172.5
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
++|++.+.||+|+||.||++.+. +++.|++|.+..... ....+.+|+.+++.++|+||+++++.+.+++..+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47899999999999999999987 688999999865432 2345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++
T Consensus 81 e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~ 148 (305)
T cd05609 81 EYVEGGDCATLLKNIG---------ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLS 148 (305)
T ss_pred ecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCc
Confidence 9999999999996543 2788899999999999999999999 999999999999999999999999987
Q ss_pred CCCCccc-------------cccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAA-------------ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
....... .........++..|+|||.+.+..++.++|+||||+++|+|++|..||.+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~ 221 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 221 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 6321100 00011224578899999999888899999999999999999999999976544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=267.93 Aligned_cols=212 Identities=23% Similarity=0.379 Sum_probs=173.2
Q ss_pred CCCCCCceecccCceEEEEEEEC-----------------CCCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeee
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-----------------SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVEL 126 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~ 126 (301)
++|++.+.||+|+||.||++.+. +...+|+|++..... ....+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57999999999999999998643 234689999875432 23568899999999999999999
Q ss_pred eeEEEcCCeeEEEEecCCCCCHHHHhcCCCCCCC--CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCce
Q 022206 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKG--AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204 (301)
Q Consensus 127 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Ni 204 (301)
++++.+++..+++|||+.+++|.+++........ ......+++..++.++.|++.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999976432211 112234778899999999999999999999 99999999999
Q ss_pred EEcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh--CCCCCCCCCC
Q 022206 205 LLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT--GRKPVDHTLP 280 (301)
Q Consensus 205 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~--g~~pf~~~~~ 280 (301)
|+++++.++|+|||++................+++.|++||......++.++|+|||||++|+|++ |..||...++
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999876543322111223345678999998888889999999999999999998 7899976543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=266.46 Aligned_cols=212 Identities=32% Similarity=0.467 Sum_probs=175.7
Q ss_pred HHHHHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhcc-CCCceeeeeeEEEcC---
Q 022206 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDG--- 133 (301)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--- 133 (301)
..+....++|++.+.||+|+||.||++... +++.+|+|++.........+.+|+.+++++ +|+|++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 344455788999999999999999999976 789999999876555556788899999998 799999999998743
Q ss_pred --CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc
Q 022206 134 --PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (301)
Q Consensus 134 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (301)
...++|+||+++++|.+++...... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLIC-----GQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 3589999999999999988642211 122788999999999999999999999 999999999999999999
Q ss_pred eEEeccccCCCCCccccccccccccccccccCccccccC-----CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-----QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+||+|||++......... .....++..|+|||.+... .++.++|||||||++|+|++|+.||....+
T Consensus 167 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~ 238 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238 (291)
T ss_pred EEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence 999999998765433221 1334678899999987543 367899999999999999999999976543
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=266.91 Aligned_cols=212 Identities=26% Similarity=0.400 Sum_probs=175.2
Q ss_pred hCCCCCCceecccCceEEEEEEECC-----------------CCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRS-----------------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVE 125 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~ 125 (301)
.++|++.+.||+|+||.||+|.+.. +..||+|.+...... ...+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4689999999999999999998652 245899998755432 356888999999999999999
Q ss_pred eeeEEEcCCeeEEEEecCCCCCHHHHhcCCCCCCCC--CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCc
Q 022206 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGA--KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSN 203 (301)
Q Consensus 126 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~N 203 (301)
+++++..++..+++||++.+++|.+++......... .....+++..++.++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 999999999999999999999999999765421111 11123889999999999999999999999 9999999999
Q ss_pred eEEcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh--CCCCCCCCC
Q 022206 204 VLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT--GRKPVDHTL 279 (301)
Q Consensus 204 ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~--g~~pf~~~~ 279 (301)
|++++++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 9999999999999999876544332222234456788999999988889999999999999999998 788987654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=260.86 Aligned_cols=201 Identities=28% Similarity=0.417 Sum_probs=171.5
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEc-CCeeEEEEe
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVD-GPLRVLAYE 141 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 141 (301)
+|++.+.||+|++|.||++.++ +++.+++|.+..... ..+.+.+|++++++++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5889999999999999999977 688999999865432 23467889999999999999999988764 446899999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+++++|.+++..... ..+++.+++.++.|++.+|.+||+.+ ++||||+|+||+++.++.++|+|||++.
T Consensus 81 ~~~~~~l~~~l~~~~~-------~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~ 150 (257)
T cd08223 81 FCEGGDLYHKLKEQKG-------KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR 150 (257)
T ss_pred ccCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceE
Confidence 9999999999875332 23789999999999999999999999 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
....... ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+
T Consensus 151 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 151 VLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred EecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 6533221 1234468899999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=265.46 Aligned_cols=204 Identities=23% Similarity=0.369 Sum_probs=174.2
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
++|++.+.||+|+||.||++.+. +++.+++|.+..... ....+.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57889999999999999999975 799999998764322 2346788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~ 153 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQ-----KRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EecCCCCHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhh
Confidence 999999999988642211 123889999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 154 RFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred hccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 765432211 123468889999999988889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=260.90 Aligned_cols=202 Identities=24% Similarity=0.409 Sum_probs=175.3
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
+|+..+.||.|+||.||.++.. ++..+++|.+.... .....+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5889999999999999999976 68999999876432 2335688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++++|.+++..... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~ 150 (256)
T cd08221 81 ANGGTLYDKIVRQKG-------QLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKI 150 (256)
T ss_pred cCCCcHHHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEE
Confidence 999999999976532 23788999999999999999999999 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
...... ......+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.
T Consensus 151 ~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~ 206 (256)
T cd08221 151 LGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206 (256)
T ss_pred cccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH
Confidence 543321 12345689999999999888889999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=263.76 Aligned_cols=207 Identities=26% Similarity=0.372 Sum_probs=166.3
Q ss_pred CCCCceecccCceEEEEEEECC-CC--EEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcC------Ce
Q 022206 68 FGTNSLIGEGSYGRVYFGVLRS-GR--AAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG------PL 135 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 135 (301)
|.+.+.||+|+||.||+|.+.. +. .+|+|.++..... ...+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567899999999999999763 33 6899988754322 35678899999999999999999986432 24
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
.+++|||+.+|+|.+++....... ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 154 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGD---CPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVA 154 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccC---CcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEEC
Confidence 689999999999999874322111 0123789999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |+.||....+
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 220 (272)
T cd05075 155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN 220 (272)
T ss_pred CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999887644322111123345778999999998899999999999999999999 8999976544
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=268.32 Aligned_cols=206 Identities=25% Similarity=0.420 Sum_probs=173.6
Q ss_pred hhCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhcc-CCCceeeeeeEEEcCC
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 134 (301)
..++|.+.+.||+|+||.||++.+. ++..+|+|.+...... .+.+.+|+.+++++ +|+||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3457999999999999999999742 3558999988754332 35688899999999 7999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
..+++|||+.+++|.+++...... .+++.++..++.|++.||+|||+++ ++|+||||+|||+++++.++|
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l 182 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRES-------FLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKI 182 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEE
Confidence 999999999999999999754321 2789999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTL 279 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~ 279 (301)
+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+..
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence 99999876543322111123345788999999988889999999999999999998 999997644
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=267.22 Aligned_cols=213 Identities=26% Similarity=0.391 Sum_probs=172.8
Q ss_pred hCCCCCCceecccCceEEEEEEECC---------------CCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRS---------------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELV 127 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~ 127 (301)
..+|++.+.||+|+||.||++++.. ...||+|.+...... ...+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3589999999999999999998642 235899998754322 34688999999999999999999
Q ss_pred eEEEcCCeeEEEEecCCCCCHHHHhcCCCCCC---CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCce
Q 022206 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVK---GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204 (301)
Q Consensus 128 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Ni 204 (301)
+++...+..+++|||+.+++|.+++....... .......+++..++.++.|++.||+|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999986532111 1111223678889999999999999999999 99999999999
Q ss_pred EEcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh--CCCCCCCCCC
Q 022206 205 LLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT--GRKPVDHTLP 280 (301)
Q Consensus 205 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~--g~~pf~~~~~ 280 (301)
++++++.+||+|||++................+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+.
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 999999999999999876543322211233345778999999988889999999999999999988 7788876543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=262.22 Aligned_cols=202 Identities=24% Similarity=0.354 Sum_probs=163.8
Q ss_pred ceecccCceEEEEEEEC---CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCC
Q 022206 72 SLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 146 (301)
+.||+|+||.||+|... ++..+++|.+...... ...+.+|+.++++++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999864 3567999988654432 246788999999999999999999999989999999999999
Q ss_pred CHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCcc
Q 022206 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (301)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (301)
+|.+++....... ....+...+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 81 DLKGYLRSCRKAE----LMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred cHHHHHHHhhhcc----cccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCc
Confidence 9999997543211 112566777889999999999999999 999999999999999999999999998654433
Q ss_pred ccccccccccccccccCccccccC-------CCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 227 AARLHSTRVLGTFGYHAPEYAMTG-------QMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
..........+++.|+|||++.+. .++.++|+||||+++|+|++ |..||....+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 215 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD 215 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh
Confidence 222222344578889999988642 35789999999999999996 9999976543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=268.33 Aligned_cols=214 Identities=26% Similarity=0.427 Sum_probs=175.2
Q ss_pred hhCCCCCCceecccCceEEEEEEEC--------CCCEEEEEEcCCCC--CchHHHHHHHHHHhcc-CCCceeeeeeEEEc
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRL-KNENVVELVGYYVD 132 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 132 (301)
...+|.+.+.||+|+||.||+|++. ++..+++|.+.... .....+.+|+.+++.+ +|+||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3568899999999999999999742 24579999886532 2235688999999999 89999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHhcCCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceE
Q 022206 133 GPLRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (301)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nil 205 (301)
....+++|||+.+++|.+++........ ..+...+++..++.++.|++.||.|||+.| ++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 9999999999999999999976432110 011234788889999999999999999999 999999999999
Q ss_pred EcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 206 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
+++++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 99999999999999876644332222233345678999999988889999999999999999998 8899976543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=266.71 Aligned_cols=214 Identities=27% Similarity=0.420 Sum_probs=175.2
Q ss_pred hhCCCCCCceecccCceEEEEEEECC------CCEEEEEEcCCCCCc--hHHHHHHHHHHhcc-CCCceeeeeeEEEcCC
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLRS------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 134 (301)
..++|++.+.||+|+||.||++.+.. ...+|+|.+...... ...+.+|+.+++++ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 44679999999999999999998642 367999998754332 24578899999999 7999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEc
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 207 (301)
..+++|||+.+++|.+++....... .......+++..++.++.|++.||.|||+.+ ++||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 9999999999999999997532110 0012335889999999999999999999999 99999999999999
Q ss_pred CCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 208 DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 208 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
+++.+||+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.+...
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 999999999999987654322211122335678999999988889999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=285.39 Aligned_cols=193 Identities=30% Similarity=0.472 Sum_probs=168.3
Q ss_pred eecccCceEEEEEEEC-CCCEEEEEEcCC-CCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCCCHHH
Q 022206 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDS-SKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD 150 (301)
Q Consensus 73 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~ 150 (301)
+||+|.||+||-|++. +....|||.+.. .....+-+..|+.+.++|+|.|||+++|.+.+++.+-|.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999987 678899999863 33444568889999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCCCCCC--CHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC-CCceEEeccccCCCCCccc
Q 022206 151 ILHGKKGVKGAKPGPVL--SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAA 227 (301)
Q Consensus 151 ~l~~~~~~~~~~~~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a~~~~~~~ 227 (301)
+++..=+. + .+...-.+..||++||.|||++. |||||||-+|+||+. .|.+||+|||.++.+-...
T Consensus 662 LLrskWGP--------lKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin 730 (1226)
T KOG4279|consen 662 LLRSKWGP--------LKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN 730 (1226)
T ss_pred HHHhccCC--------CccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC
Confidence 99764321 3 56778889999999999999998 999999999999975 7899999999998875544
Q ss_pred cccccccccccccccCcccccc--CCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 228 ARLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
.. +.++.||+.|||||++.. ..|+.++|||||||++.||.||++||-..
T Consensus 731 P~--TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El 781 (1226)
T KOG4279|consen 731 PC--TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL 781 (1226)
T ss_pred cc--ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec
Confidence 32 367789999999999875 47899999999999999999999999653
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=259.98 Aligned_cols=206 Identities=33% Similarity=0.480 Sum_probs=174.0
Q ss_pred ceecccCceEEEEEEEC-C---CCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 72 SLIGEGSYGRVYFGVLR-S---GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
+.||+|+||.||+|... . +..+++|.+...... ...+.+|+++++.++|+||+++++++.+....+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46999999999999976 3 889999999765544 46788999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
++|.+++..............+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999987521100011123899999999999999999999999 99999999999999999999999999987655
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
...........+++.|+|||.+....++.++||||||+++|+|++ |..||.+..+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 213 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH
Confidence 432122234457889999999988889999999999999999999 6999987644
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=266.99 Aligned_cols=209 Identities=29% Similarity=0.430 Sum_probs=169.8
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCC--EEEEEEcCCCCC--chHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGR--AAAIKKLDSSKQ--PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 139 (301)
++|++.+.||+|+||.||+|..+ ++. .+++|.++.... ....+.+|++++.++ +||||+++++++.+.+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57999999999999999999976 333 478888764222 235688899999999 799999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCce
Q 022206 140 YEHASKGSLHDILHGKKGVKGA-------KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~-------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (301)
+||+++++|.+++......... .....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 9999999999999754321110 01124888999999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
||+|||++......... .....+..|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 159 kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~ 224 (297)
T cd05089 159 KIADFGLSRGEEVYVKK---TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224 (297)
T ss_pred EECCcCCCccccceecc---CCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999998643221111 11223557999999988889999999999999999997 9999976554
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=265.41 Aligned_cols=201 Identities=23% Similarity=0.360 Sum_probs=168.6
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
.++|.+.+.||+|+||.||+|... +++.|++|.+...... ...+.+|+.+++.++|+||+++++++.++...++++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 478999999999999999999976 7899999998654322 2457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+. ++|.+++..... .+.+..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 151 (291)
T cd07870 84 YMH-TDLAQYMIQHPG--------GLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR 151 (291)
T ss_pred ccc-CCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccc
Confidence 996 577777654321 1677888899999999999999999 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
........ .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||.+..
T Consensus 152 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 152 AKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred ccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 54332111 1234578899999988754 57889999999999999999999997654
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=265.77 Aligned_cols=213 Identities=23% Similarity=0.406 Sum_probs=174.1
Q ss_pred hCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
..+|...+.||+|+||.||++... ++..+++|.+..... ....+.+|+++++.++|+||+++++++.+.+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 457888999999999999999742 356889998764332 2356889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhcCCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc
Q 022206 138 LAYEHASKGSLHDILHGKKGVK------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (301)
++|||+.+++|.+++....... .......+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 9999999999999997543210 0111234788999999999999999999999 999999999999999999
Q ss_pred eEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |.+||.....
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 230 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence 99999999865533222111123345788999999998899999999999999999998 9999966543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=260.61 Aligned_cols=202 Identities=26% Similarity=0.491 Sum_probs=174.8
Q ss_pred CCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
.+|++.+.||+|+||.||++.+.++..+++|.+.........+.+|++++++++|+|++++++++......++++||+.+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 46888999999999999999987788999999887666667899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
++|.+++..... .+++..++.++.|++.+|++||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 84 GCLSDYLRAQRG--------KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 999999875432 2788899999999999999999999 99999999999999999999999999865533
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTL 279 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~ 279 (301)
.... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||....
T Consensus 153 ~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 206 (256)
T cd05112 153 DQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206 (256)
T ss_pred Cccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 2211 1112235678999999988889999999999999999998 999997554
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=263.92 Aligned_cols=200 Identities=29% Similarity=0.460 Sum_probs=174.3
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
..|+..+.||+|+||.||+|.+. ++..+|+|.+..... ....+.+|+.+++++.|+||+++++.+.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 46788899999999999999976 688999999875432 235688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++++|.+++.... +++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 84 ~~~~~L~~~i~~~~----------l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~ 150 (277)
T cd06640 84 LGGGSALDLLRAGP----------FDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred CCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEccccccee
Confidence 99999999987543 788889999999999999999999 99999999999999999999999999866
Q ss_pred CCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
...... ......++..|+|||++.+..++.++|+||||+++|+|++|..||...++
T Consensus 151 ~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 206 (277)
T cd06640 151 LTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP 206 (277)
T ss_pred ccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh
Confidence 543221 11334578899999999888899999999999999999999999976554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=276.94 Aligned_cols=212 Identities=28% Similarity=0.453 Sum_probs=173.7
Q ss_pred hCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccC-CCceeeeeeEEEcCCe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK-NENVVELVGYYVDGPL 135 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 135 (301)
.++|.+.+.||+|+||.||+|++. ++..||+|++...... .+.+.+|+.++.++. |+||+++++++...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 457888999999999999999853 3468999999754332 246888999999997 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCC--------------------------------------------------------
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVK-------------------------------------------------------- 159 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~-------------------------------------------------------- 159 (301)
.++||||+.+|+|.+++.......
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999997543200
Q ss_pred ---------------------------------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEE
Q 022206 160 ---------------------------------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (301)
Q Consensus 160 ---------------------------------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill 206 (301)
.......+++..++.++.|++.||+|||+.+ ++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 0011234778888999999999999999998 9999999999999
Q ss_pred cCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCC
Q 022206 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTL 279 (301)
Q Consensus 207 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~ 279 (301)
++++.+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999876432221111123456788999999988889999999999999999998 899997643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=260.07 Aligned_cols=199 Identities=32% Similarity=0.517 Sum_probs=169.9
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEE-cCCeeEEEEecC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV-DGPLRVLAYEHA 143 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~ 143 (301)
.++|++.+.||+|+||.||++... +..+++|.+.... ..+.+.+|+.++++++|+|++++++++. +++..++++||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 457999999999999999999876 7889999886543 3456889999999999999999999754 556789999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
++++|.+++..... ..+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||++...
T Consensus 83 ~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 83 AKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152 (256)
T ss_pred CCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceec
Confidence 99999999875432 12788999999999999999999999 999999999999999999999999998654
Q ss_pred CccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
.... ....++..|+|||++.+..++.++||||||+++|+|++ |+.||.....
T Consensus 153 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~ 205 (256)
T cd05082 153 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205 (256)
T ss_pred cccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 3321 22334668999999988889999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=263.88 Aligned_cols=204 Identities=28% Similarity=0.464 Sum_probs=170.4
Q ss_pred CCCCCCceecccCceEEEEEEEC-CC---CEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SG---RAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
.+|++.+.||+|+||.||+|.++ ++ ..|++|.+..... ....+..|+.+++.++||||+++++++.++...+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 46888999999999999999976 33 3699999875432 235788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+++++|.+++..... .+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 84 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~ 152 (269)
T cd05065 84 TEFMENGALDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGL 152 (269)
T ss_pred EecCCCCcHHHHHhhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcc
Confidence 999999999999875432 2788999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccc-ccc--ccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 220 SNQAPDAAARLHST-RVL--GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~~~-~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
+............. ... .+..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~ 217 (269)
T cd05065 153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217 (269)
T ss_pred ccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH
Confidence 87654322211111 111 2457999999988899999999999999999886 9999976554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=267.43 Aligned_cols=213 Identities=26% Similarity=0.427 Sum_probs=173.2
Q ss_pred hCCCCCCceecccCceEEEEEEEC--------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhcc-CCCceeeeeeEEEcC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 133 (301)
.++|.+.+.||+|+||.||+|++. ....+|+|.+...... ...+.+|+.+++++ +|+||+++++++.++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 367889999999999999999752 2457999988754332 24577899999999 699999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhcCCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEE
Q 022206 134 PLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (301)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill 206 (301)
+..+++|||+++|+|.+++....... .......+++..+..++.|++.||.|||++| ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999997643210 0111234888999999999999999999999 9999999999999
Q ss_pred cCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 207 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
++++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999976643322111122234567999999988889999999999999999999 9999976544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=266.53 Aligned_cols=196 Identities=21% Similarity=0.363 Sum_probs=166.4
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
+|++.+.||+|+||.||+|+++ +|..+++|.+...... ...+.+|+.+++.++|+||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5888999999999999999987 7899999998653222 24577899999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+.+ +|.+++..... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 81 ~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 148 (284)
T cd07839 81 CDQ-DLKKYFDSCNG--------DIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARA 148 (284)
T ss_pred CCC-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhc
Confidence 975 88887764321 2889999999999999999999999 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVD 276 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~ 276 (301)
....... .....+++.|+|||++.+. .++.++|||||||++|+|++|..||.
T Consensus 149 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 149 FGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred cCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 5432211 1234578899999988764 46899999999999999999988864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=263.21 Aligned_cols=205 Identities=28% Similarity=0.438 Sum_probs=172.3
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCC----EEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
..+|++.+.||+|+||.||+|.++ ++. .+++|.+...... ...+.+|+.++++++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 467899999999999999999965 333 5899988765432 3568889999999999999999999887 7889
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+++||+.+|+|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~df 153 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD--------NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDF 153 (279)
T ss_pred EEEecCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCC
Confidence 99999999999999976432 2789999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCc
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~ 281 (301)
|++................++..|+|||.+....++.++|+||||+++|+|++ |..||.+....
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 218 (279)
T cd05057 154 GLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV 218 (279)
T ss_pred cccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 99977653322211122224678999999988889999999999999999998 99999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=259.50 Aligned_cols=200 Identities=34% Similarity=0.565 Sum_probs=175.3
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
.++|++.+.||+|+||.||+|... ++.|++|.+.........+.+|+.+++.++|+||+++++++.+....+++|||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 468999999999999999999876 7899999997665555678999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
+++|.+++...... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 84 KGSLVDYLRSRGRA-------VITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence 99999999754421 2889999999999999999999999 9999999999999999999999999987763
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
... .....+..|+|||.+....++.++|+||||+++|+|++ |..||.....
T Consensus 154 ~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 205 (256)
T cd05039 154 QGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205 (256)
T ss_pred ccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 322 12234667999999988888999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=266.13 Aligned_cols=200 Identities=29% Similarity=0.452 Sum_probs=173.2
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
+.|+..+.||+|+||.||+|.+. ++..||+|.+..... ....+.+|+.++++++|+||+++++.+..+...++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 35677788999999999999976 688999999875432 235688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++++|.+++.... +++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 84 ~~~~~L~~~~~~~~----------~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06642 84 LGGGSALDLLKPGP----------LEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred cCCCcHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEcccccccc
Confidence 99999999986532 788999999999999999999999 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
....... .....++..|+|||++.+..++.++|+||||+++|+|++|+.||....+
T Consensus 151 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 206 (277)
T cd06642 151 LTDTQIK--RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP 206 (277)
T ss_pred ccCcchh--hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch
Confidence 5432211 1334678899999999988899999999999999999999999976543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=262.05 Aligned_cols=204 Identities=26% Similarity=0.448 Sum_probs=171.9
Q ss_pred CCCCCCceecccCceEEEEEEEC-C---CCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-S---GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
.+|++.+.||+|+||.||+|.+. + +..+|+|.+...... ...+.+|+.++++++||||+++++++.+++..+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57889999999999999999865 2 337999998654332 35688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 84 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~ 152 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG--------QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGL 152 (267)
T ss_pred EEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCc
Confidence 999999999999975432 2788999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccc-cccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 220 SNQAPDAAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
+........... .....++..|+|||++.+..++.++|+||||+++|++++ |..||.+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~ 215 (267)
T cd05066 153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215 (267)
T ss_pred ccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH
Confidence 876644322111 112223568999999988889999999999999999886 9999977654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=241.61 Aligned_cols=207 Identities=22% Similarity=0.351 Sum_probs=177.3
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
+|.-.++||+|.||+||+|+.+ +++.||+|.+..+... .....+|+-+++.++|.|||+++++...+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 5666789999999999999976 7899999998755433 35688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
|.. +|..+.....+. +....+..++.|+++||.++|+++ +.||||||+|+||+.+|.+||+|||+++.
T Consensus 83 cdq-dlkkyfdslng~--------~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglara 150 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGD--------LDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARA 150 (292)
T ss_pred hhH-HHHHHHHhcCCc--------CCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhh
Confidence 976 899998765542 888999999999999999999999 99999999999999999999999999987
Q ss_pred CCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHh-CCCCCCCCCCcCccccc
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLV 287 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~ 287 (301)
..-..... +..+.|..|.+|+++.+. -|+...|+||.|||+.|+.. |++.|.+.+-.+|--.|
T Consensus 151 fgipvrcy--saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkri 215 (292)
T KOG0662|consen 151 FGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215 (292)
T ss_pred cCCceEee--eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHH
Confidence 76544332 334579999999998875 57889999999999999997 89999876654443333
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=257.69 Aligned_cols=197 Identities=30% Similarity=0.478 Sum_probs=167.5
Q ss_pred ceecccCceEEEEEEECCCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCCCHH
Q 022206 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLH 149 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~ 149 (301)
++||+|+||.||+|...++..+|+|.+...... ...+.+|+.+++.++|+||+++++++...+..+++|||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 369999999999999888899999998754433 245788999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCccccc
Q 022206 150 DILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229 (301)
Q Consensus 150 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 229 (301)
+++..... .+.+..++.++.|++.+|.|||+.+ ++||||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 81 SFLRKKKD--------ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred HHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc
Confidence 99865432 2788999999999999999999999 999999999999999999999999998654332111
Q ss_pred cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
......+++.|+|||++....++.++||||||+++|+|++ |..||.+...
T Consensus 150 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~ 200 (250)
T cd05085 150 -SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN 200 (250)
T ss_pred -cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 1112234677999999988889999999999999999998 9999976544
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=265.37 Aligned_cols=201 Identities=26% Similarity=0.448 Sum_probs=175.5
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
.++|.+.+.||+|+||.||++... ++..+++|.+..... ..+.+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 478999999999999999999976 688999999864332 345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++++|.+++.... +++..+..++.|++.||.|||+++ ++|+||+|+||++++++.++|+|||++..
T Consensus 98 ~~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~ 164 (293)
T cd06647 98 LAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (293)
T ss_pred CCCCcHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceec
Confidence 99999999997543 788889999999999999999999 99999999999999999999999998865
Q ss_pred CCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
....... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...++
T Consensus 165 ~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~ 220 (293)
T cd06647 165 ITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (293)
T ss_pred ccccccc--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 5433221 1334688899999999888889999999999999999999999976554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=265.57 Aligned_cols=200 Identities=27% Similarity=0.394 Sum_probs=174.3
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
.++|++.+.||+|+||+||++.+. ++..+|+|++..... ....+.+|+++++.++|+||+++++.+.+....++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 467899999999999999999976 688999998764432 34678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
|+++++|.+++.... .+++..+..++.+++.+|.|||+ .+ ++||||+|+||++++++.++|+|||++
T Consensus 84 ~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~ 151 (284)
T cd06620 84 FMDCGSLDRIYKKGG---------PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVS 151 (284)
T ss_pred cCCCCCHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcc
Confidence 999999999987543 27889999999999999999997 57 999999999999999999999999997
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
....... .....|+..|+|||++.+..++.++|+|||||++|+|++|..||....+
T Consensus 152 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 152 GELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred cchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 6543221 1334689999999999888899999999999999999999999986544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=259.96 Aligned_cols=202 Identities=24% Similarity=0.372 Sum_probs=170.9
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC------CchHHHHHHHHHHhccCCCceeeeeeEEEcC--Cee
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK------QPDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLR 136 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 136 (301)
.+|++.+.||+|+||.||+|.+. ++..+++|.+.... .....+.+|+.++++++|+||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999976 68999999875321 1224678899999999999999999998754 468
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
++++||+++++|.+++..... +++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~---------l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~d 149 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA---------LTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGD 149 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECc
Confidence 899999999999999875432 778889999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 217 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
||++......... .......++..|+|||++.+..++.++|+||||+++|+|++|+.||.+..
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 213 (264)
T cd06653 150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE 213 (264)
T ss_pred cccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC
Confidence 9998765321110 11123458899999999988888999999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=267.76 Aligned_cols=200 Identities=29% Similarity=0.495 Sum_probs=171.4
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
+.|.....||+|+||.||++... ++..||||.+..... ....+.+|+.+++.++|+||+++++.+..++..+++|||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 34445567999999999999976 689999999865332 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
++++|.+++.... +++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++...
T Consensus 102 ~~~~L~~~~~~~~----------l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 102 EGGALTDIVTHTR----------MNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168 (292)
T ss_pred CCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence 9999999886432 788999999999999999999999 999999999999999999999999998654
Q ss_pred CccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....+
T Consensus 169 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 223 (292)
T cd06658 169 SKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP 223 (292)
T ss_pred cccccc--CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 322211 1334688999999999888899999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=260.52 Aligned_cols=202 Identities=23% Similarity=0.397 Sum_probs=172.5
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-------chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
+|+..+.||+|++|.||++... +++.+|+|++..... ....+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 5888899999999999999975 789999999864331 12567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC-ceEEecc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDF 217 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Df 217 (301)
++||+.+++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+||
T Consensus 81 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~df 148 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---------AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADF 148 (268)
T ss_pred EEeccCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccc
Confidence 999999999999997543 2788999999999999999999999 99999999999998765 6999999
Q ss_pred ccCCCCCcccccc--ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 218 DLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 218 g~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|++.......... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 213 (268)
T cd06630 149 GAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH 213 (268)
T ss_pred ccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 9987664432110 11234578899999999888899999999999999999999999975443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=260.21 Aligned_cols=195 Identities=30% Similarity=0.460 Sum_probs=163.2
Q ss_pred eecccCceEEEEEEEC---CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCC
Q 022206 73 LIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (301)
Q Consensus 73 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 146 (301)
.||+|+||.||+|.++ ++..+|+|++...... .+.+.+|+.+++.+.|+||+++++++. .+..+++|||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 5788999998654332 356888999999999999999999875 45678999999999
Q ss_pred CHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCcc
Q 022206 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (301)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (301)
+|.+++.... .+++..+..++.|++.||+|||+++ ++||||||.||++++++.+||+|||++......
T Consensus 81 ~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQKNK---------HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 9999996543 2788999999999999999999999 999999999999999999999999998766433
Q ss_pred ccccc-cccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 227 AARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 227 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
..... .....+++.|+|||.+....++.++|+||||+++|+|++ |..||.+...
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 204 (257)
T cd05116 149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG 204 (257)
T ss_pred CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 22111 122234678999999988888999999999999999998 9999976544
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=262.86 Aligned_cols=212 Identities=26% Similarity=0.401 Sum_probs=175.0
Q ss_pred hCCCCCCceecccCceEEEEEEECC-----CCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEc-CCee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRS-----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVD-GPLR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 136 (301)
.++|++.+.||+|+||.||+|.+.. +..|++|.+...... ...+.+|+.+++.++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4689999999999999999999764 688999988644322 3567889999999999999999998765 5678
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
++++||+.+++|.+++....... ...+..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGE-ANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccc-cccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999997543211 111234889999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
||+++...............++..|+|||++.+..++.++||||||+++|++++ |+.||.+..+
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 225 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP 225 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH
Confidence 999976543322211223345778999999988889999999999999999999 9999976544
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=259.17 Aligned_cols=200 Identities=28% Similarity=0.404 Sum_probs=177.1
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
.+|++.+.||+|++|.||+|.+. +++.+++|.+..... ....+.+|+..+.+++|+||+++++++......++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36889999999999999999987 699999999876543 346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
+++++|.+++.... .+++..++.++.|++.+|+|||+ .+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~ 148 (264)
T cd06623 81 MDGGSLADLLKKVG---------KIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISK 148 (264)
T ss_pred cCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccce
Confidence 99999999997642 28899999999999999999999 98 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
........ .....++..|+|||.+....++.++|+||||+++|+|++|..||....
T Consensus 149 ~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 149 VLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred ecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 66443322 123457889999999988889999999999999999999999997765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=258.21 Aligned_cols=196 Identities=30% Similarity=0.478 Sum_probs=162.4
Q ss_pred eecccCceEEEEEEEC---CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCCC
Q 022206 73 LIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGS 147 (301)
Q Consensus 73 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gs 147 (301)
.||+|+||.||+|.++ .+..||+|++...... .+.+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 3557999998654332 356889999999999999999999875 457899999999999
Q ss_pred HHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCccc
Q 022206 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227 (301)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~ 227 (301)
|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 149 (257)
T cd05115 81 LNKFLSGKKD--------EITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149 (257)
T ss_pred HHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCc
Confidence 9999875332 2889999999999999999999999 9999999999999999999999999987554332
Q ss_pred cccc-cccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 228 ARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 228 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
.... .....+++.|+|||++....++.++||||||+++|+|++ |..||.+..+
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 204 (257)
T cd05115 150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG 204 (257)
T ss_pred cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 2111 111223578999999988889999999999999999996 9999976554
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=259.25 Aligned_cols=206 Identities=32% Similarity=0.428 Sum_probs=176.1
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
++|++.+.||.|+||.||+|... ++..+++|++..... ....+.+|++.++.++|+||+++++.+......++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47999999999999999999976 688999999865433 346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++++|.+++..... ...+++..+..++.|++.||++||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~ 151 (267)
T cd06610 81 LSGGSLLDIMKSSYP------RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSAS 151 (267)
T ss_pred cCCCcHHHHHHHhcc------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHH
Confidence 999999999975421 012788999999999999999999999 99999999999999999999999999876
Q ss_pred CCcccccc--ccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 223 APDAAARL--HSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 223 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
........ ......++..|+|||++... .++.++|+||||+++|+|++|+.||...++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~ 212 (267)
T cd06610 152 LADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212 (267)
T ss_pred hccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh
Confidence 55432211 11334688999999988776 788999999999999999999999976543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=269.83 Aligned_cols=212 Identities=25% Similarity=0.415 Sum_probs=170.3
Q ss_pred hCCCCCCceecccCceEEEEEEE------CCCCEEEEEEcCCCCCc--hHHHHHHHHHHhcc-CCCceeeeeeEEEc-CC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVD-GP 134 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~ 134 (301)
.++|++.+.||+|+||.||+|.+ .+++.||||.+...... ...+.+|+.++.++ +|+||+++++++.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46899999999999999999974 24688999998754322 34578899999999 68999999998764 45
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCC-----------------------------------------------------
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGA----------------------------------------------------- 161 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~----------------------------------------------------- 161 (301)
..+++|||+++|+|.+++.........
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999998653210000
Q ss_pred -----CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCcccccccccccc
Q 022206 162 -----KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236 (301)
Q Consensus 162 -----~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~ 236 (301)
.....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 00123678888999999999999999999 9999999999999999999999999987653322211122334
Q ss_pred ccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCC
Q 022206 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTL 279 (301)
Q Consensus 237 gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~ 279 (301)
+++.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 5678999999988899999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=265.01 Aligned_cols=200 Identities=27% Similarity=0.418 Sum_probs=170.6
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc------hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
+|++.+.||+|++|.||+|.+. +++.|++|.+...... ...+..|+++++.++|+||+++++++.+++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4888899999999999999976 6899999998754332 34567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+ +++|.+++..... .+++..++.++.|+++||.|||+++ ++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~e~~-~~~L~~~i~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~ 148 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSI--------VLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGL 148 (298)
T ss_pred Eccc-CCCHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEcccee
Confidence 9999 8899999976431 2889999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+......... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+..+
T Consensus 149 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~ 208 (298)
T cd07841 149 ARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD 208 (298)
T ss_pred eeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc
Confidence 8766443211 123346788999998855 4578899999999999999999888876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=269.13 Aligned_cols=215 Identities=27% Similarity=0.417 Sum_probs=174.3
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC--------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhcc-CCCceeeeeeEEE
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYV 131 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 131 (301)
....+|++.+.||+|+||.||+|.+. ....+|+|.+...... ...+.+|+++++++ +|+||+++++++.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 34457999999999999999999853 1236899988754322 35688999999999 7999999999999
Q ss_pred cCCeeEEEEecCCCCCHHHHhcCCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCce
Q 022206 132 DGPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204 (301)
Q Consensus 132 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Ni 204 (301)
.++..++++||+++|+|.+++....... ...++..+++..++.++.|++.||.|||+.+ ++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceE
Confidence 9999999999999999999997543110 0112334788899999999999999999999 99999999999
Q ss_pred EEcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 205 LLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 205 ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
|++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999876543322211122234567999999999899999999999999999998 8999976543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=266.91 Aligned_cols=199 Identities=29% Similarity=0.445 Sum_probs=171.4
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC-CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
..|.....||+|+||.||++.+. +++.||+|.+.... .....+.+|+.+++.++||||+++++.+..++..++++||+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 34455567999999999999976 78999999986433 23456888999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
++++|.+++.... +++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++...
T Consensus 101 ~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 101 QGGALTDIVSQTR----------LNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred CCCCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 9999999886532 788999999999999999999999 999999999999999999999999998654
Q ss_pred CccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
...... .....+++.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 168 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 168 SKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred cccccc--ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 332211 133568899999999988889999999999999999999999997554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=260.52 Aligned_cols=200 Identities=28% Similarity=0.465 Sum_probs=169.9
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc-----------hHHHHHHHHHHhccCCCceeeeeeEEEcCC
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-----------DQEFLAQVSMVSRLKNENVVELVGYYVDGP 134 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 134 (301)
+|.+.+.||+|+||.||+|... +++.+|+|.+...... .+.+.+|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5788899999999999999976 6899999987532111 134678999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
..++||||+++++|.+++.... .++...+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l 149 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---------RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKI 149 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEE
Confidence 9999999999999999997653 2788889999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccccccccccccccccccCccccccCC--CCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
+|||++................++..|+|||.+.... ++.++|+||||+++|+|++|..||...
T Consensus 150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 215 (272)
T cd06629 150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215 (272)
T ss_pred eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc
Confidence 9999987654322211123446789999999887654 788999999999999999999999653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=259.35 Aligned_cols=208 Identities=26% Similarity=0.394 Sum_probs=175.2
Q ss_pred hCCCCCCceecccCceEEEEEEEC---C--CCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEc-CCe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR---S--GRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD-GPL 135 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 135 (301)
...|+++..||+|.||.||+|..+ + ...+|+|.++.++.. .....+|+.+++.++|+|++.+..++.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 457999999999999999999644 2 237999999765433 2567899999999999999999999877 788
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC----Cc
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD----DI 211 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~----~~ 211 (301)
.++++||.+. +|.++++.+..... ..++...+..|+.||+.|+.|||++- |+||||||.||||..+ |.
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~----~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKA----KQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchh----ccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCe
Confidence 9999999987 99999976554332 24888999999999999999999998 9999999999999877 89
Q ss_pred eEEeccccCCCCCcccccc-ccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 212 AKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|||+|||+++.....-... .....+.|..|.|||++.+. .|+.+.||||+|||+.||+|-.+-|.+.+.
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~ 245 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE 245 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence 9999999998876543322 33556789999999998874 689999999999999999999999976543
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=261.96 Aligned_cols=206 Identities=30% Similarity=0.491 Sum_probs=173.7
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhcc-CCCceeeeeeEEEcCC------e
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGP------L 135 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~------~ 135 (301)
..++|++.+.||+|++|.||+|.++ +++.+++|++.........+.+|+.+++++ .|+||+++++++.+.. .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 4578999999999999999999986 688999999987666667789999999998 6999999999987544 4
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
.+++|||+++++|.+++...... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~ 155 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKK-----GKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLV 155 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEEC
Confidence 89999999999999998653211 112889999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCcccccc-----CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|||++......... .....+++.|+|||++.. ..++.++||||||+++|+|++|+.||....
T Consensus 156 d~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 222 (275)
T cd06608 156 DFGVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH 222 (275)
T ss_pred CCccceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc
Confidence 99998665432221 133468899999998753 346788999999999999999999997543
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=260.68 Aligned_cols=211 Identities=26% Similarity=0.415 Sum_probs=175.1
Q ss_pred CCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
++|++.+.||+|+||.||+|+.+ +...+++|.+...... ...+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 67899999999999999999964 2467999988654433 356889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
++|||+++++|.+++..............+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999976542221112224899999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
|++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+...
T Consensus 162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~ 224 (275)
T cd05046 162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224 (275)
T ss_pred ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch
Confidence 998654322211 1123356778999999988888999999999999999998 8899976443
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=263.40 Aligned_cols=212 Identities=25% Similarity=0.404 Sum_probs=174.1
Q ss_pred hCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 136 (301)
.++|++.+.||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+.++++++|+||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467999999999999999999863 4678999998754332 35688899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCc
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGA-------------KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSN 203 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~-------------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~N 203 (301)
++++||+++++|.+++......... .....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 9999999999999999754321110 11134788889999999999999999999 9999999999
Q ss_pred eEEcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCC
Q 022206 204 VLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTL 279 (301)
Q Consensus 204 ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~ 279 (301)
|++++++.++|+|||++.................++.|+|||.+.+..++.++|||||||++|+|++ |..||.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999875543222111122334677999999988899999999999999999997 889997654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=276.00 Aligned_cols=212 Identities=24% Similarity=0.318 Sum_probs=177.5
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
|..++.||-|+||+|-++.-. +...||.|.+.+...- ......|-.||....++-||++|-.|++.+.+|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 556788999999999999844 6778999998653322 23466788889989999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
++||++-.+|-+.. ++.+..+..++.++..|+++.|..| +|||||||+|||||.+|++||+||||+.-
T Consensus 711 IPGGDmMSLLIrmg---------IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMG---------IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred cCCccHHHHHHHhc---------cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccc
Confidence 99999999997765 3889999999999999999999999 99999999999999999999999999853
Q ss_pred CCccc---------c-------------------------------ccccccccccccccCccccccCCCCccccchhhH
Q 022206 223 APDAA---------A-------------------------------RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFG 262 (301)
Q Consensus 223 ~~~~~---------~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG 262 (301)
..... . +......+||+.|+|||++....|+...|+||.|
T Consensus 779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~g 858 (1034)
T KOG0608|consen 779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVG 858 (1034)
T ss_pred ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhh
Confidence 21100 0 0001235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCcCcc-ccccccc
Q 022206 263 VVLLELLTGRKPVDHTLPRGQQ-SLVTWVL 291 (301)
Q Consensus 263 ~il~~l~~g~~pf~~~~~~~~~-~~~~~~~ 291 (301)
||||||+.|++||-+++|.+.. ..+.|..
T Consensus 859 vil~em~~g~~pf~~~tp~~tq~kv~nw~~ 888 (1034)
T KOG0608|consen 859 VILYEMLVGQPPFLADTPGETQYKVINWRN 888 (1034)
T ss_pred HHHHHHhhCCCCccCCCCCcceeeeeehhh
Confidence 9999999999999999886544 4446643
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=261.51 Aligned_cols=200 Identities=30% Similarity=0.405 Sum_probs=165.7
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHH-HhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSM-VSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
++|++.+.||+|+||.||++.++ +++.||+|++...... ...+..|+.. ++.++|+||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47899999999999999999987 7999999998764332 2345556654 666789999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
|++ ++|.+++...... ...+++..++.++.|++.||+|||++ + ++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~-~~l~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~ 151 (283)
T cd06617 81 VMD-TSLDKFYKKVYDK-----GLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGIS 151 (283)
T ss_pred hhc-ccHHHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 997 5898887643211 12389999999999999999999997 7 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCcccccc----CCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT----GQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
........ .....++..|+|||++.+ ..++.++|+||||+++|+|++|+.||..
T Consensus 152 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 152 GYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred cccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 76543221 123457889999998865 4568899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=266.47 Aligned_cols=203 Identities=27% Similarity=0.459 Sum_probs=168.9
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCC----EEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
.++|+..+.||+|+||.||+|.+. ++. .+|+|.+...... ...+.+|+.+++.++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 467889999999999999999975 444 5788888654332 23678899999999999999999988654 467
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+++||+++|+|.+++..... .+++..++.++.|++.||+|||+++ ++|+||||+||++++++.+||+||
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Df 153 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKD--------NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDF 153 (303)
T ss_pred eeehhcCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccc
Confidence 89999999999999876432 2788899999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTL 279 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~ 279 (301)
|++................++..|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~ 216 (303)
T cd05110 154 GLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216 (303)
T ss_pred cccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99976643322212223345778999999988899999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=256.72 Aligned_cols=196 Identities=32% Similarity=0.474 Sum_probs=164.7
Q ss_pred ceecccCceEEEEEEEC-C---CCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 72 SLIGEGSYGRVYFGVLR-S---GRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
+.||+|+||.||+|.+. . +..+|+|.+..... ....+.+|+++++.+.|+||+++++++. .+..+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999864 2 26899999876554 3457889999999999999999999875 4567999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
++|.+++..... +++..++.++.|++.+|+|||+.+ ++|+||||+|||++.++.+||+|||++.....
T Consensus 80 ~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 80 GPLLKYLKKRRE---------IPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred CcHHHHHHhCCC---------CCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeec
Confidence 999999976542 789999999999999999999999 99999999999999999999999999876643
Q ss_pred cccccc-cccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 226 AAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 226 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
...... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~ 204 (257)
T cd05060 148 GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG 204 (257)
T ss_pred CCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH
Confidence 322111 111223567999999988889999999999999999998 9999976544
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=260.54 Aligned_cols=194 Identities=26% Similarity=0.370 Sum_probs=166.6
Q ss_pred ecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCCCH
Q 022206 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (301)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL 148 (301)
||+|+||+||+|.+. +++.+++|.+..... ....+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999976 689999999864321 234567899999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCcccc
Q 022206 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (301)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (301)
.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 150 (277)
T cd05577 81 KYHIYNVGE-------PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK 150 (277)
T ss_pred HHHHHHcCc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc
Confidence 999875442 12889999999999999999999999 99999999999999999999999999866543211
Q ss_pred ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....
T Consensus 151 ---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 151 ---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred ---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 1234578899999999888899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=259.12 Aligned_cols=199 Identities=29% Similarity=0.450 Sum_probs=172.8
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
+-|+..+.||+|+||.||+|.+. ++..+|+|.+..... ....+.+|+.++++++|+||+++++.+.++...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34778889999999999999976 789999999765432 235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++++|.+++.... +++..+..++.|++.++.+||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 84 ~~~~~l~~~i~~~~----------~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06641 84 LGGGSALDLLEPGP----------LDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQ 150 (277)
T ss_pred CCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeeccccee
Confidence 99999999986532 788999999999999999999999 99999999999999999999999999866
Q ss_pred CCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
....... .....++..|+|||.+.+...+.++|+|||||++|+|++|..||....
T Consensus 151 ~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (277)
T cd06641 151 LTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH 205 (277)
T ss_pred cccchhh--hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence 5432211 133467889999999988888999999999999999999999997644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=263.99 Aligned_cols=200 Identities=27% Similarity=0.422 Sum_probs=171.1
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
++|++.+.||+|+||.||+|.++ +++.+|+|++...... .+.+.+|+++++.++|+||+++++++.++...++++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999987 6899999988643322 3567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+++++|.++..... .+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~ 148 (286)
T cd07846 81 FVDHTVLDDLEKYPN---------GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 148 (286)
T ss_pred cCCccHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeee
Confidence 999999988775432 1789999999999999999999999 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
........ .....++..|+|||++.+ ..++.++||||||+++|+|++|++||....
T Consensus 149 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 149 TLAAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred eccCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 65433221 123457889999998865 346788999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=259.96 Aligned_cols=204 Identities=29% Similarity=0.480 Sum_probs=170.8
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCC---EEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGR---AAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
.+|+..+.||+|+||.||+|+.+ ++. .+++|.+...... ...+.+|+++++.++|+||+++++++.+.+..+++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 47888999999999999999976 333 7999988654322 35688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+++++|.+++..... .+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+
T Consensus 85 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~ 153 (268)
T cd05063 85 TEYMENGALDKYLRDHDG--------EFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGL 153 (268)
T ss_pred EEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcc
Confidence 999999999999965432 2788999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccc-cccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 220 SNQAPDAAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
+........... ......++.|+|||++.+..++.++||||||+++|+|++ |+.||...+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~ 216 (268)
T cd05063 154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216 (268)
T ss_pred ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 876543221111 111223457999999988889999999999999999997 9999976544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=257.23 Aligned_cols=198 Identities=25% Similarity=0.419 Sum_probs=172.4
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC------chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
+|+..+.||+|++|.||+|... ++..|++|.+..... ..+.+.+|+.+++.++|+||+++++++.++...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4788899999999999999987 789999998864331 235688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
+||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 81 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~ 148 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---------SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGM 148 (258)
T ss_pred EEecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCcc
Confidence 99999999999997543 2788889999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCC-CCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
+........ .....+++.|++||.+.... ++.++|+||||+++|+|++|+.||....
T Consensus 149 ~~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 149 AKQVVEFSF---AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred ceecccccc---ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 876543321 13456889999999887766 8899999999999999999999997654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=255.15 Aligned_cols=198 Identities=30% Similarity=0.509 Sum_probs=168.1
Q ss_pred ceecccCceEEEEEEECCCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCCCHH
Q 022206 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLH 149 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~ 149 (301)
++||+|+||.||++.+..++.|++|.+...... ...+.+|+++++++.|+||+++++++.+....+++|||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877899999988754433 356889999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCccccc
Q 022206 150 DILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229 (301)
Q Consensus 150 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~ 229 (301)
+++..... .+++..+..++.+++.+|.|||+++ ++||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~l~~~~~--------~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 81 TFLRKKKN--------RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred HHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcce
Confidence 99865332 2788899999999999999999999 999999999999999999999999998765422211
Q ss_pred cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
........+..|+|||.+.+..++.++|+||||+++|+|++ |..||....+
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~ 201 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN 201 (251)
T ss_pred eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH
Confidence 11112234567999999988889999999999999999999 8999976654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=261.33 Aligned_cols=200 Identities=26% Similarity=0.390 Sum_probs=172.1
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
+|++.+.||+|++|.||+|.+. ++..|++|++..... ....+.+|+.++++++|+||+++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5889999999999999999976 789999999875432 235688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+ +++|.+++..... .+++..++.++.|++.+|+|||+.+ ++|+||||+||++++++.++|+|||++..
T Consensus 81 ~-~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~ 148 (286)
T cd07832 81 M-PSDLSEVLRDEER--------PLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARL 148 (286)
T ss_pred c-CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeeccc
Confidence 9 9999999865431 2889999999999999999999999 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
....... ......++..|+|||++.+. .++.++||||||+++|+|++|.+||...+
T Consensus 149 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 205 (286)
T cd07832 149 FSEEEPR-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN 205 (286)
T ss_pred ccCCCCC-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC
Confidence 6543211 11334688999999988654 46889999999999999999999887654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=261.82 Aligned_cols=200 Identities=24% Similarity=0.382 Sum_probs=169.7
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
+|++++.||.|++|.||+|++. ++..|++|.+...... ...+.+|++++++++|+||+++++++.+++..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5889999999999999999987 7899999988654322 24688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+. ++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~-~~l~~~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~ 149 (284)
T cd07860 81 LH-QDLKKFMDASPL-------SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA 149 (284)
T ss_pred cc-cCHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhh
Confidence 96 589998865432 22889999999999999999999999 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCccccccCC-CCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
....... .....+++.|+|||++.+.. ++.++||||||+++|+|+||+.||...+
T Consensus 150 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 150 FGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred cccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 5432211 12335688999999887644 5888999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=256.23 Aligned_cols=201 Identities=24% Similarity=0.404 Sum_probs=173.7
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
+|++.+.||+|+||.||+++.. +++.+++|.+.... .....+.+|+.+++.++|+||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5889999999999999999976 78999999986432 2335688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+.+++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~ 150 (256)
T cd08218 81 CEGGDLYKKINAQRG-------VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARV 150 (256)
T ss_pred CCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceee
Confidence 999999999875432 12788899999999999999999999 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
....... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+
T Consensus 151 ~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08218 151 LNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205 (256)
T ss_pred cCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence 5443221 123457889999999988888999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=255.92 Aligned_cols=201 Identities=22% Similarity=0.363 Sum_probs=173.2
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
+|++.+.||+|++|.||++... +++.+++|.+..... ....+.+|+++++.++|+|++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5889999999999999999976 789999999865432 235688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC-CceEEeccccCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDFDLSN 221 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~Dfg~a~ 221 (301)
+++++|.+++..... ..+++..+..++.|++.+|+|||+++ ++|+||+|+||+++++ +.++|+|||++.
T Consensus 81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~ 150 (256)
T cd08220 81 APGGTLAEYIQKRCN-------SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISK 150 (256)
T ss_pred CCCCCHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCce
Confidence 999999999976432 22788999999999999999999999 9999999999999865 468999999987
Q ss_pred CCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
........ ....++..|+|||.+.+..++.++||||||+++|+|++|..||...+.
T Consensus 151 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 206 (256)
T cd08220 151 ILSSKSKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL 206 (256)
T ss_pred ecCCCccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch
Confidence 66543221 334678899999999888889999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=259.70 Aligned_cols=192 Identities=27% Similarity=0.371 Sum_probs=159.2
Q ss_pred eecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHH---HhccCCCceeeeeeEEEcCCeeEEEEecCC
Q 022206 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSM---VSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 73 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~---l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
.||+|+||.||++.+. +++.+|+|.+...... .....+|..+ +....|+||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999976 6899999988654321 1223344433 334479999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
+++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.++|+|||++....
T Consensus 81 ~~~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLSQHG---------VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 999999987543 2899999999999999999999999 9999999999999999999999999986543
Q ss_pred ccccccccccccccccccCccccc-cCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 225 DAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
.... ....|++.|+|||.+. +..++.++|+|||||++|+|++|..||.....
T Consensus 149 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 201 (279)
T cd05633 149 KKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (279)
T ss_pred ccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence 3211 2346899999999886 45688999999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=259.58 Aligned_cols=199 Identities=26% Similarity=0.462 Sum_probs=171.9
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHhccC---CCceeeeeeEEEcCCeeEEEE
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~ 140 (301)
.|+..+.||+|+||.||+|.+. +++.+++|.+..... ....+.+|+.+++.++ |+|++++++++.++...+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 5788899999999999999976 789999999865422 2356788999998886 999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++++|.+++.... +++..++.++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 82 e~~~~~~L~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06917 82 EYAEGGSVRTLMKAGP----------IAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVA 148 (277)
T ss_pred ecCCCCcHHHHHHccC----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCce
Confidence 9999999999986542 889999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
......... .....|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+...
T Consensus 149 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 207 (277)
T cd06917 149 ALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207 (277)
T ss_pred eecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 766543321 133468899999998865 4568899999999999999999999976544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=261.04 Aligned_cols=200 Identities=25% Similarity=0.370 Sum_probs=172.3
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
++|++.+.||+|++|.||+|.++ +++.|++|++.... .....+.+|+++++.++|+||+++++++.+++..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46899999999999999999987 68899999986532 224678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|++++.|..+..... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.
T Consensus 81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~ 148 (288)
T cd07833 81 YVERTLLELLEASPG---------GLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFAR 148 (288)
T ss_pred cCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeeccc
Confidence 999877766654432 2788999999999999999999999 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
........ ......++..|+|||++.+. .++.++|+||||+++|+|++|++||.+.
T Consensus 149 ~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 149 ALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred ccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 76544321 11334678899999999887 7899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=268.70 Aligned_cols=198 Identities=24% Similarity=0.312 Sum_probs=169.3
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcC------
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG------ 133 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 133 (301)
..++|++.+.||+|+||.||+|.+. +++.||+|.+.+... ....+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999977 799999999864322 234577899999999999999999988643
Q ss_pred CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceE
Q 022206 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (301)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (301)
...++||||+.+ +|.+.+... ++...+..++.|++.||+|||+.| ++||||||+||+++.++.+|
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~-----------l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~k 158 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 158 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEE
Confidence 357999999975 888887532 678888999999999999999999 99999999999999999999
Q ss_pred EeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 159 L~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 159 ILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred EccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 999999876543221 133457889999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=260.24 Aligned_cols=198 Identities=31% Similarity=0.464 Sum_probs=174.2
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
++|+..+.||+|++|.||++.++ +++.+++|.+..... ....+.+|++++++++|+||+++++.+..+...++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46888999999999999999987 689999999876533 235688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
+.+++|.+++..... .+++..+..++.|++.+|+|||+ .+ ++|+||+|+||++++++.++|+|||.+.
T Consensus 81 ~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~ 149 (265)
T cd06605 81 MDGGSLDKILKEVQG--------RIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSG 149 (265)
T ss_pred cCCCcHHHHHHHccC--------CCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccch
Confidence 999999999976431 28889999999999999999999 88 9999999999999999999999999986
Q ss_pred CCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
....... ....++..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 150 ~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 150 QLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred hhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 6543221 1256888999999998889999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=256.13 Aligned_cols=199 Identities=24% Similarity=0.275 Sum_probs=167.0
Q ss_pred HHHHHhhCCCCCCcee--cccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhcc-CCCceeeeeeEEEcCC
Q 022206 59 DELKEKTDNFGTNSLI--GEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (301)
Q Consensus 59 ~~~~~~~~~y~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 134 (301)
.+.....++|.+.+.+ |+|+||.||++..+ ++..+|+|.+........ |+.....+ +|+||+++++.+...+
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 3445566788887777 99999999999976 788999999865432221 22222222 7999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC-ceE
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAK 213 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~vk 213 (301)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++ .++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~ 150 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG---------KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIY 150 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEE
Confidence 9999999999999999997653 2899999999999999999999999 99999999999999988 999
Q ss_pred EeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|+|||++...... ....++..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 151 l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 151 LCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred EecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999998655422 23457899999999998889999999999999999999999997543
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=257.15 Aligned_cols=202 Identities=29% Similarity=0.459 Sum_probs=164.0
Q ss_pred ceecccCceEEEEEEEC-CCC--EEEEEEcCCCC--CchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 72 SLIGEGSYGRVYFGVLR-SGR--AAAIKKLDSSK--QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
+.||+|+||.||+|+++ ++. .+++|.+.... .....+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36999999999999976 444 46888876432 2335688899999999 799999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 146 GSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 146 gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
++|.+++........ ......+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999975432110 011234788999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTL 279 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~ 279 (301)
++........ ......+..|+|||++....++.++||||||+++|+|++ |..||.+.+
T Consensus 158 l~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 216 (270)
T cd05047 158 LSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216 (270)
T ss_pred Cccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC
Confidence 9854322111 111223567999999988889999999999999999997 999997644
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=259.99 Aligned_cols=200 Identities=27% Similarity=0.395 Sum_probs=167.8
Q ss_pred CCCCCCceecccCceEEEEEEEC-----CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcC--Cee
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLR 136 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 136 (301)
..|++++.||+|+||.||+++.. ++..||+|.+...... ...+.+|+.+++.++|+||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 45789999999999999999842 5788999998644322 35688999999999999999999998765 568
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
+++|||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~d 152 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN--------KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGD 152 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECC
Confidence 999999999999999865431 2788999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCC
Q 022206 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276 (301)
Q Consensus 217 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~ 276 (301)
||++......... .......++..|+|||++.+..++.++||||||+++|+|+++..|+.
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred CccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 9998766433221 11123456778999999988889999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=256.72 Aligned_cols=201 Identities=21% Similarity=0.325 Sum_probs=160.1
Q ss_pred ceecccCceEEEEEEECC---CCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCC
Q 022206 72 SLIGEGSYGRVYFGVLRS---GRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKG 146 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 146 (301)
+.||+|+||.||++...+ ...+++|.+..... ....+.+|+.+++.++||||+++++.+.+....+++|||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 369999999999998543 33566777654432 3457889999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCcc
Q 022206 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (301)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (301)
+|.+++....... ...+...+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++......
T Consensus 81 ~L~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~ 152 (268)
T cd05086 81 DLKSYLSQEQWHR-----RNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE 152 (268)
T ss_pred cHHHHHHhhhccc-----ccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcc
Confidence 9999997543211 12566778899999999999999999 999999999999999999999999997643322
Q ss_pred ccccccccccccccccCcccccc-------CCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 227 AARLHSTRVLGTFGYHAPEYAMT-------GQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
..........++..|+|||++.. ..++.++||||||+++|+|++ |..||...++
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 214 (268)
T cd05086 153 DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214 (268)
T ss_pred hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 21111234567889999998743 235778999999999999997 6789865543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=256.22 Aligned_cols=191 Identities=25% Similarity=0.378 Sum_probs=168.6
Q ss_pred ecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCCCH
Q 022206 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (301)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL 148 (301)
||.|++|.||+|++. +++.+++|++.+... ....+.+|+++++.++|+||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999987 689999999865432 235688899999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCcccc
Q 022206 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (301)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (301)
.+++..... ++...+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~---------l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~ 148 (262)
T cd05572 81 WTILRDRGL---------FDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK 148 (262)
T ss_pred HHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc
Confidence 999976532 788899999999999999999999 99999999999999999999999999877654321
Q ss_pred ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
.....+++.|++||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 149 ---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 149 ---TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ---cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 133467889999999888889999999999999999999999997665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=255.78 Aligned_cols=198 Identities=32% Similarity=0.459 Sum_probs=167.7
Q ss_pred ceecccCceEEEEEEECC--C--CEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 72 SLIGEGSYGRVYFGVLRS--G--RAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
+.||+|++|.||+|.+.+ + ..+|+|.+..... ..+.+.+|+.++++++|+||+++++++.+ ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999752 3 3699999876554 34578899999999999999999999988 889999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 80 ~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL-------GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc-------ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999976431 12789999999999999999999999 99999999999999999999999999877644
Q ss_pred ccccc-ccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 226 AAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 226 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 206 (257)
T cd05040 150 NEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG 206 (257)
T ss_pred cccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 22211 1123456788999999988899999999999999999998 9999975543
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=257.36 Aligned_cols=191 Identities=28% Similarity=0.394 Sum_probs=159.2
Q ss_pred eecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHH---HHHhccCCCceeeeeeEEEcCCeeEEEEecCC
Q 022206 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQV---SMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 73 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~---~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
.||+|+||.||+|.+. +++.||+|.+...... ......|. ..++...|++|+.+++++.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999976 6899999998653221 11233333 34455679999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
|++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 81 g~~L~~~l~~~~---------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLSQHG---------VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 999999886543 2899999999999999999999999 9999999999999999999999999987553
Q ss_pred ccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 225 DAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
.... ....|+..|+|||++.+. .++.++||||+|+++|+|++|+.||.+..
T Consensus 149 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 149 KKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred ccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 3221 234689999999998754 68899999999999999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=256.03 Aligned_cols=192 Identities=27% Similarity=0.426 Sum_probs=159.5
Q ss_pred ceecccCceEEEEEEECC-------------CCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 72 SLIGEGSYGRVYFGVLRS-------------GRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
+.||+|+||.||+|...+ ...+++|++...... ...+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998531 235889987654332 346778889999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc------
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI------ 211 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~------ 211 (301)
++|||+++++|..++..... .+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~ 149 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD--------VLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGP 149 (262)
T ss_pred EEEecccCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCc
Confidence 99999999999998865432 2788999999999999999999999 999999999999987664
Q ss_pred -eEEeccccCCCCCccccccccccccccccccCccccc-cCCCCccccchhhHHHHHHHH-hCCCCCCCCCC
Q 022206 212 -AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELL-TGRKPVDHTLP 280 (301)
Q Consensus 212 -vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~-~g~~pf~~~~~ 280 (301)
++++|||++...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||.....
T Consensus 150 ~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (262)
T cd05077 150 FIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215 (262)
T ss_pred eeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence 899999998654322 2335788899999886 467889999999999999998 59999876543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=259.85 Aligned_cols=201 Identities=31% Similarity=0.413 Sum_probs=171.2
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcC--CeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 140 (301)
++|+..+.||.|++|.||++.+. +++.+|+|.+..... ....+.+|++++++++|+||+++++++.+. ...+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999986 689999999875433 345688999999999999999999988653 4789999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++++|.+++...... ...++...+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~ 152 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKR-----GGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVS 152 (287)
T ss_pred EecCCCCHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccc
Confidence 999999999987542211 123788899999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
........ ....++..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 153 ~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 153 GELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 65533221 2345788899999998889999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=256.13 Aligned_cols=197 Identities=30% Similarity=0.535 Sum_probs=168.3
Q ss_pred CCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
++|++.+.||+|+||.||++.. +++.+|+|.+.... ....+.+|+.++++++|+|++++++++..+ ..+++|||+.+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 5689999999999999999875 47889999986543 346788999999999999999999998755 47899999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 83 ~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 83 GNLVNFLRTRGR-------ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSM 152 (254)
T ss_pred CCHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccc
Confidence 999999975432 12788899999999999999999999 99999999999999999999999999865432
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
.. .....+..|+|||.+.+..++.++|+||||+++|+|++ |++||...+.
T Consensus 153 ~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 203 (254)
T cd05083 153 GV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL 203 (254)
T ss_pred cC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH
Confidence 21 22234567999999988889999999999999999998 9999987654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=255.94 Aligned_cols=204 Identities=28% Similarity=0.421 Sum_probs=168.9
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
.+++.....||+|+||.||+|++. ++..|++|.+..... ..+.+.+|+.+++.++|+||+++++++..++..++++||
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 445556678999999999999976 688899998865443 345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC-CCceEEeccccCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSN 221 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a~ 221 (301)
+++++|.+++...... ...+...+..++.|++.||+|||+.+ ++||||||+||+++. ++.++|+|||++.
T Consensus 87 ~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 87 VPGGSLSALLRSKWGP------LKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred CCCCCHHHHHHHhccc------CCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 9999999999754211 00277888899999999999999999 999999999999986 6799999999987
Q ss_pred CCCccccccccccccccccccCccccccC--CCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
........ .....+++.|+|||++.+. .++.++|+||||+++|+|++|+.||....
T Consensus 158 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 158 RLAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred ecccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 65432211 1234578999999988654 37889999999999999999999997543
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=258.78 Aligned_cols=205 Identities=30% Similarity=0.468 Sum_probs=178.9
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
...+.|+..+.||+|++|.||+|.+. ++..+++|++.........+.+|+++++.++|+|++++++.+......++++|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 34567999999999999999999987 78999999997655445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+++++|.+++.... ..++...++.++.|++.+|+|||+.| ++|+||+|+||+++.++.++|+|||++.
T Consensus 96 ~~~~~~L~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 164 (286)
T cd06614 96 YMDGGSLTDIITQNF--------VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAA 164 (286)
T ss_pred ccCCCcHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhh
Confidence 999999999998653 12889999999999999999999999 9999999999999999999999999876
Q ss_pred CCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
........ .....+++.|++||.+.+..++.++|+||||+++|+|++|+.||....+
T Consensus 165 ~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~ 221 (286)
T cd06614 165 QLTKEKSK--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP 221 (286)
T ss_pred hhccchhh--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH
Confidence 55432211 1334578899999999888899999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=254.88 Aligned_cols=200 Identities=27% Similarity=0.454 Sum_probs=173.4
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
+|.+.+.||+|+||.||++... +++.+++|.+..... ....+.+|+.++++++|+||+++++.+.+.+..++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999976 789999999876544 345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++++|.+++..... +++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~~~~L~~~~~~~~~---------~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~ 148 (264)
T cd06626 81 CSGGTLEELLEHGRI---------LDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVK 148 (264)
T ss_pred CCCCcHHHHHhhcCC---------CChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccc
Confidence 999999999976432 778889999999999999999999 99999999999999999999999999877
Q ss_pred CCccccccc--cccccccccccCccccccCC---CCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 223 APDAAARLH--STRVLGTFGYHAPEYAMTGQ---MSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 223 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
......... .....+++.|+|||++.+.. ++.++||||||+++|+|++|+.||...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 149 LKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred cCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 654322110 11345788999999987765 788999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=255.86 Aligned_cols=191 Identities=27% Similarity=0.450 Sum_probs=162.9
Q ss_pred ceecccCceEEEEEEECC-C----------CEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 72 SLIGEGSYGRVYFGVLRS-G----------RAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
+.||+|+||.||+|.+.. + ..+++|.+.........+.+|+.+++.++|+||+++++++.. ...+++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 469999999999999763 3 257888776554435778899999999999999999999888 7789999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC-------ceE
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-------IAK 213 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-------~vk 213 (301)
||+++++|.+++..... .+++..+..++.|++.||+|||+.+ ++||||||+|||++.++ .+|
T Consensus 80 e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 80 EYVKFGPLDVFLHREKN--------NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred EcCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEE
Confidence 99999999999976542 2788899999999999999999999 99999999999999887 799
Q ss_pred EeccccCCCCCccccccccccccccccccCccccccC--CCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
|+|||++...... ....++..|+|||++... .++.++||||||+++|+|++ |..||...+.
T Consensus 149 l~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~ 212 (259)
T cd05037 149 LSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212 (259)
T ss_pred eCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence 9999998765431 233567789999998776 78899999999999999999 6888877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=255.38 Aligned_cols=203 Identities=22% Similarity=0.329 Sum_probs=172.2
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEc--CCeeEEEE
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRVLAY 140 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 140 (301)
+|++.+.||.|+||.||++.+. ++..+++|++...... ...+.+|+++++.++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5888999999999999999976 7889999998654332 3457789999999999999999998763 45689999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-----hCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH-----EKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-----~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
||+++++|.+++...... ...+++..++.++.|++.||.||| +.+ ++|+||+|+||++++++.+||+
T Consensus 81 e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKE-----RKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred hhccCCCHHHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEe
Confidence 999999999999653211 123889999999999999999999 777 9999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|||++......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus 153 d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 153 DFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred cccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 99998876543321 133468999999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=258.90 Aligned_cols=204 Identities=27% Similarity=0.472 Sum_probs=167.7
Q ss_pred ceecccCceEEEEEEECC-------CCEEEEEEcCCCC--CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 72 SLIGEGSYGRVYFGVLRS-------GRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
+.||+|+||.||+|++.+ +..+++|.+.... .....+.+|+.+++.++||||+++++++.+.+..+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998652 2579999886543 2345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC-----ceEEecc
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-----IAKISDF 217 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-----~vkl~Df 217 (301)
+++++|.+++........ ....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++ .++|+||
T Consensus 81 ~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 81 MEGGDLLSYLRDARVERF--GPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred cCCCcHHHHHHHhhhccc--CCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCc
Confidence 999999999975432110 1223788999999999999999999999 99999999999999877 8999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
|++................++..|+|||.+.+..++.++||||||+++|+|++ |..||...++
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~ 219 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN 219 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH
Confidence 99876543322211223345788999999998889999999999999999998 9999975543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=257.88 Aligned_cols=201 Identities=27% Similarity=0.403 Sum_probs=166.4
Q ss_pred CCCCCCceecccCceEEEEEEEC-----CCCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeeeeeEEEc--CCeeE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVD--GPLRV 137 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 137 (301)
.+|++.+.||+|+||.||++... ++..|++|.+...... ...+.+|+++++.++|+||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57899999999999999999742 5789999998654332 3567899999999999999999998653 34688
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+++||+++++|.+++..... .+++..++.++.|++.||+|||+.| ++||||||+||++++++.+||+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~df 152 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRE--------RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDF 152 (284)
T ss_pred EEEEecCCCCHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCC
Confidence 99999999999999965432 2788999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccc-cccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 218 DLSNQAPDAAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 218 g~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
|++........... .....++..|+|||++.+..++.++||||||+++|+|++|..|+..
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 153 GLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred cccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 99887643322111 1112234569999999888899999999999999999998877643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=258.66 Aligned_cols=201 Identities=22% Similarity=0.343 Sum_probs=167.7
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
++|++.+.||+|++|.||+|.++ +++.|++|.+...... ...+.+|++++++++|+||+++++++.++...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999987 7899999998654322 3567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC-CCceEEeccccC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLS 220 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a 220 (301)
|+++ +|.+++...... .+++..+..++.||+.||+|||+++ ++|+||+|+||++++ ++.+||+|||++
T Consensus 82 ~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~ 150 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDF-------AKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLA 150 (294)
T ss_pred cccc-cHHHHHHhCCCC-------CcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccc
Confidence 9965 888887544321 2577888899999999999999999 999999999999985 567999999998
Q ss_pred CCCCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
......... .....+++.|+|||.+.+. .++.++||||||+++|+|++|.+||...+
T Consensus 151 ~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~ 208 (294)
T PLN00009 151 RAFGIPVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208 (294)
T ss_pred cccCCCccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 765432111 1233568899999988664 57889999999999999999999997654
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=266.18 Aligned_cols=200 Identities=27% Similarity=0.386 Sum_probs=167.6
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHhccCCCceeeeeeEEEcCC-----ee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP-----LR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 136 (301)
.++|++.+.||+|+||.||+|++. +++.||+|++.... .....+.+|+.+++.++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 478999999999999999999976 78999999986422 22356778999999999999999999876443 57
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
++++||+.+ +|.+++.... +++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|
T Consensus 84 ~lv~e~~~~-~l~~~~~~~~----------l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~d 149 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQH----------LSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICD 149 (336)
T ss_pred EEEehhccc-CHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECc
Confidence 999999975 8888886543 889999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCcccccc-ccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 217 FDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 217 fg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
||++.......... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 150 FGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred ccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99987654322111 1123467899999998654 56889999999999999999999999654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=262.30 Aligned_cols=203 Identities=31% Similarity=0.410 Sum_probs=169.7
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcC--CeeE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRV 137 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 137 (301)
..++|++.+.||+|+||.||+|.++ +++.||+|++...... .....+|+.++++++|+||+++++++.+. +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3568999999999999999999986 6999999998643322 23466899999999999999999998754 5689
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+||||+.+ +|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 lv~e~~~~-~l~~~l~~~~~--------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~df 152 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPT--------PFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADF 152 (309)
T ss_pred EEEecCCC-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcc
Confidence 99999975 89888875431 2889999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|++......... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|++||.+.++
T Consensus 153 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 153 GLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred ceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 998766433211 122345788999998865 4578999999999999999999999976554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=252.74 Aligned_cols=202 Identities=32% Similarity=0.496 Sum_probs=172.5
Q ss_pred CCCCceecccCceEEEEEEEC-CC----CEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 68 FGTNSLIGEGSYGRVYFGVLR-SG----RAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~-~~----~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
+++.+.||.|+||.||++++. .+ ..+|+|.+..... ....+..|+.+++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 457789999999999999976 33 8899999976554 3467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++++|.+++...... .+++..+..++.|++.||++||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 81 e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~ 150 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK-------ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLS 150 (258)
T ss_pred eccCCCCHHHHHHhhhhc-------cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCc
Confidence 999999999999764421 1788999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
........... ....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||...+.
T Consensus 151 ~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~ 210 (258)
T smart00219 151 RDLYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN 210 (258)
T ss_pred eeccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 76654322111 12236789999999988889999999999999999998 8999976443
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=257.35 Aligned_cols=198 Identities=28% Similarity=0.474 Sum_probs=171.2
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCC
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
.|...+.||+|++|.||++.+. +++.+++|++...... ...+.+|+.+++.++|+||+++++++...+..++++||+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 4556679999999999999976 7899999988644322 3457889999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
+++|.+++.... +++..+..++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||.+....
T Consensus 100 ~~~L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 100 GGALTDIVTHTR----------MNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVS 166 (285)
T ss_pred CCCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence 999999987632 788999999999999999999999 9999999999999999999999999876543
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
..... .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~ 219 (285)
T cd06648 167 KEVPR--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP 219 (285)
T ss_pred cCCcc--cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence 32211 123458899999999988889999999999999999999999997644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=262.07 Aligned_cols=207 Identities=23% Similarity=0.376 Sum_probs=169.7
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCC----
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP---- 134 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 134 (301)
...++|++.+.||+|+||.||+|... +++.||+|.+...... ...+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 34568999999999999999999987 7899999988543222 234678999999999999999999887543
Q ss_pred ----eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC
Q 022206 135 ----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (301)
Q Consensus 135 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 210 (301)
..+++|||+.+ +|.+++..... .+++..++.++.|++.||+|||+++ ++|+||||+||+++.++
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~ 156 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLSNKNV--------KFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDG 156 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCC
Confidence 45999999975 88888765431 2889999999999999999999999 99999999999999999
Q ss_pred ceEEeccccCCCCCccccc--cccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 211 IAKISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
.+||+|||++......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.++.
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~ 230 (310)
T cd07865 157 ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ 230 (310)
T ss_pred cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999998765432211 111234578889999987664 4688999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=256.68 Aligned_cols=203 Identities=29% Similarity=0.428 Sum_probs=168.9
Q ss_pred hCCCCCCceecccCceEEEEEEECC----CCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
..+|.+.+.||+|+||.||+|.+.+ ...+++|....... ..+.+.+|+.++++++|+||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3568899999999999999998652 34689998865432 23568899999999999999999998875 45789
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
+|||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||
T Consensus 84 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g 152 (270)
T cd05056 84 VMELAPLGELRSYLQVNKY--------SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFG 152 (270)
T ss_pred EEEcCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCc
Confidence 9999999999999975432 2788999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
++......... ......+++.|+|||.+....++.++||||||+++|+|++ |..||.+.+.
T Consensus 153 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~ 214 (270)
T cd05056 153 LSRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214 (270)
T ss_pred eeeecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 98765443211 1122234568999999988889999999999999999996 9999976654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=257.72 Aligned_cols=202 Identities=25% Similarity=0.392 Sum_probs=170.9
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
+|++.+.||.|++|.||+|++. ++..||+|++...... ...+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5889999999999999999987 6899999998754322 356778999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
++ +|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++...
T Consensus 81 ~~-~l~~~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 81 DK-DLKKYMDTHGV------RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAF 150 (284)
T ss_pred Cc-cHHHHHHhcCC------CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence 86 89888865431 123889999999999999999999999 999999999999999999999999998654
Q ss_pred CccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
...... .....+++.|++||++.+. .++.++|+||||+++|+|++|+.||.+.+.
T Consensus 151 ~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 206 (284)
T cd07836 151 GIPVNT--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN 206 (284)
T ss_pred cCCccc--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 332111 1233568899999988654 568899999999999999999999987654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=299.32 Aligned_cols=204 Identities=26% Similarity=0.385 Sum_probs=175.3
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
.-+|+...+||.|.||.||-|... +|...|+|.+..... .-+.+.+|+.++..|+|||+|+++++-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 347888999999999999999966 799999998864322 2356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
|||++|+|.+++..... .++.....+..|++.|++|||++| ||||||||+||+++.+|.+|++|||.|
T Consensus 1314 EyC~~GsLa~ll~~gri---------~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI---------EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHhccCcHHHHHHhcch---------hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccce
Confidence 99999999999987543 667777789999999999999999 999999999999999999999999999
Q ss_pred CCCCcccccc--ccccccccccccCccccccC---CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARL--HSTRVLGTFGYHAPEYAMTG---QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
.......... .-....||+.|||||++.+. +...++|||||||++.||+||+.||...+.
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 8876553211 12356899999999999754 567789999999999999999999976543
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=259.21 Aligned_cols=201 Identities=26% Similarity=0.392 Sum_probs=170.4
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcC--CeeEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRVL 138 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 138 (301)
.++|++.+.||+|+||.||+|.+. +++.+++|.+...... ...+.+|+.++++++||||+++++++... ...++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 357999999999999999999987 6889999998654322 23467899999999999999999998877 88999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
++||+.+ +|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 84 v~e~~~~-~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g 151 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQ--------PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFG 151 (293)
T ss_pred EehhcCc-CHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecC
Confidence 9999985 99998875432 2889999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
++......... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||....
T Consensus 152 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 152 LAREYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred ceeeccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 98766543211 1234578899999988764 46889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=260.41 Aligned_cols=206 Identities=26% Similarity=0.410 Sum_probs=170.0
Q ss_pred CCCCCceecccCceEEEEEEEC---CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcC--CeeE
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRV 137 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 137 (301)
+|++.+.||+|+||.||+|.++ ++..||+|.+.... .....+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4888999999999999999975 37899999987632 2235678899999999999999999999988 8899
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC----CCceE
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD----DDIAK 213 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~----~~~vk 213 (301)
+||||+++ +|.+++....... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++. ++.+|
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~k 152 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAK----RVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVK 152 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCC----CcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEE
Confidence 99999976 7777765332211 123888999999999999999999999 999999999999999 89999
Q ss_pred EeccccCCCCCcccc-ccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 214 ISDFDLSNQAPDAAA-RLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|+|||++........ ........+++.|+|||++.+. .++.++||||||+++|+|++|++||.....
T Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 153 IGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 999999876543322 1112344678899999987664 578999999999999999999999976544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=257.75 Aligned_cols=204 Identities=23% Similarity=0.331 Sum_probs=167.7
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccC-CCceeeeeeEEEcCCe-----
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLK-NENVVELVGYYVDGPL----- 135 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~----- 135 (301)
++|++.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.+++.+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46899999999999999999977 7899999988654322 356788999999995 6999999999886665
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC-CCceEE
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKI 214 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~vkl 214 (301)
.+++|||+++ +|.+++...... ....+++..++.++.|++.||.|||+.+ ++||||+|+||+++. ++.+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl 152 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRG----PGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKI 152 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhccc----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEE
Confidence 8999999986 898888653321 0123789999999999999999999999 999999999999998 889999
Q ss_pred eccccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
+|||++......... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+
T Consensus 153 ~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~ 216 (295)
T cd07837 153 ADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS 216 (295)
T ss_pred eecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999998755332211 122356888999998765 457899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=256.95 Aligned_cols=199 Identities=25% Similarity=0.362 Sum_probs=168.5
Q ss_pred CCCCCceecccCceEEEEEEEC----CCCEEEEEEcCCCC-----CchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCee
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 136 (301)
+|++.+.||+|+||.||+|... +|..||+|++.... ...+.+.+|+.+++++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5888999999999999999863 68899999986432 2235678899999999 589999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
++++||+++++|.+++..... +++..+..++.|++.||.|||+.+ ++||||+|+|||+++++.+||+|
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d 148 (290)
T cd05613 81 HLILDYINGGELFTHLSQRER---------FKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD 148 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEee
Confidence 999999999999999875432 788889999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCccccccC--CCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
||++......... ......|+..|+|||.+... .++.++||||||+++|+|++|..||...
T Consensus 149 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 149 FGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred Cccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 9998765432211 11234688999999988653 4678899999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=257.24 Aligned_cols=202 Identities=29% Similarity=0.460 Sum_probs=172.1
Q ss_pred CCCCCCceecccCceEEEEEEEC-----CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEc--CCee
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVD--GPLR 136 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 136 (301)
++|++.+.||+|+||.||+|++. ++..+|+|++...... ...+.+|+++++.+.|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 56888899999999999999854 3789999999866553 5678999999999999999999999877 5678
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
+++|||+++++|.+++..... .+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d 152 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD--------QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISD 152 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc--------ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcc
Confidence 999999999999999976542 2888999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccccc-cccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 217 FDLSNQAPDAAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 217 fg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
||++........... .....++..|++||.+.+..++.++||||||+++|+|++|..||...
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 153 FGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred cccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 999987653221111 11223456799999998888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=248.92 Aligned_cols=198 Identities=31% Similarity=0.516 Sum_probs=176.2
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCC
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
+|+..+.||+|++|.||++.+. ++..+++|++..... ....+.+|+.+++.++|+|++++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 5788899999999999999987 789999999976544 45678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
+++|.+++..... .+++..+..++.|++.+|.+||+.+ ++||||+|+||++++++.++|+|||.+....
T Consensus 81 ~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 149 (253)
T cd05122 81 GGSLKDLLKSTNQ--------TLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLS 149 (253)
T ss_pred CCcHHHHHhhcCC--------CCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccc
Confidence 9999999976531 2889999999999999999999999 9999999999999999999999999987765
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
.... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 150 ~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 150 DTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred cccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 4332 23456788999999998888899999999999999999999999765
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=253.89 Aligned_cols=201 Identities=23% Similarity=0.343 Sum_probs=175.3
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchH----HHHHHHHHHhcc-CCCceeeeeeEEEcCCee
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQ----EFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~----~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 136 (301)
....+|.++++||+|+|++|.+++++ +.+.+|+|+++++...++ =.+.|-.+..+. +||.+|.++..|+++.++
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 34578999999999999999999977 789999999876543332 244555565554 789999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
++|.||++||+|--.++++.. +++..+..+..+|+.||.|||+.| ||+||||.+|+|++..|++||+|
T Consensus 327 ffvieyv~ggdlmfhmqrqrk---------lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltd 394 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTD 394 (593)
T ss_pred EEEEEEecCcceeeehhhhhc---------CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecc
Confidence 999999999999887776553 999999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
+|.++...... ..+++++|||.|.|||.+++..|...+|+|+|||+++||+.|+.||+-
T Consensus 395 ygmcke~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 395 YGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred cchhhcCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 99987654332 234788999999999999999999999999999999999999999963
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=258.17 Aligned_cols=202 Identities=18% Similarity=0.206 Sum_probs=155.5
Q ss_pred hCCCCCCceecccCceEEEEEEECC----CCEEEEEEcCCCCCch--H----------HHHHHHHHHhccCCCceeeeee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQPD--Q----------EFLAQVSMVSRLKNENVVELVG 128 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~--~----------~~~~e~~~l~~l~h~~iv~~~~ 128 (301)
.++|++.+.||+|+||.||+|.+.+ +..+++|+........ + ....++..+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999999763 4567777644322211 0 1122334456678999999998
Q ss_pred EEEcCC----eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCce
Q 022206 129 YYVDGP----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204 (301)
Q Consensus 129 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Ni 204 (301)
.+.... ..+++++++.. ++.+.+..... .++..+..++.|++.||+|||+.+ ++||||||+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Ni 157 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKC---------KNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENI 157 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhcc---------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 765443 34677887754 67777654321 567778899999999999999999 99999999999
Q ss_pred EEcCCCceEEeccccCCCCCccccc-----cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 205 LLFDDDIAKISDFDLSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 205 ll~~~~~vkl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|++.++.++|+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+..
T Consensus 158 ll~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 158 MVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999999998765322111 11123468999999999999999999999999999999999999998763
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=257.48 Aligned_cols=197 Identities=32% Similarity=0.471 Sum_probs=167.8
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
.+.|.+.+.||+|+||.||+|... +++.|++|++...... ...+.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356999999999999999999976 6899999998643221 24578899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
+||+.+ +|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+
T Consensus 94 ~e~~~g-~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~ 161 (307)
T cd06607 94 MEYCLG-SASDILEVHKK--------PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGS 161 (307)
T ss_pred HHhhCC-CHHHHHHHccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCc
Confidence 999975 77777754321 2788999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
+...... ....+++.|+|||++. ...++.++||||||+++|+|++|+.||...+
T Consensus 162 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~ 218 (307)
T cd06607 162 ASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (307)
T ss_pred ceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc
Confidence 8654322 2346788999999874 3567889999999999999999999997543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=255.83 Aligned_cols=200 Identities=23% Similarity=0.348 Sum_probs=169.6
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
|++.+.||.|++|.||+|.+. ++..|++|++..... ....+.+|+++++.++|+|++++++++.+++..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 678899999999999999976 799999999865432 2356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
+ ++|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++...
T Consensus 81 ~-~~l~~~~~~~~~-------~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~ 149 (283)
T cd07835 81 D-LDLKKYMDSSPL-------TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAF 149 (283)
T ss_pred C-cCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence 6 589999876542 12889999999999999999999999 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
...... .....+++.|+|||++.+. .++.++|+||||+++|+|++|++||...++
T Consensus 150 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 205 (283)
T cd07835 150 GVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE 205 (283)
T ss_pred CCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 332211 1223468899999987654 568899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=260.64 Aligned_cols=198 Identities=33% Similarity=0.484 Sum_probs=165.0
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHh--ccCCCceeeeeeEEEcCC----eeEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVS--RLKNENVVELVGYYVDGP----LRVL 138 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~--~l~h~~iv~~~~~~~~~~----~~~l 138 (301)
....++.++||+|.||.||+|... ++.||||++... ..+.+.+|-.+.+ .++|+||++++++-.... .++|
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ--EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHH--HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 456777889999999999999987 599999999643 3455777766654 468999999998865444 7899
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC------CCCeEecCCCCCceEEcCCCce
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA------EPRIIHRNIKSSNVLLFDDDIA 212 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------~~~ivH~Dlkp~Nill~~~~~v 212 (301)
|++|.+.|+|.++|..+. +++....+++..+++||+|||+-- +++|+|||||.+||||.+|++.
T Consensus 286 Vt~fh~kGsL~dyL~~nt----------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc 355 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT----------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC 355 (534)
T ss_pred EeeeccCCcHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence 999999999999999876 999999999999999999999632 4679999999999999999999
Q ss_pred EEeccccCCCCCccccccccccccccccccCccccccCC-CC-----ccccchhhHHHHHHHHhCCCCC
Q 022206 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MS-----SKSDVYSFGVVLLELLTGRKPV 275 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwslG~il~~l~~g~~pf 275 (301)
.|+|||+|...............+||.+|||||++.+.. .. .+.||||+|.+||||+++..-+
T Consensus 356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 999999998877555443334578999999999997642 12 3579999999999999876544
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=253.16 Aligned_cols=201 Identities=27% Similarity=0.477 Sum_probs=172.8
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
+|++.+.||+|+||.||++..+ ++..+|+|.+.... ...+.+.+|+++++.++|+||+++++.+.+....++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5888999999999999999987 68999999986532 2345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC-ceEEeccccCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSN 221 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg~a~ 221 (301)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++ .++|+|||.+.
T Consensus 81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~ 150 (257)
T cd08225 81 CDGGDLMKRINRQRG-------VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150 (257)
T ss_pred CCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccch
Confidence 999999999875432 13788999999999999999999999 99999999999999875 56999999987
Q ss_pred CCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
........ .....|++.|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 151 ~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 206 (257)
T cd08225 151 QLNDSMEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206 (257)
T ss_pred hccCCccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 66433221 123458889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=262.53 Aligned_cols=201 Identities=29% Similarity=0.417 Sum_probs=169.0
Q ss_pred HHHHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcC--
Q 022206 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG-- 133 (301)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 133 (301)
++....++|.+.+.||+|+||.||++.+. +++.||+|++..... ....+.+|+.++++++|+||+++++++...
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 44456689999999999999999999975 789999999875322 235577899999999999999999987643
Q ss_pred ----CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC
Q 022206 134 ----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (301)
Q Consensus 134 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 209 (301)
...+++++++ +++|.+++.... +++..++.++.|++.||+|||+.+ ++||||||+||+++++
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~ 156 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNED 156 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCC
Confidence 3467888876 679998886543 888999999999999999999999 9999999999999999
Q ss_pred CceEEeccccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
+.+||+|||++....... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 222 (345)
T cd07877 157 CELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222 (345)
T ss_pred CCEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999987653221 33467889999998766 567889999999999999999999997544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=255.88 Aligned_cols=192 Identities=28% Similarity=0.428 Sum_probs=158.2
Q ss_pred eecccCceEEEEEEECC-------------------------CCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeee
Q 022206 73 LIGEGSYGRVYFGVLRS-------------------------GRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVEL 126 (301)
Q Consensus 73 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~ 126 (301)
.||+|+||.||+|.... ...|++|++...... ...+.+|+.+++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 135888988654322 3467788899999999999999
Q ss_pred eeEEEcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEE
Q 022206 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (301)
Q Consensus 127 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill 206 (301)
++++.++...++||||+++++|..++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill 150 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--------RVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILL 150 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEE
Confidence 9999999999999999999999999865332 2788899999999999999999999 9999999999999
Q ss_pred cCCC-------ceEEeccccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHH-hCCCCCCC
Q 022206 207 FDDD-------IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELL-TGRKPVDH 277 (301)
Q Consensus 207 ~~~~-------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~-~g~~pf~~ 277 (301)
++.+ .+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|+|+ +|+.||..
T Consensus 151 ~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 224 (274)
T cd05076 151 ARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224 (274)
T ss_pred eccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence 8654 3899999987544322 22356788999998865 56789999999999999985 69999987
Q ss_pred CCCc
Q 022206 278 TLPR 281 (301)
Q Consensus 278 ~~~~ 281 (301)
..+.
T Consensus 225 ~~~~ 228 (274)
T cd05076 225 RTPS 228 (274)
T ss_pred cChH
Confidence 6543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=252.01 Aligned_cols=191 Identities=28% Similarity=0.391 Sum_probs=161.9
Q ss_pred ceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch----HHHHHHHHH-HhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 72 SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSM-VSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
+.||+|+||.||+|... +++.||+|++.+..... ..+..|..+ .....|+|++++++++.+++..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999976 68999999986543211 223344443 4455899999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
++|.+++..... +++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 149 (260)
T cd05611 82 GDCASLIKTLGG---------LPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE 149 (260)
T ss_pred CCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc
Confidence 999999975432 788999999999999999999999 99999999999999999999999998865433
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
.....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.
T Consensus 150 ------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 198 (260)
T cd05611 150 ------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198 (260)
T ss_pred ------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence 1334678899999999888889999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=252.12 Aligned_cols=197 Identities=26% Similarity=0.426 Sum_probs=159.5
Q ss_pred ceecccCceEEEEEEEC----CCCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEE-cCCeeEEEEecCC
Q 022206 72 SLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYV-DGPLRVLAYEHAS 144 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~ 144 (301)
+.||+|+||.||+|.+. ....+|+|.+..... ....+.+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999854 245799998854322 2356788999999999999999999765 4566889999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
+++|.+++..... ..++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++....
T Consensus 81 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSETH--------NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999999975432 1567778899999999999999999 9999999999999999999999999987553
Q ss_pred ccccc--cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCC
Q 022206 225 DAAAR--LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTL 279 (301)
Q Consensus 225 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~ 279 (301)
..... .......++..|+|||.+.+..++.++||||||+++|+|++ |.+||...+
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 207 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD 207 (262)
T ss_pred CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 32111 00112345778999999988889999999999999999999 567776543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=257.29 Aligned_cols=197 Identities=29% Similarity=0.478 Sum_probs=169.4
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
|....+||+|+||.||++..+ ++..||+|++..... ....+.+|+.+++.++|+||+++++.+..++..+++|||+++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 334467999999999999976 789999999864332 345688899999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
++|.+++.... +++..+..++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 102 ~~L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 102 GALTDIVTHTR----------MNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred CcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 99999886432 788999999999999999999999 99999999999999999999999998765543
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
.... .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||....
T Consensus 169 ~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~ 220 (292)
T cd06657 169 EVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220 (292)
T ss_pred cccc--ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2211 133457899999999888888999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=254.44 Aligned_cols=196 Identities=27% Similarity=0.394 Sum_probs=164.2
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccC-CCceeeeeeEEEcC--CeeEEEEe
Q 022206 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK-NENVVELVGYYVDG--PLRVLAYE 141 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e 141 (301)
|++.+.||+|+||.||+|.+. ++..+|+|.+...... .....+|+.+++++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 678899999999999999976 7899999998754322 234457888888885 99999999999987 88999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+.+ +|.+.+..... .+++..++.++.|++.||+|||+.+ ++||||+|+||++++ +.+||+|||++.
T Consensus 81 ~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~ 147 (282)
T cd07831 81 LMDM-NLYELIKGRKR--------PLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCR 147 (282)
T ss_pred cCCc-cHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccc
Confidence 9975 88888765331 2889999999999999999999999 999999999999999 999999999987
Q ss_pred CCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
........ ....++..|+|||++.. ..++.++|||||||++|+|++|..||.+.+
T Consensus 148 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 148 GIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred ccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 66433221 23457889999997644 556889999999999999999999997654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=256.62 Aligned_cols=202 Identities=27% Similarity=0.388 Sum_probs=175.4
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccC-CCceeeeeeEEEcCCeeEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 139 (301)
++|.+.+.||+|+||.||++... ++..+++|++..... ....+.+|++++++++ |+||+++++++.+.+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47899999999999999999977 799999999875322 2356788899999998 99999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
||++.+++|.+++.... .+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~ 148 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---------SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGT 148 (280)
T ss_pred EcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCcc
Confidence 99999999999997653 2899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccc------------------cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 220 SNQAPDAAAR------------------LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 220 a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
+......... .......++..|+|||+.....++.++|+||||++++++++|+.||...+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 8765433210 11233457889999999888888999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=262.52 Aligned_cols=198 Identities=28% Similarity=0.405 Sum_probs=168.7
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCC----
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP---- 134 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 134 (301)
...++|++.+.||+|+||.||++.+. ++..||+|++...... ...+.+|+.+++.++|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 35678999999999999999999976 7899999998643222 345788999999999999999999987554
Q ss_pred --eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCce
Q 022206 135 --LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (301)
Q Consensus 135 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (301)
..++||||+ +++|.+++.... +++..+..++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~~----------l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~ 157 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHEK----------LSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCEL 157 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCE
Confidence 358999998 679998886432 889999999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
+|+|||++....... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+
T Consensus 158 kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 158 KILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred EEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999987654321 23457889999998876 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=252.88 Aligned_cols=207 Identities=24% Similarity=0.379 Sum_probs=167.0
Q ss_pred CCCCceecccCceEEEEEEEC----CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCC------
Q 022206 68 FGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP------ 134 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 134 (301)
|.+.+.||+|+||.||+|.++ ++..+|+|++...... .+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677889999999999999854 4688999998754322 346788999999999999999999876432
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
..++++||+.+|+|.+++........ ...++...++.++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl 154 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEE---PFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCV 154 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEE
Confidence 24788999999999988753221110 113788899999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
+|||++................+++.|++||.+....++.++||||||+++|+|++ |.+||.+.+.
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~ 221 (273)
T cd05074 155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN 221 (273)
T ss_pred CcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH
Confidence 99999886643322211223345678999999988889999999999999999999 9999976544
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=255.58 Aligned_cols=192 Identities=27% Similarity=0.442 Sum_probs=160.0
Q ss_pred ceecccCceEEEEEEEC-CC-------CEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 72 SLIGEGSYGRVYFGVLR-SG-------RAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
+.||+|+||.||+|..+ .+ ..+++|.+..... ..+.+.+|+.+++.+.||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 36999999999999865 22 3488888754432 235678899999999999999999999998999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc--------eEE
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI--------AKI 214 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~--------vkl 214 (301)
+++|+|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++. +++
T Consensus 81 ~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l 149 (258)
T cd05078 81 VKFGSLDTYLKKNKN--------LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKL 149 (258)
T ss_pred CCCCcHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEe
Confidence 999999999976542 2788899999999999999999999 999999999999987765 699
Q ss_pred eccccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhC-CCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTG-RKPVDHTLP 280 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g-~~pf~~~~~ 280 (301)
+|||++...... ....+++.|+|||++.+ ..++.++||||||+++|+|++| ..||...++
T Consensus 150 ~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~ 211 (258)
T cd05078 150 SDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS 211 (258)
T ss_pred cccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH
Confidence 999988654322 23457889999999876 4578999999999999999998 577765544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=249.55 Aligned_cols=201 Identities=27% Similarity=0.422 Sum_probs=176.4
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcC--CeeEEEE
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRVLAY 140 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 140 (301)
+|.+.+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+.++++++|+||+++++.+.+. ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999987 789999999876542 346788999999999999999999999988 8899999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
|++++++|.+++.... .+++..++.++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||.+
T Consensus 81 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~ 148 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---------KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCA 148 (260)
T ss_pred EecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccE
Confidence 9999999999997653 2889999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
................++..|+|||.+.....+.++||||||+++|+|++|..||....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 149 KRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred EecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 77655432111234567889999999988889999999999999999999999997655
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=262.14 Aligned_cols=205 Identities=29% Similarity=0.408 Sum_probs=173.6
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch--------HHHHHHHHHHhccCCCceeeeeeEEE-cCCe
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--------QEFLAQVSMVSRLKNENVVELVGYYV-DGPL 135 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 135 (301)
++|-++.+||+|+|+.||+|.+- ..+.||+|+-...+.+. +...+|..+.+.|.||-||++|++|. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 56888999999999999999976 57889999765444333 23567899999999999999999997 6678
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC---CCce
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIA 212 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~v 212 (301)
++-|+|||+|.+|+-+|+.++. +++.++..|+.||+.||.||.+. .++|||-||||.|||+-+ .|.+
T Consensus 543 FCTVLEYceGNDLDFYLKQhkl---------mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeI 612 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKL---------MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEI 612 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhh---------hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCccccee
Confidence 8999999999999999988764 89999999999999999999987 467999999999999965 4789
Q ss_pred EEeccccCCCCCccccc-----cccccccccccccCccccccC----CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 213 KISDFDLSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMTG----QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
||+|||+++.+...... ..++...||.+|++||++.-. ..+.++||||+|||+|+.+.|+.||.++..
T Consensus 613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 99999999887654322 234566799999999988543 467899999999999999999999987643
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=252.35 Aligned_cols=195 Identities=28% Similarity=0.415 Sum_probs=168.2
Q ss_pred ecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCCCH
Q 022206 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (301)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL 148 (301)
||+|+||.||++++. +++.+++|++..... ....+.+|++++++++|+||+++++.+..+...++++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 599999999875433 235678899999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCcccc
Q 022206 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (301)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (301)
.+++.... .+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 81 ASLLENVG---------SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred HHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcc
Confidence 99997643 2889999999999999999999999 99999999999999999999999999876543211
Q ss_pred ------ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 229 ------RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 229 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
........++..|+|||.......+.++|+||||+++|+|++|..||....+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~ 206 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP 206 (265)
T ss_pred cccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 0112344678899999999888889999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=281.24 Aligned_cols=209 Identities=27% Similarity=0.463 Sum_probs=181.1
Q ss_pred CCCCCceecccCceEEEEEEEC-C---CCEEEEEEcCCCC--CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-S---GRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
...+.++||.|.||.|++|+.+ . ...||||.++... +.+.+|+.|+.+|-++.||||+++.|+........||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 4567889999999999999987 2 3569999998654 34568999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
|||++|+|+.||+.+.+. +...++..+++.|+.|++||.+++ +|||||..+||||+.+-..|++|||++
T Consensus 710 EyMENGsLDsFLR~~DGq--------ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQ--------FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred hhhhCCcHHHHHhhcCCc--------eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccce
Confidence 999999999999987753 889999999999999999999999 999999999999999999999999999
Q ss_pred CCCCccccccccccccc--cccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCcCccccc
Q 022206 221 NQAPDAAARLHSTRVLG--TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLV 287 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~ 287 (301)
+.+++...... ++.-| ..+|.|||.+..++++.+|||||+|++|||.++ |..||=+.++++.-.-|
T Consensus 779 Rvledd~~~~y-tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI 847 (996)
T KOG0196|consen 779 RVLEDDPEAAY-TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 847 (996)
T ss_pred eecccCCCccc-cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH
Confidence 98766542211 12212 578999999999999999999999999999886 99999887775544433
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=245.55 Aligned_cols=200 Identities=28% Similarity=0.453 Sum_probs=165.8
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccC-CCceeeeeeEEEcCCeeEEEEe
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 141 (301)
++.+.+..||.|+-|.|++++.+ +|...|||.+.+.... .++++..+.++...+ .|+||+.+++|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 34566778999999999999987 6899999998764332 345666677665554 7999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
.|.- -+..++...+. ++++..+-.+...+++||.||-++. .|+|||+||+|||+|+.|++||||||++-
T Consensus 172 lMs~-C~ekLlkrik~--------piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsG 240 (391)
T KOG0983|consen 172 LMST-CAEKLLKRIKG--------PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISG 240 (391)
T ss_pred HHHH-HHHHHHHHhcC--------CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccc
Confidence 9854 45666654442 2888888899999999999998764 49999999999999999999999999998
Q ss_pred CCCccccccccccccccccccCcccccc---CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
.+.++... +...|-+.|||||.+.- ..|+.++||||||++++||.||+.||.+..
T Consensus 241 rlvdSkAh---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~ 298 (391)
T KOG0983|consen 241 RLVDSKAH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK 298 (391)
T ss_pred eeeccccc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC
Confidence 87665543 55679999999998853 478999999999999999999999998743
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=247.78 Aligned_cols=199 Identities=30% Similarity=0.489 Sum_probs=175.1
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
+|++.+.||+|++|.||+++.. +++.+++|.+..... ....+.+|++++++++|+|++++++++.++...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5888999999999999999977 688999999876543 345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++++|.+++.... .+++..++.++.|++.+|.+||+.+ ++||||+|+||+++.++.++|+|||++..
T Consensus 81 ~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 148 (254)
T cd06627 81 AENGSLRQIIKKFG---------PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATK 148 (254)
T ss_pred CCCCcHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEecccccee
Confidence 99999999987643 2889999999999999999999999 99999999999999999999999999877
Q ss_pred CCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
....... .....++..|+|||...+..++.++|+||||+++|+|++|..||....
T Consensus 149 ~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 149 LNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred cCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 6543321 133467889999999888888999999999999999999999997544
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=257.01 Aligned_cols=203 Identities=27% Similarity=0.386 Sum_probs=169.1
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCC-----
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGP----- 134 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 134 (301)
..++|++.+.||+|+||.||+|.++ +++.|++|++..... ....+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578999999999999999999987 689999999865322 2345778999999999999999999887654
Q ss_pred -----eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC
Q 022206 135 -----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (301)
Q Consensus 135 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 209 (301)
..++++||+++ +|..++..... .+++..++.++.|++.||+|||+.+ |+|+||+|+||+++++
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~ 152 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLV--------HFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNK 152 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 78999999987 77777765421 2889999999999999999999999 9999999999999999
Q ss_pred CceEEeccccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
+.+||+|||++......... ......++..|+|||++.+ ..++.++|||||||++|+|++|++||...+
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~ 222 (302)
T cd07864 153 GQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ 222 (302)
T ss_pred CcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999998765433221 1122345778999998765 456889999999999999999999997644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=261.42 Aligned_cols=202 Identities=24% Similarity=0.391 Sum_probs=169.2
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHhccCCCceeeeeeEEE----cCCee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYV----DGPLR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~ 136 (301)
.++|++.+.||+|+||.||+|... ++..|++|++.... .....+.+|+.++++++|+||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 378999999999999999999977 79999999987532 22356778999999999999999998875 33568
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
++||||+. ++|.+++..... +++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~d 150 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQP---------LTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGD 150 (334)
T ss_pred EEEEehhh-hhHHHHhccCCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecc
Confidence 99999996 589999865432 889999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccc--cccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 217 FDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 217 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
||++......... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 216 (334)
T cd07855 151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216 (334)
T ss_pred cccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence 9998665332211 11123468899999998765 467899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=251.97 Aligned_cols=202 Identities=24% Similarity=0.409 Sum_probs=168.4
Q ss_pred CCCCCceecccCceEEEEEEECC--CCEEEEEEcCCCCC-----------chHHHHHHHHHHhc-cCCCceeeeeeEEEc
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLRS--GRAAAIKKLDSSKQ-----------PDQEFLAQVSMVSR-LKNENVVELVGYYVD 132 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~-----------~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~ 132 (301)
+|++.+.||+|+||.||+|.+.. ++.+|+|.+..... ...++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999763 78899998753211 12346678887764 799999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCCceEEcCCCc
Q 022206 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDI 211 (301)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~ 211 (301)
++..+++|||+++++|.+++...... ...+++..++.++.|++.+|.|||+ .+ ++|+||+|+||++++++.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~ 152 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEK-----KQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDK 152 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCc
Confidence 99999999999999999988532211 1238889999999999999999996 67 999999999999999999
Q ss_pred eEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
++|+|||++....... ......++..|++||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 153 ~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~ 217 (269)
T cd08528 153 VTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217 (269)
T ss_pred EEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence 9999999987654432 1134568899999999988889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=235.45 Aligned_cols=204 Identities=29% Similarity=0.366 Sum_probs=168.1
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEE
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 138 (301)
...++..-+..||+|++|.|-+-++. +|...|+|.+...- +...+..+|+.+..+. ..|++|.+|+.+.++...++
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 33455666778999999999888876 89999999986543 3345677888876555 57999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
.||.|+- ||+.+..+--. .+..+++..+-+|+..++.||.|||++- .++|||+||.|||++.+|+||+||||
T Consensus 123 cME~M~t-Sldkfy~~v~~-----~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 123 CMELMDT-SLDKFYRKVLK-----KGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred eHHHhhh-hHHHHHHHHHh-----cCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccc
Confidence 9999976 88887653221 1234888899999999999999999975 49999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCcccccc----CCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMT----GQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
++-.+.++... +--.|-..|||||.+.. ..|+-++||||||+++.||.+++.||+.
T Consensus 195 IsG~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 195 ISGYLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred cceeehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 99877665443 32357788999998753 4789999999999999999999999975
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=261.21 Aligned_cols=203 Identities=25% Similarity=0.372 Sum_probs=169.1
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHhcc-CCCceeeeeeEEEcC--Cee
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRL-KNENVVELVGYYVDG--PLR 136 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~ 136 (301)
..++|++.+.||+|+||.||+|.+. ++..+|+|++.... .....+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578999999999999999999987 68899999885422 2234577899999999 999999999988643 468
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
++||||+.+ +|.+++.... +.+..++.++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|
T Consensus 85 ~lv~e~~~~-~L~~~~~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d 150 (337)
T cd07852 85 YLVFEYMET-DLHAVIRANI----------LEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLAD 150 (337)
T ss_pred EEEeccccc-CHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEee
Confidence 999999975 9999887542 788889999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccc---cccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 217 FDLSNQAPDAAAR---LHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 217 fg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
||++......... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+..+
T Consensus 151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~ 218 (337)
T cd07852 151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST 218 (337)
T ss_pred ccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9998765433211 11233468899999998765 4578899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=264.32 Aligned_cols=204 Identities=28% Similarity=0.444 Sum_probs=176.5
Q ss_pred CCCCCCceecccCceEEEEEEEC---CC--CEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR---SG--RAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~---~~--~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
....+.+.||.|-||.||.|... .| -.||||+.+.+.. ..+.|..|..+|+.+.||||++++|++.+. ..+|
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence 34455678999999999999954 23 3588999876443 357799999999999999999999999765 5789
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
|||.++.|.|..+|+.++.. ++......++.||+.||.|||+.. +|||||..+|||+....-|||+|||
T Consensus 468 vmEL~~~GELr~yLq~nk~s--------L~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDS--------LPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred EEecccchhHHHHHHhcccc--------chHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccc
Confidence 99999999999999987754 889999999999999999999998 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCcC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRG 282 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~ 282 (301)
+++.......... +....+..|||||.+.-++++.++|||-|||++||++. |..||.+..+.+
T Consensus 537 LSR~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD 600 (974)
T KOG4257|consen 537 LSRYLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD 600 (974)
T ss_pred hhhhccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence 9998877654432 34445788999999999999999999999999999987 999999876644
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=259.38 Aligned_cols=203 Identities=27% Similarity=0.419 Sum_probs=168.3
Q ss_pred hCCCCC-CceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch---------------HHHHHHHHHHhccCCCceeeee
Q 022206 65 TDNFGT-NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---------------QEFLAQVSMVSRLKNENVVELV 127 (301)
Q Consensus 65 ~~~y~~-~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---------------~~~~~e~~~l~~l~h~~iv~~~ 127 (301)
.++|.. .+.||+|+||.||+|.+. +++.||+|++....... ..+.+|+++++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 456764 577999999999999977 78999999886432221 2467899999999999999999
Q ss_pred eEEEcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEc
Q 022206 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207 (301)
Q Consensus 128 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 207 (301)
+++..++..+++|||+.+ +|.+++.... .+++.....++.|++.||+|||+.+ ++|+||+|+||+++
T Consensus 87 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~ 153 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMAS-DLKKVVDRKI---------RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFIN 153 (335)
T ss_pred EEEecCCcEEEEEecccc-CHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEEC
Confidence 999999999999999974 8999986543 2788999999999999999999999 99999999999999
Q ss_pred CCCceEEeccccCCCCCccc------------cccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCC
Q 022206 208 DDDIAKISDFDLSNQAPDAA------------ARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 274 (301)
Q Consensus 208 ~~~~vkl~Dfg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p 274 (301)
.++.++|+|||++....... .........+++.|+|||.+.+. .++.++|+||||+++|+|++|.+|
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p 233 (335)
T PTZ00024 154 SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL 233 (335)
T ss_pred CCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999987654110 00011223467889999988764 468899999999999999999999
Q ss_pred CCCCCC
Q 022206 275 VDHTLP 280 (301)
Q Consensus 275 f~~~~~ 280 (301)
|.+.++
T Consensus 234 ~~~~~~ 239 (335)
T PTZ00024 234 FPGENE 239 (335)
T ss_pred CCCCCH
Confidence 976654
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=256.52 Aligned_cols=203 Identities=30% Similarity=0.397 Sum_probs=164.8
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHhccC-CCceeeeeeEEEcCCeeEEEEe
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 141 (301)
++|...+.||+|+||.||++.+. +++.+|+|.+..... ....+.+|+.++.++. |+||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 45667789999999999999977 689999999875432 2356788999999986 9999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
|+.. +|.++....... ....+++..+..++.|++.||+|||+. + ++||||||+||+++.++.++|+|||++
T Consensus 84 ~~~~-~l~~l~~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~ 155 (288)
T cd06616 84 LMDI-SLDKFYKYVYEV----LKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGIS 155 (288)
T ss_pred cccC-CHHHHHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchh
Confidence 9865 665543211000 011288999999999999999999974 7 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCccccccC---CCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTG---QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
......... ....|++.|+|||++.+. .++.++||||||+++|+|++|+.||....
T Consensus 156 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 156 GQLVDSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred HHhccCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 655432211 233578899999998765 68899999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=259.75 Aligned_cols=200 Identities=26% Similarity=0.381 Sum_probs=168.2
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC---CCchHHHHHHHHHHhccCCCceeeeeeEEEcC-----Ce
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYVDG-----PL 135 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 135 (301)
.++|.+.+.||+|+||.||+|++. ++..||+|.+... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999976 7899999998643 22234577899999999999999999987644 34
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
.++++||+. ++|.+++..... +++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~ 150 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQT---------LSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKIC 150 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEC
Confidence 799999996 589988875432 889999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|||++........ ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||.+.+
T Consensus 151 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 213 (337)
T cd07858 151 DFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213 (337)
T ss_pred cCccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999876643321 1133457889999998765 468899999999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=254.63 Aligned_cols=196 Identities=33% Similarity=0.484 Sum_probs=166.9
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
..|...+.||+|+||.||++++. ++..+|+|++...... ...+.+|+++++.++|+|++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34788889999999999999976 6899999998654322 245778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+.+ +|.+++..... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++
T Consensus 105 e~~~g-~l~~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~ 172 (317)
T cd06635 105 EYCLG-SASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA 172 (317)
T ss_pred eCCCC-CHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCc
Confidence 99975 78777754321 2788999999999999999999999 999999999999999999999999988
Q ss_pred CCCCccccccccccccccccccCccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
...... ....+++.|+|||++. ...++.++||||||+++|+|++|..||...+
T Consensus 173 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 228 (317)
T cd06635 173 SIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228 (317)
T ss_pred cccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 654322 3346788999999874 4567889999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=246.86 Aligned_cols=203 Identities=27% Similarity=0.457 Sum_probs=176.3
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
+|++.+.||+|+||.||++.+. ++..+++|++..... ....+.+|+++++.++|+|++++++.+..+...++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888999999999999999977 789999999875433 345688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++++|.+++..... ....+++..+..++.+++.||.+||+.+ ++|+||+|+||++++++.++|+|||.+..
T Consensus 81 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 81 ADGGDLSQKIKKQKK-----EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV 152 (258)
T ss_pred cCCCcHHHHHHHhhc-----cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceee
Confidence 999999999976431 0123899999999999999999999999 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
...... ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus 153 ~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 153 LSSTVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred cccCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 544321 1233468899999999888889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=257.06 Aligned_cols=198 Identities=25% Similarity=0.370 Sum_probs=168.7
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHhccCCCceeeeeeEEEc-CCeeE
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVD-GPLRV 137 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 137 (301)
...++|++.+.||.|+||.||+|.+. +++.||+|++.+.. .....+.+|+++++.++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 35678999999999999999999977 79999999875432 223567889999999999999999998865 56789
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+++||+. ++|.+++.... ++...+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+||
T Consensus 87 lv~e~~~-~~L~~~~~~~~----------~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~df 152 (328)
T cd07856 87 FVTELLG-TDLHRLLTSRP----------LEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDF 152 (328)
T ss_pred EEeehhc-cCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcc
Confidence 9999984 58999886533 778888899999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|++....... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 153 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 153 GLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred ccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9987543221 23456888999998765 568999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=253.69 Aligned_cols=204 Identities=28% Similarity=0.376 Sum_probs=165.7
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHH-hccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMV-SRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
++.+-+..||.|+||+|++-.++ +|+..|||.+..... ...+++.|.... +.-+.||||+++|.+..++-.|+.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 44555668999999999999988 799999999975443 446677888764 44467999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
.|+- ||+.+...-..... ..+++..+-.|....+.||.||-..- +|||||+||+|||++..|.|||||||++-
T Consensus 144 LMd~-SlDklYk~vy~vq~----~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQK----SRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred HHhh-hHHHHHHHHHHHHh----ccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchH
Confidence 9975 77766532111000 12788888889999999999998764 59999999999999999999999999998
Q ss_pred CCCccccccccccccccccccCcccccc--CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
.+..+... +.-.|-..|||||.+.. ..|+.+|||||||++|||+.||..||+.-+
T Consensus 217 qLv~SiAk---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~ 273 (361)
T KOG1006|consen 217 QLVDSIAK---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD 273 (361)
T ss_pred hHHHHHHh---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH
Confidence 77665543 44568889999998854 468999999999999999999999997643
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=252.22 Aligned_cols=200 Identities=25% Similarity=0.416 Sum_probs=169.7
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHhccCCCceeeeeeEEEcC--CeeEEEEe
Q 022206 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRVLAYE 141 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 141 (301)
|++.+.||+|++|.||+|++. ++..+++|.+.... .....+.+|+.+++.++|+|++++++++.+. +..++++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999987 58999999997653 2235678899999999999999999999887 88999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+++ +|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 81 ~~~~-~l~~~~~~~~~--------~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~ 148 (287)
T cd07840 81 YMDH-DLTGLLDSPEV--------KFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLAR 148 (287)
T ss_pred cccc-cHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEcccccee
Confidence 9985 89998865421 2889999999999999999999999 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~ 207 (287)
T cd07840 149 PYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE 207 (287)
T ss_pred eccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 66543211 1123356788999997765 4578999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=267.47 Aligned_cols=210 Identities=28% Similarity=0.421 Sum_probs=184.0
Q ss_pred HHHHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
++..-..+.....+||-|.||.||.|.|+ -.-.||||.++-+...-++|+.|+.+|+.++|||+|+++++|..+..+||
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 34444456777889999999999999998 46789999999888888999999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
|.|||..|+|.++|++..... ++...+++++.||..|++||..++ +|||||..+|+||.++..||++|||
T Consensus 341 iTEfM~yGNLLdYLRecnr~e-------v~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRSE-------VPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred EEecccCccHHHHHHHhchhh-------cchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccc
Confidence 999999999999998765432 667778899999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
|++.+.......+.. ..-.+.|.|||.+....++.++|||+|||+|||+.| |..||.+.+.
T Consensus 411 LsRlMtgDTYTAHAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl 472 (1157)
T KOG4278|consen 411 LSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 472 (1157)
T ss_pred hhhhhcCCceecccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH
Confidence 998876654332211 123678999999999999999999999999999998 9999987554
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=282.95 Aligned_cols=197 Identities=29% Similarity=0.439 Sum_probs=161.4
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHhccCCCceeeeeeEEEcC------
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDG------ 133 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 133 (301)
.-..+|+.+++||+|+||.||+++.+ +|+.||||++.... .....+.+|+..+.+|+|||||+++..|.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34568999999999999999999998 99999999997653 3335688999999999999999988654110
Q ss_pred --------------------------------------------------------------------------------
Q 022206 134 -------------------------------------------------------------------------------- 133 (301)
Q Consensus 134 -------------------------------------------------------------------------------- 133 (301)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHH
Q 022206 134 ---------------------------------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180 (301)
Q Consensus 134 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 180 (301)
..+||-||||+..+|++++..+... -.....|+++++|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--------~~~d~~wrLFreIl 707 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--------SQRDEAWRLFREIL 707 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--------hhhHHHHHHHHHHH
Confidence 1257889999988888888765521 14678999999999
Q ss_pred HHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC----cc------------ccccccccccccccccCc
Q 022206 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP----DA------------AARLHSTRVLGTFGYHAP 244 (301)
Q Consensus 181 ~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~----~~------------~~~~~~~~~~gt~~y~aP 244 (301)
+||.|+|++| +|||||||.||++++++.|||+|||+|.... .. ......+..+||..|+||
T Consensus 708 EGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 708 EGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred HHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence 9999999999 9999999999999999999999999997721 00 001122456899999999
Q ss_pred cccccC---CCCccccchhhHHHHHHHHh
Q 022206 245 EYAMTG---QMSSKSDVYSFGVVLLELLT 270 (301)
Q Consensus 245 E~~~~~---~~~~~~DvwslG~il~~l~~ 270 (301)
|++.+. .|+.++|+||||+|++||+.
T Consensus 785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred HHhcccccccccchhhhHHHHHHHHHHhc
Confidence 998765 49999999999999999974
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=249.16 Aligned_cols=202 Identities=27% Similarity=0.425 Sum_probs=174.6
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
+|++.+.||+|++|.||++.+. +++.+++|.+..... ....+.+|+++++.++|+||+++++++.+....++++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5888999999999999999976 788999999875432 234677899999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++++|.+++...... ...+++..++.++.|++.||+|||+.| ++|+||+|+||++++++.+||+|||++..
T Consensus 81 ~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 81 APFGDLSKAISKRKKK-----RKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKV 152 (256)
T ss_pred cCCCCHHHHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhh
Confidence 9999999998653211 123788999999999999999999999 99999999999999999999999999877
Q ss_pred CCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
..... .....+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 153 ~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~ 206 (256)
T cd08530 153 LKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM 206 (256)
T ss_pred hccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 65431 1234578899999999888899999999999999999999999976554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=265.18 Aligned_cols=198 Identities=22% Similarity=0.395 Sum_probs=173.5
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHH---------HHHHHHHHhccC---CCceeeeeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQE---------FLAQVSMVSRLK---NENVVELVGYY 130 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~---------~~~e~~~l~~l~---h~~iv~~~~~~ 130 (301)
+..+|..++.||.|+||.|++|.++ +...|+||.+.++..-.+. .-.|+++|..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3457999999999999999999988 6788999998765433222 345899999997 99999999999
Q ss_pred EcCCeeEEEEecC-CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC
Q 022206 131 VDGPLRVLAYEHA-SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (301)
Q Consensus 131 ~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 209 (301)
++++++||+||-- +|.+|.+++..++. +.+.++..|+.|++.|+++||++| |||||||-+|+.++.+
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~---------m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~ 706 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPR---------MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSN 706 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCc---------cchHHHHHHHHHHHhccccccccC---ceecccccccEEEecC
Confidence 9999999999865 56799999988764 889999999999999999999999 9999999999999999
Q ss_pred CceEEeccccCCCCCccccccccccccccccccCccccccCCC-CccccchhhHHHHHHHHhCCCCCCC
Q 022206 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
|-+||+|||.|.......- ..+.||..|.|||++.+..| +..-|||+||++||.++....||..
T Consensus 707 g~~klidfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 707 GFVKLIDFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred CeEEEeeccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9999999999876655432 56789999999999999888 5568999999999999999999863
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=256.40 Aligned_cols=204 Identities=25% Similarity=0.397 Sum_probs=167.0
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcC-------
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG------- 133 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------- 133 (301)
.++|++.+.||+|+||.||+|.++ +++.+++|++...... .....+|+++++.++|+||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 579999999999999999999977 6899999988543222 24567899999999999999999887543
Q ss_pred -CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCce
Q 022206 134 -PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (301)
Q Consensus 134 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (301)
...++++||+.+ +|.+.+..... .+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~--------~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~ 154 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSV--------KLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGIL 154 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 346999999976 77777764321 2899999999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCcccccc---------ccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 213 KISDFDLSNQAPDAAARL---------HSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+|+|||++.......... ......+++.|+|||.+.+. .++.++||||||+++|+|++|++||.+.+.
T Consensus 155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~ 232 (311)
T cd07866 155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232 (311)
T ss_pred EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999987654322110 11223568889999987654 578899999999999999999999976544
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=250.41 Aligned_cols=199 Identities=28% Similarity=0.401 Sum_probs=166.7
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhcc---CCCceeeeeeEEEcCCe-----
Q 022206 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRL---KNENVVELVGYYVDGPL----- 135 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~----- 135 (301)
|++.+.||+|+||.||+|+++ ++..+|+|++...... ...+.+|+.+++++ +|+|++++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678889999999999999987 5899999998743322 23456677766655 69999999999987776
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
.+++|||+.+ +|.+++...... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~-------~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~ 149 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKP-------GLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIA 149 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEe
Confidence 8999999975 899888654321 2889999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|||++......... ....+++.|+|||.+.+..++.++|+||||+++|+|++|.+||.+.+.
T Consensus 150 dfg~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~ 211 (287)
T cd07838 150 DFGLARIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE 211 (287)
T ss_pred ccCcceeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh
Confidence 99998765433211 233578899999999988899999999999999999999999986553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=252.18 Aligned_cols=199 Identities=25% Similarity=0.349 Sum_probs=167.9
Q ss_pred CCCCCceecccCceEEEEEEEC----CCCEEEEEEcCCCC-----CchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCee
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 136 (301)
+|++.+.||+|++|.||+++.. ++..+|+|++.... .....+.+|++++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788999999999999999853 46889999986432 1234577899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
++||||+.+++|.+++.... .+++..+..++.|++.+|.|||+.+ ++||||+|+||+++.++.++|+|
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~d 148 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---------HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTD 148 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---------CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEE
Confidence 99999999999999986533 2788899999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCccccccCC--CCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ--MSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
||++......... ......|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||...
T Consensus 149 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 149 FGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred Ccccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 9998765433211 112345789999999887654 688999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=257.43 Aligned_cols=195 Identities=26% Similarity=0.397 Sum_probs=165.0
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCC------
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGP------ 134 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 134 (301)
.++|.+.+.||+|+||.||+|.+. +++.||+|++..... ....+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999976 789999999865322 2345788999999999999999999886543
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
..++++||+.. +|.+++.. .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL 158 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMGH-----------PLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKI 158 (342)
T ss_pred eEEEEeccccc-CHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 46899999975 78776532 1788999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
+|||++....... ....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+
T Consensus 159 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 159 LDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred eeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999987653221 23457889999998876 467889999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=251.56 Aligned_cols=195 Identities=32% Similarity=0.490 Sum_probs=165.7
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
.|...+.||+|+||+||+|+.. +++.+++|++...... ...+.+|+++++.++|+|++++++++.+....+++||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 3677788999999999999976 7899999998643322 2457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+.+ +|.+++..... .+++..++.++.|++.+|.|||+.| ++|+||+|+||++++++.++|+|||++.
T Consensus 102 ~~~~-~l~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~ 169 (313)
T cd06633 102 YCLG-SASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS 169 (313)
T ss_pred cCCC-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCc
Confidence 9965 78777754321 2788999999999999999999999 9999999999999999999999999986
Q ss_pred CCCccccccccccccccccccCccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
..... ....|+..|+|||++. ...++.++||||||+++|+|++|..||.+.+
T Consensus 170 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~ 224 (313)
T cd06633 170 KSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224 (313)
T ss_pred ccCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 43221 3446888999999874 3567889999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=255.79 Aligned_cols=198 Identities=25% Similarity=0.346 Sum_probs=161.7
Q ss_pred ceeccc--CceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 72 SLIGEG--SYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 72 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
..||+| +||+||++++. +++.||+|++...... .+.+.+|+.+++.++||||+++++++..++..++++||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456776 99999999986 7999999998754433 24578899999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
++|.+++...... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||+.+.....
T Consensus 84 ~~l~~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~ 153 (328)
T cd08226 84 GSANSLLKTYFPE-------GMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVR 153 (328)
T ss_pred CCHHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhc
Confidence 9999998764321 2788889999999999999999999 99999999999999999999999986533221
Q ss_pred ccccc-----ccccccccccccCccccccC--CCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 226 AAARL-----HSTRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 226 ~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
..... ......++..|+|||++.+. .++.++|||||||++|+|++|..||.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred cCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 11000 00112346679999998763 47889999999999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=249.51 Aligned_cols=216 Identities=25% Similarity=0.406 Sum_probs=181.4
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC---CCchHHHHHHHHHHhccCCCceeeeeeEEEc--------C
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYVD--------G 133 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------~ 133 (301)
+.|+...+||+|.||.||+|+.+ +++.||+|++-.+ ........+|+.+|..|+|+|++.++++|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 46777889999999999999987 6888898876432 2223567899999999999999999988752 2
Q ss_pred CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceE
Q 022206 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (301)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (301)
..+|+|+.+|+. +|.-++..... .++..++..++.+++.||.|+|+.. |+|||+||+|+||+.+|.+|
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~v--------r~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilk 164 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKV--------RFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILK 164 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccc--------cccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEE
Confidence 348999999987 89998876542 2889999999999999999999998 99999999999999999999
Q ss_pred EeccccCCCCCcccc--ccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCcCcccccccc
Q 022206 214 ISDFDLSNQAPDAAA--RLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWV 290 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 290 (301)
|+|||+++....... ....+..+.|+.|.+||.+.+ ..|++..|||+.|||+.+|+||.+-|.+++..++-.+|..+
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L 244 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL 244 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence 999999976543322 112244566999999998877 57899999999999999999999999999999999998888
Q ss_pred ccc
Q 022206 291 LTS 293 (301)
Q Consensus 291 ~~~ 293 (301)
.++
T Consensus 245 cGs 247 (376)
T KOG0669|consen 245 CGS 247 (376)
T ss_pred hcc
Confidence 765
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=250.56 Aligned_cols=199 Identities=24% Similarity=0.390 Sum_probs=170.8
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
|++.+.||+|++|.||++... +++.+++|.+...... ...+.+|++++++++|+||+++++++.+++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 677889999999999999976 7899999998654332 456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
++ +|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+...
T Consensus 81 ~~-~l~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~ 148 (283)
T cd05118 81 DT-DLYKLIKDRQR--------GLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSF 148 (283)
T ss_pred CC-CHHHHHHhhcc--------cCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence 76 88888866431 2889999999999999999999999 999999999999999999999999998766
Q ss_pred CccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
...... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.
T Consensus 149 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~ 204 (283)
T cd05118 149 GSPVRP--YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE 204 (283)
T ss_pred CCCccc--ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 543211 1234578889999988776 788999999999999999999999976553
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=268.54 Aligned_cols=211 Identities=31% Similarity=0.505 Sum_probs=184.3
Q ss_pred HHHHHHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhcc-CCCceeeeeeEEE----
Q 022206 58 VDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYV---- 131 (301)
Q Consensus 58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~---- 131 (301)
.+.+....+.|++.+.||.|.+|.||+++.+ +++.+|+|++......+++...|.++++.+ .|||++.++++|.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 3444456688999999999999999999976 799999999998888888899999999887 5899999999986
Q ss_pred -cCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC
Q 022206 132 -DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (301)
Q Consensus 132 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 210 (301)
.++.+|||||||.|||..++++.-.+ ..+.+..+..|++.++.||.+||+.- ++|||||=.|||++.++
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g-------~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~ 160 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKG-------NRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENA 160 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcc-------cchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccC
Confidence 36789999999999999999987653 33899999999999999999999997 99999999999999999
Q ss_pred ceEEeccccCCCCCccccccccccccccccccCcccccc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
.|||.|||++........+ ..+..|||.|||||++.- ..|+.++|+||||++..||.-|.+|+.+..|
T Consensus 161 ~VKLvDFGvSaQldsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP 233 (953)
T KOG0587|consen 161 EVKLVDFGVSAQLDSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP 233 (953)
T ss_pred cEEEeeeeeeeeeeccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence 9999999998776554333 366789999999999853 3577899999999999999999999987554
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=269.20 Aligned_cols=205 Identities=28% Similarity=0.427 Sum_probs=175.6
Q ss_pred CCCCCceecccCceEEEEEEEC--CC--CEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR--SG--RAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
+..+.++||+|.||.|++|.|. +| -.||||.+..+... ..+|++|+.+|.+|+|+|++++||+..+ ....+|+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 4456778999999999999987 34 36899999765544 4789999999999999999999999877 6788999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
|.+++|+|.+.|.+... ..|....+..++.||+.||.||..++ +|||||..+|+|+.....|||+||||.
T Consensus 190 ELaplGSLldrLrka~~-------~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLm 259 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKK-------AILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLM 259 (1039)
T ss_pred hhcccchHHHHHhhccc-------cceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccce
Confidence 99999999999987221 23788888999999999999999998 999999999999999999999999999
Q ss_pred CCCCccccccc-cccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCcC
Q 022206 221 NQAPDAAARLH-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRG 282 (301)
Q Consensus 221 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~ 282 (301)
+.+...+.... .....-...|.|||.++...++.++|||++||+||||+| |..||-+....+
T Consensus 260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q 323 (1039)
T KOG0199|consen 260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ 323 (1039)
T ss_pred eccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH
Confidence 98876654321 223334678999999999999999999999999999998 999998876543
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=249.47 Aligned_cols=198 Identities=25% Similarity=0.422 Sum_probs=167.8
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccC-CCceeeeeeEEEcCCeeEEEEecC
Q 022206 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
|++.+.||+|++|.||+|+.. +++.|++|.+...... .....+|+..+++++ |+|++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 678899999999999999987 6889999998654332 234567889999999 999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
+++|.+++..... ..+++..++.++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++...
T Consensus 81 -~~~l~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~ 149 (283)
T cd07830 81 -EGNLYQLMKDRKG-------KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREI 149 (283)
T ss_pred -CCCHHHHHHhccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceec
Confidence 7799998876541 12789999999999999999999999 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
...... ....++..|+|||++.. ..++.++|+||||+++++|++|++||...+
T Consensus 150 ~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~ 203 (283)
T cd07830 150 RSRPPY---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS 203 (283)
T ss_pred cCCCCc---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence 432211 33457889999998754 457899999999999999999999996654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=256.51 Aligned_cols=200 Identities=27% Similarity=0.385 Sum_probs=171.6
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHhccCCCceeeeeeEEEcCC-----eeE
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP-----LRV 137 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 137 (301)
+|++.+.||+|++|.||+|+.. ++..+++|++.... ...+.+.+|+.+++.++|+||+++++++.+.. ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999976 68999999987543 23456889999999999999999999988765 789
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
++|||+.+ +|.+++.... .+++..++.++.|++.||++||+.| ++||||||+|||++.++.++|+||
T Consensus 81 lv~e~~~~-~l~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~df 147 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ---------PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDF 147 (330)
T ss_pred EEecchhh-hHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccc
Confidence 99999985 8999887543 2889999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccc-cccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 218 DLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 218 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|++......... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||.+.+
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 148 GLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred CceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 998776543210 111334578899999999887 78999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=250.17 Aligned_cols=199 Identities=28% Similarity=0.476 Sum_probs=165.1
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccC-CCceeeeeeEEEcCCeeEEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 139 (301)
..++|++.+.||+|+||.||+|.+. +++.||+|.+...... ...+..|+.++.++. |+||+++++++.+....+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 4578999999999999999999987 5899999998754322 344566777666664 99999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
|||+.+ +|.+++..... .+++..+..++.|++.||+|||+ .+ ++||||+|+||++++++.+||+|||
T Consensus 93 ~e~~~~-~l~~l~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 93 MELMST-CLDKLLKRIQG--------PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred eeccCc-CHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccc
Confidence 999865 78877765322 28889999999999999999997 57 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCC----CCccccchhhHHHHHHHHhCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ----MSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
++......... ....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||..
T Consensus 161 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 161 ISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred cchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 98665432211 2335788999999987554 78899999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=249.54 Aligned_cols=209 Identities=25% Similarity=0.423 Sum_probs=170.6
Q ss_pred HHHHHhhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhc--cCCCceeeeeeEEEcC---
Q 022206 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSR--LKNENVVELVGYYVDG--- 133 (301)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~--- 133 (301)
-......+...+.+.||+|.||+||+|+++ |+.||||++... +...+.+|.++.+. |+|+||+.+++.-..+
T Consensus 204 LVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 204 LVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred HhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 334445678889999999999999999999 899999999744 44567778777654 6999999999874432
Q ss_pred -CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-----CCCCCeEecCCCCCceEEc
Q 022206 134 -PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-----KAEPRIIHRNIKSSNVLLF 207 (301)
Q Consensus 134 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-----~~~~~ivH~Dlkp~Nill~ 207 (301)
..++||.+|.+.|||+++|.... ++....++++..++.||++||. +|+|.|.|||||..||||.
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r~t----------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK 350 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNRNT----------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 350 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhhcc----------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence 25799999999999999999865 8999999999999999999994 6778899999999999999
Q ss_pred CCCceEEeccccCCCCCccc--cccccccccccccccCccccccCC----C--CccccchhhHHHHHHHHhC--------
Q 022206 208 DDDIAKISDFDLSNQAPDAA--ARLHSTRVLGTFGYHAPEYAMTGQ----M--SSKSDVYSFGVVLLELLTG-------- 271 (301)
Q Consensus 208 ~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwslG~il~~l~~g-------- 271 (301)
+++..-|+|+|||....... -....+..+||.+|||||++...- + -..+||||||.++||++-+
T Consensus 351 kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~e 430 (513)
T KOG2052|consen 351 KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVE 430 (513)
T ss_pred cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEeh
Confidence 99999999999997655432 222345678999999999986542 1 1368999999999998743
Q ss_pred --CCCCCCCCC
Q 022206 272 --RKPVDHTLP 280 (301)
Q Consensus 272 --~~pf~~~~~ 280 (301)
++||.+..|
T Consensus 431 ey~~Pyyd~Vp 441 (513)
T KOG2052|consen 431 EYQLPYYDVVP 441 (513)
T ss_pred hhcCCcccCCC
Confidence 468876544
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=257.02 Aligned_cols=201 Identities=22% Similarity=0.330 Sum_probs=165.2
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcC---------
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDG--------- 133 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------- 133 (301)
..+|.+.+.||.|+||.||+|... ++..||+|++..... ....+.+|+++++.++|+||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 478999999999999999999976 789999998865433 335688899999999999999999776543
Q ss_pred -----CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC
Q 022206 134 -----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (301)
Q Consensus 134 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 208 (301)
...++++||+.+ +|.+++.... +++..++.++.||+.||.|||+.| ++||||||+||+++.
T Consensus 84 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~----------l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~ 149 (342)
T cd07854 84 SLTELNSVYIVQEYMET-DLANVLEQGP----------LSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINT 149 (342)
T ss_pred cccccceEEEEeecccc-cHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcC
Confidence 357899999975 9998886432 788999999999999999999999 999999999999984
Q ss_pred -CCceEEeccccCCCCCccccc-cccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 209 -DDIAKISDFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 209 -~~~vkl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
++.++|+|||++......... .......++..|+|||++.. ..++.++|||||||++|+|++|+.||....
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 567899999998765322111 01122357889999997654 567889999999999999999999997554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=258.03 Aligned_cols=198 Identities=29% Similarity=0.437 Sum_probs=168.9
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCCe----
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPL---- 135 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---- 135 (301)
..++|++.+.||+|++|.||+|++. ++..||+|++..... ....+.+|+.+++.++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999987 688999999865322 23457789999999999999999988766554
Q ss_pred --eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceE
Q 022206 136 --RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (301)
Q Consensus 136 --~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (301)
.++|+||+ +++|.+++.... +++..++.++.|++.||+|||+.| ++||||+|+||++++++.++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~k 158 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQK----------LSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELK 158 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEE
Confidence 89999998 569999987532 889999999999999999999999 99999999999999999999
Q ss_pred EeccccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|+|||++....... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+...
T Consensus 159 L~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~ 221 (343)
T cd07851 159 ILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH 221 (343)
T ss_pred Eccccccccccccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99999987654321 33457889999998765 3678899999999999999999999976543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=252.24 Aligned_cols=192 Identities=21% Similarity=0.268 Sum_probs=157.5
Q ss_pred CceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCCCHHHHhc
Q 022206 78 SYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILH 153 (301)
Q Consensus 78 ~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~ 153 (301)
+++.||.++.. +++.||+|++.... .....+.+|+.+++.++|+||+++++++.+.+..+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 34556666654 68999999987542 223568899999999999999999999999999999999999999999997
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCccccc----
Q 022206 154 GKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR---- 229 (301)
Q Consensus 154 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~---- 229 (301)
..... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||.+.........
T Consensus 92 ~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 92 THFPE-------GLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred Hhccc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 54321 2788889999999999999999999 999999999999999999999999988654322110
Q ss_pred -cccccccccccccCcccccc--CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 230 -LHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 230 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
.......++..|+|||++.. ..++.++|+|||||++|+|++|..||.+..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~ 214 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 01123346778999998866 357889999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=253.33 Aligned_cols=200 Identities=24% Similarity=0.313 Sum_probs=163.9
Q ss_pred CCCCCceecccCceEEEEEEEC-C--CCEEEEEEcCCCCC---chHHHHHHHHHHhcc-CCCceeeeeeEEEc----CCe
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-S--GRAAAIKKLDSSKQ---PDQEFLAQVSMVSRL-KNENVVELVGYYVD----GPL 135 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~~---~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~ 135 (301)
+|++.+.||+|+||.||+++.. + +..||+|++..... ....+.+|+.+++++ +|+||+++++.... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788999999999999999976 4 78999999864321 235678899999999 59999999987542 245
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
.++++|++. ++|.+++.... .+++..++.++.|++.||+|||+.| ++||||||+|||+++++.++|+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~ 147 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ---------PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKIC 147 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeC
Confidence 788889886 58999886543 2889999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccc--cccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 216 Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|||++......... .......|++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 99998765432211 11133468999999998765 568899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=242.02 Aligned_cols=192 Identities=29% Similarity=0.404 Sum_probs=167.9
Q ss_pred ecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCCCH
Q 022206 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (301)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL 148 (301)
||+|+||.||++.+. +++.+++|.+..... ....+..|+.+++.++|+||+++++.+.++...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999977 689999999875433 234678899999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCcccc
Q 022206 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228 (301)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~ 228 (301)
.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~ 148 (250)
T cd05123 81 FSHLSKEG---------RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS 148 (250)
T ss_pred HHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC
Confidence 99997653 2789999999999999999999999 99999999999999999999999999876544321
Q ss_pred ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
......++..|+|||...+...+.++|+||||+++|+|++|..||...+
T Consensus 149 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 149 --RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred --cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 1134467889999999988888999999999999999999999997654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=260.75 Aligned_cols=195 Identities=23% Similarity=0.352 Sum_probs=168.1
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEEEEe
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
....|.+...+|.|+|+.|-.+.+. +++..++|++.+.. .+..+|+.++... +|+||+++.+++.++...|+|||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 4678889889999999999999977 78999999998762 2234456554444 79999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEE-cCCCceEEeccccC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLS 220 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill-~~~~~vkl~Dfg~a 220 (301)
.+.|+-|.+.+...+ .....+..|+.+|+.|+.|||++| +|||||||+|||+ ++.++++|+|||.+
T Consensus 397 ~l~g~ell~ri~~~~----------~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a 463 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP----------EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFW 463 (612)
T ss_pred hccccHHHHHHHhcc----------hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechh
Confidence 999998888887655 233677789999999999999999 9999999999999 58999999999999
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
+...... .+.+-|..|.|||++....|++++|+||||++||+||+|+.||....
T Consensus 464 ~~~~~~~-----~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P 517 (612)
T KOG0603|consen 464 SELERSC-----DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP 517 (612)
T ss_pred hhCchhh-----cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC
Confidence 8876651 34466899999999999999999999999999999999999996543
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=272.41 Aligned_cols=145 Identities=26% Similarity=0.359 Sum_probs=130.6
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
.++|.+++.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.+++.++|+||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 468999999999999999999987 7899999998754322 25678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+.+++|.+++..... +++..++.++.||+.||.|||..+ |+||||||+|||++.++.+||+|||+
T Consensus 83 mEy~~g~~L~~li~~~~~---------l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGl 150 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGY---------FDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGL 150 (669)
T ss_pred EeCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCC
Confidence 999999999999975432 788889999999999999999999 99999999999999999999999998
Q ss_pred CC
Q 022206 220 SN 221 (301)
Q Consensus 220 a~ 221 (301)
++
T Consensus 151 s~ 152 (669)
T cd05610 151 SK 152 (669)
T ss_pred Cc
Confidence 75
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=246.78 Aligned_cols=198 Identities=28% Similarity=0.422 Sum_probs=170.2
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
|+..+.||+|.+|.||+|+.. +++.+++|.+.... .....+.+|+.+++.++|+|++++++++.+.+..++++||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567789999999999999977 69999999987643 22356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
.+ +|.+++..... .+++..++.++.|++.||++||+.+ ++||||+|+||++++++.++|+|||++...
T Consensus 81 ~~-~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~ 148 (282)
T cd07829 81 DM-DLKKYLDKRPG--------PLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAF 148 (282)
T ss_pred Cc-CHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCccccc
Confidence 85 99999976531 2889999999999999999999999 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
...... .....++..|+|||.+.+. .++.++||||||+++|+|++|.+||...+
T Consensus 149 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 149 GIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred CCCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 433221 1233457789999988766 78899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=270.00 Aligned_cols=209 Identities=25% Similarity=0.400 Sum_probs=179.8
Q ss_pred CCCCCceecccCceEEEEEEEC-C----CCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-S----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
..+.+++||+|+||+||+|.+- . .-+||+|++...... ..++..|+.+|.++.|||++++++++.... +.||
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 3556789999999999999964 3 357899988654433 578999999999999999999999998766 7889
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
++|+++|+|.++++.++.. +.....+.|..||++||.|||.+. +|||||..+|+||..-..|||.|||+
T Consensus 776 tq~mP~G~LlDyvr~hr~~--------igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgl 844 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDN--------IGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGL 844 (1177)
T ss_pred HHhcccchHHHHHHHhhcc--------ccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecch
Confidence 9999999999999876643 788899999999999999999998 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCcCccccc
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLV 287 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~ 287 (301)
++.................+.|||-|.+....|+.++||||+||++||++| |..||.+...++...++
T Consensus 845 a~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll 913 (1177)
T KOG1025|consen 845 AKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL 913 (1177)
T ss_pred hhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH
Confidence 988876654443344445788999999999999999999999999999998 99999987766555544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=248.48 Aligned_cols=213 Identities=26% Similarity=0.369 Sum_probs=179.0
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC---CCchHHHHHHHHHHhccCCCceeeeeeEEEcCC-----ee
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP-----LR 136 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 136 (301)
.+.+-.+.||-|+||.||.+.+. +|+.|++|++..- -...+.+.+|+++|..++|.|++..+++.+-.. .+
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 45677889999999999999976 8999999987532 223467899999999999999999998876442 46
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
|++.|.+.. +|..++-... .++.+.+.-+++||++||+|||+.+ |.||||||.|+|++.+..+||+|
T Consensus 133 YV~TELmQS-DLHKIIVSPQ---------~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICD 199 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSPQ---------ALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICD 199 (449)
T ss_pred HHHHHHHHh-hhhheeccCC---------CCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecc
Confidence 778888865 8888876543 2888899999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCcCcccccccccc
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVLT 292 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 292 (301)
||+++........ ..+..+.|..|.|||++.+ ..|+.+.||||.|||+.||+.++..|....|.+|-.+|..+++
T Consensus 200 FGLARvee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLG 275 (449)
T KOG0664|consen 200 FGLARTWDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLG 275 (449)
T ss_pred cccccccchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhC
Confidence 9999877655433 2234456889999999987 4789999999999999999999999999999888877766554
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=249.56 Aligned_cols=196 Identities=31% Similarity=0.490 Sum_probs=165.4
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
..|...+.||+|+||.||+|++. ++..+++|.+..... ...++.+|+++++.++|+|++++++++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777889999999999999977 688999998864322 1245778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+. ++|.+++..... .+++..+..++.|++.+|.|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 95 e~~~-~~l~~~~~~~~~--------~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 162 (308)
T cd06634 95 EYCL-GSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA 162 (308)
T ss_pred EccC-CCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccc
Confidence 9997 488877754321 2788999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
...... ....+++.|+|||.+. ...++.++|||||||++|+|++|..||...+
T Consensus 163 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 218 (308)
T cd06634 163 SIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (308)
T ss_pred eeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc
Confidence 654321 3345788999999874 3457889999999999999999999996643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=240.34 Aligned_cols=180 Identities=23% Similarity=0.283 Sum_probs=154.1
Q ss_pred cCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCCCHHHHhcCC
Q 022206 77 GSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGK 155 (301)
Q Consensus 77 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~ 155 (301)
|.++.||+++++ +++.+|+|.+.... ...+|...+....||||+++++++.+.+..+++|||+++++|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 889999999987 78999999987643 2333445555567999999999999999999999999999999998654
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCccccccccccc
Q 022206 156 KGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235 (301)
Q Consensus 156 ~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~ 235 (301)
.. +++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+....... ...
T Consensus 80 ~~---------l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~ 142 (237)
T cd05576 80 LN---------IPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGE 142 (237)
T ss_pred cC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccC
Confidence 32 788999999999999999999999 9999999999999999999999999876554321 223
Q ss_pred cccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 236 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
.++..|+|||.+.+..++.++|+||+|+++|+|++|+.||..
T Consensus 143 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 143 AVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred CcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 456789999998888889999999999999999999998764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=243.59 Aligned_cols=201 Identities=23% Similarity=0.350 Sum_probs=165.0
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC------CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS------KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
+|.+.+.||+|+||.||++++. .+..+++|+++.. ......+.+|+.+++.++||||+++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5889999999999999999976 4555666655421 12233566788999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
+||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||++++ +.++|+|||+
T Consensus 81 ~e~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~ 151 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHT-----GKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGV 151 (260)
T ss_pred EEeCCCCCHHHHHHHHhhc-----ccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCc
Confidence 9999999999988642211 123889999999999999999999999 999999999999975 5699999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
+......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~ 208 (260)
T cd08222 152 SRLLMGSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ 208 (260)
T ss_pred eeecCCCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 8765432211 13345788999999988888899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=280.55 Aligned_cols=192 Identities=27% Similarity=0.485 Sum_probs=161.7
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
....|...+.||+|+||.||+|++. ++..||+|++...... ...|++.+++++||||+++++++.+.+..++||||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 3456778889999999999999975 7899999998654322 23468889999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++|+|.++++. +++..+..++.|++.||+|||....++|+||||||+||+++.++..++. ||....
T Consensus 765 ~~~g~L~~~l~~------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 765 IEGKNLSEVLRN------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred CCCCcHHHHHhc------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 999999999963 7888999999999999999994423339999999999999998887775 555433
Q ss_pred CCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
.... ....+|+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 832 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 832 LCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred cccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 2111 223678999999999999999999999999999999999999954
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=246.06 Aligned_cols=204 Identities=20% Similarity=0.326 Sum_probs=175.6
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCC--C----ceeeeeeEEEcCCee
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN--E----NVVELVGYYVDGPLR 136 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--~----~iv~~~~~~~~~~~~ 136 (301)
...+|.++..||+|.||.|-.+.++ ++..||||+++.-.+..+..+-|++++.++.+ | -++++.++|.-.++.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 3678999999999999999999977 67899999998777777888889999999943 2 367888889999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC--------
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-------- 208 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-------- 208 (301)
+||+|.+ |-|+++++..+... +++...+..++.|+++++++||+.. ++|.||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N~y~-------~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYI-------PFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred EEEEecc-ChhHHHHhccCCcc-------ccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEec
Confidence 9999998 44999999876543 3899999999999999999999998 999999999999941
Q ss_pred ------------CCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCC
Q 022206 209 ------------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276 (301)
Q Consensus 209 ------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~ 276 (301)
+-.|+|+|||.|....... +..+.|-.|.|||++.+-+++..+||||+||||+||++|...|.
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 2368999999987654332 55677999999999999999999999999999999999999998
Q ss_pred CCCCcCc
Q 022206 277 HTLPRGQ 283 (301)
Q Consensus 277 ~~~~~~~ 283 (301)
..++.+.
T Consensus 311 tHen~EH 317 (415)
T KOG0671|consen 311 THENLEH 317 (415)
T ss_pred cCCcHHH
Confidence 7765443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=228.13 Aligned_cols=208 Identities=18% Similarity=0.302 Sum_probs=172.0
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccC-CCceeeeeeEEEcC--CeeEEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDG--PLRVLA 139 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv 139 (301)
..++|++.+++|+|.+++||.|... +.+.++||+++.- ....+.+|+++|+.|. ||||++++++..+. ....++
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4578999999999999999999955 7899999998743 3467899999999997 99999999998764 457799
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC-CCceEEeccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFD 218 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg 218 (301)
+||+++.+...+... ++...+..++.|++.||.|||++| |+|||+||.|++||. .-.++|+|||
T Consensus 114 FE~v~n~Dfk~ly~t------------l~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWG 178 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYPT------------LTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
T ss_pred hhhhccccHHHHhhh------------hchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecc
Confidence 999999888887654 778889999999999999999999 999999999999986 4579999999
Q ss_pred cCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCC-CCCcCccccccccc
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDH-TLPRGQQSLVTWVL 291 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~ 291 (301)
+|......... +-.+.+..|.-||++.. +.|+..-|+|||||++..|+..+-||-. .++.+|-..|..++
T Consensus 179 LAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVL 250 (338)
T KOG0668|consen 179 LAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVL 250 (338)
T ss_pred hHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHh
Confidence 99876554332 34456777899998865 5678899999999999999998888754 44445554444443
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=260.05 Aligned_cols=211 Identities=27% Similarity=0.442 Sum_probs=173.3
Q ss_pred hhCCCCCCceecccCceEEEEEEEC----C----CCEEEEEEcCCCCC--chHHHHHHHHHHhcc-CCCceeeeeeEEEc
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR----S----GRAAAIKKLDSSKQ--PDQEFLAQVSMVSRL-KNENVVELVGYYVD 132 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 132 (301)
..++..+.+.||+|+||.|++|... . ...||||.++.... ..+.+..|+++|+.+ .|+||+.+++.+..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3445567779999999999999843 1 45799999875433 346789999999998 59999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHhcCCCCCCCCC-----CC--CCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceE
Q 022206 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAK-----PG--PVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (301)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~-----~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nil 205 (301)
.+..++|+||+..|+|.++++..+...... +. ..++....+.++.||+.|++||++.. +|||||..+|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence 999999999999999999998776111111 11 24899999999999999999999998 999999999999
Q ss_pred EcCCCceEEeccccCCCCCcccccc-ccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCC
Q 022206 206 LFDDDIAKISDFDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDH 277 (301)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~ 277 (301)
+.++..+||+|||+|+......... ..+...-...|||||.+....++.++||||+|++|||++| |..||.+
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 9999999999999998655443321 1111113567999999999999999999999999999999 9999987
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=221.94 Aligned_cols=198 Identities=33% Similarity=0.494 Sum_probs=171.2
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCC
Q 022206 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
|.+.+.||+|++|.||++... +++.+++|.+..... ....+.+|++.++.++|+|++++++.+......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 567889999999999999987 489999999976543 35678889999999999999999999999899999999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
+++|.+++...... +++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||++....
T Consensus 81 ~~~L~~~~~~~~~~--------~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 81 GGDLFDYLRKKGGK--------LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIH 149 (225)
T ss_pred CCCHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence 99999999764321 678889999999999999999998 9999999999999999999999999987765
Q ss_pred ccccccccccccccccccCcccc-ccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 225 DAAARLHSTRVLGTFGYHAPEYA-MTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
..... ......++..|++||.+ ....++.++|+|+||+++++|++|+.||.+
T Consensus 150 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 150 RDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred Ccccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 43210 11334578889999988 666778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=245.15 Aligned_cols=210 Identities=24% Similarity=0.368 Sum_probs=153.6
Q ss_pred hhCCCCCCceecccCceEEEEEEE-----------------CCCCEEEEEEcCCCCCc---------------hHHHHHH
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVL-----------------RSGRAAAIKKLDSSKQP---------------DQEFLAQ 111 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~---------------~~~~~~e 111 (301)
..++|++.++||+|+||.||+|.. ..++.||||++...... .+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 13568999998643221 1223346
Q ss_pred HHHHhccCCCce-----eeeeeEEEc--------CCeeEEEEecCCCCCHHHHhcCCCCCC---------------CCCC
Q 022206 112 VSMVSRLKNENV-----VELVGYYVD--------GPLRVLAYEHASKGSLHDILHGKKGVK---------------GAKP 163 (301)
Q Consensus 112 ~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~---------------~~~~ 163 (301)
+.++.+++|.++ +++++++.. .+..++||||+++++|.++++...... ....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766544 566676542 356899999999999999997532110 0011
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCccccccccccccccccccC
Q 022206 164 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243 (301)
Q Consensus 164 ~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 243 (301)
...+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++......... ......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 123567788899999999999999999 999999999999999999999999998654332211 1112235789999
Q ss_pred ccccccCC--------------------C--CccccchhhHHHHHHHHhCCC-CCCC
Q 022206 244 PEYAMTGQ--------------------M--SSKSDVYSFGVVLLELLTGRK-PVDH 277 (301)
Q Consensus 244 PE~~~~~~--------------------~--~~~~DvwslG~il~~l~~g~~-pf~~ 277 (301)
||.+.... + ..+.|+||+||++|+|++|.. ||.+
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 99875432 1 124699999999999999885 7754
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=227.07 Aligned_cols=210 Identities=22% Similarity=0.415 Sum_probs=170.5
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhcc-CCCceeeeeeE-EEcCCeeEEE
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGY-YVDGPLRVLA 139 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-~~~~~~~~lv 139 (301)
...+.|.+.+.||+|.||.+.+++++ +...+++|.+........+|.+|+.---.| .|.||+.-|++ |+..+.++++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 34578999999999999999999988 788999999998888888999998764444 58899988765 6788889999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC--CCceEEecc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--DDIAKISDF 217 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~--~~~vkl~Df 217 (301)
+||++.|+|.+-+.... +.+.....++.|++.||.|+|+.+ +||||||.+||||-+ ..+||||||
T Consensus 101 qE~aP~gdL~snv~~~G----------igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAG----------IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred eccCccchhhhhcCccc----------ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeec
Confidence 99999999999887644 788889999999999999999999 999999999999964 458999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccC-----CCCccccchhhHHHHHHHHhCCCCCCCCCCcCccccccccc
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-----QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVL 291 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 291 (301)
|+......... ...-+..|.+||..... ...+.+|+|.||+++|.++||.+||+...- .+..+.+|..
T Consensus 168 G~t~k~g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~ 240 (378)
T KOG1345|consen 168 GLTRKVGTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQ 240 (378)
T ss_pred ccccccCceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHH
Confidence 99876554322 22235679999976432 346789999999999999999999985433 3333334443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=250.06 Aligned_cols=206 Identities=21% Similarity=0.255 Sum_probs=144.8
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-C----CCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeE------EEc
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-S----GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGY------YVD 132 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~------~~~ 132 (301)
..++|++.+.||+|+||.||+|++. + +..||+|++...... +....+ .++...+.++..++.. ..+
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 4678999999999999999999976 5 789999987643221 111111 1222222222222211 245
Q ss_pred CCeeEEEEecCCCCCHHHHhcCCCCCC-----------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCC
Q 022206 133 GPLRVLAYEHASKGSLHDILHGKKGVK-----------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (301)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp 201 (301)
+...++|+||+.+++|.+++....... ............+..++.|++.||.|||+.+ |+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCH
Confidence 667899999999999999987543100 0001111233456689999999999999999 99999999
Q ss_pred CceEEcC-CCceEEeccccCCCCCccccccccccccccccccCccccccC----------------------CCCccccc
Q 022206 202 SNVLLFD-DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG----------------------QMSSKSDV 258 (301)
Q Consensus 202 ~Nill~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv 258 (301)
+|||+++ ++.+||+|||++......... ......+++.|+|||.+... .++.++||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 9999986 589999999999765432211 22456789999999965432 23345699
Q ss_pred hhhHHHHHHHHhCCCCCC
Q 022206 259 YSFGVVLLELLTGRKPVD 276 (301)
Q Consensus 259 wslG~il~~l~~g~~pf~ 276 (301)
|||||++|||+++..|+.
T Consensus 363 wSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred HHHHHHHHHHHhCcCCCc
Confidence 999999999999877764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=218.84 Aligned_cols=185 Identities=35% Similarity=0.527 Sum_probs=163.8
Q ss_pred CceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCCCHHHHhcC
Q 022206 78 SYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHG 154 (301)
Q Consensus 78 ~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 154 (301)
+||.||+|.+. +++.+++|++...... ...+.+|++.+++++|+||+++++.+......++++|++.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 5899999998765433 46789999999999999999999999998999999999999999999876
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCcccccccccc
Q 022206 155 KKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234 (301)
Q Consensus 155 ~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 234 (301)
... ++...++.++.+++.++.+||+.+ ++|+||+|+||++++++.++|+|||.+........ ...
T Consensus 81 ~~~---------~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~ 145 (244)
T smart00220 81 RGR---------LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL---LTT 145 (244)
T ss_pred ccC---------CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccccc---ccc
Confidence 432 788899999999999999999999 99999999999999999999999999877654321 134
Q ss_pred ccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 235 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
..++..|++||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 146 ~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 146 FVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred ccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 4678899999999888889999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=237.99 Aligned_cols=207 Identities=21% Similarity=0.258 Sum_probs=176.9
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCC------CceeeeeeEEEcCCe
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN------ENVVELVGYYVDGPL 135 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~~~ 135 (301)
....+|.+....|+|-||+|..|.+. -|..||||++.........=+.|+++|++|+. -++++++-.|...++
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 34567888899999999999999977 58899999998776666666789999999963 488999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC-CceEE
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKI 214 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~vkl 214 (301)
+|||+|-+.- +|.++|.+..... .|....+..++.|+..||..|-..| |+|.||||+||||++. ..+||
T Consensus 509 LClVFE~Lsl-NLRevLKKyG~nv------GL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKL 578 (752)
T KOG0670|consen 509 LCLVFEPLSL-NLREVLKKYGRNV------GLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKL 578 (752)
T ss_pred eEEEehhhhc-hHHHHHHHhCccc------ceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeee
Confidence 9999999865 8999998654321 2778889999999999999999999 9999999999999975 56899
Q ss_pred eccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCcCc
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~ 283 (301)
||||.|........ +....+-.|.|||++.+..|+...|+||.||+||||+||+..|.+.++.+.
T Consensus 579 CDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M 643 (752)
T KOG0670|consen 579 CDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM 643 (752)
T ss_pred ccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH
Confidence 99999987766543 223345679999999999999999999999999999999999999876443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=246.28 Aligned_cols=202 Identities=29% Similarity=0.431 Sum_probs=164.1
Q ss_pred CCCCceecccCceE-EEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 68 FGTNSLIGEGSYGR-VYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 68 y~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
|.-.+++|.|+-|+ ||+|... ++.||||.+-.+. -.-..+|++.|+.- .||||+++++.-.+....||..|.|..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 44566789998865 7899887 7899999875432 23467899998877 699999999999999999999999987
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC---C--CceEEeccccC
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---D--DIAKISDFDLS 220 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~--~~vkl~Dfg~a 220 (301)
+|.++++.. ... ... ......+.++.|++.||++||+.+ ||||||||.||||+. + .+++|+|||++
T Consensus 588 -sL~dlie~~-~~d-~~~---~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 588 -SLQDLIESS-GLD-VEM---QSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred -hHHHHHhcc-ccc-hhh---cccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccc
Confidence 999999874 111 100 122456788999999999999999 999999999999986 3 46899999999
Q ss_pred CCCCccccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCc
Q 022206 221 NQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (301)
Q Consensus 221 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~ 281 (301)
+.+...... .+.....||-+|+|||++.....+.++|||||||++|+.++ |..||++...+
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R 721 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER 721 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh
Confidence 998765432 22355679999999999999888889999999999999988 59999876544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=219.08 Aligned_cols=202 Identities=23% Similarity=0.298 Sum_probs=169.8
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC---CCchHHHHHHHHHHhccCCCceeeeeeEEEcC------C
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYVDG------P 134 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 134 (301)
..+|.-++.+|.|+- .|-.+-+. .+++||+|++... ....+...+|+..+..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 357888889999998 66666665 7899999987543 22346678899999999999999999998643 3
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
..|+|||+|.. +|.+.+... +.-..+..++.|++.|++|||+.| |+||||||+||++..++.+||
T Consensus 95 e~y~v~e~m~~-nl~~vi~~e-----------lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi 159 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILME-----------LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKI 159 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHHh-----------cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheee
Confidence 57999999976 999988722 777889999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCcCccc
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 285 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~ 285 (301)
.|||+|...... ...+..+.|-.|.|||++.+..+.+.+||||+||++.||++|..-|.+.+-.+|..
T Consensus 160 ~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ 227 (369)
T KOG0665|consen 160 LDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWN 227 (369)
T ss_pred ccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHH
Confidence 999999776544 22355677889999999999889999999999999999999999998765544433
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=219.66 Aligned_cols=223 Identities=23% Similarity=0.333 Sum_probs=181.5
Q ss_pred HHHhhCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEE-
Q 022206 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYV- 131 (301)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~- 131 (301)
+.....++++..++-+|.||+||.|.++ +.+.|.+|.++..... -..+..|.-.+..+.|||++.+.++..
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 3334456888888999999999999765 2456778877543322 345777888888899999999999876
Q ss_pred cCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc
Q 022206 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (301)
Q Consensus 132 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (301)
+....+.++.+..-|+|..++...+... .+-...++..+...++.|++.|++|||+++ +||.||..+|++|++.-.
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~-~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDD-PSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCC-CccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhee
Confidence 4566788899999999999998655322 222344778888999999999999999999 999999999999999999
Q ss_pred eEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCcCccccc
Q 022206 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRGQQSLV 287 (301)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~~~~~~ 287 (301)
|||+|=.+++.+-..+..........+..||+||.+.+..|+.++|+|||||++|||+| |+.||.+.+|.+....+
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl 511 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL 511 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence 99999999988766655444444456789999999999999999999999999999999 99999998886655443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=237.42 Aligned_cols=200 Identities=30% Similarity=0.456 Sum_probs=175.0
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch-HHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
-.++|++++.+|+|.+|.||+++++ +++..|+|+++...... .-+..|+-+++..+|+||+.+++.+...+.+++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3578999999999999999999987 89999999998766554 446778999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
||.||+|++..+.-. ++++.++..++++.+.+|+|||++| -+|||||-.||++++.|.||+.|||.+.
T Consensus 93 ycgggslQdiy~~Tg---------plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsa 160 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSA 160 (829)
T ss_pred ecCCCcccceeeecc---------cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchh
Confidence 999999999876543 3899999999999999999999999 8999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCcccc---ccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYA---MTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
.+.....+ ...+.||+.|||||+- +...|...+|||++|++..|+---++|.-+
T Consensus 161 qitati~K--rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfd 217 (829)
T KOG0576|consen 161 QITATIAK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFD 217 (829)
T ss_pred hhhhhhhh--hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccc
Confidence 76544332 2567899999999975 456789999999999999999887777543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-28 Score=196.58 Aligned_cols=182 Identities=35% Similarity=0.575 Sum_probs=158.0
Q ss_pred ecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCCCHHH
Q 022206 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD 150 (301)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~ 150 (301)
||+|.+|.||++... +++.+++|++...... ...+.+|++.++.++|++|+++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999987 5899999999866543 4678999999999999999999999999899999999999999999
Q ss_pred HhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC-CCceEEeccccCCCCCccccc
Q 022206 151 ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQAPDAAAR 229 (301)
Q Consensus 151 ~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a~~~~~~~~~ 229 (301)
++.... ..++...++.++.+++.+|++||+.+ ++|+||+|.||+++. ++.++|+|||.+........
T Consensus 81 ~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~- 148 (215)
T cd00180 81 LLKENE--------GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS- 148 (215)
T ss_pred HHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-
Confidence 997642 12788999999999999999999999 999999999999999 89999999999876544321
Q ss_pred cccccccccccccCccccccC-CCCccccchhhHHHHHHH
Q 022206 230 LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLEL 268 (301)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l 268 (301)
......+...|++||.+... .++.+.|+|+||+++++|
T Consensus 149 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 149 -LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred -hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 11334578889999988776 788999999999999988
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=210.94 Aligned_cols=132 Identities=22% Similarity=0.389 Sum_probs=114.4
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccC-----C---CceeeeeeEEE----c
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-----N---ENVVELVGYYV----D 132 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----h---~~iv~~~~~~~----~ 132 (301)
++|.+.++||-|.|++||+|.+. +.+.||+|+.+......+..+.|+++|++++ | ..||++++.|. +
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 78999999999999999999976 7889999999887777888899999999884 2 47999999987 4
Q ss_pred CCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEc
Q 022206 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207 (301)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 207 (301)
+.++++|+|++ |.+|..+|....... ++...+.+|++|++.||.|||+.- .|||.||||+|||+.
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~YrG-------lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNYRG-------LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCCCC-------CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 66899999999 558888886544322 889999999999999999999874 499999999999994
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=213.64 Aligned_cols=201 Identities=26% Similarity=0.396 Sum_probs=168.0
Q ss_pred HHHhhCCCCCCceecccCceEEEEEEEC----CCCEEEEEEcCCCCCchHHHHHHHHHHhccC-CCceeeeeeEEEcCCe
Q 022206 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPL 135 (301)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 135 (301)
+....+.|..+++||.|.|++||++.+. ..+.||+|.+...... ..+.+|+++|..+. +.||+++.+.+..++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 4556778999999999999999999854 3678999998764433 45889999999985 7899999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC-CceEE
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKI 214 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~vkl 214 (301)
..+|+||++..+..+++.. ++...+..+++.++.||.++|.+| ||||||||.|+|.+.. +.-.|
T Consensus 110 v~ivlp~~~H~~f~~l~~~------------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~L 174 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS------------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVL 174 (418)
T ss_pred eEEEecccCccCHHHHHhc------------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceE
Confidence 9999999999999999876 778899999999999999999999 9999999999999864 67789
Q ss_pred eccccCCCCCccc-----------------c-------------------------ccccccccccccccCcccccc-CC
Q 022206 215 SDFDLSNQAPDAA-----------------A-------------------------RLHSTRVLGTFGYHAPEYAMT-GQ 251 (301)
Q Consensus 215 ~Dfg~a~~~~~~~-----------------~-------------------------~~~~~~~~gt~~y~aPE~~~~-~~ 251 (301)
+|||+|....... . ........||++|.|||++.. ..
T Consensus 175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~ 254 (418)
T KOG1167|consen 175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR 254 (418)
T ss_pred EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence 9999986210000 0 000112469999999998876 45
Q ss_pred CCccccchhhHHHHHHHHhCCCCCCC
Q 022206 252 MSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 252 ~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
.+.++||||.|+|+..+++++.||-.
T Consensus 255 QttaiDiws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 255 QTTAIDIWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred cCCccceeeccceeehhhcccccccc
Confidence 68899999999999999999999854
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=210.11 Aligned_cols=164 Identities=20% Similarity=0.189 Sum_probs=127.8
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC--CCCEEEEEEcCCCC------CchHHHHHHHHHHhccCCCceee-eeeEEEcC
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSK------QPDQEFLAQVSMVSRLKNENVVE-LVGYYVDG 133 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~ 133 (301)
...++|.+.+.||+|+||+||+|.++ +++.+|||++.... .....+.+|+++|+.++|+|++. +++ .
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~ 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----T 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----c
Confidence 35678999999999999999999875 57778999875321 12356889999999999999985 443 2
Q ss_pred CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCC-CCCceEEcCCCce
Q 022206 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI-KSSNVLLFDDDIA 212 (301)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dl-kp~Nill~~~~~v 212 (301)
+..++||||++|++|... .. .. ...++.|++.+|.|||+.| |+|||| ||+|||++.++.+
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~------------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~i 151 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP------------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEA 151 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc------------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCE
Confidence 457999999999999632 11 11 1357889999999999999 999999 9999999999999
Q ss_pred EEeccccCCCCCccccccc------cccccccccccCcccccc
Q 022206 213 KISDFDLSNQAPDAAARLH------STRVLGTFGYHAPEYAMT 249 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 249 (301)
||+|||+|+.......... -....+++.|+|||.+..
T Consensus 152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999999986644321100 124567889999998854
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=194.71 Aligned_cols=206 Identities=23% Similarity=0.311 Sum_probs=173.0
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCC-CceeeeeeEEEcCCeeEEEEe
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 141 (301)
..++|.++++||+|+||.+|+|..- +|..||||+-+... ...++..|.++.+.|++ ..|..+..+..+...-.+||+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3578999999999999999999965 79999999865443 33557788999999986 678888888888899999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC---CceEEeccc
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---DIAKISDFD 218 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~vkl~Dfg 218 (301)
.+ |.+|.++.+-.... ++..+++-++-|++.-++|+|.++ ++||||||+|+|+.-+ ..+.|+|||
T Consensus 92 LL-GPsLEdLfnfC~R~--------ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFG 159 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRR--------FTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFG 159 (341)
T ss_pred cc-CccHHHHHHHHhhh--------hhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEecc
Confidence 98 55999998766543 889999999999999999999999 9999999999999743 468999999
Q ss_pred cCCCCCcccccc-----ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCcC
Q 022206 219 LSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (301)
Q Consensus 219 ~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~ 282 (301)
+|+...+..... ......||.+|.+--...+...+.+.|+-|+|.+|..+.-|.+||++..+..
T Consensus 160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 998876554332 2245679999999877777788899999999999999999999999876643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=198.44 Aligned_cols=202 Identities=23% Similarity=0.333 Sum_probs=172.7
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccC-CCceeeeeeEEEcCCeeEEEEecC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
-.|++.++||+|+||+.|.|+.- +++.||||.-.. +....++..|....+.|. .++|...+-+..++.+-.||+|.+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 47999999999999999999965 899999997543 334466888898888886 589999998888888889999998
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC-----ceEEeccc
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-----IAKISDFD 218 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-----~vkl~Dfg 218 (301)
|-+|.++..-+... ++..++..++.|++.-++|+|++. +|.|||||+|+||..-+ .|.|+|||
T Consensus 107 -GPSLEDLFD~CgR~--------FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRR--------FSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred -CcCHHHHHHHhcCc--------ccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEecc
Confidence 55999988766543 999999999999999999999999 99999999999997543 58899999
Q ss_pred cCCCCCccccccc-----cccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 219 LSNQAPDAAARLH-----STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 219 ~a~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+|+...+.....+ .....||.+||+-....+...+.+.|+-|||-+++..|-|.+||.+...
T Consensus 175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 9998766554322 2356799999999989999999999999999999999999999988543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=206.86 Aligned_cols=204 Identities=22% Similarity=0.284 Sum_probs=166.6
Q ss_pred CCCCCceecccCceEEEEEEECC--CCEEEEEEcCCCCCch-HHHHHHHHHHhccCC----CceeeeeeEE-EcCCeeEE
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLRS--GRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKN----ENVVELVGYY-VDGPLRVL 138 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~h----~~iv~~~~~~-~~~~~~~l 138 (301)
+|.+.+.||+|+||.||+|.+.. ...+|+|+........ ..+..|..++..+.. .++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999999774 3578899876543222 267788888888863 6889999888 57888999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC-----CceE
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-----DIAK 213 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-----~~vk 213 (301)
||+.+ |.+|.++...... ..++..++..++.|++.+|++||+.| ++||||||.|+++... ..+.
T Consensus 99 VM~l~-G~sL~dl~~~~~~-------~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~ 167 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPP-------GRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLY 167 (322)
T ss_pred EEecc-CccHHHHHHhCCC-------CCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEE
Confidence 99988 6699998865442 23899999999999999999999999 9999999999999865 3699
Q ss_pred EeccccCC--CCCcccc---c-c-c-cccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 214 ISDFDLSN--QAPDAAA---R-L-H-STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 214 l~Dfg~a~--~~~~~~~---~-~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
|+|||+++ ....... . . . .....||..|.++.+..+...+.+.|+||++.++.+|+.|..||......
T Consensus 168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~ 243 (322)
T KOG1164|consen 168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMT 243 (322)
T ss_pred EEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccccc
Confidence 99999998 3211111 1 0 1 12345999999999999999999999999999999999999999776643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=186.02 Aligned_cols=170 Identities=14% Similarity=0.182 Sum_probs=133.2
Q ss_pred hhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHH----------HHHHHHHHhccCCCceeeeeeEEEcC
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE----------FLAQVSMVSRLKNENVVELVGYYVDG 133 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~----------~~~e~~~l~~l~h~~iv~~~~~~~~~ 133 (301)
..++|+..++||.|+||.||++.. ++..+|+|++.......+. +.+|+..+.+++|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467999999999999999999766 5778999999754333322 57899999999999999998886643
Q ss_pred --------CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceE
Q 022206 134 --------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (301)
Q Consensus 134 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nil 205 (301)
...+++|||++|.+|.++.. ++. ....+++.+|..+|+.| ++|||+||.||+
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nil 167 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFI 167 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEE
Confidence 35789999999999988732 332 24569999999999999 999999999999
Q ss_pred EcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHH
Q 022206 206 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 269 (301)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~ 269 (301)
++++| ++|+|||........... . .......++.++|+||||+++..+.
T Consensus 168 i~~~g-i~liDfg~~~~~~e~~a~---d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 168 VSKNG-LRIIDLSGKRCTAQRKAK---D-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EeCCC-EEEEECCCcccccchhhH---H-----------HHHHHhHhcccccccceeEeehHHH
Confidence 99988 999999987655322111 0 0234455678999999999876543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=223.43 Aligned_cols=150 Identities=20% Similarity=0.232 Sum_probs=113.5
Q ss_pred hccCC-CceeeeeeEE-------EcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 022206 116 SRLKN-ENVVELVGYY-------VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187 (301)
Q Consensus 116 ~~l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH 187 (301)
+.++| +||+++++++ .....+++++|++ +++|.+++.... ..+++..++.++.||+.||.|||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH 97 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--------RSVDAFECFHVFRQIVEIVNAAH 97 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--------ccccHHHHHHHHHHHHHHHHHHH
Confidence 34455 5777788776 2334677788887 459999997532 12889999999999999999999
Q ss_pred hCCCCCeEecCCCCCceEEcCCC-------------------ceEEeccccCCCCCccccc--------------ccccc
Q 022206 188 EKAEPRIIHRNIKSSNVLLFDDD-------------------IAKISDFDLSNQAPDAAAR--------------LHSTR 234 (301)
Q Consensus 188 ~~~~~~ivH~Dlkp~Nill~~~~-------------------~vkl~Dfg~a~~~~~~~~~--------------~~~~~ 234 (301)
++| |+||||||+||||+..+ .+|++|||+++........ .....
T Consensus 98 ~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (793)
T PLN00181 98 SQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQIL 174 (793)
T ss_pred hCC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccc
Confidence 999 99999999999996544 4555566665432110000 00012
Q ss_pred ccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 235 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
..||+.|+|||++.+..++.++|||||||+||||++|.+||..
T Consensus 175 ~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 175 AMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred cCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 3578899999999999999999999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-24 Score=186.67 Aligned_cols=201 Identities=35% Similarity=0.536 Sum_probs=170.0
Q ss_pred CCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCc----hHHHHHHHHHHhccCCC-ceeeeeeEEEcCCeeEEEEec
Q 022206 68 FGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNE-NVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~ 142 (301)
|.+.+.||.|+|+.||++.+. ..+++|.+...... ...+.+|+.++..+.|+ +|+++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 778889999999999999987 88999998754332 45688899999999988 799999999877778999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC-ceEEeccccCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSN 221 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg~a~ 221 (301)
+.+++|.+++...... ..+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.+.
T Consensus 80 ~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~ 150 (384)
T COG0515 80 VDGGSLEDLLKKIGRK------GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAK 150 (384)
T ss_pred CCCCcHHHHHHhcccc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcce
Confidence 9999999777654311 12888999999999999999999999 99999999999999988 79999999987
Q ss_pred CCCcccccc----ccccccccccccCcccccc---CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 222 QAPDAAARL----HSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 222 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
......... ......|+..|++||.+.+ ..++...|+||+|++++++++|..||....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 554433211 2255679999999999887 578889999999999999999999986654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=177.90 Aligned_cols=138 Identities=18% Similarity=0.163 Sum_probs=107.6
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEcCCCCCc---h------------------------HHHHHHHHHHhccCCCce
Q 022206 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---D------------------------QEFLAQVSMVSRLKNENV 123 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~------------------------~~~~~e~~~l~~l~h~~i 123 (301)
...||+|+||.||+|.+.+|+.||+|+++..... . .....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999998654211 0 112348899999988776
Q ss_pred eeeeeEEEcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHh-hhCCCCCeEecCCCCC
Q 022206 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL-HEKAEPRIIHRNIKSS 202 (301)
Q Consensus 124 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~~ivH~Dlkp~ 202 (301)
.....+... ..++||||++|++|...+.... .++...+..++.|++.+|.++ |+.| |+||||||+
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~---------~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~ 147 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDA---------PLSESKARELYLQVIQIMRILYQDCR---LVHADLSEY 147 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhcC---------CCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH
Confidence 444333222 2389999999987765432221 278889999999999999999 7988 999999999
Q ss_pred ceEEcCCCceEEeccccCCCC
Q 022206 203 NVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 203 Nill~~~~~vkl~Dfg~a~~~ 223 (301)
|||++ ++.++|+|||+|...
T Consensus 148 NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 148 NLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred HEEEE-CCcEEEEEccccccC
Confidence 99998 478999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-24 Score=170.84 Aligned_cols=188 Identities=15% Similarity=0.103 Sum_probs=142.8
Q ss_pred CCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchH-----HHHHHHHHHhccCC-CceeeeeeEEEcCCeeEEEEec
Q 022206 69 GTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQ-----EFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
.....|++|+||+||++.. .+.+++.+.+........ .+.+|+++|++|.| +++.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999997766 588899888876655433 57899999999964 788898885 346899999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCC-CCCceEEcCCCceEEeccccCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI-KSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dl-kp~Nill~~~~~vkl~Dfg~a~ 221 (301)
+.|.+|.+.+.. ....++.|++.+|.++|++| |+|||| ||.|||++.++.++|+|||++.
T Consensus 80 I~G~~L~~~~~~----------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~ 140 (218)
T PRK12274 80 LAGAAMYQRPPR----------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAV 140 (218)
T ss_pred ecCccHHhhhhh----------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCce
Confidence 999998754321 11347789999999999999 999999 7999999999999999999998
Q ss_pred CCCccccc----c-------ccccccccccccCccccccC-CCC-ccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAAR----L-------HSTRVLGTFGYHAPEYAMTG-QMS-SKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
........ . .......++.|++|+...-. ..+ .+.++++.|+-+|.++|+..++-++..
T Consensus 141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 55432210 0 01112357888888854332 233 567899999999999999988755543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-24 Score=172.37 Aligned_cols=140 Identities=17% Similarity=0.154 Sum_probs=110.4
Q ss_pred CCceecccCceEEEEEEECCCCEEEEEEcCCCCCc---------------------------hHHHHHHHHHHhccCCCc
Q 022206 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---------------------------DQEFLAQVSMVSRLKNEN 122 (301)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~e~~~l~~l~h~~ 122 (301)
+...||+|++|.||+|.+.+|+.||||++...... .....+|+..+.++.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 35689999999999999878999999998754211 111357888899999988
Q ss_pred eeeeeeEEEcCCeeEEEEecCCCCCHHHH-hcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCC
Q 022206 123 VVELVGYYVDGPLRVLAYEHASKGSLHDI-LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIK 200 (301)
Q Consensus 123 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlk 200 (301)
+.....+.... .++||||++|+++... +... .++......++.|++.++.++|. .| |+|||||
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~----------~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlk 145 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDV----------PLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLS 145 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhc----------cCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCC
Confidence 75544443332 4899999998855443 3322 16778889999999999999999 99 9999999
Q ss_pred CCceEEcCCCceEEeccccCCCCCc
Q 022206 201 SSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 201 p~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
|+|||++ ++.++|+|||++.....
T Consensus 146 P~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 146 EYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hhhEEEE-CCCEEEEEcccceecCC
Confidence 9999998 88999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=199.55 Aligned_cols=198 Identities=24% Similarity=0.260 Sum_probs=160.0
Q ss_pred HhhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccC---CCceeeeeeEEEcCCeeEEE
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv 139 (301)
.....|.|.+.||+|+||+||+|...+|+.||+|+-+....+. +.--.+++.+|+ -+.|..+...+.-.+.-++|
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 3346788999999999999999998889999999876544433 333345666666 24555666666666777899
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC-------CCce
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-------DDIA 212 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-------~~~v 212 (301)
+||.+.|||.++++..+ .+++..++.+..|++..++.||..+ |||+||||+|+||.. ..-+
T Consensus 773 ~ey~~~Gtlld~~N~~~---------~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTNK---------VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred eeccccccHHHhhccCC---------CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccce
Confidence 99999999999999544 3888999999999999999999999 999999999999953 2358
Q ss_pred EEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCC
Q 022206 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p 274 (301)
+|+|||.+..+.--.....-...++|-.+-.+|+..+..++...|.|.|+-+++.||.|+.-
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99999998766443333223455678899999999999999999999999999999999854
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-24 Score=199.94 Aligned_cols=201 Identities=21% Similarity=0.312 Sum_probs=159.8
Q ss_pred CCCceecccCceEEEEEEEC-CCCEEEEEEcC----CCCCch---HHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 69 GTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLD----SSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~----~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
....++|.|++|.|+.+... ....++.|.+. ...... ..+..|+.+-..+.|+|++..+..+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35778999999988888755 44445555433 111111 12556777778899999998888777766666669
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
|||++ +|..++..... +....+-.++.|++.|++|+|..| +.|||+|++|+++..+|.+||+|||.+
T Consensus 401 E~~~~-Dlf~~~~~~~~---------~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~ 467 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGK---------LTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAA 467 (601)
T ss_pred hcccH-HHHHHHhcccc---------cchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcc
Confidence 99999 99999987521 788889999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccc--cccccccccccccCccccccCCCCc-cccchhhHHHHHHHHhCCCCCCCCCCcC
Q 022206 221 NQAPDAAAR--LHSTRVLGTFGYHAPEYAMTGQMSS-KSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (301)
Q Consensus 221 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~~l~~g~~pf~~~~~~~ 282 (301)
......... ......+|+..|+|||++.+..|++ ..||||.|++++.|.+|+.||.-....+
T Consensus 468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~ 532 (601)
T KOG0590|consen 468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSD 532 (601)
T ss_pred eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccc
Confidence 765433332 3345678999999999999999976 4799999999999999999997655543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-23 Score=165.34 Aligned_cols=108 Identities=28% Similarity=0.290 Sum_probs=93.6
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
|+|.+++..... .+++..++.++.|++.||.|||+.+ ||+|||++.++.+|+ ||++.....
T Consensus 1 GsL~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEVRGR--------PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecc
Confidence 689999975432 2899999999999999999999985 999999999999999 998865533
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
. ...||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 62 ~-------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~ 108 (176)
T smart00750 62 E-------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108 (176)
T ss_pred c-------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 2 2257899999999999999999999999999999999999996543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-24 Score=191.76 Aligned_cols=185 Identities=28% Similarity=0.354 Sum_probs=157.2
Q ss_pred eecccCceEEEEEEE----CCCCEEEEEEcCCCCCc---hHHHHHHHHHHhccC-CCceeeeeeEEEcCCeeEEEEecCC
Q 022206 73 LIGEGSYGRVYFGVL----RSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 73 ~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
.+|+|+||.|++++- ..+..++.|++.+.... +.....|-.++...+ ||.++++...++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 479999999998873 24778999987643211 123455667777776 9999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
||+|...+..... +.+.....+...++-+++.+|..+ ++|||+|++||+++.+|++++.|||+++..-
T Consensus 81 gg~lft~l~~~~~---------f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM---------FDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAV 148 (612)
T ss_pred cchhhhccccCCc---------hHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhH
Confidence 9999888876553 777888889999999999999999 9999999999999999999999999987665
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
.... .+||..|||||++. .+..++|.||+|+++++|+||..||..
T Consensus 149 ~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 149 KEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 4332 28999999999887 678899999999999999999999987
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-22 Score=160.88 Aligned_cols=136 Identities=15% Similarity=0.132 Sum_probs=104.6
Q ss_pred CCCCceecccCceEEEEEEECCCCEEEEEEcCCCC-CchHHHHHHHHHHhcc-----CCCceeeeeeEEEcCC---e-eE
Q 022206 68 FGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-QPDQEFLAQVSMVSRL-----KNENVVELVGYYVDGP---L-RV 137 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~-~~ 137 (301)
+.-.+.||+|+|+.||. +......+||++.... ...+.+.+|+.+++.+ .||||+++++++.++. . +.
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34467899999999995 5432334799876542 2346789999999999 5799999999998763 4 33
Q ss_pred EEEec--CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-HHhhhCCCCCeEecCCCCCceEEcCC----C
Q 022206 138 LAYEH--ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL-EYLHEKAEPRIIHRNIKSSNVLLFDD----D 210 (301)
Q Consensus 138 lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l-~~LH~~~~~~ivH~Dlkp~Nill~~~----~ 210 (301)
+|+|| +.+++|.+++.... +++. ..++.|++.++ +|||+++ |+||||||+|||++.. +
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~----------~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~ 146 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR----------YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEV 146 (210)
T ss_pred EEecCCCCcchhHHHHHHccc----------ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCC
Confidence 78999 55799999996532 4444 35677888777 9999999 9999999999999743 3
Q ss_pred ceEEeccccC
Q 022206 211 IAKISDFDLS 220 (301)
Q Consensus 211 ~vkl~Dfg~a 220 (301)
.++|+||+.+
T Consensus 147 ~~~LiDg~G~ 156 (210)
T PRK10345 147 IPVVCDNIGE 156 (210)
T ss_pred cEEEEECCCC
Confidence 7999995444
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.4e-23 Score=165.49 Aligned_cols=198 Identities=24% Similarity=0.347 Sum_probs=158.0
Q ss_pred CCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
+..++.+|.+...|+.|+|+++ |..+++|++..... -.++|..|.-.|+.+.||||+.+++.|.....+.++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 3445567899999999999998 56667777764332 2367888999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeE-ecCCCCCceEEcCCCceEEe--ccccC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRII-HRNIKSSNVLLFDDDIAKIS--DFDLS 220 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iv-H~Dlkp~Nill~~~~~vkl~--Dfg~a 220 (301)
+.|+|+.+++..... .....++.+++.++++|++|||+.. +++ ---|....++||++-+.+|. |--++
T Consensus 270 p~gslynvlhe~t~v-------vvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfs 340 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSV-------VVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFS 340 (448)
T ss_pred cchHHHHHHhcCccE-------EEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceee
Confidence 999999999987653 3677889999999999999999986 344 34688899999999877764 32221
Q ss_pred CCCCccccccccccccccccccCccccccCCCC---ccccchhhHHHHHHHHhCCCCCCCCCCcCc
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS---SKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~il~~l~~g~~pf~~~~~~~~ 283 (301)
-. .......|.||+||.++....+ .++|+|||++++|||.|+..||.+.+|-+.
T Consensus 341 fq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec 397 (448)
T KOG0195|consen 341 FQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC 397 (448)
T ss_pred ee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh
Confidence 11 1223457899999999876543 468999999999999999999998877443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-22 Score=167.27 Aligned_cols=206 Identities=19% Similarity=0.267 Sum_probs=131.2
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHhccCC----------CceeeeeeEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKN----------ENVVELVGYY 130 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h----------~~iv~~~~~~ 130 (301)
..+...+.||.|+++.||.+++. +++.+++|++...... .+++.+|......+.+ -.++-.++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 34566789999999999999988 7999999987533222 2455555544443322 1222223322
Q ss_pred E---------cC---C-----eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 022206 131 V---------DG---P-----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193 (301)
Q Consensus 131 ~---------~~---~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 193 (301)
. .. . +.+++|+-+.+ +|.+++..-...... ...+.......+..|+++.+++||..|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh~~G--- 165 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLHSYG--- 165 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHhhcc---
Confidence 1 11 1 23677887754 898886421110000 011344455677899999999999999
Q ss_pred eEecCCCCCceEEcCCCceEEeccccCCCCCccccccccccccccccccCcccccc--------CCCCccccchhhHHHH
Q 022206 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT--------GQMSSKSDVYSFGVVL 265 (301)
Q Consensus 194 ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il 265 (301)
++|+||+|+|++++.+|.+.|+||+........... ...+..|.+||.... ..++.+.|.|+||+++
T Consensus 166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred eEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 999999999999999999999999977655443221 234577999996643 2467788999999999
Q ss_pred HHHHhCCCCCCCCCCcC
Q 022206 266 LELLTGRKPVDHTLPRG 282 (301)
Q Consensus 266 ~~l~~g~~pf~~~~~~~ 282 (301)
|.|++|..||+...+..
T Consensus 241 y~lWC~~lPf~~~~~~~ 257 (288)
T PF14531_consen 241 YSLWCGRLPFGLSSPEA 257 (288)
T ss_dssp HHHHHSS-STCCCGGGS
T ss_pred HHHHHccCCCCCCCccc
Confidence 99999999998765543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-21 Score=159.15 Aligned_cols=147 Identities=16% Similarity=0.147 Sum_probs=112.2
Q ss_pred HhhCCCCCCceecccCceEEEEEE--ECCCCEEEEEEcCCCCCc-------------------------hHHHHHHHHHH
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGV--LRSGRAAAIKKLDSSKQP-------------------------DQEFLAQVSMV 115 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~-------------------------~~~~~~e~~~l 115 (301)
.....|.+.+.||+|++|.||+|. ..+|+.||+|++...... ...+.+|+..+
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 334468999999999999999998 348999999998643210 01246799999
Q ss_pred hccCCCc--eeeeeeEEEcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 022206 116 SRLKNEN--VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193 (301)
Q Consensus 116 ~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 193 (301)
.++.+.+ +.++++. ...++||||++|++|........ .+....+..++.|++.+|++||+.| .
T Consensus 105 ~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~g--~ 169 (237)
T smart00090 105 QRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---------EPEEEEEFELYDDILEEMRKLYKEG--E 169 (237)
T ss_pred HHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---------CcchHHHHHHHHHHHHHHHHHHhcC--C
Confidence 9997532 3344432 23589999999988876543221 1455667889999999999999986 5
Q ss_pred eEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 194 ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
++||||||+||+++ ++.++|+|||.+.....
T Consensus 170 iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 170 LVHGDLSEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEeCCCChhhEEEE-CCCEEEEEChhhhccCC
Confidence 99999999999999 88999999999865443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=154.57 Aligned_cols=134 Identities=22% Similarity=0.331 Sum_probs=112.7
Q ss_pred ceecccCceEEEEEEECCCCEEEEEEcCCCCCc---------hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
+.||+|++|.||+|.+ .+..+++|+....... ...+.+|+.++..+.|+++.....++.+....+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 5778999986532211 13467889999999999988777777777888999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
++|++|.+++.... . ....++.+++.+|.++|+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~------------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986421 2 77889999999999999999 99999999999999 78899999999866
Q ss_pred C
Q 022206 223 A 223 (301)
Q Consensus 223 ~ 223 (301)
.
T Consensus 144 ~ 144 (211)
T PRK14879 144 S 144 (211)
T ss_pred C
Confidence 4
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=152.53 Aligned_cols=131 Identities=24% Similarity=0.336 Sum_probs=106.1
Q ss_pred eecccCceEEEEEEECCCCEEEEEEcCCCCC-c--------hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-P--------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
.||+|+||.||++... +..+++|+...... . ...+.+|+++++.+.|+++.....++.+.+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999854 68899998643221 1 144668999999999887655555555666778999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
+|++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~----------~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH----------H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999999875421 1 78899999999999999 99999999999999 889999999998764
Q ss_pred C
Q 022206 224 P 224 (301)
Q Consensus 224 ~ 224 (301)
.
T Consensus 140 ~ 140 (199)
T TIGR03724 140 D 140 (199)
T ss_pred C
Confidence 3
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-21 Score=182.77 Aligned_cols=171 Identities=28% Similarity=0.441 Sum_probs=128.6
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
...+|+.+++|..|++|.||+++++ +.+++|+| +++...- +++ ++....+|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li---lRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI---LRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh---hhc---cccccCCccee------------------
Confidence 3578999999999999999999988 67788884 4332111 111 33333444444
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
|+-...++.... ++. +++.+++|||+.| |+|||+||+|.+|+.-|++|+.|||+++.
T Consensus 136 ---gDc~tllk~~g~---------lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGP---------LPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKK 192 (1205)
T ss_pred ---chhhhhcccCCC---------Ccc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhh
Confidence 455555544322 332 2267899999999 99999999999999999999999999865
Q ss_pred CCcccc-------------ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCcC
Q 022206 223 APDAAA-------------RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (301)
Q Consensus 223 ~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~ 282 (301)
...... .......+|||.|.|||++..+.|+..+|+|++|+|+|+.+.|..||.+++|+.
T Consensus 193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee 265 (1205)
T KOG0606|consen 193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 265 (1205)
T ss_pred hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence 322111 111234589999999999999999999999999999999999999999997744
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-20 Score=151.14 Aligned_cols=138 Identities=16% Similarity=0.123 Sum_probs=108.7
Q ss_pred CCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCc-----------------------hHHHHHHHHHHhccCCCc
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-----------------------DQEFLAQVSMVSRLKNEN 122 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~e~~~l~~l~h~~ 122 (301)
..|.+.+.||+|+||.||++...+|+.||||++...... ......|+.++..+.+.+
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 348889999999999999999888999999987543210 112567888888887764
Q ss_pred --eeeeeeEEEcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 022206 123 --VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 200 (301)
Q Consensus 123 --iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk 200 (301)
+...++ ....+++|||++|++|.++... .....++.+++.++.++|+.+ ++||||+
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------------EDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc---------------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 444443 2456899999999998765321 234568899999999999999 9999999
Q ss_pred CCceEEcCCCceEEeccccCCCCCc
Q 022206 201 SSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 201 p~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
|+||++++++.++|+|||.+.....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-21 Score=184.21 Aligned_cols=195 Identities=19% Similarity=0.214 Sum_probs=150.9
Q ss_pred CCCCCceecccCceEEEEEEECCCCEEEEEEcCCCC--CchHH---HHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK--QPDQE---FLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~---~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
+|...+.||++.|=+|.+|+++.|. |+||++-+.. ...+. .+.|++ ...+++||.+++.-+...+...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6888999999999999999998776 9999885433 22233 334444 556689999999888778888899999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|... +|++.+..+. -+...+...|+.||+.||..+|..| |+|||||.+||||+.=.-+.|+||-.-+
T Consensus 102 yvkh-nLyDRlSTRP---------FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRP---------FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred HHhh-hhhhhhccch---------HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence 9877 8999987654 3778888899999999999999999 9999999999999987788999998764
Q ss_pred CCCcccc---c--cccccccccccccCccccccCC-----------CCccccchhhHHHHHHHHh-CCCCCC
Q 022206 222 QAPDAAA---R--LHSTRVLGTFGYHAPEYAMTGQ-----------MSSKSDVYSFGVVLLELLT-GRKPVD 276 (301)
Q Consensus 222 ~~~~~~~---~--~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~il~~l~~-g~~pf~ 276 (301)
...-... . ..-.+...-..|+|||.+.... .+++-||||+||++.||++ |++||.
T Consensus 169 PtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 169 PTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred CccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 4321111 0 0011112234699999775421 4567899999999999998 899995
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.7e-20 Score=169.49 Aligned_cols=137 Identities=22% Similarity=0.294 Sum_probs=110.9
Q ss_pred CCCCCCceecccCceEEEEEEECCCCEEEEEE-cCCCCC--------chHHHHHHHHHHhccCCCceeeeeeEEEcCCee
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKK-LDSSKQ--------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~-~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 136 (301)
..|...+.||+|+||.||++.+... .+++|+ ..+... ....+.+|+++++.++|++++....+..+....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 4556788999999999999987643 344443 222111 124578899999999999998887777777778
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
++||||++|++|.+++. ....++.+++.+|.+||+.+ ++||||||+|||+ +++.++|+|
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liD 470 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLID 470 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEe
Confidence 99999999999999874 23568899999999999999 9999999999999 678899999
Q ss_pred cccCCCCC
Q 022206 217 FDLSNQAP 224 (301)
Q Consensus 217 fg~a~~~~ 224 (301)
||+++...
T Consensus 471 FGla~~~~ 478 (535)
T PRK09605 471 FGLGKYSD 478 (535)
T ss_pred CcccccCC
Confidence 99987653
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.4e-20 Score=154.99 Aligned_cols=145 Identities=23% Similarity=0.340 Sum_probs=112.3
Q ss_pred CCCceeeeeeEEEcC---------------------------CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHH
Q 022206 119 KNENVVELVGYYVDG---------------------------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171 (301)
Q Consensus 119 ~h~~iv~~~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~ 171 (301)
+|||||+++..|.++ ..+|+||..++. +|.+++-.+. .+...
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----------~s~r~ 342 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----------RSYRT 342 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----------CchHH
Confidence 699999998876442 347899998876 9999997765 67778
Q ss_pred HHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEc--CCC--ceEEeccccCCCCCcccccc----ccccccccccccC
Q 022206 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF--DDD--IAKISDFDLSNQAPDAAARL----HSTRVLGTFGYHA 243 (301)
Q Consensus 172 ~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~--~vkl~Dfg~a~~~~~~~~~~----~~~~~~gt~~y~a 243 (301)
..-++.|+++|+.|||.+| |.|||+|.+|||+. +|+ .+.|+|||.+-.-....-+. ..-..-|...-||
T Consensus 343 ~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmA 419 (598)
T KOG4158|consen 343 GRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMA 419 (598)
T ss_pred HHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecc
Confidence 8889999999999999999 99999999999994 444 47789999874433211111 0112346778899
Q ss_pred ccccccCCC------CccccchhhHHHHHHHHhCCCCCCC
Q 022206 244 PEYAMTGQM------SSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 244 PE~~~~~~~------~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
||+.....- -.++|.|+.|-+.||+++...||..
T Consensus 420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 997653321 2478999999999999999999976
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.9e-18 Score=132.61 Aligned_cols=136 Identities=20% Similarity=0.211 Sum_probs=112.7
Q ss_pred CCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCC--CceeeeeeEEEcCCeeEEEEecCCCCC
Q 022206 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN--ENVVELVGYYVDGPLRVLAYEHASKGS 147 (301)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~gs 147 (301)
+++.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.+++ .++.+++.+....+..+++|||+.++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 46789999999999999864 7899999866543 5678899999999976 588899888887788999999999877
Q ss_pred HHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 148 LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
+..+ +......++.+++.+|+++|......++|+|++|+||++++.+.++++|||.+...
T Consensus 80 ~~~~----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 80 LDEV----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cccC----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 7543 23455678899999999999853233999999999999999899999999987643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.5e-19 Score=141.75 Aligned_cols=135 Identities=17% Similarity=0.222 Sum_probs=97.1
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEcCCCCCch---HHH----------------------HHHHHHHhccCCCc--e
Q 022206 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD---QEF----------------------LAQVSMVSRLKNEN--V 123 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~----------------------~~e~~~l~~l~h~~--i 123 (301)
.+.||+|+||.||+|.+.+++.||||++....... ..+ ..|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 56899999999999998889999999886532211 111 24555555554432 3
Q ss_pred eeeeeEEEcCCeeEEEEecCCCCCHHHH-hcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCC
Q 022206 124 VELVGYYVDGPLRVLAYEHASKGSLHDI-LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKS 201 (301)
Q Consensus 124 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp 201 (301)
.+.++. ...+++|||++++++... +.... .. .....++.+++.++.++|. .+ ++|+||||
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----------~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p 143 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----------LL-EDPEELYDQILELMRKLYREAG---LVHGDLSE 143 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----------hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCCh
Confidence 444432 245899999999543221 11100 11 4567899999999999999 88 99999999
Q ss_pred CceEEcCCCceEEeccccCCCCC
Q 022206 202 SNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
+||+++ ++.++|+|||.+....
T Consensus 144 ~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 144 YNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred hhEEEE-CCcEEEEECccccccc
Confidence 999999 8999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.3e-18 Score=141.20 Aligned_cols=135 Identities=16% Similarity=0.193 Sum_probs=104.1
Q ss_pred ceec-ccCceEEEEEEECCCCEEEEEEcCCCC--------------CchHHHHHHHHHHhccCCCce--eeeeeEEEcC-
Q 022206 72 SLIG-EGSYGRVYFGVLRSGRAAAIKKLDSSK--------------QPDQEFLAQVSMVSRLKNENV--VELVGYYVDG- 133 (301)
Q Consensus 72 ~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~- 133 (301)
..|| .|+.|+||.+... +..+++|.+.... .....+.+|+.++.+|+|++| ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8889999998876 7789998774311 122457889999999998774 6666664332
Q ss_pred C---eeEEEEecCCC-CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC
Q 022206 134 P---LRVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (301)
Q Consensus 134 ~---~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 209 (301)
. ..++|||+++| .+|.+++.... ++.. .+.+++.+|.+||+.| |+||||||+|||++.+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~----------l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~ 178 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAP----------LSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPD 178 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCC----------CCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCC
Confidence 2 23599999997 69999886432 4433 3578999999999999 9999999999999998
Q ss_pred CceEEeccccCCCCC
Q 022206 210 DIAKISDFDLSNQAP 224 (301)
Q Consensus 210 ~~vkl~Dfg~a~~~~ 224 (301)
+.++|+|||.+....
T Consensus 179 ~~v~LIDfg~~~~~~ 193 (239)
T PRK01723 179 GKFWLIDFDRGELRT 193 (239)
T ss_pred CCEEEEECCCcccCC
Confidence 999999999886644
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.9e-18 Score=152.89 Aligned_cols=167 Identities=28% Similarity=0.429 Sum_probs=131.4
Q ss_pred HhccCCCceeeeeeEEEcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 022206 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 194 (301)
Q Consensus 115 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~i 194 (301)
|+.+.|.|+.++++.+.++...+.|.+||..|+|.+.+..... .+++.....+.++|+.||+|||... -.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~--------~~d~~F~~s~~rdi~~Gl~ylh~s~--i~ 70 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI--------KLDYFFILSFIRDISKGLAYLHNSP--IG 70 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc--------CccHHHHHHHHHHHHHHHHHHhcCc--ce
Confidence 4678999999999999999999999999999999999987432 2788888999999999999999986 13
Q ss_pred EecCCCCCceEEcCCCceEEeccccCCCCCccccccccccccccccccCccccccCC-------CCccccchhhHHHHHH
Q 022206 195 IHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-------MSSKSDVYSFGVVLLE 267 (301)
Q Consensus 195 vH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~il~~ 267 (301)
.|+.++..|++++..+.+||+|||+.................-...|.|||.+.... .+.+.|+||+|++++|
T Consensus 71 ~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e 150 (484)
T KOG1023|consen 71 YHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE 150 (484)
T ss_pred eeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence 999999999999999999999999987664311111111122356799999887641 3567999999999999
Q ss_pred HHhCCCCCCCCCCcCc-cccccccc
Q 022206 268 LLTGRKPVDHTLPRGQ-QSLVTWVL 291 (301)
Q Consensus 268 l~~g~~pf~~~~~~~~-~~~~~~~~ 291 (301)
+++..-||........ .+++.+++
T Consensus 151 i~~r~~~~~~~~~~~~~~eii~~~~ 175 (484)
T KOG1023|consen 151 ILFRSGPFDLRNLVEDPDEIILRVK 175 (484)
T ss_pred HHhccCccccccccCChHHHHHHHH
Confidence 9999999977433222 34444433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5e-19 Score=155.38 Aligned_cols=124 Identities=33% Similarity=0.471 Sum_probs=106.5
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
++||.|++|.-.+|.++|.+..... ..+......++.|++.++.| ++ .+|+|+||.||+...+..+||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e------~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kI 397 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGE------ERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKI 397 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCccc------ccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhh
Confidence 5789999999999999997554321 25677888999999999999 67 999999999999999999999
Q ss_pred eccccCCCCCccc----cccccccccccccccCccccccCCCCccccchhhHHHHHHHHh
Q 022206 215 SDFDLSNQAPDAA----ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270 (301)
Q Consensus 215 ~Dfg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~ 270 (301)
.|||+........ .....+...||..||+||++.+..|+.++||||||++|+||+.
T Consensus 398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 9999987765544 1222356689999999999999999999999999999999998
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.1e-18 Score=162.06 Aligned_cols=207 Identities=24% Similarity=0.335 Sum_probs=163.8
Q ss_pred hCCCCCCceecccCceEEEEEEEC--CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccC-CCceeeeeeEEEcCCeeEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 138 (301)
...|.+.+.||+|+|+.|-+.... ....++.|.+...... ......|..+-+.+. |.|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 346777888999999999888764 3456667766544322 233444677777776 9999999999999999999
Q ss_pred EEecCCCCCHHHHhc-CCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-hCCCCCeEecCCCCCceEEcCCC-ceEEe
Q 022206 139 AYEHASKGSLHDILH-GKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH-EKAEPRIIHRNIKSSNVLLFDDD-IAKIS 215 (301)
Q Consensus 139 v~e~~~~gsL~~~l~-~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~~~~ivH~Dlkp~Nill~~~~-~vkl~ 215 (301)
++++..|+++.+.+. ... ...+...+-.++.|+..++.|+| ..+ +.|+|+||+|.+++..+ .+++.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~--------~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~ 167 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDS--------TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIA 167 (601)
T ss_pred ccCcccccccccccccCCc--------cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCC
Confidence 999999999999883 322 01455667789999999999999 888 99999999999999999 99999
Q ss_pred ccccCCCCCc-cccccccccccc-cccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCcC
Q 022206 216 DFDLSNQAPD-AAARLHSTRVLG-TFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (301)
Q Consensus 216 Dfg~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~ 282 (301)
|||+|..... ..........+| ++.|+|||...+. ...+..|+||.|+++..+++|..|+.......
T Consensus 168 df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 168 DFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred CchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 9999988766 333223345678 9999999988774 45678899999999999999999997654433
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=137.82 Aligned_cols=141 Identities=22% Similarity=0.262 Sum_probs=98.0
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEcCCCCCch-----------------------------------------HHHH
Q 022206 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD-----------------------------------------QEFL 109 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------------------------------~~~~ 109 (301)
.+.||+|++|.||+|+.++|+.||||+........ -++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46799999999999999999999999986432110 0133
Q ss_pred HHHHHHhcc----CCCceeeeeeEE-EcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHH-HH
Q 022206 110 AQVSMVSRL----KNENVVELVGYY-VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR-GL 183 (301)
Q Consensus 110 ~e~~~l~~l----~h~~iv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~-~l 183 (301)
+|+..+.++ ++.+-+.+-.++ ......++||||++|++|.++....... .. ...++.+++. .+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--------~~---~~~ia~~~~~~~l 270 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--------LD---RKALAENLARSFL 270 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--------CC---HHHHHHHHHHHHH
Confidence 444444444 222222222222 2234578999999999998876532110 22 2345555555 47
Q ss_pred HHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 184 ~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
..+|..| ++|+|+||.||++++++.++++|||++.....
T Consensus 271 ~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 271 NQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8889999 99999999999999999999999999877754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.8e-15 Score=118.57 Aligned_cols=132 Identities=14% Similarity=0.072 Sum_probs=97.9
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCcee-eeeeEEEcCCeeEEEEecCCCCCHH
Q 022206 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV-ELVGYYVDGPLRVLAYEHASKGSLH 149 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~gsL~ 149 (301)
++.|+.|.++.||++... +..+++|...........+.+|+.+++.+.+.+++ +++... ....++||||++|.++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 457899999999999876 78899999865543334567889999888665544 444432 33457999999998875
Q ss_pred HHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--CCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 150 DILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA--EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 150 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
+. . .. ...++.+++.+|+.||..+ ...++|+|++|.||+++ ++.++++|||.+...
T Consensus 80 ~~----~----------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 80 TE----D----------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cc----c----------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 43 0 11 1235678999999999987 11249999999999998 678999999987643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.8e-14 Score=130.48 Aligned_cols=163 Identities=16% Similarity=0.224 Sum_probs=127.0
Q ss_pred CCCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCC
Q 022206 89 SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVL 167 (301)
Q Consensus 89 ~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l 167 (301)
++.+|.|++.+.+... .....+.++.|+.++||||+++++.+..++..|+|+|.+.. |..+++. +
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~------------l 101 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE------------L 101 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH------------h
Confidence 6888999988765542 24567788999999999999999999999999999999864 7777765 4
Q ss_pred CHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCccccccccccccccccccCcccc
Q 022206 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 247 (301)
Q Consensus 168 ~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 247 (301)
....+...+.||+.||.+||+.+ .++|++|.-+.|+|+..|.+||++|.++.......... .....--.|..|+.+
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--KSLYLIESFDDPEEI 177 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--ccchhhhcccChhhc
Confidence 45667778999999999998554 49999999999999999999999999986654433210 111122346666644
Q ss_pred ccCCCCccccchhhHHHHHHHHhC
Q 022206 248 MTGQMSSKSDVYSFGVVLLELLTG 271 (301)
Q Consensus 248 ~~~~~~~~~DvwslG~il~~l~~g 271 (301)
.... -..|.|-||+++++++.|
T Consensus 178 ~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 178 DPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred Cccc--cchhhhhHHHHHHHHhCc
Confidence 3332 346999999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.2e-15 Score=137.70 Aligned_cols=145 Identities=17% Similarity=0.256 Sum_probs=94.3
Q ss_pred CCCCCCceecccCceEEEEEEECC-CCEEEEEEcCCCCCc-----------------------------------hH---
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQP-----------------------------------DQ--- 106 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-----------------------------------~~--- 106 (301)
..|+. +.||+|++|.||+|+.++ |+.||||++...... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45776 789999999999999886 999999998743210 01
Q ss_pred ---HHHHHHHHHhccC----CCceeeeeeEEEc-CCeeEEEEecCCCCCHHHHh--cCCCCCCCCCCCCCCCHHHHHHHH
Q 022206 107 ---EFLAQVSMVSRLK----NENVVELVGYYVD-GPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIA 176 (301)
Q Consensus 107 ---~~~~e~~~l~~l~----h~~iv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~l~~~~~~~i~ 176 (301)
++.+|+..+.+++ +.+.+.+-.++.+ ....++||||++|+.|.++- ...... ...+....+..++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d-----~~~la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTD-----MKLLAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCC-----HHHHHHHHHHHHH
Confidence 1233333333332 3333333333332 44568999999999998753 221100 0013333333444
Q ss_pred HHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC----ceEEeccccCCCCCcc
Q 022206 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----IAKISDFDLSNQAPDA 226 (301)
Q Consensus 177 ~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~vkl~Dfg~a~~~~~~ 226 (301)
.|+ ...| ++|+|+||.||+++.++ .++++|||++......
T Consensus 274 ~Qi-------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 274 TQV-------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHH-------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 444 4577 99999999999999888 9999999998776543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.9e-13 Score=109.29 Aligned_cols=136 Identities=18% Similarity=0.164 Sum_probs=97.8
Q ss_pred CceecccCceEEEEEEECC-------CCEEEEEEcCCCC-----------------------CchHHHH----HHHHHHh
Q 022206 71 NSLIGEGSYGRVYFGVLRS-------GRAAAIKKLDSSK-----------------------QPDQEFL----AQVSMVS 116 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-----------------------~~~~~~~----~e~~~l~ 116 (301)
...||.|--+.||.|...+ +..+|||+...+. .+...+. +|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998553 4799999864210 0112223 7888898
Q ss_pred ccCC--CceeeeeeEEEcCCeeEEEEecCCCCCHHH-HhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHh-hhCCCC
Q 022206 117 RLKN--ENVVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL-HEKAEP 192 (301)
Q Consensus 117 ~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~ 192 (301)
++.. -++.+++++ ...++||||+.+..+.. .+... .++......+..+++.+|..| |+.|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----------~~~~~~~~~i~~~i~~~l~~l~H~~g-- 145 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----------KLNDEEMKNAYYQVLSMMKQLYKECN-- 145 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----------ccCHHHHHHHHHHHHHHHHHHHHhCC--
Confidence 8864 455666654 45689999997754422 22211 144556677889999999998 8998
Q ss_pred CeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 193 ~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
++|+||++.|||++ ++.+.|+|||.+....
T Consensus 146 -lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 146 -LVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred -eecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999999999997 4679999999876553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.9e-13 Score=110.28 Aligned_cols=142 Identities=18% Similarity=0.260 Sum_probs=106.6
Q ss_pred ceecccCceEEEEEEECCCCEEEEEEcCCCCC--chHHHHHHHHHHhccCCC--ceeeeeeEEEcC---CeeEEEEecCC
Q 022206 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNE--NVVELVGYYVDG---PLRVLAYEHAS 144 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~---~~~~lv~e~~~ 144 (301)
+.|+.|..+.||++...+|..+++|....... ....+.+|+++++.+++. ++.+++.+.... +..+++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987678999999765443 345688999999998763 456677665543 25689999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC----------------------------------
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA---------------------------------- 190 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---------------------------------- 190 (301)
|.++.+.+... .++......++.+++.+|..||+..
T Consensus 84 G~~l~~~~~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 84 GRVLRDRLLRP----------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred CEecCCCCCCC----------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 98887765321 1556666677777777777777421
Q ss_pred -------------------CCCeEecCCCCCceEEcC--CCceEEeccccCCCC
Q 022206 191 -------------------EPRIIHRNIKSSNVLLFD--DDIAKISDFDLSNQA 223 (301)
Q Consensus 191 -------------------~~~ivH~Dlkp~Nill~~--~~~vkl~Dfg~a~~~ 223 (301)
...++|+|++|.||+++. ++.+.|+||+.+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 134799999999999998 667899999987543
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1e-12 Score=101.85 Aligned_cols=132 Identities=20% Similarity=0.288 Sum_probs=100.4
Q ss_pred ceecccCceEEEEEEECCCCEEEEEEc-CCCCCc--------hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 72 SLIGEGSYGRVYFGVLRSGRAAAIKKL-DSSKQP--------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
..+++|+-+.+|.+.+. |..+++|.- .+.... .....+|+.++.+++--.|.-.+=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 36889999999999775 445777753 332221 13467789999888765655555555677778899999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
++|..|.+++... ...++..+-.-+.-||..| |+|+||.++||++..++ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888753 1346667777788999999 99999999999997665 89999999865
Q ss_pred CC
Q 022206 223 AP 224 (301)
Q Consensus 223 ~~ 224 (301)
..
T Consensus 141 s~ 142 (204)
T COG3642 141 SD 142 (204)
T ss_pred cc
Confidence 43
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=9.5e-14 Score=124.43 Aligned_cols=201 Identities=24% Similarity=0.263 Sum_probs=157.9
Q ss_pred hhCCCCCCceecc--cCceEEEEEEE--C-CCCEEEEEEcCC--C-CCchHHHHHHHHHHhcc-CCCceeeeeeEEEcCC
Q 022206 64 KTDNFGTNSLIGE--GSYGRVYFGVL--R-SGRAAAIKKLDS--S-KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (301)
Q Consensus 64 ~~~~y~~~~~lg~--G~~g~V~~~~~--~-~~~~vavK~~~~--~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 134 (301)
....+.+.+.+|. |.+|.||.+.. . ++..+|+|.-+. . ......-.+|+...+.+ .|++.++.+..+...+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 3456788889999 99999999997 5 688899997332 1 12223345566666666 4899999999999999
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHH----HHHHhhhCCCCCeEecCCCCCceEEcCC-
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR----GLEYLHEKAEPRIIHRNIKSSNVLLFDD- 209 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~----~l~~LH~~~~~~ivH~Dlkp~Nill~~~- 209 (301)
..++-+|.|. .+|.++...... .++...++..+.+... ||.++|..+ ++|-|+||.||+...+
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~~--------~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~ 259 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPCN--------FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDW 259 (524)
T ss_pred cceeeecccc-chhHHhhhcccc--------cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheeccccc
Confidence 9999999996 588888765432 2777888889999999 999999999 9999999999999999
Q ss_pred CceEEeccccCCCCCcccccc---ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 210 DIAKISDFDLSNQAPDAAARL---HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
...+++|||+...+....... ......|...|++||.. ...++..+|+|+||.++.+..++..++..
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccC
Confidence 789999999987776544211 11122577889999965 45678899999999999999888776643
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.3e-12 Score=100.98 Aligned_cols=143 Identities=20% Similarity=0.249 Sum_probs=106.2
Q ss_pred CCceecccCceEEEEEEECCCCEEEEEEc-CCCCC--------chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKL-DSSKQ--------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
.+.+|-+|+-+.|+++.+. |+..+||.- .+... ......+|+..+.++.--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 6778999999999999887 788788854 22211 1245778898888887655554444566666777999
Q ss_pred ecCCC-CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC---ceEEec
Q 022206 141 EHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISD 216 (301)
Q Consensus 141 e~~~~-gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~D 216 (301)
||++| .++.+++....... ........++.++-+.+..||..+ ++|+||..+||++..++ .+.++|
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-------~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lId 159 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-------SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILID 159 (229)
T ss_pred EeccchhHHHHHHHHHccCc-------ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEe
Confidence 99987 57888886543211 222333688999999999999999 99999999999997655 458999
Q ss_pred cccCCCC
Q 022206 217 FDLSNQA 223 (301)
Q Consensus 217 fg~a~~~ 223 (301)
||++...
T Consensus 160 fgls~~s 166 (229)
T KOG3087|consen 160 FGLSSVS 166 (229)
T ss_pred ecchhcc
Confidence 9997554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.1e-13 Score=120.41 Aligned_cols=195 Identities=21% Similarity=0.192 Sum_probs=148.6
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC--CCCEEEEEEcCCCCCch---HHHHHHHHHHhcc-CCCceeeeeeEEEcCCee
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 136 (301)
....+|..+..||.|.|+.|+.+..+ ++..|++|.+....... ..-..|+.+...+ .|.++++++..|...+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34568999999999999999998844 68889999876543332 1223455555555 588999998888888888
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC-CceEEe
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKIS 215 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~ 215 (301)
|+-.|||+++++...+.-.. .+.+...+.+..|++.++.++|+.. ++|+|++|.||++.++ +.-++.
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~---------~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~ 409 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQ---------MLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLG 409 (524)
T ss_pred cCchhhhcCcchhhhhHHHH---------hcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcc
Confidence 89999999998877663221 2677888999999999999999999 9999999999999886 778899
Q ss_pred ccccCCCCCcccccccccccccccccc--CccccccCCCCccccchhhHHHHHHHHhCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYH--APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p 274 (301)
|||+........ ......-+++ ++.......+..+.|++|||..+.+..++..-
T Consensus 410 ~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 410 DFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred ccccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 999986532221 1112233344 55555567788999999999999999887753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.9e-13 Score=127.82 Aligned_cols=207 Identities=22% Similarity=0.249 Sum_probs=149.4
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch----HHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
..+.+.+.+.+-+|+++.++.+.-. ++...++|+......-. +....+-.++-.-++|.++...-.+.-....++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4467778888999999999988744 56556666543322111 112222222222345777766655666778899
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
+++|..+++|...++.... ....-.......+..++++||... +.|+|++|.|+++..+++.++.|||
T Consensus 882 ~~~~~~~~~~~Skl~~~~~---------~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~ 949 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGC---------LSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFG 949 (1205)
T ss_pred hhHHhccCCchhhhhcCCC---------cccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccc
Confidence 9999999999999886552 333344456667788899999987 8999999999999999999999998
Q ss_pred cCCCCCcc---------------------cc----c----cccccccccccccCccccccCCCCccccchhhHHHHHHHH
Q 022206 219 LSNQAPDA---------------------AA----R----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELL 269 (301)
Q Consensus 219 ~a~~~~~~---------------------~~----~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~ 269 (301)
+....... .. . .......+|+.|.+||.+.+......+|+|++|+++++.+
T Consensus 950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence 43321110 00 0 0112346899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCcC
Q 022206 270 TGRKPVDHTLPRG 282 (301)
Q Consensus 270 ~g~~pf~~~~~~~ 282 (301)
+|.+||...++.+
T Consensus 1030 ~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQ 1042 (1205)
T ss_pred cCCCCCCCcchhh
Confidence 9999998766643
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.4e-12 Score=107.63 Aligned_cols=155 Identities=25% Similarity=0.369 Sum_probs=115.3
Q ss_pred HHhccCCCceeeeeeEEEcC-----CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 022206 114 MVSRLKNENVVELVGYYVDG-----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188 (301)
Q Consensus 114 ~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~ 188 (301)
-+-.+.|.|+++++.||.+. .+..++.||+..|+|.++|++.+... ..+......+|+.||+.||.|||+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-----~a~~~~~wkkw~tqIlsal~yLhs 194 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-----KALFQKAWKKWCTQILSALSYLHS 194 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-----hhhhHHHHHHHHHHHHhhhhhhhc
Confidence 35566799999999998654 34678899999999999997654321 237778888999999999999999
Q ss_pred CCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCccc--cccccccccccccccCccccccCCCCccccchhhHHHHH
Q 022206 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA--ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLL 266 (301)
Q Consensus 189 ~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ 266 (301)
.. |+|+|+++.-+.|++..+|-+|+.----........ .......-.+-+.|.+||.-.....+.++|||++|+...
T Consensus 195 ~~-PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 195 CD-PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL 273 (458)
T ss_pred cC-CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence 85 669999999999999999988875211110111000 001112224578899999776677788999999999999
Q ss_pred HHHhCCCC
Q 022206 267 ELLTGRKP 274 (301)
Q Consensus 267 ~l~~g~~p 274 (301)
+|..+..-
T Consensus 274 emailEiq 281 (458)
T KOG1266|consen 274 EMAILEIQ 281 (458)
T ss_pred HHHHheec
Confidence 99887754
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.3e-10 Score=98.10 Aligned_cols=140 Identities=16% Similarity=0.050 Sum_probs=99.3
Q ss_pred ceecccCceEEEEEEECCCCEEEEEEcCCCC------------CchHHHHHHHHHHhccCCCc--eeeeeeEEEc-----
Q 022206 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK------------QPDQEFLAQVSMVSRLKNEN--VVELVGYYVD----- 132 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~----- 132 (301)
+.+-......|+++.. +|+.+.||...... .......+|+..+.+|...+ +.+++.+...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4455444555777655 47789999764222 11124778888888885433 3445555542
Q ss_pred CCeeEEEEecCCCC-CHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC---
Q 022206 133 GPLRVLAYEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--- 208 (301)
Q Consensus 133 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~--- 208 (301)
....++|+|++++. +|.+++...... .........++.+++..+..||..| |+|+|+++.|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~-------~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~ 176 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATN-------PPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFP 176 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEecccc
Confidence 23468999999985 899998532111 1455677789999999999999999 999999999999975
Q ss_pred ----CCceEEeccccCCC
Q 022206 209 ----DDIAKISDFDLSNQ 222 (301)
Q Consensus 209 ----~~~vkl~Dfg~a~~ 222 (301)
+..+.|+||+.+..
T Consensus 177 ~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 177 GREEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCCCceEEEEECCcccc
Confidence 46899999998754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.5e-11 Score=96.73 Aligned_cols=124 Identities=19% Similarity=0.212 Sum_probs=81.6
Q ss_pred EEEEEEECCCCEEEEEEcCCC--------------CC--------c-----hHHHHHHHHHHhccCCC--ceeeeeeEEE
Q 022206 81 RVYFGVLRSGRAAAIKKLDSS--------------KQ--------P-----DQEFLAQVSMVSRLKNE--NVVELVGYYV 131 (301)
Q Consensus 81 ~V~~~~~~~~~~vavK~~~~~--------------~~--------~-----~~~~~~e~~~l~~l~h~--~iv~~~~~~~ 131 (301)
.||.|...++..+|+|+.... .. . .....+|++.|.++... ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999988999999986421 00 0 12356789999999765 456666442
Q ss_pred cCCeeEEEEecCC--CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH-hhhCCCCCeEecCCCCCceEEcC
Q 022206 132 DGPLRVLAYEHAS--KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY-LHEKAEPRIIHRNIKSSNVLLFD 208 (301)
Q Consensus 132 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~-LH~~~~~~ivH~Dlkp~Nill~~ 208 (301)
..++||||++ |..+..+.... ++......++.+++..+.. +|..| ++|+||++.|||+++
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~ 142 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDD 142 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEET
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeec
Confidence 3479999998 65665544432 1123345677777775554 57998 999999999999988
Q ss_pred CCceEEeccccCCCC
Q 022206 209 DDIAKISDFDLSNQA 223 (301)
Q Consensus 209 ~~~vkl~Dfg~a~~~ 223 (301)
+ .+.|+|||.+...
T Consensus 143 ~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 143 G-KVYIIDFGQAVDS 156 (188)
T ss_dssp T-CEEE--GTTEEET
T ss_pred c-eEEEEecCcceec
Confidence 7 8999999987544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.19 E-value=4.4e-10 Score=99.60 Aligned_cols=173 Identities=16% Similarity=0.191 Sum_probs=129.6
Q ss_pred ceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeeeeeEEE----cCCeeEEEEecCCC-CCHHHH
Q 022206 79 YGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYV----DGPLRVLAYEHASK-GSLHDI 151 (301)
Q Consensus 79 ~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~e~~~~-gsL~~~ 151 (301)
-.+.|++... +|..|++|+++..... ......-++.++++.|.|+|++.+++. .+..+++|++|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3578999866 8999999999543222 123344578899999999999998876 34568999999876 688887
Q ss_pred hcCCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 152 LHGKKGVK------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 152 l~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
........ ....+...++..+|.++.|+..||.++|+.| +..+-|.|.+||++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 75433222 1223455889999999999999999999999 99999999999999988999998887544432
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK 273 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~ 273 (301)
.. . |.+.. -.+-|.=.||.++.-|.||..
T Consensus 446 d~--------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DP--------------T--EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC--------------C--cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 21 0 11111 235688999999999999854
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.3e-10 Score=93.23 Aligned_cols=137 Identities=16% Similarity=0.147 Sum_probs=100.7
Q ss_pred CCCCCCceecccCceEEEEEEECCCCEEEEEEcCCC------------------CC-----chHHHHHHHHHHhccCCC-
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS------------------KQ-----PDQEFLAQVSMVSRLKNE- 121 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~------------------~~-----~~~~~~~e~~~l~~l~h~- 121 (301)
.-+.+...||-|.-|.||.|....|.++|+|.=... .. ......+|+++|.+|...
T Consensus 91 ~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 91 IVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred hHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 346678899999999999999999999999952110 00 113367889999999755
Q ss_pred -ceeeeeeEEEcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 022206 122 -NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 200 (301)
Q Consensus 122 -~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk 200 (301)
.+.+.+++ +...+|||+++|..|...-. +....-.++..|+.-+.-+-..| +||+|++
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~--------------~~en~~~il~~il~~~~~~~~~G---iVHGDlS 229 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLRL--------------DVENPDEILDKILEEVRKAYRRG---IVHGDLS 229 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeecccC--------------cccCHHHHHHHHHHHHHHHHHcC---ccccCCc
Confidence 67777764 56789999999977655432 12223344555555555555778 9999999
Q ss_pred CCceEEcCCCceEEeccccCCCC
Q 022206 201 SSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 201 p~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
+=||+++++|.+.++||--+...
T Consensus 230 efNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 230 EFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred hheEEEecCCCEEEEeCcccccC
Confidence 99999999999999999876543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.2e-09 Score=94.67 Aligned_cols=196 Identities=17% Similarity=0.207 Sum_probs=126.8
Q ss_pred CCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhcc-CCCceeeeeeE------EEcCC-eeEEEEe
Q 022206 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGY------YVDGP-LRVLAYE 141 (301)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~------~~~~~-~~~lv~e 141 (301)
....||+|+.+-+|-.-. -...+.|++....-....- .+..|... .||-+-.-+.+ .-+++ ..-++|.
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq--k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ--KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCchHHHH--HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 456799999999985432 1234557776543322211 12223222 34432221111 11222 3667788
Q ss_pred cCCCC-CHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 142 HASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 142 ~~~~g-sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
.+.|. -+..++....... .-+-..+..++++++.++.+.+.||+.| .+-+|+.++|+|+.+++.|.|.|=+.-
T Consensus 91 ~v~g~~pI~~~y~p~tRRq---s~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQ---SYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred cCCCccchhhhcCchhhcc---cCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccce
Confidence 87764 2333333222221 1233788999999999999999999999 899999999999999999999986543
Q ss_pred CCCCccccccccccccccccccCccccc-----cCCCCccccchhhHHHHHHHHhC-CCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTG-RKPVDHT 278 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g-~~pf~~~ 278 (301)
....... ..-..+|.+.|.+||.-. +..-+...|.|.||+++++++.| +.||.+.
T Consensus 165 qi~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 165 QINANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eeccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 2221111 113457899999999643 33456789999999999999985 9999874
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.5e-09 Score=87.54 Aligned_cols=146 Identities=12% Similarity=0.114 Sum_probs=87.1
Q ss_pred ceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCC--ceeeeeeEEEcCCeeEEEEecCCCCC-H
Q 022206 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVGYYVDGPLRVLAYEHASKGS-L 148 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~gs-L 148 (301)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..- .+.+.+.+..+.+...++||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 47899999999984 25578889876533 345678899999988643 35677888777778889999999963 2
Q ss_pred HHHhcCCC---------------CCCCC-CCCCCCCHHHHHHHHH----------HHHH-HHHHhhh-CCCCCeEecCCC
Q 022206 149 HDILHGKK---------------GVKGA-KPGPVLSWAQRVKIAV----------GAAR-GLEYLHE-KAEPRIIHRNIK 200 (301)
Q Consensus 149 ~~~l~~~~---------------~~~~~-~~~~~l~~~~~~~i~~----------qi~~-~l~~LH~-~~~~~ivH~Dlk 200 (301)
.+.+.... ..... .+...++... ..+.. .+.. ...+|.. ...+.++|+|++
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111000 00000 0000011000 00000 0001 1112211 112347899999
Q ss_pred CCceEEcCCCceEEeccccCCCC
Q 022206 201 SSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 201 p~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
|.||++++++ +.++||+.+...
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCcC
Confidence 9999999888 999999987543
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.9e-09 Score=87.90 Aligned_cols=108 Identities=25% Similarity=0.249 Sum_probs=83.7
Q ss_pred hHHHHHHHHHHhccCCC--ceeeeeeEEEcC----CeeEEEEecCCC-CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHH
Q 022206 105 DQEFLAQVSMVSRLKNE--NVVELVGYYVDG----PLRVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177 (301)
Q Consensus 105 ~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~----~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~ 177 (301)
.....+|+..+..|... .+.+.+++.... ...++|+|++++ .+|.+++..... .+......++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---------~~~~~~~~ll~ 125 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---------LDPSQRRELLR 125 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---------cchhhHHHHHH
Confidence 35677888888777543 345566655542 235799999988 489999876332 44566778999
Q ss_pred HHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC---ceEEeccccCCCCC
Q 022206 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAP 224 (301)
Q Consensus 178 qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~Dfg~a~~~~ 224 (301)
+++..+.-||+.| |+|+|+++.|||++.++ .+.++||+.+....
T Consensus 126 ~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 126 ALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999999999999 99999999999999887 89999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=6e-09 Score=83.73 Aligned_cols=139 Identities=14% Similarity=0.064 Sum_probs=101.7
Q ss_pred ecccCceEEEEEEECCCCEEEEEEcCC----C---CCchHHHHHHHHHHhccCCC--ceeeeeeEEE--c--CCeeEEEE
Q 022206 74 IGEGSYGRVYFGVLRSGRAAAIKKLDS----S---KQPDQEFLAQVSMVSRLKNE--NVVELVGYYV--D--GPLRVLAY 140 (301)
Q Consensus 74 lg~G~~g~V~~~~~~~~~~vavK~~~~----~---~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~--~--~~~~~lv~ 140 (301)
-|+|+.|.|+..... |..+-+|.-.. + +.....+.+|+..+.+|..- .+.++..... . .-..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467999999987766 44788887541 1 33456799999999988642 2444442211 1 12357899
Q ss_pred ecCCC-CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc--eEEecc
Q 022206 141 EHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI--AKISDF 217 (301)
Q Consensus 141 e~~~~-gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~--vkl~Df 217 (301)
|-+.| .+|.+++...... ..+......++.+++.++.-||+.| +.|+|+.+.||+++.++. ++++||
T Consensus 105 e~L~g~~~L~~~l~~~~~~-------~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDl 174 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVS-------PYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDL 174 (216)
T ss_pred EeCCCCccHHHHHhcCCcC-------CcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEh
Confidence 97764 5899888654321 1566777899999999999999999 999999999999987676 999999
Q ss_pred ccCCCC
Q 022206 218 DLSNQA 223 (301)
Q Consensus 218 g~a~~~ 223 (301)
.-++..
T Consensus 175 Ek~r~~ 180 (216)
T PRK09902 175 EKSRRR 180 (216)
T ss_pred hccchh
Confidence 876543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.3e-09 Score=97.86 Aligned_cols=142 Identities=20% Similarity=0.243 Sum_probs=92.8
Q ss_pred ceecccCceEEEEEEECCCCEEEEEEcCCCCCch-----------------------------------------HHHHH
Q 022206 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD-----------------------------------------QEFLA 110 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------------------------------~~~~~ 110 (301)
+.|+.++-|.||+|+.++|+.||||+....-... -++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6799999999999999999999999875421110 01344
Q ss_pred HHHHHhccC-----CCceeeeeeEEEcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 022206 111 QVSMVSRLK-----NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185 (301)
Q Consensus 111 e~~~l~~l~-----h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~ 185 (301)
|...+.+++ .+++.-..=++.-.....++|||++|..+.++....... .+...+.....++. +..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--------~d~k~ia~~~~~~f--~~q 280 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--------IDRKELAELLVRAF--LRQ 280 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--------CCHHHHHHHHHHHH--HHH
Confidence 544444442 233322222233356678999999999888874322211 44333333222222 223
Q ss_pred hhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCcc
Q 022206 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA 226 (301)
Q Consensus 186 LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~ 226 (301)
+=..| ++|.|.+|.||+++.+|++.+.|||+.......
T Consensus 281 ~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 281 LLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 33356 999999999999999999999999998776543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.96 E-value=7.2e-09 Score=83.59 Aligned_cols=137 Identities=15% Similarity=0.168 Sum_probs=90.7
Q ss_pred hhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCch-H---------HHHHHHHHHhccCCCc---eeeeeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD-Q---------EFLAQVSMVSRLKNEN---VVELVGYY 130 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~---------~~~~e~~~l~~l~h~~---iv~~~~~~ 130 (301)
...+|.+.+++-......|.+.... |..+++|......... + ...+.+..+.+++... ...++-+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 3567888899988888777766655 7999999875432222 1 1233344344443222 22222221
Q ss_pred E-----cCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceE
Q 022206 131 V-----DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (301)
Q Consensus 131 ~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nil 205 (301)
. -....+++|||++|..|.++.. +++ .+...+..++..||+.| ++|+|.+|.|++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFl 167 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFL 167 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEE
Confidence 1 2234568999999988876542 222 24456777899999999 999999999999
Q ss_pred EcCCCceEEeccccCCC
Q 022206 206 LFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 206 l~~~~~vkl~Dfg~a~~ 222 (301)
+++++ ++++||+..+.
T Consensus 168 v~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 168 VSNNG-IRIIDTQGKRM 183 (229)
T ss_pred EECCc-EEEEECccccc
Confidence 98665 89999986543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.83 E-value=4.2e-08 Score=81.34 Aligned_cols=78 Identities=14% Similarity=0.150 Sum_probs=57.5
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCC--ceeeeeeEEE---cCCeeEEEEecCCC
Q 022206 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVGYYV---DGPLRVLAYEHASK 145 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~---~~~~~~lv~e~~~~ 145 (301)
++.|+.|..+.||++...+ +.+++|..... .....+.+|..+++.+... .+.+++.... .....+++|++++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 4679999999999999886 69999997654 3446678888888888533 3456665432 23457899999999
Q ss_pred CCHHH
Q 022206 146 GSLHD 150 (301)
Q Consensus 146 gsL~~ 150 (301)
..+..
T Consensus 80 ~~~~~ 84 (239)
T PF01636_consen 80 RPLDD 84 (239)
T ss_dssp EEHHH
T ss_pred ccccc
Confidence 88877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=5.3e-10 Score=101.40 Aligned_cols=194 Identities=19% Similarity=0.150 Sum_probs=141.6
Q ss_pred HHHHhhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCc-eeeeeeEEEcCCeeEE
Q 022206 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN-VVELVGYYVDGPLRVL 138 (301)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~l 138 (301)
.++.+++-+....-+++|+++++++.+....+....+++... ....-++++|.+++||| .+..++-+..++..++
T Consensus 236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred cccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 445556667777789999999999998653444446665433 33445788899999999 7777777777888999
Q ss_pred EEecCCCC-CHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 139 AYEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 139 v~e~~~~g-sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
.++++.++ +........ +-.+...+...+...-+++++++|+.. -+|+| ||+..+ +.++..||
T Consensus 312 ~~~i~s~~rs~~~~~~~s--------e~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~ 375 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVS--------EIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDF 375 (829)
T ss_pred hhhhhcCCccccccCChh--------hHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccc
Confidence 99999886 221111110 011334445566777788999999975 58898 777755 67899999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~ 276 (301)
+....+.... ......+++.|+|||+.....+....|+|++|+-..+|.-|.+|-.
T Consensus 376 ~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 376 AVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 9887765543 2256679999999999999999999999999987777777777753
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=4.5e-08 Score=75.72 Aligned_cols=131 Identities=20% Similarity=0.242 Sum_probs=95.0
Q ss_pred CCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCcee-eeeeEEEcCCeeEEEEecCCCC
Q 022206 68 FGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV-ELVGYYVDGPLRVLAYEHASKG 146 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~g 146 (301)
.+..+.|++|.+|.||++.+. +..+|+|+-.. ......+..|+++|..++..++. +++.|.. .++.|||+.|-
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~ 97 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-CceEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence 345678999999999999998 56899998654 33556789999999999876665 4454432 23559999998
Q ss_pred CHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC-CCceEEcCCCceEEeccccCCCC
Q 022206 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK-SSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk-p~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
.|.+..... +..++ ..+++.---|-..| |-|+.|+ |...++..++.+.|+||..|+..
T Consensus 98 ~L~~~~~~~------------~rk~l----~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 98 PLGKLEIGG------------DRKHL----LRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred chhhhhhcc------------cHHHH----HHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 887765531 22333 33444445566778 9999998 77777777779999999988743
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.5e-07 Score=78.92 Aligned_cols=76 Identities=17% Similarity=0.080 Sum_probs=54.5
Q ss_pred eecccCc-eEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccC-CCceeeeeeEEEcCCeeEEEEecCCCCCHHH
Q 022206 73 LIGEGSY-GRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHASKGSLHD 150 (301)
Q Consensus 73 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~ 150 (301)
.|..|.. +.||++... +..+++|...... ...+.+|+.+++.+. +-.+.+++++...++..++|||+++|.+|.+
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 3445555 789998765 4788899876443 345778888888874 3445677777776667899999999987765
Q ss_pred H
Q 022206 151 I 151 (301)
Q Consensus 151 ~ 151 (301)
.
T Consensus 82 ~ 82 (244)
T cd05150 82 L 82 (244)
T ss_pred h
Confidence 4
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=2e-09 Score=98.52 Aligned_cols=100 Identities=23% Similarity=0.428 Sum_probs=78.2
Q ss_pred HHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCccccccc-------cccccccccccCccccccC
Q 022206 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-------STRVLGTFGYHAPEYAMTG 250 (301)
Q Consensus 178 qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 250 (301)
+.+.|+.++|+.. ++||+.|.|++|.++..+.+||+.|+.+........... .....-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 3448999999876 699999999999999999999999999876554221100 0111235689999999998
Q ss_pred CCCccccchhhHHHHHHHH-hCCCCCCCCC
Q 022206 251 QMSSKSDVYSFGVVLLELL-TGRKPVDHTL 279 (301)
Q Consensus 251 ~~~~~~DvwslG~il~~l~-~g~~pf~~~~ 279 (301)
..+.++|+||||+++|.+. .|+.-+....
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~ 214 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANG 214 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccC
Confidence 8899999999999999999 5666665543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.1e-07 Score=77.71 Aligned_cols=152 Identities=17% Similarity=0.200 Sum_probs=99.8
Q ss_pred cCHHHHHHhhCCCCCCcee---cccCceEEEEEEECCCCEEEEEEcCCCCCc--------------------hHH-----
Q 022206 56 ISVDELKEKTDNFGTNSLI---GEGSYGRVYFGVLRSGRAAAIKKLDSSKQP--------------------DQE----- 107 (301)
Q Consensus 56 ~~~~~~~~~~~~y~~~~~l---g~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------~~~----- 107 (301)
.+...+.....+..+.... ..|.-+.||+|...++..+|+|++...... ..+
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 3445555666666665554 467778899999888999999988543221 111
Q ss_pred HHHHHHHHhccCC--CceeeeeeEEEcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 022206 108 FLAQVSMVSRLKN--ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185 (301)
Q Consensus 108 ~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~ 185 (301)
..+|+.-|+++.. -.+.+.+.+. .-.|||||+....+ . .+ ..+ ...+.......+..++++.+.-
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~----p-AP---~Lk-Dv~~e~~e~~~~~~~~v~~~~~ 181 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGL----P-AP---RLK-DVPLELEEAEGLYEDVVEYMRR 181 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCC----C-CC---Ccc-cCCcCchhHHHHHHHHHHHHHH
Confidence 3456666777743 3344445432 24689999965311 0 00 000 0113333577778888888888
Q ss_pred hhh-CCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 186 LHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 186 LH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
|-. .+ +||+||+.=|||+. ++.+.|+||+-|....
T Consensus 182 l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 182 LYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 777 66 99999999999999 8889999999886654
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.66 E-value=5.3e-07 Score=88.36 Aligned_cols=78 Identities=14% Similarity=0.175 Sum_probs=57.5
Q ss_pred CceecccCceEEEEEEECCC---CEEEEEEcCCCC--CchHHHHHHHHHHhccC-CCce--eeeeeEEEcC---CeeEEE
Q 022206 71 NSLIGEGSYGRVYFGVLRSG---RAAAIKKLDSSK--QPDQEFLAQVSMVSRLK-NENV--VELVGYYVDG---PLRVLA 139 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~--~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~~lv 139 (301)
++.|+.|.++.+|+....++ ..+++|+..... .....+.+|+++++.+. |.++ .+++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999887643 467888765432 23357889999999995 5554 6777777654 467899
Q ss_pred EecCCCCCH
Q 022206 140 YEHASKGSL 148 (301)
Q Consensus 140 ~e~~~~gsL 148 (301)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.65 E-value=6.3e-07 Score=74.63 Aligned_cols=74 Identities=11% Similarity=0.076 Sum_probs=49.2
Q ss_pred CceecccCceEEEEEEECC--CCEEEEEEcCCCCCchHHHHHHHHHHhccCCCce-eeeeeEEEcCCeeEEEEecCCCCC
Q 022206 71 NSLIGEGSYGRVYFGVLRS--GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHASKGS 147 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~gs 147 (301)
++.|..|-.+.+|++...+ +..|++|.........-...+|+.+++.+...++ .+++.... + .++|||++|.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCc
Confidence 4568888889999998664 6789999775432222234578888888854333 34444322 2 37999999876
Q ss_pred H
Q 022206 148 L 148 (301)
Q Consensus 148 L 148 (301)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.63 E-value=3.7e-07 Score=76.06 Aligned_cols=74 Identities=14% Similarity=0.122 Sum_probs=47.3
Q ss_pred CceecccCce-EEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCC---ceeeeeeEEEcC---CeeEEEEecC
Q 022206 71 NSLIGEGSYG-RVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---NVVELVGYYVDG---PLRVLAYEHA 143 (301)
Q Consensus 71 ~~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~---~~~~lv~e~~ 143 (301)
++.|+.|+.. .||+. +..+++|.... ......+.+|.++++.+... .+.++++..... ...+++|+++
T Consensus 2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 2 IEPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred ceeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 3567777765 58876 34677887554 33345788999999888532 344444433321 2357899999
Q ss_pred CCCCHH
Q 022206 144 SKGSLH 149 (301)
Q Consensus 144 ~~gsL~ 149 (301)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.2e-06 Score=75.49 Aligned_cols=78 Identities=15% Similarity=0.029 Sum_probs=57.7
Q ss_pred CCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCC---CceeeeeeEEEc---CCeeEEEEec
Q 022206 69 GTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN---ENVVELVGYYVD---GPLRVLAYEH 142 (301)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~---~~~~~lv~e~ 142 (301)
.-.+.||.|..+.||.....++ .+++|..+ .......+.+|...|+.|.. -.+.++++++.+ .+..++|||+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~-~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMAR-SFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEec-ccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 3456799999999999876655 57777743 32244678899999988853 357788877654 3668999999
Q ss_pred CCCCCH
Q 022206 143 ASKGSL 148 (301)
Q Consensus 143 ~~~gsL 148 (301)
++|+++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=3.8e-07 Score=83.31 Aligned_cols=141 Identities=18% Similarity=0.186 Sum_probs=89.9
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEcCCCCCch--------------------------------H------HHHHHH
Q 022206 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD--------------------------------Q------EFLAQV 112 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------------------~------~~~~e~ 112 (301)
.+.||.-+.|.||+|+.++|+.||||+-+..-... + +|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 36799999999999999999999999875432210 0 133444
Q ss_pred HHH----hccCCCc---eeeeeeEEE-cCCeeEEEEecCCCCCHHHHh--cCCCCCCCCCCCCCCCHHHHHHHHHHHHHH
Q 022206 113 SMV----SRLKNEN---VVELVGYYV-DGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182 (301)
Q Consensus 113 ~~l----~~l~h~~---iv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~ 182 (301)
+-. +.++|-+ -|.+=.++. -.....|+||||+|..+.++- .+.. ++...+..-+.+...
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g----------i~~~~i~~~l~~~~~- 314 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG----------ISPHDILNKLVEAYL- 314 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC----------CCHHHHHHHHHHHHH-
Confidence 332 2233444 111222222 345678999999998666543 3322 454544443333332
Q ss_pred HHHhhhCCCCCeEecCCCCCceEEcC----CCceEEeccccCCCCCcc
Q 022206 183 LEYLHEKAEPRIIHRNIKSSNVLLFD----DDIAKISDFDLSNQAPDA 226 (301)
Q Consensus 183 l~~LH~~~~~~ivH~Dlkp~Nill~~----~~~vkl~Dfg~a~~~~~~ 226 (301)
+.+=..| ++|+|-+|.||++.. ++.+.+.|||+...+...
T Consensus 315 -~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 315 -EQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred -HHHHhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2223346 999999999999984 668999999998776543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.5e-06 Score=67.87 Aligned_cols=127 Identities=17% Similarity=0.189 Sum_probs=91.3
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEcCCCC-----------------CchHHHHHHHHHHhccC------CCceeeee
Q 022206 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-----------------QPDQEFLAQVSMVSRLK------NENVVELV 127 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----------------~~~~~~~~e~~~l~~l~------h~~iv~~~ 127 (301)
...||+|+.=.|| .+.+....+||+..... ....+..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy--~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCY--QHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEE--ECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 4579999998898 45566778899886554 12345666766655554 67899999
Q ss_pred eEEEcCCeeEEEEecCCC------CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCC
Q 022206 128 GYYVDGPLRVLAYEHASK------GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (301)
Q Consensus 128 ~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp 201 (301)
|+.+++.-.-+|+|.+.. .+|.+++.... ++. ... ..+-+-..||-+.+ |+.+|++|
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----------~~~-~~~---~~L~~f~~~l~~~~---Iv~~dl~~ 146 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----------LTE-ELR---QALDEFKRYLLDHH---IVIRDLNP 146 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----------ccH-HHH---HHHHHHHHHHHHcC---CeecCCCc
Confidence 999998888899887632 47889986543 444 333 33344456777777 99999999
Q ss_pred CceEEcCCC----ceEEec
Q 022206 202 SNVLLFDDD----IAKISD 216 (301)
Q Consensus 202 ~Nill~~~~----~vkl~D 216 (301)
.||++.... .+.|+|
T Consensus 147 ~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 147 HNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred ccEEEEecCCCceEEEEEe
Confidence 999997432 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.3e-06 Score=73.85 Aligned_cols=144 Identities=11% Similarity=0.048 Sum_probs=79.4
Q ss_pred eecccCceEEEEEEECCCCEEEEEEcCCCCCch-HHHHHHHHHHhccCCCce-eeeeeEEEcCCeeEEEEecCCCCCHHH
Q 022206 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHASKGSLHD 150 (301)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~gsL~~ 150 (301)
.+..|-.+.+|+... ++..+++|......... -...+|..+++.+....+ .+++... . -++|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccccc
Confidence 456788889998874 46788899765432221 235678888888865433 3333332 2 368999999866532
Q ss_pred H--------------hcCCCCCCCCCCCCCCCHHH-HHHHHHH---------HHHHHHHhhhC-----CCCCeEecCCCC
Q 022206 151 I--------------LHGKKGVKGAKPGPVLSWAQ-RVKIAVG---------AARGLEYLHEK-----AEPRIIHRNIKS 201 (301)
Q Consensus 151 ~--------------l~~~~~~~~~~~~~~l~~~~-~~~i~~q---------i~~~l~~LH~~-----~~~~ivH~Dlkp 201 (301)
. +.+-.... ..+..+.... ...+..+ +...+..+-.. ....++|+|+.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~--~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQP--RFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 1 11000000 0011122111 1111111 11112222111 012389999999
Q ss_pred CceEEcCCCceEEeccccCCCCC
Q 022206 202 SNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
.||++++++ +.|+||+.+....
T Consensus 156 ~Nil~~~~~-~~lIDwE~a~~gd 177 (256)
T TIGR02721 156 YNLVVTPQG-LKLIDWEYASDGD 177 (256)
T ss_pred CcEEEeCCC-CEEEeccccCcCC
Confidence 999999877 7899999886543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.9e-06 Score=73.23 Aligned_cols=150 Identities=16% Similarity=0.153 Sum_probs=85.5
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCC--ceeeeeeE------EEcCCeeEEEEec
Q 022206 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVGY------YVDGPLRVLAYEH 142 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~------~~~~~~~~lv~e~ 142 (301)
++.|..|....+|+.... +..+++|+... ........|+.++..|.+. .+.+++.. ...++..+++++|
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 556778888899998765 45788898764 3345677788888877532 24444331 1234567899999
Q ss_pred CCCCCHHH-----------Hh---cCC-CCCCCC-CCCCCCCHHHHH----------HHHHHHHHHHHHhhhC----CCC
Q 022206 143 ASKGSLHD-----------IL---HGK-KGVKGA-KPGPVLSWAQRV----------KIAVGAARGLEYLHEK----AEP 192 (301)
Q Consensus 143 ~~~gsL~~-----------~l---~~~-~~~~~~-~~~~~l~~~~~~----------~i~~qi~~~l~~LH~~----~~~ 192 (301)
++|..+.. .+ +.. ...... .......+.... .....+..++.++... -..
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99866532 00 100 000000 000001111100 0111123334444331 112
Q ss_pred CeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 193 ~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
.++|+|+.|.||++++++.+.|+||+.+...
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~g 206 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFACTD 206 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhcCc
Confidence 3999999999999998877789999987654
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.38 E-value=9.7e-06 Score=70.76 Aligned_cols=163 Identities=17% Similarity=0.195 Sum_probs=84.8
Q ss_pred HHHHHHhhCCCCC-----CceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCC--ceeeeee--
Q 022206 58 VDELKEKTDNFGT-----NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVG-- 128 (301)
Q Consensus 58 ~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~-- 128 (301)
..++......|.+ .+.|+.|....+|+....+| .+++|+.. ......+..|+.+++.|... .+.+++.
T Consensus 9 ~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~ 85 (319)
T PRK05231 9 DDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARR 85 (319)
T ss_pred HHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCC
Confidence 3344444445544 35567788889999987654 78889876 22334445566666666322 2333332
Q ss_pred ----EEEcCCeeEEEEecCCCCCHH-----------HHh---cCC-CCCCCCCCC-CCCCH-HHHH------------HH
Q 022206 129 ----YYVDGPLRVLAYEHASKGSLH-----------DIL---HGK-KGVKGAKPG-PVLSW-AQRV------------KI 175 (301)
Q Consensus 129 ----~~~~~~~~~lv~e~~~~gsL~-----------~~l---~~~-~~~~~~~~~-~~l~~-~~~~------------~i 175 (301)
+....+..+++++|++|..+. +.+ +.. ......... ..+.+ .... ..
T Consensus 86 ~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (319)
T PRK05231 86 DGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAAL 165 (319)
T ss_pred CCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHH
Confidence 122355678999999986431 111 110 000000000 00111 0100 01
Q ss_pred HHH-HHHHHHHhhhC----CCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 176 AVG-AARGLEYLHEK----AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 176 ~~q-i~~~l~~LH~~----~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
+.+ +...+..+... -...++|+|++|.||+++.+...-|+||+.+...
T Consensus 166 l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~~ 218 (319)
T PRK05231 166 LEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACND 218 (319)
T ss_pred HHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccCC
Confidence 111 11122222211 1123999999999999987665689999988654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.3e-06 Score=68.53 Aligned_cols=105 Identities=24% Similarity=0.182 Sum_probs=79.8
Q ss_pred HHHHHHHhccCC-CceeeeeeEEEcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 022206 109 LAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187 (301)
Q Consensus 109 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH 187 (301)
..|..+++.+.+ +++.+++|+|- .+++.|+...+++......... -...++..+.+|+.++++.+.+|+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~------~~~~~w~~R~~iA~~lL~~l~~l~ 76 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQ------FLQSPWEQRAKIALQLLELLEELD 76 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccc------ccccCHHHHHHHHHHHHHHHHHHh
Confidence 357888888876 69999999983 3567899987766432000000 001688999999999999999999
Q ss_pred hCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 188 ~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
......+...|++|+|+-+++++++|++|.+.+...
T Consensus 77 ~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 77 HGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 854344899999999999999999999999976544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.6e-06 Score=71.69 Aligned_cols=74 Identities=20% Similarity=0.184 Sum_probs=49.9
Q ss_pred ceecccCceEEEEEEECC-------CCEEEEEEcCCCCCchHHHHHHHHHHhccCCCce-eeeeeEEEcCCeeEEEEecC
Q 022206 72 SLIGEGSYGRVYFGVLRS-------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~ 143 (301)
+.|..|-...+|++...+ ++.+++|.............+|.++++.+....+ .+++..+. + .+|+||+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhee
Confidence 456777788999998654 5789999976554333456778888888754333 34454443 2 3578999
Q ss_pred CCCCHH
Q 022206 144 SKGSLH 149 (301)
Q Consensus 144 ~~gsL~ 149 (301)
+|.++.
T Consensus 80 ~G~~l~ 85 (302)
T cd05156 80 PSRTLT 85 (302)
T ss_pred CCCcCC
Confidence 887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.28 E-value=3.6e-05 Score=66.82 Aligned_cols=164 Identities=17% Similarity=0.202 Sum_probs=89.2
Q ss_pred HHHHHHhhCCCCC-----CceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCC--ceeeeeeE-
Q 022206 58 VDELKEKTDNFGT-----NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVGY- 129 (301)
Q Consensus 58 ~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~- 129 (301)
...+......|.+ ++.++.|....+|++...++ .+++|...... .......|++++..|... .+.+++..
T Consensus 9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~ 86 (307)
T TIGR00938 9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSR 86 (307)
T ss_pred HHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCC
Confidence 3444444445544 55677888889999876544 67888765432 234556677777777432 23444432
Q ss_pred -----EEcCCeeEEEEecCCCCCHH-----------HHh---cCC-CCCCCCCCC-CCCC-HHHHH------------HH
Q 022206 130 -----YVDGPLRVLAYEHASKGSLH-----------DIL---HGK-KGVKGAKPG-PVLS-WAQRV------------KI 175 (301)
Q Consensus 130 -----~~~~~~~~lv~e~~~~gsL~-----------~~l---~~~-~~~~~~~~~-~~l~-~~~~~------------~i 175 (301)
...++..+++++|++|..+. ..+ +.. ......... ..+. +.... ..
T Consensus 87 ~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~ 166 (307)
T TIGR00938 87 DGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHM 166 (307)
T ss_pred CCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHH
Confidence 12245678999999885432 111 110 000000000 0000 00000 01
Q ss_pred HHHHHHHHHHhhh----CCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 176 AVGAARGLEYLHE----KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 176 ~~qi~~~l~~LH~----~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
...+...++++.. .-...++|+|+++.||++++++.+.|+||+.+...
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~~ 218 (307)
T TIGR00938 167 GAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACTD 218 (307)
T ss_pred HHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccCc
Confidence 1122334444432 11123999999999999999887789999988554
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.27 E-value=5e-05 Score=67.73 Aligned_cols=75 Identities=17% Similarity=0.162 Sum_probs=53.4
Q ss_pred CceecccCceEEEEEEECCC-CEEEEEEcCC------C--CCchHHHHHHHHHHhccC---CCceeeeeeEEEcCCeeEE
Q 022206 71 NSLIGEGSYGRVYFGVLRSG-RAAAIKKLDS------S--KQPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~------~--~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~l 138 (301)
.+.||.|.++.||++...+| +.++||.-.. . ....+....|.+.|+.+. ..++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 45799999999999998866 5899997431 1 223456677888877763 2456667765 4566789
Q ss_pred EEecCCCCC
Q 022206 139 AYEHASKGS 147 (301)
Q Consensus 139 v~e~~~~gs 147 (301)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.7e-05 Score=63.48 Aligned_cols=124 Identities=26% Similarity=0.381 Sum_probs=85.7
Q ss_pred CCCCCCceecccCc-eEEEEEEECCCCEEEEEEcCC----CC------------------CchHHHHHHHHHHhcc---C
Q 022206 66 DNFGTNSLIGEGSY-GRVYFGVLRSGRAAAIKKLDS----SK------------------QPDQEFLAQVSMVSRL---K 119 (301)
Q Consensus 66 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~----~~------------------~~~~~~~~e~~~l~~l---~ 119 (301)
.+++.++.||.|.- |.||+++.. |+.+|+|++.. .. .....|..|.....+| .
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 68889999999999 999999987 77999999321 00 0112366676665555 4
Q ss_pred CCce--eeeeeEEEcC------------------CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHH
Q 022206 120 NENV--VELVGYYVDG------------------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179 (301)
Q Consensus 120 h~~i--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi 179 (301)
+.++ ++.+||..-. ....||.||.+... .+.. .-+.+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------------~~~~----~~~~~~ 173 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------------PLQI----RDIPQM 173 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------------ccch----hHHHHH
Confidence 4556 8898886321 11345666655422 0222 335567
Q ss_pred HHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 180 ~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
.+-|..+|..| |+-+|+++.|.. +| +|+|||.+
T Consensus 174 ~~dl~~~~k~g---I~~~Dv~~~ny~---~G--~lvDfs~~ 206 (207)
T PF13095_consen 174 LRDLKILHKLG---IVPRDVKPRNYR---GG--KLVDFSSS 206 (207)
T ss_pred HHHHHHHHHCC---eeeccCcccccc---CC--EEEecccC
Confidence 77788899999 999999999987 33 88999864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=3.3e-06 Score=71.78 Aligned_cols=137 Identities=15% Similarity=0.135 Sum_probs=99.5
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCC---------CC----------c----hHHHHHHHHHHhccCC-
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS---------KQ----------P----DQEFLAQVSMVSRLKN- 120 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~---------~~----------~----~~~~~~e~~~l~~l~h- 120 (301)
..-+.+++.||-|.-+-||.+.+..|.+.++|.=... .. + +-...+|+..|+.|..
T Consensus 91 ~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~ 170 (465)
T KOG2268|consen 91 GSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER 170 (465)
T ss_pred chhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence 3457789999999999999999999999999842110 00 0 1124568888888853
Q ss_pred -CceeeeeeEEEcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCC
Q 022206 121 -ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI 199 (301)
Q Consensus 121 -~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dl 199 (301)
-.+.+.++ .++.++|||++.|-.|.+.-+-. ..-.+...+...+--|.++| +||+|+
T Consensus 171 gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~---------------d~~~ly~~lm~~Iv~la~~G---lIHgDF 228 (465)
T KOG2268|consen 171 GFPVPKPID----HNRHCVVMELVDGYPLRQVRHVE---------------DPPTLYDDLMGLIVRLANHG---LIHGDF 228 (465)
T ss_pred CCCCCCccc----ccceeeHHHhhcccceeeeeecC---------------ChHHHHHHHHHHHHHHHHcC---ceeccc
Confidence 23445554 45778999999998776654322 12234555566677788889 999999
Q ss_pred CCCceEEcCCCceEEeccccCCCC
Q 022206 200 KSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 200 kp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
.-=||++++++.++++||--....
T Consensus 229 NEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 229 NEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred chheeEEecCCCEEEeechHhhcc
Confidence 999999999999999999865444
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=98.04 E-value=7.9e-05 Score=65.68 Aligned_cols=147 Identities=14% Similarity=0.188 Sum_probs=81.7
Q ss_pred CceecccCceEEEEEEECC-----CCEEEEEEcCCCCCchHHHHHHHHHHhccCCCcee-eeeeEEEcCCeeEEEEecCC
Q 022206 71 NSLIGEGSYGRVYFGVLRS-----GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV-ELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~ 144 (301)
++.|-.|-...+|++...+ ++.+++|........--.-.+|..+++.+...++. ++++.+..+ .|.+|++
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 4456668889999987532 36899998765432222236688888888654443 455554332 4788888
Q ss_pred CCCHHHH-----------------hcCCCCCCCCCCCCCCCHHHHHHHHHHH-----------------HHHHHHh----
Q 022206 145 KGSLHDI-----------------LHGKKGVKGAKPGPVLSWAQRVKIAVGA-----------------ARGLEYL---- 186 (301)
Q Consensus 145 ~gsL~~~-----------------l~~~~~~~~~~~~~~l~~~~~~~i~~qi-----------------~~~l~~L---- 186 (301)
+.+|... ++.... . .... ...+..+..+..++ ...+..|
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~-~-~~~~-~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDM-P-GPKN-VLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCC-C-CCCC-chHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 7666421 111110 0 0000 01112222222111 1111111
Q ss_pred hh-CCCCCeEecCCCCCceEEcC-CCceEEeccccCCCCC
Q 022206 187 HE-KAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQAP 224 (301)
Q Consensus 187 H~-~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a~~~~ 224 (301)
.. .....++|+|+++.|||+++ ++.+.++||..+....
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~ 233 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP 233 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence 11 11224899999999999986 4789999999986544
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.0001 Score=63.09 Aligned_cols=75 Identities=13% Similarity=0.089 Sum_probs=48.9
Q ss_pred CCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccC---CCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 69 GTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
+-.+.|+.|..+.+|+.. .+++.+.||+-. ......+..|+.-|+.|. .-.+.+++.+...++..+++|||++.
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 345678999999999887 557899999876 333456888888888883 34577888888877778999999987
Q ss_pred C
Q 022206 146 G 146 (301)
Q Consensus 146 g 146 (301)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 5
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.0002 Score=61.76 Aligned_cols=142 Identities=14% Similarity=0.150 Sum_probs=86.8
Q ss_pred CCCCceecccCceEEEEEEECCCCEEEEEEcCC---CCCchHHHHHHHHHHhccCC--CceeeeeeEEEcCC--eeEEEE
Q 022206 68 FGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDS---SKQPDQEFLAQVSMVSRLKN--ENVVELVGYYVDGP--LRVLAY 140 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~--~~~lv~ 140 (301)
..+++.+..|.-..+|..... ++++++. ... .........+|+.+++.+.. -.+...++.+.++. ..+.||
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred CceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 334444544444556665554 7788888 331 12233567788888888754 23445566666665 679999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHH-HHHHHHHHHhhh-------------------------------
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA-VGAARGLEYLHE------------------------------- 188 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~-~qi~~~l~~LH~------------------------------- 188 (301)
+|++|..+.+.+.... .. .+++ ..+...|.-||+
T Consensus 105 ~~veGe~~~~~~~~~~----------~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~ 170 (321)
T COG3173 105 EWVEGEVVWSALPPES----------LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAK 170 (321)
T ss_pred EEecceeccCcCCccc----------ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHH
Confidence 9999854433222111 00 1111 244444444443
Q ss_pred -------------------CC-----CCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 189 -------------------KA-----EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 189 -------------------~~-----~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
+- .+.++|+|+++.|+++++++-+=++||+++..-..
T Consensus 171 ~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 171 KELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 11 24699999999999999998899999999866543
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00033 Score=62.43 Aligned_cols=80 Identities=14% Similarity=0.135 Sum_probs=52.7
Q ss_pred CCceecccCceEEEEEEECCCCEEEEEEcC-----CCC---CchHHHHHHHHHHhccC---CCceeeeeeEEEcCCeeEE
Q 022206 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLD-----SSK---QPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~-----~~~---~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~l 138 (301)
..+.||.|....||++... ++.++||.-. ... ........|+..|+.+. ..++.+++.++. +..++
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 3667899999999998875 5679999754 111 12233444566665553 246777887665 45678
Q ss_pred EEecCCC--CCHHHHh
Q 022206 139 AYEHASK--GSLHDIL 152 (301)
Q Consensus 139 v~e~~~~--gsL~~~l 152 (301)
+||++++ ..+.+-+
T Consensus 113 vME~L~~~~~ilr~~L 128 (418)
T PLN02756 113 GMRYLEPPHIILRKGL 128 (418)
T ss_pred EEeecCCcceehhhhh
Confidence 8999977 3455444
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.0015 Score=57.26 Aligned_cols=71 Identities=18% Similarity=0.186 Sum_probs=47.3
Q ss_pred cCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCC--ceeeee---e--EEEcCCeeEEEEecCCCCC
Q 022206 77 GSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELV---G--YYVDGPLRVLAYEHASKGS 147 (301)
Q Consensus 77 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~---~--~~~~~~~~~lv~e~~~~gs 147 (301)
+.-..||+....++..+++|+..........+..|+..+..|... .++... + ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 445789999988788999999865555566777888887776431 122211 1 1223456788899998754
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00028 Score=60.23 Aligned_cols=31 Identities=13% Similarity=0.362 Sum_probs=25.9
Q ss_pred CeEecCCCCCceEEcCCCc-eEEeccccCCCC
Q 022206 193 RIIHRNIKSSNVLLFDDDI-AKISDFDLSNQA 223 (301)
Q Consensus 193 ~ivH~Dlkp~Nill~~~~~-vkl~Dfg~a~~~ 223 (301)
.++|+|++|.|||+++++. .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997555 469999987654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00074 Score=59.19 Aligned_cols=79 Identities=20% Similarity=0.141 Sum_probs=50.9
Q ss_pred eecccCceEEEEEEECCC-CEEEEEEcC----C----CCCchHHHHHHHHHHhccCC--C-ceeeeeeEEEcCCeeEEEE
Q 022206 73 LIGEGSYGRVYFGVLRSG-RAAAIKKLD----S----SKQPDQEFLAQVSMVSRLKN--E-NVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~-~~vavK~~~----~----~~~~~~~~~~e~~~l~~l~h--~-~iv~~~~~~~~~~~~~lv~ 140 (301)
.||.|....||++...++ +.++||.-. . ...+..+...|...|+.... | .+.+++. .+.....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 479999999999997744 689999632 1 12333555667777766532 4 4455554 3566677999
Q ss_pred ecCCC-CCHHHHhc
Q 022206 141 EHASK-GSLHDILH 153 (301)
Q Consensus 141 e~~~~-gsL~~~l~ 153 (301)
|+++. ..|.+.|.
T Consensus 80 EdL~~~~ilR~~Li 93 (370)
T TIGR01767 80 EDLSHHKIARKGLI 93 (370)
T ss_pred hhCccchHHHHHHH
Confidence 99854 34444443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00022 Score=61.97 Aligned_cols=139 Identities=22% Similarity=0.242 Sum_probs=90.0
Q ss_pred CCceecccCceEEEEEEECCCCEEEEEEcCCCCC-----------------------chHH----HHHHHHHHhccCCCc
Q 022206 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-----------------------PDQE----FLAQVSMVSRLKNEN 122 (301)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------------------~~~~----~~~e~~~l~~l~h~~ 122 (301)
+...|..|.-+.||.|...+|..+|||+++.+.. ++.. ...|+.-|++|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 4445677889999999988999999998753211 0111 234666677776655
Q ss_pred eeeeeeEEEcCCeeEEEEecCCCCCHHH-HhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCC
Q 022206 123 VVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (301)
Q Consensus 123 iv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp 201 (301)
|.-.--+.. ....|||+|+....--. .|. ...++...+..+-.|++.-+.-|-... ++||.||.-
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkLK----------d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSE 293 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKLK----------DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSE 293 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCcccc----------cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhh
Confidence 332111111 23579999985321111 111 122666777777778887777776554 499999999
Q ss_pred CceEEcCCCceEEeccccCCCC
Q 022206 202 SNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
=|+|+. +|.+.|+|.+-+...
T Consensus 294 fN~Lyh-dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 294 FNLLYH-DGKLYIIDVSQSVEH 314 (520)
T ss_pred hhheEE-CCEEEEEEccccccC
Confidence 999995 567899998876543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00044 Score=60.66 Aligned_cols=74 Identities=8% Similarity=0.082 Sum_probs=46.3
Q ss_pred CceecccCceEEEEEEECC----CCEEEEEEcCCCCCchHHHHHHHHHHhccCCCcee-eeeeEEEcCCeeEEEEecCCC
Q 022206 71 NSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV-ELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~ 145 (301)
++.|..|=...+|++...+ +..|++|+.......--.-.+|..+++.+..-++. ++++++. ++ +|.+|+++
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 3456567788899887542 24799998755433222345678888888654443 4555542 22 47889887
Q ss_pred CCH
Q 022206 146 GSL 148 (301)
Q Consensus 146 gsL 148 (301)
.+|
T Consensus 95 ~~l 97 (330)
T PLN02421 95 RTL 97 (330)
T ss_pred CCC
Confidence 655
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0012 Score=57.58 Aligned_cols=148 Identities=19% Similarity=0.267 Sum_probs=86.3
Q ss_pred eecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCce------eee----eeEEEcCCeeEEEEec
Q 022206 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV------VEL----VGYYVDGPLRVLAYEH 142 (301)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~i------v~~----~~~~~~~~~~~lv~e~ 142 (301)
.|.+ .-..||+....+|+. ++|+.... ....++.-|+..+..|....| ... +.......+.+-+++|
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 3455 567899999886666 99998877 667778888888888743222 111 1122222377888999
Q ss_pred CCCCCHHH------------Hh---c-CCCCCC--CCCCCCCCCHHH-------------HHHHHHHHHHHHHHhhhCC-
Q 022206 143 ASKGSLHD------------IL---H-GKKGVK--GAKPGPVLSWAQ-------------RVKIAVGAARGLEYLHEKA- 190 (301)
Q Consensus 143 ~~~gsL~~------------~l---~-~~~~~~--~~~~~~~l~~~~-------------~~~i~~qi~~~l~~LH~~~- 190 (301)
++|..+.. ++ + ...... .........+.. -.....++...+..+.+.-
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99977762 11 0 001111 011100111210 0112334444444444321
Q ss_pred ------CCCeEecCCCCCceEEcCCCc-eEEeccccCCCC
Q 022206 191 ------EPRIIHRNIKSSNVLLFDDDI-AKISDFDLSNQA 223 (301)
Q Consensus 191 ------~~~ivH~Dlkp~Nill~~~~~-vkl~Dfg~a~~~ 223 (301)
...+||+|+.|.||+++.+.. +-++||+-+...
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~~ 229 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGYG 229 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccccc
Confidence 123899999999999998874 889999987553
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00017 Score=70.68 Aligned_cols=151 Identities=21% Similarity=0.260 Sum_probs=112.1
Q ss_pred HHHHHHHhccCCCceeeeeeEEEcCCe----eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 022206 109 LAQVSMVSRLKNENVVELVGYYVDGPL----RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184 (301)
Q Consensus 109 ~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~ 184 (301)
.-|+..+..+.|+|++.++.|..+... ..+..++|...++...+..... .+....+.+..++.+||.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~---------i~~~~~r~~~~~~~~GL~ 300 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS---------IPLETLRILHQKLLEGLA 300 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc---------cCHHHHHHHHHHHhhhHH
Confidence 345666888899999999998765432 2344578888888888876542 788899999999999999
Q ss_pred HhhhCCCCCeEecCCCCC---ceEEcCCCceEEe--ccccCCCCCccccccccccccccccccCccccccCCCCcc--cc
Q 022206 185 YLHEKAEPRIIHRNIKSS---NVLLFDDDIAKIS--DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSK--SD 257 (301)
Q Consensus 185 ~LH~~~~~~ivH~Dlkp~---Nill~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~D 257 (301)
|+|+.. ..|.-|... +.-++..+.+.++ ||+.+......... .....+..+.++|......+..+ .|
T Consensus 301 ~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~d 374 (1351)
T KOG1035|consen 301 YLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTD 374 (1351)
T ss_pred HHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhH
Confidence 999986 777766666 5555667777777 99988776654432 22234566888887776665544 69
Q ss_pred chhhHHHHHHHHhCCCC
Q 022206 258 VYSFGVVLLELLTGRKP 274 (301)
Q Consensus 258 vwslG~il~~l~~g~~p 274 (301)
+|.+|.....+..|..+
T Consensus 375 L~~lgll~~~~~~~~~i 391 (1351)
T KOG1035|consen 375 LWCLGLLLLQLSQGEDI 391 (1351)
T ss_pred HHHHHHHHhhhhhcCcc
Confidence 99999999998887654
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0017 Score=56.42 Aligned_cols=30 Identities=27% Similarity=0.393 Sum_probs=25.6
Q ss_pred CeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 193 ~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
.++|+|+++.||+++. +.+.|+||+.+...
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~~~ 217 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCTID 217 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccccC
Confidence 3899999999999987 67899999976543
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.48 E-value=1.6e-05 Score=79.61 Aligned_cols=163 Identities=10% Similarity=-0.048 Sum_probs=115.3
Q ss_pred HHHHHHHHhccCCCceeeeeeEEE--cCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 022206 108 FLAQVSMVSRLKNENVVELVGYYV--DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185 (301)
Q Consensus 108 ~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~ 185 (301)
...|...++...|+++.....-.. +....+..++++.+|.+.+.+-+.... .+.+...-+.....+.+....-
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee-----~~~ld~~~v~~~~kvsvl~~~~ 1350 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEE-----SPDLDRSPVHLRHKVSVLNRNV 1350 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhcccc-----CCcchhchHHHHHHHHHhccch
Confidence 334444556678888887665544 334568889999999999998654332 1224433344444443555555
Q ss_pred hhhCC--CCCeEecCCCCCceEEcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHH
Q 022206 186 LHEKA--EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGV 263 (301)
Q Consensus 186 LH~~~--~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~ 263 (301)
+|+.. +.-.+|+++|+.|.+|..+..||+.++|+.+........ .....+++.|++|++...-.++.++|+|..|+
T Consensus 1351 ~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf--~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1351 ILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF--FGLELCSPIYVLQLIKNEIKFTKRSDILRRSL 1428 (2724)
T ss_pred hhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhh--hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence 55432 233789999999999999999999999999833222111 14556788999999888888888899999999
Q ss_pred HHHHHHhCCCCCCC
Q 022206 264 VLLELLTGRKPVDH 277 (301)
Q Consensus 264 il~~l~~g~~pf~~ 277 (301)
-+|..--|..+|..
T Consensus 1429 ~ly~rs~~n~~fi~ 1442 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYFIF 1442 (2724)
T ss_pred HHHHHhcccHHHHH
Confidence 99999889888854
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0012 Score=58.69 Aligned_cols=80 Identities=16% Similarity=0.123 Sum_probs=52.9
Q ss_pred CceecccCceEEEEEEECC-CCEEEEEEcC----CC---CCchHHHHHHHHHHhccC--CC-ceeeeeeEEEcCCeeEEE
Q 022206 71 NSLIGEGSYGRVYFGVLRS-GRAAAIKKLD----SS---KQPDQEFLAQVSMVSRLK--NE-NVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~----~~---~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~lv 139 (301)
.+.||.|.-.-||++.+.+ ++.++||.-. .. ..+.++..-|.+.|+.+. -| .+.+++. .+.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 5678999999999999753 5679999632 11 333456667777777664 24 4555654 366667789
Q ss_pred EecCCC-CCHHHHh
Q 022206 140 YEHASK-GSLHDIL 152 (301)
Q Consensus 140 ~e~~~~-gsL~~~l 152 (301)
||+++. ..|++.|
T Consensus 112 MEdL~~~~ilR~~L 125 (409)
T PRK12396 112 MEDLSDHTILRTAL 125 (409)
T ss_pred HHhCcccHHHHHHH
Confidence 999854 3344444
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0003 Score=57.55 Aligned_cols=29 Identities=24% Similarity=0.512 Sum_probs=20.7
Q ss_pred eEecCCCCCceEE-cCCCceEEeccccCCC
Q 022206 194 IIHRNIKSSNVLL-FDDDIAKISDFDLSNQ 222 (301)
Q Consensus 194 ivH~Dlkp~Nill-~~~~~vkl~Dfg~a~~ 222 (301)
+.|+|+.+.|||+ +.++.++|+||..|..
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 7899999999999 8889999999998744
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.002 Score=56.01 Aligned_cols=31 Identities=16% Similarity=0.249 Sum_probs=28.0
Q ss_pred eEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 194 ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
++|+|+.+.|+|++.++.+.++||..+....
T Consensus 198 lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d~ 228 (309)
T TIGR02904 198 LVHGKLSLSHFLYDETRGGYFINFEKASFAS 228 (309)
T ss_pred eeCCCCcHHhEEEcCCCCEEEEEhhhcccCC
Confidence 9999999999999999999999999876543
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0022 Score=53.75 Aligned_cols=79 Identities=16% Similarity=0.093 Sum_probs=55.8
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC-CCCCHH
Q 022206 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA-SKGSLH 149 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~gsL~ 149 (301)
...+..|..+.|+.++..+|.++++|+.........+... ...|+..+....|++++.- ...-.+++|.+ ++.+|.
T Consensus 7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g-~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L~ 83 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARG-EAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSLA 83 (253)
T ss_pred CCCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhH-HhHhheeCCCCceeeeccc--cccchhhhhhccCCCchh
Confidence 4456779999999999889999999997654333232222 2447777878889999853 34456788999 455776
Q ss_pred HHh
Q 022206 150 DIL 152 (301)
Q Consensus 150 ~~l 152 (301)
++.
T Consensus 84 ~~~ 86 (253)
T PF04655_consen 84 SLP 86 (253)
T ss_pred hcc
Confidence 665
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0054 Score=61.71 Aligned_cols=77 Identities=13% Similarity=0.097 Sum_probs=46.2
Q ss_pred ceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCC-------Cceeeee-----eEEEc-CC--ee
Q 022206 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-------ENVVELV-----GYYVD-GP--LR 136 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-------~~iv~~~-----~~~~~-~~--~~ 136 (301)
+.|+ |..-.+|++...++..+++|+.+... .......|.+.|..|.. |.+++-. ..... ++ +.
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 4564 45688999988778899999987643 33344445556655521 2222211 11111 22 46
Q ss_pred EEEEecCCCCCHHH
Q 022206 137 VLAYEHASKGSLHD 150 (301)
Q Consensus 137 ~lv~e~~~~gsL~~ 150 (301)
+.+++|++|..|.+
T Consensus 109 vrLl~~l~G~~l~~ 122 (1013)
T PRK06148 109 LRLLSWLPGTPLAE 122 (1013)
T ss_pred EEEEeccCCCcHHh
Confidence 67899999977765
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0063 Score=54.38 Aligned_cols=75 Identities=19% Similarity=0.215 Sum_probs=44.3
Q ss_pred CceecccCceEEEEEEECCC--CE-----EEEEEcCCCCCchHHHHHHHHHHhccCCCcee-eeeeEEEcCCeeEEEEec
Q 022206 71 NSLIGEGSYGRVYFGVLRSG--RA-----AAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV-ELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~ 142 (301)
++.|..|-.+.+|++...++ .. |.+.........--+-.+|+++++.+...++. ++++.+.. +++.||
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 44566688899999975532 22 44443322111112235678888888765554 45554432 588899
Q ss_pred CCCCCHH
Q 022206 143 ASKGSLH 149 (301)
Q Consensus 143 ~~~gsL~ 149 (301)
++|.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987654
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0047 Score=50.18 Aligned_cols=102 Identities=14% Similarity=0.140 Sum_probs=65.4
Q ss_pred CEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCC
Q 022206 91 RAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLS 168 (301)
Q Consensus 91 ~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~ 168 (301)
.+..+|++...+. ...-+..+..++.++. .|+++..- ++-.+-+++|.|..... .+
T Consensus 86 G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------------~~ 143 (308)
T PF07387_consen 86 GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------------NF 143 (308)
T ss_pred chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------------ch
Confidence 3455565554333 3455677888887764 46666632 44456688898854111 11
Q ss_pred HHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 169 ~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
. .++.-=+++|.-.|+.. ...+|+|-.|+|||-|..|.+||.|-+.
T Consensus 144 ---~-N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 144 ---S-NFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ---h-HHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 1 11111246788889542 2499999999999999999999999875
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0023 Score=55.73 Aligned_cols=54 Identities=22% Similarity=0.263 Sum_probs=46.3
Q ss_pred CCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 167 LSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 167 l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
....++..++.+.+..+.-+...- ++-|||+...||||+ +|+|.|+||-+++..
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeecc
Confidence 456788889999888888777764 589999999999999 999999999998743
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.021 Score=52.13 Aligned_cols=75 Identities=11% Similarity=0.104 Sum_probs=46.1
Q ss_pred CCceecccCceEEEEEEECC---------CCEEEEEEcCCCCCchHHHHHHHHHHhccCCCcee-eeeeEEEcCCeeEEE
Q 022206 70 TNSLIGEGSYGRVYFGVLRS---------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV-ELVGYYVDGPLRVLA 139 (301)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv 139 (301)
-++.|..|=...+|++...+ ++.|++++.-.....--.-.+|..+++.+...+|- ++++.+. + ..+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~-g---g~I 184 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS-G---GRI 184 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC-C---CEE
Confidence 35567778788899998542 45788888754332222344577777777554443 4455442 2 356
Q ss_pred EecCCCCCH
Q 022206 140 YEHASKGSL 148 (301)
Q Consensus 140 ~e~~~~gsL 148 (301)
.||++|.+|
T Consensus 185 ~efi~g~~l 193 (442)
T PTZ00296 185 EEWLYGDPL 193 (442)
T ss_pred EEeeCCccC
Confidence 899987644
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.017 Score=47.27 Aligned_cols=76 Identities=13% Similarity=0.054 Sum_probs=53.0
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhcc---CCCceeeeeeEEEcCCeeEEEEecCCCCC
Q 022206 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL---KNENVVELVGYYVDGPLRVLAYEHASKGS 147 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~gs 147 (301)
.+.+.-|.....|...+. ..++.+|+-... ....+..|+.-|+.| +.-.+.+++.+..+....|+||||++-+.
T Consensus 21 r~~v~gG~inea~~v~dg-~~~~FvK~n~~~--~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 21 REEVSGGDINEAWRLRDG-TDPFFVKCNQRE--QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred ccccCCccccceeEeecC-CcceEEEecchh--hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 345666766677766554 578889974322 235577777665555 44567788888889999999999998765
Q ss_pred HH
Q 022206 148 LH 149 (301)
Q Consensus 148 L~ 149 (301)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 54
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 301 | ||||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-38 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-38 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-35 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-35 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-34 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-34 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 6e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-04 |
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 315 bits (809), Expect = e-108
Identities = 94/238 (39%), Positives = 144/238 (60%), Gaps = 11/238 (4%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLD-SSKQPDQEFLAQVSM 114
+ + +L+E T+NF LIG G +G+VY GVLR G A+K+ S Q +EF ++
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
+S ++ ++V L+G+ + +L Y++ G+L L+G P +SW QR++
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD-----LPTMSMSWEQRLE 143
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-ST 233
I +GAARGL YLH +A IIHR++KS N+LL ++ + KI+DF +S + + + H ST
Sbjct: 144 ICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELD-QTHLST 199
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVL 291
V GT GY PEY + G+++ KSDVYSFGVVL E+L R + +LPR +L W +
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 309 bits (795), Expect = e-105
Identities = 85/239 (35%), Positives = 140/239 (58%), Gaps = 12/239 (5%)
Query: 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKL--DSSKQPDQEFLAQVSM 114
S+ EL+ +DNF +++G G +G+VY G L G A+K+L + ++ + +F +V M
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
+S + N++ L G+ + R+L Y + + GS+ L + + P L W +R +
Sbjct: 81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-----PPLDWPKRQR 135
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-ST 233
IA+G+ARGL YLH+ +P+IIHR++K++N+LL ++ A + DF L+ H +T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT--HVTT 193
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS--LVTWV 290
V GT G+ APEY TG+ S K+DV+ +GV+LLEL+TG++ D L+ WV
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = e-100
Identities = 98/260 (37%), Positives = 145/260 (55%), Gaps = 24/260 (9%)
Query: 42 EMKTVTVQPIAVPVISVDELKEKTDNF------GTNSLIGEGSYGRVYFGVLRSGRAAAI 95
E K++ V S ELK T+NF + +GEG +G VY G + + A+
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 96 KKLDS-----SKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD 150
KKL + +++ Q+F ++ ++++ ++EN+VEL+G+ DG L Y + GSL D
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 151 ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210
L G P LSW R KIA GAA G+ +LHE IHR+IKS+N+LL +
Sbjct: 120 RLSCLDG------TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAF 170
Query: 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT 270
AKISDF L+ + A + ++R++GT Y APE + G+++ KSD+YSFGVVLLE++T
Sbjct: 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIIT 229
Query: 271 GRKPVDHTLPRGQQSLVTWV 290
G VD R Q L+
Sbjct: 230 GLPAVDEH--REPQLLLDIK 247
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 1e-67
Identities = 63/251 (25%), Positives = 100/251 (39%), Gaps = 27/251 (10%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMV 115
+ + L ++ + G +G V+ L A+K + + +V +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSL 72
Query: 116 SRLKNENVVELVGYYVDGPLRV----LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171
+K+EN+++ +G G L KGSL D L V+SW +
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----------VVSWNE 122
Query: 172 RVKIAVGAARGLEYLHE-------KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224
IA ARGL YLHE +P I HR+IKS NVLL ++ A I+DF L+ +
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 225 DAAARLHSTRVLGTFGYHAPEYAMTG-----QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279
+ + +GT Y APE + D+Y+ G+VL EL + D +
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 280 PRGQQSLVTWV 290
+
Sbjct: 243 DEYMLPFEEEI 253
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 3e-58
Identities = 64/220 (29%), Positives = 113/220 (51%), Gaps = 23/220 (10%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMV 115
I E++ + ++G G++G V R + AIK+++S + + F+ ++ +
Sbjct: 5 IDYKEIEVE-------EVVGRGAFGVVCKAKWR-AKDVAIKQIESESE-RKAFIVELRQL 55
Query: 116 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
SR+ + N+V+L G ++ P+ L E+A GSL+++LHG + P P + A +
Sbjct: 56 SRVNHPNIVKLYGACLN-PVC-LVMEYAEGGSLYNVLHGAE------PLPYYTAAHAMSW 107
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTR 234
+ ++G+ YLH +IHR++K N+LL + KI DF + H T
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTN 162
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
G+ + APE S K DV+S+G++L E++T RKP
Sbjct: 163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP 202
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 5e-57
Identities = 55/228 (24%), Positives = 94/228 (41%), Gaps = 33/228 (14%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKL---DSSKQPDQEFLAQV 112
I +L T + E G ++ G + G +K L D S + ++F +
Sbjct: 7 IDFKQLNFLT-------KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAY--EHASKGSLHDILHGKKGVKGAKPGPVLSWA 170
+ + NV+ ++G P GSL+++LH V+ +
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-------FVVDQS 111
Query: 171 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230
Q VK A+ ARG+ +LH EP I + S +V++ +D A+IS D+
Sbjct: 112 QAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFS-------F 163
Query: 231 HSTRVLGTFGYHAPEYAMTGQMSS----KSDVYSFGVVLLELLTGRKP 274
S + + APE A+ + +D++SF V+L EL+T P
Sbjct: 164 QSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 5e-56
Identities = 70/204 (34%), Positives = 103/204 (50%), Gaps = 13/204 (6%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
IG GS+G V+ G A+K L D + EFL +V+++ RL++ N+V +G
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
P + E+ S+GSL+ +LH L +R+ +A A+G+ YLH +
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKS------GAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
P I+HRN+KS N+L+ K+ DF LS S GT + APE
Sbjct: 158 -PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA--GTPEWMAPEVLRDE 214
Query: 251 QMSSKSDVYSFGVVLLELLTGRKP 274
+ KSDVYSFGV+L EL T ++P
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQP 238
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-55
Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 28/214 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD-----QEFLAQVSMVSRLKNENVVELVG 128
IG G +G+VY G A+K D + + + + LK+ N++ L G
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ P L E A G L+ +L GK+ + V AV ARG+ YLH+
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR----------IPPDILVNWAVQIARGMNYLHD 123
Query: 189 KAEPRIIHRNIKSSNVLL--------FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+A IIHR++KSSN+L+ + I KI+DF L+ + G +
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYA 179
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ APE S SDV+S+GV+L ELLTG P
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-55
Identities = 66/239 (27%), Positives = 114/239 (47%), Gaps = 41/239 (17%)
Query: 53 VPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPD------ 105
+P ++ +E++ + IG+G +G V+ G L AIK L
Sbjct: 13 LPTLADNEIEYE-------KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIE 65
Query: 106 --QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKP 163
QEF +V ++S L + N+V+L G + P V+ E G L+ L K
Sbjct: 66 KFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAHP----- 118
Query: 164 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-----IAKISDFD 218
+ W+ ++++ + A G+EY+ + P I+HR+++S N+ L D AK++DF
Sbjct: 119 ---IKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174
Query: 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM---SSKSDVYSFGVVLLELLTGRKP 274
LS Q+ + + +LG F + APE + + + K+D YSF ++L +LTG P
Sbjct: 175 LSQQSVHS-----VSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-51
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 25/228 (10%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQ-EFLAQVSMVSRLKNENVVELVGYYV 131
+G+G +G+ R +G +K+L + Q FL +V ++ L++ NV++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
E+ G+L I+ W+QRV A A G+ YLH
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIK--------SMDSQYPWSQRVSFAKDIASGMAYLHSM-- 127
Query: 192 PRIIHRNIKSSNVLLFDDDIAKISDFDLS------------NQAPDAAARLHSTRVLGTF 239
IIHR++ S N L+ ++ ++DF L+ ++ R V+G
Sbjct: 128 -NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
+ APE K DV+SFG+VL E++ LPR +
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL 234
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-50
Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 20/216 (9%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
IG GS+G VY G A+K L + Q Q F +V ++ + ++ N++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
L ++ + SL+ LH + + IA ARG++YLH K
Sbjct: 90 TAPQLAIVT-QWCEGSSLYHHLH--------ASETKFEMKKLIDIARQTARGMDYLHAK- 139
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE---YA 247
IIHR++KS+N+ L +D+ KI DF L+ + + ++ G+ + APE
Sbjct: 140 --SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 248 MTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283
+ S +SDVY+FG+VL EL+TG+ P + R Q
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 7e-49
Identities = 52/216 (24%), Positives = 85/216 (39%), Gaps = 29/216 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYY 130
IG+G +G+VY G AI+ +D + + + F +V + ++ENVV +G
Sbjct: 41 IGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ P + +L+ ++ K VL + +IA +G+ YLH K
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAK--------IVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLGTFGYHAPE-- 245
I+H+++KS NV D+ I+DF L G + APE
Sbjct: 151 ---ILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 246 -------YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
S SDV++ G + EL P
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-48
Identities = 51/226 (22%), Positives = 91/226 (40%), Gaps = 30/226 (13%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD 132
+G+G YG V+ G + G A+K S + ++ L++EN++ + +
Sbjct: 15 CVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 133 GPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ GSL+D L L ++I + A GL +LH
Sbjct: 74 SRHSSTQLWLITHYHEMGSLYDYLQLTT----------LDTVSCLRIVLSIASGLAHLHI 123
Query: 189 -----KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLGTFG 240
+ +P I HR++KS N+L+ + I+D L+ +Q+ + ++ RV GT
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKR 182
Query: 241 YHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280
Y APE + D+++FG+VL E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-48
Identities = 60/248 (24%), Positives = 87/248 (35%), Gaps = 39/248 (15%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLA--QVS 113
+ E DN LIG G YG VY G L R A+K S Q F+ +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVF--SFANRQNFINEKNIY 59
Query: 114 MVSRLKNENVVELVGYYVDGPLRV-----LAYEHASKGSLHDILHGKKGVKGAKPGPVLS 168
V ++++N+ + L E+ GSL L
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----------SD 109
Query: 169 WAQRVKIAVGAARGLEYLHE------KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-- 220
W ++A RGL YLH +P I HR++ S NVL+ +D ISDF LS
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 221 ----NQAPDAAARLHSTRVLGTFGYHAPEYAM-------TGQMSSKSDVYSFGVVLLELL 269
+ +GT Y APE + D+Y+ G++ E+
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 270 TGRKPVDH 277
+
Sbjct: 230 MRCTDLFP 237
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-47
Identities = 52/248 (20%), Positives = 96/248 (38%), Gaps = 35/248 (14%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFL 109
P+ V +++ IG+G YG V+ G R G A+K ++++
Sbjct: 28 PLLVQRTIAKQIQMV-------KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRE 79
Query: 110 AQVSMVSRLKNENVVELVGYYVDGPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGP 165
++ +++EN++ + + G ++ GSL+D L
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--------- 130
Query: 166 VLSWAQRVKIAVGAARGLEYLHE-----KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
L +K+A + GL +LH + +P I HR++KS N+L+ + I+D L+
Sbjct: 131 -LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189
Query: 221 --NQAPDAAARLHSTRVLGTFGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGR 272
+ + +GT Y PE Q +D+YSFG++L E+
Sbjct: 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC 249
Query: 273 KPVDHTLP 280
Sbjct: 250 VSGGIVEE 257
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-46
Identities = 55/226 (24%), Positives = 94/226 (41%), Gaps = 30/226 (13%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD 132
IG+G +G V+ G R G A+K S ++ A++ L++EN++ +
Sbjct: 49 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 133 GPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
++ GSL D L+ ++ +K+A+ A GL +LH
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHM 157
Query: 189 -----KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLGTFG 240
+ +P I HR++KS N+L+ + I+D L+ + A D + RV GT
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKR 216
Query: 241 YHAPE-----YAMTGQMSS-KSDVYSFGVVLLELLTGRKPVDHTLP 280
Y APE M S ++D+Y+ G+V E+
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 57/218 (26%), Positives = 89/218 (40%), Gaps = 41/218 (18%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
IG G++G V+ G LR+ A+K +FL + ++ + + N+V L+G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ E G L G L +++ AA G+EYL K
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLR--------TEGARLRVKTLLQMVGDAAAGMEYLESK- 232
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH-------- 242
IHR++ + N L+ + ++ KISDF +S R Y
Sbjct: 233 --CCIHRDLAARNCLVTEKNVLKISDFGMS-------------REEADGVYAASGGLRQV 277
Query: 243 -----APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE G+ SS+SDV+SFG++L E + G P
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-35
Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 24/211 (11%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVG 128
IG GS+ VY G+ + A +L K E F + M+ L++ N+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 129 YYVDGPLR----VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+ VL E + G+L L + + +GL+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLK--------RFKV-MKIKVLRSWCRQILKGLQ 143
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
+LH + P IIHR++K N+ + KI D L+ + A+ V+GT + A
Sbjct: 144 FLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMA 198
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
PE + DVY+FG+ +LE+ T P
Sbjct: 199 PEM-YEEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-35
Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 46/222 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+G G++G VY G+ AIK+L +S + ++E L + +++ + N +V L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+G + ++++ + G L D + K + + V A+G+ YL
Sbjct: 83 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMNYL 133
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH---- 242
++ R++HR++ + NVL+ KI+DF L+ ++LG
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLA-------------KLLGAEEKEYHAE 177
Query: 243 ---------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A E + + +SDV+S+GV + EL+T G KP
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-34
Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G+G +G V+ G AIK L + FL + ++ +L++E +V+L +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ SKGSL D L G+ G L Q V +A A G+ Y+
Sbjct: 252 PIYIVT-EYMSKGSLLDFLKGET-------GKYLRLPQLVDMAAQIASGMAYVERM---N 300
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS 253
+HR+++++N+L+ ++ + K++DF L+ D + APE A+ G+ +
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFT 359
Query: 254 SKSDVYSFGVVLLELLT-GRKP 274
KSDV+SFG++L EL T GR P
Sbjct: 360 IKSDVWSFGILLTELTTKGRVP 381
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 19/204 (9%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVG-YY 130
IG+G+ G VY + + +G+ AI++++ +QP +E + + ++ KN N+V + Y
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
V L V+ E+ + GSL D++ + Q + + LE+LH
Sbjct: 88 VGDELWVVM-EYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSN- 135
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
++IHR+IKS N+LL D K++DF Q ++ + ++GT + APE
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRK 191
Query: 251 QMSSKSDVYSFGVVLLELLTGRKP 274
K D++S G++ +E++ G P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-33
Identities = 51/204 (25%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
IG G +G V+ G + AIK + +++F+ + ++ +L + +V+L G ++
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
L E G L D L ++G + + + + + G+ YL E
Sbjct: 76 APICLVTEFMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEA---C 124
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH--APEYAMTGQ 251
+IHR++ + N L+ ++ + K+SDF ++ D +++ F +PE +
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFSR 181
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
SSKSDV+SFGV++ E+ + G+ P
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 35/220 (15%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYY 130
LIG G +G+V+ G+ IK++ + + ++E V +++L + N+V G +
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGCW 73
Query: 131 VDGPLRVLAY----------------EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
E KG+L + ++G K L ++
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-------LDKVLALE 126
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
+ +G++Y+H K ++I+R++K SN+ L D KI DF L + R TR
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---TR 180
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT Y +PE + + D+Y+ G++L ELL
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 50/206 (24%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVG 128
IGEGS+G+ GR IK+++ S+ +E +V++++ +K+ N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ + + ++ G L ++ +KGV Q + V L+++H+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVL-------FQEDQILDWFVQICLALKHVHD 143
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
+ +I+HR+IKS N+ L D ++ DF ++ + +GT Y +PE
Sbjct: 144 R---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICE 198
Query: 249 TGQMSSKSDVYSFGVVLLELLTGRKP 274
++KSD+++ G VL EL T +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G+G +G V+ G AIK L + FL + ++ +L++E +V+L +
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 334
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ SKGSL D L G+ G L Q V +A A G+ Y+
Sbjct: 335 PIYIVT-EYMSKGSLLDFLKGET-------GKYLRLPQLVDMAAQIASGMAYVERM---N 383
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS 253
+HR+++++N+L+ ++ + K++DF L+ D + APE A+ G+ +
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFT 442
Query: 254 SKSDVYSFGVVLLELLT-GRKP 274
KSDV+SFG++L EL T GR P
Sbjct: 443 IKSDVWSFGILLTELTTKGRVP 464
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 4e-33
Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ G A+K L FLA+ +++ +L+++ +V L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E+ GSL D L G L+ + + +A A G+ ++ E+
Sbjct: 81 PIYIIT-EYMENGSLVDFLKTPS-------GIKLTINKLLDMAAQIAEGMAFIEER---N 129
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH--APEYAMTGQ 251
IHR+++++N+L+ D KI+DF L+ D ++ R F APE G
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGT 186
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
+ KSDV+SFG++L E++T GR P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIP 210
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-33
Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V+ A+K + + FLA+ +++ L+++ +V+L
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 255
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
P+ ++ E +KGSL D L + G + + + A G+ ++ ++
Sbjct: 256 PIYIIT-EFMAKGSLLDFLKSDE-------GSKQPLPKLIDFSAQIAEGMAFIEQR---N 304
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH--APEYAMTGQ 251
IHR+++++N+L+ + KI+DF L+ D ++ R F APE G
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGS 361
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
+ KSDV+SFG++L+E++T GR P
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIP 385
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-33
Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 22/210 (10%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFL------AQVSMVSRLKNENVV 124
+G G VY AIK + + +E L S+L ++N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN--SSQLSHQNIV 74
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
++ + L E+ +L + + GP LS + G++
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--------GP-LSVDTAINFTNQILDGIK 125
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
+ H+ RI+HR+IK N+L+ + KI DF ++ +A + + VLGT Y +P
Sbjct: 126 HAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIA-KALSETSLTQTNHVLGTVQYFSP 181
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
E A +D+YS G+VL E+L G P
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-33
Identities = 53/222 (23%), Positives = 99/222 (44%), Gaps = 46/222 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+G G++G VY G+ AIK+L +S + ++E L + +++ + N +V L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+G + ++++ + G L D + K + + V A+G+ YL
Sbjct: 83 LGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMNYL 133
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH---- 242
++ R++HR++ + NVL+ KI+DF L+ ++LG
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLA-------------KLLGAEEKEYHAE 177
Query: 243 ---------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A E + + +SDV+S+GV + EL+T G KP
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 5e-33
Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 45/221 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA---AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELVG 128
+G G++G V GV R + AIK L + K +E + + ++ +L N +V L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
L ++ E A G LH L GK+ + + ++ + G++YL E
Sbjct: 78 VCQAEALMLVM-EMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEE 128
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT--FGYH---- 242
K +HR++ + NVLL + AKISDF LS + LG Y
Sbjct: 129 K---NFVHRDLAARNVLLVNRHYAKISDFGLS-------------KALGADDSYYTARSA 172
Query: 243 --------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + SS+SDV+S+GV + E L+ G+KP
Sbjct: 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-33
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 21/220 (9%)
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL 118
E +E+ +G GS+G V+ ++G A+KK+ +E + + L
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE----LVACAGL 107
Query: 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ +V L G +GP + E GSL ++ K L + +
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---------KQMGCLPEDRALYYLGQ 158
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISDFDLSNQ-APDAAARLHSTR-- 234
A GLEYLH + RI+H ++K+ NVLL D A + DF + PD + T
Sbjct: 159 ALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ GT + APE M +K D++S ++L +L G P
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-32
Identities = 52/222 (23%), Positives = 92/222 (41%), Gaps = 46/222 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-----AIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+G G +G V+ GV + IK + S +Q Q + + L + ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+G L+++ ++ GSL D + +G L + V A+G+ YL
Sbjct: 81 LGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGA--------LGPQLLLNWGVQIAKGMYYL 131
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH---- 242
E ++HRN+ + NVLL +++DF ++ +L
Sbjct: 132 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVA-------------DLLPPDDKQLLYS 175
Query: 243 ---------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A E G+ + +SDV+S+GV + EL+T G +P
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-32
Identities = 48/214 (22%), Positives = 87/214 (40%), Gaps = 37/214 (17%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V G + A+K + + EF + + +L + +V+ G
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
+ E+ S G L + L G L +Q +++ G+ +L +
Sbjct: 76 YPIYIVTEYISNGCLLNYLRSH--------GKGLEPSQLLEMCYDVCEGMAFLESH---Q 124
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH----------- 242
IHR++ + N L+ D K+SDF ++ R + Y
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMT-------------RYVLDDQYVSSVGTKFPVKW 171
Query: 243 -APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + SSKSDV++FG+++ E+ + G+ P
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 28/216 (12%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFL------AQVSMVSRLKNENVV 124
++G G V+ LR R A+K L + D F AQ + L + +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ--NAAALNHPAIV 75
Query: 125 EL--VGYYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+ G + P L Y E+ +L DI+H + GP ++ + +++ A
Sbjct: 76 AVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTE--------GP-MTPKRAIEVIADA 125
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST-RVLGT 238
+ L + H+ IIHR++K +N+++ + K+ DF ++ D+ + T V+GT
Sbjct: 126 CQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y +PE A + ++SDVYS G VL E+LTG P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 51/207 (24%), Positives = 89/207 (42%), Gaps = 15/207 (7%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ----VSMVSRLKNENVVELV 127
IG G + VY L G A+KK+ D + A + ++ +L + NV++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
+++ + E A G L ++ K K ++ K V LE++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFK-----KQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 247
+ R++HR+IK +NV + + K+ D L HS ++GT Y +PE
Sbjct: 154 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERI 208
Query: 248 MTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ KSD++S G +L E+ + P
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-32
Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 39/220 (17%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IG G +G VY G L A+K L + +FL + ++ + NV+ L+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 128 G--YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
G +G V+ + G L + + + + + A+G++Y
Sbjct: 93 GICLRSEGSPLVV-LPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKY 143
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHST---RVLGTFGY 241
L K + +HR++ + N +L + K++DF L+ R ++ V G
Sbjct: 144 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA--------RDMYDKEYYSVHNKTGA 192
Query: 242 H------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A E T + ++KSDV+SFGV+L EL+T G P
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V +G R AIK + + EF+ + ++ L +E +V+L G
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
+ E+ + G L + L + Q +++ +EYL K +
Sbjct: 92 RPIFIITEYMANGCLLNYLR--------EMRHRFQTQQLLEMCKDVCEAMEYLESK---Q 140
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH--APEYAMTGQ 251
+HR++ + N L+ D + K+SDF LS D +++ V F PE M +
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSK 197
Query: 252 MSSKSDVYSFGVVLLELLT-GRKP 274
SSKSD+++FGV++ E+ + G+ P
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 17/223 (7%)
Query: 61 LKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVS 116
+ + +++ IG GSYGR G+ K+LD + E +++V+++
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 117 RLKNENVVELVGYYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 173
LK+ N+V +D L Y E+ G L ++ KG K L +
Sbjct: 61 ELKHPNIVRYYDRIIDRTNTTL-YIVMEYCEGGDLASVI-----TKGTKERQYLDEEFVL 114
Query: 174 KIAVGAARGLEYLHEKAEP--RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
++ L+ H +++ ++HR++K +NV L K+ DF L+ +
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 174
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ +GT Y +PE + KSD++S G +L EL P
Sbjct: 175 T--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 47/222 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA---AIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G G++G V G + + A+K L + E LA+ +++ +L N +V ++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G ++ E A G L+ L + + +++ + G++YL
Sbjct: 85 GICEAESWMLVM-EMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLE 134
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG--YH--- 242
E +HR++ + NVLL AKISDF LS + L Y
Sbjct: 135 ES---NFVHRDLAARNVLLVTQHYAKISDFGLS-------------KALRADENYYKAQT 178
Query: 243 ---------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + SSKSDV+SFGV++ E + G+KP
Sbjct: 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 2e-32
Identities = 49/220 (22%), Positives = 93/220 (42%), Gaps = 44/220 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+GEG +G VY GV + + A+K K D + ++F+++ ++ L + ++V+L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G + P ++ E G L L + L V ++ + + YL
Sbjct: 80 GIIEEEPTWIIM-ELYPYGELGHYLE--------RNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH----- 242
+HR+I N+L+ + K+ DF LS R + Y+
Sbjct: 131 SI---NCVHRDIAVRNILVASPECVKLGDFGLS-------------RYIEDEDYYKASVT 174
Query: 243 -------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+PE + ++ SDV+ F V + E+L+ G++P
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 67/210 (31%), Positives = 109/210 (51%), Gaps = 33/210 (15%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
IG+G +G V G R G A+K K D++ Q FLA+ S++++L++ N+V+L+G V
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLG--V 254
Query: 132 ---DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ + E+ +KGSL D L + VL +K ++ +EYL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHSTRVLGTFGYH--APE 245
+HR++ + NVL+ +D++AK+SDF L + ST+ G APE
Sbjct: 308 N---NFVHRDLAARNVLVSEDNVAKVSDFGL--------TKEASSTQDTGKLPVKWTAPE 356
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ S+KSDV+SFG++L E+ + GR P
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-32
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV- 131
+G G YG VY GV + A+K L +EFL + +++ +K+ N+V+L+G V
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG--VC 285
Query: 132 --DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ P ++ E + G+L D L +S + +A + +EYL +K
Sbjct: 286 TREPPFYIIT-EFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKK 337
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
IHRN+ + N L+ ++ + K++DF LS H+ + APE
Sbjct: 338 ---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 393
Query: 250 GQMSSKSDVYSFGVVLLELLT-GRKP 274
+ S KSDV++FGV+L E+ T G P
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-32
Identities = 44/221 (19%), Positives = 89/221 (40%), Gaps = 30/221 (13%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLK--NENVVELV 127
IG G +V+ + + AIK ++ + +Q + +++ +++L+ ++ ++ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
Y + + E + L+ L KK + +R + +H
Sbjct: 76 DYEITDQYIYMVMECGN-IDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIH 125
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE-- 245
+ I+H ++K +N L D + K+ DF ++NQ + +GT Y PE
Sbjct: 126 QH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 246 ---------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277
++S KSDV+S G +L + G+ P
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-32
Identities = 63/224 (28%), Positives = 94/224 (41%), Gaps = 48/224 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL----DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+G+GS+G V G + A+K L S + +F+ +V+ + L + N++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L G + P++++ E A GSL D L +G + AV A G+ Y
Sbjct: 86 LYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQVAEGMGY 136
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG--YH- 242
L K R IHR++ + N+LL D+ KI DF L R L Y
Sbjct: 137 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLM-------------RALPQNDDHYVM 180
Query: 243 -----------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE T S SD + FGV L E+ T G++P
Sbjct: 181 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-32
Identities = 52/225 (23%), Positives = 99/225 (44%), Gaps = 38/225 (16%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGY 129
+G G +G V+ AIK++ + ++ + +V +++L++ +V
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 130 YVDGP---------LRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+++ +V Y + K +L D ++G+ ++ + L ++
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI---- 127
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-----------NQAPDA 226
A +E+LH K ++HR++K SN+ DD+ K+ DF L P
Sbjct: 128 --AEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 227 AARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLT 270
A H+ +V GT Y +PE + G S K D++S G++L ELL
Sbjct: 183 AYARHTGQV-GTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-32
Identities = 65/208 (31%), Positives = 107/208 (51%), Gaps = 29/208 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV-- 131
IG+G +G V G R G A+K + + Q FLA+ S++++L++ N+V+L+G V
Sbjct: 29 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLG--VIV 84
Query: 132 -DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ + E+ +KGSL D L + VL +K ++ +EYL
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGN- 136
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR-LHSTRVLGTFGYH--APEYA 247
+HR++ + NVL+ +D++AK+SDF L + ST+ G APE
Sbjct: 137 --NFVHRDLAARNVLVSEDNVAKVSDFGL--------TKEASSTQDTGKLPVKWTAPEAL 186
Query: 248 MTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ S+KSDV+SFG++L E+ + GR P
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-32
Identities = 44/221 (19%), Positives = 89/221 (40%), Gaps = 30/221 (13%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLK--NENVVELV 127
IG G +V+ + + AIK ++ + +Q + +++ +++L+ ++ ++ L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
Y + + E + L+ L KK + +R + +H
Sbjct: 95 DYEITDQYIYMVMECGN-IDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIH 144
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE-- 245
+ I+H ++K +N L D + K+ DF ++NQ + +GT Y PE
Sbjct: 145 QH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 246 ---------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277
++S KSDV+S G +L + G+ P
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-32
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVG-YY 130
IGEGS G V SGR A+K +D KQ +E L V ++ ++ NVVE+ Y
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
V L VL E G+L DI+ L+ Q + + L YLH +
Sbjct: 113 VGEELWVLM-EFLQGGALTDIV---------SQVR-LNEEQIATVCEAVLQALAYLHAQ- 160
Query: 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG 250
+IHR+IKS ++LL D K+SDF Q + S ++GT + APE
Sbjct: 161 --GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRS 216
Query: 251 QMSSKSDVYSFGVVLLELLTGRKP 274
+++ D++S G++++E++ G P
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-32
Identities = 51/210 (24%), Positives = 80/210 (38%), Gaps = 22/210 (10%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFL------AQVSMVSRLKNENVV 124
L+G G G VY R A+K + + D F A+ RL+ +VV
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREART--AGRLQEPHVV 97
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+ + + + L +L + GP L+ + V I L+
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLR--------RQGP-LAPPRAVAIVRQIGSALD 148
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
H HR++K N+L+ DD A + DF ++ A +GT Y AP
Sbjct: 149 AAHAA---GATHRDVKPENILVSADDFAYLVDFGIA-SATTDEKLTQLGNTVGTLYYMAP 204
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
E + ++D+Y+ VL E LTG P
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-32
Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 43/218 (19%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-AIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV- 131
+G G YG VY GV + A+K L +EFL + +++ +K+ N+V+L+G V
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG--VC 78
Query: 132 --DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ P ++ E + G+L D L +S + +A + +EYL +K
Sbjct: 79 TREPPFYIIT-EFMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKK 130
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH------- 242
IHR++ + N L+ ++ + K++DF LS R++ Y
Sbjct: 131 ---NFIHRDLAARNCLVGENHLVKVADFGLS-------------RLMTGDTYTAHAGAKF 174
Query: 243 -----APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + S KSDV++FGV+L E+ T G P
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-32
Identities = 54/230 (23%), Positives = 91/230 (39%), Gaps = 30/230 (13%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYY 130
+GEG + V L G A+K++ +Q D+E + M + N++ LV Y
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 131 VDGPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+ +G+L + + + G L+ Q + + +G RGLE +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL-------GTF 239
H HR++K +N+LL D+ + D NQA L T
Sbjct: 151 HA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 240 GYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283
Y APE + + + ++DV+S G VL ++ G P D +G
Sbjct: 208 SYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 45/221 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA---AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELVG 128
+G G++G V GV R + AIK L + K +E + + ++ +L N +V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
L ++ E A G LH L GK+ + + ++ + G++YL E
Sbjct: 404 VCQAEALMLVM-EMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEE 454
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT--FGYH---- 242
K +HRN+ + NVLL + AKISDF LS + LG Y
Sbjct: 455 K---NFVHRNLAARNVLLVNRHYAKISDFGLS-------------KALGADDSYYTARSA 498
Query: 243 --------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + SS+SDV+S+GV + E L+ G+KP
Sbjct: 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-31
Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 44/220 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IGEG +G V+ G+ S AIK K +S ++FL + + + + ++V+L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G + P+ ++ E + G L L L A + A + L YL
Sbjct: 83 GVITENPVWIIM-ELCTLGELRSFLQ--------VRKYSLDLASLILYAYQLSTALAYLE 133
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH----- 242
K R +HR+I + NVL+ +D K+ DF LS R + Y+
Sbjct: 134 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLS-------------RYMEDSTYYKASKG 177
Query: 243 -------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + +S SDV+ FGV + E+L G KP
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 55/232 (23%), Positives = 105/232 (45%), Gaps = 50/232 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G+V+ + A+K L D + ++F + +++ L++E++V+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 127 VGYYV---DGPLRVLAYEHASKGSLHDIL-------HGKKGVKGAKPGPVLSWAQRVKIA 176
G V PL ++ +E+ G L+ L + + L +Q + IA
Sbjct: 83 YG--VCGDGDPLIMV-FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
A G+ YL + +HR++ + N L+ + + KI DF +S R +
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS-------------RDV 183
Query: 237 GTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ Y+ PE M + +++SDV+SFGV+L E+ T G++P
Sbjct: 184 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-31
Identities = 64/233 (27%), Positives = 100/233 (42%), Gaps = 51/233 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+GE +G+VY G L AIK L + +EF + + +RL++ NVV
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 126 LVGYYV---DGPLRVLAYEHASKGSLHDILHGK-------KGVKGAKPGPVLSWAQRVKI 175
L+G V D PL ++ + + S G LH+ L + L V +
Sbjct: 77 LLG--VVTKDQPLSMI-FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
A G+EYL ++H+++ + NVL++D KISD L R
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF-------------RE 177
Query: 236 LGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ Y+ APE M G+ S SD++S+GVVL E+ + G +P
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 43/221 (19%), Positives = 87/221 (39%), Gaps = 30/221 (13%)
Query: 73 LIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLK--NENVVELV 127
IG G +V+ + + AIK ++ + +Q + +++ +++L+ ++ ++ L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
Y + + E L+ L KK + +R + +H
Sbjct: 123 DYEITDQYIYMVMECG-NIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIH 172
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE-- 245
+ I+H ++K +N L D + K+ DF ++NQ + +G Y PE
Sbjct: 173 QH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 246 ---------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277
++S KSDV+S G +L + G+ P
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-31
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYY 130
++G+G+YG VY G L + AIK++ + L + +++ LK++N+V+ +G +
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+ + E GSL +L K G + + +++ GL+YLH+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI------LEGLKYLHDN- 141
Query: 191 EPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
+I+HR+IK NVL+ + KISDF S + + GT Y APE
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDK 197
Query: 250 GQM--SSKSDVYSFGVVLLELLTGRKP 274
G +D++S G ++E+ TG+ P
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-31
Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 28/214 (13%)
Query: 74 IGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQPDQ--EFLAQVSMVSRLKNENVVEL 126
+GEG +G+V +G A+K L + P + ++ ++ L +E++++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 127 VG---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
G L+++ E+ GSL D L + AQ + A G+
Sbjct: 99 KGCCEDAGAASLQLVM-EYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGM 147
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA--RLHSTRVLGTFGY 241
YLH + IHR++ + NVLL +D + KI DF L+ P+ R+ F Y
Sbjct: 148 AYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 204
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + SDV+SFGV L ELLT
Sbjct: 205 -APECLKEYKFYYASDVWSFGVTLYELLTHCDSS 237
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-31
Identities = 51/225 (22%), Positives = 91/225 (40%), Gaps = 49/225 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IG G +G VY G L A+K L + +FL + ++ + NV+ L+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 128 G--YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
G +G V+ + G L + + + + + A+G+++
Sbjct: 157 GICLRSEGSPLVVL-PYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGMKF 207
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH--- 242
L K + +HR++ + N +L + K++DF L+ R + +
Sbjct: 208 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLA-------------RDMYDKEFDSVH 251
Query: 243 ------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A E T + ++KSDV+SFGV+L EL+T G P
Sbjct: 252 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-31
Identities = 63/259 (24%), Positives = 111/259 (42%), Gaps = 46/259 (17%)
Query: 43 MKTVTVQPIAVPVISVDELKE-KTDNFGTNSLIGEGSYGRVYFGVLRSGRAA------AI 95
M +V + + + V + E + + +G+GS+G VY GV + AI
Sbjct: 1 MASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI 60
Query: 96 KKL--DSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV---DGPLRVLAYEHASKGSLHD 150
K + +S + EFL + S++ +VV L+G V P V+ E ++G L
Sbjct: 61 KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG--VVSQGQPTLVI-MELMTRGDLKS 117
Query: 151 ILHGKKGVKGAKP-GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209
L + P S ++ +++A A G+ YL+ + +HR++ + N ++ +D
Sbjct: 118 YLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174
Query: 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH-------------APEYAMTGQMSSKS 256
KI DF ++ R + Y+ +PE G ++ S
Sbjct: 175 FTVKIGDFGMT-------------RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 221
Query: 257 DVYSFGVVLLELLT-GRKP 274
DV+SFGVVL E+ T +P
Sbjct: 222 DVWSFGVVLWEIATLAEQP 240
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-31
Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 49/225 (21%)
Query: 74 IGEGSYGRVYFGVLR-----SGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G+G++G V +G A+K+L S ++F ++ ++ L ++ +V+
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 128 G---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G LR++ E+ G L D L + L ++ + + +G+E
Sbjct: 91 GVSYGPGRQSLRLVM-EYLPSGCLRDFLQ--------RHRARLDASRLLLYSSQICKGME 141
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG--YH 242
YL + R +HR++ + N+L+ + KI+DF L+ ++L Y
Sbjct: 142 YLGSR---RCVHRDLAARNILVESEAHVKIADFGLA-------------KLLPLDKDYYV 185
Query: 243 ------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE S +SDV+SFGVVL EL T K
Sbjct: 186 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-31
Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 47/224 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IG+G +G VY G AIK + Q + FL + ++ L + NV+ L+
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 128 GYYVDG-PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G + L + + G L + P + + + ARG+EYL
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIR--------SPQRNPTVKDLISFGLQVARGMEYL 140
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH---- 242
E+ + +HR++ + N +L + K++DF L+ R + Y+
Sbjct: 141 AEQ---KFVHRDLAARNCMLDESFTVKVADFGLA-------------RDILDREYYSVQQ 184
Query: 243 -----------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
A E T + ++KSDV+SFGV+L ELLT G P
Sbjct: 185 HRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-31
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIK--KLDSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IGEG +G V+ G+ S AIK K +S ++FL + + + + ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G + P+ ++ E + G L L +K L A + A + L YL
Sbjct: 458 GVITENPVWIIM-ELCTLGELRSFLQVRK--------FSLDLASLILYAYQLSTALAYLE 508
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 247
K R +HR+I + NVL+ +D K+ DF LS D+ S L APE
Sbjct: 509 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESI 564
Query: 248 MTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ +S SDV+ FGV + E+L G KP
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-31
Identities = 53/218 (24%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNEN 122
+ + +G+G++G+VY +G AA K +++ + + ++++ ++ +++ +
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 123 VVELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
+V+L+G YY DG L ++ E G++ I+ L+ Q +
Sbjct: 78 IVKLLGAYYHDGKLWIMI-EFCPGGAVDAIMLELDRG--------LTEPQIQVVCRQMLE 128
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L +LH K RIIHR++K+ NVL+ + +++DF +S + + S +GT +
Sbjct: 129 ALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYW 183
Query: 242 HAPEYAMTGQMS-----SKSDVYSFGVVLLELLTGRKP 274
APE M M K+D++S G+ L+E+ P
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-31
Identities = 62/212 (29%), Positives = 110/212 (51%), Gaps = 17/212 (8%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV 123
+ F +GEGSYG VY + +G+ AIK++ QE + ++S++ + + +V
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-QEIIKEISIMQQCDSPHV 86
Query: 124 VELVG-YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
V+ G Y+ + L ++ E+ GS+ DI+ + L+ + I +G
Sbjct: 87 VKYYGSYFKNTDLWIVM-EYCGAGSVSDIIRLRNKT--------LTEDEIATILQSTLKG 137
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
LEYLH R IHR+IK+ N+LL + AK++DF ++ Q D A+ ++ V+GT +
Sbjct: 138 LEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWM 192
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + +D++S G+ +E+ G+ P
Sbjct: 193 APEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-30
Identities = 65/230 (28%), Positives = 114/230 (49%), Gaps = 19/230 (8%)
Query: 49 QPIAVPVISVDELKEK-TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD- 105
P+ + + LK + F IG+GS+G V+ G+ R+ + AIK +D + D
Sbjct: 4 SPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE 63
Query: 106 -QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPG 164
++ +++++S+ + V + G Y+ + E+ GS D+L +PG
Sbjct: 64 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---------EPG 114
Query: 165 PVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224
P L Q I +GL+YLH + + IHR+IK++NVLL + K++DF ++ Q
Sbjct: 115 P-LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170
Query: 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
D + ++ +GT + APE SK+D++S G+ +EL G P
Sbjct: 171 DTQIKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-30
Identities = 49/234 (20%), Positives = 96/234 (41%), Gaps = 38/234 (16%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV 123
+F +++G+G++G+V R AIKK+ +++ L++V +++ L ++ V
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 124 VELVGYYVDGPLRVLAY-------------EHASKGSLHDILHGKKGVKGAKPGPVLSWA 170
V +++ V E+ G+L+D++ +
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRLF 122
Query: 171 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230
+++ L Y+H + IIHR++K N+ + + KI DF L+ + L
Sbjct: 123 RQI------LEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 231 HS------------TRVLGTFGYHAPE-YAMTGQMSSKSDVYSFGVVLLELLTG 271
T +GT Y A E TG + K D+YS G++ E++
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 45/222 (20%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
IG G G V +G LR AIK L +++ ++FL++ S++ + + N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G G L ++ E+ GSL L G + Q V + G G+ YL
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--------FTIMQLVGMLRGVGAGMRYLS 168
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG--TFGYH--- 242
+ +HR++ + NVL+ + + K+SDF LS RVL +
Sbjct: 169 DL---GYVHRDLAARNVLVDSNLVCKVSDFGLS-------------RVLEDDPDAAYTTT 212
Query: 243 ---------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE SS SDV+SFGVV+ E+L G +P
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 74 IGEGSYGRVYFGVLRSGRAA-----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
IG G +G VY G+L++ AIK L +++ +FL + ++ + + N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
G ++ E+ G+L L K G S Q V + G A G++YL
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLVGMLRGIAAGMKYL 163
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-----VLGTFGY 241
+HR++ + N+L+ + + K+SDF LS D ++T + T
Sbjct: 164 ANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT--- 217
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE + +S SDV+SFG+V+ E++T G +P
Sbjct: 218 -APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-30
Identities = 55/226 (24%), Positives = 94/226 (41%), Gaps = 50/226 (22%)
Query: 74 IGEGSYGRVYFGVL-----RSGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG +G+V +G A+K L +S + ++ ++ L +EN+V+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 127 VG---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
G ++++ E GSL + L K ++ Q++K AV +G+
Sbjct: 89 KGICTEDGGNGIKLIM-EFLPSGSLKEYLPKNKNK--------INLKQQLKYAVQICKGM 139
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL--GTFGY 241
+YL + + +HR++ + NVL+ + KI DF L+ + + Y
Sbjct: 140 DYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT-------------KAIETDKEYY 183
Query: 242 H------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
APE M + SDV+SFGV L ELLT
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD 229
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-30
Identities = 62/242 (25%), Positives = 108/242 (44%), Gaps = 25/242 (10%)
Query: 36 KEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAA 94
E K ++ Q V + D+ ++ S +G G+ G V+ + SG A
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKI-------SELGAGNGGVVFKVSHKPSGLVMA 62
Query: 95 IKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDIL 152
K + +P + + ++ ++ + +V G + + EH GSL +L
Sbjct: 63 RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 122
Query: 153 HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212
+ P +L K+++ +GL YL EK +I+HR++K SN+L+
Sbjct: 123 KKAGRI----PEQILG-----KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEI 171
Query: 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
K+ DF +S Q D+ A + V GT Y +PE S +SD++S G+ L+E+ GR
Sbjct: 172 KLCDFGVSGQLIDSMAN---SFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
Query: 273 KP 274
P
Sbjct: 228 YP 229
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-30
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 24/208 (11%)
Query: 74 IGEGSYGRVYFGVLR-----SGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G+G++G V +G A+KKL S+++ ++F ++ ++ L+++N+V+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 128 G---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G L+++ E+ GSL D L K + + ++ +G+E
Sbjct: 78 GVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKGME 128
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD--AAARLHSTRVLGTFGYH 242
YL K R IHR++ + N+L+ +++ KI DF L+ P ++ F Y
Sbjct: 129 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY- 184
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT 270
APE + S SDV+SFGVVL EL T
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-30
Identities = 63/235 (26%), Positives = 109/235 (46%), Gaps = 31/235 (13%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSM 114
I + L++ F L+G G+YG+VY G +++G+ AAIK +D + ++E +++M
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINM 73
Query: 115 VSRLKN-ENVVELVGYYVDGPLRVLAY------EHASKGSLHDILHGKKGVKGAKPGPVL 167
+ + + N+ G ++ + E GS+ D+ +K K L
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL------IKNTKGNT-L 126
Query: 168 SWAQRVKIAV---GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224
IA RGL +LH+ ++IHR+IK NVLL ++ K+ DF +S Q
Sbjct: 127 KEEW---IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180
Query: 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMS-----SKSDVYSFGVVLLELLTGRKP 274
R ++ +GT + APE + KSD++S G+ +E+ G P
Sbjct: 181 RTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-30
Identities = 54/231 (23%), Positives = 101/231 (43%), Gaps = 49/231 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG++G+V+ + A+K L ++S+ Q+F + +++ L+++++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 127 VGYYV---DGPLRVLAYEHASKGSLHDIL------HGKKGVKGAKPGPVLSWAQRVKIAV 177
G V PL ++ +E+ G L+ L L Q + +A
Sbjct: 109 FG--VCTEGRPLLMV-FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
A G+ YL +HR++ + N L+ + KI DF +S R +
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMS-------------RDIY 209
Query: 238 TFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ Y+ PE + + +++SDV+SFGVVL E+ T G++P
Sbjct: 210 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-30
Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G G +G V G L+ AIK L +++ ++FL + S++ + + N++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G ++ E+ GSL L K + Q V + G A G++YL
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLR--------KHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR-----VLGTFGYH 242
+ +HR++ + N+L+ + + K+SDF L D ++TR + T
Sbjct: 165 DM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT---- 217
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+PE + +S SDV+S+G+VL E+++ G +P
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-30
Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 49/229 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIKKL---DSSKQPDQEFLAQVSMVSRLKNENVVEL 126
+GEG +G V G L+ A+K + +SS++ +EFL++ + + + NV+ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 127 VG-------YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+G + P+ +L G LH L + + +K V
Sbjct: 102 LGVCIEMSSQGIPKPMVIL--PFMKYGDLHTYL---LYSRLETGPKHIPLQTLLKFMVDI 156
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
A G+EYL + +HR++ + N +L DD ++DF LS + + +
Sbjct: 157 ALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLS-------------KKIYSG 200
Query: 240 GYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
Y+ A E +SKSDV++FGV + E+ T G P
Sbjct: 201 DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-30
Identities = 55/230 (23%), Positives = 93/230 (40%), Gaps = 50/230 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA----AIK--KLDSSKQPD-QEFLAQVSMVSRLKNENVVEL 126
+G+G +G V L+ + A+K K D D +EFL + + + + +V +L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 127 VG--------YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
VG + P+ +L G LH L + + L V+ V
Sbjct: 91 VGVSLRSRAKGRLPIPMVIL--PFMKHGDLHAFL---LASRIGENPFNLPLQTLVRFMVD 145
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
A G+EYL + IHR++ + N +L +D ++DF LS R + +
Sbjct: 146 IACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLS-------------RKIYS 189
Query: 239 FGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
Y+ A E + SDV++FGV + E++T G+ P
Sbjct: 190 GDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-30
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 24/208 (11%)
Query: 74 IGEGSYGRVYFGVL-----RSGRAAAIKKL-DSSKQPDQEFLAQVSMVSRLKNENVVELV 127
+G+G++G V +G A+KKL S+++ ++F ++ ++ L+++N+V+
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 128 G---YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G L+++ E+ GSL D L K + + ++ +G+E
Sbjct: 109 GVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKGME 159
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD--AAARLHSTRVLGTFGYH 242
YL K R IHR++ + N+L+ +++ KI DF L+ P ++ F Y
Sbjct: 160 YLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY- 215
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLT 270
APE + S SDV+SFGVVL EL T
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFT 243
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-30
Identities = 48/227 (21%), Positives = 89/227 (39%), Gaps = 50/227 (22%)
Query: 74 IGEGSYGRVYFGVLRSGRAA--------AIKKL-DSSKQPDQEFLAQVSMVSRLKNENVV 124
+G+G++ +++ GV R +K L + + + F SM+S+L ++++V
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
G V G +L E GSL L K ++ ++++A A +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLK--------KNKNCINILWKLEVAKQLAAAMH 127
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDD--------IAKISDFDLSNQAPDAAARLHSTRVL 236
+L E +IH N+ + N+LL ++ K+SD +S +
Sbjct: 128 FLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-------------ITV 171
Query: 237 GTFGYH-------APEYAMTGQM-SSKSDVYSFGVVLLELLT-GRKP 274
PE + + +D +SFG L E+ + G KP
Sbjct: 172 LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-29
Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 21/214 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRL-KN 120
+F S +G GSYG V+ GR A+K+ S + ++ LA+V ++ ++
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
V L + +G + L E SL G L AQ
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCE--------AWGASLPEAQVWGYLRDTL 167
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
L +LH + ++H ++K +N+ L K+ DF L + A A + G
Sbjct: 168 LALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQE-GDPR 221
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE + G + +DV+S G+ +LE+ +
Sbjct: 222 YMAPE-LLQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-29
Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 32/227 (14%)
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL 118
+ EK ++F +L+G+GS+ VY + +G AIK +D + + MV R+
Sbjct: 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA------MYKAGMVQRV 58
Query: 119 KNE----------NVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVL 167
+NE +++EL Y+ D V L E G ++ L +
Sbjct: 59 QNEVKIHCQLKHPSILELYNYFED-SNYVYLVLEMCHNGEMNRYLKNRVKP--------F 109
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
S + G+ YLH I+HR++ SN+LL + KI+DF L+ Q
Sbjct: 110 SENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166
Query: 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ ++ GT Y +PE A +SDV+S G + LL GR P
Sbjct: 167 EKHYTL--CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 48/240 (20%), Positives = 92/240 (38%), Gaps = 35/240 (14%)
Query: 54 PVISVDELKEKTD-------NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSS--KQP 104
P + D+ E+T +F ++G G+ G + + + R A+K++
Sbjct: 5 PSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA 64
Query: 105 DQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKP 163
D+E V ++ NV+ D + +A E + +L + + +
Sbjct: 65 DRE----VQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV--------EQK 111
Query: 164 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-----IAKISDFD 218
+ + + GL +LH I+HR++K N+L+ + A ISDF
Sbjct: 112 DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFG 168
Query: 219 LSNQ-APDAAARLHSTRVLGTFGYHAPEY---AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
L + A + + V GT G+ APE + D++S G V +++
Sbjct: 169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-29
Identities = 45/260 (17%), Positives = 94/260 (36%), Gaps = 34/260 (13%)
Query: 39 PAKEMKTVTVQPIAVPVISVDELKEKT--DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIK 96
P MK + + ++ ++ +++ + +G + ++ + + A+K
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALK 60
Query: 97 KLD--------SSKQPDQEFLAQVSMVSRLKNE----------NVVELVGYYVDGPLRV- 137
K + + + + ++ S KNE + G + V
Sbjct: 61 KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN-YDEVY 119
Query: 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 197
+ YE+ S+ V + I Y+H + I HR
Sbjct: 120 IIYEYMENDSILKFDE-YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NICHR 176
Query: 198 NIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS---S 254
++K SN+L+ + K+SDF S D ++ +R GT+ + PE + + S +
Sbjct: 177 DVKPSNILMDKNGRVKLSDFGESEYMVD--KKIKGSR--GTYEFMPPE-FFSNESSYNGA 231
Query: 255 KSDVYSFGVVLLELLTGRKP 274
K D++S G+ L + P
Sbjct: 232 KVDIWSLGICLYVMFYNVVP 251
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 43/226 (19%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+G G++G VY G + A+K L S+Q + +FL + ++S+ ++N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+G + R + E + G L L + L+ + +A A G +Y
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPS--QPSSLAMLDLLHVARDIACGCQY 155
Query: 186 LHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L E IHR+I + N LL +AKI DF ++ R + Y+
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-------------RDIYRASYY 199
Query: 243 -------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
PE M G +SK+D +SFGV+L E+ + G P
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 58/219 (26%), Positives = 87/219 (39%), Gaps = 19/219 (8%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKN 120
K D+ +G G+YG V SG+ A+K++ ++ + L + + R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD 64
Query: 121 -ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
V G + E SL P +L KIAV
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILG-----KIAVSI 118
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
+ LE+LH K +IHR++K SNVL+ K+ DF +S D A+ G
Sbjct: 119 VKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCK 173
Query: 240 GYHAPE----YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE S KSD++S G+ ++EL R P
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 63/222 (28%), Positives = 110/222 (49%), Gaps = 32/222 (14%)
Query: 73 LIGEGSYGRVYFGVLRSG---RAAAIKKL--DSSKQPDQEFLAQVSMVSRL-KNENVVEL 126
+IGEG++G+V ++ AAIK++ +SK ++F ++ ++ +L + N++ L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 127 VGY-YVDGPLRVLAYEHASKGSLHDILHGKK-------GVKGAKPGPVLSWAQRVKIAVG 178
+G G L + E+A G+L D L + LS Q + A
Sbjct: 92 LGACEHRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
ARG++YL +K + IHR++ + N+L+ ++ +AKI+DF LS R V T
Sbjct: 151 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS--------RGQEVYVKKT 199
Query: 239 FG-----YHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
G + A E ++ SDV+S+GV+L E+++ G P
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 59/241 (24%), Positives = 111/241 (46%), Gaps = 59/241 (24%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
IGEG++GRV+ A+K L ++S +F + ++++ N N+V+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 126 LVGYYV---DGPLRVLAYEHASKGSLHDIL---------------HGKKGVKGAKPGPVL 167
L+G V P+ +L +E+ + G L++ L + + P L
Sbjct: 115 LLG--VCAVGKPMCLL-FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
S A+++ IA A G+ YL E+ + +HR++ + N L+ ++ + KI+DF LS
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS------- 221
Query: 228 ARLHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 273
R + + Y+ PE + +++SDV+++GVVL E+ + G +
Sbjct: 222 ------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275
Query: 274 P 274
P
Sbjct: 276 P 276
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-28
Identities = 60/216 (27%), Positives = 89/216 (41%), Gaps = 39/216 (18%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
+G+G +G VY +S A+K L ++ L + + +L+ E
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQ------LEKAGVEHQLRREVEIQSHLRHP 69
Query: 122 NVVELVGYYVDGPLRV-LAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVG 178
N++ L GY+ D RV L E+A G+++ L K +
Sbjct: 70 NILRLYGYFHD-ATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-----------TYITE 117
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
A L Y H K R+IHR+IK N+LL KI+DF S AP + + GT
Sbjct: 118 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---SRRTD-LCGT 170
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y PE K D++S GV+ E L G+ P
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-28
Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 17/219 (7%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLD-SSKQPDQEFLAQ-VSMVSRLKNEN 122
D++ +IG G+ V AIK+++ Q + L + + +S+ + N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GA 179
+V +V L + S GS+ DI+ K G L + IA
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDEST---IATILREV 130
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR---VL 236
GLEYLH+ IHR++K+ N+LL +D +I+DF +S + +
Sbjct: 131 LEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 237 GTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKP 274
GT + APE + K+D++SFG+ +EL TG P
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-28
Identities = 34/283 (12%), Positives = 64/283 (22%), Gaps = 44/283 (15%)
Query: 36 KEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAA 94
+ A E T TV P L + + G V+ + A
Sbjct: 32 EPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91
Query: 95 IKKLDSSKQPDQEFLAQV----SMVSRLKNENVVELVGYY-------------------- 130
+K + + L ++ +RL E+ E
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 131 ------VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+L AS L + + R
Sbjct: 152 SPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAA 208
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
L K ++H + N+ + D + D + Y
Sbjct: 209 NLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPR 260
Query: 245 EYAM--TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQS 285
E+ T + + + G+ + + P P + S
Sbjct: 261 EFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-28
Identities = 63/209 (30%), Positives = 93/209 (44%), Gaps = 18/209 (8%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKN-ENVVELVGY 129
IG G+YG V V SG+ A+K++ S+ ++ L + +V R + +V+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ E S + + P +L KI + + L +L E
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG-----KITLATVKALNHLKEN 144
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE---- 245
+IIHR+IK SN+LL K+ DF +S Q D+ A+ TR G Y APE
Sbjct: 145 L--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDP 199
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
A +SDV+S G+ L EL TGR P
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-27
Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 24/228 (10%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQP-DQEFLAQ-VSMVSRL 118
+ + +G G +G V + +G AIK+ P ++E + ++ +L
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 119 KNENVVELV------GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+ NVV L +LA E+ G L L+ + G K GP+ +
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAAR 229
+ + L YLHE RIIHR++K N++L I KI D + +
Sbjct: 130 I------SSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--E 178
Query: 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277
L + V GT Y APE + + D +SFG + E +TG +P
Sbjct: 179 LCTEFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 59/226 (26%), Positives = 96/226 (42%), Gaps = 43/226 (19%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+G G++G VY G + A+K L S+Q + +FL + ++S+ ++N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+G + R + E + G L L + L+ + +A A G +Y
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETR--PRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 186 LHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L E IHR+I + N LL +AKI DF ++ R + GY+
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-------------RDIYRAGYY 240
Query: 243 -------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
PE M G +SK+D +SFGV+L E+ + G P
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 45/227 (19%), Positives = 83/227 (36%), Gaps = 41/227 (18%)
Query: 72 SLIGEGSYGRVYFGV-LR-SGRAAAIKKLDSSKQPDQEFL------AQVSMVSRLKNENV 123
I G G +Y + +GR +K L S D E Q ++ + + ++
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQF--LAEVVHPSI 141
Query: 124 VEL--VGYYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
V++ + D + Y E+ SL K L A+ + +
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----------LPVAEAIAYLLE 190
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST-RVLG 237
L YLH +++ ++K N++L ++ K+ D A +R++S + G
Sbjct: 191 ILPALSYLHSI---GLVYNDLKPENIML-TEEQLKLIDLG-------AVSRINSFGYLYG 239
Query: 238 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284
T G+ APE + +D+Y+ G L L + G
Sbjct: 240 TPGFQAPEIV-RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP 285
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 61/234 (26%), Positives = 110/234 (47%), Gaps = 50/234 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA--------AIKKL--DSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG++G+V A+K L D++++ + ++++ M+ + K++N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 123 VVELVGY-YVDGPLRVLAYEHASKGSLHDIL-------HGKKGVKGAKPGPVLSWAQRVK 174
++ L+G DGPL V+ E+ASKG+L + L P +++ V
Sbjct: 103 IINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
ARG+EYL + + IHR++ + NVL+ ++++ KI+DF L+ R
Sbjct: 162 CTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLA-------------R 205
Query: 235 VLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ Y+ APE + +SDV+SFGV++ E+ T G P
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-27
Identities = 57/261 (21%), Positives = 95/261 (36%), Gaps = 35/261 (13%)
Query: 26 PAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFG 85
+PG V A +P + VD + +G+G + + +
Sbjct: 3 APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVD--PRSRRRYVRGRFLGKGGFAKCFEI 60
Query: 86 V-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE----------NVVELVGYYVDGP 134
+ A K + S L + ++ E +VV G++ D
Sbjct: 61 SDADTKEVFAGKIVPKSL------LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-N 113
Query: 135 LRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
V + E + SL ++ +K + + A+ G +YLH R
Sbjct: 114 DFVFVVLELCRRRSLLELHKRRKALTEPE-------ARY--YLRQIVLGCQYLHRN---R 161
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS 253
+IHR++K N+ L +D KI DF L+ + R GT Y APE S
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHS 219
Query: 254 SKSDVYSFGVVLLELLTGRKP 274
+ DV+S G ++ LL G+ P
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPP 240
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-27
Identities = 66/236 (27%), Positives = 108/236 (45%), Gaps = 54/236 (22%)
Query: 74 IGEGSYGRVYFGVLRSGRAA--------AIKKL--DSSKQPDQEFLAQVSMVSRLKN-EN 122
+GEG++G+V A+K L D++++ + ++++ M+ + +N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 123 VVELVGYYV---DGPLRVLAYEHASKGSLHDIL-------HGKKGVKGAKPGPVLSWAQR 172
++ L+G DGPL V+ E+ASKG+L + L P LS
Sbjct: 137 IINLLG--ACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
V A ARG+EYL K + IHR++ + NVL+ +D++ KI+DF L+
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLA------------ 238
Query: 233 TRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
R + Y+ APE + +SDV+SFGV+L E+ T G P
Sbjct: 239 -RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-27
Identities = 53/233 (22%), Positives = 98/233 (42%), Gaps = 49/233 (21%)
Query: 74 IGEGSYGRVYFGVLR------SGRAAAIKKL--DSSKQPDQEFLAQVSMVSRL-KNENVV 124
+G G++G+V + R A+K L ++ + ++++ ++ + + NVV
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 125 ELVG--YYVDGPLRVLAYEHASKGSLHDILHGKKG-------VKGAKPGPVLSWAQRVKI 175
L+G GPL V+ E G+L L K+ L+ +
Sbjct: 95 NLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
+ A+G+E+L + + IHR++ + N+LL + ++ KI DF L+ R
Sbjct: 154 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLA-------------RD 197
Query: 236 LGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ + APE + +SDV+SFGV+L E+ + G P
Sbjct: 198 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-27
Identities = 53/236 (22%), Positives = 91/236 (38%), Gaps = 35/236 (14%)
Query: 53 VPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ 111
+P + VD + +G+G + + + + A K + S L +
Sbjct: 4 IPEVLVD--PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL------LLK 55
Query: 112 VSMVSRLKNE----------NVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKG 160
++ E +VV G++ D V + E + SL ++ +K +
Sbjct: 56 PHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSLLELHKRRKALTE 114
Query: 161 AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+ A+ G +YLH R+IHR++K N+ L +D KI DF L+
Sbjct: 115 PE-------ARY--YLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
Query: 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
+ R GT Y APE S + DV+S G ++ LL G+ P +
Sbjct: 163 TKVEYDGERKKVL--CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-27
Identities = 61/236 (25%), Positives = 109/236 (46%), Gaps = 54/236 (22%)
Query: 74 IGEGSYGRVYFGVLRSGRAA--------AIKKL--DSSKQPDQEFLAQVSMVSRL-KNEN 122
+GEG +G+V A+K L D++++ + ++++ M+ + K++N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 123 VVELVGYYV---DGPLRVLAYEHASKGSLHDIL-------HGKKGVKGAKPGPVLSWAQR 172
++ L+G DGPL V+ E+ASKG+L + L P +++
Sbjct: 149 IINLLG--ACTQDGPLYVI-VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
V ARG+EYL + + IHR++ + NVL+ ++++ KI+DF L+
Sbjct: 206 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLA------------ 250
Query: 233 TRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
R + Y+ APE + +SDV+SFGV++ E+ T G P
Sbjct: 251 -RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 1e-26
Identities = 29/278 (10%), Positives = 82/278 (29%), Gaps = 48/278 (17%)
Query: 36 KEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAA 94
++ A + + ++ P EL E+ +++G+ +G +
Sbjct: 48 MQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFE 107
Query: 95 IKKLDSSKQPDQE-----------------------------FLAQVSMVSRLKNENVVE 125
+ +++P F+ +V + + ++
Sbjct: 108 VHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIR 167
Query: 126 LVG----YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
+ +V + ++ + ++L + L R+++ + R
Sbjct: 168 VRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS-----LVHHARLQLTLQVIR 222
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L LH ++H ++ +++L ++ F+ A+A R
Sbjct: 223 LLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL-VRDGASAVSPIGRGFAPPET 278
Query: 242 HAPE-----YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
A M+ D ++ G+ + + P
Sbjct: 279 TAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 35/214 (16%), Positives = 74/214 (34%), Gaps = 23/214 (10%)
Query: 74 IGEG--SYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEF---LAQVSMVSRLKNENVVELV 127
IG+G V +G +++++ ++ ++ + + N+V
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
++ + + GS D++ ++ I G + L+Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLI------CTHFMDG-MNELAIAYILQGVLKALDYIH 145
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL-----GTFGYH 242
+HR++K+S++L+ D +S + R +
Sbjct: 146 HM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 243 APEYAMTGQM--SSKSDVYSFGVVLLELLTGRKP 274
+PE +KSD+YS G+ EL G P
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 27/210 (12%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQV----SMVSRLKNENVVELV 127
+G+G +G VY ++ A+K L S+ + Q+ + S L++ N++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 128 GYYVDGPLRV-LAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
Y+ D R+ L E A +G L+ L HG+ + + A L
Sbjct: 81 NYFHD-RKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-----------TFMEELADALH 128
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
Y HE+ ++IHR+IK N+L+ KI+DF S AP R + GT Y P
Sbjct: 129 YCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRTM--CGTLDYLPP 181
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
E K D++ GV+ E L G P
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-26
Identities = 55/241 (22%), Positives = 102/241 (42%), Gaps = 59/241 (24%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKNENVVE 125
+GEG +G+V + A+K L ++S ++ L++ +++ ++ + +V++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 126 LVGYYV---DGPLRVLAYEHASKGSLHDIL---------------HGKKGVKGAKPGPVL 167
L G DGPL ++ E+A GSL L L
Sbjct: 91 LYG--ACSQDGPLLLIV-EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
+ + A ++G++YL E +++HR++ + N+L+ + KISDF LS
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLS------- 197
Query: 228 ARLHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRK 273
R + + A E +++SDV+SFGV+L E++T G
Sbjct: 198 ------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 274 P 274
P
Sbjct: 252 P 252
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 57/231 (24%), Positives = 97/231 (41%), Gaps = 48/231 (20%)
Query: 74 IGEGSYGRVYFGVLR------SGRAAAIKKL--DSSKQPDQEFLAQVSMVSRLKN-ENVV 124
+G G++G+V + A+K L + + ++++ ++S L EN+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 125 ELVGYYV---DGPLRVLAYEHASKGSLHDILHGKKGV-----KGAKPGPVLSWAQRVKIA 176
L+G GP+ V+ E+ G L + L K V A S + +
Sbjct: 114 NLLG--ACTHGGPVLVIT-EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
A+G+ +L K IHR++ + NVLL + +AKI DF L AR ++
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGL--------ARD----IM 215
Query: 237 GTFGYH------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
Y APE + +SDV+S+G++L E+ + G P
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 8e-26
Identities = 33/294 (11%), Positives = 86/294 (29%), Gaps = 55/294 (18%)
Query: 37 EAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAI 95
++ A + + ++ P EL E+ +++G+ +G + +
Sbjct: 44 QSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEV 103
Query: 96 KKLDSSKQPDQE-----------------------------FLAQVSMVSRLKNENVVEL 126
+++P F+ +V + + ++ +
Sbjct: 104 HVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRV 163
Query: 127 VGYYVDG--PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
D R Y +L G+ + + L R+++ + R L
Sbjct: 164 RLDERDMWVLSRFFLYPRMQ-SNLQTF--GEVLLSHSSTHKSLVHHARLQLTLQVIRLLA 220
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
LH ++H ++ +++L ++ F+ + + G+ P
Sbjct: 221 SLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG------ARVVSSVSRGFEPP 271
Query: 245 EYAMT-----------GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
E M+ D ++ G+V+ + P+ G +
Sbjct: 272 ELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI 325
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKN-ENVVELVGY 129
+G G+ G+V+ ++G A+K++ S + + L + +V + + +V+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
++ +A E + + + P +L K+ V + L YL EK
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPI----PERILG-----KMTVAIVKALYYLKEK 143
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE---- 245
+IHR++K SN+LL + K+ DF +S + D A+ R G Y APE
Sbjct: 144 H--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDP 198
Query: 246 -YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
++DV+S G+ L+EL TG+ P
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 52/239 (21%), Positives = 96/239 (40%), Gaps = 30/239 (12%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNEN 122
+ + ++G+G+ V+ G + +G AIK ++ +P + + ++ +L ++N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 123 VVELVGYYVDGPLR--VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+V+L + R VL E GSL+ +L G L + V
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV------V 122
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLF----DDDIAKISDFDLSNQAPDAAARLHSTRVL 236
G+ +L E I+HRNIK N++ + K++DF + + D + S +
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LY 176
Query: 237 GTFGYHAPE--------YAMTGQMSSKSDVYSFGVVLLELLTGRKP-VDHTLPRGQQSL 286
GT Y P+ + + D++S GV TG P PR + +
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 46/238 (19%), Positives = 89/238 (37%), Gaps = 35/238 (14%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLK 119
+ + + ++G GS G V F GR A+K++ E + +++
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALME----IKLLTESD 66
Query: 120 N-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ NV+ +A E + +L D++ K + + + +
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKN--VSDENLKLQKEYNPISLLRQ 123
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLL-------------FDDDIAKISDFDLSNQAPD 225
A G+ +LH +IIHR++K N+L+ ++ ISDF L +
Sbjct: 124 IASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 226 AAARLHSTR--VLGTFGYHAPE-------YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ + GT G+ APE +++ D++S G V +L+ K
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ----VSMVSRLKNENVVELVG 128
IG GS+G VYF +R+ AIKK+ S + E V + +L++ N ++ G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
Y+ L E+ GS D+L K L + + GA +GL YLH
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLEVHKKP--------LQEVEIAAVTHGALQGLAYLHS 172
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
+IHR++K+ N+LL + + K+ DF ++ A +GT + APE +
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVIL 223
Query: 249 TGQMS---SKSDVYSFGVVLLELLTGRKP 274
K DV+S G+ +EL + P
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 44/248 (17%), Positives = 85/248 (34%), Gaps = 40/248 (16%)
Query: 53 VPVISVD-ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAA------AIKKLDSSKQPD 105
+P I E + + + L+GEG++ +VY A +K +
Sbjct: 51 LPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP-- 108
Query: 106 QEFLAQVSMVSRLKNE---NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAK 162
EF ++ RLK ++ ++ VL E S G+L + ++ K
Sbjct: 109 WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYK----NT 164
Query: 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA---------- 212
P V+ + A+ +E +H+ IIH +IK N +L + +
Sbjct: 165 PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221
Query: 213 -KISDF----DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSS-KSDVYSFGVVLL 266
+ D D+ T T G+ E ++ + + + D + +
Sbjct: 222 LALIDLGQSIDMKLFPKGTIF----TAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVY 276
Query: 267 ELLTGRKP 274
+L G
Sbjct: 277 CMLFGTYM 284
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 56/227 (24%), Positives = 90/227 (39%), Gaps = 34/227 (14%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKN-ENVVELVGY 129
++ EG + VY + SGR A+K+L S+++ + Q V + +L N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 130 YVDGPLR-------VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
G L KG L + L K + LS +KI R
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFL------KKMESRGPLSCDTVLKIFYQTCRA 148
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----------DLSNQAPDAAARLHS 232
++++H + +P IIHR++K N+LL + K+ DF D S A A
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 233 TRVLGTFGYHAPEYAMTGQMS-----SKSDVYSFGVVLLELLTGRKP 274
T Y PE + S K D+++ G +L L + P
Sbjct: 208 ITRNTTPMYRTPE--IIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 41/221 (18%), Positives = 78/221 (35%), Gaps = 27/221 (12%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRL-KNENVVELV 127
IG G +G V+ V G AIK+ Q L +V + L ++ +VV
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
+ + ++ E+ + GSL D + + L + + RGL Y+H
Sbjct: 78 SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK-----DLLLQVGRGLRYIH 132
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDA------------AARLHSTRV 235
++H +IK SN+ + I + + + R+ S +V
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 236 L-GTFGYHAPE-YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
G + A E K+D+++ + ++
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 53/234 (22%), Positives = 92/234 (39%), Gaps = 50/234 (21%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRLKN-ENVV 124
+G G++G+V + A+K L + + ++++ ++S L N N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 125 ELVGYY-VDGPLRVLAYEHASKGSLHDILHGKKGVK---------GAKPGPVLSWAQRVK 174
L+G + GP V+ E+ G L + L K+ L +
Sbjct: 91 NLLGACTIGGPTLVIT-EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
+ A+G+ +L K IHR++ + N+LL I KI DF L+ R
Sbjct: 150 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA-------------R 193
Query: 235 VLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ + APE + +SDV+S+G+ L EL + G P
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-25
Identities = 52/239 (21%), Positives = 96/239 (40%), Gaps = 30/239 (12%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNEN 122
+ + ++G+G+ V+ G + +G AIK ++ +P + + ++ +L ++N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 123 VVELVGYYVDGPLR--VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+V+L + R VL E GSL+ +L G L + V
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV------V 122
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLF----DDDIAKISDFDLSNQAPDAAARLHSTRVL 236
G+ +L E I+HRNIK N++ + K++DF + + D + S +
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LY 176
Query: 237 GTFGYHAPE--------YAMTGQMSSKSDVYSFGVVLLELLTGRKP-VDHTLPRGQQSL 286
GT Y P+ + + D++S GV TG P PR + +
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-24
Identities = 54/239 (22%), Positives = 104/239 (43%), Gaps = 55/239 (23%)
Query: 74 IGEGSYGRVYFGVLRSGRAA------AIKKL--DSSKQPDQEFLAQVSMVSRL-KNENVV 124
+G G++G+V A+K L + + ++++ M+++L +EN+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 125 ELVGY-YVDGPLRVLAYEHASKGSLHDIL--------------HGKKGVKGAKPGPVLSW 169
L+G + GP+ ++ E+ G L + L +K ++ + VL++
Sbjct: 113 NLLGACTLSGPIYLIF-EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229
+ A A+G+E+L K +HR++ + NVL+ + KI DF L+
Sbjct: 172 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLA--------- 219
Query: 230 LHSTRVLGTFGYH-------------APEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
R + + + APE G + KSDV+S+G++L E+ + G P
Sbjct: 220 ----RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-24
Identities = 63/244 (25%), Positives = 96/244 (39%), Gaps = 53/244 (21%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSK-----------------QPDQEFLAQVSM 114
IG+GSYG V A+K L K +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 115 VSRLKNE----------NVVELVGYYV-DGPLRVLAY---EHASKGSLHDILHGKKGVKG 160
+ ++ E NVV+L V D P Y E ++G + ++ K
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP---- 133
Query: 161 AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
LS Q +G+EYLH + +IIHR+IK SN+L+ +D KI+DF +S
Sbjct: 134 ------LSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS---SKSDVYSFGVVLLELLTGRKP-VD 276
N+ + A L +T GT + APE + DV++ GV L + G+ P +D
Sbjct: 185 NEFKGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242
Query: 277 HTLP 280
+
Sbjct: 243 ERIM 246
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 3e-22
Identities = 41/170 (24%), Positives = 71/170 (41%), Gaps = 22/170 (12%)
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAY---EHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171
+ R+ + VG +V Y + K +L D ++ + ++ + G L
Sbjct: 112 IRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF----------DLSN 221
++ A +E+LH K ++HR++K SN+ DD+ K+ DF +
Sbjct: 172 QI------AEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG 271
A T +GT Y +PE S K D++S G++L ELL
Sbjct: 223 VLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-20
Identities = 60/250 (24%), Positives = 104/250 (41%), Gaps = 39/250 (15%)
Query: 39 PAKEMKTVTVQPIAVPVISVDELKEKTDNFGTN----SLIGEGSYGRVYFGVLR-SGRAA 93
P M + P ++ T F ++G+GS+G V + +G+
Sbjct: 2 PGSMMDHLHATPGMF-------VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQEC 54
Query: 94 AIKKLD----SSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLH 149
A+K + K + L +V ++ +L + N+++L ++ D L E + G L
Sbjct: 55 AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELF 114
Query: 150 D--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207
D I + A A+ ++ + + Y+H+ +I+HR++K N+LL
Sbjct: 115 DEIISRKRFSEVDA--------ARIIRQVLSG---ITYMHKN---KIVHRDLKPENLLLE 160
Query: 208 DDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVV 264
+I DF LS + +GT Y APE + G K DV+S GV+
Sbjct: 161 SKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVI 216
Query: 265 LLELLTGRKP 274
L LL+G P
Sbjct: 217 LYILLSGCPP 226
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-20
Identities = 61/227 (26%), Positives = 94/227 (41%), Gaps = 31/227 (13%)
Query: 61 LKEKTDNFGTN----SLIGEGSYGRVYFGVLR-SGRAAAIK---KLDSSKQPDQEFLAQV 112
+ K + +G G+YG V + + AIK K S + + L +V
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWA 170
+++ L + N+++L ++ D L E G L D I K A A
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA--------A 139
Query: 171 QRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAA 227
+K + + YLH+ I+HR++K N+LL + + KI DF LS +
Sbjct: 140 VIIKQVLSG---VTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193
Query: 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
LGT Y APE + + K DV+S GV+L LL G P
Sbjct: 194 KM---KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 7e-20
Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 44/222 (19%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ--VSMVSRLKNENVVELVGY 129
+GEG+YG V V + A A+K +D + D + + + L +ENVV+ G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR-------- 181
+G ++ L E+ S G L D + + + A+
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLMA 116
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD-AAARLHSTRVLGTFG 240
G+ YLH I HR+IK N+LL + D KISDF L+ RL + GT
Sbjct: 117 GVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLP 172
Query: 241 YHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
Y APE + + DV+S G+VL +L G P D
Sbjct: 173 YVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 55/233 (23%), Positives = 89/233 (38%), Gaps = 57/233 (24%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
L+GEGSYG+V + + A+K L K + + +K E
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKK-----LRRIPNGEANVKKEIQLLRRLRHK 66
Query: 122 NVVELVG-YYVDGPLRV-LAYEHASKGS--LHD-ILHGKKGVKGAKPGPVLSWAQRVKIA 176
NV++LV Y + ++ + E+ G + D + +
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-------------------FP 107
Query: 177 VGAAR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
V A GLEYLH + I+H++IK N+LL KIS ++ AA
Sbjct: 108 VCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
Query: 229 --RLHSTRVLGTFGYHAPEYAMTGQM--SSKSDVYSFGVVLLELLTGRKPVDH 277
+++ G+ + PE A K D++S GV L + TG P +
Sbjct: 165 DDTCRTSQ--GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-19
Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 44/222 (19%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ--VSMVSRLKNENVVELVGY 129
+GEG+YG V V + A A+K +D + D + + + L +ENVV+ G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR-------- 181
+G ++ L E+ S G L D + + + A+
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLMA 116
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD-AAARLHSTRVLGTFG 240
G+ YLH I HR+IK N+LL + D KISDF L+ RL + GT
Sbjct: 117 GVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLP 172
Query: 241 YHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
Y APE + + DV+S G+VL +L G P D
Sbjct: 173 YVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-18
Identities = 27/208 (12%), Positives = 50/208 (24%), Gaps = 48/208 (23%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVS----MVSRLKNENVVEL 126
G + + + R A+ +D + L + +SR+ V +
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+ ++ E GSL ++ P P ++ A +
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTS-------PSP----VGAIRAMQSLAAAADAA 145
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246
H + S V + D L
Sbjct: 146 HRAG---VALSIDHPSRVRVSIDGDVV----------------------LAYPATMPDA- 179
Query: 247 AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ + D+ G L LL R P
Sbjct: 180 ------NPQDDIRGIGASLYALLVNRWP 201
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-18
Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 63/231 (27%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
+G G++G+V G +G A+K L+ K + + +V ++K E
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQK------IRSLDVVGKIKREIQNLKLFRHP 71
Query: 122 NVVELVGYYV-DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++++L Y V P + E+ S G L D + + ++
Sbjct: 72 HIIKL--YQVISTPTDFFMVMEYVSGGELFDYI-----------------CKHGRVEEME 112
Query: 180 AR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
AR ++Y H ++HR++K NVLL AKI+DF LSN D L
Sbjct: 113 ARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLR 168
Query: 232 STRVLGTFGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
++ G+ Y APE YA + D++S GV+L LL G P D
Sbjct: 169 TS--CGSPNYAAPEVISGRLYA-----GPEVDIWSCGVILYALLCGTLPFD 212
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 64/263 (24%), Positives = 105/263 (39%), Gaps = 44/263 (16%)
Query: 36 KEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTN----SLIGEGSYGRVYFGVLR-SG 90
+ + + Q IA+ +++K G + +G G+YG V +
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMY--VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH 61
Query: 91 RAAAIKKLDSSK-------------QPDQEFLAQ-VSMVSRLKNENVVELVGYYVDGPLR 136
AIK + S+ + E + +S++ L + N+++L + D
Sbjct: 62 SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121
Query: 137 VLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRI 194
L E G L + I K A A +K + + YLH+ I
Sbjct: 122 YLVTEFYEGGELFEQIINRHKFDECDA--------ANIMKQILSG---ICYLHKH---NI 167
Query: 195 IHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ 251
+HR+IK N+LL + + KI DF LS+ +L LGT Y APE + +
Sbjct: 168 VHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-KLRD--RLGTAYYIAPE-VLKKK 223
Query: 252 MSSKSDVYSFGVVLLELLTGRKP 274
+ K DV+S GV++ LL G P
Sbjct: 224 YNEKCDVWSCGVIMYILLCGYPP 246
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 3e-18
Identities = 59/245 (24%), Positives = 80/245 (32%), Gaps = 47/245 (19%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIK-----KLDSSKQPDQEFLAQ-VSMVSRLKNENVVEL 126
IG+GSYG V + + AIK K+ D E + V ++ +L + N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG-------- 178
Y D L E G L D L+ K + Q
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 179 ----------------AAR-------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA--K 213
+ L YLH + I HR+IK N L + K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 214 ISDFDLSN--QAPDAAARLHSTRVLGTFGYHAPE--YAMTGQMSSKSDVYSFGVVLLELL 269
+ DF LS + T GT + APE K D +S GV+L LL
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 270 TGRKP 274
G P
Sbjct: 271 MGAVP 275
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-17
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNEN 122
F ++G G++ V+ R G+ A+K + S L ++++ ++K+EN
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVG 178
+V L Y L + S G L D IL ++GV K A + ++ +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRIL--ERGVYTEKDA--------SLVIQQVLS 117
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRV 235
A ++YLHE I+HR++K N+L ++ I+DF LS + +
Sbjct: 118 A---VKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STA 167
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT GY APE S D +S GV+ LL G P
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 39/222 (17%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKNENVVELVGY 129
IG+G++ +V + +GR AIK +D ++ + L + V ++ L + N+V+L +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 130 YV-DGPLRV-LAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
V + + L E+AS G + D L HG+ + + ++Y
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHGR-----------MKEKEARSKFRQIVSAVQY 129
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
H+K RI+HR++K+ N+LL D KI+DF SN+ G Y APE
Sbjct: 130 CHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDAFC-GAPPYAAPE 183
Query: 246 ------YAMTGQMSSKSDVYSFGVVLLELLTGRKP-VDHTLP 280
Y + DV+S GV+L L++G P L
Sbjct: 184 LFQGKKYD-----GPEVDVWSLGVILYTLVSGSLPFDGQNLK 220
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKNENVVELVGY 129
+G+GS+G V R + + A+K ++ + D + + V ++ +L + N+++L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 130 YVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
D + E + G L D I + A A+ +K + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--------ARIIKQVFSG---ITYMH 138
Query: 188 EKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
+ I+HR++K N+LL + KI DF LS ++ +GT Y AP
Sbjct: 139 KH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKD--RIGTAYYIAP 192
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
E + G K DV+S GV+L LL+G P
Sbjct: 193 E-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 1e-17
Identities = 51/221 (23%), Positives = 94/221 (42%), Gaps = 38/221 (17%)
Query: 74 IGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY 130
+G G+YG VY + + A+K+++ + +++++ LK+ NV+ L +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-CREIALLRELKHPNVISLQKVF 87
Query: 131 VDGPLR--VLAYEHASKGSLHD---ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+ R L +++A HD I+ + K K L + G+ Y
Sbjct: 88 LSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDD----IAKISDFDLSNQAPDAAARL---------HS 232
LH ++HR++K +N+L+ + KI+D ARL
Sbjct: 144 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF--------ARLFNSPLKPLADL 192
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
V+ TF Y APE + + +K+ D+++ G + ELLT
Sbjct: 193 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 3e-17
Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 63/231 (27%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
+G G++G+V G +G A+K L+ K + + +V +++ E
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQK------IRSLDVVGKIRREIQNLKLFRHP 76
Query: 122 NVVELVGYYV-DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++++L Y V P + + E+ S G L D + + ++
Sbjct: 77 HIIKL--YQVISTPSDIFMVMEYVSGGELFDYI-----------------CKNGRLDEKE 117
Query: 180 AR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
+R G++Y H ++HR++K NVLL AKI+DF LSN D L
Sbjct: 118 SRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLR 173
Query: 232 STRVLGTFGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
++ G+ Y APE YA + D++S GV+L LL G P D
Sbjct: 174 TS--CGSPNYAAPEVISGRLYA-----GPEVDIWSSGVILYALLCGTLPFD 217
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-17
Identities = 46/245 (18%), Positives = 85/245 (34%), Gaps = 44/245 (17%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
L+G G +G VY G+ + AIK ++ + D ++ +R+ E
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW---GELPNGTRVPMEVVLLKKVSSG 106
Query: 122 --NVVELVGYYVDGPLRVLAYEHAS-KGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIA 176
V+ L+ ++ VL E L D G L
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-----------LQEELARSFF 155
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI-AKISDFDLSNQAPDAAARLHSTRV 235
+ + H ++HR+IK N+L+ + K+ DF D
Sbjct: 156 WQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDF-- 208
Query: 236 LGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVLTSS 294
GT Y PE+ + + V+S G++L +++ G P + + ++ +
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQVFFR 263
Query: 295 HFLSS 299
+SS
Sbjct: 264 QRVSS 268
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-17
Identities = 48/207 (23%), Positives = 85/207 (41%), Gaps = 18/207 (8%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQE--FLAQVSMVSRLKNENVVELVGYY 130
+G G++G V+ R SG IK ++ + A++ ++ L + N++++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
D + E G L + + + LS ++ L Y H +
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGK-----ALSEGYVAELMKQMMNALAYFHSQ- 143
Query: 191 EPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 247
++H+++K N+L D KI DF L+ + GT Y APE
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAA-GTALYMAPE-V 197
Query: 248 MTGQMSSKSDVYSFGVVLLELLTGRKP 274
++ K D++S GVV+ LLTG P
Sbjct: 198 FKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-17
Identities = 58/240 (24%), Positives = 92/240 (38%), Gaps = 52/240 (21%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
IG G++G + A+K ++ D+ ++ L++ N+V V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRF--KEV 84
Query: 132 -DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR-------- 181
P + + E+AS G L++ + + + AR
Sbjct: 85 ILTPTHLAIIMEYASGGELYERI-----------------CNAGRFSEDEARFFFQQLLS 127
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHSTRVLGT 238
G+ Y H +I HR++K N LL D A KI DF S + + + ST +GT
Sbjct: 128 GVSYCHSM---QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHS-QPKST--VGT 180
Query: 239 FGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPV-DHTLPRGQQSLVTWVL 291
Y APE Y +DV+S GV L +L G P D PR + + +L
Sbjct: 181 PAYIAPEVLLRQEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL 235
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 5e-17
Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 25/208 (12%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYV 131
IG GS+G V V + + A KK+ D + Q + ++ L + N++ L +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 132 DGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
D L E + G L + + A A+ +K + A + Y H+
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDA--------ARIMKDVLSA---VAYCHKL 125
Query: 190 AEPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEY 246
+ HR++K N L D K+ DF L+ + ++ T+V GT Y +P+
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKV-GTPYYVSPQ- 178
Query: 247 AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ G + D +S GV++ LL G P
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-17
Identities = 43/222 (19%), Positives = 79/222 (35%), Gaps = 35/222 (15%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSR-----------LKN 120
L+G+G +G V+ G L AIK + ++ L+ +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGS-LHD--ILHGKKGVKGAKPGPVLSWAQRVKIAV 177
V+ L+ ++ +L E L D G G ++
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-----------CFFG 146
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVL 236
+++ H + ++HR+IK N+L+ AK+ DF D
Sbjct: 147 QVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--YTDF--D 199
Query: 237 GTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDH 277
GT Y PE+ Q + + V+S G++L +++ G P +
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 6e-17
Identities = 53/266 (19%), Positives = 106/266 (39%), Gaps = 20/266 (7%)
Query: 14 KASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSL 73
K + G + + + P + D++ +
Sbjct: 105 DERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEE 164
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYV 131
+G G++G V+ R+ G A K + + + D+E + + + +S L++ +V L +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
D V+ YE S G L + + + +S + V+ +GL ++HE
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHEN-- 274
Query: 192 PRIIHRNIKSSNVLLF--DDDIAKISDFDLSNQ-APDAAARLHSTRVLGTFGYHAPEYAM 248
+H ++K N++ + K+ DF L+ P + ++ GT + APE A
Sbjct: 275 -NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV----TTGTAEFAAPEVAE 329
Query: 249 TGQMSSKSDVYSFGVVLLELLTGRKP 274
+ +D++S GV+ LL+G P
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 8e-17
Identities = 58/215 (26%), Positives = 88/215 (40%), Gaps = 20/215 (9%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIK-----KLDSSKQPDQEFLAQ-VSMVSRLKNENVVEL 126
IG+G + V + R G+ A+K K SS E L + S+ LK+ ++VEL
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 127 VGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+ Y + + +E L + VK A G V S A L Y
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEI-----VKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
H+ IIHR++K VLL + + K+ F ++ Q ++ +GT + A
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMA 201
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278
PE DV+ GV+L LL+G P T
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 60/231 (25%), Positives = 98/231 (42%), Gaps = 64/231 (27%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---------- 121
+GEGS+G+V ++ + A+K + L + M R++ E
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQL------LKKSDMHMRVEREISYLKLLRHP 69
Query: 122 NVVELVGYYV-DGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
++++L Y V P + + E+A G L D + ++ ++
Sbjct: 70 HIIKL--YDVITTPTDIVMVIEYAG-GELFDYI-----------------VEKKRMTEDE 109
Query: 180 AR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
R +EY H +I+HR++K N+LL D+ KI+DF LSN D L
Sbjct: 110 GRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLK 165
Query: 232 STRVLGTFGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
++ G+ Y APE YA + DV+S G+VL +L GR P D
Sbjct: 166 TS--CGSPNYAAPEVINGKLYA-----GPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 66/265 (24%), Positives = 108/265 (40%), Gaps = 35/265 (13%)
Query: 24 NNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEK-----TDNFGTNSLIGEGS 78
++ +G G + T + P ++ + +D F S +G G+
Sbjct: 6 HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGA 65
Query: 79 YGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNENVVELVGYYVDGPLR 136
VY + + A+K L K D++ + + ++ RL + N+++L +
Sbjct: 66 TSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123
Query: 137 VLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
L E + G L D I+ +KG + A A VK + A + YLHE
Sbjct: 124 SLVLELVTGGELFDRIV--EKGYYSERDA--------ADAVKQILEA---VAYLHEN--- 167
Query: 193 RIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
I+HR++K N+L D KI+DF LS L T GT GY APE
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTVC-GTPGYCAPEILRG 224
Query: 250 GQMSSKSDVYSFGVVLLELLTGRKP 274
+ D++S G++ LL G +P
Sbjct: 225 CAYGPEVDMWSVGIITYILLCGFEP 249
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 51/229 (22%), Positives = 84/229 (36%), Gaps = 38/229 (16%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE-- 121
D + + +G G+ G V R + AI+ + K + ++ E
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGS-AREADPALNVETEIE 192
Query: 122 --------NVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQ 171
++++ ++ D + E G L D + + + K
Sbjct: 193 ILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK--------- 242
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAA 228
++YLHE IIHR++K NVLL + + KI+DF S + +
Sbjct: 243 --LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS- 296
Query: 229 RLHSTRVLGTFGYHAPE---YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
L T GT Y APE T + D +S GV+L L+G P
Sbjct: 297 -LMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-16
Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 36/222 (16%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKN-ENVVELVGY 129
++GEG++ RV + + + A+K ++ + + + V M+ + + NV+EL+ +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGV---KGAKPGPVLSWAQRVKIAVGAARGLEYL 186
+ + L +E GS+ +H K+ A + V+ A L++L
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIH-KRRHFNELEA--------SVVVQDVASA---LDFL 127
Query: 187 HEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLS------NQAPDAAARLHSTRVLG 237
H K I HR++K N+L + KI DFDL + T G
Sbjct: 128 HNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-G 183
Query: 238 TFGYHAPEYAMTGQMSSKS-----DVYSFGVVLLELLTGRKP 274
+ Y APE + D++S GV+L LL+G P
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 4e-16
Identities = 52/234 (22%), Positives = 91/234 (38%), Gaps = 41/234 (17%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIK-----KLDSSKQPDQEFLAQV--- 112
E + + T S +G G++G V+ V + +K K+ + L +V
Sbjct: 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79
Query: 113 -SMVSRLKNENVVELVGYYVDGPLRVLAYE-HASKGSLHD--ILHGKKGVKGAKPGPVLS 168
+++SR+++ N+++++ + + L E H S L H + L
Sbjct: 80 IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-----------LD 128
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
I + YL K IIHR+IK N+++ +D K+ DF +
Sbjct: 129 EPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER--G 183
Query: 229 RLHSTRVLGTFGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
+L T GT Y APE Y + +++S GV L L+ P
Sbjct: 184 KLFYTFC-GTIEYCAPEVLMGNPYR-----GPELEMWSLGVTLYTLVFEENPFC 231
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 6e-16
Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQ-VSMVSRLKNEN 122
D + +G G++G V+ V ++ GR K +++ D+ + +S++++L +
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
++ L + D VL E S G L D + + +S A+ + A G
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAE--------DYKMSEAEVINYMRQACEG 161
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIA--KISDFDLSNQA-PDAAARLHSTRVLGTF 239
L+++HE I+H +IK N++ + KI DF L+ + PD ++ T
Sbjct: 162 LKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV----TTATA 214
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ APE + +D+++ GV+ LL+G P
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-16
Identities = 47/224 (20%), Positives = 77/224 (34%), Gaps = 37/224 (16%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE----------- 121
+G G V + + + A+K +D + + E
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
N+++L Y L ++ KG L D K + ++ +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET--------RKIMRALLEV 136
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
+ LH+ I+HR++K N+LL DD K++DF S Q GT
Sbjct: 137 ---ICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVC-GTP 187
Query: 240 GYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277
Y APE + D++S GV++ LL G P H
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-15
Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 39/219 (17%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQPDQEF----LAQVSMVSRLKN---ENV 123
IG G+YG VY SG A+K + + + +V+++ RL+ NV
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 124 VEL----VGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
V L D ++V L +EH D+ + P P L +
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVD----QDL----RTYLDKAPPPGLPAETIKDLMRQ 128
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-----T 233
RGL++LH I+HR++K N+L+ K++DF L AR++S T
Sbjct: 129 FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL--------ARIYSYQMALT 177
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
V+ T Y APE + ++ D++S G + E+ +
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-15
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 27/219 (12%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKN 120
+ + ++G+GS+G V R + A+K ++ + D + + V ++ +L +
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
N+++L D + E + G L D I + A A+ +K
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA--------ARIIKQVFS 132
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRV 235
+ Y+H+ I+HR++K N+LL + KI DF LS R+
Sbjct: 133 G---ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRI 184
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT Y APE + G K DV+S GV+L LL+G P
Sbjct: 185 -GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 57/281 (20%), Positives = 109/281 (38%), Gaps = 29/281 (10%)
Query: 7 CEEDDIRKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDE-LKEKT 65
++ + S++G N +K + V A P + K
Sbjct: 23 SMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQ 82
Query: 66 DNF------GTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQ-VSMVSR 117
++G G +G+V+ + G A K + + D+E + +S++++
Sbjct: 83 GAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQ 142
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQRVKIA 176
L + N+++L + VL E+ G L D I+ + L+ +
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII--DESYN-------LTELDTILFM 193
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLF--DDDIAKISDFDLSNQ-APDAAARLHST 233
G+ ++H+ I+H ++K N+L D KI DF L+ + P ++
Sbjct: 194 KQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV--- 247
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT + APE +S +D++S GV+ LL+G P
Sbjct: 248 -NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 1e-15
Identities = 61/224 (27%), Positives = 93/224 (41%), Gaps = 37/224 (16%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS--KQPDQEFLAQVSMVSRLKNE- 121
++F + +IG G +G VY +G+ A+K LD K E LA NE
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA--------LNER 240
Query: 122 NVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV-KIAVGA 179
++ LV D P V ++Y + L IL G G + + +
Sbjct: 241 IMLSLVST-GDCPFIVCMSYAFHTPDKLSFILDLMNG------GDLHYHLSQHGVFSEAD 293
Query: 180 AR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
R GLE++H + +++R++K +N+LL + +ISD L+
Sbjct: 294 MRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-- 348
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
V GT GY APE G S D +S G +L +LL G P
Sbjct: 349 -ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-15
Identities = 49/210 (23%), Positives = 90/210 (42%), Gaps = 29/210 (13%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYV 131
+GEGS+ V + S +A A+K + + + + +++ + + N+V+L +
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--KEITALKLCEGHPNIVKLHEVFH 76
Query: 132 DGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
D L E + G L + I KK A + ++ V A + ++H
Sbjct: 77 DQLHTFLVMELLNGGELFERIK--KKKHFSETEA--------SYIMRKLVSA---VSHMH 123
Query: 188 EKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
+ ++HR++K N+L D++ KI DF + P L + T Y AP
Sbjct: 124 DV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAP 178
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
E D++S GV+L +L+G+ P
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-15
Identities = 46/212 (21%), Positives = 86/212 (40%), Gaps = 29/212 (13%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKNENVVELVGY 129
+G+G++ V V G+ A +++ K D + L + + LK+ N+V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 130 YVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVGAARGLEY 185
+ L ++ + G L + I+ + A + ++ + A + +
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIV--AREYYSEADA--------SHCIQQILEA---VLH 125
Query: 186 LHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
H+ ++HRN+K N+LL K++DF L+ + GT GY
Sbjct: 126 CHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYL 180
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+PE D+++ GV+L LL G P
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 58/261 (22%), Positives = 103/261 (39%), Gaps = 41/261 (15%)
Query: 31 GGFYVKEAPAKEMKTVTVQP----IAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV 86
G F + AP +K + I V +++ + +IG GS+G V+
Sbjct: 1 GSFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAK 60
Query: 87 LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGY-YVDGPLRV-----LAY 140
L AIKK+ Q + ++ ++ +K+ NVV+L + Y +G + L
Sbjct: 61 LVESDEVAIKKV---LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117
Query: 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK-----IAVGAARGLEYLHEKAEPRII 195
E+ + +++ +K P +K + R L Y+H I
Sbjct: 118 EYVPE-TVYRASRHYAKLKQTMP------MLLIKLYMYQLL----RSLAYIHSI---GIC 163
Query: 196 HRNIKSSNVLLF-DDDIAKISDFDLSNQAPDAAARLH--STRVLGTFGYHAPEYAMTGQM 252
HR+IK N+LL + K+ DF + + +R Y APE
Sbjct: 164 HRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPELIFGATN 218
Query: 253 SSKS-DVYSFGVVLLELLTGR 272
+ + D++S G V+ EL+ G+
Sbjct: 219 YTTNIDIWSTGCVMAELMQGQ 239
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 53/232 (22%), Positives = 85/232 (36%), Gaps = 38/232 (16%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
K D + + +G G+ G V R + AIK + K + ++
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGS-AREADPALNVET 64
Query: 121 E----------NVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLS 168
E ++++ ++ D + E G L D + + +
Sbjct: 65 EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATC------- 116
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPD 225
+ A ++YLHE IIHR++K NVLL + + KI+DF S +
Sbjct: 117 -KLYFYQMLLA---VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 226 AAARLHSTRVLGTFGYHAPE---YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
L T GT Y APE T + D +S GV+L L+G P
Sbjct: 170 --TSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-15
Identities = 56/288 (19%), Positives = 98/288 (34%), Gaps = 46/288 (15%)
Query: 13 RKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTN- 71
R+A + + N K A+ T + ++ F
Sbjct: 37 RRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKY 96
Query: 72 ---SLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE------ 121
+IG G V V R+ G A+K ++ + + + + + E
Sbjct: 97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLE-EVREATRRETHILRQ 155
Query: 122 -----NVVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQR 172
+++ L+ Y L ++ KG L D + +K K
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT--EKVALSEKET--------RSI 205
Query: 173 VKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS 232
++ + A + +LH I+HR++K N+LL D+ ++SDF S
Sbjct: 206 MRSLLEA---VSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GEKLR 257
Query: 233 TRVLGTFGYHAPE------YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT GY APE + D+++ GV+L LL G P
Sbjct: 258 ELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 62/259 (23%), Positives = 103/259 (39%), Gaps = 43/259 (16%)
Query: 43 MKTVTVQPIAVPVISVDELKEKTDNFGTN----SLIGEGSYGRVYFGVLRS-GRAAAIKK 97
M+TV V I +L + F IG GSY + ++ A+K
Sbjct: 1 MQTVGVHSIVQ------QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI 54
Query: 98 LDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHD-ILHGK 155
+D SK+ E ++ ++ R N++ L Y DG + E G L D IL +
Sbjct: 55 IDKSKRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL--R 109
Query: 156 KGV---KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-- 210
+ + A + + +EYLH + ++HR++K SN+L D+
Sbjct: 110 QKFFSEREA--------SAVLFTITKT---VEYLHAQ---GVVHRDLKPSNILYVDESGN 155
Query: 211 --IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLE 267
+I DF + Q L T T + APE + Q + D++S GV+L
Sbjct: 156 PESIRICDFGFAKQLRAENGLLM-TPC-YTANFVAPE-VLERQGYDAACDIWSLGVLLYT 212
Query: 268 LLTGRKPVDHTLPRGQQSL 286
+LTG P + + +
Sbjct: 213 MLTGYTPFANGPDDTPEEI 231
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 50/239 (20%), Positives = 89/239 (37%), Gaps = 44/239 (18%)
Query: 56 ISVDELKEKTDNFG-----TNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFL 109
+ + K + ++G G G+V R G+ A+K L S + QE
Sbjct: 14 VLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE-- 71
Query: 110 AQVSMVSRLKN-ENVVELVGYYVDGPLRVLAY----EHASKGSLHD-ILHGKKGVKG--- 160
V + ++V ++ Y + E G L I ++G +
Sbjct: 72 --VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ--ERGDQAFTE 127
Query: 161 --AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKIS 215
A A+ ++ A +++LH I HR++K N+L + + K++
Sbjct: 128 REA--------AEIMRDIGTA---IQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLT 173
Query: 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
DF + + A + T T Y APE + D++S GV++ LL G P
Sbjct: 174 DFGFAKETTQNALQ---TPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 53/224 (23%), Positives = 103/224 (45%), Gaps = 47/224 (20%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLA--QVSMVSRLKNENVVEL 126
IG+G++G V+ ++G+ A+KK +++ K+ P A ++ ++ LK+ENVV L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP---ITALREIKILQLLKHENVVNL 81
Query: 127 VGYYVDGPLRVLAYEHASKGSL--------HDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ + KGS+ HD+ G+ + ++ ++
Sbjct: 82 IEICRTKASP----YNRCKGSIYLVFDFCEHDL----AGLLSNVLVK-FTLSEIKRVMQM 132
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRV 235
GL Y+H +I+HR++K++NVL+ D + K++DF L+ + A ++ ++ RV
Sbjct: 133 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189
Query: 236 LGTFGYHAPE-------YAMTGQMSSKSDVYSFGVVLLELLTGR 272
+ T Y PE Y D++ G ++ E+ T
Sbjct: 190 V-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 48/210 (22%), Positives = 89/210 (42%), Gaps = 26/210 (12%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKNENVVELVGY 129
+G+G++ V V ++ G A K +++ K D + L + + +L++ N+V L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 130 YVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
+ L ++ + G L + + A + ++ + + + Y H
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADA--------SHCIQQILES---IAYCH 145
Query: 188 EKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
I+HRN+K N+LL K++DF L+ + D + GT GY +P
Sbjct: 146 SN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFA-GTPGYLSP 199
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
E S D+++ GV+L LL G P
Sbjct: 200 EVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 4e-14
Identities = 30/113 (26%), Positives = 54/113 (47%), Gaps = 4/113 (3%)
Query: 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
L+ + + A+G+E+L + + IHR++ + N+LL + ++ KI DF L+
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD 242
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274
+ + APE + +SDV+SFGV+L E+ + G P
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 4e-14
Identities = 41/205 (20%), Positives = 83/205 (40%), Gaps = 19/205 (9%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD 132
+G G +G V+ V S + K + ++S+++ ++ N++ L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192
V+ +E S + + ++ L+ + V L++LH
Sbjct: 73 MEELVMIFEFISGLDIFERINTS--------AFELNEREIVSYVHQVCEALQFLHSH--- 121
Query: 193 RIIHRNIKSSNVLLFDDDIA--KISDFDLSNQ-APDAAARLHSTRVLGTFGYHAPEYAMT 249
I H +I+ N++ + KI +F + Q P RL + Y+APE
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL----LFTAPEYYAPEVHQH 177
Query: 250 GQMSSKSDVYSFGVVLLELLTGRKP 274
+S+ +D++S G ++ LL+G P
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINP 202
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-14
Identities = 65/274 (23%), Positives = 109/274 (39%), Gaps = 62/274 (22%)
Query: 24 NNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVY 83
P+ ++ ++ TV P P + + ++ +IG GS+G VY
Sbjct: 18 QQPSAFGSMKVSRDKDGSKVTTVVATPGQGP------DRPQEVSYTDTKVIGNGSFGVVY 71
Query: 84 FGVLR-SGRAAAIKKLDSSKQPDQEF-LAQVSMVSRLKNENVVELVGY-YVDGPLRV--- 137
L SG AIKK+ D+ F ++ ++ +L + N+V L + Y G +
Sbjct: 72 QAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127
Query: 138 --LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK-----IAVGAARGLEYLHEKA 190
L ++ + +++ + + + + PV+ VK + R L Y+H
Sbjct: 128 LNLVLDYVPE-TVYRVA--RHYSRAKQTLPVI----YVKLYMYQLF----RSLAYIHSF- 175
Query: 191 EPRIIHRNIKSSNVLLFDD-DIAKISDFDLSNQAPDAAARLHS----------TRVLGTF 239
I HR+IK N+LL D + K+ DF A+ +R
Sbjct: 176 --GICHRDIKPQNLLLDPDTAVLKLCDFGS--------AKQLVRGEPNVSYICSRY---- 221
Query: 240 GYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE + S DV+S G VL ELL G+
Sbjct: 222 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 5e-14
Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 30/212 (14%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLKNENVVELVGY 129
+G+G++ V V ++ G A K +++ K D + L + + +L++ N+V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 130 YVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVGAARGLEY 185
+ L ++ + G L + I+ + A + ++ + + + Y
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIV--AREFYSEADA--------SHCIQQILES---IAY 120
Query: 186 LHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
H I+HRN+K N+LL K++DF L+ + D + GT GY
Sbjct: 121 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFA-GTPGYL 174
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+PE S D+++ GV+L LL G P
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 7e-14
Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 51/222 (22%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVG 128
IGEG+YG V+ + A+K+ LD + P L ++ ++ LK++N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA-LREICLLKELKHKNIVRL-- 66
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGV-----------KG--AKPGPVLSWAQRVKI 175
HD+LH K + K L
Sbjct: 67 --------------------HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF 106
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN--QAPDAAARLHST 233
+GL + H + ++HR++K N+L+ + K+++F L+ P R +S
Sbjct: 107 LFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---RCYSA 160
Query: 234 RVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
V+ T Y P+ ++ S S D++S G + EL +P
Sbjct: 161 EVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 7e-14
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGY 129
IGEG+YG VY G A+KK L+ + P + ++S++ LK+ N+V+L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT-IREISILKELKHSNIVKLYDV 68
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
VL +EH D+ K + G L + G+ Y H++
Sbjct: 69 IHTKKRLVLVFEHLD----QDL----KKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDR 119
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN--QAPDAAARLHSTRVLGTFGYHAPEYA 247
R++HR++K N+L+ + KI+DF L+ P R ++ ++ T Y AP+
Sbjct: 120 ---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---RKYTHEIV-TLWYRAPDVL 172
Query: 248 MTGQMSSKS-DVYSFGVVLLELLTGR 272
M + S + D++S G + E++ G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 8e-14
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGY 129
+GEG+YG VY GR A+K+ LD+ + P + ++S++ L + N+V L+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA-IREISLLKELHHPNIVSLIDV 87
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
L +E D+ K V L +Q RG+ + H+
Sbjct: 88 IHSERCLTLVFEFME----KDL----KKVLDENKTG-LQDSQIKIYLYQLLRGVAHCHQH 138
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ--APDAAARLHSTRVLGTFGYHAPEYA 247
RI+HR++K N+L+ D K++DF L+ P R ++ V+ T Y AP+
Sbjct: 139 ---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV---RSYTHEVV-TLWYRAPDVL 191
Query: 248 MTGQMSSKS-DVYSFGVVLLELLTGR 272
M + S S D++S G + E++TG+
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 39/218 (17%)
Query: 74 IGEGSYGRVYFG--VLRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKN---ENVV 124
IGEG+YG+V+ + GR A+K+ + + ++ P + +V+++ L+ NVV
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST-IREVAVLRHLETFEHPNVV 77
Query: 125 EL----VGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
L D ++ L +EH D+ P P + +
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVD----QDL----TTYLDKVPEPGVPTETIKDMMFQL 129
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHS-----TR 234
RGL++LH R++HR++K N+L+ K++DF L AR++S T
Sbjct: 130 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------ARIYSFQMALTS 178
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
V+ T Y APE + ++ D++S G + E+ +
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 4e-13
Identities = 51/236 (21%), Positives = 96/236 (40%), Gaps = 52/236 (22%)
Query: 60 ELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQPDQEF----LAQV 112
++K + + +GEG + VY + + AIKK L + L ++
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 113 SMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGV-----------KG- 160
++ L + N++ L D K + +
Sbjct: 64 KLLQELSHPNIIGL----------------------LDAFGHKSNISLVFDFMETDLEVI 101
Query: 161 -AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219
VL+ + + +GLEYLH+ I+HR++K +N+LL ++ + K++DF L
Sbjct: 102 IKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL 158
Query: 220 SNQ--APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
+ +P+ R ++ +V+ T Y APE +M D+++ G +L ELL
Sbjct: 159 AKSFGSPN---RAYTHQVV-TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 5e-13
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 27/220 (12%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE-NV 123
D F ++G G +G V+ ++ +G+ A KKL+ ++ L + E +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN------KKRLKKRKGYQGAMVEKKI 238
Query: 124 VELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKG-------VKGAKPGPVLSWAQRVKI 175
+ V V LAY +K L ++ G + P + +
Sbjct: 239 LAKV----HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
GLE+LH++ II+R++K NVLL DD +ISD L+ + +
Sbjct: 295 TAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK-GYA 350
Query: 236 LGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
GT G+ APE + G+ S D ++ GV L E++ R P
Sbjct: 351 -GTPGFMAPE-LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 6e-13
Identities = 49/224 (21%), Positives = 87/224 (38%), Gaps = 31/224 (13%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSR------ 117
D + T +G G + V +S G A K + + + R
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 118 -LKNENVVELVGYYVDGPLRVLAYEHASKGSLHD--ILHGKKGVKGAKPGPVLSWAQRVK 174
+++ NV+ L Y + +L E + G L D + A + +K
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA--------TEFLK 121
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQAPDAAARL 230
+ + YLH +I H ++K N++L D ++ KI DF L+++ D
Sbjct: 122 QILNG---VYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEF 174
Query: 231 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ GT + APE + ++D++S GV+ LL+G P
Sbjct: 175 --KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-13
Identities = 52/213 (24%), Positives = 85/213 (39%), Gaps = 27/213 (12%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSR-------LKNENVVE 125
+G G + V +S G A K + + + R + + N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L Y + VL E S G L D L K+ LS + G+ Y
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNY 130
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQAPDAAARLHSTRVLGTFGY 241
LH K +I H ++K N++L D +I K+ DF L+++ D + GT +
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEF 184
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE + ++D++S GV+ LL+G P
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-13
Identities = 60/280 (21%), Positives = 100/280 (35%), Gaps = 41/280 (14%)
Query: 13 RKASKNGPFVPNNPAGNPGGFYVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDN---FG 69
+ S PF P P + PA+ Q V S ++K+
Sbjct: 6 QGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKV 65
Query: 70 TNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELV 127
T+ ++G G G+V + + A+K L + +E V + R ++V +V
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVRIV 121
Query: 128 GYYVDGPLRVLAY----EHASKGSLHD-ILHGKKGVKG-----AKPGPVLSWAQRVKIAV 177
Y + E G L I +G + A ++ +K
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREA--------SEIMKSIG 171
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTR 234
A ++YLH I HR++K N+L I K++DF + + +T
Sbjct: 172 EA---IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTP 223
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
T Y APE + D++S GV++ LL G P
Sbjct: 224 C-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 7e-13
Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 37/219 (16%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-------DQEFLAQ-----VSMVSRLKNE 121
I GSYG V GV G AIK++ ++ FL + + +++ +
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 122 NVVELVGYYVDGPLRV-------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
N++ L + L E L ++H ++ V+S
Sbjct: 90 NILGL--RDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQR--------IVISPQHIQY 138
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
GL LHE ++HR++ N+LL D++ I DF+L+ + A + T
Sbjct: 139 FMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTH 192
Query: 235 VLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
+ Y APE M + +K D++S G V+ E+ +
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 7e-13
Identities = 41/224 (18%), Positives = 83/224 (37%), Gaps = 38/224 (16%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN- 120
D++ +G G Y V+ + + + +K L K ++ ++ ++ L+
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGG 90
Query: 121 ENVVELVGYYVDGPLRVLAY--EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
N++ L D R A EH + + L+
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------------QTLTDYDIRFYMYE 138
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHST---- 233
+ L+Y H I+HR++K NV++ + ++ D+ L A +
Sbjct: 139 ILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL--------AEFYHPGQEY 187
Query: 234 --RVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
RV + + PE + QM S D++S G +L ++ ++P
Sbjct: 188 NVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE-NV 123
+ F ++G+G +G V +R +G+ A KKL+ ++ + + + NE +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE------KKRIKKRKGEAMALNEKQI 237
Query: 124 VELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV---GA 179
+E V + V LAY + +K +L +L G G + + A
Sbjct: 238 LEKV----NSRFVVSLAYAYETKDALCLVLTLMNG------GDLKFHIYHMGQAGFPEAR 287
Query: 180 AR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH 231
A GLE LH + RI++R++K N+LL D +ISD L+ P+ +
Sbjct: 288 AVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTI 342
Query: 232 STRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
RV GT GY APE + + + S D ++ G +L E++ G+ P
Sbjct: 343 KGRV-GTVGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-12
Identities = 49/217 (22%), Positives = 90/217 (41%), Gaps = 35/217 (16%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSR-------LKNENVVE 125
+G G + V + G+ A K + + + R +++ N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHD-ILHGKKGV---KGAKPGPVLSWAQRVKIAVGAAR 181
L + + VL E S G L D + +K A Q +K +
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLA--EKESLTEDEA--------TQFLKQILD--- 119
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQAPDAAARLHSTRVLG 237
G+ YLH K RI H ++K N++L D ++ K+ DF ++++ +A + + G
Sbjct: 120 GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGNEFKN--IFG 173
Query: 238 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
T + APE + ++D++S GV+ LL+G P
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 45/237 (18%), Positives = 83/237 (35%), Gaps = 50/237 (21%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEF-LAQVSMVSRLKNENVVELVGYYV 131
+G GS+G V SG+ A+KK+ D + ++ ++ L + N+++LV Y+
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKV----LQDPRYKNRELDIMKVLDHVNIIKLVDYFY 70
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWA----------------QRVKI 175
K V + +K
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 176 AVGAA----------------RGLEYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISDFD 218
+ + R + ++H I HR+IK N+L+ D+ K+ DF
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 219 LSNQAPDAAARLH--STRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
+ + + + +R Y APE + + S D++S G V EL+ G+
Sbjct: 188 SAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE------FLAQVSMVSRLKNENVVEL 126
+G G+Y VY G+ +G A+K++ + D E + ++S++ LK+EN+V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 127 VGYYVDGPLRVLAYEHASK--GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
L +E D +G + V + ++ +GL
Sbjct: 69 YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL------LQGLA 122
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
+ HE +I+HR++K N+L+ K+ DF L+ +A S+ V+ T Y AP
Sbjct: 123 FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA-RAFGIPVNTFSSEVV-TLWYRAP 177
Query: 245 E-------YAMTGQMSSKSDVYSFGVVLLELLTGR 272
+ Y S+ D++S G +L E++TG+
Sbjct: 178 DVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 52/214 (24%), Positives = 85/214 (39%), Gaps = 29/214 (13%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSR-------LKNENVVE 125
+G G + V +S G A K + + + R + + NV+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L Y + VL E S G L D L K+ LS + G+ Y
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNY 130
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQ-APDAAARLHSTRVLGTFG 240
LH K +I H ++K N++L D +I K+ DF L+++ + + GT
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN----IFGTPE 183
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ APE + ++D++S GV+ LL+G P
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 3e-12
Identities = 50/224 (22%), Positives = 93/224 (41%), Gaps = 44/224 (19%)
Query: 66 DNFGTNSLIGEGSYGRVYFG-VLRSGRAAAIKK--LDSSKQPDQEFLAQVSMVSRLKNEN 122
+ + +GEG+Y VY G + A+K+ L+ + + +VS++ LK+ N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGV-----------KG--AKPGPVLSW 169
+V L HDI+H +K + K G +++
Sbjct: 62 IVTL----------------------HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINM 99
Query: 170 AQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR 229
RGL Y H + +++HR++K N+L+ + K++DF L+ +A +
Sbjct: 100 HNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTK 155
Query: 230 LHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
+ V+ T Y P+ + S D++ G + E+ TGR
Sbjct: 156 TYDNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-12
Identities = 51/252 (20%), Positives = 94/252 (37%), Gaps = 42/252 (16%)
Query: 39 PAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKK 97
P M +++ D F + G+G++G V G + +G + AIKK
Sbjct: 2 PGSMMSLNAAAAADERS------RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK 55
Query: 98 LDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR--------VLAYEHASKGSLH 149
+ + L + ++ L + N+V+L Y + E+ +LH
Sbjct: 56 VIQDPRFRNRELQIMQDLAVLHHPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPD-TLH 113
Query: 150 DILHGKKGVKGAKPGPVLSWAQRVK-----IAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204
+ A P +K + R + LH + + HR+IK NV
Sbjct: 114 RCCRNYYRRQVAPP------PILIKVFLFQLI----RSIGCLHLPS-VNVCHRDIKPHNV 162
Query: 205 LLFDDD-IAKISDFDLSNQAPDAAARLH--STRVLGTFGYHAPEYAMTGQMSSKS-DVYS 260
L+ + D K+ DF + + + + +R Y APE Q + + D++S
Sbjct: 163 LVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-----YRAPELIFGNQHYTTAVDIWS 217
Query: 261 FGVVLLELLTGR 272
G + E++ G
Sbjct: 218 VGCIFAEMMLGE 229
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 5e-12
Identities = 48/214 (22%), Positives = 90/214 (42%), Gaps = 31/214 (14%)
Query: 74 IGEGSYGRVYFGVLRS-GRAAAIKKLDSSK--QPDQEFLAQ-VSMVSRLK-NENVVELVG 128
+G G + V + +S G+ A K L + Q + + ++++ K V+ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 129 YYVDGPLRVLAYEHASKGSLHD-ILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR----GL 183
Y + +L E+A+ G + L + ++S + + G+
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCL--------PELAEMVS----ENDVIRLIKQILEGV 144
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDDIA---KISDFDLSNQAPDAAARLHSTRVLGTFG 240
YLH+ I+H ++K N+LL KI DF +S + A L ++GT
Sbjct: 145 YYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELRE--IMGTPE 198
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE +++ +D+++ G++ LLT P
Sbjct: 199 YLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L+YL + RIIHR++K N+LL + I+DF+++ P +T + GT Y
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT-MAGTKPY 180
Query: 242 HAPE--YAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + G S + D +S GV ELL GR+P
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 6e-12
Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 23/206 (11%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLKNENVVELVG- 128
IGEGSYG V+ +G+ AIKK S+ L ++ M+ +LK+ N+V L+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHG-KKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
+ L L +E+ H +LH + +G V S + + + + H
Sbjct: 71 FRRKRRL-HLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQT------LQAVNFCH 119
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA 247
+ IHR++K N+L+ + K+ DF + + + + V T Y +PE
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGFA-RLLTGPSDYYDDEVA-TRWYRSPELL 174
Query: 248 MTGQMSSKS-DVYSFGVVLLELLTGR 272
+ DV++ G V ELL+G
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-12
Identities = 55/232 (23%), Positives = 100/232 (43%), Gaps = 45/232 (19%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLD-----SSKQPDQEFLAQVSMV 115
K++ ++F ++GEGS+ V + R AIK L+ + + ++
Sbjct: 26 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVM 84
Query: 116 SRLKNENVVELVGYYVDGPLR---VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
SRL + V+L + D + L+Y K G +L + ++
Sbjct: 85 SRLDHPFFVKLYFTFQD-DEKLYFGLSY-----------------AKN---GELLKYIRK 123
Query: 173 V-KIAVGAAR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223
+ R LEYLH K IIHR++K N+LL +D +I+DF +
Sbjct: 124 IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL 180
Query: 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
+ + + +GT Y +PE +T + + KS D+++ G ++ +L+ G P
Sbjct: 181 SPESKQARANSFVGTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 7e-12
Identities = 47/219 (21%), Positives = 94/219 (42%), Gaps = 35/219 (15%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNENVVELVGYYV 131
+G G G V+ V + AIKK+ + + L ++ ++ RL ++N+V++ + +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKV--FEI 76
Query: 132 DGPLRVLAYEHASKGS---------------LHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
GP + + L ++L L
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP----------LLEEHARLFM 126
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLS-NQAPDAAARLHSTR 234
RGL+Y+H ++HR++K +N+ + +D + KI DF L+ P + + H +
Sbjct: 127 YQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 235 VLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
L T Y +P ++ +K+ D+++ G + E+LTG+
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 21/216 (9%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEF----LAQVSMVSR 117
+ + + L+GEGSYG V +GR AIKK S D+ + ++ ++ +
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQ 80
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
L++EN+V L+ L +E ++ D L G V + ++
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPN--GLDYQVVQKYLFQI---- 133
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
G+ + H IIHR+IK N+L+ + K+ DF + + A ++ V
Sbjct: 134 --INGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFA-RTLAAPGEVYDDEVA- 186
Query: 238 TFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
T Y APE + K+ DV++ G ++ E+ G
Sbjct: 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 36/213 (16%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
+G G+YG V ++G A+KKL S+ A+ + ++ +K+ENV+ L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGL- 93
Query: 128 GYYVDGPLRVLA-------YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
V P R L H L++I+ +K L+ +
Sbjct: 94 -LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQIL 142
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
RGL+Y+H IIHR++K SN+ + +D KI DF L+ D +TR
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----- 194
Query: 241 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE + +++ D++S G ++ ELLTGR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 49/213 (23%), Positives = 85/213 (39%), Gaps = 36/213 (16%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
IG G+ G V R AIKKL S+ + A+ + ++ + ++N++ L
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIIGL- 89
Query: 128 GYYVDGPLRV--------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
V P + + E +L ++ + L + +
Sbjct: 90 -LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME-----------LDHERMSYLLYQM 136
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
G+++LH IIHR++K SN+++ D KI DF L A A T + T
Sbjct: 137 LCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTR 190
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
Y APE + D++S G ++ E++ G
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 3e-11
Identities = 48/213 (22%), Positives = 86/213 (40%), Gaps = 36/213 (16%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
IG G+ G V R AIKKL S+ + A+ + ++ + ++N++ L
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIISL- 126
Query: 128 GYYVDGPLRV--------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
V P + L E +L ++ + L + +
Sbjct: 127 -LNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQM 173
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
G+++LH IIHR++K SN+++ D KI DF L+ A + T + T
Sbjct: 174 LCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTR 227
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
Y APE + D++S G ++ E++ +
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 49/225 (21%), Positives = 85/225 (37%), Gaps = 57/225 (25%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK--LDSSKQ--PDQEFLAQVSMVSRLKNENVVELVG 128
+GEG+YG VY + + AIK+ L+ ++ P + +VS++ L++ N++EL
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA-IREVSLLKELQHRNIIEL-- 98
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGV------------KGAKPGPVLSWAQRVKIA 176
++H + K P +S
Sbjct: 99 --------------------KSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFL 138
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA------KISDFDL--SNQAPDAAA 228
G+ + H + R +HR++K N LL A KI DF L + P
Sbjct: 139 YQLINGVNFCHSR---RCLHRDLKPQN-LLLSVSDASETPVLKIGDFGLARAFGIPI--- 191
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
R + ++ T Y PE + + S S D++S + E+L
Sbjct: 192 RQFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 36/213 (16%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
+G G+YG V V R+G AIKKL + E A+ + ++ +++ENV+ L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLKHMRHENVIGL- 89
Query: 128 GYYVDGPLRVLA-------YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
V P L L ++ +K L + +
Sbjct: 90 -LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----------LGEDRIQFLVYQML 138
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GL Y+H IIHR++K N+ + +D KI DF L+ QA TR
Sbjct: 139 KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----- 190
Query: 241 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE + +++ D++S G ++ E++TG+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 37/213 (17%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
+G G+YG V + RSG AIKKL S+ E A+ + ++ +++ENV+ L
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLKHMQHENVIGL- 88
Query: 128 GYYVDGPLRVLA-------YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
V P L + L I+ K S + +
Sbjct: 89 -LDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK-----------FSEEKIQYLVYQML 136
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GL+Y+H ++HR++K N+ + +D KI DF L+ A TR
Sbjct: 137 KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW----- 188
Query: 241 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE ++ +++ D++S G ++ E+LTG+
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 36/215 (16%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQP-DQEFLAQ-----VSMVSRLKNENVVEL 126
IGEG+YG V + AIKK+ P + + Q + ++ R ++EN++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKIS----PFEHQTYCQRTLREIKILLRFRHENIIGI 90
Query: 127 VGYYVDGPLRV-------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+ + + + L+ +L + LS
Sbjct: 91 --NDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH----------LSNDHICYFLYQI 137
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS-NQAPDAAARLHSTRVLGT 238
RGL+Y+H A ++HR++K SN+LL KI DF L+ PD T + T
Sbjct: 138 LRGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 239 FGYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE + + +KS D++S G +L E+L+ R
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 50/237 (21%), Positives = 92/237 (38%), Gaps = 37/237 (15%)
Query: 54 PVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLA 110
+ + +L+ K +++ +IG G++G V ++R + + A+K L + +
Sbjct: 57 TINKIRDLRMKAEDYEVVKVIGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFE------MI 108
Query: 111 QVSMVSRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSW 169
+ S + E + + + + P V L Y L+ ++ G G +++
Sbjct: 109 KRSDSAFFWEERDI-MA--FANSPWVVQLFYAFQDDRYLYMVMEYMPG------GDLVNL 159
Query: 170 AQRVKIAVGAAR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221
+ AR L+ +H IHR++K N+LL K++DF
Sbjct: 160 MSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 216
Query: 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSK----SDVYSFGVVLLELLTGRKP 274
+ T V GT Y +PE + D +S GV L E+L G P
Sbjct: 217 KMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 6e-10
Identities = 52/212 (24%), Positives = 81/212 (38%), Gaps = 25/212 (11%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYV 131
IG GS+G +Y G + +G AIK + K + + + ++ + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 75
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
+G V+ E SL D L K S + +A +EY+H K
Sbjct: 76 EGDYNVMVMELLGP-SLED-LFNFCSRK-------FSLKTVLLLADQMISRIEYIHSK-- 124
Query: 192 PRIIHRNIKSSNVLLFDDDIAK---ISDFDLSNQAPDAAARLH-----STRVLGTFGYHA 243
IHR++K N L+ I DF L+ + DA H + + GT Y A
Sbjct: 125 -NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-A 182
Query: 244 PEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 274
G + S + D+ S G VL+ G P
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 6e-10
Identities = 49/237 (20%), Positives = 96/237 (40%), Gaps = 40/237 (16%)
Query: 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVS 113
V +++ ++F +IG G++G V V++ + + A+K L +K + + +
Sbjct: 65 KVKQMRLHREDFEILKVIGRGAFGEVA--VVKLKNADKVFAMKIL--NKW----EMLKRA 116
Query: 114 MVSRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
+ + E V LV D L Y +L+ ++ G G +L+ +
Sbjct: 117 ETACFREERDV-LV--NGDSKWITTLHYAFQDDNNLYLVMDYYVG------GDLLTLLSK 167
Query: 173 V--KIAVGAAR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
++ AR ++ +H+ +HR+IK N+L+ + +++DF +
Sbjct: 168 FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLK 224
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKS-----DVYSFGVVLLELLTGRKP 274
+ S V GT Y +PE + D +S GV + E+L G P
Sbjct: 225 LMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 7e-10
Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L+YLH + +++R++K N++L D KI+DF L + A + + GT Y
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 315
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + ++ D + GVV+ E++ GR P
Sbjct: 316 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 9e-10
Identities = 50/239 (20%), Positives = 95/239 (39%), Gaps = 38/239 (15%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVS 113
V+ + E++ + D+F +IG G++ V ++ +G+ A+K + +K + +
Sbjct: 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM--NKW----DMLKRG 103
Query: 114 MVSRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR 172
VS + E V LV D L + + L+ ++ G G +L+ +
Sbjct: 104 EVSCFREERDV-LV--NGDRRWITQLHFAFQDENYLYLVMEYYVG------GDLLTLLSK 154
Query: 173 V--KIAVGAAR--------GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
+I AR ++ +H +HR+IK N+LL +++DF +
Sbjct: 155 FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLK 211
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVY-------SFGVVLLELLTGRKP 274
A + S +GT Y +PE + Y + GV E+ G+ P
Sbjct: 212 L-RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 1e-09
Identities = 36/96 (37%), Positives = 58/96 (60%), Gaps = 11/96 (11%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAARLHSTRVLGTF 239
L++LH II+R++K N+LL D++ I K++DF LS ++ D + +S GT
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILL-DEEGHI-KLTDFGLSKESIDHEKKAYS--FCGTV 190
Query: 240 GYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
Y APE + + ++S D +SFGV++ E+LTG P
Sbjct: 191 EYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 2e-09
Identities = 28/96 (29%), Positives = 51/96 (53%), Gaps = 11/96 (11%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAARLHSTRVLGTF 239
L +LH+K II+R++K N++L + + K++DF L ++ H+ GT
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIML-NHQGHV-KLTDFGLCKESIHDGTVTHT--FCGTI 185
Query: 240 GYHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
Y APE + +++ D +S G ++ ++LTG P
Sbjct: 186 EYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 12/101 (11%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
R ++ LH +IHR++K SN+L+ + K+ DF L+ ++AA +
Sbjct: 123 RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 241 --------YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE +T S++ DV+S G +L EL R
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
LEYLH + +++R+IK N++L D KI+DF L + A + + GT Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEY 171
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + ++ D + GVV+ E++ GR P
Sbjct: 172 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L YLHE+ II+R++K NVLL + K++D+ + + + GT Y
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNY 176
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + G+ S D ++ GV++ E++ GR P
Sbjct: 177 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 55.3 bits (132), Expect = 6e-09
Identities = 42/248 (16%), Positives = 76/248 (30%), Gaps = 54/248 (21%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKL---------DSSKQPDQEFLAQVSMV 115
T+ IGEG +G V+ + AIK + S ++ +E L ++ +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 116 SRLKN---------ENVVELVGYY-VDGP-----LRVLAYEHASKGSLHDILHGKKGVKG 160
L E + L + V G L+ + +++KGS +D K +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 161 --------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206
+ S A I L R HR++ NVLL
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNVLL 195
Query: 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP--EYAMTGQMSSKSDVYSFGVV 264
+ K+ + + + G +Y ++ V+ +
Sbjct: 196 KKTSLKKLHYTLNGK-----------SSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSM 244
Query: 265 LLELLTGR 272
+L TG
Sbjct: 245 DEDLFTGD 252
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-09
Identities = 45/216 (20%), Positives = 75/216 (34%), Gaps = 59/216 (27%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYV 131
+G G G+V + + A+K L + +E V + R + ++V +V Y
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVRIVDVYE 81
Query: 132 DGPLRVLAY----EHASKGSLHD-ILHGKKGVKG-----AKPGPVLSWAQRVKIAVGAAR 181
+ E G L I +G + A ++ +K A
Sbjct: 82 NLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREA--------SEIMKSIGEA-- 129
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLHSTRVLGT 238
++YLH I HR++K N+L I K++DF A + G
Sbjct: 130 -IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF---AKE---------TTGE 173
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y D++S GV++ LL G P
Sbjct: 174 -KY-----------DKSCDMWSLGVIMYILLCGYPP 197
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L +LH+K II+R++K NVLL + K++DF + + + GT Y
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDY 190
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + + + D ++ GV+L E+L G P
Sbjct: 191 IAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L YLHE+ II+R++K NVLL + K++D+ + + + GT Y
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNY 219
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + G+ S D ++ GV++ E++ GR P
Sbjct: 220 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 36/94 (38%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL++LH K I++R++K N+LL D KI+DF + + A+ ++ GT Y
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDY 184
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + GQ + S D +SFGV+L E+L G+ P
Sbjct: 185 IAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
L YLH I++R++K N+LL ++DF L + + + + GT Y
Sbjct: 151 ALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEY 205
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + Q ++ D + G VL E+L G P
Sbjct: 206 LAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL +L K II+R++K NV+L + KI+DF + + + GT Y
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDY 508
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + Q KS D ++FGV+L E+L G+ P
Sbjct: 509 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 48/249 (19%), Positives = 90/249 (36%), Gaps = 56/249 (22%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
IG GSYG V R AIKK+ + + + +++++RL +++VV++
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKI--LRVFEDLIDCKRILREIAILNRLNHDHVVKV- 117
Query: 128 GYYVDGPLRV-------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+ P V + E A + + L+ +
Sbjct: 118 -LDIVIPKDVEKFDELYVVLEIADS-DFKKLF---------RTPVYLTELHIKTLLYNLL 166
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS---NQAPDAAARLHSTRVLG 237
G++Y+H I+HR++K +N L+ D K+ DF L+ + + ++L +
Sbjct: 167 VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 238 TFG----------------------YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
Y APE + + +++ DV+S G + ELL K
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
Query: 275 VDHTLPRGQ 283
Sbjct: 284 NVAYHADRG 292
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL +L K II+R++K NV+L + KI+DF + + + GT Y
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDY 187
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + Q KS D ++FGV+L E+L G+ P
Sbjct: 188 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-08
Identities = 47/216 (21%), Positives = 79/216 (36%), Gaps = 31/216 (14%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKK-LDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
IGEGS+G ++ G L + + AIK S P + + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT-YKLLAGCTGIPNVYYFGQ 76
Query: 132 DGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+G VL + SL D+L G+K S A ++ +HEK
Sbjct: 77 EGLHNVLVIDLLGP-SLEDLLDLCGRK----------FSVKTVAMAAKQMLARVQSIHEK 125
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAK-----ISDFDLSNQAPDAAARLH-----STRVLGTF 239
+ +++R+IK N L+ + + DF + D + H + GT
Sbjct: 126 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 240 GYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 274
Y G + S + D+ + G V + L G P
Sbjct: 183 RY-MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 7e-08
Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 12/98 (12%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQA-PDAAARLHSTRVLGT 238
LE+LH+ II+R+IK N+LL D + + ++DF LS + D R + GT
Sbjct: 171 ALEHLHKLG---IIYRDIKLENILL-DSNGHV-VLTDFGLSKEFVADETERAYD--FCGT 223
Query: 239 FGYHAPEYAMTGQMS-SKS-DVYSFGVVLLELLTGRKP 274
Y AP+ G K+ D +S GV++ ELLTG P
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 9e-08
Identities = 47/279 (16%), Positives = 89/279 (31%), Gaps = 61/279 (21%)
Query: 35 VKEAPAKEMKTVT---VQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGR 91
VK A A + + AV I D + IG+G +G +Y + S
Sbjct: 4 VKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAA---WKVGLPIGQGGFGCIYLADMNSSE 60
Query: 92 AAAIK-----KLDSSKQPDQEF-------LAQVSMVSRLKNENVVELVG----------Y 129
+ K++ S A+ + + ++ +G
Sbjct: 61 SVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHD 120
Query: 130 YVDGPLRVLAYEHASKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
R + + L I + K+ S +++++ LEY+H
Sbjct: 121 KNGKSYRFMIMDRFGS-DLQKIYEANAKR----------FSRKTVLQLSLRILDILEYIH 169
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKI--SDFDLSNQAPDAAARLH-----STRVLGTFG 240
E +H +IK+SN+LL + ++ D+ L+ + GT
Sbjct: 170 EH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGT-- 224
Query: 241 YHAPEYA-----MTGQMSSKSDVYSFGVVLLELLTGRKP 274
E+ S + D+ G +++ LTG P
Sbjct: 225 ---IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 25/212 (11%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYV 131
IG GS+G +Y G +++ AIK ++ K + L + + L+ + + + V
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV 73
Query: 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE 191
+G VL + SL D L K LS + +A +E++H K+
Sbjct: 74 EGDYNVLVMDLLGP-SLED-LFNFCSRK-------LSLKTVLMLADQMINRVEFVHSKS- 123
Query: 192 PRIIHRNIKSSNVLL---FDDDIAKISDFDLSNQAPDAAARLH-----STRVLGTFGYHA 243
+HR+IK N L+ + I DF L+ + D + H + + GT Y A
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-A 180
Query: 244 PEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 274
G + S + D+ S G VL+ L G P
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 45/215 (20%), Positives = 78/215 (36%), Gaps = 29/215 (13%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD 132
IG G++G + G L + AIK + Q L + + ++ +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC 76
Query: 133 GPLRVLAYEHASKGSLHDI--LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
G + E SL D+ L + S + IA+ +EY+H K
Sbjct: 77 GKYNAMVLELLGP-SLEDLFDLCDRT----------FSLKTVLMIAIQLISRMEYVHSKN 125
Query: 191 EPRIIHRNIKSSNVLL-----FDDDIAKISDFDLSNQAPDAAARLH-----STRVLGTFG 240
+I+R++K N L+ + I DF L+ + D + H + GT
Sbjct: 126 ---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTAR 182
Query: 241 YHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKP 274
Y G + S + D+ + G + + L G P
Sbjct: 183 Y-MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 2e-07
Identities = 37/241 (15%), Positives = 71/241 (29%), Gaps = 71/241 (29%)
Query: 34 YVKEAPAKEMKTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGS-YGRVY--FGVLRSG 90
+V K+ VQ + ++S +E+ +I F L S
Sbjct: 29 FVDNFDCKD-----VQDMPKSILSKEEIDH---------IIMSKDAVSGTLRLFWTLLSK 74
Query: 91 RAAAIKK-LDSSKQPDQEFLAQ----------------VSMVSRLKNENVVELVGYYVDG 133
+ ++K ++ + + +FL + RL N+N V Y V
Sbjct: 75 QEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV-FAKYNVSR 133
Query: 134 P-----LRVLAYEHASKGSLHDILHGKKG---------------VKGAKPGPVLSWAQRV 173
LR E ++ ++ G G V+ + W
Sbjct: 134 LQPYLKLRQALLELRPAKNV--LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF-W---- 186
Query: 174 KIAVGAARG-------LEYLHEKAEPRIIHRNIKSSNV-LLFDDDIAKISDFDLSNQAPD 225
+ + L+ L + +P R+ SSN+ L A++ S +
Sbjct: 187 -LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN 245
Query: 226 A 226
Sbjct: 246 C 246
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 42/223 (18%), Positives = 89/223 (39%), Gaps = 37/223 (16%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN---------- 120
+G G + V+ + + A+K + K + ++ ++ R+ +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 121 -ENVVELVGY-YVDGPLR---VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
++++L+ + GP V+ +E + +L ++ + + +I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRG-------IPLIYVKQI 136
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA------KISDFDLSNQAPDAAAR 229
+ GL+Y+H + IIH +IK NVL+ D KI+D + +
Sbjct: 137 SKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---- 190
Query: 230 LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
H T + T Y +PE + +D++S ++ EL+TG
Sbjct: 191 -HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-07
Identities = 48/261 (18%), Positives = 90/261 (34%), Gaps = 47/261 (18%)
Query: 44 KTVTVQPIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIK--KLDS 100
+ + Q + P V + E + + IG G +G +Y A K++
Sbjct: 16 ENLYFQSMPFPEGKVLDDMEG-NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY 74
Query: 101 SKQP--DQEF-----LAQVSMVSRLKNENVVELVG----------YYVDGPLRVLAYEHA 143
+ E +A+ + + ++ +G + R + E
Sbjct: 75 QENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL 134
Query: 144 SKGSLHDIL--HGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201
L I +G VL ++ + LEY+HE +H +IK+
Sbjct: 135 GI-DLQKISGQNGTFKKST-----VL------QLGIRMLDVLEYIHEN---EYVHGDIKA 179
Query: 202 SNVLLFDDDIAKI--SDFDLSNQAPDAAARLH----STRVL-GTFGYHAPEYAMTG-QMS 253
+N+LL + ++ +D+ LS + + GT + A G +S
Sbjct: 180 ANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEF-TSLDAHKGVALS 238
Query: 254 SKSDVYSFGVVLLELLTGRKP 274
+SDV G +L L G+ P
Sbjct: 239 RRSDVEILGYCMLRWLCGKLP 259
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 25/94 (26%), Positives = 45/94 (47%), Gaps = 12/94 (12%)
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL-GTFGY 241
EYLH +I+R++K N+L+ +++DF + + T L GT
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEA 204
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
APE + + +K+ D ++ GV++ E+ G P
Sbjct: 205 LAPE-IILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 51/240 (21%), Positives = 92/240 (38%), Gaps = 61/240 (25%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQ-----VSMVSRLKNENVVELV 127
IG GSYG VY + + AIKK+ ++ + + +++++RLK++ ++ L
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKSDYIIRL- 90
Query: 128 GYYVDGPLRV-------LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK-----I 175
Y + P + + E A L + L+ + +K +
Sbjct: 91 -YDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPI---------FLT-EEHIKTILYNL 138
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
+G ++HE + IIHR++K +N LL D K+ DF L+ +
Sbjct: 139 LLG----ENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 236 LGTFG--------------------YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
Y APE + + +KS D++S G + ELL +
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 7e-07
Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 12/95 (12%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL-GTFG 240
LEYLH K II+R++K N+LL + KI+DF + PD T L GT
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYTLCGTPD 168
Query: 241 YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKP 274
Y APE ++ + +KS D +SFG+++ E+L G P
Sbjct: 169 YIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 27/112 (24%), Positives = 49/112 (43%), Gaps = 23/112 (20%)
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+ ++YLH ++HR++K SN+LL + K++DF LS + ++ +
Sbjct: 120 KVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 241 -------------------YHAPEYAMTGQMSSKS-DVYSFGVVLLELLTGR 272
Y APE + +K D++S G +L E+L G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 30/93 (32%), Positives = 43/93 (46%), Gaps = 10/93 (10%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA--KISDFDLSNQAPDAAARLHSTRVLGTF 239
L+ LH+ RIIH ++K N+LL + K+ DF S +R F
Sbjct: 212 CLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR----F 264
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
Y APE + + D++S G +L ELLTG
Sbjct: 265 -YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 27/93 (29%), Positives = 41/93 (44%), Gaps = 8/93 (8%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA--KISDFDLSNQAPDAAARLHSTRVLGTF 239
L +L E IIH ++K N+LL + + KI DF S Q + F
Sbjct: 169 ALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSRF 223
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272
Y +PE + D++S G +L+E+ TG
Sbjct: 224 -YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 5e-05
Identities = 29/135 (21%), Positives = 45/135 (33%), Gaps = 46/135 (34%)
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDI------------------------------ 211
GL+YLH K RIIH +IK N+LL ++
Sbjct: 158 GLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 212 -----------AKISDFDLSNQAPDAAARL---HSTRVLGTFGYHAPEYAMTGQMSSKSD 257
K ++ A A H T + T Y + E + ++ +D
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275
Query: 258 VYSFGVVLLELLTGR 272
++S + EL TG
Sbjct: 276 IWSTACMAFELATGD 290
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 50/258 (19%), Positives = 84/258 (32%), Gaps = 56/258 (21%)
Query: 57 SVDELKEK---TDNFGTN----SLIGEGSYGRVYFGVLRSGRAAAIK--------KLDSS 101
S++ L TD G S + G +Y S KLD+
Sbjct: 26 SLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAK 85
Query: 102 KQP---DQEFL---AQVSMVSRLKNENVVELVG----YY---VDGPLRVLAYEHASKGSL 148
+Q F A+ V++ K L+ R L + SL
Sbjct: 86 DGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SL 144
Query: 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208
L P VLS +++A LE+LHE +H N+ + N+ +
Sbjct: 145 QSALD-------VSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDP 194
Query: 209 DDIAKI--SDFDLSNQAPDA----AARLHSTRVL-GTFGYHAPEYA-----MTGQMSSKS 256
+D +++ + + + + + A S G E+ S +S
Sbjct: 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGD-----LEFISMDLHKGCGPSRRS 249
Query: 257 DVYSFGVVLLELLTGRKP 274
D+ S G +L+ L G P
Sbjct: 250 DLQSLGYCMLKWLYGFLP 267
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 301 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.97 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.95 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.83 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.62 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.42 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.33 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.1 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 99.03 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.97 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.87 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.82 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.8 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.64 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.61 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.43 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.42 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.33 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.29 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 98.28 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 98.22 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 98.2 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 98.12 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 98.11 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 98.05 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 98.01 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.85 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 97.51 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.41 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.58 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.52 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.32 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.85 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 88.13 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.11 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 85.0 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 82.0 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-58 Score=391.65 Aligned_cols=203 Identities=24% Similarity=0.362 Sum_probs=183.2
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
++|++++.||+|+||+||+|+++ +++.||+|++.+. ....+.+.+|+++|++++|||||++++++.+++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999987 7999999999643 233467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
|||+||+|.+++..... +++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 112 Ey~~gG~L~~~i~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla 179 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGS---------FDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTA 179 (311)
T ss_dssp CCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCc
Confidence 99999999999976542 899999999999999999999999 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+..............+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+.
T Consensus 180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 239 (311)
T 4aw0_A 180 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239 (311)
T ss_dssp EECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 876544333334567899999999999999999999999999999999999999987554
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-57 Score=392.57 Aligned_cols=204 Identities=25% Similarity=0.403 Sum_probs=176.9
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
.++|++++.||+|+||+||+|+++ +++.||||++.+.... .+.+.+|+++|++|+|||||++++++.+++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 478999999999999999999987 7999999999765433 356889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
|||+||+|.+++...+.. .+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+|
T Consensus 103 Ey~~gg~L~~~i~~~~~~-------~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla 172 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGV-------LFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIA 172 (350)
T ss_dssp ECCTTCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEE
T ss_pred eCCCCCcHHHHHHHcCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccc
Confidence 999999999999754421 2789999999999999999999999 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+........ ....+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+.
T Consensus 173 ~~~~~~~~~--~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~ 230 (350)
T 4b9d_A 173 RVLNSTVEL--ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM 230 (350)
T ss_dssp SCCCHHHHH--HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eeecCCccc--ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 887643322 2456799999999999999999999999999999999999999987654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-57 Score=394.56 Aligned_cols=200 Identities=30% Similarity=0.483 Sum_probs=180.8
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
+.|++++.||+|+||+||+|+++ +|+.||||++..... ..+.+.+|+.+|+.++|||||++++++.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999987 799999999865433 3456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
+||+|.+++.... +++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+..
T Consensus 154 ~gg~L~~~l~~~~----------l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 220 (346)
T 4fih_A 154 EGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 220 (346)
T ss_dssp TTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceec
Confidence 9999999997643 899999999999999999999999 999999999999999999999999999876
Q ss_pred CccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
...... ....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.++
T Consensus 221 ~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 275 (346)
T 4fih_A 221 SKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 275 (346)
T ss_dssp CSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred CCCCCc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 543222 2567899999999999999999999999999999999999999987654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-57 Score=399.76 Aligned_cols=200 Identities=30% Similarity=0.483 Sum_probs=181.3
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
+.|++++.||+|+||.||+|+++ +|+.||||++..... ..+.+.+|+.+|+.++|||||++++++.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999987 799999999975443 3456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
+||+|.+++.... +++..+..++.||+.||+|||++| ||||||||+|||++.+|.+||+|||+|+..
T Consensus 231 ~gG~L~~~i~~~~----------l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~ 297 (423)
T 4fie_A 231 EGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV 297 (423)
T ss_dssp TTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHHhccC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceEC
Confidence 9999999997543 899999999999999999999999 999999999999999999999999999876
Q ss_pred CccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
...... ....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.++
T Consensus 298 ~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 352 (423)
T 4fie_A 298 SKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 352 (423)
T ss_dssp CSSCCC--BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred CCCCcc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 443222 2567899999999999999999999999999999999999999987654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-55 Score=370.43 Aligned_cols=201 Identities=25% Similarity=0.373 Sum_probs=164.5
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
..++|++.+.||+|+||+||+|+++ +++.||+|++.+... ....+.+|+++|++++||||+++++++.+++.+|+
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 3578999999999999999999987 799999999975432 23568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||||| +|+|.+++..... +++..+..++.||+.||+|||++| |+||||||+|||+++++++||+|||
T Consensus 91 vmEy~-~g~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFG 157 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDK---------MSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFG 157 (275)
T ss_dssp EEECC-CEEHHHHHHHSCS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSS
T ss_pred EEeCC-CCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecC
Confidence 99999 5799999876542 899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+|+........ ...+||+.|||||++.+..+ +.++|||||||++|+|++|+.||.+.+.
T Consensus 158 la~~~~~~~~~---~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~ 217 (275)
T 3hyh_A 158 LSNIMTDGNFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI 217 (275)
T ss_dssp CC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCeecCCCCcc---CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence 99776543322 45689999999999998876 5799999999999999999999976543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-55 Score=379.21 Aligned_cols=201 Identities=26% Similarity=0.338 Sum_probs=175.3
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
...|++.++||+|+||+||+|+++ +|+.||||+++..... .+|+.+++.++|||||++++++.+++.+|||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 456888999999999999999987 7999999999765432 46899999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC-ceEEeccccCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQ 222 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg~a~~ 222 (301)
+||+|.+++..... +++..+..++.||+.||+|||+++ ||||||||+|||++.+| ++||+|||+|+.
T Consensus 133 ~gg~L~~~l~~~~~---------l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~ 200 (336)
T 4g3f_A 133 EGGSLGQLIKQMGC---------LPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALC 200 (336)
T ss_dssp TTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred CCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence 99999999976432 899999999999999999999999 99999999999999987 699999999987
Q ss_pred CCccccc---cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 223 APDAAAR---LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 223 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
....... ......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..
T Consensus 201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~ 262 (336)
T 4g3f_A 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG 262 (336)
T ss_dssp C------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS
T ss_pred ccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH
Confidence 6543211 1223467999999999999999999999999999999999999999876553
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=378.08 Aligned_cols=201 Identities=24% Similarity=0.330 Sum_probs=171.9
Q ss_pred CCCCCCceecccCceEEEEEEEC----CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
++|++++.||+|+||+||+|++. +++.||+|++++... ....+.+|+.+|++++|||||++++++.+++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 47999999999999999999863 478999999865322 23467889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
|||||+||+|.+++..... +++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||
T Consensus 104 vmEy~~gg~L~~~l~~~~~---------l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFG 171 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVM---------FTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFG 171 (304)
T ss_dssp EECCCTTCEEHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSE
T ss_pred EEEcCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccc
Confidence 9999999999999976442 899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+|+........ ....+||+.|||||++.+..|+.++|||||||++|+|+||++||.+.+.
T Consensus 172 la~~~~~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~ 231 (304)
T 3ubd_A 172 LSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR 231 (304)
T ss_dssp EEEC-----CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cceeccCCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH
Confidence 99765443222 2456899999999999999999999999999999999999999987654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-54 Score=369.01 Aligned_cols=202 Identities=31% Similarity=0.470 Sum_probs=169.4
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
.+++++.+.||+|+||+||+|+++ ..||||+++..... .+.+.+|+.+|++++|||||++++++.+ +.++||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 467889999999999999999876 36999998754433 3568899999999999999999998754 56899999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
||++|+|.+++..... .+++..++.++.|++.||+|||+++ ||||||||+|||+++++.+||+|||+|+
T Consensus 112 y~~gGsL~~~l~~~~~--------~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~ 180 (307)
T 3omv_A 112 WCEGSSLYKHLHVQET--------KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLAT 180 (307)
T ss_dssp CCSSCBHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCB
T ss_pred cCCCCCHHHHHhhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCce
Confidence 9999999999975432 2899999999999999999999999 9999999999999999999999999998
Q ss_pred CCCccccccccccccccccccCcccccc---CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
..............+||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.++
T Consensus 181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~ 242 (307)
T 3omv_A 181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242 (307)
T ss_dssp C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence 7654333333355689999999999864 3589999999999999999999999987654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-55 Score=373.86 Aligned_cols=212 Identities=25% Similarity=0.443 Sum_probs=178.7
Q ss_pred CCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
++|.+.+.||+|+||+||+|++. ++..||||+++..... .+++.+|+++|++++|||||++++++.+++.+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57889999999999999999864 4678999999754322 4678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCC----CCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 139 AYEHASKGSLHDILHGKKGV----KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~----~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
|||||++|+|.++|...... ........+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 99999999999999754310 00111234899999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.++
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~ 236 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 236 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999976554433333344579999999999999999999999999999999999 9999987654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-54 Score=365.99 Aligned_cols=197 Identities=27% Similarity=0.404 Sum_probs=169.7
Q ss_pred CCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEc----CCeeEEEE
Q 022206 69 GTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD----GPLRVLAY 140 (301)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~ 140 (301)
++.+.||+|+||+||+|+++ ++..||+|++...... .+.+.+|+.+|++|+|||||++++++.+ +..+|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 67778999999999999987 7899999998654332 3568899999999999999999999864 35689999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC-CCceEEecccc
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDL 219 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~ 219 (301)
|||+||+|.+++..... +++..+..++.||+.||+|||+++ ++|+||||||+|||++. +|.+||+|||+
T Consensus 109 Ey~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp ECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred eCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcC
Confidence 99999999999976432 899999999999999999999975 24999999999999984 79999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|+...... ....+||+.|||||++.+ .|+.++|||||||++|+|+||++||.+...
T Consensus 179 a~~~~~~~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~ 234 (290)
T 3fpq_A 179 ATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN 234 (290)
T ss_dssp GGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred CEeCCCCc----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc
Confidence 97543321 245689999999998865 699999999999999999999999976443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-54 Score=370.17 Aligned_cols=213 Identities=29% Similarity=0.403 Sum_probs=181.1
Q ss_pred CCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCC--CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
.++++.+.||+|+||+||+|++. +++.||||+++... ...+++.+|+.++++++|||||++++++.+++.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677889999999999999863 46789999996543 23467999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhcCCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC
Q 022206 138 LAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 210 (301)
+|||||++|+|.++|........ ......+++..++.++.||+.||+|||+++ ||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999965432111 011234899999999999999999999999 99999999999999999
Q ss_pred ceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCc
Q 022206 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (301)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~ 281 (301)
++||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |..||.+.++.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~ 254 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999987655443333455679999999999999999999999999999999998 89999876653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-54 Score=371.83 Aligned_cols=212 Identities=24% Similarity=0.405 Sum_probs=172.7
Q ss_pred CCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
++|.+.+.||+|+||+||+|+++ ++..||||+++..... .+++.+|+++|++++|||||++++++.+.+.+++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56788899999999999999864 4788999999754332 3679999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCC------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCce
Q 022206 139 AYEHASKGSLHDILHGKKGVKG------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (301)
|||||++|+|.+++........ ......+++.+++.++.|++.||+|||+++ ||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999976542111 011234899999999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||.+.++
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~ 266 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH
Confidence 9999999987655443333355679999999999999999999999999999999999 9999987654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=357.51 Aligned_cols=201 Identities=24% Similarity=0.438 Sum_probs=162.5
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCC-------
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGP------- 134 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------- 134 (301)
.++|++++.||+|+||+||+|+++ +++.||||++...... .+.+.+|+++|++|+|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 356999999999999999999987 7999999998754433 356889999999999999999999987544
Q ss_pred -----eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC
Q 022206 135 -----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (301)
Q Consensus 135 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 209 (301)
.+|+|||||++|+|.+++....... ...+..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~------~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~ 154 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIE------ERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMD 154 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGG------GSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCC------hhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCC
Confidence 3799999999999999998654311 1456778899999999999999999 9999999999999999
Q ss_pred CceEEeccccCCCCCccccc----------cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 210 DIAKISDFDLSNQAPDAAAR----------LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
+.+||+|||+|+........ ......+||+.|||||++.+..|+.++|||||||++|||++ ||..
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 99999999999876543221 11234579999999999999999999999999999999996 7854
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=368.77 Aligned_cols=204 Identities=25% Similarity=0.377 Sum_probs=174.8
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch---HHHHHHHHHHhccCCCceeeeeeEEEc------CCe
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVD------GPL 135 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~ 135 (301)
++|++++.||+|+||+||+|+++ +|+.||||++.+..... ..+.+|+++|+.|+|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999987 79999999997654432 457889999999999999999998753 367
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
+|+|||||+ |+|.+++..... +++..+..++.||+.||.|||++| ||||||||+|||++.+|.+||+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~---------l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~ 200 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQP---------LTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIG 200 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEeCCC-CCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEe
Confidence 899999996 589999976542 899999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCcccc--ccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCCcC
Q 022206 216 DFDLSNQAPDAAA--RLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (301)
Q Consensus 216 Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~ 282 (301)
|||+|+....... .......+||+.|+|||++.+. .++.++||||+||++|||++|++||.+.+...
T Consensus 201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~ 270 (398)
T 4b99_A 201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH 270 (398)
T ss_dssp CCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH
T ss_pred ecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH
Confidence 9999987643321 1223467899999999998875 56899999999999999999999998766433
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=360.53 Aligned_cols=219 Identities=23% Similarity=0.365 Sum_probs=182.4
Q ss_pred HHHHHhhCCCCCCceecccCceEEEEEEECC------CCEEEEEEcCCCCCc--hHHHHHHHHHHhccCC-CceeeeeeE
Q 022206 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLRS------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKN-ENVVELVGY 129 (301)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h-~~iv~~~~~ 129 (301)
.++....++|++.+.||+|+||+||+|.+.. ++.||||.+...... .+.+.+|+++|++++| ||||+++++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 3444445789999999999999999998642 357999999765443 3568899999999976 899999999
Q ss_pred EEc-CCeeEEEEecCCCCCHHHHhcCCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCC
Q 022206 130 YVD-GPLRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (301)
Q Consensus 130 ~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp 201 (301)
|.+ ++.+++|||||++|+|.++|+....... ......+++..++.++.||+.||+|||+++ ||||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCc
Confidence 875 4578999999999999999975432110 011234899999999999999999999999 99999999
Q ss_pred CceEEcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 202 SNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
+|||+++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+...
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987655443333455679999999999999999999999999999999998 9999987553
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-52 Score=357.03 Aligned_cols=202 Identities=25% Similarity=0.368 Sum_probs=163.7
Q ss_pred CCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCC----eeEEEEe
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP----LRVLAYE 141 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e 141 (301)
++|.+.+.||+|+||+||+|+++ |+.||||+++..........+|+..+.+++|||||++++++.+++ .++||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 46788899999999999999985 899999999754333333445666677899999999999998654 5799999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC-----CCCeEecCCCCCceEEcCCCceEEec
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA-----EPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
||++|+|.++++... +++..++.++.|++.||+|||++. .++|+||||||+|||++.++++||+|
T Consensus 82 y~~~gsL~~~l~~~~----------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 82 YHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp CCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CCCCCcHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 999999999998654 899999999999999999999871 11299999999999999999999999
Q ss_pred cccCCCCCccccc--cccccccccccccCccccccC------CCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 217 FDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTG------QMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 217 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
||+|+........ ......+||+.|||||++.+. .++.++|||||||++|||+||.+||...
T Consensus 152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 9998765433221 112345799999999998764 3577999999999999999998877543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-51 Score=376.85 Aligned_cols=201 Identities=27% Similarity=0.376 Sum_probs=175.0
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHH---HHHHHhccCCCceeeeeeEEEcCCee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLA---QVSMVSRLKNENVVELVGYYVDGPLR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~~ 136 (301)
.++|+++++||+|+||+||+|+++ +|+.||+|++.+.. .......+ ++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 468999999999999999999987 79999999986421 12223333 46667788999999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
|+|||||+||+|.+++..... +++..+..++.||+.||+|||++| ||||||||+|||++.+|++||+|
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~---------l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~D 335 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGV---------FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISD 335 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecc
Confidence 999999999999999976432 899999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCccccc-cCCCCccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
||+|+...... ....+||+.|||||++. +..|+.++|||||||++|+|++|++||.+.+..
T Consensus 336 FGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~ 397 (689)
T 3v5w_A 336 LGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397 (689)
T ss_dssp CTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC
T ss_pred cceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 99997765432 24568999999999996 468999999999999999999999999765443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=352.65 Aligned_cols=202 Identities=25% Similarity=0.389 Sum_probs=172.4
Q ss_pred HHhhCCCCCCceecccCceEEEEEEEC----CCCEEEEEEcCCCCCchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCee
Q 022206 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (301)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 136 (301)
....++|++.+.||+|+||+||+|+++ +++.||+|++.... ....+.+|+++|+.+ +||||+++++++.+.+.+
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 345678999999999999999999864 46789999987644 345688999999988 699999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC-CceEEe
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKIS 215 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~ 215 (301)
|+|||||++|+|.+++.. +++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||+
T Consensus 96 ~lvmE~~~g~~L~~~~~~------------l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~ 160 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILNS------------LSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALV 160 (361)
T ss_dssp EEEEECCCCCCHHHHHTT------------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEEC
T ss_pred EEEEeCCCcccHHHHHcC------------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEEC
Confidence 999999999999999952 889999999999999999999999 9999999999999876 899999
Q ss_pred ccccCCCCCcccc--------------------------ccccccccccccccCccccccC-CCCccccchhhHHHHHHH
Q 022206 216 DFDLSNQAPDAAA--------------------------RLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLEL 268 (301)
Q Consensus 216 Dfg~a~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l 268 (301)
|||+|+....... .......+||+.|+|||++.+. .|+.++||||+||++|+|
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~el 240 (361)
T 4f9c_A 161 DFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSL 240 (361)
T ss_dssp CCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred cCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHH
Confidence 9999975432211 0011345799999999998775 589999999999999999
Q ss_pred HhCCCCCCCCC
Q 022206 269 LTGRKPVDHTL 279 (301)
Q Consensus 269 ~~g~~pf~~~~ 279 (301)
++|+.||...+
T Consensus 241 l~G~~Pf~~~~ 251 (361)
T 4f9c_A 241 LSGRYPFYKAS 251 (361)
T ss_dssp HHTCSSSSCCS
T ss_pred HHCCCCCCCCC
Confidence 99999996543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=368.08 Aligned_cols=202 Identities=23% Similarity=0.352 Sum_probs=180.6
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
.++|++++.||+|+||+||+|+++ +|+.||+|++...... .+.+.+|+.+|+.|+||||+++++++.+.+.+|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999987 7999999998764433 35688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC--CceEEeccccC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD--DIAKISDFDLS 220 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~--~~vkl~Dfg~a 220 (301)
|+||+|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|
T Consensus 236 ~~gg~L~~~i~~~~~--------~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a 304 (573)
T 3uto_A 236 MSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT 304 (573)
T ss_dssp CCCCBHHHHHTCTTS--------CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSC
T ss_pred cCCCcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccce
Confidence 999999999965432 2899999999999999999999999 9999999999999854 89999999999
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+........ ...+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+.
T Consensus 305 ~~~~~~~~~---~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~ 361 (573)
T 3uto_A 305 AHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 361 (573)
T ss_dssp EECCTTSEE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred eEccCCCce---eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 876544322 456899999999999999999999999999999999999999987654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=323.46 Aligned_cols=202 Identities=24% Similarity=0.347 Sum_probs=179.1
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
.++|++++.||+|+||+||+|+++ +++.||+|++.+. ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999987 7999999998642 33446688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||++||+|.+++..... +++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 84 ~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~ 151 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp EECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccc
Confidence 999999999999975432 899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 152 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 210 (337)
T 1o6l_A 152 CKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp CBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred hhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH
Confidence 976432221 12456799999999999999999999999999999999999999976543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=335.83 Aligned_cols=206 Identities=21% Similarity=0.323 Sum_probs=179.6
Q ss_pred HHHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCe
Q 022206 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (301)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 135 (301)
+....++|++++.||+|+||+||+|+++ +++.||+|++.+. ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3344578999999999999999999987 6899999998642 2223457889999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
+++||||++||+|.+++.... +++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~~----------~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~ 210 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLA 210 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEe
Confidence 999999999999999997543 889999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCccccccCC----CCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ----MSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|||++........ ......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.
T Consensus 211 DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 278 (410)
T 3v8s_A 211 DFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 278 (410)
T ss_dssp CCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh
Confidence 9999976543321 1224568999999999998765 78899999999999999999999987654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=323.73 Aligned_cols=203 Identities=28% Similarity=0.383 Sum_probs=179.3
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
...++|++.+.||+|+||.||+|++. +++.||+|++...... ...+.+|+++++.++||||+++++++.+.+..++
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 34678999999999999999999986 8999999998654332 3567899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||||+++++|.+++..... +++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 92 v~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG 159 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGR---------MKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFG 159 (328)
T ss_dssp EECCCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTT
T ss_pred EEECCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeecc
Confidence 9999999999999965432 899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCC-ccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS-SKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
++........ ....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+.
T Consensus 160 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 219 (328)
T 3fe3_A 160 FSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 219 (328)
T ss_dssp CCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH
Confidence 9876543322 2456799999999999888775 789999999999999999999987654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=315.36 Aligned_cols=202 Identities=26% Similarity=0.443 Sum_probs=180.1
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC-CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 4568999999999999999999976 79999999986433 334668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+++++|.+++.... +++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 98 ~~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (297)
T 3fxz_A 98 YLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (297)
T ss_dssp CCTTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCCCCCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCce
Confidence 999999999997643 889999999999999999999999 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+..+
T Consensus 165 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 221 (297)
T 3fxz_A 165 QITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (297)
T ss_dssp ECCSTTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ecCCcccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 65443221 2455799999999999999999999999999999999999999976543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=323.93 Aligned_cols=205 Identities=24% Similarity=0.382 Sum_probs=178.8
Q ss_pred HHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCe
Q 022206 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (301)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 135 (301)
....++|++.+.||+|+||.||+|+++ +++.||+|++.+. ......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345689999999999999999999987 7899999998653 23345677888888876 89999999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
.++||||++||+|.+++..... +++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~ 160 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIA 160 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEe
Confidence 9999999999999999976432 899999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|||+++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 161 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (345)
T 1xjd_A 161 DFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223 (345)
T ss_dssp CCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999976433221 12456899999999999999999999999999999999999999976543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=326.61 Aligned_cols=203 Identities=24% Similarity=0.352 Sum_probs=174.4
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 137 (301)
..++|++++.||+|+||+||+|+++ +++.||+|++.+. ......+.+|..+++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4578999999999999999999987 6899999998643 22335577899999888 7999999999999999999
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+||||++||+|.+++..... +++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 101 lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DF 168 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRR---------FDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADF 168 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccc
Confidence 99999999999999976432 899999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|+++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 169 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 229 (353)
T 3txo_A 169 GMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE 229 (353)
T ss_dssp TTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH
Confidence 99976433222 22456899999999999998999999999999999999999999987654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=321.15 Aligned_cols=202 Identities=26% Similarity=0.387 Sum_probs=179.5
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-------chHHHHHHHHHHhccCCCceeeeeeEEEcCCe
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 135 (301)
..++|++.+.||+|+||.||+|+++ +++.||+|++.+... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3568999999999999999999987 799999999865432 23678999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC----c
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----I 211 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~ 211 (301)
.++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.| |+||||||+|||+++++ .
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~ 157 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPH 157 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS---------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccC
Confidence 999999999999999997643 2899999999999999999999999 99999999999998877 7
Q ss_pred eEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+||+|||++........ ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 158 vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~ 223 (361)
T 2yab_A 158 IKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223 (361)
T ss_dssp EEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred EEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999976654322 2456799999999999999999999999999999999999999976543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=317.96 Aligned_cols=199 Identities=28% Similarity=0.408 Sum_probs=178.5
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
.++|++.+.||+|+||.||+|+++ +++.||+|++.+. ....+.+.+|..+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 468999999999999999999987 7999999998643 23345678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+++|+|.+++..... +++..+..++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 85 ~e~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~ 152 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQR---------FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF 152 (318)
T ss_dssp ECCCCSCBHHHHHHHTSS---------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred EeCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCc
Confidence 999999999999976442 889999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+...... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 153 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 208 (318)
T 1fot_A 153 AKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208 (318)
T ss_dssp CEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 9765432 2456799999999999999999999999999999999999999976543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=334.51 Aligned_cols=208 Identities=20% Similarity=0.294 Sum_probs=179.2
Q ss_pred HHHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCe
Q 022206 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (301)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 135 (301)
+....++|+++++||+|+||+||+|+++ +++.||+|++.+. ......+.+|..++..++||||+++++++.+.+.
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 3344578999999999999999999987 6889999998642 1222347889999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
+++||||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~--------~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFED--------RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCcHHHHHHHccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEc
Confidence 9999999999999999976322 2899999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|||++......... .....+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+.
T Consensus 218 DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 286 (437)
T 4aw2_A 218 DFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 286 (437)
T ss_dssp CCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred chhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh
Confidence 99999765433221 223467999999999987 45689999999999999999999999987654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=326.45 Aligned_cols=201 Identities=22% Similarity=0.345 Sum_probs=176.8
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 137 (301)
..++|++++.||+|+||+||+|+++ +++.||+|++.+... ....+.+|..+++++ +||||+++++++.+.+.++
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3568999999999999999999987 688999999875322 224578889998877 8999999999999999999
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+||||+++|+|.+++..... +++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+||
T Consensus 130 lV~E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF 197 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 197 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEcCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeec
Confidence 99999999999999976432 899999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
|+++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 198 Gla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 198 GMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp TTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred ceeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 99976332221 225668999999999999999999999999999999999999999643
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=317.76 Aligned_cols=219 Identities=41% Similarity=0.684 Sum_probs=187.8
Q ss_pred HHHhhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
+....++|++.+.||+|+||.||+|++++++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 4456789999999999999999999988899999999875543 346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+++|+|.+++...... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 114 ~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLP-----TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp EECCTTCBTGGGSSSSCCC-----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred EEcCCCCcHHHHHhccCCC-----ccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999754321 123889999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCcCccccc
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~~~~ 287 (301)
+................||+.|+|||++.+..++.++||||||+++|+|++|+.||....+.......
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~ 253 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHH
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHH
Confidence 87654332222224456899999999998889999999999999999999999999877665544433
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=317.12 Aligned_cols=203 Identities=19% Similarity=0.241 Sum_probs=180.9
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
..++|++.+.||+|+||.||+|.+. +++.+|+|.+.........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 3578999999999999999999987 689999999986655566788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC--CCceEEeccccC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--DDIAKISDFDLS 220 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~--~~~vkl~Dfg~a 220 (301)
+++++|.+++..... .+++..++.++.|++.||.|||++| |+||||||+|||++. ++.+||+|||++
T Consensus 83 ~~g~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a 151 (321)
T 1tki_A 83 ISGLDIFERINTSAF--------ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp CCCCBHHHHHTSSSC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred CCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence 999999999975432 2899999999999999999999999 999999999999987 789999999999
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.
T Consensus 152 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 208 (321)
T 1tki_A 152 RQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp EECCTTCEE---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred eECCCCCcc---ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH
Confidence 776543221 345689999999999988889999999999999999999999976543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=324.67 Aligned_cols=202 Identities=25% Similarity=0.362 Sum_probs=178.3
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
.++|++++.||+|+||.||+|+++ +++.||+|++.+. ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 468999999999999999999987 6899999998642 23346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+.||+|.+++..... +++..++.++.||+.||.|||+.| |+||||||+|||++.+|.+||+|||+
T Consensus 94 ~e~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~ 161 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVH---------FKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNI 161 (384)
T ss_dssp ECCCTTEEHHHHHHTTCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccce
Confidence 999999999999986432 899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCcccccc---CCCCccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
+........ ....+||+.|+|||++.. ..++.++|||||||++|+|++|+.||......
T Consensus 162 a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~ 223 (384)
T 4fr4_A 162 AAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST 223 (384)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS
T ss_pred eeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc
Confidence 976543322 245679999999999864 45889999999999999999999999765443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=310.95 Aligned_cols=204 Identities=24% Similarity=0.382 Sum_probs=174.4
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
..++|++.+.||+|+||.||+|++. ++..||+|++...... ...+.+|+.+++.++||||+++++++.+++..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 3578999999999999999999987 7899999998543332 2567899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||||+++++|.+++..... +++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 89 v~e~~~g~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg 156 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGP---------LSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFG 156 (294)
T ss_dssp EEECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCS
T ss_pred EEeCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999976432 899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
++......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.
T Consensus 157 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 217 (294)
T 4eqm_A 157 IAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA 217 (294)
T ss_dssp SSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH
T ss_pred Ccccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99876543221 12345789999999999999999999999999999999999999976543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=320.28 Aligned_cols=204 Identities=24% Similarity=0.314 Sum_probs=178.6
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCee
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLR 136 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 136 (301)
...++|++++.||+|+||.||+|+++ +++.||+|++.+. ......+.+|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34679999999999999999999987 5889999998643 23345678899999887 799999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
|+||||++||+|.+++..... +++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~D 164 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGR---------FKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIAD 164 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEe
Confidence 999999999999999975432 899999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
||++........ .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 165 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 226 (353)
T 2i0e_A 165 FGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 226 (353)
T ss_dssp CTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH
Confidence 999976432221 12456899999999999999999999999999999999999999986543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=316.97 Aligned_cols=205 Identities=30% Similarity=0.440 Sum_probs=177.9
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
..++|++.+.||+|+||.||+|++. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3578999999999999999999987 7999999998644322 356889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++++|.+++..... +++..++.++.|++.||+|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 85 e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 152 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 152 (323)
T ss_dssp ECCTTEEGGGGSBTTTB---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EcCCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeecc
Confidence 99999999999976542 899999999999999999999999 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
................||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.....
T Consensus 153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 76543332222345679999999999987765 7789999999999999999999976544
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=323.62 Aligned_cols=203 Identities=23% Similarity=0.321 Sum_probs=170.3
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHH-HhccCCCceeeeeeEEEcCCeeE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSM-VSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
..++|++++.||+|+||.||+|+++ +++.||+|++.+... ....+.+|..+ ++.++||||+++++++.+.+..|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3568999999999999999999987 688999999865432 22345566665 57789999999999999999999
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+||||++||+|.+++..... +++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+||
T Consensus 116 lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DF 183 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERC---------FLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDF 183 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeC
Confidence 99999999999999976432 889999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|+++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 184 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 244 (373)
T 2r5t_A 184 GLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 244 (373)
T ss_dssp CBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH
T ss_pred ccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH
Confidence 99875332211 22456899999999999999999999999999999999999999976543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=319.88 Aligned_cols=199 Identities=23% Similarity=0.327 Sum_probs=178.7
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
.++|++++.||+|+||.||+|+++ +++.||+|++.+. ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 468999999999999999999987 7999999998643 22346688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+++|+|.+++..... +++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 120 ~e~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~ 187 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp EECCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEccccc
Confidence 999999999999976432 899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+...... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 188 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 243 (350)
T 1rdq_E 188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243 (350)
T ss_dssp CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH
Confidence 9765432 1445799999999999999999999999999999999999999976544
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=318.21 Aligned_cols=199 Identities=23% Similarity=0.351 Sum_probs=176.0
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 138 (301)
.++|++++.||+|+||.||+|+++ +++.||+|++.+.... ...+.+|..+++.+ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 467999999999999999999987 6899999999754322 24577899999887 89999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||||+++|+|.+++..... +++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 88 v~e~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG 155 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 155 (345)
T ss_dssp EECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGG
T ss_pred EEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecc
Confidence 9999999999999975432 899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
+++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 156 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 156 MCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp GCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 9976432221 12456899999999999999999999999999999999999999965
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=328.01 Aligned_cols=209 Identities=20% Similarity=0.274 Sum_probs=179.5
Q ss_pred HHHHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCC
Q 022206 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGP 134 (301)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 134 (301)
+.....++|++++.||+|+||+||+|+++ +++.||+|++.+... ....+.+|..++..++|+||+++++++.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 33445678999999999999999999987 799999999864221 2234788999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
.+|+||||++||+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL 203 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGE--------RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRL 203 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEEcCCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEE
Confidence 99999999999999999975321 2899999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccccccccccccccccccCccccc-------cCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-------TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+|||++......... .....+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+.
T Consensus 204 ~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 275 (412)
T 2vd5_A 204 ADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST 275 (412)
T ss_dssp CCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred eechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH
Confidence 999999765433221 123467999999999987 35689999999999999999999999987654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=317.43 Aligned_cols=201 Identities=25% Similarity=0.384 Sum_probs=177.9
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
..++|++.+.||+|+||.||+|.++ +++.||+|++...... ...+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3568999999999999999999987 7899999999765433 24678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC---CceEEec
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---DIAKISD 216 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~vkl~D 216 (301)
|||+.+|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|
T Consensus 107 ~e~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~D 174 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREF---------YSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLAD 174 (362)
T ss_dssp ECCCCSCBHHHHHTTCSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECC
T ss_pred EecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEee
Confidence 999999999999976532 899999999999999999999999 9999999999999865 4599999
Q ss_pred cccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 175 fG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 234 (362)
T 2bdw_A 175 FGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234 (362)
T ss_dssp CTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 999977654322 134579999999999999899999999999999999999999997654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=320.13 Aligned_cols=214 Identities=26% Similarity=0.426 Sum_probs=179.4
Q ss_pred hhCCCCCCceecccCceEEEEEEEC--------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhcc-CCCceeeeeeEEEc
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVD 132 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 132 (301)
..++|++.+.||+|+||.||+|++. ++..||+|++...... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3468999999999999999999862 3457999999765432 25688999999999 89999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHhcCCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceE
Q 022206 133 GPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (301)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nil 205 (301)
.+..++||||+++|+|.+++....... ...+...+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 999999999999999999997653210 0111234889999999999999999999999 999999999999
Q ss_pred EcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 206 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999976554332222334467889999999999999999999999999999999 9999987554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=311.74 Aligned_cols=202 Identities=25% Similarity=0.375 Sum_probs=178.5
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-------chHHHHHHHHHHhccCCCceeeeeeEEEcCCe
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 135 (301)
..++|++.+.||+|+||.||+|.++ +++.||+|++..... ....+.+|+.+++.++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3457999999999999999999987 799999999865332 24678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC----c
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----I 211 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~ 211 (301)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~ 156 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKE---------SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR 156 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSS---------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCC
T ss_pred EEEEEEcCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCC
Confidence 999999999999999997543 2899999999999999999999999 99999999999999887 8
Q ss_pred eEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+...
T Consensus 157 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 222 (326)
T 2y0a_A 157 IKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 222 (326)
T ss_dssp EEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred EEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 99999999976643322 1345799999999999989999999999999999999999999976543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=321.08 Aligned_cols=207 Identities=19% Similarity=0.191 Sum_probs=175.1
Q ss_pred HhhCCCCCCceecccCceEEEEEE------ECCCCEEEEEEcCCCCCchHHHHHHHHHHhccC---CCceeeeeeEEEcC
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGV------LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK---NENVVELVGYYVDG 133 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~ 133 (301)
...++|.+.+.||+|+||.||+|. ..+++.||+|++... ...++.+|+++++.++ |+||+++++++...
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 345789999999999999999994 336899999999754 4556778888888876 89999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC-----
Q 022206 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD----- 208 (301)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~----- 208 (301)
+..++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNT----PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTS----TTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcc----cccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCc
Confidence 9999999999999999999742211 0123899999999999999999999999 999999999999998
Q ss_pred ------CCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 209 ------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 209 ------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
++.+||+|||++...............+||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 8999999999996543222222234567999999999999999999999999999999999999999643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=314.57 Aligned_cols=202 Identities=27% Similarity=0.386 Sum_probs=176.9
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
..++|.+.+.||+|+||.||+|.+. +++.||+|++... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 4578999999999999999999986 7999999998642 2233578899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||||+ +|+|.+++..... +++..++.++.|++.||.|||+.| |+||||||+|||+++++.+||+|||
T Consensus 87 v~E~~-~g~l~~~l~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG 153 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKR---------MTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFG 153 (336)
T ss_dssp EECCC-CEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSS
T ss_pred EEECC-CCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEec
Confidence 99999 6789988865432 899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
++......... ...+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+....
T Consensus 154 ~s~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~ 214 (336)
T 3h4j_B 154 LSNIMTDGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP 214 (336)
T ss_dssp CTBTTTTSBTT---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST
T ss_pred cceeccCCccc---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH
Confidence 99766543322 45579999999999988776 68999999999999999999999775443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=317.84 Aligned_cols=202 Identities=24% Similarity=0.320 Sum_probs=169.6
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
..++|++++.||+|+||.||+++++ +++.||+|++.........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 3578999999999999999999987 799999999987766678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc--eEEeccccC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI--AKISDFDLS 220 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~--vkl~Dfg~a 220 (301)
+++|+|.+++..... +++..++.++.|++.||+|||++| |+||||||+|||++.++. +||+|||++
T Consensus 98 ~~~~~L~~~l~~~~~---------~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a 165 (361)
T 3uc3_A 98 ASGGELYERICNAGR---------FSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYS 165 (361)
T ss_dssp CCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred CCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence 999999999965432 899999999999999999999999 999999999999987765 999999998
Q ss_pred CCCCccccccccccccccccccCccccccCCCCcc-ccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSK-SDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
........ .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...
T Consensus 166 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 166 KSSVLHSQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp ------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred ccccccCC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 75433222 134579999999999988877655 8999999999999999999987544
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=309.65 Aligned_cols=206 Identities=25% Similarity=0.385 Sum_probs=175.7
Q ss_pred HhhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
...++|++++.||+|+||.||+|++.+++.||+|++...... ...+.+|+++++.++||||+++++++.++...++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 356889999999999999999999988999999998754332 35688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+++ +|.+++..... .+++..++.++.|++.||.|||+.| |+||||||+|||++.++.+||+|||+
T Consensus 98 ~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~ 165 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENKT--------GLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGL 165 (311)
T ss_dssp EECCSE-EHHHHHHTCTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EcCCCC-CHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcC
Confidence 999986 88888865432 2889999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCcC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~ 282 (301)
+......... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.....
T Consensus 166 a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 227 (311)
T 3niz_A 166 ARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227 (311)
T ss_dssp CEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT
T ss_pred ceecCCCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 9765432221 134568999999999876 568999999999999999999999998765543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=312.94 Aligned_cols=202 Identities=24% Similarity=0.354 Sum_probs=169.3
Q ss_pred hCCCCCCceecccCceEEEEEEE----CCCCEEEEEEcCCCC-----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVL----RSGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 135 (301)
.++|++.+.||+|+||.||+|+. .+++.||+|++.+.. .....+.+|+.+++.++||||+++++++.+++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999997 368999999997643 223457789999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
.++||||+++++|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~ 163 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGI---------FMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLT 163 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEEC
T ss_pred EEEEEeCCCCCcHHHHHHhCCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEE
Confidence 9999999999999999975432 889999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.
T Consensus 164 Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 226 (327)
T 3a62_A 164 DFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR 226 (327)
T ss_dssp CCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH
Confidence 9999876433221 12445799999999999998999999999999999999999999976543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=321.78 Aligned_cols=200 Identities=22% Similarity=0.327 Sum_probs=165.6
Q ss_pred hhCCCCCC-ceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHH-hccCCCceeeeeeEEEc----CCee
Q 022206 64 KTDNFGTN-SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMV-SRLKNENVVELVGYYVD----GPLR 136 (301)
Q Consensus 64 ~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----~~~~ 136 (301)
..++|.+. +.||+|+||+||+|.++ +++.||||++.. ...+.+|+.++ +..+||||+++++++.. ...+
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 44577776 78999999999999987 789999999863 24577888886 45589999999998875 5678
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC---CCceE
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAK 213 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~vk 213 (301)
++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+|
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~k 204 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILK 204 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEE
T ss_pred EEEEEeCCCCcHHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEE
Confidence 999999999999999986532 13899999999999999999999999 999999999999997 78999
Q ss_pred EeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|+|||++........ ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus 205 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 205 LTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp ECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred EEecccccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 999999976543322 2456789999999999999999999999999999999999999977654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=307.16 Aligned_cols=206 Identities=27% Similarity=0.456 Sum_probs=178.1
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC-CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
.++|.+.+.||+|+||.||+|.+. +++.||+|++.... .....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 468999999999999999999987 79999999886533 2346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 89 ~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 157 (310)
T 3s95_A 89 IKGGTLRGIIKSMDS--------QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARL 157 (310)
T ss_dssp CTTCBHHHHHHHCCT--------TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred cCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeeccccee
Confidence 999999999976432 2899999999999999999999999 99999999999999999999999999976
Q ss_pred CCcccccc------------ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 223 APDAAARL------------HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 223 ~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~ 228 (310)
T 3s95_A 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR 228 (310)
T ss_dssp CC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCB
T ss_pred cccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhh
Confidence 54332211 011457999999999999999999999999999999999999999775543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=323.45 Aligned_cols=203 Identities=22% Similarity=0.300 Sum_probs=177.7
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
...++|++.+.||+|+||.||+|.++ +++.+|+|++...... ...+.+|+.+++.++||||+++++++.+++..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34578999999999999999999987 7999999998765543 2457899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEc---CCCceEEe
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKIS 215 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~vkl~ 215 (301)
||||+.+|+|.+.+..... +++..+..++.||+.||.|||++| |+||||||+|||++ +++.+||+
T Consensus 88 v~E~~~gg~L~~~i~~~~~---------~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~ 155 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREY---------YSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLA 155 (444)
T ss_dssp EECCCBCCBHHHHHHHCSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred EEEeCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEc
Confidence 9999999999999876542 899999999999999999999999 99999999999998 46789999
Q ss_pred ccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|||++......... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+
T Consensus 156 DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~ 217 (444)
T 3soa_A 156 DFGLAIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217 (444)
T ss_dssp CCSSCBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCceeEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc
Confidence 99999776543221 134579999999999999899999999999999999999999997654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=316.62 Aligned_cols=204 Identities=30% Similarity=0.394 Sum_probs=175.3
Q ss_pred hhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCC----eeEEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP----LRVLA 139 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv 139 (301)
..++|++.+.||+|+||.||+|++. ++.||||++...........+|+.++++++||||+++++++.+.. .+++|
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 4578999999999999999999987 799999999765555556677899999999999999999998744 36999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC----------CCCCeEecCCCCCceEEcCC
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK----------AEPRIIHRNIKSSNVLLFDD 209 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----------~~~~ivH~Dlkp~Nill~~~ 209 (301)
|||+++|+|.+++.... +++..++.++.|++.||.|||+. + |+||||||+|||++.+
T Consensus 101 ~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~ 167 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANV----------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNN 167 (322)
T ss_dssp EECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTT
T ss_pred EecCCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCC
Confidence 99999999999997643 89999999999999999999998 8 9999999999999999
Q ss_pred CceEEeccccCCCCCccccccccccccccccccCccccccC-----CCCccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-----QMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
+.+||+|||++................||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....
T Consensus 168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 244 (322)
T 3soc_A 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244 (322)
T ss_dssp CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence 99999999999765443322223445799999999998763 4556889999999999999999999876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=303.04 Aligned_cols=204 Identities=25% Similarity=0.469 Sum_probs=182.1
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
.++|++.+.||+|+||.||+|.+.+++.||+|++.......+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 46799999999999999999999888999999998877777889999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
+++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 89 ~~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 89 HGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp TCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CCcHHHHHHhcCc--------ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccc
Confidence 9999999976442 2889999999999999999999999 9999999999999999999999999987654
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.....
T Consensus 158 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~ 213 (269)
T 4hcu_A 158 DDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 213 (269)
T ss_dssp CHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred ccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH
Confidence 43221 1233456888999999999999999999999999999999 9999987554
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=330.30 Aligned_cols=203 Identities=26% Similarity=0.401 Sum_probs=179.8
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
.++|++.+.||+|+||.||+|+++ +++.||+|++.+. ......+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999987 7999999998642 23345678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||++||+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+
T Consensus 263 mEy~~gg~L~~~l~~~~~-------~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGl 332 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ-------AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGL 332 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEcCCCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEeccc
Confidence 999999999999976442 12899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+......... ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus 333 a~~~~~~~~~---~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~ 390 (576)
T 2acx_A 333 AVHVPEGQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390 (576)
T ss_dssp CEECCTTCCE---ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS
T ss_pred ceecccCccc---cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc
Confidence 9776543221 345799999999999998999999999999999999999999987644
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=307.30 Aligned_cols=198 Identities=30% Similarity=0.465 Sum_probs=176.3
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
|...+.||+|+||.||+|++. +|+.||||++..... ..+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 677789999999999999987 799999999875443 346688999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
++|.+++.... +++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 127 ~~L~~~l~~~~----------l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 193 (321)
T 2c30_A 127 GALTDIVSQVR----------LNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 193 (321)
T ss_dssp CBHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeeccc
Confidence 99999987543 899999999999999999999999 99999999999999999999999999876543
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....+
T Consensus 194 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~ 246 (321)
T 2c30_A 194 DVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP 246 (321)
T ss_dssp SSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred Cccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 3221 2445799999999999998999999999999999999999999976543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=315.50 Aligned_cols=201 Identities=26% Similarity=0.358 Sum_probs=163.1
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
..++|++.+.||+|+||.||+|++. +++.||+|++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 4567999999999999999999987 68899999987543 345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC---CCceEEecccc
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKISDFDL 219 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~vkl~Dfg~ 219 (301)
+++++|.+++..... +++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 130 ~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 130 VTGGELFDRIVEKGY---------YSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp CCSCBHHHHHTTCSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred CCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 999999999976432 889999999999999999999999 999999999999975 88999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 198 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 255 (349)
T 2w4o_A 198 SKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255 (349)
T ss_dssp ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC
T ss_pred ccccCcccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 876543322 1345789999999999998999999999999999999999999976543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=310.28 Aligned_cols=215 Identities=37% Similarity=0.669 Sum_probs=186.8
Q ss_pred ccccCHHHHHHhhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEE
Q 022206 53 VPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYY 130 (301)
Q Consensus 53 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~ 130 (301)
....+..++....++|++.+.||+|+||.||+|++.+++.||+|++...... ...+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 4456778888899999999999999999999999888999999998754322 24688999999999999999999999
Q ss_pred EcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC---CCCCeEecCCCCCceEEc
Q 022206 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK---AEPRIIHRNIKSSNVLLF 207 (301)
Q Consensus 131 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~~~~ivH~Dlkp~Nill~ 207 (301)
.+....++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. + |+||||||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~ 168 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPES-----QPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLD 168 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTT-----CCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEEC
Confidence 9999999999999999999999865432 23389999999999999999999999 8 99999999999999
Q ss_pred CCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCC
Q 022206 208 DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276 (301)
Q Consensus 208 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~ 276 (301)
.++.+||+|||++......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 169 EEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp TTCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CCCCEEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 9999999999999765433221 1234568999999999988889999999999999999999999995
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=328.12 Aligned_cols=206 Identities=24% Similarity=0.370 Sum_probs=180.2
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
.++|++.+.||+|+||.||+|+++ +++.||+|++.+.. .....+.+|+.+++.++||||+++++++.+...+++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 468999999999999999999987 79999999986432 2345688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||++||+|.+++...... ...+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 264 mE~~~gg~L~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGl 335 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDED-----NPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGL 335 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTT-----SCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEeccCCCHHHHHHHhhcc-----cccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecce
Confidence 9999999999998754321 123899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+......... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus 336 a~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~ 394 (543)
T 3c4z_A 336 AVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394 (543)
T ss_dssp CEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC
T ss_pred eeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc
Confidence 9765443221 2345899999999999999999999999999999999999999987543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=313.21 Aligned_cols=204 Identities=25% Similarity=0.364 Sum_probs=176.0
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC------CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS------KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
.++|++.+.||+|+||.||+|+++ +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 457999999999999999999987 7999999998531 223567899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc---eEE
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI---AKI 214 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---vkl 214 (301)
+||||+++++|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl 174 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKL 174 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEE
T ss_pred EEEeCCCCCCHHHHHHHhccc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEE
Confidence 999999999998887543211 123889999999999999999999999 999999999999987654 999
Q ss_pred eccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 175 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 175 GGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 99999976654322 124457999999999999999999999999999999999999999764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=305.69 Aligned_cols=201 Identities=29% Similarity=0.399 Sum_probs=169.9
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---------------------------hHHHHHHHHHH
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---------------------------DQEFLAQVSMV 115 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---------------------------~~~~~~e~~~l 115 (301)
..++|++.+.||+|+||.||+|++. +++.||+|++...... .+.+.+|++++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 3578999999999999999999987 7899999998654311 24588999999
Q ss_pred hccCCCceeeeeeEEEc--CCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 022206 116 SRLKNENVVELVGYYVD--GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193 (301)
Q Consensus 116 ~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ 193 (301)
+.++||||+++++++.+ ....++||||+++++|.+++... .+++..++.++.|++.||.|||+++
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~--- 157 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----------PLSEDQARFYFQDLIKGIEYLHYQK--- 157 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 99999999999999986 66899999999999998865433 2899999999999999999999999
Q ss_pred eEecCCCCCceEEcCCCceEEeccccCCCCCccccccccccccccccccCccccccCC---CCccccchhhHHHHHHHHh
Q 022206 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQ---MSSKSDVYSFGVVLLELLT 270 (301)
Q Consensus 194 ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~~l~~ 270 (301)
|+||||||+|||++.++.+||+|||++......... .....||+.|+|||++.+.. ++.++||||||+++|+|++
T Consensus 158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~ 235 (298)
T 2zv2_A 158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235 (298)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred eeccCCCHHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence 999999999999999999999999998765443221 13457999999999987665 3778999999999999999
Q ss_pred CCCCCCCCC
Q 022206 271 GRKPVDHTL 279 (301)
Q Consensus 271 g~~pf~~~~ 279 (301)
|+.||.+..
T Consensus 236 g~~pf~~~~ 244 (298)
T 2zv2_A 236 GQCPFMDER 244 (298)
T ss_dssp SSCSSCCSS
T ss_pred CCCCCCCcc
Confidence 999997643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=314.38 Aligned_cols=202 Identities=24% Similarity=0.323 Sum_probs=177.8
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
..++|++.+.||+|+||.||+|.++ +++.||+|++..... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 4568999999999999999999987 789999999875432 23568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC--CCceEEecccc
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--DDIAKISDFDL 219 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~--~~~vkl~Dfg~ 219 (301)
|+.+++|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 129 ~~~gg~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 129 FLSGGELFDRIAAEDY--------KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp CCCCCBHHHHTTCTTC--------CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred cCCCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEeccc
Confidence 9999999999975432 2899999999999999999999999 999999999999974 47899999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
+......... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus 198 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 254 (387)
T 1kob_A 198 ATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254 (387)
T ss_dssp CEECCTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ceecCCCcce---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence 9766543221 33468999999999999999999999999999999999999998654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=313.27 Aligned_cols=205 Identities=23% Similarity=0.307 Sum_probs=179.8
Q ss_pred HHHHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccC-----CCceeeeeeEEEcC
Q 022206 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-----NENVVELVGYYVDG 133 (301)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~ 133 (301)
+.....++|++++.||+|+||.||+|++. +++.||+|++............|+.+++.+. ||||+++++++...
T Consensus 29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~ 108 (360)
T 3llt_A 29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY 108 (360)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence 33445689999999999999999999986 7899999999765555567788999999986 99999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC-----
Q 022206 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD----- 208 (301)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~----- 208 (301)
+..++||||+ +++|.+++...... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 109 ~~~~lv~e~~-~~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 109 DHMCLIFEPL-GPSLYEIITRNNYN-------GFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp TEEEEEECCC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred CeeEEEEcCC-CCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence 9999999999 88999999765421 2889999999999999999999999 999999999999975
Q ss_pred --------------------CCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHH
Q 022206 209 --------------------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLEL 268 (301)
Q Consensus 209 --------------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l 268 (301)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 7899999999987544322 445789999999999999999999999999999999
Q ss_pred HhCCCCCCCCCC
Q 022206 269 LTGRKPVDHTLP 280 (301)
Q Consensus 269 ~~g~~pf~~~~~ 280 (301)
++|+.||...+.
T Consensus 253 l~g~~pf~~~~~ 264 (360)
T 3llt_A 253 YTGSLLFRTHEH 264 (360)
T ss_dssp HHSSCSCCCSSH
T ss_pred HHCCCCCCCCcH
Confidence 999999976543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=304.23 Aligned_cols=200 Identities=26% Similarity=0.424 Sum_probs=171.2
Q ss_pred CCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
++|++++.||+|+||.||+|++.+++.||+|++...... ...+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 579999999999999999999988999999998654332 36788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++ +|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEG--------GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA 149 (288)
T ss_dssp CSE-EHHHHHHTSTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred cCC-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccc
Confidence 986 99999876432 2889999999999999999999999 99999999999999999999999999865
Q ss_pred CCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+
T Consensus 150 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (288)
T 1ob3_A 150 FGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (288)
T ss_dssp HCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCccccc--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4322111 1344689999999998764 58999999999999999999999997654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=315.99 Aligned_cols=196 Identities=23% Similarity=0.315 Sum_probs=167.3
Q ss_pred CceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCCCCH
Q 022206 71 NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSL 148 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL 148 (301)
.+.||+|+||.||+|.+. +++.||+|++..... ....+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 668999999999999986 799999999876442 346788999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEE--cCCCceEEeccccCCCCCcc
Q 022206 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL--FDDDIAKISDFDLSNQAPDA 226 (301)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill--~~~~~vkl~Dfg~a~~~~~~ 226 (301)
.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++......
T Consensus 174 ~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 174 FDRIIDESY--------NLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp HHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred HHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 998865432 2889999999999999999999999 9999999999999 56789999999999766443
Q ss_pred ccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 227 AARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 243 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 293 (373)
T 2x4f_A 243 EKL---KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND 293 (373)
T ss_dssp CBC---CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ccc---ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 322 345699999999999988899999999999999999999999987554
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=306.04 Aligned_cols=208 Identities=24% Similarity=0.360 Sum_probs=162.3
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
..++|++++.||+|+||.||+|.++ +++.||+|++.... .....+.+|+.+++.++||||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 3568999999999999999999977 78999999986543 23467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++ +|.+++....... ....+++..+..++.|++.||.|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 83 e~~~~-~L~~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 83 EFMDN-DLKKYMDSRTVGN---TPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLA 155 (317)
T ss_dssp ECCCC-BHHHHHHHHHSSS---CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred EecCC-CHHHHHHhccccc---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccc
Confidence 99985 9999986532111 1123889999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
......... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 156 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 214 (317)
T 2pmi_A 156 RAFGIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214 (317)
T ss_dssp EETTSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eecCCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 765432211 134568999999999876 4689999999999999999999999976554
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=310.75 Aligned_cols=205 Identities=20% Similarity=0.290 Sum_probs=177.7
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEEEEec
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
.++|++.+.||+|+||.||+|++. +++.||||++..... ...+.+|+.+++.+ +|+||+++++++.+++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 468999999999999999999976 789999999865432 34588999999999 999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc-----eEEecc
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI-----AKISDF 217 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----vkl~Df 217 (301)
+ +++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+||
T Consensus 87 ~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 87 L-GPSLEDLFDLCDR--------TFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDF 154 (330)
T ss_dssp C-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred C-CCCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence 9 8899999985421 2899999999999999999999999 999999999999998887 999999
Q ss_pred ccCCCCCcccccc-----ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCcC
Q 022206 218 DLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (301)
Q Consensus 218 g~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~ 282 (301)
|++.......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.....
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~ 224 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT 224 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc
Confidence 9997654332211 1235679999999999999999999999999999999999999998765443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=300.73 Aligned_cols=205 Identities=24% Similarity=0.368 Sum_probs=181.7
Q ss_pred hhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
..++|++.+.||+|+||.||+|.++++..||+|++.........+.+|++++++++||||+++++++.++...++||||+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 45789999999999999999999998889999999887777788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 86 ~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 86 SNGCLLNYLRSHGK--------GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYV 154 (268)
T ss_dssp TTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred CCCcHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceec
Confidence 99999999976432 2889999999999999999999999 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 155 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 211 (268)
T 3sxs_A 155 LDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN 211 (268)
T ss_dssp CTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred chhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh
Confidence 443222 1133456788999999998889999999999999999999 9999976543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=323.93 Aligned_cols=202 Identities=25% Similarity=0.344 Sum_probs=169.4
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
.++|++.+.||+|+||.||+|++. +++.||+|++... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999987 7999999998642 22335577899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
|||+++|+|.+++..... +++..+..++.||+.||+|||+ .| |+||||||+|||++.++.+||+|||
T Consensus 227 ~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG 294 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERV---------FSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFG 294 (446)
T ss_dssp ECCCSSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCC
T ss_pred EeeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCC
Confidence 999999999999975432 8999999999999999999998 88 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
++......... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 295 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 354 (446)
T 4ejn_A 295 LCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 354 (446)
T ss_dssp CCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CceeccCCCcc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence 99764333221 2456799999999999999999999999999999999999999976543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=310.05 Aligned_cols=205 Identities=25% Similarity=0.417 Sum_probs=169.7
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch----HHHHHHHHHHhccCCCceeeeeeEEEcCCe---
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVGYYVDGPL--- 135 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 135 (301)
..++|++.+.||+|+||.||+|++. +++.||+|++....... ..+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4578999999999999999999986 78999999997654332 457889999999999999999999876543
Q ss_pred -eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 136 -RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 136 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl 157 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKV 157 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEE
T ss_pred ccEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEE
Confidence 499999999999999997543 2899999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+..+
T Consensus 158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 224 (311)
T 3ork_A 158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224 (311)
T ss_dssp CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 999999766443221 122345689999999999999999999999999999999999999977654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=301.62 Aligned_cols=204 Identities=25% Similarity=0.431 Sum_probs=178.9
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
.++|++.+.||+|+||.||++.+.++..||+|++.......+.+.+|+++++.++|+||+++++++.+.+..++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 46899999999999999999999988899999998777777889999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
+++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++....
T Consensus 103 ~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 103 NGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp TCBHHHHHHCGGG--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 9999999976332 2899999999999999999999999 9999999999999999999999999987654
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.....
T Consensus 172 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~ 227 (283)
T 3gen_A 172 DDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227 (283)
T ss_dssp CHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh
Confidence 43222 1233456788999999998999999999999999999998 9999986554
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=304.79 Aligned_cols=208 Identities=34% Similarity=0.478 Sum_probs=170.9
Q ss_pred HhhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCch---HHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
....+|++.+.||+|+||.||+|++. +..||+|++....... ..+.+|+.++++++||||+++++++.+.+..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 34568999999999999999999875 7899999987654433 4678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+++++|.+++...... ..+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||+
T Consensus 113 ~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAR------EQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp EECCTTCBHHHHHHSTTHH------HHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred EecCCCCcHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 9999999999999764321 12788999999999999999999985 2399999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.++
T Consensus 186 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~ 244 (309)
T 3p86_A 186 SRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP 244 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred Ccccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 875443321 12345789999999999999999999999999999999999999987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=300.59 Aligned_cols=197 Identities=21% Similarity=0.368 Sum_probs=169.4
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
++|++.+.||+|+||+||+|+++ +++.||+|++...... ...+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999987 7899999998654332 3668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+++ +|.+.+..... .+++..++.++.|++.||+|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 82 ~~~~-~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~ 149 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNG--------DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp CCSE-EHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCC-CHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccce
Confidence 9987 56665544321 2899999999999999999999999 9999999999999999999999999997
Q ss_pred CCCccccccccccccccccccCccccccCC-CCccccchhhHHHHHHHHhCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVD 276 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~pf~ 276 (301)
........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 150 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 150 AFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp ECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred ecCCcccc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence 65432221 24457899999999987765 7999999999999999999887753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=312.95 Aligned_cols=207 Identities=17% Similarity=0.259 Sum_probs=178.2
Q ss_pred hhCCCCCCceeccc--CceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 64 KTDNFGTNSLIGEG--SYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 64 ~~~~y~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
..++|++++.||+| +||.||+|+++ +++.||||++...... ...+.+|+.+++.++||||+++++++.+++..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35789999999999 99999999987 7999999999754333 255778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+||||+++++|.+++...... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~df 172 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMD-------GMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGL 172 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTT-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCG
T ss_pred EEEEccCCCCHHHHHhhhccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccc
Confidence 999999999999999765321 2899999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccc-----cccccccccccccCcccccc--CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 218 DLSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 218 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|.+......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 987654322111 11123468999999999987 5789999999999999999999999987554
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=321.16 Aligned_cols=202 Identities=26% Similarity=0.387 Sum_probs=178.7
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
..++|.+.+.||+|+||.||+|++. +|+.||||++.... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3578999999999999999999987 79999999986432 233568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||||+++|+|.+++..... +++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 94 v~E~~~gg~L~~~l~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG 161 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNGR---------LDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFG 161 (476)
T ss_dssp EEECCSSEEHHHHTTSSSS---------CCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCS
T ss_pred EEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEecc
Confidence 9999999999999975432 899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
++........ ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+...
T Consensus 162 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 221 (476)
T 2y94_A 162 LSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV 221 (476)
T ss_dssp SCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS
T ss_pred chhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH
Confidence 9976544322 245579999999999988765 6899999999999999999999986543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=312.72 Aligned_cols=204 Identities=24% Similarity=0.386 Sum_probs=164.8
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccC-CCceeeeeeEEEcCC--e
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLK-NENVVELVGYYVDGP--L 135 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~ 135 (301)
...++|++++.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.+++.+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 35689999999999999999999987 7999999998654332 345778999999997 999999999997544 6
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
.|+||||+++ +|.+++.... +++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+
T Consensus 86 ~~lv~e~~~~-~L~~~~~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~ 151 (388)
T 3oz6_A 86 VYLVFDYMET-DLHAVIRANI----------LEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVA 151 (388)
T ss_dssp EEEEEECCSE-EHHHHHHHTC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEecccCc-CHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEec
Confidence 8999999985 9999997643 889999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccc-------------------cccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCC
Q 022206 216 DFDLSNQAPDAA-------------------ARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPV 275 (301)
Q Consensus 216 Dfg~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf 275 (301)
|||+++...... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||
T Consensus 152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 231 (388)
T 3oz6_A 152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231 (388)
T ss_dssp CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence 999997543210 0111234579999999999876 67899999999999999999999999
Q ss_pred CCCCC
Q 022206 276 DHTLP 280 (301)
Q Consensus 276 ~~~~~ 280 (301)
.+.+.
T Consensus 232 ~~~~~ 236 (388)
T 3oz6_A 232 PGSST 236 (388)
T ss_dssp CCSSH
T ss_pred CCCCH
Confidence 87654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=306.14 Aligned_cols=205 Identities=30% Similarity=0.488 Sum_probs=174.3
Q ss_pred hCCCCCCceecccCceEEEEEEEC-C---CCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-S---GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
.++|++.+.||+|+||.||+|++. + +..||||++...... ...+.+|+.+++.++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999986 3 445999999764333 3568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 128 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg 196 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDG--------QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFG 196 (325)
T ss_dssp EEECCTTCBHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCS
T ss_pred EeeCCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCC
Confidence 9999999999999965432 2899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 219 LSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 219 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 260 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH
Confidence 99776543221 11223346788999999998999999999999999999999 9999976554
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=301.17 Aligned_cols=203 Identities=26% Similarity=0.382 Sum_probs=172.1
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC------CchHHHHHHHHHHhccC---CCceeeeeeEEEcC
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK------QPDQEFLAQVSMVSRLK---NENVVELVGYYVDG 133 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~ 133 (301)
..++|++.+.||+|+||.||+|++. +++.||+|++.... .....+.+|+.+++.++ ||||+++++++.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4579999999999999999999976 79999999986322 12346777887777665 99999999999875
Q ss_pred C-----eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC
Q 022206 134 P-----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (301)
Q Consensus 134 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 208 (301)
. ..+++||++.+ +|.+++...... .+++..++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~ 155 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPP-------GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTS 155 (308)
T ss_dssp CSSSEEEEEEEEECCCC-BHHHHHHTCCTT-------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECT
T ss_pred CCCCceeEEEEehhhhc-CHHHHHhhccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcC
Confidence 5 57999999975 999999865432 2899999999999999999999999 999999999999999
Q ss_pred CCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 209 DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 209 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
++.+||+|||++......... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 156 ~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 224 (308)
T 3g33_A 156 GGTVKLADFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 224 (308)
T ss_dssp TSCEEECSCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH
T ss_pred CCCEEEeeCccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999766433222 455789999999999999999999999999999999999999977554
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=321.11 Aligned_cols=199 Identities=23% Similarity=0.281 Sum_probs=167.8
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcC------
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDG------ 133 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 133 (301)
..++|++++.||+|+||.||+|.+. +++.||||++..... ....+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999987 789999999975322 235678999999999999999999999755
Q ss_pred CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceE
Q 022206 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (301)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (301)
...++||||+++ +|.+.+... +++..+..++.||+.||+|||+.| |+||||||+|||++.++.+|
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~~-----------l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~k 204 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 204 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTSC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred CeEEEEEeCCCC-CHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEE
Confidence 356999999987 577776532 788999999999999999999999 99999999999999999999
Q ss_pred EeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|+|||++........ ....+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.
T Consensus 205 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~ 268 (464)
T 3ttj_A 205 ILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 268 (464)
T ss_dssp ECCCCCC-----CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEEEeeeecCCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999976644322 2456799999999999999999999999999999999999999987653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=304.32 Aligned_cols=203 Identities=23% Similarity=0.359 Sum_probs=175.0
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHhccCCCceeeeeeEEEcCC--eeEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP--LRVLA 139 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 139 (301)
.++|++.+.||+|+||.||+|++. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999987 69999999987533 23466789999999999999999999988655 78999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEE----cCCCceEEe
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKIS 215 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~vkl~ 215 (301)
|||+++++|.+++...... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLT 158 (319)
T ss_dssp EECCTTCBHHHHHHSGGGT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred EeCCCCCCHHHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEc
Confidence 9999999999999764321 12889999999999999999999999 9999999999999 778889999
Q ss_pred ccccCCCCCccccccccccccccccccCccccc--------cCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM--------TGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|||++......... ....||+.|+|||++. +..++.++|||||||++|+|++|+.||....
T Consensus 159 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 159 DFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp CCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred cCCCceecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999766543322 3456899999999886 4678899999999999999999999997543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=315.60 Aligned_cols=206 Identities=27% Similarity=0.454 Sum_probs=177.5
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
..++|.+.+.||+|+||.||+|+++ +++.||+|++...... ...+.+|+.+++.++||||+++++++.+++..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3467899999999999999999987 7899999998754332 245788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++|+|.+++..... .+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++
T Consensus 192 e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s 260 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGA--------RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMS 260 (377)
T ss_dssp ECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred EcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCc
Confidence 99999999999975432 2889999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
................+++.|+|||++.+..++.++||||||+++|||++ |..||.+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~ 321 (377)
T 3cbl_A 261 REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN 321 (377)
T ss_dssp EECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH
T ss_pred eecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 76543322211122345788999999998889999999999999999998 9999987654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=333.46 Aligned_cols=203 Identities=24% Similarity=0.319 Sum_probs=178.5
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 137 (301)
..++|++++.||+|+||.||+|+++ +++.||||++.+. ......+..|..++..+ +|++|+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999987 6889999998642 23345678889999887 6999999999999999999
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+||||+++|+|.+++..... +++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+||
T Consensus 419 lV~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DF 486 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGR---------FKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADF 486 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCC
T ss_pred EEEeCcCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeec
Confidence 99999999999999976432 899999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+.
T Consensus 487 Gla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~ 547 (674)
T 3pfq_A 487 GMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547 (674)
T ss_dssp TTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH
Confidence 99975432221 22556899999999999999999999999999999999999999987554
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=303.38 Aligned_cols=202 Identities=27% Similarity=0.394 Sum_probs=178.6
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-------chHHHHHHHHHHhccCCCceeeeeeEEEcCCe
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 135 (301)
..++|++.+.||+|+||.||+|++. +++.||+|++..... ....+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3467999999999999999999987 789999999865332 24678999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC----c
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----I 211 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~ 211 (301)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++ .
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~ 157 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPH 157 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCS---------CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCC
Confidence 999999999999999997643 2889999999999999999999999 99999999999999887 7
Q ss_pred eEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+...
T Consensus 158 ~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 223 (321)
T 2a2a_A 158 IKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223 (321)
T ss_dssp EEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred EEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH
Confidence 99999999876654322 1345689999999999989999999999999999999999999976543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=305.93 Aligned_cols=194 Identities=24% Similarity=0.358 Sum_probs=152.3
Q ss_pred CceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccC-CCceeeeeeEEEcCCeeEEEEecCCCCCH
Q 022206 71 NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVLAYEHASKGSL 148 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~gsL 148 (301)
.+.||+|+||.||+|.++ +++.||+|++... ......+|+.+++.+. ||||+++++++.++...++||||+++++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 478999999999999987 7899999998643 3466788999999997 99999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC---ceEEeccccCCCCCc
Q 022206 149 HDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPD 225 (301)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~Dfg~a~~~~~ 225 (301)
.+++..... +++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||++.....
T Consensus 94 ~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 94 FERIKKKKH---------FSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp HHHHHHCSC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred HHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 999976542 899999999999999999999999 99999999999998765 899999999976543
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 214 (325)
T 3kn6_A 162 DNQP--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214 (325)
T ss_dssp ------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred CCCc--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 3221 2345689999999999999999999999999999999999999976543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=304.09 Aligned_cols=204 Identities=23% Similarity=0.399 Sum_probs=171.5
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHhccCCCceeeeeeEEEcCC------
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP------ 134 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 134 (301)
..++|++.+.||+|+||.||+|+++ +++.||||++.... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3567999999999999999999987 79999999986433 33467899999999999999999999986543
Q ss_pred ---------------------------------------------------eeEEEEecCCCCCHHHHhcCCCCCCCCCC
Q 022206 135 ---------------------------------------------------LRVLAYEHASKGSLHDILHGKKGVKGAKP 163 (301)
Q Consensus 135 ---------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~ 163 (301)
..+++|||+++++|.+++......
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~----- 158 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL----- 158 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG-----
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc-----
Confidence 379999999999999999865432
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCccccc----------cccc
Q 022206 164 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAAR----------LHST 233 (301)
Q Consensus 164 ~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~----------~~~~ 233 (301)
....+..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......... ....
T Consensus 159 -~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 159 -EDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp -GGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred -cchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence 12566778999999999999999999 999999999999999999999999999776543211 1123
Q ss_pred cccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCC
Q 022206 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276 (301)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~ 276 (301)
...||+.|+|||++.+..++.++||||||+++|+|++|..|+.
T Consensus 235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 4569999999999999999999999999999999999988763
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=308.61 Aligned_cols=201 Identities=23% Similarity=0.364 Sum_probs=176.6
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---------chHHHHHHHHHHhccCCCceeeeeeEEEc
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---------PDQEFLAQVSMVSRLKNENVVELVGYYVD 132 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 132 (301)
...++|++.+.||+|+||.||+|+++ +++.||+|++..... ....+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 45678999999999999999999977 789999999876432 12356789999999999999999999999
Q ss_pred CCeeEEEEecCCCC-CHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc
Q 022206 133 GPLRVLAYEHASKG-SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (301)
Q Consensus 133 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (301)
.+..++||||+.+| +|.+++..... +++..++.++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 168 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPR---------LDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFT 168 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCc
Confidence 99999999999776 99999986542 899999999999999999999999 999999999999999999
Q ss_pred eEEeccccCCCCCccccccccccccccccccCccccccCCC-CccccchhhHHHHHHHHhCCCCCCCC
Q 022206 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
+||+|||++......... ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||...
T Consensus 169 ~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 169 IKLIDFGSAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp EEECCCTTCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred EEEeecccceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 999999999766543322 34578999999999988776 78999999999999999999999753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=309.96 Aligned_cols=199 Identities=26% Similarity=0.393 Sum_probs=172.5
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEEEEe
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
..++|++.+.||+|+||.||+|.++ +++.||+|++.+.... ..+|++++.++ +||||+++++++.++...++|||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 4567999999999999999999987 7899999999765433 34678888877 79999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC----CceEEecc
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD----DIAKISDF 217 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~----~~vkl~Df 217 (301)
|+++|+|.+++..... +++..+..++.||+.||+|||++| |+||||||+|||+.++ +.+||+||
T Consensus 97 ~~~gg~L~~~i~~~~~---------~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Df 164 (342)
T 2qr7_A 97 LMKGGELLDKILRQKF---------FSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDF 164 (342)
T ss_dssp CCCSCBHHHHHHTCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred CCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence 9999999999976542 899999999999999999999999 9999999999998543 35999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|++......... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 165 g~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 224 (342)
T 2qr7_A 165 GFAKQLRAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP 224 (342)
T ss_dssp TTCEECBCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST
T ss_pred CCcccCcCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC
Confidence 999765433221 244578999999999988888999999999999999999999997643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=312.75 Aligned_cols=211 Identities=27% Similarity=0.418 Sum_probs=176.8
Q ss_pred hCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 136 (301)
.++|++.+.||+|+||.||+|++. ++..||||++...... ...+.+|+.+++.++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467999999999999999999943 4678999999754333 34688899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC---ceE
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD---IAK 213 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~vk 213 (301)
++||||+++|+|.+++....... .....+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+|
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred EEEEEeCCCCCHHHHHHhhcccc--CccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999997543211 11234889999999999999999999999 99999999999999555 599
Q ss_pred EeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
|+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~ 292 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 292 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999865433222222234567999999999999999999999999999999998 9999987654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=299.55 Aligned_cols=202 Identities=25% Similarity=0.386 Sum_probs=171.6
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
.++|++++.||+|+||.||+|++. +++.||+|++...... ...+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 468999999999999999999987 6999999998765443 245778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++++|.+++..... +++..+..++.|++.||.|||+.| |+||||||+||+++.++.+||+|||++
T Consensus 82 e~~~~~~l~~~~~~~~~---------~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRG---------VPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFA 149 (311)
T ss_dssp ECCSEEHHHHHHHTSSC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EeCCCchHHHHHhhhcC---------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCc
Confidence 99999999998875442 889999999999999999999999 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
......... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+...
T Consensus 150 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 208 (311)
T 4agu_A 150 RLLTGPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD 208 (311)
T ss_dssp EECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred hhccCcccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 765533221 134568999999999876 5679999999999999999999999987654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=308.72 Aligned_cols=220 Identities=22% Similarity=0.361 Sum_probs=181.4
Q ss_pred HHHHHHhhCCCCCCceecccCceEEEEEEE-----C-CCCEEEEEEcCCCCCch--HHHHHHHHHHhcc-CCCceeeeee
Q 022206 58 VDELKEKTDNFGTNSLIGEGSYGRVYFGVL-----R-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRL-KNENVVELVG 128 (301)
Q Consensus 58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~-~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l-~h~~iv~~~~ 128 (301)
...+....++|++.+.||+|+||.||+|++ . +++.||||++....... ..+.+|+++++++ +||||+++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 344455668999999999999999999983 2 56899999997654332 4688999999999 7899999999
Q ss_pred EEEcCC-eeEEEEecCCCCCHHHHhcCCCCCCCC----------------------------------------------
Q 022206 129 YYVDGP-LRVLAYEHASKGSLHDILHGKKGVKGA---------------------------------------------- 161 (301)
Q Consensus 129 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~---------------------------------------------- 161 (301)
++.+.+ ..++||||+++|+|.+++.........
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 988755 489999999999999999765421000
Q ss_pred -----------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCcccccc
Q 022206 162 -----------KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARL 230 (301)
Q Consensus 162 -----------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~ 230 (301)
.....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence 00122889999999999999999999999 9999999999999999999999999998764433332
Q ss_pred ccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 231 HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 301 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 301 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch
Confidence 3345568999999999999999999999999999999998 9999976543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=305.39 Aligned_cols=202 Identities=24% Similarity=0.376 Sum_probs=177.9
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
..++|.+.+.||+|+||.||++.+. +++.+|+|++..... ..+.+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 4568999999999999999999987 688999999865322 23568889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||||+++++|.+++..... +++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 119 v~e~~~~~~L~~~~~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 186 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKA---------LTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFG 186 (335)
T ss_dssp EECCCTTCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCT
T ss_pred EEecCCCCCHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeecc
Confidence 9999999999999875432 899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
++......... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 187 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 187 LATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp TCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 98765432211 234568999999999998889999999999999999999999997644
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=319.78 Aligned_cols=202 Identities=24% Similarity=0.349 Sum_probs=158.1
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEc-----CCe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD-----GPL 135 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~ 135 (301)
.++|++++.||+|+||.||+|+++ +++.||||++...... ...+.+|+.+|+.++|+||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999987 7999999998654333 3568899999999999999999999843 356
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
+|+|||++. ++|.+++..... +++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~ 198 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPVY---------LTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVC 198 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSCC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEeccc-cchhhhcccCCC---------CCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeec
Confidence 899999985 599999976432 899999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccc-------------------------cccccccccccccCcccc-ccCCCCccccchhhHHHHHHHH
Q 022206 216 DFDLSNQAPDAAAR-------------------------LHSTRVLGTFGYHAPEYA-MTGQMSSKSDVYSFGVVLLELL 269 (301)
Q Consensus 216 Dfg~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~ 269 (301)
|||+++........ ......+||+.|+|||++ ....++.++|||||||++|||+
T Consensus 199 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ell 278 (458)
T 3rp9_A 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278 (458)
T ss_dssp CCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred ccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHH
Confidence 99999875422110 112345789999999976 4567999999999999999999
Q ss_pred h-----------CCCCCCCCC
Q 022206 270 T-----------GRKPVDHTL 279 (301)
Q Consensus 270 ~-----------g~~pf~~~~ 279 (301)
+ |+++|.+.+
T Consensus 279 tg~~~~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 279 NMIKENVAYHADRGPLFPGSS 299 (458)
T ss_dssp TTSTTTCSSGGGCCCSCC---
T ss_pred HhccccccccccccccCCCCc
Confidence 9 677776543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=305.84 Aligned_cols=201 Identities=22% Similarity=0.395 Sum_probs=168.5
Q ss_pred hhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCch---HHHHHHHHHHhccCC--CceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKN--ENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~l 138 (301)
..++|++.+.||+|+||.||++.+.+++.||+|++....... ..+.+|+.+++.++| +||+++++++.++...++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 356799999999999999999999889999999987554432 567899999999986 999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||| +.+++|.+++..... +++..+..++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|||
T Consensus 87 v~e-~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG 152 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFG 152 (343)
T ss_dssp EEC-CCSEEHHHHHHHSCC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred EEe-CCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecc
Confidence 999 567799999986542 889999999999999999999999 99999999999996 6789999999
Q ss_pred cCCCCCccccccccccccccccccCcccccc-----------CCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----------GQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
++................||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 153 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 153 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp SSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 9987654433322345679999999999865 67888999999999999999999999764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=309.66 Aligned_cols=200 Identities=21% Similarity=0.385 Sum_probs=168.6
Q ss_pred CCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHhccC--CCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLK--NENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~ 140 (301)
.+|++.+.||+|+||.||+|.+.+++.||||++...... ...+.+|+.+++.++ |+||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 469999999999999999999888999999998755433 356889999999996 599999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
| +.+++|.+++..... +++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||++
T Consensus 136 E-~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a 201 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIA 201 (390)
T ss_dssp E-CCSEEHHHHHHHCSS---------CCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred e-cCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcc
Confidence 9 567899999976542 788899999999999999999999 99999999999995 589999999999
Q ss_pred CCCCccccccccccccccccccCcccccc-----------CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMT-----------GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
...............+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 87654433222345679999999999865 368889999999999999999999997643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=307.76 Aligned_cols=214 Identities=29% Similarity=0.436 Sum_probs=181.2
Q ss_pred hhCCCCCCceecccCceEEEEEEEC--------CCCEEEEEEcCCCCCch--HHHHHHHHHHhcc-CCCceeeeeeEEEc
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRL-KNENVVELVGYYVD 132 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 132 (301)
..++|.+.+.||+|+||.||+|++. .+..||+|++....... ..+.+|+++++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4568999999999999999999963 23579999997654433 5688999999999 89999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHhcCCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceE
Q 022206 133 GPLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (301)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nil 205 (301)
.+..++||||+++|+|.+++....... .......+++..++.++.|++.||.|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 999999999999999999997654211 0112234899999999999999999999999 999999999999
Q ss_pred EcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 206 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999987654433223344567899999999999999999999999999999999 9999976543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=318.71 Aligned_cols=206 Identities=24% Similarity=0.436 Sum_probs=179.6
Q ss_pred HhhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
...++|++.+.||+|+||.||+|.++++..||||++.......+.+.+|+.+|+.++||||+++++++. .+..++||||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 345678999999999999999999988889999999877666788999999999999999999999886 6678999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+.+|+|.+++...... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 264 ~~~g~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGS-------KQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp CTTCBHHHHHHSHHHH-------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred cCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 9999999999754311 2788899999999999999999999 99999999999999999999999999976
Q ss_pred CCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
....... ......+++.|+|||++....++.++||||||+++|+|++ |+.||.+.+.
T Consensus 334 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~ 391 (454)
T 1qcf_A 334 IEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391 (454)
T ss_dssp BCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 6443221 1123346789999999998999999999999999999999 9999987554
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=294.92 Aligned_cols=202 Identities=22% Similarity=0.333 Sum_probs=176.8
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC-CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS-KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
...++|++.+.||+|+||.||+|.++ ++..+|+|++... ....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 34567999999999999999999987 6789999998653 334567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEE---cCCCceEEecc
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDF 217 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~Df 217 (301)
||+++++|.+++..... +++..++.++.|++.||.|||+.+ ++||||||+||++ +.++.+||+||
T Consensus 86 e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRV---------FRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp ECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred eccCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEec
Confidence 99999999998875432 889999999999999999999999 9999999999999 77889999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|++......... ....||+.|+|||++.+. ++.++||||||+++|+|++|+.||.....
T Consensus 154 g~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 212 (277)
T 3f3z_A 154 GLAARFKPGKMM---RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD 212 (277)
T ss_dssp TTCEECCTTSCB---CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccceeccCccch---hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH
Confidence 998765433222 445789999999988654 89999999999999999999999976543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=296.15 Aligned_cols=202 Identities=25% Similarity=0.382 Sum_probs=177.3
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
..++|++.+.||+|+||.||+|.++ +++.||+|++...... ...+.+|+.++++++||||+++++++.+++..+++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999999999999987 6899999998654433 25678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc---eEEec
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI---AKISD 216 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---vkl~D 216 (301)
|||+++++|.+.+..... +++..++.++.|++.||.|||+.+ ++||||||+||+++.++. +||+|
T Consensus 84 ~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~D 151 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREF---------YSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLAD 151 (284)
T ss_dssp ECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECC
T ss_pred EecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEee
Confidence 999999999998875432 899999999999999999999999 999999999999986654 99999
Q ss_pred cccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+...
T Consensus 152 fg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 212 (284)
T 3kk8_A 152 FGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 212 (284)
T ss_dssp CTTCEECCSSCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ceeeEEcccCccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch
Confidence 9998765543322 345789999999999999999999999999999999999999976543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=307.12 Aligned_cols=217 Identities=27% Similarity=0.411 Sum_probs=179.5
Q ss_pred HHHhhCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEc
Q 022206 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVD 132 (301)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 132 (301)
+....++|++.+.||+|+||.||+|++. +++.||+|++...... ...+.+|+.+++.++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445678999999999999999999975 3478999999765433 3568899999999999999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHhcCCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEec
Q 022206 133 GPLRVLAYEHASKGSLHDILHGKKGVKG---------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 197 (301)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~---------------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~ 197 (301)
++..++||||+++++|.+++........ ......+++..++.++.||+.||.|||+++ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 9999999999999999999976431100 001134899999999999999999999999 9999
Q ss_pred CCCCCceEEcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCC
Q 022206 198 NIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVD 276 (301)
Q Consensus 198 Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~ 276 (301)
||||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999865543322222234567899999999999999999999999999999999 999997
Q ss_pred CCCC
Q 022206 277 HTLP 280 (301)
Q Consensus 277 ~~~~ 280 (301)
+...
T Consensus 279 ~~~~ 282 (343)
T 1luf_A 279 GMAH 282 (343)
T ss_dssp TSCH
T ss_pred CCCh
Confidence 6543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=294.34 Aligned_cols=204 Identities=25% Similarity=0.458 Sum_probs=181.0
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
.++|++.+.||+|+||.||+|.+.+++.||+|++.......+.+.+|+.+++.++||||+++++++.+.+..+++|||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 35789999999999999999999888899999998777677889999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
+++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 87 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 87 HGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp TCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CCcHHHHHhhCcc--------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccc
Confidence 9999999976432 2789999999999999999999999 9999999999999999999999999987654
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
..... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.....
T Consensus 156 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 211 (267)
T 3t9t_A 156 DDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 211 (267)
T ss_dssp CHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred ccccc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH
Confidence 33211 1233457889999999998899999999999999999999 9999986543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=296.84 Aligned_cols=206 Identities=30% Similarity=0.449 Sum_probs=159.6
Q ss_pred HHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCee
Q 022206 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (301)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 136 (301)
....++|++.+.||+|+||.||+|++. +++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 445678999999999999999999986 79999999986432 2236688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~d 155 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVK--------PFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIAD 155 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECC
T ss_pred EEEEecCCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEe
Confidence 999999999999999976432 2899999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 156 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 156 FGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp CTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred ecceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence 9998765432221 1345689999999999988899999999999999999999999976543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=307.62 Aligned_cols=205 Identities=25% Similarity=0.448 Sum_probs=165.3
Q ss_pred hCCCCCCceecccCceEEEEEEEC----CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
.++|.+.+.||+|+||.||+|+++ ++..||||++...... ...+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 358999999999999999999865 4678999999765433 3568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 124 v~e~~~~~sL~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg 192 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDA--------QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFG 192 (373)
T ss_dssp EEECCTTCBHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-
T ss_pred EEeCCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCc
Confidence 9999999999999976432 2899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccccc-ccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 219 LSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 219 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
++.......... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+...
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~ 256 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256 (373)
T ss_dssp ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 997765432211 1122245778999999999999999999999999999998 9999976544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=306.76 Aligned_cols=206 Identities=26% Similarity=0.438 Sum_probs=168.8
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCE----EEEEEcCCCC--CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRA----AAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
.++|++.+.||+|+||.||+|++. +++. ||+|.+.... .....+.+|+.++++++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 467999999999999999999976 4443 5888875432 33467899999999999999999999998765 77
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+++|++.+|+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Df 161 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT--------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCT
T ss_pred EEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccC
Confidence 89999999999999976442 2889999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCcC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRG 282 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~ 282 (301)
|++................+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.....
T Consensus 162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 227 (327)
T 3poz_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227 (327)
T ss_dssp THHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred cceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH
Confidence 99876543333222234457889999999999999999999999999999999 999998765533
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=306.04 Aligned_cols=205 Identities=26% Similarity=0.414 Sum_probs=171.9
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCE----EEEEEcCCCC--CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRA----AAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
.++|++.+.||+|+||.||+|++. +++. |++|.+.... .....+.+|+.+++.++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 468999999999999999999976 4554 7888775432 22345778999999999999999999886 55688
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+||||+.+|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Df 159 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRG--------ALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADF 159 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGG--------GSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSC
T ss_pred EEEEeCCCCCHHHHHHHccc--------cCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCC
Confidence 99999999999999976532 2788899999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCc
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~ 281 (301)
|++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus 160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 224 (325)
T 3kex_A 160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA 224 (325)
T ss_dssp SGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT
T ss_pred CcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH
Confidence 99987654443333345567889999999999999999999999999999999 99999876543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=321.73 Aligned_cols=207 Identities=28% Similarity=0.421 Sum_probs=182.0
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
...+|++.+.||+|+||.||+|.++ ++..||||++.......+.+.+|+.+|++++||||+++++++.+....++||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3467889999999999999999987 588999999987776778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++|+|.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 298 ~~~g~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 298 MTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp CTTCBHHHHHHHSCT-------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred cCCCCHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeeccccee
Confidence 999999999975432 12889999999999999999999999 99999999999999999999999999977
Q ss_pred CCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCc
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~ 281 (301)
....... ......+++.|+|||++....++.++||||||+++|+|++ |..||.+.+..
T Consensus 368 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~ 426 (495)
T 1opk_A 368 MTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 426 (495)
T ss_dssp CTTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred ccCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 6433221 1123346789999999998899999999999999999999 99999876543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=302.62 Aligned_cols=215 Identities=25% Similarity=0.396 Sum_probs=180.2
Q ss_pred hhCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCe
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 135 (301)
..++|.+.+.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.+++.++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3578999999999999999999862 4578999999765433 2568899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKG---------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 200 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~---------------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk 200 (301)
.++||||+++++|.+++........ ......+++..++.++.|++.||.|||+++ ++|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999976542100 001123889999999999999999999999 9999999
Q ss_pred CCceEEcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCC
Q 022206 201 SSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTL 279 (301)
Q Consensus 201 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~ 279 (301)
|+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999876644333222334457889999999998889999999999999999999 999998765
Q ss_pred Cc
Q 022206 280 PR 281 (301)
Q Consensus 280 ~~ 281 (301)
..
T Consensus 258 ~~ 259 (314)
T 2ivs_A 258 PE 259 (314)
T ss_dssp GG
T ss_pred HH
Confidence 53
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=306.73 Aligned_cols=197 Identities=26% Similarity=0.382 Sum_probs=167.4
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCC------
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP------ 134 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 134 (301)
.++|++.+.||+|+||.||+|.+. +++.||||++...... ...+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 478999999999999999999986 7999999998654333 356789999999999999999999998653
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
..++||||+ +++|.+++.... +++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl 169 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHEK----------LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKI 169 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEE
Confidence 469999999 779999997643 889999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 170 ~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 231 (367)
T 1cm8_A 170 LDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 231 (367)
T ss_dssp CCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred Eeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999765432 144578999999999877 6789999999999999999999999987654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=293.56 Aligned_cols=205 Identities=29% Similarity=0.424 Sum_probs=178.5
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... .....+.+|+.+++.++||||+++++++.+++..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3567999999999999999999987 78999999986432 33467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 85 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 152 (276)
T 2yex_A 85 EYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 152 (276)
T ss_dssp ECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EecCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCc
Confidence 9999999999987543 2889999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
................||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 76543322222345678999999999887665 7789999999999999999999976544
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=302.44 Aligned_cols=211 Identities=24% Similarity=0.369 Sum_probs=161.3
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCC---EEEEEEcCCCC---CchHHHHHHHHHHhccCCCceeeeeeEEEcCCee
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGR---AAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 136 (301)
..++|++.+.||+|+||.||+|++. ++. .||+|++.... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 3568999999999999999999976 333 89999987543 2246788999999999999999999999877655
Q ss_pred ------EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC
Q 022206 137 ------VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (301)
Q Consensus 137 ------~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 210 (301)
+++|||+.+++|.+++........ ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGEN---PFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDM 174 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTS
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhcccc---ccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCC
Confidence 999999999999999964331110 113889999999999999999999999 99999999999999999
Q ss_pred ceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 245 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN 245 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh
Confidence 999999999977654433222234456889999999999999999999999999999999 9999987654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=294.25 Aligned_cols=218 Identities=42% Similarity=0.640 Sum_probs=184.2
Q ss_pred cccccCHHHHHHhhCCCCCC------ceecccCceEEEEEEECCCCEEEEEEcCCCC-----CchHHHHHHHHHHhccCC
Q 022206 52 AVPVISVDELKEKTDNFGTN------SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRLKN 120 (301)
Q Consensus 52 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h 120 (301)
....++..++....++|... +.||+|+||.||+|.+. ++.||+|++.... .....+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34556777788877777766 89999999999999874 7899999986432 224678899999999999
Q ss_pred CceeeeeeEEEcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 022206 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 200 (301)
Q Consensus 121 ~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk 200 (301)
|||+++++++.+.+..+++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|||||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlk 160 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG------TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIK 160 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG------CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC------CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCC
Confidence 9999999999999999999999999999999974322 123889999999999999999999999 9999999
Q ss_pred CCceEEcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 201 SSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 201 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|+||+++.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||.....
T Consensus 161 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred HHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 9999999999999999999876544332222344578999999998765 478899999999999999999999987544
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=312.91 Aligned_cols=202 Identities=31% Similarity=0.516 Sum_probs=174.9
Q ss_pred hhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCC-eeEEEEec
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP-LRVLAYEH 142 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~ 142 (301)
..++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.+|++++||||+++++++.+.. ..++||||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 3467889999999999999999987 7899999997654 4577999999999999999999999987665 78999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++|+|.+++..... ..++...++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 269 ~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp CTTCBHHHHHHHHCT-------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 999999999976432 12688999999999999999999999 99999999999999999999999999875
Q ss_pred CCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCcC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRG 282 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~ 282 (301)
..... ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+.....
T Consensus 339 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~ 394 (450)
T 1k9a_A 339 ASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 394 (450)
T ss_dssp CC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT
T ss_pred ccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 43321 22356889999999999999999999999999999998 999998765543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=295.08 Aligned_cols=201 Identities=29% Similarity=0.447 Sum_probs=174.6
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
..++|++.+.||+|+||.||+|.+. ++..||+|++.... .....+.+|+.+++.++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3578999999999999999999987 68899999985422 224568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||||+++++|.+++..... +++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 87 v~e~~~~~~l~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg 154 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSK---------FDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG 154 (279)
T ss_dssp EECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCC
T ss_pred EEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecc
Confidence 9999999999999975432 889999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
++........ ....|++.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 155 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 212 (279)
T 3fdn_A 155 WSVHAPSSRR----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 212 (279)
T ss_dssp EESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ccccCCcccc----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH
Confidence 9866543321 345689999999999999999999999999999999999999986553
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=292.67 Aligned_cols=200 Identities=33% Similarity=0.528 Sum_probs=165.4
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCc-----hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
.++|++.+.||+|+||.||+|.+. ++.||+|++...... .+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999986 889999998654322 35688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC--------CCc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--------DDI 211 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~--------~~~ 211 (301)
|||+++++|.+++.... +++..++.++.|++.||.|||+.+..+++||||||+|||++. ++.
T Consensus 85 ~e~~~~~~L~~~~~~~~----------~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~ 154 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGKR----------IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI 154 (271)
T ss_dssp EECCTTEEHHHHHTSSC----------CCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred EEcCCCCCHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence 99999999999996543 899999999999999999999987445789999999999986 678
Q ss_pred eEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
+||+|||++........ ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+
T Consensus 155 ~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 218 (271)
T 3dtc_A 155 LKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218 (271)
T ss_dssp EEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred eEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999976543322 24468999999999999999999999999999999999999998654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=303.19 Aligned_cols=201 Identities=22% Similarity=0.377 Sum_probs=167.3
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch--HHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
++|++++.||+|+||.||+|++. +++.||+|++....... ..+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999987 78999999986543222 2355789999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++ +|.+++..... .+++..+..++.|++.||.|||+.| |+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 149 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGN--------IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARA 149 (324)
T ss_dssp CSE-EHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEEC
T ss_pred ccc-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCccccc
Confidence 985 89998876432 2889999999999999999999999 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
....... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+.
T Consensus 150 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (324)
T 3mtl_A 150 KSIPTKT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV 206 (324)
T ss_dssp C--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccCCccc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 5433221 134468999999999876 5689999999999999999999999987654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=305.91 Aligned_cols=217 Identities=27% Similarity=0.311 Sum_probs=174.5
Q ss_pred HHHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC------CCchHHHHHHHHHHhccCCCceeeeeeEEEcC
Q 022206 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS------KQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133 (301)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 133 (301)
+....++|++.+.||+|+||.||+|.+. ++..||+|++... ......+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3456678999999999999999999987 7889999998532 33446789999999999999999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhcCCCCCCC-------------------------------CCCCCCCCHHHHHHHHHHHHHH
Q 022206 134 PLRVLAYEHASKGSLHDILHGKKGVKG-------------------------------AKPGPVLSWAQRVKIAVGAARG 182 (301)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------------------~~~~~~l~~~~~~~i~~qi~~~ 182 (301)
+..++||||+++|+|.+++........ ......+++..++.++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999999952111000 0001124577788999999999
Q ss_pred HHHhhhCCCCCeEecCCCCCceEEcCCC--ceEEeccccCCCCCcccc--ccccccccccccccCcccccc--CCCCccc
Q 022206 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAA--RLHSTRVLGTFGYHAPEYAMT--GQMSSKS 256 (301)
Q Consensus 183 l~~LH~~~~~~ivH~Dlkp~Nill~~~~--~vkl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 256 (301)
|+|||+.+ |+||||||+|||++.++ .+||+|||++........ ........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999999 99999999999998776 899999999875433211 111234578999999999875 6788999
Q ss_pred cchhhHHHHHHHHhCCCCCCCCCC
Q 022206 257 DVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 257 DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
||||||+++|+|++|+.||.+...
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~ 281 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVND 281 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCh
Confidence 999999999999999999976544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=296.19 Aligned_cols=205 Identities=20% Similarity=0.242 Sum_probs=177.3
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEEEEe
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
..++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+|+.+++.+ +|+|++++++++.+....++|||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 3568999999999999999999976 79999999986443 334588899999999 79999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc-----eEEec
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI-----AKISD 216 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----vkl~D 216 (301)
|+ +++|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++. +||+|
T Consensus 87 ~~-~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~D 154 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVD 154 (298)
T ss_dssp CC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred ec-CCCHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence 99 8899999976432 2899999999999999999999999 999999999999987765 99999
Q ss_pred cccCCCCCccccc-----cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 217 FDLSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 217 fg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+....
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 224 (298)
T 1csn_A 155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 224 (298)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc
Confidence 9999765443221 1124457999999999999999999999999999999999999999876543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=311.09 Aligned_cols=201 Identities=25% Similarity=0.407 Sum_probs=165.1
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---------chHHHHHHHHHHhccCCCceeeeeeEEEc
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---------PDQEFLAQVSMVSRLKNENVVELVGYYVD 132 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 132 (301)
...++|.+.+.||+|+||.||+|.++ +++.||+|++..... ....+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45689999999999999999999987 789999999864321 11247899999999999999999999754
Q ss_pred CCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC--
Q 022206 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-- 210 (301)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-- 210 (301)
+..++||||+++++|.+++..... +++..++.++.|++.||+|||+++ |+||||||+|||++.++
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~ 278 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKR---------LKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEED 278 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSS
T ss_pred -CceEEEEEcCCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCc
Confidence 557999999999999998875432 899999999999999999999999 99999999999997544
Q ss_pred -ceEEeccccCCCCCccccccccccccccccccCcccccc---CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 211 -IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 211 -~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 279 ~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 279 CLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp CCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred ceEEEeecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 599999999987654322 245679999999998853 567889999999999999999999997643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=316.49 Aligned_cols=201 Identities=27% Similarity=0.404 Sum_probs=174.1
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC--------------CchHHHHHHHHHHhccCCCceeeeee
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--------------QPDQEFLAQVSMVSRLKNENVVELVG 128 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~~~~ 128 (301)
..++|++++.||+|+||.||+|+++ +++.||+|++.... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999987 68999999986543 22456889999999999999999999
Q ss_pred EEEcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC
Q 022206 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (301)
Q Consensus 129 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 208 (301)
++.+....++|||||++|+|.+++..... +++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~ 181 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHK---------FDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLEN 181 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEec
Confidence 99999999999999999999998865432 899999999999999999999999 999999999999998
Q ss_pred CC---ceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 209 DD---IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 209 ~~---~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
++ .+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.
T Consensus 182 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 252 (504)
T 3q5i_A 182 KNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND 252 (504)
T ss_dssp TTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 76 699999999976644322 24457999999999876 4689999999999999999999999987654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=292.98 Aligned_cols=200 Identities=24% Similarity=0.403 Sum_probs=174.1
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-------chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
++|++.+.||+|+||.||+|++. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56999999999999999999987 799999999864322 2467899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC----ceE
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----IAK 213 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~vk 213 (301)
+||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++ .+|
T Consensus 85 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~k 152 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE---------SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIK 152 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEE
T ss_pred EEEeecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceE
Confidence 9999999999999997543 2899999999999999999999999 99999999999999877 899
Q ss_pred EeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|+|||++......... ....|++.|+|||++.+..++.++||||||+++|+|++|..||.+...
T Consensus 153 l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 216 (283)
T 3bhy_A 153 LIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK 216 (283)
T ss_dssp ECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred EEecccceeccCCCcc---cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch
Confidence 9999998765443221 345689999999999988999999999999999999999999976543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=298.85 Aligned_cols=208 Identities=27% Similarity=0.413 Sum_probs=183.5
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
...++|++.+.||+|+||.||+|.++ ++..||+|++.......+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 34578999999999999999999987 58899999998877777889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 90 ~~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp CCTTEEHHHHHHHCCT-------TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred cCCCCcHHHHHHhccc-------CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccce
Confidence 9999999999976432 23899999999999999999999999 9999999999999999999999999997
Q ss_pred CCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCc
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~ 281 (301)
........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..
T Consensus 160 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~ 219 (288)
T 3kfa_A 160 LMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 219 (288)
T ss_dssp TSCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred eccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 66543221 1233456889999999999999999999999999999999 99999876543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=302.21 Aligned_cols=214 Identities=25% Similarity=0.409 Sum_probs=177.7
Q ss_pred hhCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCC--CchHHHHHHHHHHhcc-CCCceeeeeeEEEcCC
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 134 (301)
..++|++.+.||+|+||.||+|.+. ++..||+|++.... .....+.+|+.+++++ +||||+++++++.+.+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 3578999999999999999999962 45689999987532 2346789999999999 8999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCC--------------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKG--------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 200 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~--------------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk 200 (301)
..++||||+++|+|.+++........ ......+++..++.++.||+.||.|||+.| |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 99999999999999999976542100 011123789999999999999999999999 9999999
Q ss_pred CCceEEcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCC
Q 022206 201 SSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTL 279 (301)
Q Consensus 201 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~ 279 (301)
|+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999976654333222344567889999999999999999999999999999998 999997765
Q ss_pred C
Q 022206 280 P 280 (301)
Q Consensus 280 ~ 280 (301)
.
T Consensus 280 ~ 280 (344)
T 1rjb_A 280 V 280 (344)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=306.88 Aligned_cols=203 Identities=24% Similarity=0.332 Sum_probs=173.5
Q ss_pred hCCCCCCceecccCceEEEEEEEC----CCCEEEEEEcCCCC-----CchHHHHHHHHHHhcc-CCCceeeeeeEEEcCC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 134 (301)
.++|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+|+++++.+ +|+||+++++++.++.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 468999999999999999999973 68999999986432 2335577899999999 6999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
..++||||+++++|.+++..... +++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl 200 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRER---------FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVL 200 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEE
Confidence 99999999999999999975432 889999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccccccccccccccccccCcccccc--CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 201 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 267 (355)
T 1vzo_A 201 TDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 267 (355)
T ss_dssp SCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred eeCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc
Confidence 999998765433221 1234579999999999885 3578899999999999999999999976543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=302.41 Aligned_cols=205 Identities=23% Similarity=0.384 Sum_probs=169.6
Q ss_pred HHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc------hHHHHHHHHHHhccCCCceeeeeeEEEcCC
Q 022206 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP------DQEFLAQVSMVSRLKNENVVELVGYYVDGP 134 (301)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 134 (301)
....++|++.+.||+|+||.||+|++. +++.||+|++...... ...+.+|+.+++.++||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 445689999999999999999999987 6899999998753221 246789999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
..++||||+++ +|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 153 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSL--------VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKL 153 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCS--------SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred ceEEEEEcCCC-CHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEE
Confidence 99999999987 89998876432 2778889999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+|||++......... .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.
T Consensus 154 ~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~ 218 (346)
T 1ua2_A 154 ADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 218 (346)
T ss_dssp CCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EecccceeccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 999999876433221 2345789999999998764 588999999999999999999999977553
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=301.11 Aligned_cols=208 Identities=30% Similarity=0.504 Sum_probs=173.3
Q ss_pred HHHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhcc-CCCceeeeeeEEEc------
Q 022206 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVD------ 132 (301)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------ 132 (301)
+....++|++.+.||+|+||.||+|++. +++.||+|++.........+.+|+.+++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 3445688999999999999999999986 789999999987666678899999999999 79999999999986
Q ss_pred CCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCce
Q 022206 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (301)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (301)
....++||||+++++|.+++..... ..+++..++.++.||+.||.|||+.| ++||||||+|||++.++.+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGG-------GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred cceEEEEEEcCCCCcHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 5688999999999999999976432 12889999999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCccccccccccccccccccCccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
||+|||++......... .....||+.|+|||++. +..++.++||||||+++|+|++|..||.+..+
T Consensus 169 kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 239 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239 (326)
T ss_dssp EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred EEeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH
Confidence 99999998765433211 13456899999999986 56688999999999999999999999976543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=317.91 Aligned_cols=201 Identities=28% Similarity=0.461 Sum_probs=176.5
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
..++|++.+.||+|+||.||+|+++ +++.||||++.... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999987 79999999986432 235678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEE---cCCCceEEe
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKIS 215 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~ 215 (301)
||||+.+++|.+++..... +++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+
T Consensus 104 v~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 171 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKR---------FSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRII 171 (484)
T ss_dssp EECCCCSCBHHHHHHTCSC---------CBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred EEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEE
Confidence 9999999999999876542 899999999999999999999999 9999999999999 467899999
Q ss_pred ccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|||++......... ....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.
T Consensus 172 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 232 (484)
T 3nyv_A 172 DFGLSTHFEASKKM---KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE 232 (484)
T ss_dssp CTTHHHHBCCCCSH---HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eeeeeEEccccccc---ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH
Confidence 99998655433221 34569999999998876 689999999999999999999999987654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=316.41 Aligned_cols=202 Identities=27% Similarity=0.397 Sum_probs=175.5
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCC---CCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDS---SKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
...++|++.+.||+|+||.||+|+++ +++.||+|++.. .......+.+|+.++++++||||+++++++.+....++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 35578999999999999999999987 799999999853 23345678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEc---CCCceEEe
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKIS 215 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~vkl~ 215 (301)
||||+.+++|.+.+..... +++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+
T Consensus 99 v~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 166 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKR---------FSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKII 166 (486)
T ss_dssp EECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred EEEcCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEE
Confidence 9999999999998865432 899999999999999999999999 99999999999995 45679999
Q ss_pred ccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.
T Consensus 167 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 227 (486)
T 3mwu_A 167 DFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227 (486)
T ss_dssp SCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999976544322 144579999999998875 589999999999999999999999977554
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=309.89 Aligned_cols=201 Identities=26% Similarity=0.396 Sum_probs=168.3
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcC-----C
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG-----P 134 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 134 (301)
..++|++.+.||+|+||.||+|+++ +++.||||++...... ...+.+|+.+++.++|+||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3578999999999999999999987 6899999999754333 35688999999999999999999998766 5
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
..|+||||+.+ +|.+++.... .+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||
T Consensus 104 ~~~lv~e~~~~-~L~~~~~~~~---------~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL 170 (432)
T 3n9x_A 104 ELYIVLEIADS-DLKKLFKTPI---------FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKV 170 (432)
T ss_dssp CEEEEEECCSE-EHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecCCc-CHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEE
Confidence 78999999975 9999997643 2899999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccccc--------------------cccccccccccccCcccc-ccCCCCccccchhhHHHHHHHHhCCC
Q 022206 215 SDFDLSNQAPDAAAR--------------------LHSTRVLGTFGYHAPEYA-MTGQMSSKSDVYSFGVVLLELLTGRK 273 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~~g~~ 273 (301)
+|||+++........ ......+||+.|+|||++ ....++.++|||||||++|+|++|..
T Consensus 171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence 999999766433211 112456789999999986 55679999999999999999999666
Q ss_pred CCCC
Q 022206 274 PVDH 277 (301)
Q Consensus 274 pf~~ 277 (301)
||..
T Consensus 251 p~~~ 254 (432)
T 3n9x_A 251 SHIN 254 (432)
T ss_dssp TTCS
T ss_pred cccc
Confidence 6543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=296.40 Aligned_cols=205 Identities=26% Similarity=0.379 Sum_probs=171.6
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
..++|.+.+.||+|+||.||+|.++ ++..+|+|++.... ...+.+.+|+++++.++||||+++++++.+....++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 4568999999999999999999987 78999999986543 33477899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEc---CCCceEEecc
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDF 217 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~vkl~Df 217 (301)
||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++ .++.+||+||
T Consensus 100 e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Df 171 (285)
T 3is5_A 100 ETCEGGELLERIVSAQAR-----GKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDF 171 (285)
T ss_dssp CCCSCCBHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EeCCCCcHHHHHHhhhhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEee
Confidence 999999999988542110 012899999999999999999999999 99999999999994 5678999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|++......... ....||+.|+|||++. ..++.++||||||+++|+|++|+.||.+...
T Consensus 172 g~a~~~~~~~~~---~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~ 230 (285)
T 3is5_A 172 GLAELFKSDEHS---TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL 230 (285)
T ss_dssp CCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ecceecCCcccC---cCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH
Confidence 999765543222 4457899999999875 5688999999999999999999999976543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=314.98 Aligned_cols=205 Identities=29% Similarity=0.502 Sum_probs=173.9
Q ss_pred hhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
..++|++.+.||+|+||.||+|.++.+..||||++.......+.+.+|+.+|++++||||+++++++.+ +..++||||+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 346788999999999999999999877889999998776667889999999999999999999999876 6789999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
++|+|.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 261 ~~gsL~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 261 SKGSLLDFLKGETG-------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp TTCBHHHHHSHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred cCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceec
Confidence 99999999975321 12889999999999999999999999 999999999999999999999999999876
Q ss_pred CccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
...... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+...
T Consensus 331 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~ 387 (452)
T 1fmk_A 331 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred CCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 543221 1123346789999999999999999999999999999999 9999987654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=295.35 Aligned_cols=194 Identities=18% Similarity=0.339 Sum_probs=171.6
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccC-CCceeeeeeEEEc--CCeeEEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVD--GPLRVLAY 140 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~ 140 (301)
.++|++.+.||+|+||.||+|++. +++.||+|++... ....+.+|+.+++.++ |+||+++++++.+ ....+++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 468999999999999999999976 7899999998743 4567899999999997 9999999999987 67789999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC-ceEEecccc
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDL 219 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg~ 219 (301)
||+.+++|.+++.. +++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 113 e~~~~~~l~~~~~~------------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~ 177 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT------------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGL 177 (330)
T ss_dssp ECCCCCCHHHHGGG------------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred eccCchhHHHHHHh------------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence 99999999999853 788999999999999999999999 99999999999999776 899999999
Q ss_pred CCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
+......... ....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 178 a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 178 AEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp CEECCTTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ceEcCCCCcc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 9765433221 44578999999999877 67899999999999999999999999543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=302.60 Aligned_cols=204 Identities=26% Similarity=0.417 Sum_probs=177.0
Q ss_pred HHHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---------hHHHHHHHHHHhcc-CCCceeeeeeE
Q 022206 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---------DQEFLAQVSMVSRL-KNENVVELVGY 129 (301)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l-~h~~iv~~~~~ 129 (301)
.....++|++.+.||+|+||.||+|+++ +|+.||||++...... ...+.+|+.+++.+ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445678999999999999999999987 7999999998654321 24577899999999 79999999999
Q ss_pred EEcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC
Q 022206 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (301)
Q Consensus 130 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 209 (301)
+......++||||+++++|.+++.... .+++..+..++.|++.||.|||+.| ++||||||+|||++.+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~ 236 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKV---------ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDN 236 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 999999999999999999999997543 2899999999999999999999999 9999999999999999
Q ss_pred CceEEeccccCCCCCccccccccccccccccccCcccccc------CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT------GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 237 ~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 237 MQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp CCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 9999999999876654322 245679999999998863 357889999999999999999999997644
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=297.64 Aligned_cols=205 Identities=24% Similarity=0.382 Sum_probs=170.1
Q ss_pred hhCCCCCC-ceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEEE
Q 022206 64 KTDNFGTN-SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 64 ~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 139 (301)
..+.|++. +.||+|+||.||+|++. +++.||||++..... ....+.+|+.+++++ +||||+++++++.+++..++|
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 35678884 78999999999999976 799999999865433 356788999999885 799999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc---eEEec
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI---AKISD 216 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---vkl~D 216 (301)
|||+++++|.+++..... +++..++.++.|++.||+|||+++ |+||||||+|||++.++. +||+|
T Consensus 90 ~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~D 157 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRH---------FNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICD 157 (316)
T ss_dssp EECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred EEcCCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEE
Confidence 999999999999976432 889999999999999999999999 999999999999998775 99999
Q ss_pred cccCCCCCcccc-----ccccccccccccccCcccccc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 217 FDLSNQAPDAAA-----RLHSTRVLGTFGYHAPEYAMT-----GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 217 fg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 231 (316)
T 2ac3_A 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231 (316)
T ss_dssp TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccc
Confidence 999876542211 011123468999999999875 4578899999999999999999999987654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=303.53 Aligned_cols=199 Identities=23% Similarity=0.293 Sum_probs=165.2
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCC-----
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP----- 134 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 134 (301)
..++|++++.||+|+||.||+|.+. +++.||||++...... ...+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3578999999999999999999987 7899999998754332 246788999999999999999999997665
Q ss_pred -eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceE
Q 022206 135 -LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (301)
Q Consensus 135 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (301)
..++||||+++ +|.+++... +++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHHSC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred cceEEEEEcCCC-CHHHHHhhc-----------cCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEE
Confidence 78999999986 788888632 788999999999999999999999 99999999999999999999
Q ss_pred EeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 168 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 231 (371)
T 2xrw_A 168 ILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 231 (371)
T ss_dssp ECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEeecccccccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999976543321 1345789999999999999999999999999999999999999987553
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=302.85 Aligned_cols=203 Identities=22% Similarity=0.356 Sum_probs=167.2
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
...++|++.+.||+|+||.||+|++. +++.||+|++...... ...+.+|+.+++.++||||+++++++.+++..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34578999999999999999999977 7899999999754433 2457789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEc-----CCCceE
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF-----DDDIAK 213 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~-----~~~~vk 213 (301)
||||+++ +|.+++..... +++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+|
T Consensus 111 v~e~~~~-~L~~~~~~~~~---------~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~k 177 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKNPD---------VSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLK 177 (329)
T ss_dssp EEECCSE-EHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEE
T ss_pred EEecCCC-CHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEE
Confidence 9999985 99999976542 889999999999999999999999 99999999999994 455699
Q ss_pred EeccccCCCCCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|+|||++......... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+...
T Consensus 178 l~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 243 (329)
T 3gbz_A 178 IGDFGLARAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243 (329)
T ss_dssp ECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ECcCCCccccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence 9999998654322211 1344689999999998874 589999999999999999999999976543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=299.43 Aligned_cols=203 Identities=25% Similarity=0.398 Sum_probs=172.4
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
..++|++.+.||+|+||.||+|++. +++.||+|++...... ...+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 3568999999999999999999987 6899999998654433 24577899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+++++|.+++..... +++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 103 ~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 170 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNG---------LDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGF 170 (331)
T ss_dssp EECCSEEHHHHHHHSTTC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EecCCcchHHHHHhhccC---------CCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCC
Confidence 999999999988765432 899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+......... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||...+.
T Consensus 171 ~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (331)
T 4aaa_A 171 ARTLAAPGEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230 (331)
T ss_dssp C--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ceeecCCccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9765433221 1345689999999998775 789999999999999999999999987653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=306.04 Aligned_cols=203 Identities=21% Similarity=0.300 Sum_probs=167.8
Q ss_pred hhCCCCCCceecccCceEEEEEEECC------CCEEEEEEcCCCCCch------------HHHHHHHHHHhccCCCceee
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLRS------GRAAAIKKLDSSKQPD------------QEFLAQVSMVSRLKNENVVE 125 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~------------~~~~~e~~~l~~l~h~~iv~ 125 (301)
..++|++.+.||+|+||.||+|.+.. ++.||+|++....... .....|+..++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999999863 4789999986543211 12334555677788999999
Q ss_pred eeeEEEcC----CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCC
Q 022206 126 LVGYYVDG----PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (301)
Q Consensus 126 ~~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp 201 (301)
+++++... ...++||||+ +++|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp 180 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--------RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKA 180 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCH
Confidence 99998764 4589999999 9999999976432 2899999999999999999999999 99999999
Q ss_pred CceEEc--CCCceEEeccccCCCCCcccccc-----ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCC
Q 022206 202 SNVLLF--DDDIAKISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274 (301)
Q Consensus 202 ~Nill~--~~~~vkl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p 274 (301)
+|||++ .++.+||+|||++.......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 181 ~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~P 260 (364)
T 3op5_A 181 SNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260 (364)
T ss_dssp GGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999 88999999999997664432211 11234599999999999999999999999999999999999999
Q ss_pred CCCC
Q 022206 275 VDHT 278 (301)
Q Consensus 275 f~~~ 278 (301)
|.+.
T Consensus 261 f~~~ 264 (364)
T 3op5_A 261 WEDN 264 (364)
T ss_dssp TGGG
T ss_pred cccc
Confidence 9854
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=315.49 Aligned_cols=201 Identities=28% Similarity=0.428 Sum_probs=172.2
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC---CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
..++|++++.||+|+||.||+|+++ ++..||+|++.... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457999999999999999999987 78999999986542 2346789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC---CCceEEec
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKISD 216 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~vkl~D 216 (301)
||||.+|+|.+.+..... +++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|
T Consensus 115 ~e~~~~g~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D 182 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMK---------FNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVD 182 (494)
T ss_dssp EECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECC
T ss_pred EecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEE
Confidence 999999999998865432 889999999999999999999999 999999999999976 45599999
Q ss_pred cccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
||++........ .....||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+.
T Consensus 183 fG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 242 (494)
T 3lij_A 183 FGLSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD 242 (494)
T ss_dssp CTTCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999876654332 24557999999999876 5689999999999999999999999987654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=300.82 Aligned_cols=205 Identities=26% Similarity=0.441 Sum_probs=167.7
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCE----EEEEEcCCC--CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRA----AAIKKLDSS--KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
.++|++.+.||+|+||.||+|++. +++. |++|.+... ......+.+|+.+++.++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 578999999999999999999976 4554 577776532 334577899999999999999999999998765 78
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
++++++.+|+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~Df 161 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF 161 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCT
T ss_pred EEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccC
Confidence 88999999999999976532 2889999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCc
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~ 281 (301)
|++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus 162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 226 (327)
T 3lzb_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226 (327)
T ss_dssp TC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred cceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence 99987654433323334457889999999999999999999999999999999 99999876553
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=296.76 Aligned_cols=205 Identities=22% Similarity=0.326 Sum_probs=167.3
Q ss_pred HHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHhccCCCceeeeeeEEEcCCee
Q 022206 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (301)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 136 (301)
....++|++.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.+++.++||||+++++++.+++..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 345689999999999999999999987 7899999998754322 25688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
+++|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~D 177 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQG---------PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVD 177 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECS
T ss_pred EEEEEecCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEec
Confidence 99999999999999997543 2889999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
||++......... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 178 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 178 FGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp CCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred CccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence 9998765443211 1234568999999999998899999999999999999999999997654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=295.29 Aligned_cols=202 Identities=31% Similarity=0.532 Sum_probs=162.2
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCch---HHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
.++|++.+.||+|+||.||+|++. ..+|+|++....... +.+.+|+.+++.++|+||++++++. .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 578999999999999999999875 359999987654332 5688999999999999999999964 5667899999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.
T Consensus 100 ~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 100 WCEGSSLYHHLHASET--------KFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp CCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred ecCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecc
Confidence 9999999999965432 2889999999999999999999999 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
...............||+.|+|||++. +..++.++||||||+++|+|++|+.||.+...
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 230 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch
Confidence 654433222224457899999999886 56778899999999999999999999976543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=292.90 Aligned_cols=200 Identities=28% Similarity=0.438 Sum_probs=177.1
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
..++|++.+.||+|+||.||+|++. ++..||+|++... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 3468999999999999999999987 6889999998542 2234678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
+|||+++++|.+++..... +++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 92 v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg 159 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGR---------FDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFG 159 (284)
T ss_dssp EECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEEeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEeccc
Confidence 9999999999999976432 889999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
++....... .....|++.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 160 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 160 WSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp TCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 986554322 134578999999999999899999999999999999999999997654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=300.49 Aligned_cols=196 Identities=31% Similarity=0.501 Sum_probs=171.4
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch----HHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
+.|++.+.||+|+||.||+|++. +++.||||++....... ..+.+|+.+++.++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45899999999999999999976 78999999987543322 45789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+. |+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 134 e~~~-g~l~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 201 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA 201 (348)
T ss_dssp ECCS-EEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred ecCC-CCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCc
Confidence 9998 488888754321 2899999999999999999999999 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
...... ....||+.|+|||++. ...++.++|||||||++|+|++|+.||.+.+
T Consensus 202 ~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 257 (348)
T 1u5q_A 202 SIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257 (348)
T ss_dssp BSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred eecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 765432 3457899999999884 5678999999999999999999999997654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=293.12 Aligned_cols=205 Identities=27% Similarity=0.442 Sum_probs=178.3
Q ss_pred hhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
..++|++.+.||+|+||.||+|.+.++..||+|++.......+.+.+|+++++.++||||+++++++. .+..++||||+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 34689999999999999999999988889999999877667788999999999999999999999876 45689999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
++++|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+|||++...
T Consensus 90 ~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 90 ENGSLVDFLKTPSG-------IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp TTCBHHHHTTSHHH-------HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCCHHHHHhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 99999999975421 12889999999999999999999999 999999999999999999999999998766
Q ss_pred CccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
...... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+...
T Consensus 160 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 216 (279)
T 1qpc_A 160 EDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216 (279)
T ss_dssp SSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred cCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH
Confidence 543221 1133456889999999988889999999999999999999 9999976543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=292.55 Aligned_cols=201 Identities=29% Similarity=0.459 Sum_probs=178.3
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
.+.|++.+.||+|+||.||+|++. +++.||+|++.... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356999999999999999999976 78999999986543 334678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+++++|.+++.... +++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 101 ~~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 167 (303)
T 3a7i_A 101 YLGGGSALDLLEPGP----------LDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAG 167 (303)
T ss_dssp CCTTEEHHHHHTTSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccce
Confidence 999999999997533 899999999999999999999999 9999999999999999999999999987
Q ss_pred CCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....+
T Consensus 168 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 224 (303)
T 3a7i_A 168 QLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP 224 (303)
T ss_dssp ECBTTBCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ecCccccc--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH
Confidence 65443211 2445789999999999998999999999999999999999999976543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=296.78 Aligned_cols=214 Identities=23% Similarity=0.377 Sum_probs=180.7
Q ss_pred hhCCCCCCceecccCceEEEEEEE------CCCCEEEEEEcCCCCCc--hHHHHHHHHHHhcc-CCCceeeeeeEEEcCC
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGP 134 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 134 (301)
..++|++.+.||+|+||.||+|.+ .+++.||+|++...... .+.+.+|+.+++++ +||||+++++++.+++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346899999999999999999985 25788999999765433 35688999999999 9999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCC---------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceE
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVK---------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nil 205 (301)
..++||||+++|+|.+++....... .......+++..++.++.|++.||.|||+++ ++||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 9999999999999999997654210 0011224899999999999999999999999 999999999999
Q ss_pred EcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 206 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 99999999999999987655433222344567889999999999999999999999999999999 9999977543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=299.73 Aligned_cols=216 Identities=25% Similarity=0.405 Sum_probs=179.5
Q ss_pred HHhhCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcC
Q 022206 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDG 133 (301)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 133 (301)
....++|++.+.||+|+||.||+|++. +++.||+|.+...... ...+.+|+.+++.++|+||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 344578999999999999999999864 3678999999755433 24588999999999999999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhcCCCCCC-CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCce
Q 022206 134 PLRVLAYEHASKGSLHDILHGKKGVK-GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (301)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (301)
+..++||||+++++|.+++....... .......+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence 99999999999999999996532100 0000112688999999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 246 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence 9999999976544332222234467889999999999999999999999999999999 8999976543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=292.85 Aligned_cols=202 Identities=24% Similarity=0.376 Sum_probs=177.5
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
..++|.+.+.||+|+||.||+|.+. +++.+|+|++..... ..+.+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3468999999999999999999987 688999999865422 23567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
+|||+++++|.+++..... +++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 93 v~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 160 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKA---------LTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFG 160 (294)
T ss_dssp EEECCTTCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEecc
Confidence 9999999999999875432 889999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
++......... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 161 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 161 LATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp TCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 98765432211 234568999999999998889999999999999999999999997654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=296.32 Aligned_cols=202 Identities=27% Similarity=0.402 Sum_probs=169.6
Q ss_pred hCCCCCCceecccCceEEEEEEE----C-CCCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeeeeeEEEc--CCee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVL----R-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVD--GPLR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~----~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 136 (301)
.++|++.+.||+|+||.||+|++ . +++.||+|++...... ...+.+|+.+++.++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46899999999999999999984 2 6889999998754332 3568899999999999999999999864 3568
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~D 157 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGD 157 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC
T ss_pred EEEEEeCCCCCHHHHHHhccc--------ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEcc
Confidence 999999999999999976542 2889999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 217 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
||++......... .......+++.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred CcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 9999876543221 112334577889999999999999999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=304.97 Aligned_cols=199 Identities=28% Similarity=0.442 Sum_probs=175.3
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
.++|++.+.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999987 7899999998765433 3568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
|+++++|.+++..... +++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++
T Consensus 112 ~~~~~~L~~~l~~~~~---------~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp CCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred CCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCC
Confidence 9999999999976432 88999999999999999999996 8 999999999999999999999999998
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 180 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 180 GQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp HHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred cccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 544222 1234578999999999999999999999999999999999999997654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=308.56 Aligned_cols=201 Identities=23% Similarity=0.298 Sum_probs=175.4
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhcc------CCCceeeeeeEEEcCCee
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRL------KNENVVELVGYYVDGPLR 136 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~ 136 (301)
...+|++.+.||+|+||.||+|.+. +++.||||++.........+.+|+.+++.+ +|+||+++++++......
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 3467999999999999999999987 689999999986655556778888888777 567999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc--eEE
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI--AKI 214 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~--vkl 214 (301)
++||||+. ++|.+++...... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL 243 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQ-------GFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKV 243 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEE
T ss_pred EEEEeccC-CCHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEE
Confidence 99999997 5999998765422 2889999999999999999999999 999999999999999887 999
Q ss_pred eccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.
T Consensus 244 ~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 244 IDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp CCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 999998654322 1345789999999999999999999999999999999999999987654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=296.81 Aligned_cols=201 Identities=25% Similarity=0.419 Sum_probs=166.6
Q ss_pred hhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhc--cCCCceeeeeeEEEc----CCeeE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSR--LKNENVVELVGYYVD----GPLRV 137 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~----~~~~~ 137 (301)
..++|++.+.||+|+||.||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++.+ ....+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 356899999999999999999998 4899999998654 33455666666655 799999999998654 35689
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--------hCCCCCeEecCCCCCceEEcCC
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH--------EKAEPRIIHRNIKSSNVLLFDD 209 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~~~~ivH~Dlkp~Nill~~~ 209 (301)
+||||+++|+|.+++.... +++..++.++.|++.||+||| +.+ |+||||||+|||++.+
T Consensus 83 lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~ 149 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLTT----------LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKN 149 (301)
T ss_dssp EEECCCTTCBHHHHHTTCC----------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTT
T ss_pred EehhhccCCCHHHHHhhcc----------cCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCC
Confidence 9999999999999996543 899999999999999999999 888 9999999999999999
Q ss_pred CceEEeccccCCCCCccccc--cccccccccccccCccccccC------CCCccccchhhHHHHHHHHhC----------
Q 022206 210 DIAKISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTG------QMSSKSDVYSFGVVLLELLTG---------- 271 (301)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~~l~~g---------- 271 (301)
+.+||+|||++......... .......||+.|+|||++.+. .++.++||||||+++|+|++|
T Consensus 150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 229 (301)
T 3q4u_A 150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229 (301)
T ss_dssp SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence 99999999998654332221 112344799999999998876 345789999999999999999
Q ss_pred CCCCCCCCC
Q 022206 272 RKPVDHTLP 280 (301)
Q Consensus 272 ~~pf~~~~~ 280 (301)
..||....+
T Consensus 230 ~~pf~~~~~ 238 (301)
T 3q4u_A 230 KPPFYDVVP 238 (301)
T ss_dssp CCTTTTTSC
T ss_pred cccccccCC
Confidence 888866443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=299.60 Aligned_cols=211 Identities=22% Similarity=0.334 Sum_probs=177.4
Q ss_pred CHHHHHHhhCCCCCC-ceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccC-CCceeeeeeEE
Q 022206 57 SVDELKEKTDNFGTN-SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLK-NENVVELVGYY 130 (301)
Q Consensus 57 ~~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~-h~~iv~~~~~~ 130 (301)
.+.......++|.+. +.||+|+||.||+|++. +++.||+|++..... ....+.+|+.+++.+. ||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 334445566778887 89999999999999987 799999999865332 2467889999999985 69999999999
Q ss_pred EcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC--
Q 022206 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-- 208 (301)
Q Consensus 131 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-- 208 (301)
.+.+..++||||+.+++|.+++..... ..+++..++.++.|++.||+|||+.| |+||||||+|||++.
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~ 168 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPELA-------EMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIY 168 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBT
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCC
Confidence 999999999999999999999865432 23899999999999999999999999 999999999999987
Q ss_pred -CCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 209 -DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 209 -~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
++.+||+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 169 ~~~~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 238 (327)
T 3lm5_A 169 PLGDIKIVDFGMSRKIGHACEL---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN 238 (327)
T ss_dssp TBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCcEEEeeCccccccCCcccc---ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 789999999999766443221 345799999999999999999999999999999999999999976543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=311.03 Aligned_cols=206 Identities=13% Similarity=0.202 Sum_probs=162.9
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHH---HHhccCCCceeeee-------eE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVS---MVSRLKNENVVELV-------GY 129 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~---~l~~l~h~~iv~~~-------~~ 129 (301)
.++|++.+.||+|+||.||+|++. +++.||||++... ....+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467889999999999999999975 7999999998643 223467889994 55556899999998 66
Q ss_pred EEcCC-----------------eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 022206 130 YVDGP-----------------LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192 (301)
Q Consensus 130 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 192 (301)
+.+.+ ..+++|||+ +|+|.+++........ ....+++..++.++.||+.||+|||+++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 226 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS--THKSLVHHARLQLTLQVIRLLASLHHYG-- 226 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTT--TTHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccccc--ccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 66553 278999999 5799999975432100 0112445788889999999999999999
Q ss_pred CeEecCCCCCceEEcCCCceEEeccccCCCCCccccccccccccccccccCccccccC-----------CCCccccchhh
Q 022206 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-----------QMSSKSDVYSF 261 (301)
Q Consensus 193 ~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dvwsl 261 (301)
|+||||||+|||++.++.+||+|||++...... .....| +.|+|||++.+. .++.++|||||
T Consensus 227 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl 299 (377)
T 3byv_A 227 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299 (377)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred -eecCCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence 999999999999999999999999998754332 134567 999999999887 89999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCcC
Q 022206 262 GVVLLELLTGRKPVDHTLPRG 282 (301)
Q Consensus 262 G~il~~l~~g~~pf~~~~~~~ 282 (301)
||++|+|++|+.||.+.....
T Consensus 300 G~il~elltg~~Pf~~~~~~~ 320 (377)
T 3byv_A 300 GLVIYWIWCADLPITKDAALG 320 (377)
T ss_dssp HHHHHHHHHSSCCC------C
T ss_pred HHHHHHHHHCCCCCccccccc
Confidence 999999999999998765443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=294.69 Aligned_cols=197 Identities=25% Similarity=0.300 Sum_probs=164.5
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch---HHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 139 (301)
.++|++.+.||+|+||+||+|++. +++.||||++....... .....|+..+..+ +|+||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 357999999999999999999987 79999999987544333 2344555555444 899999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+ +++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 136 ~e~~-~~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~ 203 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGA--------SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGL 203 (311)
T ss_dssp EECC-CCBHHHHHHHHCS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTT
T ss_pred Eecc-CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEcccee
Confidence 9999 5699998875432 2899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
+........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus 204 a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 204 LVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp CEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred eeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 876544322 244568999999998876 789999999999999999999766543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=303.59 Aligned_cols=197 Identities=29% Similarity=0.424 Sum_probs=155.8
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcC------C
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG------P 134 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 134 (301)
.++|++++.||+|+||.||+|.+. +++.||||++...... ...+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999999976 7899999999754332 35678999999999999999999998754 5
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
..++++|++ +++|.+++.... +++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL 173 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 173 (367)
T ss_dssp CCEEEEECC-CEECC-----CC----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred eEEEEeccc-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEE
Confidence 679999999 679999887533 899999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 174 ~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 235 (367)
T 2fst_X 174 LDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235 (367)
T ss_dssp CC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999765432 134578999999999877 6789999999999999999999999987654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=297.96 Aligned_cols=214 Identities=26% Similarity=0.421 Sum_probs=178.1
Q ss_pred hhCCCCCCceecccCceEEEEEEEC--------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhcc-CCCceeeeeeEEEc
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVD 132 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 132 (301)
..++|++.+.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.+++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3478999999999999999999863 4678999999765433 35688999999999 89999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHhcCCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceE
Q 022206 133 GPLRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVL 205 (301)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nil 205 (301)
.+..++||||+++++|.+++........ ......+++..++.++.|++.||.|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999986542100 011223889999999999999999999999 999999999999
Q ss_pred EcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 206 LFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 99999999999999976654332222234457889999999988889999999999999999999 9999976543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=295.04 Aligned_cols=201 Identities=26% Similarity=0.403 Sum_probs=175.4
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
..++|.+.+.||+|+||.||+|++. +++.||+|++..... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 4567999999999999999999987 799999999875433 33568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEE---cCCCceEEeccc
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFD 218 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~Dfg 218 (301)
|+++++|.+++..... +++..++.++.|++.||.|||+.+ ++||||||+||++ +.++.+||+|||
T Consensus 87 ~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg 154 (304)
T 2jam_A 87 LVSGGELFDRILERGV---------YTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFG 154 (304)
T ss_dssp CCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred cCCCccHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCC
Confidence 9999999999865432 889999999999999999999999 9999999999999 778899999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 155 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 212 (304)
T 2jam_A 155 LSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE 212 (304)
T ss_dssp TTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred cceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 987654321 1334689999999999998999999999999999999999999976543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=301.01 Aligned_cols=205 Identities=23% Similarity=0.372 Sum_probs=173.0
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEc--------
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD-------- 132 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 132 (301)
.++|++++.||+|+||.||+|+++ +++.||+|++...... ...+.+|+.+++.++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 468999999999999999999986 7999999998654322 3568899999999999999999999886
Q ss_pred CCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCce
Q 022206 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (301)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (301)
.+..++||||+++ +|.+.+..... .+++..++.++.|++.||.|||+.| |+||||||+|||++.++.+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~ 163 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV--------KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL 163 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred CceEEEEEeccCC-CHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCE
Confidence 4568999999986 77777765432 2899999999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCcccc--ccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 213 KISDFDLSNQAPDAAA--RLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..
T Consensus 164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 235 (351)
T 3mi9_A 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 235 (351)
T ss_dssp EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 9999999876542211 111234568999999998876 45799999999999999999999999876543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=289.60 Aligned_cols=200 Identities=32% Similarity=0.536 Sum_probs=170.8
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch--------HHHHHHHHHHhccCCCceeeeeeEEEcCCe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--------QEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 135 (301)
.++|++.+.||+|+||.||+|++. +++.||+|++....... +.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 478999999999999999999986 79999999986543321 56889999999999999999999987655
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc----
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI---- 211 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---- 211 (301)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ .+++||||||+|||++.++.
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~ 166 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAH--------PIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPV 166 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSC
T ss_pred -eEEEEecCCCCHHHHHhcccC--------CccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCce
Confidence 699999999999998865432 2899999999999999999999985 23999999999999988776
Q ss_pred -eEEeccccCCCCCccccccccccccccccccCccccc--cCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 212 -AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM--TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 212 -vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+||+|||++....... ....||+.|+|||++. ...++.++||||||+++|+|++|+.||.....
T Consensus 167 ~~kl~Dfg~~~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 233 (287)
T 4f0f_A 167 CAKVADFGLSQQSVHSV-----SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233 (287)
T ss_dssp CEEECCCTTCBCCSSCE-----ECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred eEEeCCCCccccccccc-----cccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence 9999999987554322 4457899999999984 45578899999999999999999999976554
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=308.36 Aligned_cols=203 Identities=23% Similarity=0.359 Sum_probs=174.3
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHhccCCCceeeeeeEEEcCC--eeEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGP--LRVLA 139 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 139 (301)
.++|++.+.||+|+||.||+|++. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999987 69999999987533 23466789999999999999999999998655 77999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEE----cCCCceEEe
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKIS 215 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~vkl~ 215 (301)
|||+++|+|.+++...... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+
T Consensus 88 ~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLT 158 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred EecCCCCCHHHHHHhhhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEe
Confidence 9999999999999764321 12889999999999999999999999 9999999999999 777889999
Q ss_pred ccccCCCCCccccccccccccccccccCcccccc--------CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT--------GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|||++......... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 159 DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~ 227 (396)
T 4eut_A 159 DFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (396)
T ss_dssp CGGGCEECCCGGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred cCCCceEccCCCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 99999776544322 34579999999998865 466789999999999999999999997543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=300.02 Aligned_cols=207 Identities=25% Similarity=0.389 Sum_probs=169.8
Q ss_pred HHHHHHhhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCc------------hHHHHHHHHHHhccCCCceee
Q 022206 58 VDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP------------DQEFLAQVSMVSRLKNENVVE 125 (301)
Q Consensus 58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~h~~iv~ 125 (301)
..++....++|++.+.||+|+||.||+|.+.++..||||++...... ...+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 44667778999999999999999999999888999999998543221 156889999999999999999
Q ss_pred eeeEEEc-----CCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 022206 126 LVGYYVD-----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 200 (301)
Q Consensus 126 ~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk 200 (301)
+++++.. ....++||||+.+ +|.+++..... .+++..++.++.|++.||.|||+.+ |+|||||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 161 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRI--------VISPQHIQYFMYHILLGLHVLHEAG---VVHRDLH 161 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCC
T ss_pred eeeeEEeccCCCcceEEEEEccCCC-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCC
Confidence 9999853 3468999999985 88888875432 2899999999999999999999999 9999999
Q ss_pred CCceEEcCCCceEEeccccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 201 SSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 201 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|+|||++.++.+||+|||++......... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 162 PGNILLADNNDITICDFNLAREDTADANK---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp GGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hHHEEEcCCCCEEEEecCccccccccccc---ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999754433222 44578999999998877 678999999999999999999999998754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=291.50 Aligned_cols=205 Identities=28% Similarity=0.415 Sum_probs=164.3
Q ss_pred hhCCCCCCceecccCceEEEEEEECC----CCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
..++|++.+.||+|+||.||+|.+.. +..||+|++...... .+.+.+|+.+++.++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 34689999999999999999999752 457999998754332 356889999999999999999999874 56789
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+||
T Consensus 92 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Df 160 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF 160 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-
T ss_pred EEEecCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcc
Confidence 99999999999999975432 2889999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCc
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~ 281 (301)
|++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus 161 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~ 224 (281)
T 1mp8_A 161 GLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 224 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred ccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH
Confidence 999776543221 1233456789999999998999999999999999999997 99999876543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=318.75 Aligned_cols=205 Identities=29% Similarity=0.502 Sum_probs=179.2
Q ss_pred hhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
..++|++.+.||+|+||.||+|.++.+..||||++.......+.+.+|+++|+.++|+||+++++++.+ +..++||||+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 346788999999999999999999877889999998776667889999999999999999999999876 6789999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
.+|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++...
T Consensus 344 ~~gsL~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 344 SKGSLLDFLKGETG-------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp TTEEHHHHHSHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred cCCcHHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 99999999975321 12889999999999999999999999 999999999999999999999999999876
Q ss_pred CccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
...... ......+++.|+|||++....++.++||||||+++|+|++ |+.||.+...
T Consensus 414 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~ 470 (535)
T 2h8h_A 414 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 470 (535)
T ss_dssp CCHHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH
T ss_pred CCCcee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 543221 1123356789999999999999999999999999999999 9999987654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=299.88 Aligned_cols=203 Identities=26% Similarity=0.346 Sum_probs=174.6
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch--HHHHHHHHHHhccCCCceeeeeeEEEcC-----Cee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYYVDG-----PLR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~ 136 (301)
.++|++++.||+|+||.||+|.+. ++..||+|++....... ..+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999987 78899999997544332 5688999999999999999999998754 468
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
++|||++.+ +|.+++.... +++..++.++.|++.||.|||+.| |+||||||+|||++.++.+||+|
T Consensus 106 ~iv~e~~~~-~L~~~l~~~~----------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~D 171 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICD 171 (364)
T ss_dssp EEEEECCSE-EHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred EEEEcccCc-CHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEe
Confidence 999999985 9999997643 899999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCcccccc-ccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 217 FDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 217 fg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 238 (364)
T 3qyz_A 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238 (364)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG
T ss_pred CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH
Confidence 99997665433211 1234579999999998654 55899999999999999999999999876543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=302.88 Aligned_cols=203 Identities=22% Similarity=0.332 Sum_probs=167.6
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEc---------
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD--------- 132 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------- 132 (301)
...++|++.+.||+|+||.||+|++. +++.||+|++..+... ..+|+++++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 45678999999999999999999986 7999999998654332 3468999999999999999999843
Q ss_pred -----------------------------CCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 022206 133 -----------------------------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183 (301)
Q Consensus 133 -----------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l 183 (301)
....++||||+++ +|.+.+...... ...+++..++.++.||+.||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRS-----GRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp -----------------------------CCEEEEEECCCSE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHH
Confidence 3448899999985 887777531110 11389999999999999999
Q ss_pred HHhhhCCCCCeEecCCCCCceEEc-CCCceEEeccccCCCCCccccccccccccccccccCccccccC-CCCccccchhh
Q 022206 184 EYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSF 261 (301)
Q Consensus 184 ~~LH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvwsl 261 (301)
.|||+.| |+||||||+|||++ +++.+||+|||++......... ....+|+.|+|||++.+. .++.++|||||
T Consensus 155 ~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 228 (383)
T 3eb0_A 155 GFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSI 228 (383)
T ss_dssp HHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred HHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence 9999999 99999999999998 6899999999999765443322 445789999999988775 48999999999
Q ss_pred HHHHHHHHhCCCCCCCCCC
Q 022206 262 GVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 262 G~il~~l~~g~~pf~~~~~ 280 (301)
||++|+|++|+.||.+.+.
T Consensus 229 G~il~ell~g~~pf~~~~~ 247 (383)
T 3eb0_A 229 GCVFGELILGKPLFSGETS 247 (383)
T ss_dssp HHHHHHHHHSSCSSCCSSH
T ss_pred HHHHHHHHhCCCCCCCCCh
Confidence 9999999999999987654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=291.05 Aligned_cols=203 Identities=27% Similarity=0.385 Sum_probs=175.5
Q ss_pred HHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----------chHHHHHHHHHHhccC-CCceeeeeeE
Q 022206 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----------PDQEFLAQVSMVSRLK-NENVVELVGY 129 (301)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~e~~~l~~l~-h~~iv~~~~~ 129 (301)
....++|++.+.||+|+||.||+|.++ +++.||+|++..... ..+.+.+|+.+++++. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 345689999999999999999999987 789999999865431 1245778999999995 9999999999
Q ss_pred EEcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC
Q 022206 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (301)
Q Consensus 130 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 209 (301)
+.+....++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~ 160 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDD 160 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred eccCCeEEEEEeccCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCC
Confidence 999999999999999999999997543 2899999999999999999999999 9999999999999999
Q ss_pred CceEEeccccCCCCCccccccccccccccccccCccccc------cCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM------TGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
+.+||+|||++......... ....|++.|+|||++. ...++.++||||||+++|+|++|..||....
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 161 MNIKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp CCEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CcEEEecccchhhcCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 99999999998765433221 3456899999999885 4567889999999999999999999997654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=299.00 Aligned_cols=210 Identities=21% Similarity=0.314 Sum_probs=164.1
Q ss_pred HHHHHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCe--
Q 022206 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL-- 135 (301)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-- 135 (301)
.......++|++.+.||+|+||.||+|++. +++.||||++...........++++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 345567789999999999999999999987 78999999987666666677888889999999999999999875333
Q ss_pred -----eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--hCCCCCeEecCCCCCceEEcC
Q 022206 136 -----RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH--EKAEPRIIHRNIKSSNVLLFD 208 (301)
Q Consensus 136 -----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~~~~ivH~Dlkp~Nill~~ 208 (301)
.++||||+++ +|.+.+...... ...+++..+..++.|++.||.||| +.+ |+||||||+|||++.
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~ 166 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRR-----QVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNE 166 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEET
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeC
Confidence 7899999987 555444321000 112888999999999999999999 998 999999999999997
Q ss_pred -CCceEEeccccCCCCCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 209 -DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 209 -~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
++.+||+|||++......... ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 237 (360)
T 3e3p_A 167 ADGTLKLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237 (360)
T ss_dssp TTTEEEECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCcEEEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh
Confidence 899999999999876543322 345689999999998665 489999999999999999999999987654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=304.39 Aligned_cols=200 Identities=22% Similarity=0.303 Sum_probs=171.7
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccC--------CCceeeeeeEEE----
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK--------NENVVELVGYYV---- 131 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~~~~---- 131 (301)
.++|++.+.||+|+||.||+|++. +++.||+|++.........+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 478999999999999999999976 7899999999866545577889999999885 788999999987
Q ss_pred cCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeEecCCCCCceEEcCCC
Q 022206 132 DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDD 210 (301)
Q Consensus 132 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~Nill~~~~ 210 (301)
+....++||||+.+ +|.+.+..... ..+++..++.++.||+.||+|||++ | |+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 116 NGTHICMVFEVLGH-HLLKWIIKSNY-------QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp TEEEEEEEECCCCC-BHHHHHHHTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred CCceEEEEEeccCc-cHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 56689999999954 66666644321 1289999999999999999999998 8 99999999999999775
Q ss_pred -------------------------------------------------ceEEeccccCCCCCccccccccccccccccc
Q 022206 211 -------------------------------------------------IAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241 (301)
Q Consensus 211 -------------------------------------------------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y 241 (301)
.+||+|||++...... .....||+.|
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y 259 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQY 259 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGG
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcc
Confidence 7999999998765432 1445789999
Q ss_pred cCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 242 ~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcc
Confidence 999999999999999999999999999999999986554
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=292.60 Aligned_cols=202 Identities=30% Similarity=0.477 Sum_probs=172.8
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
..++|++.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 4578999999999999999999987 69999999987643 346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 106 ~~~~~L~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 106 CGAGSVSDIIRLRN--------KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp CTTEEHHHHHHHHT--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 99999999986322 12899999999999999999999999 99999999999999999999999999876
Q ss_pred CCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
....... .....|++.|+|||++.+..++.++||||||+++|+|++|+.||.+..
T Consensus 175 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 175 LTDTMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp CBTTBSC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred hhhhccc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 5433221 234568999999999998889999999999999999999999997654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=295.57 Aligned_cols=201 Identities=26% Similarity=0.404 Sum_probs=169.6
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---------chHHHHHHHHHHhccCCCceeeeeeEEEcC
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---------PDQEFLAQVSMVSRLKNENVVELVGYYVDG 133 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 133 (301)
..++|++.+.||+|+||.||+|.+. +++.||||++..... ....+.+|+.+++.++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999987 689999999865321 123478899999999999999999998766
Q ss_pred CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc--
Q 022206 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI-- 211 (301)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-- 211 (301)
. .++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~ 154 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDC 154 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSC
T ss_pred c-eEEEEecCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCC
Confidence 5 899999999999999987543 2899999999999999999999999 999999999999987654
Q ss_pred -eEEeccccCCCCCccccccccccccccccccCccccc---cCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 212 -AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 212 -vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+||+|||++......... ....||+.|+|||++. ...++.++||||||+++|+|++|..||.....
T Consensus 155 ~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 155 LIKITDFGHSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp CEEECCCTTCEECCCCHHH---HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred eEEEccCccceeccccccc---ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 999999998766443221 3446899999999874 46788999999999999999999999976543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=296.64 Aligned_cols=215 Identities=26% Similarity=0.414 Sum_probs=178.7
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CC-----CEEEEEEcCCCCCc--hHHHHHHHHHHhcc-CCCceeeeeeEEEcC
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SG-----RAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~-----~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 133 (301)
...++|++.+.||+|+||.||+|.+. ++ ..||+|.+...... ...+.+|+.+++.+ +||||+++++++.++
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 34578999999999999999999976 33 47999999765433 35688999999999 899999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhcCCCCCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC
Q 022206 134 PLRVLAYEHASKGSLHDILHGKKGVKG-----AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD 208 (301)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 208 (301)
+..++||||+++|+|.+++........ ......+++..++.++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence 999999999999999999964321000 001123789999999999999999999999 999999999999999
Q ss_pred CCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 209 DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 209 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 99999999999976544332222234557889999999999999999999999999999998 9999976543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=295.40 Aligned_cols=204 Identities=25% Similarity=0.423 Sum_probs=167.7
Q ss_pred HHHHhhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhc--cCCCceeeeeeEEEcC----
Q 022206 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSR--LKNENVVELVGYYVDG---- 133 (301)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~---- 133 (301)
......++|++.+.||+|+||.||+|++. ++.||+|++.... .....+|.+++.. ++||||+++++++.+.
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 34455678999999999999999999987 8999999986432 3344555555544 4899999999999877
Q ss_pred CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC--------CCCCeEecCCCCCceE
Q 022206 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK--------AEPRIIHRNIKSSNVL 205 (301)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------~~~~ivH~Dlkp~Nil 205 (301)
...++||||+++|+|.+++.... +++..++.++.|++.||.|||+. + |+||||||+|||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nil 174 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKSTT----------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNIL 174 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEE
T ss_pred CceEEEEeccCCCcHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEE
Confidence 78999999999999999997643 89999999999999999999998 8 999999999999
Q ss_pred EcCCCceEEeccccCCCCCcccccc--ccccccccccccCccccccCCCCcc------ccchhhHHHHHHHHhC------
Q 022206 206 LFDDDIAKISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMTGQMSSK------SDVYSFGVVLLELLTG------ 271 (301)
Q Consensus 206 l~~~~~vkl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~~l~~g------ 271 (301)
++.++.+||+|||++.......... ......||+.|+|||++.+..++.. +|||||||++|+|++|
T Consensus 175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~ 254 (337)
T 3mdy_A 175 VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI 254 (337)
T ss_dssp ECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccc
Confidence 9999999999999996654332211 1134579999999999987766655 9999999999999999
Q ss_pred ----CCCCCCCC
Q 022206 272 ----RKPVDHTL 279 (301)
Q Consensus 272 ----~~pf~~~~ 279 (301)
..||....
T Consensus 255 ~~~~~~p~~~~~ 266 (337)
T 3mdy_A 255 VEEYQLPYHDLV 266 (337)
T ss_dssp CCCCCCTTTTTS
T ss_pred cccccccHhhhc
Confidence 67776543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=288.75 Aligned_cols=201 Identities=24% Similarity=0.373 Sum_probs=169.1
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
..++|++.+.||+|+||.||+|.+. +++.||+|++... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 4578999999999999999999987 7999999998542 2234578899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||||+++++|.+++..... +++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 89 v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg 156 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGR---------VEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFG 156 (276)
T ss_dssp EEECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEeccCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecc
Confidence 9999999999999975432 889999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
++......... ....+++.|+|||++.+..+ +.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 215 (276)
T 2h6d_A 157 LSNMMSDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215 (276)
T ss_dssp GGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccCCCcce---ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 98776543221 34468999999999987765 689999999999999999999997643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=292.13 Aligned_cols=197 Identities=26% Similarity=0.431 Sum_probs=170.4
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CC-------CEEEEEEcCCCC-CchHHHHHHHHHHhccCCCceeeeeeEEEcCCe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SG-------RAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~-------~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 135 (301)
.++|.+.+.||+|+||.||+|+++ ++ ..||+|++.... ...+.+.+|+.+++.++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 468999999999999999999976 34 479999986543 234678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc----
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI---- 211 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---- 211 (301)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~ 155 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN--------CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTG 155 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGT
T ss_pred CEEEEECCCCCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccc
Confidence 9999999999999999976542 2889999999999999999999999 999999999999998887
Q ss_pred ----eEEeccccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHh-CCCCCCCC
Q 022206 212 ----AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLT-GRKPVDHT 278 (301)
Q Consensus 212 ----vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~-g~~pf~~~ 278 (301)
+||+|||++...... ....+|+.|+|||++.+ ..++.++||||||+++|+|++ |.+||...
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~ 222 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222 (289)
T ss_dssp BCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc
Confidence 999999998765433 22357889999999887 678999999999999999999 55566543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=289.77 Aligned_cols=205 Identities=25% Similarity=0.353 Sum_probs=170.4
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC-----CCchHHHHHHHHHHhccCCCceeeeeeEEE--cCCe
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS-----KQPDQEFLAQVSMVSRLKNENVVELVGYYV--DGPL 135 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~ 135 (301)
..++|++.+.||+|+||.||+|.+. +++.||+|++... ......+.+|+.+++.++|+||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4578999999999999999999986 7899999998643 234467899999999999999999999984 4567
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
.++||||++++ |.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~ 151 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPE-------KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKIS 151 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTT-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEehhccCC-HHHHHHhCcc-------cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEee
Confidence 89999999886 7777765332 12899999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCccccccCCC--CccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM--SSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|||++................||+.|+|||++.+... +.++||||||+++|+|++|+.||.+..
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 152 ALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp CCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 9999876543222222234568999999999876543 779999999999999999999998654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=284.94 Aligned_cols=200 Identities=24% Similarity=0.334 Sum_probs=172.5
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcC--CeeEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDG--PLRVLA 139 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 139 (301)
.++|++.+.||+|+||.||+|+++ ++.||+|++...... .+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 468999999999999999999987 889999999765433 34688999999999999999999999877 788999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ .+++||||||+||+++.++.++|+|||+
T Consensus 88 ~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN-------FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADV 159 (271)
T ss_dssp EECCTTCBHHHHHHSCSS-------CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred ecccCCCcHHHHHhhccc-------CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccc
Confidence 999999999999986542 13899999999999999999999974 2399999999999999999999999998
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCc---cccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSS---KSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+..... ....||+.|+|||++.+..++. ++||||||+++|+|++|+.||.+...
T Consensus 160 ~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 216 (271)
T 3kmu_A 160 KFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN 216 (271)
T ss_dssp CCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH
T ss_pred eeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh
Confidence 754322 3346899999999998765544 79999999999999999999976544
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=293.94 Aligned_cols=218 Identities=22% Similarity=0.367 Sum_probs=180.0
Q ss_pred HHHHHhhCCCCCCceecccCceEEEEEEE------CCCCEEEEEEcCCCCCc--hHHHHHHHHHHhcc-CCCceeeeeeE
Q 022206 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVL------RSGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGY 129 (301)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~ 129 (301)
..+....++|++.+.||+|+||.||+|++ .+++.||+|++...... ...+.+|+.+++++ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 34444567899999999999999999984 25689999999765443 24688999999999 68999999999
Q ss_pred EEcCC-eeEEEEecCCCCCHHHHhcCCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCC
Q 022206 130 YVDGP-LRVLAYEHASKGSLHDILHGKKGVKGA-------KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (301)
Q Consensus 130 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~-------~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp 201 (301)
+.+.+ ..+++|||+++++|.+++......... .....+++..++.++.|++.||.|||+.+ |+||||||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp 176 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 176 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCcc
Confidence 87654 589999999999999999765431100 00122788999999999999999999999 99999999
Q ss_pred CceEEcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCC
Q 022206 202 SNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTL 279 (301)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~ 279 (301)
+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999999999999987654333222344567899999999999999999999999999999998 999997654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=292.26 Aligned_cols=205 Identities=22% Similarity=0.365 Sum_probs=164.1
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ....+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 467999999999999999999986 799999999875322 235688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 111 ~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~ 182 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQ-----KRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGL 182 (310)
T ss_dssp EECCCSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--
T ss_pred EecCCCCCHHHHHHHhccc-----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccc
Confidence 9999999999998642111 112889999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
+......... .....|++.|+|||++.+..++.++||||||+++|+|++|..||.+..
T Consensus 183 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 240 (310)
T 2wqm_A 183 GRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240 (310)
T ss_dssp ------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred eeeecCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 8765433221 134568999999999999999999999999999999999999997543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=288.34 Aligned_cols=206 Identities=22% Similarity=0.333 Sum_probs=170.2
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEE-EcCCeeEEEEe
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY-VDGPLRVLAYE 141 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e 141 (301)
..++|++.+.||+|+||.||+|++. +++.||+|++..... ...+.+|+.+++.++|++++..+..+ .+.+..+++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 4578999999999999999999986 789999998654332 24578899999999988777666655 67788899999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEE---cCCCceEEeccc
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFD 218 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~Dfg 218 (301)
|+ +++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||+ ++++.+||+|||
T Consensus 86 ~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp CC-CCBHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred cc-CCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 99 8899999974332 2899999999999999999999999 9999999999999 788999999999
Q ss_pred cCCCCCccccc-----cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCcC
Q 022206 219 LSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (301)
Q Consensus 219 ~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~ 282 (301)
++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.....
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 222 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 222 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhh
Confidence 99765443221 11234578999999999999999999999999999999999999998765543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=317.42 Aligned_cols=203 Identities=31% Similarity=0.464 Sum_probs=168.0
Q ss_pred CCCCCc-eecccCceEEEEEEEC---CCCEEEEEEcCCCC--CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 67 NFGTNS-LIGEGSYGRVYFGVLR---SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 67 ~y~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
++.+.+ .||+|+||.||+|.++ ++..||||+++... ...+.+.+|+++|+.++||||+++++++.+ +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 344444 7999999999999864 46679999997643 235779999999999999999999999876 5689999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||+.+|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 415 E~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp ECCTTCBHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred EeCCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 99999999999975432 2899999999999999999999999 999999999999999999999999999
Q ss_pred CCCCcccccc-ccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCc
Q 022206 221 NQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (301)
Q Consensus 221 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~ 281 (301)
+......... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~ 546 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 546 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence 8765432211 1122345689999999999999999999999999999998 99999876653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=290.66 Aligned_cols=206 Identities=25% Similarity=0.394 Sum_probs=171.8
Q ss_pred hhCCCCCCceecccCceEEEEEEECC----CCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEE-cCCee
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYV-DGPLR 136 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 136 (301)
...+|++.+.||+|+||.||+|++.. ...+|+|.+...... ...+.+|+.++++++||||+++++++. .++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 44579999999999999999999652 235899998764433 356889999999999999999999864 56678
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
+++|||+++++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~D 171 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVAD 171 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTC--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECS
T ss_pred EEEEeCCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECc
Confidence 999999999999999975432 2789999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccc--cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 217 FDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 217 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
||++......... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.+...
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 238 (298)
T 3f66_A 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238 (298)
T ss_dssp CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT
T ss_pred ccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH
Confidence 9999876543321 11234457889999999999999999999999999999999 7778776554
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=306.38 Aligned_cols=201 Identities=26% Similarity=0.342 Sum_probs=165.2
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcC------CeeE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG------PLRV 137 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~ 137 (301)
..+|++.+.||+|+||.||+|++. +++.||||++..... ...+|+++++.++|+||+++++++... ..++
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 347999999999999999999987 699999999865432 234689999999999999999988532 2367
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC-CceEEec
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-DIAKISD 216 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~D 216 (301)
+||||+++ +|.+++...... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~D 200 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRA-----KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 200 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred eehhcccc-cHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEecc
Confidence 99999986 677666421100 112899999999999999999999999 9999999999999965 6789999
Q ss_pred cccCCCCCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
||+++........ ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.
T Consensus 201 FG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~ 262 (420)
T 1j1b_A 201 FGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 262 (420)
T ss_dssp CTTCEECCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred chhhhhcccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999765433221 345789999999998764 789999999999999999999999987653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=290.22 Aligned_cols=197 Identities=27% Similarity=0.476 Sum_probs=172.4
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEc----------
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD---------- 132 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---------- 132 (301)
...+|++.+.||+|+||.||+|++. +++.||+|++.... ..+.+|+++++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 4567999999999999999999987 79999999987543 457789999999999999999998854
Q ss_pred ------CCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEE
Q 022206 133 ------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (301)
Q Consensus 133 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill 206 (301)
....++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||++
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 155 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-------EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFL 155 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGG-------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEE
Confidence 4458999999999999999975432 12889999999999999999999999 9999999999999
Q ss_pred cCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCC
Q 022206 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276 (301)
Q Consensus 207 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~ 276 (301)
++++.+||+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp EETTEEEECCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred cCCCCEEECcchhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 99999999999998766543221 34568999999999999999999999999999999999998874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=294.29 Aligned_cols=201 Identities=19% Similarity=0.331 Sum_probs=175.1
Q ss_pred hhCCCCCCceecccCceEEEEEEE-C-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCc------eeeeeeEEEcCCe
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVL-R-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN------VVELVGYYVDGPL 135 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~ 135 (301)
..++|++.+.||+|+||.||+|.+ + +++.||+|++.........+.+|+.+++.++|++ ++++++++.+.+.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 347899999999999999999997 3 6889999999765545567889999999887654 9999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC-------
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD------- 208 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~------- 208 (301)
.++||||+ +++|.+++...... .+++..++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFL-------PFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCC-------CCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEecccccccc
Confidence 99999999 78999999765421 2889999999999999999999999 999999999999987
Q ss_pred ------------CCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCC
Q 022206 209 ------------DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276 (301)
Q Consensus 209 ------------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~ 276 (301)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 668999999998654332 134578999999999999999999999999999999999999998
Q ss_pred CCCC
Q 022206 277 HTLP 280 (301)
Q Consensus 277 ~~~~ 280 (301)
..+.
T Consensus 236 ~~~~ 239 (339)
T 1z57_A 236 THDS 239 (339)
T ss_dssp CSCH
T ss_pred CCCh
Confidence 7554
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=291.80 Aligned_cols=212 Identities=25% Similarity=0.379 Sum_probs=165.4
Q ss_pred hhCCCCCCceecccCceEEEEEEEC----CCCEEEEEEcCCCCCch---HHHHHHHHHHhccCCCceeeeeeEEEcCC--
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVDGP-- 134 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 134 (301)
..++|.+.+.||+|+||.||+|.+. ++..||+|++....... ..+.+|+.++++++||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3467999999999999999999864 34589999987654332 46889999999999999999999988654
Q ss_pred ---eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc
Q 022206 135 ---LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (301)
Q Consensus 135 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (301)
..+++|||+++++|.+++........ ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETG---PKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTS---CCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcC---CccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCc
Confidence 35999999999999999853321111 123899999999999999999999999 999999999999999999
Q ss_pred eEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCc
Q 022206 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (301)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~ 281 (301)
+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 256 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH 256 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH
Confidence 99999999977654332222234457889999999999999999999999999999999 99999876543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=298.42 Aligned_cols=200 Identities=19% Similarity=0.279 Sum_probs=165.8
Q ss_pred hCCCCCCceecccCceEEEEEEEC----CCCEEEEEEcCCCCCc------------hHHHHHHHHHHhccCCCceeeeee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQP------------DQEFLAQVSMVSRLKNENVVELVG 128 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~h~~iv~~~~ 128 (301)
.++|++.+.||+|+||.||+|.+. ++..+|+|++...... ...+.+|+..++.++|+||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999976 5788999998765432 123567788899999999999999
Q ss_pred EEEc----CCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCce
Q 022206 129 YYVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNV 204 (301)
Q Consensus 129 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Ni 204 (301)
++.+ ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 182 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---------TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANL 182 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHE
Confidence 9987 77899999999 899999997654 2899999999999999999999999 99999999999
Q ss_pred EEcCCC--ceEEeccccCCCCCccccc-----cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 205 LLFDDD--IAKISDFDLSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 205 ll~~~~--~vkl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
|++.++ .+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999877 9999999999765433211 011345789999999999999999999999999999999999999965
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=287.01 Aligned_cols=205 Identities=22% Similarity=0.337 Sum_probs=173.6
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEE-EcCCeeEEEEe
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY-VDGPLRVLAYE 141 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e 141 (301)
..++|++.+.||+|+||.||+|++. +++.||+|++..... ...+.+|+.+++.++|++++..+..+ .++...++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 3578999999999999999999985 799999999865433 34688999999999998866666554 57778899999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEE---cCCCceEEeccc
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFD 218 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~Dfg 218 (301)
|+ +++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||+ ++++.+||+|||
T Consensus 86 ~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 153 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp CC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred ec-CCCHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence 99 8899999974332 2899999999999999999999999 9999999999999 478899999999
Q ss_pred cCCCCCcccccc-----ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 219 LSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 219 ~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
++.......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 221 (296)
T 3uzp_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 221 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred CcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCch
Confidence 987655432211 123457899999999999999999999999999999999999999875543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=287.46 Aligned_cols=204 Identities=31% Similarity=0.474 Sum_probs=173.4
Q ss_pred hCCCCCCc-eecccCceEEEEEEEC---CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 65 TDNFGTNS-LIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 65 ~~~y~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
.++|.+.+ .||+|+||.||+|.+. ++..||+|++...... .+.+.+|+++++.++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45677776 9999999999999864 5788999999765432 35688999999999999999999998 4556899
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 87 v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp EEECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCT
T ss_pred EEEeCCCCCHHHHHHhCCc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECccc
Confidence 9999999999999975432 2899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 219 LSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 219 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 219 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred ceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 99766433221 11123456889999999988889999999999999999998 9999987654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=294.96 Aligned_cols=210 Identities=28% Similarity=0.435 Sum_probs=172.4
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEE--EEEEcCCC--CCchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAA--AIKKLDSS--KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~v--avK~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 138 (301)
.++|++.+.||+|+||.||+|++. ++..+ ++|.+... ......+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 368999999999999999999976 56644 89988643 22345688999999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc
Q 022206 139 AYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (301)
||||+++++|.+++........ ......+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 9999999999999976531000 000123899999999999999999999999 999999999999999999
Q ss_pred eEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
+||+|||++........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 181 ~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 247 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247 (327)
T ss_dssp EEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred EEEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence 99999999865433221 133456889999999988889999999999999999998 9999977654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=292.54 Aligned_cols=201 Identities=27% Similarity=0.388 Sum_probs=171.2
Q ss_pred hCCCCCCceecccCceEEEEEEE----C-CCCEEEEEEcCCCC--CchHHHHHHHHHHhccCCCceeeeeeEEEcC--Ce
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVL----R-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDG--PL 135 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~----~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 135 (301)
...|++.+.||+|+||.||+|++ . +++.||+|++.... .....+.+|+.+++.++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35689999999999999999983 2 68999999987543 2346788999999999999999999999876 66
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
.++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~ 168 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKN--------KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIG 168 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEEC
Confidence 8999999999999999954332 2899999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCC
Q 022206 216 DFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276 (301)
Q Consensus 216 Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~ 276 (301)
|||++......... .......+|+.|+|||++.+..++.++||||||+++|+|++|..|+.
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 169 DFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 99999766543321 12234568888999999999999999999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=296.93 Aligned_cols=196 Identities=25% Similarity=0.407 Sum_probs=169.0
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCee---
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR--- 136 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--- 136 (301)
..++|.+.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3578999999999999999999987 7999999999764433 35678999999999999999999999877655
Q ss_pred ---EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceE
Q 022206 137 ---VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAK 213 (301)
Q Consensus 137 ---~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vk 213 (301)
++||||+.+ +|.+++... +++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 120 ~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~k 184 (371)
T 4exu_A 120 YDFYLVMPFMQT-DLQKIMGME-----------FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELK 184 (371)
T ss_dssp CCCEEEEECCCE-EHHHHTTSC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred eeEEEEEccccc-cHHHHhhcC-----------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEE
Confidence 999999984 898887432 889999999999999999999999 99999999999999999999
Q ss_pred EeccccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|+|||++....... ....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+
T Consensus 185 L~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 185 ILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EEecCcccccccCc-----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999997654322 34578999999999887 678999999999999999999999998754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=290.51 Aligned_cols=197 Identities=31% Similarity=0.537 Sum_probs=164.8
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
.++|++.+.||+|+||.||+|++. ++.||+|++... ...+.+.+|+.++++++||||+++++++.+ ..++||||++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 357899999999999999999986 788999998643 345678999999999999999999998764 4789999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh---CCCCCeEecCCCCCceEEcCCCc-eEEeccccC
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE---KAEPRIIHRNIKSSNVLLFDDDI-AKISDFDLS 220 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~~~~ivH~Dlkp~Nill~~~~~-vkl~Dfg~a 220 (301)
+++|.+++...... ..++...++.++.|++.||.|||+ ++ |+||||||+|||++.++. +||+|||++
T Consensus 83 ~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 83 GGSLYNVLHGAEPL------PYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp TCBHHHHHHCSSSE------ECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred CCCHHHHHhccCCC------CccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccc
Confidence 99999999765421 127888999999999999999999 67 999999999999998886 799999998
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
....... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 154 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 154 CDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp ----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred ccccccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 7654321 33468999999999999999999999999999999999999997543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=291.49 Aligned_cols=199 Identities=29% Similarity=0.430 Sum_probs=171.9
Q ss_pred CCC-CCCceecccCceEEEEEEEC-----CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEc--CCe
Q 022206 66 DNF-GTNSLIGEGSYGRVYFGVLR-----SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVD--GPL 135 (301)
Q Consensus 66 ~~y-~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 135 (301)
++| ++++.||+|+||.||++.++ +++.||+|++...... ...+.+|+.+++.++||||+++++++.+ ...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 345 99999999999999988643 5889999999865433 3568899999999999999999999987 467
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
.++||||+++++|.+++.... +++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~ 176 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIG 176 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEecccCCcHHHHHhhCC----------CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEEC
Confidence 899999999999999997654 889999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 216 DFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 216 Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
|||++......... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 177 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 177 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp CGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred CccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 99999776543221 112344578889999999998899999999999999999999999965
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=304.63 Aligned_cols=200 Identities=12% Similarity=0.086 Sum_probs=154.0
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHhcc--CCCceeeee-------eEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRL--KNENVVELV-------GYY 130 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l--~h~~iv~~~-------~~~ 130 (301)
..+|.+.+.||+|+||.||+|++. +++.||+|++...... ...+.+|+.+++.| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 346999999999999999999987 7899999999875532 24566775544444 699988755 454
Q ss_pred EcC-----------------CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHH------HHHHHHHHHHHHHhh
Q 022206 131 VDG-----------------PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQR------VKIAVGAARGLEYLH 187 (301)
Q Consensus 131 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~------~~i~~qi~~~l~~LH 187 (301)
... ...++||||++ ++|.+++...... +....+ +.++.||+.||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--------~~~~~~~~~~vk~~i~~qi~~aL~~LH 211 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV--------YVFRGDEGILALHILTAQLIRLAANLQ 211 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS--------CCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc--------cchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence 433 33799999999 7999999764221 333344 677799999999999
Q ss_pred hCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCccccccccccccccccccCcccccc--CCCCccccchhhHHHH
Q 022206 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVL 265 (301)
Q Consensus 188 ~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il 265 (301)
+++ |+||||||+|||++.++.+||+|||++....... ....+|+.|+|||++.+ ..++.++|||||||++
T Consensus 212 ~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il 283 (371)
T 3q60_A 212 SKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283 (371)
T ss_dssp HTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHH
T ss_pred HCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHH
Confidence 999 9999999999999999999999999997654322 13456799999999987 6789999999999999
Q ss_pred HHHHhCCCCCCCCCCc
Q 022206 266 LELLTGRKPVDHTLPR 281 (301)
Q Consensus 266 ~~l~~g~~pf~~~~~~ 281 (301)
|+|++|+.||.+..+.
T Consensus 284 ~elltg~~Pf~~~~~~ 299 (371)
T 3q60_A 284 YRVWCLFLPFGLVTPG 299 (371)
T ss_dssp HHHHHSSCSTTBCCTT
T ss_pred HHHHhCCCCCCCcCcc
Confidence 9999999999877543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=292.92 Aligned_cols=205 Identities=28% Similarity=0.458 Sum_probs=168.5
Q ss_pred hCCCCCCceecccCceEEEEEEEC-C----CCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-S----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
..+|.+.+.||+|+||.||+|.+. + +..||+|++...... ...+.+|+.+++.++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 467888999999999999999865 2 235999999765433 346889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 123 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Df 191 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDF 191 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC
T ss_pred EEEeCCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCC
Confidence 99999999999999975432 2899999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 218 DLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 218 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
|++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+...
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 256 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH
Confidence 999776543221 11123346788999999998999999999999999999999 9999976543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=300.63 Aligned_cols=202 Identities=23% Similarity=0.311 Sum_probs=164.6
Q ss_pred hhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCC------eeE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP------LRV 137 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~ 137 (301)
...+|++.+.||+|+||.||+|++..+..+|+|++...... ..+|+++++.++||||+++++++.... ..+
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 34679999999999999999999986677999987544322 236899999999999999999986433 378
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEc-CCCceEEec
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISD 216 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~D 216 (301)
+||||++++.+..+...... ...+++..++.++.||+.||+|||+.| |+||||||+|||++ .++.+||+|
T Consensus 115 lv~e~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~D 185 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKL------KQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLID 185 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred EEeeccCccHHHHHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEee
Confidence 99999987443333321100 012889999999999999999999999 99999999999999 799999999
Q ss_pred cccCCCCCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
||++......... ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.
T Consensus 186 FG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 247 (394)
T 4e7w_A 186 FGSAKILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247 (394)
T ss_dssp CTTCEECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCcccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999765433322 345789999999988765 589999999999999999999999987653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=290.30 Aligned_cols=210 Identities=22% Similarity=0.329 Sum_probs=173.6
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEE--cCCeeE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYV--DGPLRV 137 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~ 137 (301)
..++|++.+.||+|+||.||+|++. +++.||+|++...... .+.+.+|+.++++++||||+++++++. .....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 4578999999999999999999987 7899999999754433 356889999999999999999999875 467899
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--CCCeEecCCCCCceEEcCCCceEEe
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA--EPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
+||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ..+++||||||+||+++.++.+||+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~ 158 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred EEEeCCCCCCHHHHHHhhccc-----CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence 999999999999999753211 123889999999999999999999975 1239999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|||++......... .....|++.|+|||++.+..++.++||||||+++|+|++|+.||...+.
T Consensus 159 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 221 (279)
T 2w5a_A 159 DFGLARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 221 (279)
T ss_dssp CCCHHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCchheeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH
Confidence 99998665432211 1234689999999999988999999999999999999999999987543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=294.41 Aligned_cols=211 Identities=27% Similarity=0.419 Sum_probs=172.0
Q ss_pred hCCCCCCceecccCceEEEEEEE-----C-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVL-----R-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~-----~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 136 (301)
.++|++.+.||+|+||.||+|++ . ++..||+|++...... ...+.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 47899999999999999999983 2 5789999999654332 35688899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC---CCceE
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAK 213 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~vk 213 (301)
++||||+++++|.+++....... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++. +..+|
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCS--SSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred EEEEecCCCCcHHHHHHhhcccc--cccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999997654221 11133889999999999999999999999 999999999999984 44699
Q ss_pred EeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
|+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 251 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH
Confidence 999999864432222222234567899999999998999999999999999999998 9999976543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=302.31 Aligned_cols=210 Identities=22% Similarity=0.372 Sum_probs=157.9
Q ss_pred CCCCC-CceecccCceEEEEEEEC---CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEE--cCCeeEEE
Q 022206 66 DNFGT-NSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV--DGPLRVLA 139 (301)
Q Consensus 66 ~~y~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv 139 (301)
+.|++ .++||+|+||.||+|+++ +++.||+|++..... ...+.+|+.+++.++||||+++++++. .....++|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 45666 558999999999999965 578999999975433 356889999999999999999999995 46789999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEE----cCCCceEEe
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL----FDDDIAKIS 215 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~vkl~ 215 (301)
|||+.+ +|.+++..............+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999975 88888753221111111123889999999999999999999999 9999999999999 677899999
Q ss_pred ccccCCCCCccccc-cccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 216 Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|||++......... .......||+.|+|||++.+. .++.++|||||||++|+|++|++||.....
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 99999876433211 112446789999999998874 589999999999999999999999976543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=299.87 Aligned_cols=198 Identities=29% Similarity=0.438 Sum_probs=160.7
Q ss_pred hhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHH--HHhccCCCceeeeeeEEE-----cCCee
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVS--MVSRLKNENVVELVGYYV-----DGPLR 136 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~--~l~~l~h~~iv~~~~~~~-----~~~~~ 136 (301)
..++|++.+.||+|+||.||+|+.. ++.||+|++.... ...+..|.+ .+..++|+||+++++.+. .....
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEEC-CeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 4578999999999999999999874 8999999986543 233444444 455689999999997553 23357
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC---------CCCCeEecCCCCCceEEc
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK---------AEPRIIHRNIKSSNVLLF 207 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---------~~~~ivH~Dlkp~Nill~ 207 (301)
++||||+++|+|.+++.... .++..++.++.|++.||.|||+. + |+||||||+|||++
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~ 154 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT----------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVK 154 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEEC
T ss_pred EEEEecCCCCcHHHHHhhcc----------cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEc
Confidence 89999999999999997654 68889999999999999999999 8 99999999999999
Q ss_pred CCCceEEeccccCCCCCcccc------ccccccccccccccCcccccc-------CCCCccccchhhHHHHHHHHhCCCC
Q 022206 208 DDDIAKISDFDLSNQAPDAAA------RLHSTRVLGTFGYHAPEYAMT-------GQMSSKSDVYSFGVVLLELLTGRKP 274 (301)
Q Consensus 208 ~~~~vkl~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~~g~~p 274 (301)
.++.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p 234 (336)
T 3g2f_A 155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234 (336)
T ss_dssp TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence 999999999999976543211 111234569999999999876 3456789999999999999999776
Q ss_pred CCC
Q 022206 275 VDH 277 (301)
Q Consensus 275 f~~ 277 (301)
|..
T Consensus 235 ~~~ 237 (336)
T 3g2f_A 235 LFP 237 (336)
T ss_dssp GST
T ss_pred CCC
Confidence 643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=286.13 Aligned_cols=204 Identities=27% Similarity=0.402 Sum_probs=170.3
Q ss_pred CCCCCCceecccCceEEEEEEEC-CC---CEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCee-EE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SG---RAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR-VL 138 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~l 138 (301)
..|.+.+.||+|+||.||+|.+. ++ ..+|+|.+...... .+.+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 35667799999999999999864 22 37999998764433 35688999999999999999999999866655 99
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
+|||+.+++|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||
T Consensus 101 v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg 169 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQR--------NPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFG 169 (298)
T ss_dssp EECCCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTT
T ss_pred EEecccCCCHHHHHhcccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCC
Confidence 9999999999999976432 2788999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccc--cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 219 LSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 219 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
++......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...++
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~ 234 (298)
T 3pls_A 170 LARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234 (298)
T ss_dssp SSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG
T ss_pred CcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH
Confidence 99866443321 12234567899999999999999999999999999999999 5556655444
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=298.51 Aligned_cols=205 Identities=25% Similarity=0.390 Sum_probs=162.5
Q ss_pred CCCCCCceecccCceEEEEEEEC--C--CCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEE-cCCeeEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR--S--GRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYV-DGPLRVL 138 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~--~--~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~l 138 (301)
..|++.+.||+|+||.||+|.+. + +..||+|.+..... ....+.+|+.++++++||||+++++++. .++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 34777899999999999999864 2 24689999865433 2357889999999999999999999875 4567899
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||||+++|+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 169 v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG 237 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFG 237 (373)
T ss_dssp EEECCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-
T ss_pred EEECCCCCCHHHHHhhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecc
Confidence 9999999999999976432 2788999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccc--cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCc
Q 022206 219 LSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (301)
Q Consensus 219 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~ 281 (301)
++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||.+.+..
T Consensus 238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~ 303 (373)
T 3c1x_A 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303 (373)
T ss_dssp --------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS
T ss_pred ccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH
Confidence 99765433211 11123457889999999999999999999999999999999 78899776543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=298.22 Aligned_cols=200 Identities=19% Similarity=0.258 Sum_probs=171.2
Q ss_pred hCCCCCCceecccCceEEEEEEECC---------CCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceee----------
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRS---------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVE---------- 125 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~---------- 125 (301)
.++|++.+.||+|+||.||+|++.. ++.||+|++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 4789999999999999999999873 789999998754 45888999999999999987
Q ss_pred -----eeeEEEc-CCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCC
Q 022206 126 -----LVGYYVD-GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNI 199 (301)
Q Consensus 126 -----~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dl 199 (301)
+++++.. +...++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Di 185 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-------HVLSERSVLQVACRLLDALEFLHENE---YVHGNV 185 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-------GCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCC
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCC
Confidence 5667665 77899999999 8999999986521 12899999999999999999999999 999999
Q ss_pred CCCceEEcCCC--ceEEeccccCCCCCcccccc-----ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCC
Q 022206 200 KSSNVLLFDDD--IAKISDFDLSNQAPDAAARL-----HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR 272 (301)
Q Consensus 200 kp~Nill~~~~--~vkl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~ 272 (301)
||+|||++.++ .+||+|||++.......... ......||+.|+|||++.+..++.++||||||+++|+|++|+
T Consensus 186 kp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 265 (352)
T 2jii_A 186 TAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265 (352)
T ss_dssp CGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred CHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999998 99999999997765433211 113347899999999999989999999999999999999999
Q ss_pred CCCCCCC
Q 022206 273 KPVDHTL 279 (301)
Q Consensus 273 ~pf~~~~ 279 (301)
.||....
T Consensus 266 ~pf~~~~ 272 (352)
T 2jii_A 266 LPWTNCL 272 (352)
T ss_dssp CTTGGGT
T ss_pred CCcccCC
Confidence 9998654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=284.45 Aligned_cols=201 Identities=27% Similarity=0.391 Sum_probs=170.6
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEc----CCee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD----GPLR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 136 (301)
...|++.+.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.+++.++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 345888999999999999999987 7889999998654322 3568899999999999999999998865 4568
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEc-CCCceEEe
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKIS 215 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~ 215 (301)
++||||+++++|.+++..... +++..++.++.|++.||.|||+.+ ++++||||||+|||++ +++.+||+
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~ 174 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred EEEEEecCCCCHHHHHHHccC---------CCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEe
Confidence 999999999999999976432 889999999999999999999984 2399999999999998 78999999
Q ss_pred ccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|||++........ ....||+.|+|||++. ..++.++||||||+++|+|++|+.||.....
T Consensus 175 Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 234 (290)
T 1t4h_A 175 DLGLATLKRASFA----KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN 234 (290)
T ss_dssp CTTGGGGCCTTSB----EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred eCCCccccccccc----ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc
Confidence 9999865443221 3456899999999876 4589999999999999999999999976433
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=292.58 Aligned_cols=214 Identities=27% Similarity=0.375 Sum_probs=159.8
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC--CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
...++|++.+.||+|+||.||+|.+. +++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 44679999999999999999999976 78999999986543 2345678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+++++|.+++....... ......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKG-EHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTT-TTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred ehhccCCchHHHHHHHhhcc-ccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999986411100 001123899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCcccc---ccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 220 SNQAPDAAA---RLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 232 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP 232 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch
Confidence 865433211 111134568999999998875 5689999999999999999999999976543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=290.88 Aligned_cols=203 Identities=23% Similarity=0.398 Sum_probs=170.8
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC-CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
..++|++.+.||+|+||.||+|++. +++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3568999999999999999999987 68999999986543 334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDR--------GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp CCTTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred eCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 9999999999865321 2899999999999999999999999 9999999999999999999999999864
Q ss_pred CCCccccccccccccccccccCccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
....... ......||+.|+|||++. ...++.++||||||+++|+|++|..||...+
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 166 KNLKTLQ--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp HHHHHHH--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccccccc--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 3221111 113456899999999883 5678899999999999999999999997654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=285.25 Aligned_cols=200 Identities=22% Similarity=0.307 Sum_probs=170.2
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 138 (301)
..++|++.+.||+|+||.||+|++. +++.||+|++..... ....+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4567999999999999999999987 799999999875432 235678899999988 99999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC---------
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD--------- 209 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~--------- 209 (301)
||||+++++|.+++...... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~ 160 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRI-----MSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEE 160 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------
T ss_pred EEEecCCCcHHHHHHhhccc-----ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccc
Confidence 99999999999999753211 012899999999999999999999999 9999999999999844
Q ss_pred ----------CceEEeccccCCCCCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 210 ----------DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 210 ----------~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
..+||+|||++...... ....||+.|+|||++.+. .++.++||||||+++|+|++|.+|+..
T Consensus 161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 161 GDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp ---------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred cccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 47999999998765432 234589999999998765 566899999999999999999988754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=303.26 Aligned_cols=204 Identities=24% Similarity=0.362 Sum_probs=173.6
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCC-CceeeeeeEEEcCCeeEEEEec
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
.++|++.+.||+|+||.||+|++. +++.||||++..... ...+.+|+++++.++| ++|..+..++.+.+..++||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 578999999999999999999986 799999998765433 2457889999999987 5566666667788899999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEE---cCCCceEEecccc
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFDL 219 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~Dfg~ 219 (301)
+ +++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+
T Consensus 85 ~-g~sL~~ll~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSR--------KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp C-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred C-CCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 9 8899999975332 2899999999999999999999999 9999999999999 5889999999999
Q ss_pred CCCCCccccc-----cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 220 SNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 220 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
+......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~ 219 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch
Confidence 9766543221 1123567999999999999999999999999999999999999999876553
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=288.88 Aligned_cols=202 Identities=28% Similarity=0.333 Sum_probs=157.8
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch---HHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
..++|++.+.||+|+||.||+|++. +++.||+|++....... ..+.++...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3578999999999999999999986 78999999997654333 2234445557888999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
|||+++ +|.+++...... ...+++..++.++.|++.||.|||++ + ++||||||+||+++.++.+||+|||
T Consensus 85 ~e~~~~-~l~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDK-----GQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFG 155 (290)
T ss_dssp EECCSE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred Eehhcc-chHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecC
Confidence 999985 888877532110 12389999999999999999999998 9 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCcccc----ccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYA----MTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
++......... ....||+.|+|||++ .+..++.++||||||+++|+|++|+.||..
T Consensus 156 ~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 156 ISGYLVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp -----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred Ccccccccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 99776543322 334689999999996 456788999999999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=289.36 Aligned_cols=203 Identities=28% Similarity=0.433 Sum_probs=170.1
Q ss_pred hCCCCCCc-eecccCceEEEEEEE--C-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 65 TDNFGTNS-LIGEGSYGRVYFGVL--R-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 65 ~~~y~~~~-~lg~G~~g~V~~~~~--~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
.++|.+.+ .||+|+||.||+|.+ . +++.||+|++...... ...+.+|+.+++.++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 46788888 999999999999964 3 4788999999754322 45688999999999999999999998 566789
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+||||+++++|.+++..... +++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+||
T Consensus 94 lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCC
T ss_pred EEEEeCCCCCHHHHHHhCcC---------CCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccC
Confidence 99999999999999976432 889999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCcccccc-ccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 218 DLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 218 g~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
|++.......... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 226 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9987654332211 1122346788999999988889999999999999999999 9999987554
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=295.67 Aligned_cols=202 Identities=20% Similarity=0.334 Sum_probs=175.3
Q ss_pred hhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCc----h--------------HHHHHHHHHHhccCCCceee
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP----D--------------QEFLAQVSMVSRLKNENVVE 125 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~--------------~~~~~e~~~l~~l~h~~iv~ 125 (301)
..++|++.+.||+|+||.||+|++ +++.||+|++...... . ..+.+|+.+++.++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 357999999999999999999999 8999999998532111 1 77899999999999999999
Q ss_pred eeeEEEcCCeeEEEEecCCCCCHHHH------hcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecC
Q 022206 126 LVGYYVDGPLRVLAYEHASKGSLHDI------LHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRN 198 (301)
Q Consensus 126 ~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~D 198 (301)
+++++.+.+..++||||+++++|.++ +.... ...+++..++.++.|++.||.|||+ .| ++|||
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~d 177 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-------TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRD 177 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-------CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCC
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-------ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecC
Confidence 99999999999999999999999998 44321 1238999999999999999999999 98 99999
Q ss_pred CCCCceEEcCCCceEEeccccCCCCCccccccccccccccccccCccccccC-CCCc-cccchhhHHHHHHHHhCCCCCC
Q 022206 199 IKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSS-KSDVYSFGVVLLELLTGRKPVD 276 (301)
Q Consensus 199 lkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~~l~~g~~pf~ 276 (301)
|||+||+++.++.+||+|||++....... .....|++.|+|||++.+. .++. ++||||||+++|+|++|..||.
T Consensus 178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 253 (348)
T 2pml_X 178 VKPSNILMDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253 (348)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECBTTE----ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CChHhEEEcCCCcEEEecccccccccccc----ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999987654331 2445789999999999877 5666 9999999999999999999998
Q ss_pred CCCC
Q 022206 277 HTLP 280 (301)
Q Consensus 277 ~~~~ 280 (301)
....
T Consensus 254 ~~~~ 257 (348)
T 2pml_X 254 LKIS 257 (348)
T ss_dssp CSSC
T ss_pred CCCc
Confidence 6544
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=296.29 Aligned_cols=202 Identities=26% Similarity=0.310 Sum_probs=173.1
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccC-CC-----ceeeeeeEEEcCCe
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NE-----NVVELVGYYVDGPL 135 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~~ 135 (301)
...++|++.+.||+|+||.||+|++. +++.||||++.........+.+|+.+++.++ |+ +|+++++++...+.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 34679999999999999999999987 7889999999765444566778888888875 44 49999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--hCCCCCeEecCCCCCceEEc--CCCc
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH--EKAEPRIIHRNIKSSNVLLF--DDDI 211 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~~~~ivH~Dlkp~Nill~--~~~~ 211 (301)
.++||||+.+ +|.+++...... .+++..+..++.|++.||.||| +.+ |+||||||+|||++ .++.
T Consensus 131 ~~lv~e~~~~-~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~ 199 (382)
T 2vx3_A 131 LCLVFEMLSY-NLYDLLRNTNFR-------GVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSA 199 (382)
T ss_dssp EEEEEECCCC-BHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCC
T ss_pred eEEEEecCCC-CHHHHHhhcCcC-------CCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCc
Confidence 9999999975 999999765321 2889999999999999999999 467 99999999999995 4778
Q ss_pred eEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 200 ~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp EEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999765432 1345789999999999999999999999999999999999999987554
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=287.38 Aligned_cols=199 Identities=32% Similarity=0.516 Sum_probs=166.5
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcC-CeeEEEEecC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG-PLRVLAYEHA 143 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~ 143 (301)
.++|++.+.||+|+||.||++.+. ++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+. +..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 468999999999999999999886 7899999987543 456789999999999999999999987654 4789999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 98 ~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 98 AKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp TTEEHHHHHHHHHH-------HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CCCCHHHHHHhccc-------ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 99999999975431 12688899999999999999999999 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
.... ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||.....
T Consensus 168 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 220 (278)
T 1byg_A 168 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 220 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred cccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 4322 23357889999999999999999999999999999998 9999976544
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=293.23 Aligned_cols=203 Identities=25% Similarity=0.372 Sum_probs=174.4
Q ss_pred hCCCCCCceecccCceEEEEEEE----C-CCCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeeeeeEEE--cCCee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVL----R-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYV--DGPLR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~----~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 136 (301)
.++|++.+.||+|+||.||+|++ . +++.||+|++...... .+.+.+|++++++++|+||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46899999999999999999984 2 6889999999765433 356889999999999999999999887 45678
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~D 170 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRA--------RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIAD 170 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECC
T ss_pred EEEEeecCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcc
Confidence 999999999999999975332 2899999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 217 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
||++......... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 9999766433221 1223446788899999999988999999999999999999999998643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=284.67 Aligned_cols=204 Identities=23% Similarity=0.378 Sum_probs=170.5
Q ss_pred hhCCCCCCceecccCceEEEEEEECC----CCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
..++|++.+.||+|+||.||+|++.. +..||+|.+...... .+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34689999999999999999998642 346999998765332 3568899999999999999999998765 4568
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+||||+++++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+||
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Df 157 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKN--------SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDF 157 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCC
T ss_pred EEEecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCcc
Confidence 99999999999999975432 2889999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
|++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.....
T Consensus 158 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~ 220 (281)
T 3cc6_A 158 GLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220 (281)
T ss_dssp CGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG
T ss_pred CCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh
Confidence 998776543221 1233457889999999998999999999999999999998 9999976544
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=292.55 Aligned_cols=202 Identities=27% Similarity=0.394 Sum_probs=171.3
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcC-----Ce
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDG-----PL 135 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 135 (301)
..++|++.+.||+|+||.||+|.+. +++.||||++...... ...+.+|+.+++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4578999999999999999999987 7899999999754333 34677999999999999999999987654 67
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
.+++|||+.+ +|.+++.... +++..++.++.|++.||.|||+.| |+||||||+|||++.++.+||+
T Consensus 89 ~~lv~e~~~~-~L~~~~~~~~----------~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 154 (353)
T 2b9h_A 89 VYIIQELMQT-DLHRVISTQM----------LSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVC 154 (353)
T ss_dssp EEEEECCCSE-EHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEEC
T ss_pred EEEEEeccCc-cHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEE
Confidence 8999999985 9999987643 899999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCcccccc--------ccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARL--------HSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999987654322110 1123468999999998764 678999999999999999999999998754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=287.42 Aligned_cols=203 Identities=24% Similarity=0.391 Sum_probs=172.4
Q ss_pred hhCCCCCCceecccCceEEEEEEEC--CCCEEEEEEcCCCC---CchHHHHHHHHHHhcc---CCCceeeeeeEEE----
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSK---QPDQEFLAQVSMVSRL---KNENVVELVGYYV---- 131 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~---- 131 (301)
..++|++.+.||+|+||.||+|++. +++.||+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999984 67899999886422 2233566777777666 8999999999987
Q ss_pred -cCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC
Q 022206 132 -DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD 210 (301)
Q Consensus 132 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 210 (301)
.....++||||+. ++|.+++..... ..+++..++.++.|++.||.|||+.| ++||||||+||+++.++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~ 157 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE-------PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSG 157 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT-------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCC
Confidence 5667899999998 599999976432 12889999999999999999999999 99999999999999999
Q ss_pred ceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 211 IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 211 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+...
T Consensus 158 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (326)
T 1blx_A 158 QIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224 (326)
T ss_dssp CEEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CEEEecCcccccccCCCC---ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 999999999977654332 2445789999999999988999999999999999999999999986543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=291.95 Aligned_cols=201 Identities=18% Similarity=0.319 Sum_probs=172.5
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CC-CEEEEEEcCCCCCchHHHHHHHHHHhccCCCc------eeeeeeEEEcCCe
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SG-RAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN------VVELVGYYVDGPL 135 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~ 135 (301)
..++|++.+.||+|+||.||+|.+. ++ ..||+|++.........+.+|+.+++.++|++ ++.+++++...+.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 3578999999999999999999986 44 68999999765555567888999999987765 8999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEE---------
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL--------- 206 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill--------- 206 (301)
.++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~-------~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~ 165 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNF-------QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLY 165 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-------CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEE
T ss_pred EEEEEecc-CCChHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccc
Confidence 99999999 5577777654431 12889999999999999999999999 9999999999999
Q ss_pred ----------cCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCC
Q 022206 207 ----------FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276 (301)
Q Consensus 207 ----------~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~ 276 (301)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 166 NEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp CCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 567899999999986543321 44578999999999999999999999999999999999999998
Q ss_pred CCCC
Q 022206 277 HTLP 280 (301)
Q Consensus 277 ~~~~ 280 (301)
....
T Consensus 241 ~~~~ 244 (355)
T 2eu9_A 241 THEN 244 (355)
T ss_dssp CSSH
T ss_pred CCCH
Confidence 7554
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=297.48 Aligned_cols=200 Identities=20% Similarity=0.285 Sum_probs=170.5
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccC-----------CCceeeeeeEEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-----------NENVVELVGYYV 131 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~ 131 (301)
..++|++.+.||+|+||.||+|++. +++.||+|++.........+.+|+.++++++ |+||+++++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 3478999999999999999999986 7899999999866555677888999988876 789999999988
Q ss_pred cCC----eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeEecCCCCCceEE
Q 022206 132 DGP----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLL 206 (301)
Q Consensus 132 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~Nill 206 (301)
..+ ..+++||++ +++|.+++...... .+++..++.++.||+.||+|||++ + |+||||||+|||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll 165 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHR-------GIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLM 165 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhcc-------CCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEE
Confidence 644 789999999 78999999764321 288999999999999999999998 9 9999999999999
Q ss_pred c------CCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 207 F------DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 207 ~------~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
+ ..+.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 166 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 166 EIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred eccCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 5 34489999999987654321 34578999999999999999999999999999999999999998654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=291.73 Aligned_cols=206 Identities=25% Similarity=0.408 Sum_probs=173.0
Q ss_pred HHHHHhhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhc--cCCCceeeeeeEEEcCC--
Q 022206 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSR--LKNENVVELVGYYVDGP-- 134 (301)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~-- 134 (301)
.......++|++.+.||+|+||.||+|++. ++.||+|++... ....+.+|.++++. ++||||+++++++....
T Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 35 LVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred eecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 334455678999999999999999999985 899999998643 34567788888877 78999999999998776
Q ss_pred --eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--------hCCCCCeEecCCCCCce
Q 022206 135 --LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH--------EKAEPRIIHRNIKSSNV 204 (301)
Q Consensus 135 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~~~~ivH~Dlkp~Ni 204 (301)
..++||||+++|+|.+++.... +++..++.++.|++.||.||| +.+ |+||||||+||
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NI 178 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNI 178 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGE
T ss_pred cceeEEEEeecCCCcHHHHHhccC----------ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHE
Confidence 7899999999999999997643 899999999999999999999 788 99999999999
Q ss_pred EEcCCCceEEeccccCCCCCccccc--cccccccccccccCccccccCC------CCccccchhhHHHHHHHHhC-----
Q 022206 205 LLFDDDIAKISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTGQ------MSSKSDVYSFGVVLLELLTG----- 271 (301)
Q Consensus 205 ll~~~~~vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~~l~~g----- 271 (301)
|++.++.+||+|||++......... .......||+.|+|||++.+.. ++.++||||||+++|+|++|
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 9999999999999998654432211 1124457899999999987652 33689999999999999999
Q ss_pred -----CCCCCCCCC
Q 022206 272 -----RKPVDHTLP 280 (301)
Q Consensus 272 -----~~pf~~~~~ 280 (301)
..||....+
T Consensus 259 ~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 259 IHEDYQLPYYDLVP 272 (342)
T ss_dssp BCCCCCCTTTTTSC
T ss_pred cccccccCccccCc
Confidence 789876543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=291.47 Aligned_cols=195 Identities=26% Similarity=0.413 Sum_probs=167.5
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCe-----
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPL----- 135 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 135 (301)
.++|.+.+.||+|+||.||+|+++ +++.||||++...... ...+.+|+.+++.++||||+++++++.+...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 478999999999999999999987 7999999999764433 2567889999999999999999999987654
Q ss_pred -eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 136 -RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 136 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
.+++|||+.+ +|.+++... +++..++.++.|++.||.|||++| |+||||||+||+++.++.+||
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl 167 (353)
T 3coi_A 103 DFYLVMPFMQT-DLQKIMGLK-----------FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKI 167 (353)
T ss_dssp CCEEEEECCSE-EGGGTTTSC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEE
T ss_pred eEEEEeccccC-CHHHHhcCC-----------CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEE
Confidence 4999999984 888877431 889999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
+|||++....... ....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+
T Consensus 168 ~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 168 LDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp CSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred eecccccCCCCCc-----cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999987654321 34568999999998877 678999999999999999999999998755
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=283.65 Aligned_cols=204 Identities=26% Similarity=0.383 Sum_probs=175.7
Q ss_pred HHHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC---CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCee
Q 022206 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS---KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (301)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 136 (301)
.....++|++.+.||+|+||.||+|++. +++.||+|++... ......+.+|+.++++++||||+++++++.+.+..
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 3455678999999999999999999987 7899999998543 23456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC---CceE
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD---DIAK 213 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~vk 213 (301)
+++|||+++++|.+++..... +++..++.++.|++.||.|||+.+ ++||||||+||+++.+ +.+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~k 164 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKR---------FSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIK 164 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred EEEEEccCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEE
Confidence 999999999999998865432 889999999999999999999999 9999999999999754 4799
Q ss_pred EeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|+|||++......... ....+|+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.
T Consensus 165 L~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (287)
T 2wei_A 165 IIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227 (287)
T ss_dssp ECSTTGGGTBCCCSSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EeccCcceeecCCCcc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 9999998765433211 33458999999998865 488999999999999999999999976543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=287.01 Aligned_cols=203 Identities=22% Similarity=0.333 Sum_probs=165.1
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEE----------
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYV---------- 131 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~---------- 131 (301)
..++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3578999999999999999999987 689999999865432 2356889999999999999999999873
Q ss_pred ----cCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEc
Q 022206 132 ----DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF 207 (301)
Q Consensus 132 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 207 (301)
+....++||||+. |+|.+++.... +++..++.++.|++.||+|||+++ |+||||||+|||++
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQGP----------LLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFIN 154 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhcCC----------ccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEc
Confidence 4467899999998 59999997533 889999999999999999999999 99999999999997
Q ss_pred -CCCceEEeccccCCCCCcccc-ccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 208 -DDDIAKISDFDLSNQAPDAAA-RLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 208 -~~~~vkl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+++.+||+|||++........ ........+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+...
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 230 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 567999999999987643221 111233457899999998865 6789999999999999999999999987654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=281.84 Aligned_cols=202 Identities=29% Similarity=0.458 Sum_probs=170.4
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
++|.....||+|+||.||+|.+. ++..||+|.+..... ....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 44556669999999999999986 788999999865433 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC-CCceEEeccccCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIAKISDFDLSNQ 222 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~Dfg~a~~ 222 (301)
++++|.+++...... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++. ++.+||+|||++..
T Consensus 102 ~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~ 172 (295)
T 2clq_A 102 PGGSLSALLRSKWGP------LKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKR 172 (295)
T ss_dssp SEEEHHHHHHHTTCC------CTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred CCCCHHHHHHhhccC------CCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccc
Confidence 999999999764321 12678889999999999999999999 999999999999987 89999999999876
Q ss_pred CCccccccccccccccccccCccccccC--CCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
....... .....|++.|+|||++.+. .++.++||||||+++|+|++|+.||...
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 173 LAGINPC--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp SCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred cCCCCCc--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 5432211 2345689999999998764 3789999999999999999999999653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=286.94 Aligned_cols=204 Identities=22% Similarity=0.381 Sum_probs=168.3
Q ss_pred HHhhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHhccC--CCceeeeeeEEEcCCee
Q 022206 62 KEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLK--NENVVELVGYYVDGPLR 136 (301)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~ 136 (301)
....++|++.+.||+|+||.||+|.+.+++.||+|++...... ...+.+|+.++++++ |+||+++++++.+.+..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 3455789999999999999999999888999999998654433 356789999999997 59999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
+++|| +.+++|.+++..... +++..++.++.|++.||.|||+.+ ++||||||+|||++ ++.+||+|
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~D 169 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLID 169 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECC
T ss_pred EEEEe-cCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEee
Confidence 99999 567799999976542 889999999999999999999999 99999999999996 48999999
Q ss_pred cccCCCCCccccccccccccccccccCcccccc-----------CCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-----------GQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
||++................||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 999987654433222234578999999999865 467889999999999999999999997643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=288.87 Aligned_cols=205 Identities=26% Similarity=0.352 Sum_probs=169.0
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC-CchHHHHHHHHHHhccCCCceeeeeeEEE----cCCeeEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYV----DGPLRVL 138 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~l 138 (301)
.++|++.+.||+|+||.||++++. +++.||+|++.... .....+.+|+.+++.++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 468999999999999999999986 79999999886433 23456889999999999999999999987 3447899
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||||+.+++|.+++...... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 108 v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDK-----GNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCS
T ss_pred EEEeCCCCcHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecC
Confidence 99999999999999753211 123899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCcccccc-------ccccccccccccCccccccCC---CCccccchhhHHHHHHHHhCCCCCCC
Q 022206 219 LSNQAPDAAARL-------HSTRVLGTFGYHAPEYAMTGQ---MSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 219 ~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
++.......... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 986654221110 012335799999999987554 68899999999999999999999954
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=313.99 Aligned_cols=197 Identities=29% Similarity=0.431 Sum_probs=164.6
Q ss_pred ceecccCceEEEEEEEC---CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 72 SLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
+.||+|+||.||+|.+. +++.||||+++.... ..+.+.+|++++++++||||+++++++.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 467899999975432 24679999999999999999999999865 457899999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
|+|.+++..... +++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 454 g~L~~~l~~~~~---------l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 454 GPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred CCHHHHHhhCCC---------CCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 999999975432 889999999999999999999999 99999999999999999999999999876543
Q ss_pred cccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCc
Q 022206 226 AAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (301)
Q Consensus 226 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~ 281 (301)
.... .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+....
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~ 579 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 579 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 3221 11123346789999999999999999999999999999998 99999876553
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=285.10 Aligned_cols=196 Identities=23% Similarity=0.400 Sum_probs=162.7
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEc----------
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD---------- 132 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---------- 132 (301)
..++|++.+.||+|+||.||+|++. +++.||+|++.........+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 3567999999999999999999986 79999999996544445678899999999999999999998865
Q ss_pred ---CCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC
Q 022206 133 ---GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (301)
Q Consensus 133 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 209 (301)
....++||||+++++|.+++..... .+++..++.++.|++.||+|||+++ ++||||||+|||++.+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~ 152 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENL--------NQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDES 152 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCG--------GGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT
T ss_pred cccCCceEEEEecCCCCCHHHhhhcccc--------ccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCC
Confidence 3568999999999999999975432 2788899999999999999999999 9999999999999999
Q ss_pred CceEEeccccCCCCCcccc------------ccccccccccccccCccccccC-CCCccccchhhHHHHHHHHh
Q 022206 210 DIAKISDFDLSNQAPDAAA------------RLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLT 270 (301)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~ 270 (301)
+.+||+|||++........ ........||+.|+|||++.+. .++.++||||||+++|+|++
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 9999999999976643210 1111345689999999998765 68999999999999999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=285.57 Aligned_cols=205 Identities=30% Similarity=0.387 Sum_probs=152.1
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch--HHHHHHHH-HHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVS-MVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
..++|++.+.||+|+||.||+|.++ +++.||+|++....... ..+..|+. +++.++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3578999999999999999999987 78999999997654332 34555555 67778999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
|||+.+ +|.+++...... ....+++..+..++.|++.||.|||+. + ++||||||+|||++.++.+||+|||
T Consensus 100 ~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSV----LDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHT----TCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCS
T ss_pred EeecCC-ChHHHHHHHHhh----hcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCC
Confidence 999986 888877531100 011288999999999999999999998 9 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCcccc----ccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYA----MTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
++......... ....||+.|+|||++ .+..++.++||||||+++|+|++|+.||.+..
T Consensus 172 ~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 172 ISGQLVDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp SSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred Cceeccccccc---ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 99776543222 334689999999998 45678999999999999999999999997643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=290.87 Aligned_cols=203 Identities=22% Similarity=0.378 Sum_probs=172.6
Q ss_pred HHHHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc-------hHHHHHHHHHHhccC--CCceeeeeeE
Q 022206 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-------DQEFLAQVSMVSRLK--NENVVELVGY 129 (301)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l~--h~~iv~~~~~ 129 (301)
+.....++|++.+.||+|+||.||+|++. +++.||+|++...... ...+.+|+.+++.++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 33445678999999999999999999976 7899999998653221 244677899999996 5999999999
Q ss_pred EEcCCeeEEEEecCCC-CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEc-
Q 022206 130 YVDGPLRVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF- 207 (301)
Q Consensus 130 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~- 207 (301)
+.+.+..++++|++.+ ++|.+++..... +++..++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 184 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDL 184 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEET
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeC
Confidence 9999999999999986 899999975432 889999999999999999999999 99999999999999
Q ss_pred CCCceEEeccccCCCCCccccccccccccccccccCccccccCCC-CccccchhhHHHHHHHHhCCCCCCCC
Q 022206 208 DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 208 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
+++.+||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...
T Consensus 185 ~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 185 NRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp TTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred CCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 78999999999987664322 134568999999999887665 67899999999999999999999753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=287.97 Aligned_cols=202 Identities=27% Similarity=0.409 Sum_probs=172.5
Q ss_pred hCCCCCCceecccCceEEEEEEE----C-CCCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeeeeeEEEcCC--ee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVL----R-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGP--LR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~----~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~ 136 (301)
.++|++++.||+|+||.||+|++ . +++.||+|++...... ...+.+|+.+++.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46799999999999999999984 2 6889999999765433 356889999999999999999999987544 78
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~D 188 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGD 188 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTT--------SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECC
T ss_pred EEEEECCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEec
Confidence 999999999999999976532 2889999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCcccccc-ccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 217 FDLSNQAPDAAARL-HSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 217 fg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
||++.......... ......++..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp CTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred CcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 99997665432211 11234567889999999988899999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=288.74 Aligned_cols=200 Identities=22% Similarity=0.343 Sum_probs=164.0
Q ss_pred HHhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc-------hHHHHHHHHHHhcc----CCCceeeeeeE
Q 022206 62 KEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-------DQEFLAQVSMVSRL----KNENVVELVGY 129 (301)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l----~h~~iv~~~~~ 129 (301)
....++|++.+.||+|+||.||+|++. +++.||+|++...... ...+.+|+.+++++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 345678999999999999999999976 7899999999754322 22355688888888 89999999999
Q ss_pred EEcCCeeEEEEec-CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEc-
Q 022206 130 YVDGPLRVLAYEH-ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF- 207 (301)
Q Consensus 130 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~- 207 (301)
+.+.+..++++|+ +.+++|.+++..... +++..++.++.|++.||.|||+.+ ++||||||+||+++
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~ 174 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGP---------LGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDL 174 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEET
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeC
Confidence 9999999999999 789999999976432 899999999999999999999999 99999999999999
Q ss_pred CCCceEEeccccCCCCCccccccccccccccccccCccccccCCCC-ccccchhhHHHHHHHHhCCCCCCC
Q 022206 208 DDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS-SKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 208 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
+++.+||+|||++....... .....|++.|+|||++.+..+. .++||||||+++|+|++|+.||..
T Consensus 175 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 175 RRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp TTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred CCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 78999999999987664432 1345689999999998876664 589999999999999999999965
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=287.68 Aligned_cols=200 Identities=22% Similarity=0.326 Sum_probs=147.5
Q ss_pred hhCCCCCCc-eecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEc----CCeeE
Q 022206 64 KTDNFGTNS-LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD----GPLRV 137 (301)
Q Consensus 64 ~~~~y~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~ 137 (301)
..++|.+.+ .||+|+||.||+|+++ +++.||+|++.... ....+....++.++|+||+++++++.. ....+
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 457899855 6999999999999988 79999999986532 222222334677799999999999875 45689
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC---CCceEE
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKI 214 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~vkl 214 (301)
+||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||
T Consensus 103 lv~e~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl 172 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGD-------QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKL 172 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-C-------CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEE
T ss_pred EEEeccCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEE
Confidence 99999999999999986542 23899999999999999999999999 999999999999986 456999
Q ss_pred eccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 173 ~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (336)
T 3fhr_A 173 TDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 234 (336)
T ss_dssp CCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred eccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccc
Confidence 9999987654322 1345689999999999888899999999999999999999999976554
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=309.06 Aligned_cols=205 Identities=28% Similarity=0.409 Sum_probs=171.5
Q ss_pred HhhCCCCCCceecccCceEEEEEEECC----CCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCee
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 136 (301)
...++|++.+.||+|+||.||+|.+.. +..||+|++...... .+.+.+|+.+++.++||||+++++++. ++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 345679999999999999999999752 457999998754333 256889999999999999999999985 4568
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
++||||+++|+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~D 534 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKF--------SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGD 534 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTT--------TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC
T ss_pred EEEEEcCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEe
Confidence 999999999999999975432 2889999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 535 FG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 598 (656)
T 2j0j_A 535 FGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598 (656)
T ss_dssp CCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 9999876543321 1233456789999999998999999999999999999997 9999987544
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=282.90 Aligned_cols=204 Identities=30% Similarity=0.461 Sum_probs=163.4
Q ss_pred hCCCCCCceecccCceEEEEEEEC--CCC--EEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR--SGR--AAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 136 (301)
.++|++.+.||+|+||.||+|++. ++. .||+|++..... ..+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 468999999999999999999853 333 689999875422 2356889999999999999999999988765 8
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
++++||+++++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~D 164 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGD 164 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECC
T ss_pred eeeEecccCCCHHHHHHhccC--------CcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcc
Confidence 899999999999999975432 2889999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 217 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
||++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+...
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 230 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 230 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred ccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH
Confidence 9998766443221 11233457888999999988889999999999999999999 9999976543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=285.88 Aligned_cols=204 Identities=26% Similarity=0.363 Sum_probs=167.8
Q ss_pred HhhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
...++|++.+.||+|+||.||+|.+.. .+|+|++..... ....+.+|+.++++++|+||+++++++.+.+..+++
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 346789999999999999999999863 599999875432 234577899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+||+++ ++.+||+|||+
T Consensus 108 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAKI--------VLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp CBCCCSEEHHHHTTSSCC--------CCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred eecccCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence 999999999999976432 2788999999999999999999999 99999999999998 67999999999
Q ss_pred CCCCCcccc---ccccccccccccccCcccccc---------CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 220 SNQAPDAAA---RLHSTRVLGTFGYHAPEYAMT---------GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+........ ........|++.|+|||++.+ ..++.++||||||+++|+|++|+.||.....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 248 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 876532211 111233458999999998864 3578899999999999999999999976543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=293.59 Aligned_cols=191 Identities=20% Similarity=0.189 Sum_probs=158.7
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCC---------chHHHHHHHHHHhccC---------CCceeee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ---------PDQEFLAQVSMVSRLK---------NENVVEL 126 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~---------h~~iv~~ 126 (301)
.++|++.+.||+|+||+||+|++ +++.||||++..... ..+.+.+|+.+++.++ |+||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46799999999999999999998 589999999875432 1267889999988886 5555555
Q ss_pred eeE-----------------EEc-------------CCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHH
Q 022206 127 VGY-----------------YVD-------------GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176 (301)
Q Consensus 127 ~~~-----------------~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~ 176 (301)
.++ +.+ .+..++||||+++|++.+.+.... +++..++.++
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~----------~~~~~~~~i~ 167 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKL----------SSLATAKSIL 167 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTC----------CCHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcC----------CCHHHHHHHH
Confidence 544 433 778999999999997766664322 8999999999
Q ss_pred HHHHHHHHHhh-hCCCCCeEecCCCCCceEEcCCC--------------------ceEEeccccCCCCCccccccccccc
Q 022206 177 VGAARGLEYLH-EKAEPRIIHRNIKSSNVLLFDDD--------------------IAKISDFDLSNQAPDAAARLHSTRV 235 (301)
Q Consensus 177 ~qi~~~l~~LH-~~~~~~ivH~Dlkp~Nill~~~~--------------------~vkl~Dfg~a~~~~~~~~~~~~~~~ 235 (301)
.||+.||+||| +.+ |+||||||+|||++.++ .+||+|||+|+.... ...
T Consensus 168 ~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~ 237 (336)
T 2vuw_A 168 HQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIV 237 (336)
T ss_dssp HHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEE
T ss_pred HHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcE
Confidence 99999999999 899 99999999999999887 899999999975532 234
Q ss_pred cccccccCccccccCCCCccccchhhHHH-HHHHHhCCCCCCC
Q 022206 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVV-LLELLTGRKPVDH 277 (301)
Q Consensus 236 ~gt~~y~aPE~~~~~~~~~~~DvwslG~i-l~~l~~g~~pf~~ 277 (301)
.||+.|+|||++.+.. +.++|||||+++ .+++++|..||.+
T Consensus 238 ~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 238 VFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp ECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred EEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 7999999999998766 889999998777 7788999999954
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=283.52 Aligned_cols=208 Identities=23% Similarity=0.339 Sum_probs=155.5
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHhccC-CCceeeeeeEEE--------c
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLK-NENVVELVGYYV--------D 132 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~-h~~iv~~~~~~~--------~ 132 (301)
...+|++.+.||+|+||.||+|++. +++.||+|++...... ...+.+|+.+++++. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3458999999999999999999987 7899999988544322 356889999999996 999999999984 3
Q ss_pred CCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCce
Q 022206 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (301)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (301)
....+++|||+. |+|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||||+|||++.++.+
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMES------RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHT------TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCE
T ss_pred CceEEEEEEecC-CCHHHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCE
Confidence 445799999997 599998864211 112899999999999999999999974 239999999999999999999
Q ss_pred EEeccccCCCCCcccccc----------ccccccccccccCcccc---ccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 213 KISDFDLSNQAPDAAARL----------HSTRVLGTFGYHAPEYA---MTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
||+|||++.......... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||.+..
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 999999997765432210 11234689999999988 56678899999999999999999999997643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=279.61 Aligned_cols=200 Identities=26% Similarity=0.410 Sum_probs=152.5
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch---HHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
..++|++.+.||+|+||.||+|+++ +++.||+|++....... ..+.++..+++.++||||+++++++.+++..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3568999999999999999999987 79999999997654432 2233444567888999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
|||+ ++.+..+...... .+++..++.++.|++.||.|||+. + ++||||||+||+++.++.+||+|||
T Consensus 103 ~e~~-~~~~~~l~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg 170 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQG--------PIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFG 170 (318)
T ss_dssp ECCC-SEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCT
T ss_pred Eecc-CCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECC
Confidence 9999 5566666543221 288999999999999999999995 8 9999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccCccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
++......... ....||+.|+|||++. ...++.++||||||+++|+|++|+.||...
T Consensus 171 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 171 ISGRLVDDKAK---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp TC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CchhccCCccc---cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 98765443221 3456899999999984 456788999999999999999999999763
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=303.41 Aligned_cols=203 Identities=25% Similarity=0.381 Sum_probs=171.8
Q ss_pred HhhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEc------C
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVD------G 133 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~ 133 (301)
...++|++.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.++++++||||+++++++.. +
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 34578999999999999999999986 7999999998764333 3568899999999999999999998765 6
Q ss_pred CeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc--
Q 022206 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI-- 211 (301)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-- 211 (301)
+..++||||+++|+|.+++...... ..+++..++.++.|++.||+|||+.| |+||||||+||+++.++.
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~------~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~ 161 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENC------CGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRL 161 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCT------TCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccC------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCce
Confidence 7789999999999999999864421 12778889999999999999999999 999999999999997664
Q ss_pred -eEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 212 -AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 212 -vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
+||+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 162 ~vKL~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 162 IHKIIDLGYAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp EEEECSCCCCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eEEEccccccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 999999999876543322 445789999999999999999999999999999999999999965
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=292.22 Aligned_cols=206 Identities=23% Similarity=0.332 Sum_probs=158.7
Q ss_pred CCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEEEEecCC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++.+ +||||+++++++.+++..++||||+.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 345567889999999998776668999999998643 235678899999876 89999999999999999999999996
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC-------------Cc
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD-------------DI 211 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-------------~~ 211 (301)
|+|.+++......... .....+..++.++.||+.||+|||+++ |+||||||+|||++.+ +.
T Consensus 93 -gsL~~~l~~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 93 -LNLQDLVESKNVSDEN--LKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp -EEHHHHHHTC--------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred -CCHHHHHhccCCCchh--hhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 5999999865431110 001133346789999999999999999 9999999999999754 48
Q ss_pred eEEeccccCCCCCcccccc--ccccccccccccCcccccc-------CCCCccccchhhHHHHHHHHh-CCCCCCCCC
Q 022206 212 AKISDFDLSNQAPDAAARL--HSTRVLGTFGYHAPEYAMT-------GQMSSKSDVYSFGVVLLELLT-GRKPVDHTL 279 (301)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~~-g~~pf~~~~ 279 (301)
+||+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 9999999998765432211 1234579999999999865 568899999999999999999 999997654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=292.98 Aligned_cols=200 Identities=23% Similarity=0.324 Sum_probs=159.5
Q ss_pred CCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEEEEecCC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
.+|.+.+.||+|+||+|+.....+++.||||++..... ....+|+++++.+ +||||+++++++.+....++||||+.
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 46889999999999997765566799999999865432 2356899999999 79999999999999999999999997
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC---C--CceEEecccc
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---D--DIAKISDFDL 219 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~--~~vkl~Dfg~ 219 (301)
+ +|.+++...... +....++.++.||+.||.|||+++ |+||||||+|||++. + ..+||+|||+
T Consensus 102 g-~L~~~l~~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 102 A-TLQEYVEQKDFA--------HLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp E-EHHHHHHSSSCC--------CCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred C-CHHHHHHhcCCC--------ccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 5 999999765421 333456789999999999999999 999999999999953 2 3578999999
Q ss_pred CCCCCccccc-cccccccccccccCccccc---cCCCCccccchhhHHHHHHHHh-CCCCCCCCC
Q 022206 220 SNQAPDAAAR-LHSTRVLGTFGYHAPEYAM---TGQMSSKSDVYSFGVVLLELLT-GRKPVDHTL 279 (301)
Q Consensus 220 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~ 279 (301)
+......... .......||+.|+|||++. ...++.++|||||||++|+|++ |..||....
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~ 234 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence 9776543211 1224457999999999987 4567789999999999999999 999996543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=271.97 Aligned_cols=175 Identities=16% Similarity=0.127 Sum_probs=154.4
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch----HHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
..++|++.+.||+|+||.||+|++. +++.||+|++....... ..+.+|+.+++.++||||+++++++.+++..++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 3478999999999999999999987 68999999998654433 568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
||||++|++|.+++... .....+..++.|++.||+|||++| |+||||||+|||++.+|.+||++++
T Consensus 109 v~e~~~g~~L~~~l~~~-----------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~ 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS-----------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC
T ss_pred EEEecCCCCHHHHHhcC-----------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc
Confidence 99999999999999542 345578889999999999999999 9999999999999999999998544
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
|++ .++.++|||||||++|+|++|+.||.+.+..
T Consensus 175 ----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~ 208 (286)
T 3uqc_A 175 ----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVR 208 (286)
T ss_dssp ----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred ----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence 233 2688999999999999999999999876653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=305.85 Aligned_cols=192 Identities=21% Similarity=0.347 Sum_probs=165.2
Q ss_pred hCCCCCCceecccCceEEEEEEEC--CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCe-----
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPL----- 135 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 135 (301)
.++|++.+.||+|+||.||+|.+. +++.||||++...... ...+.+|+.+++.++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999986 5899999998654332 3467899999999999999999999987655
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
.|+||||++|++|.+++.. . +++..++.++.||+.||.|||++| |+||||||+|||++.+ .+||+
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-~----------l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~ 223 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-K----------LPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLI 223 (681)
T ss_dssp EEEEEECCCCEECC----C-C----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEEC
T ss_pred eEEEEEeCCCCcHHHHHhC-C----------CCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEE
Confidence 7999999999999987754 1 899999999999999999999999 9999999999999875 89999
Q ss_pred ccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
|||++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.
T Consensus 224 DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 224 DLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp CCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred ecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccc
Confidence 99998765432 345799999999988765 488999999999999999999998753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=264.21 Aligned_cols=179 Identities=21% Similarity=0.360 Sum_probs=152.6
Q ss_pred hhCCCCCC-ceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHH-hccCCCceeeeeeEEEc----CCee
Q 022206 64 KTDNFGTN-SLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMV-SRLKNENVVELVGYYVD----GPLR 136 (301)
Q Consensus 64 ~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----~~~~ 136 (301)
..++|.+. +.||+|+||.||+|.+. +++.||+|++.. .....+|+.++ +.++||||+++++++.+ ....
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 45678887 78999999999999986 789999999853 35577888887 66689999999999876 6778
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC---CCceE
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAK 213 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~vk 213 (301)
++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~k 160 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILK 160 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTT-------CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEE
T ss_pred EEEEeecCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEE
Confidence 999999999999999986542 13899999999999999999999999 999999999999998 78999
Q ss_pred EeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 214 ISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|+|||++.... +..++.++|||||||++|+|++|+.||.....
T Consensus 161 l~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 203 (299)
T 3m2w_A 161 LTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 203 (299)
T ss_dssp ECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred Eeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 99999874322 23467789999999999999999999976543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=280.76 Aligned_cols=205 Identities=13% Similarity=0.174 Sum_probs=155.1
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHhccCC-Ccee---------eee--
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKN-ENVV---------ELV-- 127 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h-~~iv---------~~~-- 127 (301)
..+|.+.+.||+|+||.||+|++. +++.||||++...... .+.+.+|+.+++.++| .|.. ..+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345778899999999999999977 7999999998743222 3678899999999977 2211 111
Q ss_pred ----------eEEEc-----CCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCC
Q 022206 128 ----------GYYVD-----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEP 192 (301)
Q Consensus 128 ----------~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 192 (301)
.++.. ....+++|+.+ +++|.+++....... .....+++..++.++.|++.||+|||+++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 231 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLHHYG-- 231 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT--TTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 11111 12356777765 569999985211000 00112778889999999999999999999
Q ss_pred CeEecCCCCCceEEcCCCceEEeccccCCCCCccccccccccccccccccCcccc----------ccCCCCccccchhhH
Q 022206 193 RIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYA----------MTGQMSSKSDVYSFG 262 (301)
Q Consensus 193 ~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG 262 (301)
|+||||||+|||++.++.+||+|||++...... ....+| +.|+|||++ ....++.++||||||
T Consensus 232 -iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 232 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred -cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 999999999999999999999999998765443 244567 999999998 455678899999999
Q ss_pred HHHHHHHhCCCCCCCCCCc
Q 022206 263 VVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 263 ~il~~l~~g~~pf~~~~~~ 281 (301)
|++|+|++|+.||......
T Consensus 305 vil~elltg~~Pf~~~~~~ 323 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDAAL 323 (413)
T ss_dssp HHHHHHHHSSCCCCTTGGG
T ss_pred HHHHHHHHCCCCCCCcchh
Confidence 9999999999999876543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=280.12 Aligned_cols=183 Identities=15% Similarity=0.078 Sum_probs=129.0
Q ss_pred ecccCceEEEEEEEC-CCCEEEEEEcCCCCC-----------chHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEEEE
Q 022206 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-----------PDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----------~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
++.|+.|.+..++.. .|+.+++|++.+... ..+++.+|+++|+++ .|+||+++++++.++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 566777766666543 589999999865421 124688999999999 6999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
||++|++|.+++..... ++.. +|+.||+.||+|||++| ||||||||+|||++++|++||+|||+|
T Consensus 322 Eyv~G~~L~d~i~~~~~---------l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlA 386 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEE---------IDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSI 386 (569)
T ss_dssp ECCCSEEHHHHHHTTCC---------CCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTE
T ss_pred ecCCCCcHHHHHHhCCC---------CCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccC
Confidence 99999999999986542 5543 57899999999999999 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p 274 (301)
+........ ....+||+.|+|||++.+. +...+|+||+|+++++|.++..+
T Consensus 387 r~~~~~~~~--~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 387 VTTPQDCSW--PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ESCC---CC--SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred eeCCCCCcc--ccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 876543322 2456799999999988764 56789999999988776555443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=244.34 Aligned_cols=185 Identities=16% Similarity=0.119 Sum_probs=145.6
Q ss_pred CCCceecccCceEEEEEEECCCCEEEEEEcCCCCCc---------hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 69 GTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
...+.||+|+||.||++.. .+..+++|+....... .+.+.+|++++++++||||+++..++.+.+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3466899999999999954 4788999986543221 13478999999999999999666666677788999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+++++|.+++.. +..++.|++.+|+|||+++ |+||||||+|||+++ .+||+|||+
T Consensus 418 mE~~~ggsL~~~l~~-----------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGl 475 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGL 475 (540)
T ss_dssp EECCCSEEHHHHSTT-----------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTT
T ss_pred EECCCCCCHHHHHHH-----------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECcc
Confidence 999999999999874 3478999999999999999 999999999999998 999999999
Q ss_pred CCCCCcccccc-----ccccccccccccCcccccc--CCCCccccchhhHHHHHHHHhCCCCCC
Q 022206 220 SNQAPDAAARL-----HSTRVLGTFGYHAPEYAMT--GQMSSKSDVYSFGVVLLELLTGRKPVD 276 (301)
Q Consensus 220 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~pf~ 276 (301)
++......... ......||+.|+|||++.. ..|+...|+||..+-..+...++.+|.
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 98876543221 1135679999999999987 678888999999888888888877774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=204.01 Aligned_cols=159 Identities=14% Similarity=0.085 Sum_probs=124.8
Q ss_pred HhhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCC-------------------chHHHHHHHHHHhccCCCce
Q 022206 63 EKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ-------------------PDQEFLAQVSMVSRLKNENV 123 (301)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~e~~~l~~l~h~~i 123 (301)
.....|.+.+.||+|+||.||+|.+.+++.||+|++..... ....+.+|+.++++++ |
T Consensus 87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~- 163 (282)
T 1zar_A 87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G- 163 (282)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-
T ss_pred hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-
Confidence 34455667799999999999999997799999999864321 2345789999999999 5
Q ss_pred eeeeeEEEcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCc
Q 022206 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSN 203 (301)
Q Consensus 124 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~N 203 (301)
+++.+++.. +..++||||++|++|.+ +.. .....++.|++.||.|||+.| |+||||||+|
T Consensus 164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~N 223 (282)
T 1zar_A 164 LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYN 223 (282)
T ss_dssp SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred CCcCeEEec-cceEEEEEecCCCcHHH-cch---------------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHH
Confidence 666665543 56799999999999998 421 123469999999999999999 9999999999
Q ss_pred eEEcCCCceEEeccccCCCCCccccccccccccccccccCcccccc----------CCCCccccchh
Q 022206 204 VLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT----------GQMSSKSDVYS 260 (301)
Q Consensus 204 ill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dvws 260 (301)
||++ ++.+||+|||++.. +..++|||.+.. ..++..+|+|.
T Consensus 224 ILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 9999 99999999998742 345788887753 34555667665
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=175.57 Aligned_cols=136 Identities=16% Similarity=0.156 Sum_probs=106.3
Q ss_pred CCCCCceecccCceEEEEEEE-CCCCE--EEEEEcCCCCCc-------------------------hHHHHHHHHHHhcc
Q 022206 67 NFGTNSLIGEGSYGRVYFGVL-RSGRA--AAIKKLDSSKQP-------------------------DQEFLAQVSMVSRL 118 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~-------------------------~~~~~~e~~~l~~l 118 (301)
-|++.+.||+|+||.||+|.+ .+|+. ||||++...... ...+.+|+.+++++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999998 57888 999987543211 12578899999999
Q ss_pred CCCce--eeeeeEEEcCCeeEEEEecCCC-C----CHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-hCC
Q 022206 119 KNENV--VELVGYYVDGPLRVLAYEHASK-G----SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH-EKA 190 (301)
Q Consensus 119 ~h~~i--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~ 190 (301)
.|+++ ..+++. ...++||||+.+ | +|.++... .++..+..++.|++.+|.||| +.|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------------~~~~~~~~i~~qi~~~l~~lH~~~g 191 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------------LKELDVEGIFNDVVENVKRLYQEAE 191 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------------GGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------------cChHHHHHHHHHHHHHHHHHHHHCC
Confidence 88764 334432 356899999942 3 77776542 223456789999999999999 999
Q ss_pred CCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 191 EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 191 ~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
|+||||||+|||+++ .++|+|||+|...
T Consensus 192 ---ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 ---LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred ---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999988 8999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.83 E-value=8.3e-21 Score=166.23 Aligned_cols=143 Identities=11% Similarity=0.126 Sum_probs=103.0
Q ss_pred HHHhhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCC---------------chHH--------HHHHHHHHhc
Q 022206 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQ---------------PDQE--------FLAQVSMVSR 117 (301)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---------------~~~~--------~~~e~~~l~~ 117 (301)
+.....-|++.+.||+|+||.||+|.+.+|+.||||+++.... .... ..+|...|.+
T Consensus 90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 3344445999999999999999999998999999998753210 0011 1345666666
Q ss_pred cCCCceeeeeeEEEcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEec
Q 022206 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 197 (301)
Q Consensus 118 l~h~~iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~ 197 (301)
+.+.++.-..-+... ..++||||++|++|.++... .....++.|++.+|.+||+.| ||||
T Consensus 170 L~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~~---------------~~~~~l~~qll~~l~~lH~~g---IVHr 229 (397)
T 4gyi_A 170 LYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSSV---------------PDPASLYADLIALILRLAKHG---LIHG 229 (397)
T ss_dssp HHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCCC---------------SCHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHhcCCCCCeeeecc--CceEEEEecCCccHhhhccc---------------HHHHHHHHHHHHHHHHHHHCC---CcCC
Confidence 654443221111112 24799999999888765421 123467899999999999999 9999
Q ss_pred CCCCCceEEcCCC----------ceEEeccccCCCC
Q 022206 198 NIKSSNVLLFDDD----------IAKISDFDLSNQA 223 (301)
Q Consensus 198 Dlkp~Nill~~~~----------~vkl~Dfg~a~~~ 223 (301)
||||.|||++++| .+.|+||+-+...
T Consensus 230 DLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 230 DFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9999999999876 3899999987554
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=1.5e-15 Score=127.44 Aligned_cols=147 Identities=17% Similarity=0.121 Sum_probs=115.1
Q ss_pred HHHhhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCC-CchHHHHHHHHHHhccC-CCceeeeeeEEEcCCeeEE
Q 022206 61 LKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 138 (301)
+......|++...++.|+.+.||++... ++.+++|+..... .....+.+|+.+++.+. +..+.+++++..+.+..|+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3455678999999999999999999865 6899999986421 22345888999999885 5678889999988889999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC----------------------------
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA---------------------------- 190 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---------------------------- 190 (301)
|||+++|.+|.+.+... .....++.+++.+|..||+..
T Consensus 88 v~e~i~G~~l~~~~~~~--------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T 3tm0_A 88 LMSEADGVLCSEEYEDE--------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp EEECCSSEEHHHHCCTT--------------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred EEEecCCeehhhccCCc--------------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccc
Confidence 99999999998864211 123467889999999999811
Q ss_pred ----------------------------CCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 191 ----------------------------EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 191 ----------------------------~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
...++|+|++|.|||+++++.+.|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 12389999999999998766667999997643
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.50 E-value=6.2e-14 Score=117.17 Aligned_cols=139 Identities=12% Similarity=0.024 Sum_probs=101.0
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCc--eeeeeeEEEcCCeeEEEEec
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN--VVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~ 142 (301)
..+|.+..+.+.|..+.||++...+|..+++|..... ....+.+|+.+++.+.+.+ +.+++.+..+++..++||||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 3445544333466679999998777888999997654 2345778999998886544 55688888887889999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--------------------------------
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA-------------------------------- 190 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-------------------------------- 190 (301)
++|.+|. ... .. ...++.+++..|..||+..
T Consensus 97 i~G~~l~--~~~------------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (264)
T 1nd4_A 97 VPGQDLL--SSH------------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 159 (264)
T ss_dssp CSSEETT--TSC------------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred cCCcccC--cCc------------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence 9998884 221 11 1245677777777777643
Q ss_pred -----------------------CCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 191 -----------------------EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 191 -----------------------~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
...++|+|++|.|||+++++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999998643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.42 E-value=6.5e-13 Score=116.56 Aligned_cols=142 Identities=18% Similarity=0.181 Sum_probs=105.8
Q ss_pred CCCceecccCceEEEEEEECCCCEEEEEEcC--CCC--CchHHHHHHHHHHhccCC--CceeeeeeEEEcC---CeeEEE
Q 022206 69 GTNSLIGEGSYGRVYFGVLRSGRAAAIKKLD--SSK--QPDQEFLAQVSMVSRLKN--ENVVELVGYYVDG---PLRVLA 139 (301)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~--~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~---~~~~lv 139 (301)
..++.|+.|.++.||++... +..+++|+.. ... .....+.+|+.+++.|.. ..+.+++.++.+. +..++|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 34678999999999998876 4688899876 332 223568889999999874 5578888887766 458899
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC-----------------------------
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA----------------------------- 190 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----------------------------- 190 (301)
|||++|.++.+... ..++......++.+++..|..||+..
T Consensus 120 me~v~G~~l~~~~~-----------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (359)
T 3dxp_A 120 MEFVSGRVLWDQSL-----------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL 188 (359)
T ss_dssp EECCCCBCCCCTTC-----------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred EEecCCeecCCCcc-----------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence 99999977744211 11677888889999999999999731
Q ss_pred --------------------------CCCeEecCCCCCceEEcCCCc--eEEeccccCCC
Q 022206 191 --------------------------EPRIIHRNIKSSNVLLFDDDI--AKISDFDLSNQ 222 (301)
Q Consensus 191 --------------------------~~~ivH~Dlkp~Nill~~~~~--vkl~Dfg~a~~ 222 (301)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134999999999999997653 68999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.33 E-value=7.8e-13 Score=113.38 Aligned_cols=184 Identities=18% Similarity=0.179 Sum_probs=120.8
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccC-CCc--eeeeeeEEEcCC---eeEEEEecCC
Q 022206 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NEN--VVELVGYYVDGP---LRVLAYEHAS 144 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~~--iv~~~~~~~~~~---~~~lv~e~~~ 144 (301)
++.++.|..+.||++. ..+++|+.... .....+.+|+.+++.+. +.. +.+++....... ..|+||++++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 5669999999999873 67899986432 23466889999998884 322 334444433332 3588999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC----------------------------------
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA---------------------------------- 190 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---------------------------------- 190 (301)
|.+|.+..... ++..+...++.+++..|..||+..
T Consensus 100 G~~l~~~~~~~-----------l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 100 GVPLTPLLLNN-----------LPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp CEECCHHHHHT-----------SCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred CeECCcccccc-----------CCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 98887533211 667777788888888888888621
Q ss_pred ---------------------CCCeEecCCCCCceEEcC--CCceEEeccccCCCCCccccccccccccccccc---cCc
Q 022206 191 ---------------------EPRIIHRNIKSSNVLLFD--DDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY---HAP 244 (301)
Q Consensus 191 ---------------------~~~ivH~Dlkp~Nill~~--~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y---~aP 244 (301)
.+.++|+|++|.||++++ ++.+.|+||+.+......... . ....+ ..|
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl---~---~~~~~~~~~~~ 242 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF---I---SLMEDDEEYGM 242 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH---H---TTCCTTTSCCH
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH---H---HHHhhccccCH
Confidence 134899999999999998 456789999987543211100 0 00011 122
Q ss_pred ccccc-----CC---------CCccccchhhHHHHHHHHhCCCCCC
Q 022206 245 EYAMT-----GQ---------MSSKSDVYSFGVVLLELLTGRKPVD 276 (301)
Q Consensus 245 E~~~~-----~~---------~~~~~DvwslG~il~~l~~g~~pf~ 276 (301)
+.... .. .....+.|+++.++|.+.+|..+|-
T Consensus 243 ~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 243 EFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 21110 00 1123589999999999999998873
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=99.03 E-value=2e-09 Score=90.38 Aligned_cols=135 Identities=12% Similarity=0.067 Sum_probs=99.0
Q ss_pred eecccCce-EEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCC-CceeeeeeEEEcCCeeEEEEecCCCCCHH
Q 022206 73 LIGEGSYG-RVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLH 149 (301)
Q Consensus 73 ~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~gsL~ 149 (301)
.+..|..+ .||+.... ++..+++|+-... ....+.+|...|+.|.. -.+.+++.++.+.+..++|||+++|.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 34455544 68988866 5678999986432 34668889999988853 34678888888899999999999999888
Q ss_pred HHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC---------------------------------------
Q 022206 150 DILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA--------------------------------------- 190 (301)
Q Consensus 150 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--------------------------------------- 190 (301)
+...... .....+..++...|..||...
T Consensus 109 ~~~~~~~-------------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (272)
T 4gkh_A 109 QVLEEYP-------------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP 175 (272)
T ss_dssp HHHHHCG-------------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred ccccCCH-------------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence 7664321 223346667777777777532
Q ss_pred ----------------CCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 191 ----------------EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 191 ----------------~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
.+.++|+|+++.|||+++++.+-|+||+.+..
T Consensus 176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11379999999999999877777999998743
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=5e-09 Score=89.69 Aligned_cols=137 Identities=17% Similarity=0.134 Sum_probs=94.8
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCC---ceeeeeeEEE-cCCeeEEEEecCCCC
Q 022206 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE---NVVELVGYYV-DGPLRVLAYEHASKG 146 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~~~g 146 (301)
++.++.|....||+. +..+++|+... ......+.+|+.+|+.+.+. .+.+++.+.. ..+..+++||+++|.
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 556889999999988 67888898532 22245688999999998752 3556666664 455678999999998
Q ss_pred CHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC------------------------------------
Q 022206 147 SLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA------------------------------------ 190 (301)
Q Consensus 147 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------------------------------------ 190 (301)
+|.+..-.. ++......++.++...|..||+..
T Consensus 99 ~l~~~~~~~-----------l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~ 167 (306)
T 3tdw_A 99 ILGEDGMAV-----------LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES 167 (306)
T ss_dssp ECHHHHHTT-----------SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred ECchhhhhh-----------CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence 887632211 344445555555555555555432
Q ss_pred ---------------------CCCeEecCCCCCceEEcC---CCc-eEEeccccCCCC
Q 022206 191 ---------------------EPRIIHRNIKSSNVLLFD---DDI-AKISDFDLSNQA 223 (301)
Q Consensus 191 ---------------------~~~ivH~Dlkp~Nill~~---~~~-vkl~Dfg~a~~~ 223 (301)
.+.++|+|++|.||+++. ++. +.|+||+.+...
T Consensus 168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 223799999999999987 455 489999987543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.82 E-value=8.2e-09 Score=90.16 Aligned_cols=80 Identities=10% Similarity=0.024 Sum_probs=56.4
Q ss_pred Ccee-cccCceEEEEEEEC-------CCCEEEEEEcCCCC---C-chHHHHHHHHHHhccCC---CceeeeeeEEEcC--
Q 022206 71 NSLI-GEGSYGRVYFGVLR-------SGRAAAIKKLDSSK---Q-PDQEFLAQVSMVSRLKN---ENVVELVGYYVDG-- 133 (301)
Q Consensus 71 ~~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~-~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~-- 133 (301)
.+.| +.|..+.+|++... +++.+++|...... . ....+.+|+.+++.|.. -.+.+++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88989999988754 26789999865432 1 22457788888888853 3566778776654
Q ss_pred -CeeEEEEecCCCCCHHH
Q 022206 134 -PLRVLAYEHASKGSLHD 150 (301)
Q Consensus 134 -~~~~lv~e~~~~gsL~~ 150 (301)
+..++|||+++|.++.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999876643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=1.9e-07 Score=82.79 Aligned_cols=74 Identities=20% Similarity=0.119 Sum_probs=49.7
Q ss_pred CceecccCceEEEEEEEC-CCCEEEEEEcCCCC--------CchHHHHHHHHHHhccCC--Cc-eeeeeeEEEcCCeeEE
Q 022206 71 NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK--------QPDQEFLAQVSMVSRLKN--EN-VVELVGYYVDGPLRVL 138 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~e~~~l~~l~h--~~-iv~~~~~~~~~~~~~l 138 (301)
.+.||.|..+.||++... +++.+++|...... .....+..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567999999999999865 57889999764321 123456778888887743 33 3455543 4455689
Q ss_pred EEecCCCC
Q 022206 139 AYEHASKG 146 (301)
Q Consensus 139 v~e~~~~g 146 (301)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.61 E-value=7e-07 Score=77.13 Aligned_cols=149 Identities=17% Similarity=0.246 Sum_probs=81.3
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCC--Cceeeeee------EEEcCCeeEEEEec
Q 022206 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN--ENVVELVG------YYVDGPLRVLAYEH 142 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~------~~~~~~~~~lv~e~ 142 (301)
++.|+.|..+.||++...++ .+++|+.... ...+..|+.+++.|.. -.+.+++. +....+..+++|+|
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 34566677899999987644 5899988752 3444556666665532 12334433 12346678999999
Q ss_pred CCCCCHH---------------HHhcCCCCC--C-CCCC-CCCCCHHH-------------------------------H
Q 022206 143 ASKGSLH---------------DILHGKKGV--K-GAKP-GPVLSWAQ-------------------------------R 172 (301)
Q Consensus 143 ~~~gsL~---------------~~l~~~~~~--~-~~~~-~~~l~~~~-------------------------------~ 172 (301)
++|.++. .+-...... . .... .....+.. .
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 111100000 0 0000 00011111 0
Q ss_pred HHHHHHHHHHHHHhhh--------C--CCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 173 VKIAVGAARGLEYLHE--------K--AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 173 ~~i~~qi~~~l~~LH~--------~--~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
..+..++..++.+|+. . ....++|+|+++.|||++.++.+.|+||+.+...
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g 253 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD 253 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence 1112223445666653 0 1224999999999999988888999999987543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.43 E-value=1.6e-06 Score=74.07 Aligned_cols=76 Identities=16% Similarity=0.077 Sum_probs=60.6
Q ss_pred CCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccC---CCceeeeeeEEEcCCeeEEEEecCCCC
Q 022206 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK---NENVVELVGYYVDGPLRVLAYEHASKG 146 (301)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~g 146 (301)
-.+.|+.|..+.+|+.... +..+++|+.... ....+..|+..|+.|. ...+.+++.+....+..++||||++|.
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 3567899999999998864 678999987543 3566888999888884 356788888888888899999999987
Q ss_pred CH
Q 022206 147 SL 148 (301)
Q Consensus 147 sL 148 (301)
.+
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.42 E-value=2.3e-06 Score=72.24 Aligned_cols=77 Identities=22% Similarity=0.229 Sum_probs=56.2
Q ss_pred CCCCCceecccCceEEEEEEECCCCEEEEEEcCCCC-CchHHHHHHHHHHhccCCC---ceeeeeeEEEcCCeeEEEEec
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNE---NVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~lv~e~ 142 (301)
...-++.+|.|..+.||+++..+|+.+++|+..... .....+.+|+..|+.|... .+.+++.+ + ..+++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEe
Confidence 344567899999999999999999999999875433 2345678899999888532 34455543 2 24788999
Q ss_pred CCCCC
Q 022206 143 ASKGS 147 (301)
Q Consensus 143 ~~~gs 147 (301)
++++.
T Consensus 92 l~~~~ 96 (288)
T 3f7w_A 92 VDERP 96 (288)
T ss_dssp CCCCC
T ss_pred ecccC
Confidence 98764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.33 E-value=4e-06 Score=74.76 Aligned_cols=73 Identities=16% Similarity=0.178 Sum_probs=44.9
Q ss_pred CCceecccCceEEEEEEECCCCEEEEEEcCC-----CCC-----chHHHHHHHHHHh-ccCCCceeeeeeEEEcCCeeEE
Q 022206 70 TNSLIGEGSYGRVYFGVLRSGRAAAIKKLDS-----SKQ-----PDQEFLAQVSMVS-RLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~-----~~~-----~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~l 138 (301)
-++.||.|..+.||++.. +++.++||.... ... ....+..|+..+. ......+.+++.+. .+..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 356789999999999965 467899994321 111 1223333433322 12234566666654 566789
Q ss_pred EEecC-CC
Q 022206 139 AYEHA-SK 145 (301)
Q Consensus 139 v~e~~-~~ 145 (301)
|||++ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.29 E-value=4.1e-06 Score=71.19 Aligned_cols=74 Identities=8% Similarity=0.007 Sum_probs=46.9
Q ss_pred CCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCce-eeeeeEEEcCCeeEEEEecC-CC
Q 022206 68 FGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHA-SK 145 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~-~~ 145 (301)
+.-++.|+.|..+.+|++ ..+++|+............+|+.+++.+...++ .+++.. +.+.-++++||+ +|
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 334788999999999999 668889876432221223567777777753333 344443 344457899999 66
Q ss_pred CCH
Q 022206 146 GSL 148 (301)
Q Consensus 146 gsL 148 (301)
.+|
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.28 E-value=8.4e-06 Score=69.80 Aligned_cols=164 Identities=15% Similarity=0.203 Sum_probs=87.5
Q ss_pred cCHHHHHHhhCCCCC-----CceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCc--eeeeee
Q 022206 56 ISVDELKEKTDNFGT-----NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN--VVELVG 128 (301)
Q Consensus 56 ~~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~ 128 (301)
.+...+......|.+ .+.|+.|....+|++...++ .+++|..... .....+..|+.+++.|...+ +.+++.
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 344555555556665 34466788899999987654 7889988652 12345667787777774322 333332
Q ss_pred E------EEcCCeeEEEEecCCCCCHHH-----------H---hcC-CCCCCCCCCCCCCC---HHHHHH----------
Q 022206 129 Y------YVDGPLRVLAYEHASKGSLHD-----------I---LHG-KKGVKGAKPGPVLS---WAQRVK---------- 174 (301)
Q Consensus 129 ~------~~~~~~~~lv~e~~~~gsL~~-----------~---l~~-~~~~~~~~~~~~l~---~~~~~~---------- 174 (301)
. ....+..+++++|++|..+.. . ++. .......... ... +...+.
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~-~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPN-ALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBC-TTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccC-ccChHHHHHHHHHHHHHHHhhh
Confidence 1 123456789999999865321 0 111 0000000000 011 111000
Q ss_pred --HHHHHHHHHHHhhhC----CCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 175 --IAVGAARGLEYLHEK----AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 175 --i~~qi~~~l~~LH~~----~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+...+...++.+... ....++|+|+++.|||+++++.+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 001133344444421 122499999999999998876668999998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.22 E-value=1.4e-05 Score=68.61 Aligned_cols=76 Identities=13% Similarity=0.123 Sum_probs=52.3
Q ss_pred CceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCC--ceeeeeeE-----EEcCCeeEEEEecC
Q 022206 71 NSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNE--NVVELVGY-----YVDGPLRVLAYEHA 143 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~-----~~~~~~~~lv~e~~ 143 (301)
+..|+ |....||++...+|+.+++|...........+..|..+++.|... .+.+++.. ...++..+++++++
T Consensus 31 ~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp CEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred EEeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 34577 888999998876677899999875444556777888888777532 24444443 22345667899999
Q ss_pred CCCC
Q 022206 144 SKGS 147 (301)
Q Consensus 144 ~~gs 147 (301)
+|.+
T Consensus 110 ~G~~ 113 (328)
T 1zyl_A 110 GGRQ 113 (328)
T ss_dssp CCEE
T ss_pred CCCC
Confidence 8854
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=5e-06 Score=72.94 Aligned_cols=146 Identities=16% Similarity=0.196 Sum_probs=82.1
Q ss_pred CceecccCceEEEEEEEC--------CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCce-eeeeeEEEcCCeeEEEEe
Q 022206 71 NSLIGEGSYGRVYFGVLR--------SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e 141 (301)
++.|..|-...+|++... +++.+++|+............+|..+++.|...++ .++++.+.+ .+|||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 456778888999999864 24789999864433345667789999988853333 456655443 28899
Q ss_pred cCCCCCHHHH--------------h---cCCCCCCCCCCCCCCCHHHHHHHHHHHHH-------------------HHHH
Q 022206 142 HASKGSLHDI--------------L---HGKKGVKGAKPGPVLSWAQRVKIAVGAAR-------------------GLEY 185 (301)
Q Consensus 142 ~~~~gsL~~~--------------l---~~~~~~~~~~~~~~l~~~~~~~i~~qi~~-------------------~l~~ 185 (301)
|++|.+|..- | +...... .. .+..-+.++..+..++.. .+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~-~~-~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPF-TK-EPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSS-CC-SCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCC-CC-CcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 9998654311 1 1111000 00 010012333344433311 1222
Q ss_pred ----hhhCC-CCCeEecCCCCCceEEcCC----CceEEeccccCCC
Q 022206 186 ----LHEKA-EPRIIHRNIKSSNVLLFDD----DIAKISDFDLSNQ 222 (301)
Q Consensus 186 ----LH~~~-~~~ivH~Dlkp~Nill~~~----~~vkl~Dfg~a~~ 222 (301)
|...+ ...++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22221 2248999999999999876 7899999998754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=98.12 E-value=3.3e-05 Score=66.50 Aligned_cols=149 Identities=11% Similarity=0.096 Sum_probs=73.9
Q ss_pred CceecccCceE-EEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCC--CceeeeeeEEEcCCeeEEEEecCCCCC
Q 022206 71 NSLIGEGSYGR-VYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN--ENVVELVGYYVDGPLRVLAYEHASKGS 147 (301)
Q Consensus 71 ~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~gs 147 (301)
.+.|+.|+... +|+....+++.+++|...... ...+..|+.+++.+.. -.+.+++.+..+.+ +++||++.+.+
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 34566665555 667765446778888654332 1234556777666642 23456666533333 68999998777
Q ss_pred HHHHhcCCCCC-----------------CCCCCCCCCCHHHHH-------H-------------HHHHHHHHHHHhh---
Q 022206 148 LHDILHGKKGV-----------------KGAKPGPVLSWAQRV-------K-------------IAVGAARGLEYLH--- 187 (301)
Q Consensus 148 L~~~l~~~~~~-----------------~~~~~~~~l~~~~~~-------~-------------i~~qi~~~l~~LH--- 187 (301)
+.+.+...... .....-+.+...... . ....+...+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 76544321100 000000112211100 0 0011111222221
Q ss_pred hCCCCCeEecCCCCCceEEcCC----CceEEeccccCCCC
Q 022206 188 EKAEPRIIHRNIKSSNVLLFDD----DIAKISDFDLSNQA 223 (301)
Q Consensus 188 ~~~~~~ivH~Dlkp~Nill~~~----~~vkl~Dfg~a~~~ 223 (301)
......++|||+++.|||++.+ +.+.|+||+.+...
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1112349999999999999874 67899999987543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=98.11 E-value=7.7e-06 Score=73.12 Aligned_cols=73 Identities=14% Similarity=0.170 Sum_probs=50.2
Q ss_pred CceecccCceEEEEEEECC--------CCEEEEEEcCCCCCchHHHHHHHHHHhccCCCce-eeeeeEEEcCCeeEEEEe
Q 022206 71 NSLIGEGSYGRVYFGVLRS--------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e 141 (301)
++.|+.|....||++...+ ++.+++|+.... .....+.+|+.+++.|...++ .++++.+.+ .+|+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 4568889899999998652 578999988432 222556689998888854334 456665432 28899
Q ss_pred cCCCCCH
Q 022206 142 HASKGSL 148 (301)
Q Consensus 142 ~~~~gsL 148 (301)
|++|.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9987443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=98.05 E-value=2.3e-05 Score=70.51 Aligned_cols=74 Identities=12% Similarity=-0.010 Sum_probs=47.8
Q ss_pred CceecccCceEEEEEEECC-CCEEEEEEcCCCCCchHHHHHHHHHHhccCCCce-eeeeeEEEcCCeeEEEEecCCCCCH
Q 022206 71 NSLIGEGSYGRVYFGVLRS-GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYEHASKGSL 148 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~gsL 148 (301)
++.|+.|-...+|++...+ +..+++|+........-...+|+.+++.|...++ .++++.+. + .+|+||++|.+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 4568888899999998774 5789999875432211123578888888865444 46666552 2 258999987544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=7.7e-06 Score=71.57 Aligned_cols=74 Identities=8% Similarity=0.026 Sum_probs=44.6
Q ss_pred CceecccCceEEEEEEECC---------CCEEEEEEcCCCCCchHHHHHHHHHHhccCCCc-eeeeeeEEEcCCeeEEEE
Q 022206 71 NSLIGEGSYGRVYFGVLRS---------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN-VVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~ 140 (301)
.+.|+.|....+|++...+ ++.+++|+.............|..+++.|...+ +.++++.. . -++||
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 4567888899999998763 268899987543211112456788887775333 34566543 2 26889
Q ss_pred ecCCCCCH
Q 022206 141 EHASKGSL 148 (301)
Q Consensus 141 e~~~~gsL 148 (301)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99988543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=5.3e-05 Score=65.47 Aligned_cols=72 Identities=13% Similarity=0.089 Sum_probs=45.4
Q ss_pred Cceec--ccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCC---CceeeeeeE------EEcCCeeEEE
Q 022206 71 NSLIG--EGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN---ENVVELVGY------YVDGPLRVLA 139 (301)
Q Consensus 71 ~~~lg--~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~------~~~~~~~~lv 139 (301)
.+.+. .|....||++...++ .+++|+...... ..|+.+++.|.. +++.+++.. ....+..+++
T Consensus 26 ~~~l~~G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l 99 (339)
T 3i1a_A 26 AQFIQGGADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIA 99 (339)
T ss_dssp EEEETTTSCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEE
T ss_pred eEEeeccCccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEE
Confidence 34453 344789999987766 999998765432 345555655532 224444432 2345678999
Q ss_pred EecCCCCCH
Q 022206 140 YEHASKGSL 148 (301)
Q Consensus 140 ~e~~~~gsL 148 (301)
|+|++|..+
T Consensus 100 ~~~i~G~~~ 108 (339)
T 3i1a_A 100 YPFIHAPNG 108 (339)
T ss_dssp EECCCCCBT
T ss_pred EeccCCCcC
Confidence 999998765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00024 Score=63.15 Aligned_cols=74 Identities=9% Similarity=0.027 Sum_probs=48.6
Q ss_pred CceecccCceEEEEEEECC--------CCEEEEEEcCCCCCchHHHHHHHHHHhccCCCc-eeeeeeEEEcCCeeEEEEe
Q 022206 71 NSLIGEGSYGRVYFGVLRS--------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNEN-VVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e 141 (301)
++.|..|-...+|++...+ ++.+++++........-+..+|..+++.|...+ ..++++.+ . -++|+|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 4567778889999998763 578999987543222223457888888775333 34555433 2 268899
Q ss_pred cCCCCCH
Q 022206 142 HASKGSL 148 (301)
Q Consensus 142 ~~~~gsL 148 (301)
|++|.+|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0042 Score=49.49 Aligned_cols=102 Identities=17% Similarity=0.178 Sum_probs=66.1
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
.+|.++|..... ++++.++|.++.|.+.+|.-+-. .. -..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~--------PlsEEqaWALc~Qc~~~L~~~~~~~~---~~~~i~~~~~i~l~~dG~V~f~~-~~s~--- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ--------PINEEQAWAVCYQCCGSLRAAARRRQ---PRHRVRSAAQIRVWRDGAVTLAP-AADD--- 97 (229)
T ss_dssp EEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCSGGGEEEETTSCEEECC-C------
T ss_pred ccHHHHHHHcCC--------CcCHHHHHHHHHHHHHHHHhhhhccc---CCceecCCcceEEecCCceeccc-cccc---
Confidence 479999976543 49999999999999999877622 11 11344568999999999988764 1110
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCC
Q 022206 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKP 274 (301)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p 274 (301)
.....+.+||... ...+.+.=|||||+++|..+- |-.+
T Consensus 98 -----------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 98 -----------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp --------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred -----------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 0122466888653 344567789999999999885 4433
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0098 Score=52.41 Aligned_cols=30 Identities=23% Similarity=0.417 Sum_probs=25.1
Q ss_pred eEecCCCCCceEE------cCCCceEEeccccCCCC
Q 022206 194 IIHRNIKSSNVLL------FDDDIAKISDFDLSNQA 223 (301)
Q Consensus 194 ivH~Dlkp~Nill------~~~~~vkl~Dfg~a~~~ 223 (301)
++|+|+.+.|||+ ++++.+.++||.+|...
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 5799999999999 34677999999988553
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.32 E-value=0.27 Score=38.95 Aligned_cols=82 Identities=5% Similarity=0.049 Sum_probs=58.9
Q ss_pred CCCceeeeeeEEEcCCeeEEEEecCC-CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEec
Q 022206 119 KNENVVELVGYYVDGPLRVLAYEHAS-KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHR 197 (301)
Q Consensus 119 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~ 197 (301)
.||+++.. .+-.+++.+.+.++.-+ +-++.. +.. ++....++++.+|+....+++. =+|=
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~------------~~~~eKlr~l~ni~~l~~~~~~-----r~tf 103 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS------------FTKNEKLRYLLNIKNLEEVNRT-----RYTF 103 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG------------SCHHHHHHHHHHGGGGGGGGGS-----SEEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh------------cCHHHHHHHHHHHHHHHHHhcC-----ceEE
Confidence 57888876 45566676666655443 223333 222 7889999999999988755544 3688
Q ss_pred CCCCCceEEcCCCceEEecccc
Q 022206 198 NIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 198 Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
-|+|+||+++.++.+++.=-|+
T Consensus 104 ~L~P~NL~f~~~~~p~i~~RGi 125 (215)
T 4ann_A 104 VLAPDELFFTRDGLPIAKTRGL 125 (215)
T ss_dssp CCSGGGEEECTTSCEEESCCEE
T ss_pred EEecceEEEcCCCCEEEEEccC
Confidence 9999999999999999986664
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.85 E-value=0.67 Score=36.80 Aligned_cols=81 Identities=7% Similarity=-0.003 Sum_probs=59.2
Q ss_pred CCCceeeeeeEEEcCCeeEEEEecCCC-CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-HhhhCCCCCeEe
Q 022206 119 KNENVVELVGYYVDGPLRVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE-YLHEKAEPRIIH 196 (301)
Q Consensus 119 ~h~~iv~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~-~LH~~~~~~ivH 196 (301)
.||++ --.+-.+++.+.+.++.-++ -++..+ .. ++....++++.+|+.... +++. -+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-~~------------~~~~eKlrll~nl~~L~~~~~~~-----r~t 107 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-RK------------TTLLSRIRAAIHLVSKVKHHSAR-----RLI 107 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-HT------------SCHHHHHHHHHHHHHHHSSCCSS-----SEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-Hh------------cCHHHHHHHHHHHHHHHHHhhhC-----cee
Confidence 57777 34444677777777766533 344433 32 788999999999988766 4444 578
Q ss_pred cCCCCCceEEcCCCceEEecccc
Q 022206 197 RNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 197 ~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
--|+|+||+++.++.+++.=.|+
T Consensus 108 f~l~P~NL~f~~~~~p~i~hRGi 130 (219)
T 4ano_A 108 FIVCPENLMFNRALEPFFLHVGV 130 (219)
T ss_dssp CCCCGGGEEECTTCCEEESCCEE
T ss_pred EEEeCceEEEeCCCcEEEEEcCC
Confidence 89999999999999999987775
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=88.13 E-value=0.98 Score=38.25 Aligned_cols=81 Identities=12% Similarity=0.096 Sum_probs=42.4
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC-CCCeEe-cCCCCCceEEcCCC-c
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA-EPRIIH-RNIKSSNVLLFDDD-I 211 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-~~~ivH-~Dlkp~Nill~~~~-~ 211 (301)
...++|+|.+|..|.+.-...-. ..+.......+.. +-++..+..+. ..+.+. .--.+.|||+++++ .
T Consensus 156 ~~~l~meyv~G~~L~e~~~~~~~-------~~f~~~~~k~LG~--Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~~~n~~ 226 (342)
T 1cja_A 156 ANILLMELVRGITLNKLTTTSAP-------EVLTKSTMQQLGS--LMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGAT 226 (342)
T ss_dssp SEEEEEECCCEEESTTCCSSSHH-------HHSCHHHHHHHHH--HHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTTC
T ss_pred cceehhhhcCCCccccchhhhhh-------hhcCHHHHHhhch--hheehhhhcCCccCcccccCCCChhheEEeCCCCe
Confidence 45699999988666543221000 0022222221111 23345555443 112222 12478999998754 4
Q ss_pred eEEeccccCCCCC
Q 022206 212 AKISDFDLSNQAP 224 (301)
Q Consensus 212 vkl~Dfg~a~~~~ 224 (301)
+.++|-+++....
T Consensus 227 ~~~IDhn~af~~~ 239 (342)
T 1cja_A 227 VVPIDSKIIPLDA 239 (342)
T ss_dssp EEECSCCCCCCCS
T ss_pred EEEEcCCccccCC
Confidence 8899999886544
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.11 E-value=0.096 Score=46.98 Aligned_cols=60 Identities=5% Similarity=0.006 Sum_probs=18.3
Q ss_pred CCCceecccCceEEEEEEECC-CCEEEE------EEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEE
Q 022206 69 GTNSLIGEGSYGRVYFGVLRS-GRAAAI------KKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYV 131 (301)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~-~~~vav------K~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~ 131 (301)
.+.+.|| ||.||++.+.. ..+||+ |........ ...+.+|..+++.++|+|+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 4556676 99999999763 467888 655432222 235777888888899999999988754
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=85.00 E-value=6.4 Score=36.30 Aligned_cols=90 Identities=12% Similarity=0.091 Sum_probs=51.2
Q ss_pred eeeeeEEEcCCeeEEEEecCCCCCHHHHhcCCCCC-------CCCCCCC-CCCHHHHHHHHHHHHH--HHHHhhhCCCCC
Q 022206 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGV-------KGAKPGP-VLSWAQRVKIAVGAAR--GLEYLHEKAEPR 193 (301)
Q Consensus 124 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~~~~-~l~~~~~~~i~~qi~~--~l~~LH~~~~~~ 193 (301)
+..|.+...+...-+ +|++++.++.+++...... ....... .........++..++- .+.|+ .|
T Consensus 402 i~~Y~Vipls~~~Gl-IE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YI--LG--- 475 (614)
T 3ls8_A 402 LTPYKVLATSTKHGF-MQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYI--LG--- 475 (614)
T ss_dssp CCCCCEEESSSSEEE-EECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHH--HT---
T ss_pred eeccEEEEecCCCce-EEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhhee--ee---
Confidence 455666666666555 4888776666655422100 0000000 0123334445554443 23444 23
Q ss_pred eEecCCCCCceEEcCCCceEEeccccCC
Q 022206 194 IIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 194 ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
=+|=+++|||++.+|++.=+|||.+-
T Consensus 476 --igDRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 476 --VGDRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp --CCCCCTTSEEECTTSCEEECCCSSCT
T ss_pred --ccCCCCcceeEcCCCCEeeeehHHhh
Confidence 26889999999999999999999873
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=82.00 E-value=34 Score=32.11 Aligned_cols=90 Identities=11% Similarity=0.024 Sum_probs=50.9
Q ss_pred eeeeeEEEcCCeeEEEEecCCCCCHHHHhcCCCCC------CCCCCCCCC--CHHHHHHHHHHHHH--HHHHhhhCCCCC
Q 022206 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGV------KGAKPGPVL--SWAQRVKIAVGAAR--GLEYLHEKAEPR 193 (301)
Q Consensus 124 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~~~~l--~~~~~~~i~~qi~~--~l~~LH~~~~~~ 193 (301)
++.|.+...+...-++ |+++..+|.+++...... ....+...+ .......++.+++- .+.|+= |
T Consensus 476 i~~Y~Vipls~~~GLI-E~V~s~tl~~i~~~~~~l~~~f~~~~p~~~~~~~~~~~ar~nF~~SlA~~Svv~YIL--G--- 549 (696)
T 2x6h_A 476 LTPYKVLATSSKHGFL-QYVDSCTVAEVLAREGNIHNFFRKHHPCDNGPYGISAEVMDTYIKSCAGYCVITYLL--G--- 549 (696)
T ss_dssp CCCCCEEESSTTCEEE-ECCCCEEHHHHHHHSSSHHHHHHHHSBCTTSSSSBCHHHHHHHHHHHHHHHHHHHHH--T---
T ss_pred EeccEEEeccCCCCee-eeCCCccHHHHHHhcChHHHHHHHHCCCccchhhhHHHHHHHHHHHHHHHHHHHHHc--c---
Confidence 3445555555555554 777777777776533200 000000001 12233444444432 234442 2
Q ss_pred eEecCCCCCceEEcCCCceEEeccccCC
Q 022206 194 IIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 194 ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
=+|=+++||||++.|++.=+|||.+-
T Consensus 550 --lGDRH~~NILid~tG~v~HIDFG~~f 575 (696)
T 2x6h_A 550 --VGDRHLDNLLLTTNGKLFHIDFGYIL 575 (696)
T ss_dssp --CCCCCTTTEEECTTSCEEECCCCSCT
T ss_pred --CCCCCCcceEEeCCCCEEEEeehhhh
Confidence 36999999999999999999999863
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 301 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-58 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-50 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-48 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-45 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-40 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-13 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 8e-60
Identities = 56/231 (24%), Positives = 102/231 (44%), Gaps = 18/231 (7%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKN 120
K D+F S +G G+ G V+ + SG A K + +P + + ++ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+V G + + EH GSL +L + K+++
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVI 114
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
+GL YL EK +I+HR++K SN+L+ K+ DF +S Q D+ + +GT
Sbjct: 115 KGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRS 168
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVL 291
Y +PE S +SD++S G+ L+E+ GR P+ + + + +
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 2e-58
Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 12/209 (5%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVE 125
+ +G G +G V+ G A+K L FLA+ +++ +L+++ +V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L P+ + E+ GSL D L G+K L+ + + +A A G+ +
Sbjct: 73 LYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAF 124
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
+ E+ IHR+++++N+L+ D KI+DF L+ D + APE
Sbjct: 125 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPE 180
Query: 246 YAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
G + KSDV+SFG++L E++T +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRI 209
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 5e-58
Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 16/222 (7%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDS-SKQPDQEFLAQVSMVSRLKNENVV 124
IG GS+G VY G A + + + + Q Q F +V ++ + ++ N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 125 ELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+GY L + + SL+ LH + + + IA A+G++
Sbjct: 68 LFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETK--------FEMIKLIDIARQTAQGMD 118
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
YLH K IIHR++KS+N+ L +D KI DF L+ + ++ G+ + AP
Sbjct: 119 YLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 245 EYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283
E S +SDVY+FG+VL EL+TG+ P + R Q
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-54
Identities = 51/201 (25%), Positives = 89/201 (44%), Gaps = 12/201 (5%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
+G G +G V +G R AIK + + EF+ + ++ L +E +V+L G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
+ E+ + G L + L + Q +++ +EYL K +
Sbjct: 72 RPIFIITEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESK---Q 120
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS 253
+HR++ + N L+ D + K+SDF LS D S + PE M + S
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFS 179
Query: 254 SKSDVYSFGVVLLELLTGRKP 274
SKSD+++FGV++ E+ + K
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKM 200
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 9e-54
Identities = 50/210 (23%), Positives = 94/210 (44%), Gaps = 12/210 (5%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
IG G +G V+ G + AIK + +++F+ + ++ +L + +V+L G ++
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72
Query: 134 PLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPR 193
L +E G L D L + + + + + G+ YL E
Sbjct: 73 APICLVFEFMEHGCLSDYLR--------TQRGLFAAETLLGMCLDVCEGMAYLEEA---C 121
Query: 194 IIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMS 253
+IHR++ + N L+ ++ + K+SDF ++ D ST + +PE + S
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYS 180
Query: 254 SKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283
SKSDV+SFGV++ E+ + K +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 6e-52
Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 12/219 (5%)
Query: 56 ISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMV 115
++ D + ++ +G+G +G V+ G AIK L + FL + ++
Sbjct: 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVM 66
Query: 116 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
+L++E +V+L + P+ + E+ SKGSL D L G+ G L Q V +
Sbjct: 67 KKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGET-------GKYLRLPQLVDM 118
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
A A G+ Y+ +HR+++++N+L+ ++ + K++DF L+ D
Sbjct: 119 AAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGA 174
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ APE A+ G+ + KSDV+SFG++L EL T +
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 213
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 9e-52
Identities = 50/230 (21%), Positives = 92/230 (40%), Gaps = 21/230 (9%)
Query: 73 LIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKN-ENV 123
+G G++G+V + A+K L S + ++++ ++S L N N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKG---------VKGAKPGPVLSWAQRVK 174
V L+G G ++ E+ G L + L K+ L +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
+ A+G+ +L K IHR++ + N+LL I KI DF L+ + + +
Sbjct: 150 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284
+ APE + +SDV+S+G+ L EL + +P +
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 3e-51
Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 21/227 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKN 120
++F +G+G +G VY + S A+K L ++ + +V + S L++
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
N++ L GY+ D L E+A G+++ L + A
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---------FDEQRTATYITELA 116
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
L Y H K R+IHR+IK N+LL KI+DF S AP + T + GT
Sbjct: 117 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLD 169
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
Y PE K D++S GV+ E L G+ P + + +
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 216
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 3e-51
Identities = 61/216 (28%), Positives = 107/216 (49%), Gaps = 18/216 (8%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVE 125
IG+G +G V G R G A+K + + Q FLA+ S++++L++ N+V+
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQ 64
Query: 126 LVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
L+G V+ + + E+ +KGSL D L + VL +K ++ +E
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAME 117
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
YL +HR++ + NVL+ +D++AK+SDF L+ +A + AP
Sbjct: 118 YLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAP 169
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280
E + S+KSDV+SFG++L E+ + + +P
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 205
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (425), Expect = 5e-51
Identities = 56/232 (24%), Positives = 100/232 (43%), Gaps = 26/232 (11%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQPD--QEFLAQVSMVSR 117
+N IGEG++GRV+ A+K L D +F + ++++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK---------------GAK 162
N N+V+L+G G L +E+ + G L++ L +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
P LS A+++ IA A G+ YL E + +HR++ + N L+ ++ + KI+DF LS
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
A + PE + +++SDV+++GVVL E+ +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 167 bits (423), Expect = 8e-51
Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 12/228 (5%)
Query: 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMV 115
+ D+ + + + +G G YG VY GV + A+K L +EFL + +++
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 67
Query: 116 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
+K+ N+V+L+G P + E + G+L D L + +S + +
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-------VSAVVLLYM 120
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
A + +EYL +K IHR++ + N L+ ++ + K++DF LS H
Sbjct: 121 ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGA 176
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283
+ APE + S KSDV++FGV+L E+ T + Q
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 224
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-50
Identities = 49/217 (22%), Positives = 102/217 (47%), Gaps = 20/217 (9%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD-QEFLAQVSMVSRLKNEN 122
D + +G+G++G+VY + + AA K +D+ + + ++++ ++ +++ + N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+V+L+ + + E + G++ ++ + L+ +Q +
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--------LTESQIQVVCKQTLDA 122
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
L YLH+ +IIHR++K+ N+L D K++DF +S + R S +GT +
Sbjct: 123 LNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWM 177
Query: 243 APEYAMTGQM-----SSKSDVYSFGVVLLELLTGRKP 274
APE M K+DV+S G+ L+E+ P
Sbjct: 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-50
Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 15/219 (6%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQE---FLAQVSMVSRLK 119
+ +++ IG GSYGR + G+ K+LD + E +++V+++ LK
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 120 NENVVELVGYYVDGPLRVL--AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+ N+V +D L E+ G L ++ KG K L +++
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT-----KGTKERQYLDEEFVLRVMT 116
Query: 178 GAARGLEYLHEK--AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
L+ H + ++HR++K +NV L K+ DF L+ + +
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAF 174
Query: 236 LGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+GT Y +PE + KSD++S G +L EL P
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 213
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-50
Identities = 52/242 (21%), Positives = 101/242 (41%), Gaps = 26/242 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRS------GRAAAIKKLDSSKQPD--QEFLAQVSMVSR 117
+N ++G G++G+V A+K L + ++++ M+++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 118 LKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKG--------------VKGAK 162
L + EN+V L+G L +E+ G L + L K+ ++ +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 163 PGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
VL++ + A A+G+E+L K +HR++ + NVL+ + KI DF L+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282
+ + + APE G + KSDV+S+G++L E+ + +P
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 283 QQ 284
Sbjct: 274 AN 275
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-50
Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 60 ELKEKTDNFG-TNSLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPD--QEFLAQVS 113
+L K DN + +G G++G V GV R AIK L + +E + +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 114 MVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 173
++ +L N +V L+G L +L E A G LH L GK+ + +
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE--------IPVSNVA 112
Query: 174 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLHS 232
++ + G++YL EK +HR++ + NVLL + AKISDF LS D +
Sbjct: 113 ELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169
Query: 233 TRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ ++APE + SS+SDV+S+GV + E L+ +
Sbjct: 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 211
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-50
Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 16/223 (7%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNEN 122
+++ +GEG+YG V V R + A A+K +D + D + ++ + L +EN
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
VV+ G+ +G ++ L E+ S G L D + G + + G
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAG 115
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
+ YLH I HR+IK N+LL + D KISDF L+ ++ GT Y
Sbjct: 116 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 243 APEYAMTGQMSS-KSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284
APE + + DV+S G+VL +L G P D Q+
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 4e-50
Identities = 62/238 (26%), Positives = 116/238 (48%), Gaps = 26/238 (10%)
Query: 50 PIAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLRSG---RAAAIKKLD--SSKQP 104
P PV+ +++K + +IGEG++G+V ++ AAIK++ +SK
Sbjct: 1 PTIYPVLDWNDIKFQ-------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD 53
Query: 105 DQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVK---- 159
++F ++ ++ +L + N++ L+G LA E+A G+L D L + ++
Sbjct: 54 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 113
Query: 160 ---GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216
LS Q + A ARG++YL +K + IHR++ + N+L+ ++ +AKI+D
Sbjct: 114 FAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 170
Query: 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
F LS + T + A E ++ SDV+S+GV+L E+++
Sbjct: 171 FGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 8e-50
Identities = 51/218 (23%), Positives = 92/218 (42%), Gaps = 28/218 (12%)
Query: 74 IGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDG 133
IG+G +G V+ G R G A+K S ++ A++ L++EN++ +
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 134 PLRV----LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
L ++ GSL D L+ ++ +K+A+ A GL +LH +
Sbjct: 70 NGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHME 119
Query: 190 A-----EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH--STRVLGTFGYH 242
+P I HR++KS N+L+ + I+D L+ + A + +GT Y
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 243 APEYAMT------GQMSSKSDVYSFGVVLLELLTGRKP 274
APE + ++D+Y+ G+V E+
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (415), Expect = 3e-49
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 26/209 (12%)
Query: 74 IGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVG 128
IG GS+G VYF +R+ AIKK+ S + Q+ + +V + +L++ N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
Y+ L E+ + + KK L + + GA +GL YLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKP---------LQEVEIAAVTHGALQGLAYLHS 133
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
+IHR++K+ N+LL + + K+ DF ++ + +GT + APE +
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVIL 184
Query: 249 T---GQMSSKSDVYSFGVVLLELLTGRKP 274
GQ K DV+S G+ +EL + P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 163 bits (413), Expect = 3e-49
Identities = 59/236 (25%), Positives = 105/236 (44%), Gaps = 29/236 (12%)
Query: 57 SVDELKEKTDNFGTN---------SLIGEGSYGRVYFGVLRS----GRAAAIKKLDS--S 101
+ ++ E F +IG G +G V G L+ AIK L S +
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 102 KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGA 161
++ ++FL++ S++ + + NV+ L G ++ E GSL L G
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-- 125
Query: 162 KPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221
+ Q V + G A G++YL + +HR++ + N+L+ + + K+SDF LS
Sbjct: 126 ------TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 176
Query: 222 QAPDAAARLHSTRVLG---TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
D + T LG + APE + +S SDV+S+G+V+ E+++ +
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 232
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-48
Identities = 55/220 (25%), Positives = 105/220 (47%), Gaps = 17/220 (7%)
Query: 57 SVDELKEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE-FLAQVSM 114
S+ + + + IG+G+ G VY + + +G+ AI++++ +QP +E + ++ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 115 VSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVK 174
+ KN N+V + Y+ G + E+ + GSL D++ Q
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----------DEGQIAA 120
Query: 175 IAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTR 234
+ + LE+LH ++IHR+IKS N+LL D K++DF Q + +
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRST 175
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
++GT + APE K D++S G++ +E++ G P
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-48
Identities = 53/229 (23%), Positives = 98/229 (42%), Gaps = 25/229 (10%)
Query: 55 VISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSKQPDQ--EF 108
VI L +F +IG G +G VY G L A+K L+ + +F
Sbjct: 21 VIGPSSL---IVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 75
Query: 109 LAQVSMVSRLKNENVVELVGYYVDGPLRV-LAYEHASKGSLHDILHGKKGVKGAKPGPVL 167
L + ++ + NV+ L+G + + + G L + + +
Sbjct: 76 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--------P 127
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD-- 225
+ + + A+G+++L K + +HR++ + N +L + K++DF L+ D
Sbjct: 128 TVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184
Query: 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ + T + A E T + ++KSDV+SFGV+L EL+T P
Sbjct: 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-48
Identities = 58/226 (25%), Positives = 100/226 (44%), Gaps = 19/226 (8%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSG-----RAAAIKKLDSSKQPDQ--EFLAQVSMVSRL 118
+IG G +G VY G+L++ AIK L + Q +FL + ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 119 KNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
+ N++ L G ++ E+ G+L L K G S Q V + G
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLVGMLRG 118
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST-RVLG 237
A G++YL +HR++ + N+L+ + + K+SDF LS D ++T
Sbjct: 119 IAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 238 TFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283
+ APE + +S SDV+SFG+V+ E++T + L +
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 4e-48
Identities = 55/219 (25%), Positives = 87/219 (39%), Gaps = 24/219 (10%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDS---SKQPDQEFLAQVSMVSRLKNENVVELVGY 129
IG GS+ VY G+ + A +L +K Q F + M+ L++ N+V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 130 YVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
+ VL E + G+L L K V+ +GL++
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQF 127
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAP 244
LH + P IIHR++K N+ + KI D L+ + + V+GT + AP
Sbjct: 128 LHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 182
Query: 245 EYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283
E + DVY+FG+ +LE+ T P Q
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 220
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-47
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 74 IGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELV 127
+G G++G V G + + A+K L + E LA+ +++ +L N +V ++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 128 GYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLH 187
G +L E A G L+ L + + +++ + G++YL
Sbjct: 75 GICEAESW-MLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLE 124
Query: 188 EKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ-APDAAARLHSTRVLGTFGYHAPEY 246
E +HR++ + NVLL AKISDF LS D T ++APE
Sbjct: 125 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 247 AMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ SSKSDV+SFGV++ E + +
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQK 209
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 1e-45
Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 19/218 (8%)
Query: 64 KTDNFGTNSLIGEGSYGRVYFGVLRS-----GRAAAIKKLDSSKQPD--QEFLAQVSMVS 116
K F ++G G++G VY G+ AIK+L + P +E L + +++
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 117 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
+ N +V L+G + ++++ + G L D + K +
Sbjct: 67 SVDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNI--------GSQYLLNWC 117
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
V A+G+ YL ++ R++HR++ + NVL+ KI+DF L+ H+
Sbjct: 118 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ A E + + +SDV+S+GV + EL+T
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 212
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-45
Identities = 51/218 (23%), Positives = 88/218 (40%), Gaps = 17/218 (7%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQV----SMVS 116
K++ ++F ++GEGS+ V L + R AIK L+ + + V ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 117 RLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIA 176
RL + V+L + D +A G L +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---------FDETCTRFYT 114
Query: 177 VGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVL 236
LEYLH IIHR++K N+LL +D +I+DF + + + + +
Sbjct: 115 AEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 171
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GT Y +PE SD+++ G ++ +L+ G P
Sbjct: 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-45
Identities = 59/232 (25%), Positives = 106/232 (45%), Gaps = 12/232 (5%)
Query: 52 AVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLD--SSKQ 103
A V DE + + + +G+GS+G VY GV + AIK ++ +S +
Sbjct: 6 AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 65
Query: 104 PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKP 163
EFL + S++ +VV L+G G ++ E ++G L L + P
Sbjct: 66 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 125
Query: 164 -GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222
S ++ +++A A G+ YL+ + +HR++ + N ++ +D KI DF ++
Sbjct: 126 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ + L + +PE G ++ SDV+SFGVVL E+ T +
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 234
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 5e-45
Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 19/215 (8%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQPD--QEFLAQVSMVSRLK 119
+ IGEG +G V+ G+ S A AIK + ++FL + + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+ ++V+L+G + P+ ++ E + G L L +K L A + A
Sbjct: 67 HPHIVKLIGVITENPVWII-MELCTLGELRSFLQVRKYS--------LDLASLILYAYQL 117
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
+ L YL K R +HR+I + NVL+ +D K+ DF LS D+ +++
Sbjct: 118 STALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPI 173
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ APE + +S SDV+ FGV + E+L
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 208
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 9e-45
Identities = 60/236 (25%), Positives = 106/236 (44%), Gaps = 21/236 (8%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRS--------GRAAAIKKL--DSSKQPDQEFLAQVSMV 115
D +GEG++G+V A+K L D++++ + ++++ M+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 116 SRLKN-ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKG-------VKGAKPGPVL 167
+ +N++ L+G + E+ASKG+L + L ++ P L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 168 SWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAA 227
S V A ARG+EYL K + IHR++ + NVL+ +D++ KI+DF L+
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 228 ARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283
+T + APE + +SDV+SFGV+L E+ T +P +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-44
Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 21/218 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLD----SSKQPDQEFLAQVSMVSR 117
+ +G+GS+G V G + + A+K L S + +F+ +V+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
L + N++ L G + P++ + E A GSL D L +G + AV
Sbjct: 68 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAV 118
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLH-STRVL 236
A G+ YL K R IHR++ + N+LL D+ KI DF L P
Sbjct: 119 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 237 GTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
F + APE T S SD + FGV L E+ T +
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-43
Identities = 48/236 (20%), Positives = 97/236 (41%), Gaps = 20/236 (8%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKL--DSSKQPDQEFLAQVSMVSR 117
D +G G++G+V + R A+K L ++ + ++++ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 118 LKNE-NVVELVGYYV-DGPLRVLAYEHASKGSLHDILHGKKG-------VKGAKPGPVLS 168
+ + NVV L+G G ++ E G+L L K+ L+
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 169 WAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAA 228
+ + A+G+E+L + + IHR++ + N+LL + ++ KI DF L+
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284
+ + APE + +SDV+SFGV+L E+ + + ++
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 149 bits (376), Expect = 3e-43
Identities = 49/213 (23%), Positives = 94/213 (44%), Gaps = 18/213 (8%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE-FLAQVSMVSRLKNENV 123
D++ + +G G++G V+ +G A K + + + D+E ++ +S L++ +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 124 VELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGL 183
V L + D V+ YE S G L + + + +S + V+ +GL
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--------MSEDEAVEYMRQVCKGL 137
Query: 184 EYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
++HE +H ++K N++ K+ DF L+ + +T GT +
Sbjct: 138 CHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEF 191
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE A + +D++S GV+ LL+G P
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 224
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 148 bits (374), Expect = 8e-43
Identities = 52/221 (23%), Positives = 98/221 (44%), Gaps = 20/221 (9%)
Query: 60 ELKEKT--DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE-FLAQVSMV 115
E+K+ + D + +G G++G V+ V +GR K +++ D+ ++S++
Sbjct: 21 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIM 80
Query: 116 SRLKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
++L + ++ L + D VL E S G L D + + +S A+ +
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--------MSEAEVINY 132
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLL--FDDDIAKISDFDLSNQAPDAAARLHST 233
A GL+++HE I+H +IK N++ KI DF L+ + +T
Sbjct: 133 MRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 189
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
T + APE + +D+++ GV+ LL+G P
Sbjct: 190 ---ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 227
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 3e-42
Identities = 40/219 (18%), Positives = 84/219 (38%), Gaps = 17/219 (7%)
Query: 62 KEKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN 120
KE + + +G G +G V+ V S + K + ++S+++ ++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
N++ L + V+ +E S + + ++ L+ + V
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERIN--------TSAFELNEREIVSYVHQVC 112
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDD--IAKISDFDLSNQAPDAAARLHSTRVLGT 238
L++LH I H +I+ N++ KI +F + Q + +
Sbjct: 113 EALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTA 166
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277
Y+APE +S+ +D++S G ++ LL+G P
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 143 bits (362), Expect = 7e-42
Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 22/220 (10%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE----FLAQVSMVSRLK 119
+D + ++G G V+ LR R A+K L + D F + + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 120 NENVVELVGYYVD----GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
+ +V + GPL + E+ +L DI+H + ++ + +++
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---------MTPKRAIEV 116
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST-R 234
A + L + H+ IIHR++K +N+++ + K+ DF ++ D+ + T
Sbjct: 117 IADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173
Query: 235 VLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
V+GT Y +PE A + ++SDVYS G VL E+LTG P
Sbjct: 174 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 213
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 141 bits (357), Expect = 5e-41
Identities = 55/241 (22%), Positives = 92/241 (38%), Gaps = 33/241 (13%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD----------QEFLAQVSM 114
+N+ ++G G V + + + A+K +D + + L +V +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 115 VSRLKNE-NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 173
+ ++ N+++L Y L ++ KG L D L K LS +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETR 113
Query: 174 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 233
KI + LH+ I+HR++K N+LL DD K++DF S Q
Sbjct: 114 KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLR 167
Query: 234 RVLGTFGYHAPEYAMTGQM------SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
V GT Y APE + D++S GV++ LL G P H ++
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227
Query: 288 T 288
Sbjct: 228 M 228
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 143 bits (362), Expect = 6e-41
Identities = 56/236 (23%), Positives = 94/236 (39%), Gaps = 25/236 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLD----SSKQPDQEFLAQVSMVSRLKN 120
++F + +IG G +G VY +G+ A+K LD KQ + L + M+S +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 121 ---ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+V + + + + G LH L A A
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---------EADMRFYAA 114
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLG 237
GLE++H + +++R++K +N+LL + +ISD L+ +G
Sbjct: 115 EIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVG 167
Query: 238 TFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVLT 292
T GY APE G S +D +S G +L +LL G P + + + LT
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-40
Identities = 47/215 (21%), Positives = 91/215 (42%), Gaps = 20/215 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQV-----SMVSRLK 119
++F + ++G+GS+G+V+ + + + AIK L + + + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 120 NENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGA 179
+ + + + E+ + G L + ++ A
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEI 112
Query: 180 ARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTF 239
GL++LH K I++R++K N+LL D KI+DF + + A+ + GT
Sbjct: 113 ILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTP 167
Query: 240 GYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE + + + D +SFGV+L E+L G+ P
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (346), Expect = 3e-39
Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 21/216 (9%)
Query: 65 TDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE--FLAQVSMVSRLKNE 121
D + ++G G++ V R+ + AIK + +E +++++ ++K+
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N+V L Y G L + S G L D + K + ++
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---------FYTERDASRLIFQVLD 118
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
++YLH+ I+HR++K N+L + +D ISDF LS + + GT
Sbjct: 119 AVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STACGT 172
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
GY APE S D +S GV+ LL G P
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 208
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 5e-39
Identities = 60/231 (25%), Positives = 98/231 (42%), Gaps = 22/231 (9%)
Query: 72 SLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVG 128
S IGEG+YG V + AIKK+ + Q L ++ ++ R ++EN++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 129 YYVDGPLRVLAY----EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLE 184
+ + H L+ +L + LS RGL+
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----------LSNDHICYFLYQILRGLK 123
Query: 185 YLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA-PDAAARLHSTRVLGTFGYHA 243
Y+H ++HR++K SN+LL KI DF L+ A PD T + T Y A
Sbjct: 124 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 244 PEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVLTS 293
PE + + +KS D++S G +L E+L+ R Q + + +L S
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 231
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 133 bits (336), Expect = 6e-38
Identities = 47/229 (20%), Positives = 93/229 (40%), Gaps = 16/229 (6%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNEN 122
+ + IGEG+YG VY G A+KK+ K+ + + ++S++ LK+ N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+V+L VL +EH + + + G L + G
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---------LESVTAKSFLLQLLNG 112
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
+ Y H++ R++HR++K N+L+ + KI+DF L+ + ++ +
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRA 168
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVL 291
+ + S+ D++S G + E++ G Q + +L
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 133 bits (336), Expect = 1e-37
Identities = 55/227 (24%), Positives = 92/227 (40%), Gaps = 22/227 (9%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKN 120
+F +G GS+GRV+ R +GR A+K L + + M+S + +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
++ + G + D + ++ G L +L + A
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---------PNPVAKFYAAEVC 114
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
LEYLH K II+R++K N+LL + KI+DF + PD + + GT
Sbjct: 115 LALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPD 166
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
Y APE T + D +SFG+++ E+L G P + +
Sbjct: 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI 213
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 2e-37
Identities = 49/233 (21%), Positives = 92/233 (39%), Gaps = 27/233 (11%)
Query: 72 SLIGEGSYGRVYFGVLR--SGRAAAIKKLDSSKQPDQEFLAQV------SMVSRLKNENV 123
+ IGEG+YG+V+ GR A+K++ + L+ + + ++ NV
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 124 VELVGYYVDGPLR-----VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
V L L +EH + + P P + +
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK--------VPEPGVPTETIKDMMFQ 124
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGT 238
RGL++LH R++HR++K N+L+ K++DF L+ ++ T V+ T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVT 178
Query: 239 FGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVL 291
Y APE + ++ D++S G + E+ + + Q + V+
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 6e-37
Identities = 44/213 (20%), Positives = 88/213 (41%), Gaps = 16/213 (7%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNE 121
+NF IGEG+YG VY + +G A+KK+ + + + ++S++ L +
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 122 NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAAR 181
N+V+L+ L +E + + + +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--------IPLPLIKSYLFQLLQ 113
Query: 182 GLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
GL + H R++HR++K N+L+ + K++DF L+ +A R ++ V+ +
Sbjct: 114 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVVTLWYR 169
Query: 242 HAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
S+ D++S G + E++T R
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-36
Identities = 58/249 (23%), Positives = 93/249 (37%), Gaps = 24/249 (9%)
Query: 51 IAVPVISVDELKEKTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFL 109
+A P D +E ++ +IG GS+G VY L SG AIKK+ K+
Sbjct: 7 VATPGQGPDRPQE--VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKN 61
Query: 110 AQVSMVSRLKNENVVELVGYYV------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKP 163
++ ++ +L + N+V L ++ D L ++ + H +
Sbjct: 62 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA------ 115
Query: 164 GPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQ 222
L R L Y+H I HR+IK N+LL D + K+ DF + Q
Sbjct: 116 KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 223 APDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282
+ + + + +S DV+S G VL ELL G+
Sbjct: 173 LVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 230
Query: 283 QQSLVTWVL 291
Q + VL
Sbjct: 231 QLVEIIKVL 239
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 8e-36
Identities = 48/229 (20%), Positives = 94/229 (41%), Gaps = 22/229 (9%)
Query: 73 LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD------QEFLAQVSMVSRLKNENVVE 125
+GEG + VY + + + AIKK+ + + + L ++ ++ L + N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 126 LVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEY 185
L+ + L ++ I L+ + + +GLEY
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---------LTPSHIKAYMLMTLQGLEY 115
Query: 186 LHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE 245
LH+ I+HR++K +N+LL ++ + K++DF L+ T + T Y APE
Sbjct: 116 LHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPE 170
Query: 246 YAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVLTS 293
+M D+++ G +L ELL + Q + + L +
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT 219
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (321), Expect = 1e-35
Identities = 44/225 (19%), Positives = 80/225 (35%), Gaps = 23/225 (10%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYY- 130
IG GS+G +Y G + +G AIK + + + + ++ + + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+G V+ E + S + +A +EY+H K
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSRK---------FSLKTVLLLADQMISRIEYIHSK- 122
Query: 191 EPRIIHRNIKSSNVLLFDDD---IAKISDFDLSNQAPDAAARLH-----STRVLGTFGYH 242
IHR++K N L+ + I DF L+ + DA H + + GT Y
Sbjct: 123 --NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
+ + + S + D+ S G VL+ G P ++
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 127 bits (320), Expect = 1e-35
Identities = 40/231 (17%), Positives = 77/231 (33%), Gaps = 25/231 (10%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYY 130
IGEGS+G ++ G L + + AIK + + L + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 131 VDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA 190
+G VL + + G S A ++ +HEK
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLLD---------LCGRKFSVKTVAMAAKQMLARVQSIHEK- 120
Query: 191 EPRIIHRNIKSSNVLL-----FDDDIAKISDFDLSNQAPDAAARLH-----STRVLGTFG 240
+++R+IK N L+ + ++ + DF + D + H + GT
Sbjct: 121 --SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVL 291
Y + + + S + D+ + G V + L G P + +
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 9e-35
Identities = 44/217 (20%), Positives = 82/217 (37%), Gaps = 27/217 (12%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD-------QEFLAQVSMVSRLKN--EN 122
L+G G +G VY G+ + AIK ++ + D +V ++ ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 123 VVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
V+ L+ ++ VL E ++G L
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--------LQEELARSFFWQVLEA 122
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGY 241
+ + H ++HR+IK N+L+ + K+ DF D T GT Y
Sbjct: 123 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVY 175
Query: 242 HAPEYAMTGQMSSKS-DVYSFGVVLLELLTGRKPVDH 277
PE+ + +S V+S G++L +++ G P +H
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 1e-34
Identities = 45/226 (19%), Positives = 86/226 (38%), Gaps = 27/226 (11%)
Query: 60 ELKEKT--DNFG-TNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMV 115
++K+ D++ T+ ++G G G+V R+ A+K L + +E
Sbjct: 3 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL---HW 59
Query: 116 SRLKNENVVELVGYYVDGPLR----VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQ 171
+ ++V +V Y + ++ E G L + + + +
Sbjct: 60 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ-------DRGDQAFTERE 112
Query: 172 RVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL---FDDDIAKISDFDLSNQAPDAAA 228
+I ++YLH I HR++K N+L + I K++DF + + +
Sbjct: 113 ASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169
Query: 229 RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
T Y APE + D++S GV++ LL G P
Sbjct: 170 LTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 212
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-34
Identities = 48/214 (22%), Positives = 87/214 (40%), Gaps = 19/214 (8%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE----FLAQVSMVSRLKN 120
++F L+G+G++G+V +GR A+K L ++ + + ++ ++
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+ L + E+A+ G L L ++ + +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIV 115
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
LEYLH + +++R+IK N++L D KI+DF L + A + GT
Sbjct: 116 SALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPE 170
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
Y APE D + GVV+ E++ GR P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 1e-33
Identities = 50/221 (22%), Positives = 92/221 (41%), Gaps = 27/221 (12%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD-------QEFLAQVSMVSR 117
D + T +G G + V +G A K + + ++ +VS++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 118 LKNENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAV 177
+++ NV+ L Y + +L E + G L D L K+ L+ + +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------LTEEEATEFLK 120
Query: 178 GAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA----KISDFDLSNQAPDAAARLHST 233
G+ YLH +I H ++K N++L D ++ KI DF L+++
Sbjct: 121 QILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFK 174
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
+ GT + APE + ++D++S GV+ LL+G P
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 121 bits (304), Expect = 1e-32
Identities = 46/214 (21%), Positives = 82/214 (38%), Gaps = 22/214 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQE----FLAQVSMVSRLKN 120
D F +G GS+GRV SG A+K LD K + L + ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+V+L + D + E+ + G + L S A
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIV 151
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFG 240
EYLH +I+R++K N+L+ +++DF + + + + GT
Sbjct: 152 LTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPE 203
Query: 241 YHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
APE ++ + D ++ GV++ E+ G P
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 3e-32
Identities = 40/205 (19%), Positives = 80/205 (39%), Gaps = 17/205 (8%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
IGEG+YG V+ R + A+K++ + L ++ ++ LK++N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
L +E + + +GL + H +
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---------PEIVKSFLFQLLKGLGFCHSR 120
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT 249
++HR++K N+L+ + K+++F L+ +A R +S V+ +
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLA-RAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 250 GQMSSKSDVYSFGVVLLELLTGRKP 274
S+ D++S G + EL +P
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRP 201
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 3e-32
Identities = 47/225 (20%), Positives = 98/225 (43%), Gaps = 11/225 (4%)
Query: 74 IGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGY 129
IG+G++G V+ R +G+ A+KK+ + + L ++ ++ LK+ENVV L+
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEK 189
+ + H G+ + ++ ++ GL Y+H
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLYYIHR- 135
Query: 190 AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ--APDAAARLHSTRVLGTFGYHAPEYA 247
+I+HR++K++NVL+ D + K++DF L+ + T + T Y PE
Sbjct: 136 --NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193
Query: 248 MTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVL 291
+ + D++ G ++ E+ T + + Q +L++ +
Sbjct: 194 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 3e-31
Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 18/224 (8%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
+G G+YG V V R+G AIKKL Q + + ++ ++ +++ENV+ L+
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 129 YYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE 188
+ + GK L + + +GL Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----LGEDRIQFLVYQMLKGLRYIHA 139
Query: 189 KAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAM 248
IIHR++K N+ + +D KI DF L+ QA T + T Y APE +
Sbjct: 140 A---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVIL 191
Query: 249 TGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVL 291
+ D++S G ++ E++TG+ + Q + V
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (278), Expect = 6e-29
Identities = 37/213 (17%), Positives = 81/213 (38%), Gaps = 11/213 (5%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYV 131
+G G + V+ + + A+K + K + ++ ++ R+ + + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 132 DGPLRVLAY--EHASKGSLHDILHGKKGVKG-----AKPGPVLSWAQRVKIAVGAARGLE 184
+ L++L + G ++ G + +I+ GL+
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 185 YLHEKAEPRIIHRNIKSSNVLL-FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHA 243
Y+H + IIH +IK NVL+ D + +++ H T + T Y +
Sbjct: 140 YMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 244 PEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276
PE + +D++S ++ EL+TG +
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 109 bits (272), Expect = 3e-28
Identities = 37/218 (16%), Positives = 82/218 (37%), Gaps = 26/218 (11%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-N 120
D++ +G G Y V+ + + + +K L K+ ++ ++ ++ L+
Sbjct: 32 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGG 89
Query: 121 ENVVELVGYYVDGPLR--VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVG 178
N++ L D R L +EH + + L+
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------------LTDYDIRFYMYE 137
Query: 179 AARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLSNQAPDAAARLHSTRVLG 237
+ L+Y H I+HR++K NV++ + ++ D+ L+ +
Sbjct: 138 ILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVA 191
Query: 238 TFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKP 274
+ + PE + QM D++S G +L ++ ++P
Sbjct: 192 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 9e-28
Identities = 53/221 (23%), Positives = 91/221 (41%), Gaps = 26/221 (11%)
Query: 63 EKTDNFGTNSLIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRL 118
E + + S +G G+YG V ++G A+KKL Q + ++ ++ +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 119 KNENVVELVGYYVDGP-----LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRV 173
K+ENV+ L+ + V H L++I+ +K L+
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQ 124
Query: 174 KIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHST 233
+ RGL+Y+H IIHR++K SN+ + +D KI DF L+ D +
Sbjct: 125 FLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTG 177
Query: 234 RVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKP 274
V + + D++S G ++ ELLTGR
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 1e-27
Identities = 51/234 (21%), Positives = 93/234 (39%), Gaps = 25/234 (10%)
Query: 66 DNFGTNSLIGEGSYGRVYFGVL----RSGRAAAIKKLDSSKQPD-----QEFLAQVSMVS 116
+NF ++G G+YG+V+ +G+ A+K L + + + ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 117 RLKNE-NVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKI 175
++ +V L + L ++ + G L L ++ + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---------FTEHEVQIY 134
Query: 176 AVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRV 235
LE+LH+ II+R+IK N+LL + ++DF LS + A +
Sbjct: 135 VGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDF 190
Query: 236 LGTFGYHAPEYAMTGQM--SSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLV 287
GT Y AP+ G D +S GV++ ELLTG P + Q+ +
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 3e-26
Identities = 47/229 (20%), Positives = 82/229 (35%), Gaps = 28/229 (12%)
Query: 73 LIGEGSYGRVYFGV-LRSGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVG 128
IG G+ G V R AIKKL Q + ++ ++ + ++N++ L+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 129 YYV------DGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARG 182
+ + L E I + + G
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------------DHERMSYLLYQMLCG 131
Query: 183 LEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYH 242
+++LH IIHR++K SN+++ D KI DF L+ A T + T Y
Sbjct: 132 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 185
Query: 243 APEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWVL 291
APE + D++S G ++ E++ + Q + V L
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 66.3 bits (161), Expect = 1e-13
Identities = 26/160 (16%), Positives = 46/160 (28%), Gaps = 27/160 (16%)
Query: 72 SLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-----------QPDQEFLAQVSMVSRLKN 120
L+GEG V+ +K D F +R +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 121 ENVVELVGYYVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAA 180
+ +L G V P +A L D + ++
Sbjct: 66 RALQKLQGLAV--PKVYAWEGNAVLMELIDAKELYRVR----------VENPDEVLDMIL 113
Query: 181 RGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220
+ + + I+H ++ NVL+ ++ I I DF S
Sbjct: 114 EEVAKFYHR---GIVHGDLSQYNVLVSEEGI-WIIDFPQS 149
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 301 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.95 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.07 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.76 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.43 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.1 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.83 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.71 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-55 Score=369.42 Aligned_cols=204 Identities=30% Similarity=0.446 Sum_probs=179.1
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
.++|++++.||+|+||+||+|+++ +++.||||++..... ..+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 568999999999999999999987 799999999865432 23568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
||++|+|.+++..... +++..+..++.||+.||+|||++| |+||||||+|||+++++.+||+|||+|+
T Consensus 84 y~~gg~L~~~l~~~~~---------l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT 151 (271)
T ss_dssp CCTTEEGGGGSBTTTB---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccCCCcHHHHHhcCCC---------CCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhhe
Confidence 9999999999975442 899999999999999999999999 9999999999999999999999999998
Q ss_pred CCCccccccccccccccccccCccccccCCC-CccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
..............+||+.|+|||++.+..+ +.++|||||||++|+|++|++||.....
T Consensus 152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~ 211 (271)
T d1nvra_ 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211 (271)
T ss_dssp ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence 7654443333356689999999999988776 5789999999999999999999976543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-54 Score=365.40 Aligned_cols=200 Identities=26% Similarity=0.448 Sum_probs=180.2
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC-CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
++|++++.||+|+||+||+|+++ +|+.||||++.... ...+.+.+|+.+++.++||||+++++++.+++..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999986 79999999986543 33467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
+||+|.+++.... +++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+..
T Consensus 100 ~gg~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 100 AGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (293)
T ss_dssp TTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCCcHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheee
Confidence 9999999987643 899999999999999999999999 999999999999999999999999999876
Q ss_pred CccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
...... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 167 ~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 221 (293)
T d1yhwa1 167 TPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (293)
T ss_dssp CSTTCC--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred cccccc--ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH
Confidence 443221 2456799999999999999999999999999999999999999976554
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-54 Score=361.22 Aligned_cols=200 Identities=29% Similarity=0.447 Sum_probs=180.3
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
.++|++++.||+|+||+||+|+++ +++.||+|++.+. ......+.+|+++++.++||||+++++++.+++..++|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 467999999999999999999987 7899999998632 23346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
||||++|+|.+++..... +++..+..++.||+.||+|||++| |+||||||+|||+++++.+||+|||+
T Consensus 85 mEy~~~g~L~~~l~~~~~---------l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~ 152 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSK---------FDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGW 152 (263)
T ss_dssp EECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred EeecCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccce
Confidence 999999999999976432 899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|........ ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 153 a~~~~~~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 209 (263)
T d2j4za1 153 SVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 209 (263)
T ss_dssp CSCCCCCCC----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred eeecCCCcc----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH
Confidence 977654322 445799999999999999999999999999999999999999987654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-54 Score=365.53 Aligned_cols=203 Identities=24% Similarity=0.362 Sum_probs=177.8
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
++|++++.||+|+||+||+|+++ +++.||||++.+. ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999987 7999999998642 233467899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccC
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLS 220 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a 220 (301)
|||+||+|.+++..... +++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|
T Consensus 88 Ey~~gg~L~~~~~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a 155 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS---------FDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTA 155 (288)
T ss_dssp CCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EccCCCCHHHhhhccCC---------CCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccc
Confidence 99999999999876542 899999999999999999999999 999999999999999999999999999
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+..............+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.++
T Consensus 156 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 215 (288)
T d1uu3a_ 156 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 215 (288)
T ss_dssp EECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH
Confidence 876544333333556899999999999999999999999999999999999999987554
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=369.68 Aligned_cols=201 Identities=27% Similarity=0.423 Sum_probs=178.0
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC--chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ--PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
+.++|++++.||+|+||+||+|+++ +|+.||+|+++.... ....+.+|+.+|+.++||||+++++++.+.+.+++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4578999999999999999999987 789999999875432 3467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
||++||+|.+++.+... +++..+..++.|++.||.|||+ ++ |+||||||+|||++++|++||+|||+
T Consensus 84 Ey~~gg~L~~~l~~~~~---------l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGl 151 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGV 151 (322)
T ss_dssp ECCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred EcCCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCC
Confidence 99999999999976432 8999999999999999999997 48 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|....... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.
T Consensus 152 a~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 152 SGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp CHHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred ccccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 87543321 2456899999999999999999999999999999999999999976543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-53 Score=359.85 Aligned_cols=202 Identities=24% Similarity=0.414 Sum_probs=177.7
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
+.|++++.||+|+||+||+|+++ +++.||+|++..... ..+.+.+|+++|++++||||+++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999987 799999999875433 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
++|+|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|...
T Consensus 92 ~~g~L~~~~~~~~~--------~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 92 AGGAVDAVMLELER--------PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp TTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhcc
Confidence 99999999764322 2899999999999999999999999 999999999999999999999999998765
Q ss_pred CccccccccccccccccccCccccc-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAM-----TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
...... .....||+.|+|||++. +..|+.++|||||||++|+|++|++||.+.++
T Consensus 161 ~~~~~~--~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~ 220 (288)
T d2jfla1 161 TRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220 (288)
T ss_dssp HHHHHH--HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred CCCccc--ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH
Confidence 443222 24567999999999884 45678999999999999999999999987654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=358.88 Aligned_cols=209 Identities=23% Similarity=0.343 Sum_probs=167.3
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch---HHHHHHHHHHhccCCCceeeeeeEEEc--CCeeEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVD--GPLRVL 138 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 138 (301)
.++|++++.||+|+||+||+|+++ +|+.||+|++....... +.+.+|++++++++||||+++++++.+ ++.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 468999999999999999999987 79999999997655433 457899999999999999999999865 456899
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCC--CCeEecCCCCCceEEcCCCceEEec
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAE--PRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~--~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
|||||++|+|.+++...... ...+++..++.++.||+.||+|||+.+. .+|+||||||+|||++.++.+||+|
T Consensus 83 vmEy~~~g~L~~~i~~~~~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D 157 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 157 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred EEecCCCCcHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence 99999999999998642211 1138999999999999999999998641 2499999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
||+|+........ .....||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+.
T Consensus 158 FG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~ 219 (269)
T d2java1 158 FGLARILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 219 (269)
T ss_dssp HHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccceeecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH
Confidence 9999776543222 2456799999999999999999999999999999999999999987554
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=363.42 Aligned_cols=202 Identities=24% Similarity=0.347 Sum_probs=181.9
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
.++|++++.||+|+||+||+|+++ +++.||+|++++. ......+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 468999999999999999999987 7999999998643 23346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
||||+||+|.+++..... +++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 84 ~ey~~gg~L~~~~~~~~~---------~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~ 151 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp EECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred eeccCCCchhhhhhcccC---------CcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccc
Confidence 999999999999986543 899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|+........ ....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+.
T Consensus 152 a~~~~~~~~~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~ 210 (337)
T d1o6la_ 152 CKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp CBCSCCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccccCCcc--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH
Confidence 9876443222 2456899999999999999999999999999999999999999987654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.9e-53 Score=361.07 Aligned_cols=202 Identities=25% Similarity=0.395 Sum_probs=164.3
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEE
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAY 140 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 140 (301)
..+.|++.+.||+|+||+||+|+++ +++.||||++.+.... ...+.+|+.+|+.++||||+++++++.+++.+|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3467999999999999999999987 7899999998754322 345788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEc---CCCceEEecc
Q 022206 141 EHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF---DDDIAKISDF 217 (301)
Q Consensus 141 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~vkl~Df 217 (301)
|||+||+|.+++..... +++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+||
T Consensus 87 E~~~gg~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DF 154 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGF---------YTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDF 154 (307)
T ss_dssp CCCCSCBHHHHHHTCSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred eccCCCcHHHhhhcccC---------CCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEecc
Confidence 99999999999976542 899999999999999999999999 99999999999995 4789999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|+|+........ ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus 155 G~a~~~~~~~~~---~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 214 (307)
T d1a06a_ 155 GLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 214 (307)
T ss_dssp ---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ceeEEccCCCee---eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH
Confidence 999766443322 456799999999999999999999999999999999999999976543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-52 Score=351.50 Aligned_cols=203 Identities=32% Similarity=0.499 Sum_probs=169.6
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCC---CchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK---QPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
.++|++.+.||+|+||+||+|+++ ..||||+++... ...+.+.+|+.++++++||||+++++++. ++.+++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 478999999999999999999865 469999987543 23467889999999999999999999865 456899999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
||++|+|.+++..... .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 84 y~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIET--------KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLAT 152 (276)
T ss_dssp CCCEEEHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred cCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEcccccee
Confidence 9999999999975432 2899999999999999999999999 9999999999999999999999999998
Q ss_pred CCCccccccccccccccccccCcccccc---CCCCccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
...............||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+.++.
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~ 215 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH
Confidence 7654443333355679999999999864 35789999999999999999999999876553
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.2e-52 Score=358.66 Aligned_cols=199 Identities=28% Similarity=0.407 Sum_probs=180.0
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
.++|++++.||+|+||+||+|+++ +|+.||||++.+. ....+.+.+|+.++++++||||+++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 467999999999999999999987 7999999998642 23346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
||||+||+|..++..... +++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 83 mE~~~gg~l~~~~~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~ 150 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQR---------FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGF 150 (316)
T ss_dssp ECCCCSCBHHHHHHHTSS---------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eeecCCcccccccccccc---------ccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCcc
Confidence 999999999999986653 788899999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|+...... ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 151 a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 206 (316)
T d1fota_ 151 AKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 206 (316)
T ss_dssp CEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ceEecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH
Confidence 97765432 456899999999999999999999999999999999999999987554
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-52 Score=349.24 Aligned_cols=203 Identities=26% Similarity=0.471 Sum_probs=171.7
Q ss_pred CCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
++|++.+.||+|+||.||+|++++++.||||+++......+++.+|++++++++||||+++++++.+++..++||||+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 57899999999999999999998888999999988777788899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
|+|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 85 g~L~~~l~~~~~--------~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 85 GCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp CBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred CcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccC
Confidence 999999876542 2889999999999999999999999 99999999999999999999999999977654
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
.... ......||+.|+|||++.+..++.++|||||||++|||+| |.+||...+.
T Consensus 154 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~ 208 (263)
T d1sm2a_ 154 DQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 208 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH
T ss_pred CCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH
Confidence 3322 1234568999999999999999999999999999999999 5677765443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.5e-52 Score=360.51 Aligned_cols=202 Identities=23% Similarity=0.352 Sum_probs=179.6
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
.++|++++.||+|+||.||+|+++ +|+.||||++...... .+.+.+|+.+|++++||||+++++++.+++.+++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999987 7999999999765433 35688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC--CCceEEeccccC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD--DDIAKISDFDLS 220 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~--~~~vkl~Dfg~a 220 (301)
|+||+|.+++..... .+++..+..++.||+.||+|||++| |+||||||+|||++. ++.+||+|||+|
T Consensus 105 ~~gg~L~~~l~~~~~--------~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a 173 (350)
T d1koaa2 105 MSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT 173 (350)
T ss_dssp CCSCBHHHHHTCTTS--------CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred CCCCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchh
Confidence 999999999965432 2899999999999999999999999 999999999999964 578999999999
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+........ ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 174 ~~~~~~~~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 230 (350)
T d1koaa2 174 AHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 230 (350)
T ss_dssp EECCTTSCE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eeccccccc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH
Confidence 776543322 456799999999999999999999999999999999999999986554
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-51 Score=360.06 Aligned_cols=202 Identities=24% Similarity=0.323 Sum_probs=179.7
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc-hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
.++|++++.||+|+||+||+|+++ +|+.||||++...... ...+.+|+.+|++++||||+++++++.+++.+|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 467999999999999999999987 7999999998765432 35678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEc--CCCceEEeccccC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF--DDDIAKISDFDLS 220 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~~vkl~Dfg~a 220 (301)
|+||+|.+++..... .+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+|
T Consensus 108 ~~gg~L~~~~~~~~~--------~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 108 LSGGELFDRIAAEDY--------KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp CCCCBHHHHTTCTTC--------CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred CCCChHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccc
Confidence 999999998765432 2899999999999999999999999 99999999999998 5789999999999
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
......... ....||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+.
T Consensus 177 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 233 (352)
T d1koba_ 177 TKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 233 (352)
T ss_dssp EECCTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred eecCCCCce---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 876543322 445789999999999999999999999999999999999999987654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-52 Score=354.73 Aligned_cols=202 Identities=27% Similarity=0.404 Sum_probs=179.1
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 143 (301)
.++|++.+.||+|+||+||+|+++ +++.||||+++.+....+++.+|+++|++++||||+++++++.+++..++|||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 467899999999999999999987 6889999999887777788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
++|+|.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+..
T Consensus 96 ~~g~l~~~l~~~~~-------~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 96 TYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp TTCBHHHHHHHSCT-------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred cCcchHHHhhhccc-------cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeec
Confidence 99999999975432 23899999999999999999999999 999999999999999999999999999876
Q ss_pred CccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCC
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
...... ......|++.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 166 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~ 218 (287)
T d1opja_ 166 TGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 218 (287)
T ss_dssp CSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 543322 12334588999999999999999999999999999999996665543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-51 Score=352.58 Aligned_cols=196 Identities=30% Similarity=0.466 Sum_probs=174.2
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch----HHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD----QEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
.|+.++.||+|+||+||+|++. +++.||||++....... +.+.+|+.+|++++||||+++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4999999999999999999987 78999999997654432 457899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
||.+|+|..++..... +++..++.++.||+.||.|||++| |+||||||+|||+++++.+||+|||+|.
T Consensus 96 ~~~~g~l~~~~~~~~~---------l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~ 163 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKP---------LQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS 163 (309)
T ss_dssp CCSEEHHHHHHHHTSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred ecCCCchHHHHHhCCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeeccccc
Confidence 9999999877654432 899999999999999999999999 9999999999999999999999999997
Q ss_pred CCCccccccccccccccccccCcccccc---CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMT---GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
..... ....||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+.
T Consensus 164 ~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~ 219 (309)
T d1u5ra_ 164 IMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (309)
T ss_dssp SSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH
Confidence 65432 34579999999999864 4588999999999999999999999976554
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=342.21 Aligned_cols=204 Identities=25% Similarity=0.430 Sum_probs=184.5
Q ss_pred CCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
++|++.+.||+|+||+||+|++++++.||||+++......+++.+|+.++++++||||+++++++.+++.+++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 68999999999999999999999888999999988877888999999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
|+|.+++..... .+++..++.++.|++.||+|||+.| |+||||||+|||+++++.+||+|||+++....
T Consensus 84 g~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 84 GCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EEHHHHHHSGGG--------CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred CcHHHhhhcccc--------CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccC
Confidence 999999765543 2888999999999999999999999 99999999999999999999999999976654
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCc
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~ 281 (301)
.... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..
T Consensus 153 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~ 208 (258)
T d1k2pa_ 153 DEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208 (258)
T ss_dssp SSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH
T ss_pred CCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH
Confidence 3322 2234568999999999999999999999999999999998 89999877654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=349.44 Aligned_cols=201 Identities=25% Similarity=0.381 Sum_probs=178.8
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC-------chHHHHHHHHHHhccCCCceeeeeeEEEcCCee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ-------PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 136 (301)
.++|++++.||+|+||+||+|+++ +|+.||||++.+... ..+.+.+|+.+|++++||||+++++++.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999987 799999999864322 246789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC----ce
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD----IA 212 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~v 212 (301)
++|||||++|+|.+++..... +++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~---------l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~v 156 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKES---------LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRI 156 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCE
T ss_pred EEEEEcCCCccccchhccccc---------cchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccce
Confidence 999999999999999976432 899999999999999999999999 99999999999998776 59
Q ss_pred EEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
||+|||+|......... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 157 kl~DfG~a~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 221 (293)
T d1jksa_ 157 KIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 221 (293)
T ss_dssp EECCCTTCEECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EecchhhhhhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH
Confidence 99999999776543322 455789999999999999999999999999999999999999987654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-51 Score=359.00 Aligned_cols=199 Identities=23% Similarity=0.325 Sum_probs=179.9
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
.++|++++.||+|+||+||+|+++ +|+.||||++.+. ....+.+.+|+++|+.++||||+++++++.+....++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 368999999999999999999987 7999999998642 23346688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+.+|+|.+++..... +++..++.++.||+.||.|||+++ ||||||||+|||++.+|.+||+|||+
T Consensus 120 ~e~~~~g~l~~~l~~~~~---------l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp EECCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccccccchhhhHhhcCC---------CCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeecee
Confidence 999999999999976542 899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|+...... ....||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.++
T Consensus 188 a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 243 (350)
T d1rdqe_ 188 AKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243 (350)
T ss_dssp CEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eeeccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH
Confidence 98765432 456799999999999999999999999999999999999999987654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=343.82 Aligned_cols=198 Identities=27% Similarity=0.404 Sum_probs=169.2
Q ss_pred CCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEc----CCeeEEE
Q 022206 68 FGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVD----GPLRVLA 139 (301)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv 139 (301)
|++.+.||+|+||+||+|+++ ++..||+|++...... .+.+.+|+++|++++||||+++++++.+ +..+++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 367778999999999999987 7899999998654322 3568899999999999999999999864 4568999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEc-CCCceEEeccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLF-DDDIAKISDFD 218 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~Dfg 218 (301)
|||+++|+|.+++..... +++..+..++.||+.||+|||+++ ++|+||||||+|||++ +++.+||+|||
T Consensus 91 mE~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFG 160 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLG 160 (270)
T ss_dssp EECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EeCCCCCcHHHHHhcccc---------ccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecC
Confidence 999999999999976432 899999999999999999999975 3499999999999997 47899999999
Q ss_pred cCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+|+...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..+
T Consensus 161 la~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~ 217 (270)
T d1t4ha_ 161 LATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN 217 (270)
T ss_dssp GGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred cceeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc
Confidence 997543322 245679999999998865 599999999999999999999999976543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=345.38 Aligned_cols=203 Identities=27% Similarity=0.448 Sum_probs=177.0
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHAS 144 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 144 (301)
.++|++.+.||+|+||.||+|+++++..||||+++......+.+.+|++++++++||||+++++++.+ +..++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 35789999999999999999999988899999998877777889999999999999999999998754 56799999999
Q ss_pred CCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCC
Q 022206 145 KGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAP 224 (301)
Q Consensus 145 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~ 224 (301)
+|+|.+++...... .+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 91 ~g~L~~~~~~~~~~-------~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 91 NGSLVDFLKTPSGI-------KLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp TCBHHHHTTSHHHH-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCcHHHHHhhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEcc
Confidence 99999988654321 2899999999999999999999999 9999999999999999999999999998765
Q ss_pred ccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhC-CCCCCCCC
Q 022206 225 DAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG-RKPVDHTL 279 (301)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g-~~pf~~~~ 279 (301)
..... ......||+.|+|||++.+..++.++|||||||++|||+|| .+||...+
T Consensus 161 ~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~ 215 (272)
T d1qpca_ 161 DNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (272)
T ss_dssp SSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CCccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC
Confidence 43322 22345689999999999989999999999999999999995 55555443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-51 Score=350.74 Aligned_cols=203 Identities=19% Similarity=0.240 Sum_probs=181.5
Q ss_pred hhCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
..++|++++.||+|+||+||+|.++ +++.||+|+++........+.+|+++|+.++||||+++++++.+++.+|+||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 3578999999999999999999987 789999999987766666788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC--CceEEeccccC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD--DIAKISDFDLS 220 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~--~~vkl~Dfg~a 220 (301)
|+||+|.+++..... .+++.+++.++.||+.||+|||++| |+||||||+|||++.+ ..+||+|||++
T Consensus 83 ~~gg~L~~~i~~~~~--------~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 83 ISGLDIFERINTSAF--------ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp CCCCBHHHHHTSSSC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred CCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchh
Confidence 999999999976532 2899999999999999999999999 9999999999999854 48999999999
Q ss_pred CCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
......... ....+|+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 152 ~~~~~~~~~---~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~ 208 (321)
T d1tkia_ 152 RQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp EECCTTCEE---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred hccccCCcc---cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH
Confidence 776543322 445789999999999999999999999999999999999999987654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-50 Score=346.86 Aligned_cols=205 Identities=28% Similarity=0.468 Sum_probs=166.0
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCC---EEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGR---AAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
++|++.+.||+|+||+||+|+++ +++ .||||.+...... .+.+.+|+++|++++|||||++++++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 56888999999999999999986 333 5889988654433 35689999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
||||++|+|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++++||+|||+
T Consensus 106 ~Ey~~~g~L~~~~~~~~~--------~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL 174 (299)
T ss_dssp EECCTTEEHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EEecCCCcceeeeccccC--------CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCccc
Confidence 999999999998876542 2899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccc---cccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCc
Q 022206 220 SNQAPDAAARLH---STRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (301)
Q Consensus 220 a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~ 281 (301)
++.......... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.++.
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred ceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence 987654332211 122357899999999999999999999999999999998 89999876553
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=348.88 Aligned_cols=202 Identities=24% Similarity=0.390 Sum_probs=177.7
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCC----CCchHHHHHHHHHHh-ccCCCceeeeeeEEEcCCeeEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSS----KQPDQEFLAQVSMVS-RLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
++|++++.||+|+||+||+|+++ +++.||||++.+. ......+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999987 7999999998642 223345666766654 68999999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+++|+|.+++..... +++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 82 mEy~~~g~L~~~i~~~~~---------~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~ 149 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM 149 (320)
T ss_dssp EECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EeecCCCcHHHHhhccCC---------CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccch
Confidence 999999999999976543 889999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.++.
T Consensus 150 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~ 209 (320)
T d1xjda_ 150 CKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 209 (320)
T ss_dssp CBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hhhccccccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH
Confidence 9866543322 24567999999999999999999999999999999999999999876653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1e-50 Score=355.62 Aligned_cols=203 Identities=27% Similarity=0.377 Sum_probs=175.0
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCC----CchHHHHH---HHHHHhccCCCceeeeeeEEEcCCee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSK----QPDQEFLA---QVSMVSRLKNENVVELVGYYVDGPLR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~~ 136 (301)
.++|++++.||+|+||.||+|+++ +|+.||||++.+.. .....+.+ ++.+++.++||||+++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 478999999999999999999987 79999999986422 11223333 46677788899999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
|+|||||+||+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~---------~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~D 150 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGV---------FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISD 150 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECC
T ss_pred EEEEEecCCCcHHHHHHhccc---------ccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEee
Confidence 999999999999999976542 889999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCcCc
Q 022206 217 FDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQ 283 (301)
Q Consensus 217 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~ 283 (301)
||+|+...... .....||+.|+|||++.. ..++.++|||||||++|+|+||+.||.+......
T Consensus 151 FGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 214 (364)
T d1omwa3 151 LGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 214 (364)
T ss_dssp CTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH
T ss_pred eceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99997665432 245579999999999864 5689999999999999999999999987655443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=349.04 Aligned_cols=213 Identities=25% Similarity=0.412 Sum_probs=177.2
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CC-----CEEEEEEcCCC--CCchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SG-----RAAAIKKLDSS--KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~-----~~vavK~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 135 (301)
.++|++.+.||+|+||+||+|++. .+ ..||+|.+... ......+.+|+.+++++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 367999999999999999999975 22 36999988643 23346788999999998 89999999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCC--------------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCC
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKG--------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKS 201 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~--------------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp 201 (301)
.++|||||++|+|.+++........ ......+++..++.++.|++.||+|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999976542110 111234889999999999999999999999 99999999
Q ss_pred CceEEcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 202 SNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 202 ~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
+|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |++||.+...
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987655443333345568999999999999999999999999999999998 8999987654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=341.00 Aligned_cols=204 Identities=31% Similarity=0.477 Sum_probs=174.1
Q ss_pred CCCCCCce-ecccCceEEEEEEEC---CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 66 DNFGTNSL-IGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 66 ~~y~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
++|.+.+. ||+|+||+||+|.++ ++..||||+++..... .+.+.+|+++|++++||||+++++++.+ +.+++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45667774 999999999999875 3557999999765433 3578999999999999999999999875 457999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
||||++|+|.+++..... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 87 mE~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp EECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTT
T ss_pred EEeCCCCcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchh
Confidence 999999999999865432 2899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCc
Q 022206 220 SNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (301)
Q Consensus 220 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~ 281 (301)
++........ .......||+.|+|||++....++.++|||||||++|||+| |+.||.+.+..
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~ 219 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 219 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH
Confidence 9876543322 22234568999999999999999999999999999999998 99999876543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.4e-50 Score=338.52 Aligned_cols=201 Identities=27% Similarity=0.393 Sum_probs=177.2
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----------hHHHHHHHHHHhccC-CCceeeeeeEEEc
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----------DQEFLAQVSMVSRLK-NENVVELVGYYVD 132 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----------~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 132 (301)
.++|++.+.||+|+||+||+|+++ +++.||||++.+.... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 468999999999999999999986 7999999998754322 135788999999997 9999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCce
Q 022206 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (301)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (301)
++..|+|||||++|+|.+++..... +++..+..++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~ 149 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNI 149 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCe
Confidence 9999999999999999999975432 899999999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCccccccccccccccccccCcccccc------CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMT------GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
||+|||++......... ....||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.++
T Consensus 150 kl~DFG~a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~ 220 (277)
T d1phka_ 150 KLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 220 (277)
T ss_dssp EECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEccchheeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH
Confidence 99999999876543322 45679999999998853 3468899999999999999999999987654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.7e-50 Score=339.27 Aligned_cols=204 Identities=25% Similarity=0.414 Sum_probs=170.3
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc----hHHHHHHHHHHhccCCCceeeeeeEEEcCC----e
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP----DQEFLAQVSMVSRLKNENVVELVGYYVDGP----L 135 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~ 135 (301)
.++|++.+.||+|+||+||+|++. +++.||||++...... ...+.+|+++++.++||||+++++++.+.+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999986 7999999999765433 245789999999999999999999987643 4
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
.|+||||++|++|.+++..... +++..++.++.||+.||+|||++| |+||||||+|||++.++.++|+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~---------l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~ 153 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGP---------MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVM 153 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEEC
T ss_pred EEEEEECCCCCEehhhhcccCC---------CCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceee
Confidence 7899999999999998876542 899999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCcccc-ccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAA-RLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 216 Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|||.+........ .......+||+.|+|||++.+..++.++|||||||++|+|+||++||.+.++
T Consensus 154 d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 219 (277)
T d1o6ya_ 154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 219 (277)
T ss_dssp CCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred hhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH
Confidence 9998865433221 1223456799999999999999999999999999999999999999987554
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-50 Score=346.12 Aligned_cols=199 Identities=23% Similarity=0.339 Sum_probs=172.1
Q ss_pred hCCCCCCc-eecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhc-cCCCceeeeeeEEEc----CCeeE
Q 022206 65 TDNFGTNS-LIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSR-LKNENVVELVGYYVD----GPLRV 137 (301)
Q Consensus 65 ~~~y~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~----~~~~~ 137 (301)
.++|++.+ .||+|+||+||+|++. +++.||||+++. ...+.+|+.++.+ ++||||+++++++.+ +..+|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 46898875 6999999999999986 799999999864 3567789988655 589999999999875 46789
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC---CCceEE
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKI 214 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~vkl 214 (301)
+|||||+||+|.+++..... ..+++..+..++.||+.||+|||++| |+||||||+|||+++ ++.+||
T Consensus 86 ivmEy~~gg~L~~~i~~~~~-------~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl 155 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKL 155 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSC-------CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEE
T ss_pred EEEECCCCCcHHHHHHhcCC-------CCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccc
Confidence 99999999999999976432 13899999999999999999999999 999999999999985 567999
Q ss_pred eccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+|||+|+........ ....||+.|+|||++.+..|+.++|||||||++|+|+||++||.+.+.
T Consensus 156 ~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~ 218 (335)
T d2ozaa1 156 TDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 218 (335)
T ss_dssp CCCTTCEECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC
T ss_pred cccceeeeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH
Confidence 999999766543322 456799999999999999999999999999999999999999976654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-50 Score=337.36 Aligned_cols=197 Identities=29% Similarity=0.433 Sum_probs=166.1
Q ss_pred ceecccCceEEEEEEEC---CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 72 SLIGEGSYGRVYFGVLR---SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 72 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
+.||+|+||+||+|.++ +++.||||+++..... .+.+.+|+++|++++||||+++++++.++ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 46999999999999864 3568999998654322 35689999999999999999999998654 57899999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
|+|.+++..... +++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 92 g~L~~~l~~~~~---------l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 92 GPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp EEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CcHHHHHhhccC---------CCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccc
Confidence 999999976542 899999999999999999999999 99999999999999999999999999976544
Q ss_pred cccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCc
Q 022206 226 AAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (301)
Q Consensus 226 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~ 281 (301)
.... .......||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+..
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~ 217 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 217 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH
Confidence 3222 12234568999999999999999999999999999999998 99999876543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=336.06 Aligned_cols=202 Identities=29% Similarity=0.497 Sum_probs=170.6
Q ss_pred CCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEecCCC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEHASK 145 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 145 (301)
++|++.+.||+|+||.||+|+++++..||||+++......+.+.+|+.++++++|+|||++++++.+ +..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 5799999999999999999999988889999998877777889999999999999999999999854 567899999999
Q ss_pred CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCCCc
Q 022206 146 GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQAPD 225 (301)
Q Consensus 146 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~~~ 225 (301)
|+|..++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 96 g~l~~~~~~~~~-------~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 96 GSLLDFLKGETG-------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CBHHHHHSHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred Cchhhhhhhccc-------ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccC
Confidence 999999875432 12899999999999999999999999 99999999999999999999999999987654
Q ss_pred cccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCC-CCCCCC
Q 022206 226 AAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRK-PVDHTL 279 (301)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~-pf~~~~ 279 (301)
.... ......||+.|+|||++....++.++|||||||++|||++|.. ||....
T Consensus 166 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~ 219 (285)
T d1fmka3 166 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 219 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC
Confidence 3322 1234568999999999999999999999999999999999654 454433
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=337.80 Aligned_cols=197 Identities=23% Similarity=0.350 Sum_probs=167.7
Q ss_pred CCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc------hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 70 TNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP------DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
.+++||+|+||+||+|+++ +|+.||||+++..... ...+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4678999999999999987 7999999998754332 24588999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+.++++..+..... .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|..
T Consensus 82 ~~~~~~~~~~~~~~---------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~ 149 (299)
T d1ua2a_ 82 METDLEVIIKDNSL---------VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 149 (299)
T ss_dssp CSEEHHHHHTTCCS---------SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred hcchHHhhhhhccc---------CCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccc
Confidence 99987776665433 2788899999999999999999999 99999999999999999999999999977
Q ss_pred CCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
....... ....+||+.|+|||++.. ..++.++|||||||++|+|++|.+||.+.++
T Consensus 150 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~ 206 (299)
T d1ua2a_ 150 FGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 206 (299)
T ss_dssp TTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH
Confidence 6543322 234579999999998865 4679999999999999999999999987554
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-49 Score=339.54 Aligned_cols=206 Identities=26% Similarity=0.436 Sum_probs=171.0
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCC----EEEEEEcCCC--CCchHHHHHHHHHHhccCCCceeeeeeEEEcCCeeE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGR----AAAIKKLDSS--KQPDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRV 137 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 137 (301)
..+|++++.||+|+||+||+|++. +|+ +||+|++... ....+.+.+|+.++++++||||+++++++.++ ..+
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 357999999999999999999976 444 5889988643 33456799999999999999999999999875 467
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
+++|++.+|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DF 155 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF 155 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSS--------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCC
T ss_pred EEEEeccCCccccccccccc--------CCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeecc
Confidence 78899999999998876543 2899999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCcC
Q 022206 218 DLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPRG 282 (301)
Q Consensus 218 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~~ 282 (301)
|+|+...............||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+...
T Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~ 221 (317)
T d1xkka_ 156 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221 (317)
T ss_dssp SHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG
T ss_pred ccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH
Confidence 99977654433333344568999999999999999999999999999999998 899998765543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=331.48 Aligned_cols=200 Identities=28% Similarity=0.443 Sum_probs=164.5
Q ss_pred CCCCCCceecccCceEEEEEEECC-C----CEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRS-G----RAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~-~----~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 138 (301)
+.|++.++||+|+||.||+|.++. + ..||||++...... ...+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 468889999999999999999763 2 36999998755443 2468899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccc
Q 022206 139 AYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFD 218 (301)
Q Consensus 139 v~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg 218 (301)
+|||+.+++|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 87 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG 155 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG 155 (283)
T ss_dssp EEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred EEEecccCcchhhhhcccc--------cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccc
Confidence 9999999999998865542 2899999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCCccccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCC
Q 022206 219 LSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVD 276 (301)
Q Consensus 219 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~ 276 (301)
+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~ 214 (283)
T d1mqba_ 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 214 (283)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcc
Confidence 99876543322 12234468999999999999999999999999999999999655543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=333.84 Aligned_cols=201 Identities=23% Similarity=0.385 Sum_probs=170.2
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
++|++++.||+|+||+||+|++. +++.||||++..... ....+.+|+++|++++||||+++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999986 799999999965432 24678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
|+.++ +.+++..... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 82 ~~~~~-~~~~~~~~~~-------~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~ 150 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASAL-------TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150 (298)
T ss_dssp CCSEE-HHHHHHHTTT-------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHH
T ss_pred ecCCc-hhhhhhhhcc-------cCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcce
Confidence 99874 4444433221 12899999999999999999999999 9999999999999999999999999986
Q ss_pred CCCccccccccccccccccccCccccccCC-CCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
....... ......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+
T Consensus 151 ~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~ 207 (298)
T d1gz8a_ 151 AFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207 (298)
T ss_dssp HHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence 5543222 124457999999999877665 4789999999999999999999997654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=328.31 Aligned_cols=203 Identities=28% Similarity=0.417 Sum_probs=164.3
Q ss_pred CCCCCCceecccCceEEEEEEECC----CCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 139 (301)
++|++.+.||+|+||.||+|++.. +..||||.+...... ...+.+|++++++++||||+++++++. ++..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 579999999999999999999752 356889988654433 356889999999999999999999985 5678999
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDL 219 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~ 219 (301)
|||+++|+|.+++..... .+++..++.++.||+.||.|||+++ ++||||||+||++++++.+||+|||+
T Consensus 86 ~E~~~~g~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp EECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---
T ss_pred EEeccCCcHHhhhhccCC--------CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchh
Confidence 999999999998765432 2899999999999999999999999 99999999999999999999999999
Q ss_pred CCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCc
Q 022206 220 SNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (301)
Q Consensus 220 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~ 281 (301)
|+........ ......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.++.
T Consensus 155 a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~ 216 (273)
T d1mp8a_ 155 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 216 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred heeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH
Confidence 9876543222 2244568999999999999999999999999999999998 89999876654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-49 Score=331.82 Aligned_cols=198 Identities=22% Similarity=0.377 Sum_probs=170.3
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc-------hHHHHHHHHHHhccC--CCceeeeeeEEEcCC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP-------DQEFLAQVSMVSRLK--NENVVELVGYYVDGP 134 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~ 134 (301)
.++|++.+.||+|+||+||+|++. +++.||||++.+.... ...+.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 468999999999999999999987 7999999998643221 133668999999986 899999999999999
Q ss_pred eeEEEEecCCC-CCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC-CCce
Q 022206 135 LRVLAYEHASK-GSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-DDIA 212 (301)
Q Consensus 135 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~v 212 (301)
..++||||+.+ +++.+++..... +++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~---------l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~v 150 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 150 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEE
T ss_pred eEEEEEEeccCcchHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeE
Confidence 99999999976 688888765432 899999999999999999999999 999999999999985 5799
Q ss_pred EEeccccCCCCCccccccccccccccccccCccccccCCC-CccccchhhHHHHHHHHhCCCCCCCC
Q 022206 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQM-SSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
||+|||+|....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.
T Consensus 151 kl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 151 KLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp EECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred EECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 999999997654332 245679999999999987765 56789999999999999999999764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-48 Score=331.58 Aligned_cols=215 Identities=26% Similarity=0.397 Sum_probs=178.8
Q ss_pred hhCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCCe
Q 022206 64 KTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGPL 135 (301)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 135 (301)
..++|++++.||+|+||+||+|+++ +++.||||+++..... ..++.+|++++++++||||+++++++.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 3568999999999999999999964 3578999999765443 3568999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCC
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKG---------------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIK 200 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~---------------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlk 200 (301)
.+++|||+++|+|.+++........ ......+++..++.++.|++.||+|||+++ +||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 9999999999999999964332110 111234889999999999999999999999 9999999
Q ss_pred CCceEEcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCC-CCCCCCC
Q 022206 201 SSNVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR-KPVDHTL 279 (301)
Q Consensus 201 p~Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~-~pf~~~~ 279 (301)
|+|||++.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++|. +||.+.+
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999987654444333334567899999999999999999999999999999999985 6787765
Q ss_pred Cc
Q 022206 280 PR 281 (301)
Q Consensus 280 ~~ 281 (301)
+.
T Consensus 248 ~~ 249 (301)
T d1lufa_ 248 HE 249 (301)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.8e-48 Score=328.44 Aligned_cols=201 Identities=24% Similarity=0.372 Sum_probs=172.2
Q ss_pred CCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEec
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
++|++++.||+|+||+||+|++++++.||||++...... ...+.+|+.+|++++||||+++++++.+++..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 689999999999999999999999999999999764332 46789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
+.++.+..+..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~~~~~~~~~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~ 149 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG---------GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA 149 (286)
T ss_dssp CSEEHHHHHHTSTT---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred ehhhhHHHHHhhcC---------CcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEeccccccee
Confidence 99877777765443 2899999999999999999999999 99999999999999999999999999866
Q ss_pred CCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 223 APDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
...... ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.++
T Consensus 150 ~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~ 206 (286)
T d1ob3a_ 150 FGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (286)
T ss_dssp HCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH
Confidence 443222 12344689999999998764 568999999999999999999999976543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=324.48 Aligned_cols=200 Identities=32% Similarity=0.515 Sum_probs=166.7
Q ss_pred hCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEc-CCeeEEEEecC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD-GPLRVLAYEHA 143 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~ 143 (301)
.++|++.+.||+|+||.||+|+++ |..||||+++.+. ..+.+.+|++++++++||||+++++++.+ .+.+++||||+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 457889999999999999999986 7899999997643 45679999999999999999999999865 45689999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
++|+|.+++...... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~g~L~~~l~~~~~~-------~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 84 AKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp TTEEHHHHHHHHHHH-------HCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceec
Confidence 999999999654311 2789999999999999999999999 999999999999999999999999999765
Q ss_pred CccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCc
Q 022206 224 PDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (301)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~ 281 (301)
.... ....+|+.|+|||++.+..++.++|||||||++|||+| |++||...+..
T Consensus 154 ~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~ 207 (262)
T d1byga_ 154 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 207 (262)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred CCCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH
Confidence 4322 33467899999999999999999999999999999998 78998766543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=326.85 Aligned_cols=202 Identities=23% Similarity=0.357 Sum_probs=169.5
Q ss_pred hCCCCCCceecccCceEEEEEEEC-C-CCEEEEEEcCCCC---CchHHHHHHHHHHhcc---CCCceeeeeeEEEc----
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-S-GRAAAIKKLDSSK---QPDQEFLAQVSMVSRL---KNENVVELVGYYVD---- 132 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~---~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~---- 132 (301)
.++|++++.||+|+||+||+|++. + ++.||||++.... .....+.+|+.+++.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999985 4 5679999985422 2233466777776665 79999999999853
Q ss_pred -CCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCc
Q 022206 133 -GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDI 211 (301)
Q Consensus 133 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 211 (301)
....+++||++.++++......... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~ 154 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEP--------GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ 154 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCC
Confidence 3468999999998777655443322 2889999999999999999999999 999999999999999999
Q ss_pred eEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 212 AKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 212 vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+||+|||++......... ....||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.++
T Consensus 155 ~kl~dfg~~~~~~~~~~~---~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~ 220 (305)
T d1blxa_ 155 IKLADFGLARIYSFQMAL---TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220 (305)
T ss_dssp EEECSCCSCCCCCGGGGG---CCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eeecchhhhhhhcccccC---CCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH
Confidence 999999998776544332 566899999999999999999999999999999999999999987654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=326.16 Aligned_cols=218 Identities=22% Similarity=0.354 Sum_probs=168.1
Q ss_pred HHHHhhCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhcc-CCCceeeeeeEE
Q 022206 60 ELKEKTDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYY 130 (301)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~ 130 (301)
++....++|++.+.||+|+||.||+|++. +++.||||+++..... ...+.+|...+.++ +|+||+.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 33334478999999999999999999964 2468999998754433 34567777777776 689999999987
Q ss_pred Ec-CCeeEEEEecCCCCCHHHHhcCCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCC
Q 022206 131 VD-GPLRVLAYEHASKGSLHDILHGKKGVKG-------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSS 202 (301)
Q Consensus 131 ~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~ 202 (301)
.+ +..+++|||||++|+|.+++........ ......+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcc
Confidence 65 4568999999999999999975432110 011234889999999999999999999999 999999999
Q ss_pred ceEEcCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhC-CCCCCCCCC
Q 022206 203 NVLLFDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG-RKPVDHTLP 280 (301)
Q Consensus 203 Nill~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g-~~pf~~~~~ 280 (301)
|||+++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+|| .+||.+...
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999876554443334556799999999999999999999999999999999986 578876543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=324.25 Aligned_cols=214 Identities=29% Similarity=0.431 Sum_probs=176.5
Q ss_pred hCCCCCCceecccCceEEEEEEECC--------CCEEEEEEcCCCCCc--hHHHHHHHHHHhcc-CCCceeeeeeEEEcC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLRS--------GRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDG 133 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 133 (301)
.++|++++.||+|+||.||+|+... +..||||+++..... ..++.+|...+.++ +||||+++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4689999999999999999998642 247999999766543 35688888888888 799999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhcCCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEE
Q 022206 134 PLRVLAYEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (301)
Q Consensus 134 ~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill 206 (301)
+..++||||+++|+|.+++....... .......+++..++.++.||+.||+|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 99999999999999999997654211 1122345899999999999999999999999 9999999999999
Q ss_pred cCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCCc
Q 022206 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLPR 281 (301)
Q Consensus 207 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~~ 281 (301)
+.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |.+||.+.+..
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 9999999999999987765544433455678999999999999999999999999999999998 79999766543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=324.03 Aligned_cols=204 Identities=30% Similarity=0.453 Sum_probs=164.2
Q ss_pred hCCCCCCceecccCceEEEEEEEC--CC--CEEEEEEcCCCCC----chHHHHHHHHHHhccCCCceeeeeeEEEcCCee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR--SG--RAAAIKKLDSSKQ----PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 136 (301)
.++|++.+.||+|+||.||+|++. ++ ..||||++.+... ..+.+.+|+.+|++++||||+++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 357999999999999999999854 23 3789999875432 23568999999999999999999999965 467
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEec
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISD 216 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 216 (301)
++||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~D 154 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGD 154 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECC
T ss_pred heeeeeecCcchhhhhhcccC--------CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeecc
Confidence 899999999999998865432 2899999999999999999999999 99999999999999999999999
Q ss_pred cccCCCCCccccc-cccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 217 FDLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 217 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
||+++........ .......|++.|+|||++.+..++.++||||||+++|||+| |+.||.+.+.
T Consensus 155 fGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~ 220 (273)
T d1u46a_ 155 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 220 (273)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred chhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH
Confidence 9999876544322 22234457889999999999999999999999999999998 8999986654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-47 Score=323.91 Aligned_cols=209 Identities=28% Similarity=0.438 Sum_probs=171.5
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCC--EEEEEEcCCC--CCchHHHHHHHHHHhcc-CCCceeeeeeEEEcCCeeEEE
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGR--AAAIKKLDSS--KQPDQEFLAQVSMVSRL-KNENVVELVGYYVDGPLRVLA 139 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 139 (301)
++|++.+.||+|+||+||+|+++ ++. .||||.+... ....+.+.+|+++|+++ +||||+++++++.+++.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 67889999999999999999976 454 4778877532 22345789999999998 799999999999999999999
Q ss_pred EecCCCCCHHHHhcCCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCce
Q 022206 140 YEHASKGSLHDILHGKKGVK-------GAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (301)
|||+++|+|.+++....... .......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 99999999999997542100 0011234899999999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCC-CCCCCCCC
Q 022206 213 KISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGR-KPVDHTLP 280 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~-~pf~~~~~ 280 (301)
||+|||+++........ ....||+.|+|||.+.+..++.++|||||||++|||++|. +||.+.+.
T Consensus 167 kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~ 232 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 232 (309)
T ss_dssp EECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred EEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH
Confidence 99999998765543322 3446899999999999999999999999999999999965 67876554
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=325.41 Aligned_cols=200 Identities=26% Similarity=0.349 Sum_probs=163.7
Q ss_pred CCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEcCC----eeEEEEe
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVDGP----LRVLAYE 141 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e 141 (301)
.+|.+.+.||+|+||.||+|++. |+.||||+++.+.........|+..+..++||||+++++++.+.+ .+++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 46778899999999999999975 789999999754333223344555567789999999999988654 5799999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh--------CCCCCeEecCCCCCceEEcCCCceE
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE--------KAEPRIIHRNIKSSNVLLFDDDIAK 213 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--------~~~~~ivH~Dlkp~Nill~~~~~vk 213 (301)
|+++|+|.++++... +++..++.++.|++.||.|||+ ++ |+||||||+||||+.++.+|
T Consensus 82 y~~~g~L~~~l~~~~----------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~---IvHrDlKp~NILl~~~~~~K 148 (303)
T d1vjya_ 82 YHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCC 148 (303)
T ss_dssp CCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred cccCCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---eeccccCccceEEcCCCCeE
Confidence 999999999998654 8899999999999999999997 46 99999999999999999999
Q ss_pred EeccccCCCCCccccc--cccccccccccccCccccccCC------CCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 214 ISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTGQ------MSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 214 l~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|+|||++......... .......||+.|+|||++.+.. ++.++|||||||++|||+||..||....
T Consensus 149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~ 222 (303)
T d1vjya_ 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence 9999998765433221 1224567999999999987643 5678999999999999999999886543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.7e-46 Score=318.82 Aligned_cols=205 Identities=20% Similarity=0.255 Sum_probs=175.4
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCC-CceeeeeeEEEcCCeeEEEEec
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGPLRVLAYEH 142 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~ 142 (301)
.++|++++.||+|+||+||+|++. +++.||||++.... ....+.+|++.++.|+| +|++.+++++.++...++||||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 468999999999999999999987 78999999986543 23457788999999976 8999999999999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC-----CCceEEecc
Q 022206 143 ASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD-----DDIAKISDF 217 (301)
Q Consensus 143 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~vkl~Df 217 (301)
+ +++|.+++..... .++...+..++.|++.||+|||++| |+||||||+|||++. ++.+||+||
T Consensus 83 ~-~~~l~~~~~~~~~--------~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DF 150 (293)
T d1csna_ 83 L-GPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDF 150 (293)
T ss_dssp C-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred c-CCCHHHHHHhhcc--------chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEccc
Confidence 9 5799999876442 2899999999999999999999999 999999999999974 578999999
Q ss_pred ccCCCCCccccc-----cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCcC
Q 022206 218 DLSNQAPDAAAR-----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPRG 282 (301)
Q Consensus 218 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~ 282 (301)
|+|+........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~ 220 (293)
T d1csna_ 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220 (293)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC
T ss_pred ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh
Confidence 999765433211 11235679999999999999999999999999999999999999998765543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=325.03 Aligned_cols=203 Identities=27% Similarity=0.354 Sum_probs=169.1
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEcCC----eeE
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVDGP----LRV 137 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~ 137 (301)
..+|++++.||+|+||+||+|+++ +|+.||||++.+.... .+.+.+|+.+|+.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 457999999999999999999986 8999999999765433 356889999999999999999999987543 234
Q ss_pred EEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEecc
Q 022206 138 LAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDF 217 (301)
Q Consensus 138 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 217 (301)
++++++.+|+|.+++.... +++..++.++.|++.||+|||++| |+||||||+|||+++++.+||+||
T Consensus 87 ~l~~~~~~g~L~~~l~~~~----------l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~Df 153 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDF 153 (345)
T ss_dssp EEEEECCCEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEeecCCchhhhhhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEccc
Confidence 5556677899999997543 899999999999999999999999 999999999999999999999999
Q ss_pred ccCCCCCccccc-cccccccccccccCccccc-cCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 218 DLSNQAPDAAAR-LHSTRVLGTFGYHAPEYAM-TGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 218 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
|++......... ......+||+.|+|||++. ...++.++||||+||++|+|++|+.||.+.+.
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~ 218 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH
Confidence 999766443322 1234567999999999885 45678999999999999999999999976543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=321.65 Aligned_cols=213 Identities=23% Similarity=0.376 Sum_probs=179.7
Q ss_pred hCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCc--hHHHHHHHHHHhcc-CCCceeeeeeEEEcCCe
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQP--DQEFLAQVSMVSRL-KNENVVELVGYYVDGPL 135 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 135 (301)
.++|++.+.||+|+||.||+|++. +++.||||+++..... ...+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 368999999999999999999852 4678999999765543 34688999999999 69999999999999999
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEE
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKG---------AKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLL 206 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~---------~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill 206 (301)
.+++||||++|+|.+++........ ......+++..+..++.||+.||+|||+++ ++||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 9999999999999999976542111 112234889999999999999999999999 9999999999999
Q ss_pred cCCCceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 022206 207 FDDDIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLT-GRKPVDHTLP 280 (301)
Q Consensus 207 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~pf~~~~~ 280 (301)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |.+||.....
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999988765444434455678999999999999999999999999999999999 6666765544
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=325.39 Aligned_cols=197 Identities=26% Similarity=0.382 Sum_probs=166.8
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCc---hHHHHHHHHHHhccCCCceeeeeeEEEcCC------
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQP---DQEFLAQVSMVSRLKNENVVELVGYYVDGP------ 134 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 134 (301)
.++|++++.||+|+||+||+|+++ +|+.||||++++.... .+.+.+|+++|+.++||||+++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 578999999999999999999987 7999999999765443 246789999999999999999999998654
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
.+++||||+ +.+|..+++... +++..++.++.||+.||+|||++| |+||||||+|||++.++.+||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~~----------l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl 162 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHEK----------LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKI 162 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecc-cccHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccc
Confidence 469999999 568888876543 899999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+|||+|....... +...||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.
T Consensus 163 ~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~ 224 (346)
T d1cm8a_ 163 LDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224 (346)
T ss_dssp CCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh
Confidence 9999997654322 456789999999998764 568999999999999999999999977643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=321.83 Aligned_cols=204 Identities=22% Similarity=0.339 Sum_probs=168.5
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEc--------
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVD-------- 132 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 132 (301)
.++|++++.||+|+||+||+|+++ +|+.||||++..... ....+.+|+++|+.++|+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999986 799999999865433 23668899999999999999999998865
Q ss_pred CCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCce
Q 022206 133 GPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIA 212 (301)
Q Consensus 133 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~v 212 (301)
+...+++||++.++.+..+..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~---------~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV---------KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred CceEEEEEeccCCCccchhhhccc---------ccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcE
Confidence 346899999998876665544332 2889999999999999999999999 9999999999999999999
Q ss_pred EEeccccCCCCCccccc--cccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 213 KISDFDLSNQAPDAAAR--LHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 213 kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
||+|||++......... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.++
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~ 227 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 227 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH
Confidence 99999999765433221 112345799999999998765 689999999999999999999999986554
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=324.59 Aligned_cols=207 Identities=24% Similarity=0.343 Sum_probs=177.2
Q ss_pred hCCCCCCceecccCceEEEEEEEC----CCCEEEEEEcCCCC-----CchHHHHHHHHHHhccCC-CceeeeeeEEEcCC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR----SGRAAAIKKLDSSK-----QPDQEFLAQVSMVSRLKN-ENVVELVGYYVDGP 134 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~ 134 (301)
.++|++++.||+|+||+||+|++. +|+.||||++++.. ...+.+.+|++++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 467999999999999999999863 47899999986432 234567889999999977 89999999999999
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
..+++|||+.+|+|.+++..... +++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~---------~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL 170 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRER---------FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVL 170 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEE
T ss_pred ceeeeeecccccHHHHHHHhccc---------ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEE
Confidence 99999999999999999976543 788999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccccccccccccccccccCccccccC--CCCccccchhhHHHHHHHHhCCCCCCCCCCcCcc
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG--QMSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQ 284 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~pf~~~~~~~~~ 284 (301)
+|||++.......... .....|++.|+|||.+.+. .++.++|||||||+||+|++|+.||.+.+.....
T Consensus 171 ~DFG~a~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~ 241 (322)
T d1vzoa_ 171 TDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ 241 (322)
T ss_dssp SCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH
T ss_pred eeccchhhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999997665433321 2445799999999998764 4678999999999999999999999877655443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=322.77 Aligned_cols=213 Identities=25% Similarity=0.406 Sum_probs=179.9
Q ss_pred hCCCCCCceecccCceEEEEEEEC------CCCEEEEEEcCCCCCch--HHHHHHHHHHhccCCCceeeeeeEEEcCCee
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR------SGRAAAIKKLDSSKQPD--QEFLAQVSMVSRLKNENVVELVGYYVDGPLR 136 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 136 (301)
.++|++.+.||+|+||.||+|.++ ++..||||+++...... ..+.+|++++++++||||+++++++..+...
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 468899999999999999999864 25789999997654333 3578999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhcCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 137 VLAYEHASKGSLHDILHGKKGV-KGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
++||||+++|+|.+++...... ........+++..+..++.|++.||.|||+++ |+||||||+|||++.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999999998643210 00011123788999999999999999999998 9999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhC-CCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTG-RKPVDHTLP 280 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g-~~pf~~~~~ 280 (301)
|||+++...............||+.|+|||.+.+..++.++||||||+++|||+|| .+||.+.+.
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~ 241 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH
Confidence 99999877655544444556789999999999999999999999999999999997 588876554
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=314.10 Aligned_cols=197 Identities=25% Similarity=0.408 Sum_probs=167.0
Q ss_pred CceecccCceEEEEEEECC----CCEEEEEEcCCCCCc--hHHHHHHHHHHhccCCCceeeeeeEEEc-CCeeEEEEecC
Q 022206 71 NSLIGEGSYGRVYFGVLRS----GRAAAIKKLDSSKQP--DQEFLAQVSMVSRLKNENVVELVGYYVD-GPLRVLAYEHA 143 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~ 143 (301)
.++||+|+||+||+|++.. ...||||+++..... ..++.+|+++|++++||||+++++++.+ +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5689999999999999752 235899998754333 3568999999999999999999999765 56899999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCCCC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQA 223 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~~ 223 (301)
++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 112 ~~g~l~~~~~~~~~--------~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 180 (311)
T ss_dssp TTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred ecCchhhhhccccc--------cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhc
Confidence 99999999876543 2678889999999999999999999 999999999999999999999999999876
Q ss_pred Cccccc--cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 022206 224 PDAAAR--LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHT 278 (301)
Q Consensus 224 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~ 278 (301)
...... .......||+.|+|||.+....++.++||||||+++|||+||..||...
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred cccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 543322 1123356899999999999999999999999999999999977777543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=322.90 Aligned_cols=199 Identities=27% Similarity=0.345 Sum_probs=164.6
Q ss_pred CCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCceeeeeeEEEc------CCeeEEE
Q 022206 67 NFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVVELVGYYVD------GPLRVLA 139 (301)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~lv 139 (301)
+|+.+++||+|+||+||+|+++ +++.||||++..+... ..+|+++|++++|+||+++++++.. ...+++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 6889999999999999999987 7999999999765433 3469999999999999999999853 3357899
Q ss_pred EecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC-ceEEeccc
Q 022206 140 YEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFD 218 (301)
Q Consensus 140 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg 218 (301)
||||+++.+..+...... ...+++..+..++.||+.||+|||++| |+||||||+|||++.++ .+||+|||
T Consensus 98 ~Ey~~~~~~~~l~~~~~~------~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG 168 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRA------KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG 168 (350)
T ss_dssp EECCSEEHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCT
T ss_pred EeccCCccHHHHHhhhhc------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEeccc
Confidence 999987644443321110 123899999999999999999999999 99999999999999765 89999999
Q ss_pred cCCCCCccccccccccccccccccCcccccc-CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 219 LSNQAPDAAARLHSTRVLGTFGYHAPEYAMT-GQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 219 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
++......... ....||+.|+|||.+.+ ..++.++|||||||++|||++|++||...+.
T Consensus 169 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~ 228 (350)
T d1q5ka_ 169 SAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228 (350)
T ss_dssp TCEECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred chhhccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH
Confidence 98766443322 44579999999998765 5789999999999999999999999976553
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.2e-45 Score=318.41 Aligned_cols=194 Identities=18% Similarity=0.330 Sum_probs=169.0
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccC-CCceeeeeeEEEc--CCeeEEEEe
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-NENVVELVGYYVD--GPLRVLAYE 141 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e 141 (301)
++|++++.||+|+||+||+|+++ +++.||||+++.. ....+.+|+.+|+.++ ||||+++++++.. ...+++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 57999999999999999999986 7999999998754 3567889999999995 9999999999874 456899999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCC-ceEEeccccC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDD-IAKISDFDLS 220 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~Dfg~a 220 (301)
||.+++|.++... +++..+..++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+|
T Consensus 113 ~~~~~~L~~~~~~------------l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a 177 (328)
T d3bqca1 113 HVNNTDFKQLYQT------------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLA 177 (328)
T ss_dssp CCCSCBGGGTTTS------------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGC
T ss_pred ecCCCcHHHHhcC------------CCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccc
Confidence 9999999876432 899999999999999999999999 99999999999998654 6999999999
Q ss_pred CCCCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 221 NQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
........ .....+|+.|+|||.+.+. .++.++|||||||++|+|++|+.||....
T Consensus 178 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 178 EFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp EECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred eeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 76654332 2456789999999998765 57999999999999999999999997654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-45 Score=310.04 Aligned_cols=198 Identities=20% Similarity=0.327 Sum_probs=173.4
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCC---chHHHHHHHHHHhccCCCceeeeeeEEEcCCeeEEEEe
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQ---PDQEFLAQVSMVSRLKNENVVELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 141 (301)
++|++++.||+|+||+||+|++. +++.||||+++.... ....+.+|+.+++.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999987 789999999865433 24678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEeccccCC
Q 022206 142 HASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKISDFDLSN 221 (301)
Q Consensus 142 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~ 221 (301)
++.+++|..++..... +++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+.
T Consensus 82 ~~~~~~l~~~~~~~~~---------~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~ 149 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGD---------LDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp CCSEEHHHHHHHTTTC---------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eccccccccccccccc---------cchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhh
Confidence 9999999888876543 889999999999999999999999 9999999999999999999999999997
Q ss_pred CCCccccccccccccccccccCccccccCC-CCccccchhhHHHHHHHHhCCCCCCC
Q 022206 222 QAPDAAARLHSTRVLGTFGYHAPEYAMTGQ-MSSKSDVYSFGVVLLELLTGRKPVDH 277 (301)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~pf~~ 277 (301)
........ .....+++.|+|||++.... ++.++|||||||++|+|++|+.||..
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 150 AFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp ECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred cccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 76543322 13345788899999887654 68999999999999999999998743
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-45 Score=318.77 Aligned_cols=197 Identities=29% Similarity=0.428 Sum_probs=168.1
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch---HHHHHHHHHHhccCCCceeeeeeEEEcC-----Ce
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVDG-----PL 135 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 135 (301)
.++|++++.||+|+||+||+|++. +|+.||||++.+..... ..+.+|+++|+.++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999986 79999999998654433 4578999999999999999999998633 34
Q ss_pred eEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEEe
Q 022206 136 RVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKIS 215 (301)
Q Consensus 136 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 215 (301)
.+++++++.+|+|.+++..+. +++..+..++.||+.||+|||++| |+||||||+|||++.++.+|++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~~----------l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~ 163 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL 163 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred eEEEEEeecCCchhhhccccc----------ccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCcccccccccccccc
Confidence 466778888999999997543 899999999999999999999999 9999999999999999999999
Q ss_pred ccccCCCCCccccccccccccccccccCccccccC-CCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 216 DFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTG-QMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 216 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
|||++....... ....||+.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+
T Consensus 164 dfg~a~~~~~~~-----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 164 DFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp CC----CCTGGG-----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccchhcccCccc-----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 999987664432 445789999999987765 46889999999999999999999997654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-44 Score=310.14 Aligned_cols=203 Identities=23% Similarity=0.319 Sum_probs=167.6
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCcee-eeeeEEEcCCeeEEEEecC
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENVV-ELVGYYVDGPLRVLAYEHA 143 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~ 143 (301)
++|++++.||+|+||+||+|++. +++.||||++..... ...+.+|+++++.++|+|++ .+..++.+++..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 57999999999999999999986 789999999865433 34578899999999877654 5556667888999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcC---CCceEEeccccC
Q 022206 144 SKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFD---DDIAKISDFDLS 220 (301)
Q Consensus 144 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~vkl~Dfg~a 220 (301)
.+ +|.+.+..... .+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+|
T Consensus 86 ~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 86 GP-SLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp CC-BHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred CC-chhhhhhhccC--------CCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcc
Confidence 55 67666654332 2899999999999999999999999 999999999999864 457999999999
Q ss_pred CCCCccccc-----cccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCCc
Q 022206 221 NQAPDAAAR-----LHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLPR 281 (301)
Q Consensus 221 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~~ 281 (301)
+........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~ 219 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchH
Confidence 876543221 1224557999999999999999999999999999999999999999876543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-45 Score=317.67 Aligned_cols=198 Identities=22% Similarity=0.263 Sum_probs=161.9
Q ss_pred hCCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCch---HHHHHHHHHHhccCCCceeeeeeEEEc------CC
Q 022206 65 TDNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPD---QEFLAQVSMVSRLKNENVVELVGYYVD------GP 134 (301)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~ 134 (301)
.++|+++++||+|+||+||+|+++ +|+.||||++....... ..+.+|+.++++++||||+++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 478999999999999999999987 79999999997654433 457899999999999999999999864 36
Q ss_pred eeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCCCceEE
Q 022206 135 LRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDDDIAKI 214 (301)
Q Consensus 135 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 214 (301)
.+|+|||||.++.+ +.+.. .+++..++.++.|++.||.|||++| |+||||||+|||++.++.+|+
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~~-----------~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp EEEEEEECCSEEHH-HHHTS-----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEE
T ss_pred eeEEEEeccchHHH-Hhhhc-----------CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceee
Confidence 78999999987544 44432 1889999999999999999999999 999999999999999999999
Q ss_pred eccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 022206 215 SDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTLP 280 (301)
Q Consensus 215 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~~ 280 (301)
+|||++......... ....+|+.|+|||++.+..++.++||||+||++|+|++|++||.+.+.
T Consensus 161 ~df~~~~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~ 223 (355)
T d2b1pa1 161 LDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223 (355)
T ss_dssp CCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred echhhhhcccccccc---ccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH
Confidence 999998766544322 455789999999999999999999999999999999999999976653
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-39 Score=284.05 Aligned_cols=199 Identities=19% Similarity=0.261 Sum_probs=159.7
Q ss_pred CCCCCCceecccCceEEEEEEEC-CCCEEEEEEcCCCCCchHHHHHHHHHHhccC-----------CCceeeeeeEEEc-
Q 022206 66 DNFGTNSLIGEGSYGRVYFGVLR-SGRAAAIKKLDSSKQPDQEFLAQVSMVSRLK-----------NENVVELVGYYVD- 132 (301)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~- 132 (301)
++|+++++||+|+||+||+|+++ +|+.||||++++.....+...+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 46999999999999999999986 7999999999876555567888999888775 4789999988764
Q ss_pred -CCeeEEEEecCCCCC-HHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCCCCeEecCCCCCceEEcCC
Q 022206 133 -GPLRVLAYEHASKGS-LHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHE-KAEPRIIHRNIKSSNVLLFDD 209 (301)
Q Consensus 133 -~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~ 209 (301)
....+++++++..+. .......... ..+++..+..++.|++.||+|||+ .| |+||||||+|||++.+
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEH-------RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIV 162 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEE
T ss_pred cccceeeeeeecccccccccccccccc-------cCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeecc
Confidence 345666666665443 3333322221 238889999999999999999997 88 9999999999999866
Q ss_pred C------ceEEeccccCCCCCccccccccccccccccccCccccccCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 022206 210 D------IAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPEYAMTGQMSSKSDVYSFGVVLLELLTGRKPVDHTL 279 (301)
Q Consensus 210 ~------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~pf~~~~ 279 (301)
+ .++++|||.+...... .....||+.|+|||++....++.++|+||+||++++|++|+.||....
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 5 4999999998654432 245679999999999999999999999999999999999999997654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.95 E-value=2e-28 Score=194.93 Aligned_cols=162 Identities=14% Similarity=0.115 Sum_probs=118.3
Q ss_pred CCCceecccCceEEEEEEECCCCEEEEEEcCCCCCc-------------------hHHHHHHHHHHhccCCCceeeeeeE
Q 022206 69 GTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSKQP-------------------DQEFLAQVSMVSRLKNENVVELVGY 129 (301)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------------------~~~~~~e~~~l~~l~h~~iv~~~~~ 129 (301)
.+.+.||+|+||.||+|++.+|+.||||++...... .....+|+..+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 467899999999999999988999999987532110 1223467888999999999888765
Q ss_pred EEcCCeeEEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCCCCeEecCCCCCceEEcCC
Q 022206 130 YVDGPLRVLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKAEPRIIHRNIKSSNVLLFDD 209 (301)
Q Consensus 130 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 209 (301)
. ..+++|||+++..+.+ ++......++.|++.+|.|||++| |+||||||+|||++++
T Consensus 83 ~----~~~lvme~~~~~~~~~----------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~ 139 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE 139 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT
T ss_pred c----CCEEEEEeeccccccc----------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC
Confidence 3 2379999999865543 223345678999999999999999 9999999999999865
Q ss_pred CceEEeccccCCCCCccccccccccccccccccCcc-----ccccCCCCccccchhhHHH
Q 022206 210 DIAKISDFDLSNQAPDAAARLHSTRVLGTFGYHAPE-----YAMTGQMSSKSDVYSFGVV 264 (301)
Q Consensus 210 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~DvwslG~i 264 (301)
+ ++|+|||+|......... .|.... .+..+.|+.++|+||+.--
T Consensus 140 ~-~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 140 G-IWIIDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp E-EEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred C-EEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 5 899999998665432211 111110 0123567889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.07 E-value=4.4e-10 Score=91.85 Aligned_cols=149 Identities=17% Similarity=0.130 Sum_probs=103.7
Q ss_pred HHHHHhhCCCCCCceecccCceEEEEEEECCCCEEEEEEcCCCC-CchHHHHHHHHHHhccC-CCceeeeeeEEEcCCee
Q 022206 59 DELKEKTDNFGTNSLIGEGSYGRVYFGVLRSGRAAAIKKLDSSK-QPDQEFLAQVSMVSRLK-NENVVELVGYYVDGPLR 136 (301)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 136 (301)
.++......|+..+..+-++.+.||+.... ++.+++|...... .....+.+|...++.+. +-.+.+++.+..+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 355666778887777666666889988644 6677888775432 23345778888887774 33467788888888899
Q ss_pred EEEEecCCCCCHHHHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--------------------------
Q 022206 137 VLAYEHASKGSLHDILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA-------------------------- 190 (301)
Q Consensus 137 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-------------------------- 190 (301)
++||++++|.++.+...... ....++.++...+..||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~--------------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQ--------------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA 151 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCS--------------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred EEEEEecccccccccccccc--------------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhh
Confidence 99999999988876543211 12234555566666666421
Q ss_pred ------------------------------CCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 191 ------------------------------EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 191 ------------------------------~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11278999999999998876677999998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.76 E-value=1.1e-08 Score=82.82 Aligned_cols=131 Identities=13% Similarity=0.041 Sum_probs=87.8
Q ss_pred eecccCc-eEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCC--CceeeeeeEEEcCCeeEEEEecCCCCCHH
Q 022206 73 LIGEGSY-GRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKN--ENVVELVGYYVDGPLRVLAYEHASKGSLH 149 (301)
Q Consensus 73 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~gsL~ 149 (301)
.+..|.. +.||+....++..+++|...... ...+..|...++.+.. -.+.+++.+..+++..+++|++++|.++.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 4455543 67999998888889999865443 3346778888877754 33567788878888899999999986653
Q ss_pred HHhcCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC---------------------------------------
Q 022206 150 DILHGKKGVKGAKPGPVLSWAQRVKIAVGAARGLEYLHEKA--------------------------------------- 190 (301)
Q Consensus 150 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--------------------------------------- 190 (301)
+.. .... .++.++...|..||...
T Consensus 95 ~~~--------------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
T d1nd4a_ 95 SSH--------------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 157 (255)
T ss_dssp TSC--------------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred ccc--------------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhH
Confidence 311 1111 12233344444444211
Q ss_pred ----------------CCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 191 ----------------EPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 191 ----------------~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 158 ~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 158 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 12379999999999999877678999997643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.43 E-value=8.2e-07 Score=76.40 Aligned_cols=75 Identities=20% Similarity=0.098 Sum_probs=48.8
Q ss_pred CceecccCceEEEEEEEC-CCCEEEEEEcCC--------CCCchHHHHHHHHHHhccC-C--CceeeeeeEEEcCCeeEE
Q 022206 71 NSLIGEGSYGRVYFGVLR-SGRAAAIKKLDS--------SKQPDQEFLAQVSMVSRLK-N--ENVVELVGYYVDGPLRVL 138 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--------~~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~~~~~l 138 (301)
.+.||.|....||++... +++.+++|.-.. ......+...|...|+.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 457899999999999876 477899996421 1122344566888777663 2 345555543 4556789
Q ss_pred EEecCCCCC
Q 022206 139 AYEHASKGS 147 (301)
Q Consensus 139 v~e~~~~gs 147 (301)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.10 E-value=8.7e-06 Score=67.97 Aligned_cols=70 Identities=14% Similarity=0.112 Sum_probs=50.5
Q ss_pred cCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCce--eeee-----eEEEcCCeeEEEEecCCCC
Q 022206 77 GSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV--VELV-----GYYVDGPLRVLAYEHASKG 146 (301)
Q Consensus 77 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~-----~~~~~~~~~~lv~e~~~~g 146 (301)
+....||++...+|..+++|+.........++..|...+..|....+ +..+ ..+..++..+.+++++.|.
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 33578999999999999999988776677888889988888753222 2111 1234466788899999873
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.83 E-value=3.7e-05 Score=65.82 Aligned_cols=73 Identities=14% Similarity=0.165 Sum_probs=49.9
Q ss_pred CceecccCceEEEEEEECC--------CCEEEEEEcCCCCCchHHHHHHHHHHhccCCCce-eeeeeEEEcCCeeEEEEe
Q 022206 71 NSLIGEGSYGRVYFGVLRS--------GRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV-VELVGYYVDGPLRVLAYE 141 (301)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e 141 (301)
++.|+.|-...+|++...+ .+.|++++.-. ........+|..+++.+...++ .++++++.+ .+|+|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4678889999999998653 34677777653 3334556688888888854344 466666532 57899
Q ss_pred cCCCCCH
Q 022206 142 HASKGSL 148 (301)
Q Consensus 142 ~~~~gsL 148 (301)
|++|.+|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.71 E-value=5.1e-05 Score=62.72 Aligned_cols=164 Identities=15% Similarity=0.158 Sum_probs=84.7
Q ss_pred cCHHHHHHhhCCCCCCcee-----cccCceEEEEEEECCCCEEEEEEcCCCCCchHHHHHHHHHHhccCCCce--eeeee
Q 022206 56 ISVDELKEKTDNFGTNSLI-----GEGSYGRVYFGVLRSGRAAAIKKLDSSKQPDQEFLAQVSMVSRLKNENV--VELVG 128 (301)
Q Consensus 56 ~~~~~~~~~~~~y~~~~~l-----g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~~ 128 (301)
.+..++.....+|.+.+.. ..|--.+.|++...+| .+++|+.... ....++..|+.++..|...++ ...+.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccce
Confidence 3566777888889886554 3566688999987754 5899988653 233456667777777643221 11111
Q ss_pred ------EEEcCCeeEEEEecCCCCCHHH--------------Hhc-CCCCCCCCCCCCCCCHH-----------------
Q 022206 129 ------YYVDGPLRVLAYEHASKGSLHD--------------ILH-GKKGVKGAKPGPVLSWA----------------- 170 (301)
Q Consensus 129 ------~~~~~~~~~lv~e~~~~gsL~~--------------~l~-~~~~~~~~~~~~~l~~~----------------- 170 (301)
+.........++.+..+..... .++ ............ ....
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNA-LSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCT-TSHHHHHHHHHHHGGGGGGTS
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccc-cchhhcchhhhHHHHhhhhcc
Confidence 1222345566666666532211 000 000000000000 0000
Q ss_pred -HHHHHHHHHHHHHHHhhhC-CCCCeEecCCCCCceEEcCCCceEEeccccCCC
Q 022206 171 -QRVKIAVGAARGLEYLHEK-AEPRIIHRNIKSSNVLLFDDDIAKISDFDLSNQ 222 (301)
Q Consensus 171 -~~~~i~~qi~~~l~~LH~~-~~~~ivH~Dlkp~Nill~~~~~vkl~Dfg~a~~ 222 (301)
.....+..+...+...+.. -...+||+|+.++||+++.+...-|+||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 0111222222333332221 112399999999999999887778999998754
|